Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,regulation of immune response (GO:0050776),0.6695585494168567,2.1718795435443314,0.0,0.0009947695250614181,0.001,40/135,9.72%,ITGB7;JAML;ITGA4;FGR;ITGAL;SLAMF7;CD300E;KLRD1;FOXP1;CD300C;CD226;LYN;TREML4;PTPN22;SAMHD1;LILRB1;CD40;SYK;BCL6;PLSCR1;CD300A;DHX58;PILRA;SELL;CD300LG;KLRK1;BIRC3;SPN;ITGB2;IRF4;CD276;DENND1B;TIRAP;AHR;TRAF3;CLEC2D;SPPL2A;ICAM1;CD300LD;IRF7
prerank,positive regulation of immune effector process (GO:0002699),0.797222082049605,2.055610054222177,0.0,0.008455540963022055,0.016,6/27,3.27%,CCR2;PTPRC;IL1B;LILRB1;DHX58;ANKRD17
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),0.8259151875079865,2.00820674847639,0.0,0.01823744129279267,0.049,8/21,2.88%,CARD11;PTPRC;FOXP1;TESPA1;CD226;STAP1;NFAM1;PRKCH
prerank,leukocyte cell-cell adhesion (GO:0007159),0.8001880682728356,2.0028912648368564,0.0,0.015418927638451983,0.056,11/24,9.14%,ITGA4;ITGAL;PECAM1;SYK;MSN;CD177;OLR1;ITGB2;F11R;EZR;ICAM1
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),0.7146587481555582,1.9981709594793529,0.0,0.013528865540835289,0.06,17/45,10.76%,CIITA;CD44;SP100;HCK;IFNGR1;OAS2;JAK2;TRIM26;TRIM62;IRF2;STAT1;IRF4;OASL;TRIM25;ICAM1;IRF7;B2M
prerank,T cell activation (GO:0042110),0.6613475764191554,1.993129485424209,0.0,0.013097798746642008,0.07,13/69,5.71%,CD74;DPP4;JAML;CD44;PTPRC;LCP1;PTPN22;MSN;LFNG;ZAP70;PPP3CA;IRF4;CD276
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),0.8793002949099529,1.9875226034924378,0.0,0.013642553486556595,0.081,4/16,1.35%,PTPRC;KLRD1;CYRIB;LILRB1
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),0.92966392356803,1.9863866185809294,0.0,0.01231027287263505,0.084,5/10,1.72%,BTLA;FGR;LYN;LILRB1;CD40
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.6581539336120131,1.9781384880130009,0.0,0.013263593667485576,0.1,26/70,10.64%,FGR;MYO1G;VAV3;HCK;LYN;PRKCE;WIPF1;ACTR3;PLCG2;FYN;SYK;PAK1;WASF2;CRK;MYO1C;ABI1;CDC42;ELMO2;GRB2;ACTR2;WIPF3;RAC1;ARPC1B;ARPC2;ARPC4;PIK3CA
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.6500092637446142,1.9670091404223655,0.0,0.015916312400982693,0.126,26/73,10.64%,FGR;MYO1G;VAV3;HCK;LYN;PRKCE;WIPF1;ACTR3;PLCG2;FYN;SYK;PAK1;WASF2;CRK;MYO1C;ABI1;CDC42;ELMO2;GRB2;ACTR2;WIPF3;RAC1;ARPC1B;ARPC2;ARPC4;PIK3CA
prerank,regulation of B cell proliferation (GO:0030888),0.7025468072164255,1.9668822820885061,0.0,0.014559808503171666,0.127,12/44,8.43%,CD74;VAV3;PTPRC;LYN;TNFSF13B;CD40;CD300A;RC3H1;TIRAP;AHR;IKZF3;EPHB2
prerank,Fc-gamma receptor signaling pathway (GO:0038094),0.6523566630389441,1.9642707959915653,0.0,0.014009670811281641,0.132,26/71,10.64%,FGR;MYO1G;VAV3;HCK;LYN;PRKCE;WIPF1;ACTR3;PLCG2;FYN;SYK;PAK1;WASF2;CRK;MYO1C;ABI1;CDC42;ELMO2;GRB2;ACTR2;WIPF3;RAC1;ARPC1B;ARPC2;ARPC4;PIK3CA
prerank,innate immune response (GO:0045087),0.5915311058236836,1.9546197086679462,0.0,0.017676289253014434,0.175,49/217,10.88%,CD74;CIITA;FGR;CD300E;KLRD1;IFNLR1;SP100;CYBB;ALPK1;HCK;LYN;KYNU;PLCG2;FYN;PPARG;CD40;SYK;PTX3;TRIM26;MSRB1;DHX58;REL;SLA;ANKRD17;CXCL10;CORO1A;MALT1;POLR3A;SLPI;IKBKB;ZAP70;TRIM62;STYK1;IFIH1;IRAK4;CXCL16;PTK2B;TRIM25;TLR3;CAPZA1;NRROS;IRF7;NCF2;MBL2;CYLD;B2M;TRIM14;SETD2;RNASE6
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.6244758984736443,1.9397934096687868,0.0,0.023306028872867517,0.23,32/105,13.50%,CARD11;KLRD1;CLEC10A;LYN;MUC3B;MUC3A;PLCG2;FYN;SYK;PSME3;PAK1;NFKB1;MALT1;PSMB7;IKBKB;PSME2;FBXW11;RPS6KA5;PDPK1;PAK2;PSME4;PSMB8;PSMA5;PSMD9;PSMB3;PSMD6;TAB3;PSMC4;MAP3K7;PSMD10;PSMB1;FCER1G
prerank,regulation of T cell receptor signaling pathway (GO:0050856),0.7235010182336709,1.937369782243471,0.001447178002894356,0.022813381108075195,0.24,15/33,15.28%,CARD11;TESPA1;CD226;PTPN22;CD300A;LAPTM5;RC3H1;PRNP;EZR;KCNN4;RPS3;LGALS3;PTPRJ;RAB29;RELA
prerank,cellular response to lectin (GO:1990858),0.6244843505343097,1.937126233531254,0.0,0.020305001482136008,0.242,32/104,13.50%,CARD11;KLRD1;CLEC10A;LYN;MUC3B;MUC3A;PLCG2;FYN;SYK;PSME3;PAK1;NFKB1;MALT1;PSMB7;IKBKB;PSME2;FBXW11;RPS6KA5;PDPK1;PAK2;PSME4;PSMB8;PSMA5;PSMD9;PSMB3;PSMD6;TAB3;PSMC4;MAP3K7;PSMD10;PSMB1;FCER1G
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.6244843505343097,1.937126233531254,0.0,0.020305001482136008,0.242,32/104,13.50%,CARD11;KLRD1;CLEC10A;LYN;MUC3B;MUC3A;PLCG2;FYN;SYK;PSME3;PAK1;NFKB1;MALT1;PSMB7;IKBKB;PSME2;FBXW11;RPS6KA5;PDPK1;PAK2;PSME4;PSMB8;PSMA5;PSMD9;PSMB3;PSMD6;TAB3;PSMC4;MAP3K7;PSMD10;PSMB1;FCER1G
prerank,inflammatory response (GO:0006954),0.5821520110496179,1.9197075244775115,0.0,0.02835093146425042,0.333,48/195,10.39%,CIITA;CCR2;ITGAL;CD44;IL1B;CYBB;FPR1;GPR68;CD40;LTB4R;XCR1;ITCH;FPR3;CCR1;NFKB1;PTX3;ADGRE5;STAT3;NFAM1;FOS;PTGER2;REL;MAPKAPK2;CXCL10;PTGER4;IKBKB;OLR1;PARP4;HP;HPR;TRAF3IP2;ITGB2;HSPG2;TAC4;ADORA1;CCRL2;F11R;AFAP1L2;NOX1;RAC1;HDAC9;IL6;TACR1;NRROS;HRH1;NLRC4;PTGER3;ANXA1
prerank,catecholamine metabolic process (GO:0006584),-0.7523235914136497,-1.9151742976545936,0.0,0.725228388933381,0.474,4/14,1.80%,PRKN;RNF180;SNCAIP;COMT
prerank,camera-type eye morphogenesis (GO:0048593),-0.8193600578440678,-1.9097955682109256,0.0022271714922048997,0.3919470023872875,0.502,6/10,11.95%,SKI;LRP6;NF1;KDM2B;SHROOM2;VEGFA
prerank,regulation of neutrophil chemotaxis (GO:0090022),0.7707757650744772,1.9080811741351482,0.0,0.034241014178429875,0.41,7/23,8.19%,CD74;DPP4;CAMK1D;RIPOR2;RAC2;TIRAP;RAC1
prerank,regulation of dendritic spine development (GO:0060998),-0.6992656244617671,-1.906079686156427,0.0,0.276132984907689,0.524,6/19,4.60%,TANC2;APOE;MEF2C;NLGN1;CAMK1;KIF1A
prerank,regulation of interleukin-8 production (GO:0032677),0.6451098975076337,1.9057685575174985,0.001277139208173691,0.03422007166211279,0.422,20/69,12.51%,CD74;PTPRC;IL1B;PTPN22;BCL3;KLF4;SYK;STAT3;HSPA1A;TIRAP;ANXA4;AFAP1L2;CD2;TLR3;IL6;ANXA1;RIPK1;CACTIN;MAP2K5;TLR2
prerank,negative regulation of platelet activation (GO:0010544),-0.7278987525009604,-1.8979406418956497,0.002631578947368421,0.22732926138462675,0.557,5/16,8.54%,APOE;PRKG1;SERPINE2;CD9;PDGFA
prerank,positive regulation of interleukin-2 production (GO:0032743),0.7594486060014127,1.8949500486787787,0.0015360983102918587,0.04050133066321488,0.489,8/25,5.82%,CCR2;CARD11;PTPRC;IL1B;PLCG2;MALT1;IRF4;GLMN
prerank,central nervous system neuron differentiation (GO:0021953),-0.5772747114943144,-1.8785227241451503,0.0,0.2445749294896674,0.65,10/33,6.92%,OPHN1;LRP6;NTRK2;MAP2;CTNNB1;MDGA2;SPOCK1;GRID2;RYK;FAIM2
prerank,regulation of MHC class II biosynthetic process (GO:0045346),0.8598369869141405,1.8772609266613882,0.0,0.05326538638737958,0.609,2/11,2.34%,CIITA;JAK2
prerank,regulation of cytokine production (GO:0001817),0.5824766411274434,1.874614097921657,0.0,0.05384730690006373,0.621,32/126,10.39%,CCR2;CLEC9A;FGR;FFAR4;PTPRC;FOXP1;LYN;CD47;BCL6;ACE2;NFAM1;PLD4;MAPKAPK2;NPTN;PTGER4;EIF2AK2;ATP2B1;IL33;ADRA2A;SRGN;IFIH1;MAPK14;CD276;RPS6KA5;GLMN;TRAF3;AFAP1L2;HDAC9;IL6;IRF7;IGF2BP3;ANXA1
prerank,Fc receptor signaling pathway (GO:0038093),0.5918537661394476,1.871939791108938,0.0,0.054505080227323546,0.637,38/110,13.50%,CARD11;GRAP2;VAV3;LYN;PLCG2;SYK;PSME3;PAK1;NFKB1;FOS;MALT1;PSMB7;IKBKB;PSME2;PPP3CA;FBXW11;MAP3K1;GRB2;PDPK1;PAK2;RAC1;PSME4;SOS1;PSMB8;PSMA5;PSMD9;PIK3CA;PSMB3;PSMD6;TAB3;PSMC4;MAP3K7;PSMD10;PSMB1;BTK;MAPK8;KIT;FCER1G
prerank,regulation of B cell activation (GO:0050864),0.7244163695489249,1.864131692357706,0.0015060240963855422,0.06127780274378337,0.697,10/25,11.69%,FOXJ1;LAPTM5;THEMIS2;AHR;IKZF3;SAMSN1;ZFP36L2;IL6;SLAMF8;FCGR2B
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),0.7970854443602172,1.863241056111403,0.001597444089456869,0.05995399406812471,0.702,1/17,0.01%,PLBD1
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),0.5889483448384384,1.859519692868541,0.0,0.06174939718529396,0.725,37/109,13.50%,CARD11;GRAP2;VAV3;LYN;PLCG2;SYK;PSME3;PAK1;NFKB1;FOS;MALT1;PSMB7;IKBKB;PSME2;PPP3CA;FBXW11;MAP3K1;GRB2;PDPK1;PAK2;RAC1;PSME4;SOS1;PSMB8;PSMA5;PSMD9;PIK3CA;PSMB3;PSMD6;TAB3;PSMC4;MAP3K7;PSMD10;PSMB1;BTK;MAPK8;FCER1G
prerank,anterior/posterior axis specification (GO:0009948),-0.719915048696496,-1.857071154023919,0.0024813895781637717,0.268378334537876,0.746,3/15,5.60%,SKI;WLS;TASOR
prerank,regulation of cytokine production involved in immune response (GO:0002718),0.7524208737572505,1.8528587411234165,0.0015313935681470138,0.06672061314519084,0.762,3/22,3.22%,CCR2;LILRB1;LAPTM5
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),0.8401664511732324,1.8456829089213629,0.004975124378109453,0.07337282807263358,0.81,7/12,8.51%,PTPRC;LYN;PTPN22;CD300A;RC3H1;CBFB;ELF1
prerank,T cell activation involved in immune response (GO:0002286),0.8383911280694084,1.8440334006433514,0.0,0.07298292415533938,0.813,4/12,1.35%,CD74;ITGAL;LCP1;LILRB1
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),-0.681702070601545,-1.8430456976161071,0.0,0.2774334542243657,0.806,10/17,12.13%,CACNA1D;SLC8A1;CACNB2;CACNA2D1;KCNJ2;CACNA1C;ANK2;ATP1A2;HCN2;SCN1B
prerank,positive regulation of T cell mediated immunity (GO:0002711),0.7452751539199414,1.8384394670980202,0.0,0.07797709502900795,0.844,9/22,17.38%,IL1B;CYRIB;MALT1;FBXO38;STX7;B2M;MAP3K7;TRAF2;HSPD1
prerank,positive regulation of B cell proliferation (GO:0030890),0.7112508332355156,1.8378392384247457,0.0015105740181268882,0.07613095521485666,0.847,5/29,1.72%,CD74;VAV3;PTPRC;TNFSF13B;CD40
prerank,regulation of collagen biosynthetic process (GO:0032965),0.762600221577634,1.8376662699835378,0.0030211480362537764,0.0741254018826069,0.851,4/19,8.61%,CIITA;VIM;SCX;IL6
prerank,aromatic amino acid family catabolic process (GO:0009074),0.8107489309065027,1.8345801778260582,0.001567398119122257,0.07595357903116005,0.863,5/15,4.94%,KMO;TAT;KYNU;HGD;HAAO
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),0.8391052527343376,1.8342937580991983,0.0,0.07403927465099985,0.863,2/12,0.33%,CCR2;IL1B
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),0.8429288150802312,1.8340188121481542,0.003401360544217687,0.07248001289544723,0.864,2/12,0.33%,CCR2;IL1B
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),0.7575508712550099,1.833144119880192,0.004608294930875576,0.07151586315306413,0.867,5/20,1.06%,IL1B;HCK;LYN;PRKCE;PTPN22
prerank,positive regulation of cytokine production (GO:0001819),0.5425122975589342,1.8269158538787162,0.0,0.07772291368177241,0.887,53/292,8.61%,CD74;CCR2;CLEC9A;CARD11;FGR;PTPRC;IL1B;FOXP1;RARA;CYRIB;CD226;PTPN22;PAEP;PLCG2;LILRB1;SULF2;CD40;SYK;POLR3F;NFKB1;STAT3;NFAM1;HSPA1A;DHX58;LAPTM5;SORL1;MALT1;POLR3A;PTGER4;MRE11;EIF2AK2;IL6R;LRRFIP1;IL33;ADRA2A;RAB7B;IRF4;IFIH1;MAPK14;CD276;GLMN;TIRAP;IL17RA;ADAM17;DDX41;TMED10;PLCB1;AFAP1L2;CD2;NOX1;TLR3;IL6ST;IL6
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),0.8019891577026285,1.82522428489909,0.006557377049180328,0.07769405059838666,0.89,4/14,3.22%,CD74;PLCG2;LILRB1;LAPTM5
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),0.7722833328921954,1.8252072312755172,0.0,0.07577656857155354,0.89,6/19,8.19%,CD74;CAMK1D;RIPOR2;RAC2;TIRAP;RAC1
prerank,positive regulation of macrophage migration (GO:1905523),-0.6417464771839462,-1.8157702110303775,0.005361930294906166,0.34314327886422524,0.882,10/19,17.37%,CSF1R;TREM2;CMKLR1;P2RY12;CSF1;P2RX4;AKIRIN1;MDK;CX3CL1;CCL3
prerank,response to axon injury (GO:0048678),-0.6559306943122553,-1.815175810948907,0.005420054200542005,0.30681442767521006,0.885,12/18,27.26%,RTN4RL1;TREM2;P2RY12;APOD;P2RX4;NREP;DPYSL3;MTR;TYROBP;SOD1;DHFR;MORN4
prerank,regulation of glucose transmembrane transport (GO:0010827),0.7698492004080445,1.814078779860507,0.0032520325203252032,0.08848596238778031,0.928,9/18,15.17%,FFAR4;IL1B;PRKAG2;C2CD5;RTN2;BRAF;CLIP3;OCLN;SLC2A1
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),0.8355300525986958,1.8138153780574429,0.0,0.08675811357857084,0.928,3/12,3.74%,CD74;CD44;TAF9
prerank,negative regulation of immune response (GO:0050777),0.5569101905916198,1.8104240986717508,0.0,0.08959865978053193,0.938,37/154,13.32%,CCR2;FGR;HCK;LYN;CRHR2;CYSLTR2;PLCG2;CREB1;LILRB1;FYN;ITCH;SYK;RXFP2;CD300A;PTGER2;DHX58;SPI1;PTGER4;HTR4;MYH9;DPEP1;RC3H1;MAPK14;ADAM17;CYSLTR1;SAMSN1;GNB1;IL6;PRKAR2A;ADCY7;CACTIN;GLP2R;ACOD1;FCGR2B;ADCY5;LGALS3;GNG2
prerank,positive regulation of immune response (GO:0050778),0.6037446231921809,1.807963689106001,0.00125,0.09117967033119773,0.943,15/64,13.30%,CD74;PTPRC;CD226;LILRB1;POLR3F;PLSCR1;CD177;ITGB2;IL6ST;IFI35;SLC15A4;FCGR2B;NLRP3;MYB;GBP5
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.8494336703083586,1.8070392950417786,0.0,0.09052402678058907,0.944,3/11,3.74%,CD74;CD44;TAF9
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),0.7938640990800767,1.804183296565138,0.0047694753577106515,0.0924703149817962,0.946,2/15,1.94%,CCR2;SYK
prerank,regulation of B cell receptor signaling pathway (GO:0050855),0.7327880066963143,1.8038725424635464,0.004411764705882353,0.09077801048911538,0.947,9/21,8.51%,FOXP1;LYN;PTPN22;STAP1;NFAM1;PRKCH;CD300A;CBFB;ELF1
prerank,cellular potassium ion homeostasis (GO:0030007),-0.7485499826243041,-1.8028491494268666,0.0,0.3187161301993143,0.919,5/13,7.62%,KCNMA1;ATP1B3;KCNJ2;ATP1B1;ATP1A2
prerank,acute inflammatory response (GO:0002526),0.7530966824550719,1.8027787218694926,0.0015290519877675841,0.09046185368527274,0.951,6/23,10.22%,PLSCR1;IL6R;HP;HPR;IL6;MBL2
prerank,regulation of viral entry into host cell (GO:0046596),0.7057130953405231,1.8008802050609405,0.0,0.09137668637349884,0.954,7/30,7.46%,CD74;CIITA;PTX3;TRIM26;TRIM62;LGALS1;TRIM25
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",0.8160780856568347,1.7990612544966769,0.0033333333333333335,0.09235440270670207,0.957,4/13,7.19%,CD74;CD44;PTTG1IP;DYRK1A
prerank,mesonephric tubule development (GO:0072164),-0.7000436043145364,-1.795398706585443,0.002570694087403599,0.31778741120245524,0.938,6/15,9.40%,SALL1;ROBO2;NPNT;PKD2;FGFR2;SLIT2
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),-0.6695838580057959,-1.7947516254789637,0.002688172043010753,0.29307521017217175,0.939,9/16,11.23%,SIRPA;TREM2;ABCD2;APPL2;APOD;NLRC3;PYCARD;CUEDC2;CHID1
prerank,melanocyte differentiation (GO:0030318),-0.7477600236923513,-1.788094379815398,0.0024271844660194173,0.2906826800831575,0.953,4/11,3.14%,LRMDA;MITF;MEF2C;ENPP1
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),0.7722935784311912,1.7834159614369867,0.0,0.11478860107816564,0.984,6/17,8.19%,CD74;CAMK1D;RIPOR2;RAC2;TIRAP;RAC1
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),-0.7545186415031755,-1.7823893165888447,0.009259259259259259,0.28884868489297244,0.96,3/10,6.65%,LRP6;CTNNB1;RYK
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),0.804576643008998,1.778698871397379,0.001692047377326565,0.12029059179973457,0.986,2/12,0.33%,CD44;IL1B
prerank,response to cytokine (GO:0034097),0.5565642378161434,1.7773807333125993,0.0,0.12032957405978778,0.986,24/141,6.24%,CD74;CIITA;PID1;IL1B;IFNLR1;SP100;KYNU;FLT3;CD40;MCL1;MAPKAPK3;PLSCR1;JAK2;STAT3;REL;MAPKAPK2;TAF9;PTPN6;PTPN7;EIF2AK2;IL6R;PTPN12;STAT1;CXCL16
prerank,regulation of cation transmembrane transport (GO:1904062),-0.571745155892615,-1.775065601123581,0.0032258064516129032,0.2932606474636238,0.971,7/29,8.98%,CACNA1D;WNK1;SLMAP;CD63;KCNN2;DPP10;SNTA1
prerank,tryptophan metabolic process (GO:0006568),0.8612042631013485,1.7749762885833966,0.001718213058419244,0.12278034971359912,0.987,5/11,10.19%,KMO;KYNU;HAAO;ATP7A;KYAT1
prerank,myotube differentiation (GO:0014902),-0.6480656306903629,-1.773724249792821,0.005405405405405406,0.2784720234703228,0.972,9/17,16.06%,IGF1;SKI;MEF2C;PLD3;ADGRB3;SORT1;JAM2;ADAMTS5;MYEF2
prerank,response to interferon-gamma (GO:0034341),0.6099812205518683,1.7702846049924241,0.0,0.12850613591929777,0.992,7/67,1.72%,CD74;CIITA;SP100;CD47;KYNU;DAPK1;CD40
prerank,positive regulation of locomotion (GO:0040017),-0.5646418370155402,-1.7694383990280258,0.014749262536873156,0.2742885284258665,0.974,7/27,10.68%,CSF1R;TREM2;P2RY12;AIF1;CFAP20;PPM1F;CCDC25
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),0.7973111340963954,1.7681481623242286,0.006932409012131715,0.1301194066263373,0.993,4/12,5.91%,CD74;FOXP1;KLF4;TIRAP
prerank,positive regulation of interleukin-8 production (GO:0032757),0.6217707210341146,1.7678515961300718,0.0025906735751295338,0.12832526873292296,0.993,10/49,8.61%,CD74;IL1B;SYK;STAT3;HSPA1A;TIRAP;AFAP1L2;CD2;TLR3;IL6
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),0.8309119951847217,1.7661768093229104,0.0034904013961605585,0.12926858466186053,0.993,2/10,4.50%,KCNE3;SUMO1
prerank,positive regulation of B cell activation (GO:0050871),0.6266865468928406,1.764401544684118,0.0,0.130297947282621,0.993,10/50,8.61%,CD74;VAV3;PTPRC;TNFSF13B;CD40;SYK;MAD2L2;TIRAP;EPHB2;IL6
prerank,positive regulation of interferon-gamma production (GO:0032729),0.6218094871269005,1.761016912297253,0.0,0.13439336283579761,0.993,9/48,8.52%,CCR2;IL1B;CYRIB;CD226;PTPN22;LILRB1;CD276;CD2;TLR3
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),0.5868132604489597,1.757195407784537,0.0024600246002460025,0.13895788726308764,0.994,24/72,13.61%,CD74;PTPRC;TRAF1;IFNGR1;SYK;JAK2;PTPN6;IKBKB;VRK2;SUMO1;BIRC3;STAT1;HIPK1;CBFB;SPATA2;ELF1;SPPL2A;CYLD;PTPN1;RIPK1;RNF31;CLIP3;LIFR;AGPAT1
prerank,protein autophosphorylation (GO:0046777),0.5412658766687078,1.7564470213488401,0.0,0.13780766856052454,0.994,55/157,16.96%,FGR;LRRK2;GRK5;STK10;MAP4K1;HCK;LYN;FLT3;SIK1;STK24;VRK1;DAPK1;SLK;LMTK2;MAPKAPK3;PIM1;PAK1;STK17B;JAK2;ERN1;MAPKAPK2;EIF2AK2;EIF2AK1;VRK2;TAOK3;STK4;PTK2B;PDPK1;MKNK2;DYRK1A;PAK2;SIK2;MINK1;PIKFYVE;OXSR1;CAMKK2;RIPK1;CAD;SMG1;CDK12;EIF2AK3;AKT1;KIT;MARK3;STK39;FGFR3;MAP3K13;AURKB;TAF1;INSR;DAPK3;FES;MAP3K9;HTATIP2;MAP3K3
prerank,interleukin-27-mediated signaling pathway (GO:0070106),0.784713214025698,1.755231695210764,0.008237232289950576,0.1375308343378564,0.994,10/13,14.21%,IL27RA;OAS2;JAK2;STAT3;STAT1;OASL;IL6ST;EBI3;TYK2;CANX
prerank,positive regulation of cytokinesis (GO:0032467),0.6666105467168675,1.7545269004690336,0.002886002886002886,0.1365632038623378,0.994,10/32,9.32%,SVIL;CDC14A;PRKCE;RACGAP1;CUL3;KIF23;CDC42;PKN2;RHOA;SPAST
prerank,calcium ion import into cytosol (GO:1902656),-0.6551282146833685,-1.7526668191617694,0.002631578947368421,0.311197490927713,0.99,5/15,13.66%,SLC8A1;CACNA2D1;TRPV2;TRPM2;TRPV4
prerank,high-density lipoprotein particle assembly (GO:0034380),-0.7754192917177484,-1.7525541978074168,0.002197802197802198,0.29545750264848164,0.991,3/10,4.01%,ABCA1;APOE;PRKACA
prerank,regulation of interleukin-2 production (GO:0032663),0.6378065027897483,1.7520797903670764,0.0014005602240896359,0.13926773350859856,0.995,13/43,10.39%,CCR2;CARD11;PTPRC;IL1B;PLCG2;LAPTM5;MALT1;IRF4;GLMN;PRNP;EZR;RPS3;ANXA1
prerank,regulation of cellular component size (GO:0032535),0.6700261994020182,1.7517624867440325,0.007267441860465116,0.13768514562781903,0.995,12/30,8.84%,VAV3;RAP1GAP2;RIN3;EPS8;MSN;PICALM;PTEN;MTPN;RARG;EZR;RAC1;PPP1R15A
prerank,regulation of T cell mediated immunity (GO:0002709),0.8348795710408687,1.7508587362154884,0.0017094017094017094,0.13727819445847572,0.995,2/10,0.33%,CCR2;IL1B
prerank,receptor signaling pathway via STAT (GO:0097696),0.6989957694657832,1.7507996579614766,0.00145985401459854,0.13540568711718365,0.995,9/25,10.41%,CCR2;STAT4;STAT5A;JAK2;STAT3;STAT5B;STAT1;IFNAR1;IL31RA
prerank,negative regulation of smooth muscle cell migration (GO:0014912),-0.6908194593563908,-1.7500769555934175,0.002544529262086514,0.28761323904212954,0.995,10/14,25.52%,PRKG1;MEF2C;LRP1;AIF1;SLIT2;SERPINE1;IGFBP5;TRIB1;CORO1B;NDRG4
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),0.7497684229566487,1.7492160099025762,0.0,0.13615367238666717,0.996,3/17,4.50%,KCNE3;RNF207;SUMO1
prerank,calcium ion import across plasma membrane (GO:0098703),-0.6746855216628295,-1.748889825539963,0.005128205128205128,0.2777706129360967,0.995,5/14,13.66%,SLC8A1;CACNA2D1;TRPV2;TRPM2;TRPV4
prerank,natural killer cell activation (GO:0030101),0.7081156206755407,1.7475851587963624,0.0,0.13719292849918474,0.996,8/23,10.94%,SLAMF7;PTPRC;ELF4;RABL3;KLRK1;KAT7;CD2;PBX1
prerank,regulation of monocyte differentiation (GO:0045655),0.7809496856182028,1.7460320852631939,0.00686106346483705,0.13795071470077078,0.996,2/14,0.38%,CD74;FOXP1
prerank,dendritic cell migration (GO:0036336),0.7546398943191819,1.7458728956528098,0.008116883116883116,0.1363248736636252,0.996,3/16,1.95%,CCR2;EPS8;CCR1
prerank,positive regulation of tumor necrosis factor production (GO:0032760),0.5848763990102702,1.7432637428129991,0.0012376237623762376,0.13877716223596553,0.998,16/69,8.61%,CCR2;PTPRC;IFNGR1;PLCG2;OAS2;SYK;JAK2;STAT3;IL33;SPN;IFIH1;TIRAP;CD2;EPHB2;TLR3;IL6
prerank,RNA catabolic process (GO:0006401),0.6198877054747689,1.7395670283462812,0.00410958904109589,0.14395928167409094,0.998,20/46,15.75%,DNA2;ZC3H12D;HSPA1A;ERN1;SND1;FEN1;XRN2;RNASEH2C;DCP2;LSM5;ZFP36L2;RNASE6;ZPR1;METTL3;RNASEH2A;RNASEH1;RNH1;PNPT1;NCBP1;SIDT2
prerank,positive regulation of neutrophil migration (GO:1902624),0.744182960210749,1.7394425839745977,0.0,0.1422520420837828,0.998,6/18,8.19%,CD74;CAMK1D;RIPOR2;RAC2;TIRAP;RAC1
prerank,regulation of macrophage cytokine production (GO:0010935),0.7933416921711024,1.738147344569046,0.0016666666666666668,0.1429850301548807,0.998,4/13,3.22%,CD74;PLCG2;LILRB1;LAPTM5
prerank,positive regulation of lymphocyte proliferation (GO:0050671),0.5975017475315755,1.7379863222915837,0.0,0.14150273516880146,0.998,11/63,8.61%,CD74;VAV3;PTPRC;IL1B;TNFSF13B;CD40;CD276;TIRAP;EPHB2;IL6ST;IL6
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),0.6712236826472879,1.737044528999126,0.005772005772005772,0.1415123416677115,0.998,9/29,10.41%,CCR2;STAT4;STAT5A;JAK2;STAT3;STAT5B;STAT1;IFNAR1;IL31RA
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.6990887382662468,1.7363925891926812,0.0030911901081916537,0.1409172880374979,0.998,1/23,0.01%,PLBD1
prerank,cation transmembrane transport (GO:0098655),-0.5052296478847269,-1.7363544362854937,0.0035087719298245615,0.30210953110696376,0.998,14/44,13.03%,MFSD12;TRPM3;PKD2;SLC7A1;ATP1B1;SLC36A4;SFXN1;ATP1A2;SLC25A20;SLC22A5;SLC7A2;SLC7A8;SLC3A2;TRPM2
prerank,negative regulation of T cell mediated immunity (GO:0002710),0.8083499064881648,1.735842317435866,0.005253940455341506,0.14020032993834364,0.998,4/11,6.45%,PTPRC;KLRD1;LILRB1;AHR
prerank,regulation of response to external stimulus (GO:0032101),0.5483466832952542,1.7353068979205204,0.001152073732718894,0.13957476113979037,0.998,36/121,15.78%,CCR2;FGR;FOXP1;CYRIB;HCK;SPAAR;PTPN22;SAMHD1;STK24;BCL6;ACE2;JAK2;CD36;DHX58;AKNA;ADGRA2;BIRC3;TIRAP;CAMKMT;TRAF3;SPATA2;EPHB2;SBNO2;ANXA1;CYLD;FCGR2B;NMT2;AREL1;PDE6B;ADAMTS12;CASP12;MYD88;XIAP;RELA;CELF1;LRP8
prerank,cytokine-mediated signaling pathway (GO:0019221),0.5014708654533284,1.7308688509706402,0.0,0.14597636213492743,0.999,135/532,13.79%,CIITA;CCR2;GRAP2;CD44;IL1B;IFNLR1;SP100;TRAF1;HCK;STAT4;LCP1;FPR1;FLT3;SAMHD1;IL27RA;IFNGR1;IL18RAP;FYN;ITGAX;TNFSF13B;OAS2;CD40;MCL1;MAP3K8;CNN2;ANXA2;STAT5A;SYK;CCR1;BCL6;PSME3;PIM1;NFKB1;MSN;JAK2;STAT3;VIM;MAP3K14;FOS;TRIM26;CRK;CD36;IFIT2;SLA;IL10RA;CXCL10;GPR35;PTPN6;SPI1;STAT5B;NFKBIA;MMP1;CBL;IL6R;PSMB7;IKBKB;CDC42;PSME2;TRIM62;IRF2;F13A1;IL33;BIRC3;TRAF3IP2;STAT1;IL2RG;ITGB2;PELI1;IRF4;FBXW11;IRAK4;RPS6KA5;UBE2N;IL17RA;CCND1;GRB2;PTK2B;ADAM17;CSF2RB;TALDO1;OASL;PDCD4;PAK2;TRAF3;TRIM25;ARF1;PLCB1;IFNAR1;PSME4;IL6ST;HGF;IL6;SOS1;IFI35;CAPZA1;OPRM1;ICAM1;IL1R2;IRF7;PSMB8;SMAD4;LMNB1;PSMA5;PSMD9;FN1;ANXA1;IL31RA;PIK3CA;RIPK1;B2M;YWHAZ;IL17RB;PSMB3;FOXO3;PSMD6;JAGN1;TAB3;PSMC4;RPLP0;MAP3K7;PSMD10;SNRPA1;EBI3;PSMB1;HSPA9;LIFR;AKT1;KIT;STAT2;CSK;FCER1G;JUNB;TNFRSF1B;TYK2;IFIT1
prerank,cellular response to interferon-gamma (GO:0071346),0.5677296588972892,1.7307150029347649,0.0,0.14457716603392637,0.999,25/88,14.90%,CIITA;CD44;SP100;HCK;CD47;IFNGR1;DAPK1;OAS2;JAK2;TRIM26;TRIM62;IRF2;STAT1;IRF4;OASL;TRIM25;ICAM1;IRF7;B2M;ACOD1;TLR2;GBP5;SYNCRIP;GBP2;GBP3
prerank,positive regulation of interleukin-6 production (GO:0032755),0.5797545553874603,1.7301800296527103,0.005095541401273885,0.143720511382683,0.999,16/68,12.51%,CD74;IL1B;PLCG2;SYK;STAT3;IL6R;IL33;RAB7B;IFIH1;TIRAP;IL17RA;TLR3;IL6;MBP;APP;TLR2
prerank,lymphocyte proliferation (GO:0046651),0.7007031822793108,1.7301588065545321,0.006060606060606061,0.1420764945205367,0.999,5/22,2.53%,PTPRC;FLT3;CD40;MSN;ELF4
prerank,response to molecule of bacterial origin (GO:0002237),0.584448797532414,1.7281760136779447,0.0036991368680641184,0.1442762823964078,0.999,15/69,8.61%,IL1B;FOXP1;CYRIB;PTPN22;MAPKAPK3;JAK2;RPS6KA3;ERBIN;MAPKAPK2;SLPI;PELI1;TIRAP;ADAM17;IFNAR1;IL6
prerank,response to peptide (GO:1901652),0.6507202092845873,1.7268238892982053,0.006963788300835654,0.14527065305638298,0.999,13/33,13.22%,STAT4;FYN;STAT5A;STAT3;CACNA1A;ERBIN;STAT5B;KAT7;STAT1;PRNP;ANXA1;GNAI1;STAT2
prerank,interleukin-35-mediated signaling pathway (GO:0070757),0.8090220921408487,1.7262608396855361,0.003424657534246575,0.144490273515171,0.999,8/11,14.21%,STAT4;IL27RA;JAK2;STAT3;STAT1;IL6ST;EBI3;CANX
prerank,indolalkylamine catabolic process (GO:0046218),0.8583397818690026,1.7258554985639931,0.0017513134851138354,0.1435933043647645,0.999,4/10,10.19%,KMO;KYNU;HAAO;KYAT1
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),0.6939814789289387,1.7225782945708217,0.006033182503770739,0.14805486431330775,0.999,3/24,3.74%,CD74;CD44;TAF9
prerank,cellular response to purine-containing compound (GO:0071415),-0.728061553848764,-1.7225020436447644,0.007159904534606206,0.3330395118181126,0.999,4/10,13.03%,SLC8A1;RYR3;P2RY6;TRPM2
prerank,positive regulation of type 2 immune response (GO:0002830),0.7686093396281075,1.720412188206511,0.008532423208191127,0.15017740368454685,0.999,4/14,8.61%,CD74;RARA;DENND1B;IL6
prerank,apical junction assembly (GO:0043297),0.5970460876280617,1.7200420559399403,0.006693440428380187,0.14912892706138134,0.999,15/53,15.91%,PECAM1;MARVELD3;FRMPD2;CLDN1;CTNNA1;AFDN;PKN2;PAK2;F11R;PDCD6IP;RHOA;CLDN14;TBCD;OCLN;APC
prerank,negative regulation of viral entry into host cell (GO:0046597),0.7965926788198567,1.7175949831523911,0.0016366612111292963,0.15193232617174607,0.999,3/12,2.61%,CIITA;PTX3;TRIM26
prerank,cellular response to ATP (GO:0071318),-0.6810743300939227,-1.717346113305742,0.008310249307479225,0.33673726334133625,0.999,5/14,7.79%,RYR3;P2RY12;P2RX7;P2RX4;HSP90B1
prerank,immunoglobulin mediated immune response (GO:0016064),0.8281070366267502,1.7166296944911879,0.0017543859649122807,0.15211507609822156,0.999,2/10,2.31%,CD74;GAPT
prerank,regulation of mRNA processing (GO:0050684),-0.5444667580095008,-1.7154059269390771,0.010033444816053512,0.3292152524826176,0.999,15/32,14.66%,QKI;SON;AHCYL1;CDK11B;SRSF3;SAFB2;SRPK1;KHDRBS3;TIA1;JMJD6;SRPK2;KHDRBS2;DHX9;IWS1;PTCD2
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),0.6836094352692819,1.7148279140505638,0.0060882800608828,0.1539274949305563,1.0,7/25,13.20%,CD226;PLCG2;LAPTM5;MALT1;B2M;MAP3K7;KIT
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),0.7695373475451982,1.7139649256862368,0.008389261744966443,0.1541581898368617,1.0,7/14,15.28%,CARD11;TESPA1;CD226;KCNN4;RPS3;RAB29;RELA
prerank,regulation of interferon-gamma production (GO:0032649),0.5709124181645916,1.7138233217049286,0.0025380710659898475,0.15287659082567592,1.0,13/71,8.52%,CCR2;IL1B;RARA;CYRIB;CD226;CD47;PTPN22;LILRB1;LAPTM5;CD276;PRNP;CD2;TLR3
prerank,regulation of leukocyte activation (GO:0002694),0.7698770648496537,1.7130362498144651,0.0065252854812398045,0.1526869713874883,1.0,3/14,2.32%,CD74;LYN;PLSCR1
prerank,tryptophan catabolic process (GO:0006569),0.8395285480735549,1.7122732287081859,0.0017331022530329288,0.15254137535310497,1.0,4/11,10.19%,KMO;KYNU;HAAO;KYAT1
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),-0.6138135104841098,-1.7112057112742598,0.01078167115902965,0.3315307547736441,0.999,7/20,7.62%,KCNMA1;SLC8A1;ATP1B3;KCNJ2;ATP6AP1;ATP1B1;ATP1A2
prerank,alpha-amino acid catabolic process (GO:1901606),0.666832576130542,1.709255145543997,0.011527377521613832,0.15664635711142152,1.0,8/29,11.96%,KMO;TAT;KYNU;HGD;HAAO;KYAT1;MTRR;ACAT1
prerank,ganglioside biosynthetic process (GO:0001574),0.750522159833982,1.7091053344983969,0.006688963210702341,0.15525299033211026,1.0,5/15,8.25%,ST3GAL1;ST8SIA4;ST8SIA6;B4GALT5;ST6GALNAC3
prerank,positive regulation of leukocyte degranulation (GO:0043302),0.7833342835173068,1.7045606750001019,0.008210180623973728,0.16268382791715216,1.0,5/13,10.90%,FGR;SYK;CD177;ITGB2;AP1G1
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),-0.7069253857095399,-1.7039058255698023,0.009478672985781991,0.3430777202258331,1.0,3/11,6.65%,LRP6;CTNNB1;RYK
prerank,manganese ion transport (GO:0006828),-0.6704571247388527,-1.7032163942132275,0.01240694789081886,0.332775648478497,1.0,7/14,16.27%,SLC11A1;TRPC4;SLC11A2;TRPC1;TRPC7;TRPC3;ATP2C1
prerank,interleukin-12-mediated signaling pathway (GO:0035722),0.60485515221295,1.6994382789956486,0.003942181340341655,0.17085890939671408,1.0,19/46,13.65%,STAT4;LCP1;CNN2;ANXA2;MSN;JAK2;CDC42;PSME2;TALDO1;PDCD4;PAK2;ARF1;PLCB1;CAPZA1;LMNB1;RPLP0;SNRPA1;HSPA9;TYK2
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.6588727119245625,1.6992260061626605,0.007342143906020558,0.1695125531071005,1.0,6/29,4.56%,KLRD1;CYRIB;CD226;STAP1;SPI1;KLRK1
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.6773983109790452,1.6981227250238884,0.0074850299401197605,0.1703424386724219,1.0,6/27,12.26%,CD74;CD44;PTTG1IP;DYRK1A;SPRED3;PSMD10
prerank,tyrosine metabolic process (GO:0006570),0.8005358232149029,1.6978722569961189,0.01054481546572935,0.16925158853285546,1.0,2/11,1.12%,TAT;HGD
prerank,defense response to symbiont (GO:0140546),0.5521445466549909,1.6975678133783645,0.004796163069544364,0.16840425399030404,1.0,31/92,15.44%,PTPRC;IFNLR1;SAMHD1;LILRB1;OAS2;CD40;PLSCR1;MAP3K14;IFIT2;EIF2AK2;IRF2;STAT1;IFIH1;FLNA;OASL;DDIT4;RNASE1;TLR3;IL6;IRF7;SETD2;RNASE6;ACOD1;PQBP1;TLR2;NT5C3A;STAT2;IFIT1;MYD88;RELA;IFITM3
prerank,positive regulation of defense response to virus by host (GO:0002230),0.6876641144133862,1.6956262170562433,0.010526315789473684,0.17070429266632653,1.0,7/24,12.34%,PTPN22;LILRB1;DTX3L;TRAF3IP2;STAT1;PARP9;PQBP1
prerank,T cell receptor signaling pathway (GO:0050852),0.5294755570963056,1.6952945301793803,0.0,0.16976791472653674,1.0,39/138,13.34%,CARD11;GRAP2;PTPRC;PTPN22;PLCG2;FYN;PSME3;PAK1;NFKB1;MALT1;PSMB7;IKBKB;ZAP70;PSME2;NFKBIZ;THEMIS2;BCAR1;RC3H1;FBXW11;CD276;DENND1B;UBE2N;PDPK1;PAK2;PSME4;PSMB8;PSMA5;PSMD9;PIK3CA;NFKBID;RNF31;PSMB3;PSMD6;PSMC4;MAP3K7;PSMD10;ICOSLG;PSMB1;CSK
prerank,regulation of endothelial cell chemotaxis (GO:2001026),-0.6304058289145159,-1.6948501546076122,0.015424164524421594,0.3488895096667441,1.0,4/15,12.15%,LGMN;FGF2;P2RX4;PRKD1
prerank,regulation of lamellipodium organization (GO:1902743),0.7574051250175171,1.6943167324387856,0.00859106529209622,0.17017793566005246,1.0,5/14,8.19%,CD44;CDC42;CARMIL1;CAPZB;RAC1
prerank,mature B cell differentiation involved in immune response (GO:0002313),0.7868090946267964,1.6943039766511792,0.006944444444444444,0.16867168676739597,1.0,7/12,11.69%,NOTCH2;DOCK10;DOCK11;LFNG;PTK2B;IL6;FCGR2B
prerank,regulation of defense response to virus by host (GO:0050691),0.6552189246316219,1.693783498414287,0.008571428571428572,0.1682670415382908,1.0,8/30,12.34%,IFNLR1;PTPN22;LILRB1;DTX3L;TRAF3IP2;STAT1;PARP9;PQBP1
prerank,cellular response to chemokine (GO:1990869),0.614137983538634,1.6930372642601301,0.006720430107526882,0.1681600660860461,1.0,11/46,13.88%,CCR2;CCR1;CXCL10;GPR35;RIPOR2;PTK2B;RHOA;OXSR1;DUSP1;STK39;LRCH1
prerank,regulation of actin filament-based process (GO:0032970),0.566159315694162,1.690376306493329,0.00984009840098401,0.17199914130250538,1.0,17/70,8.94%,RND3;IQGAP2;IQGAP1;CNN2;PAK1;CELSR1;ARHGAP18;CRK;CORO1A;CCDC88A;RAC2;DLC1;F11R;RHOBTB3;EZR;RAC1;RHOA
prerank,heart process (GO:0003015),0.7571127665761448,1.6887660513670888,0.009836065573770493,0.17344455432179562,1.0,4/14,7.07%,ACE;FYN;GPX1;SGCD
prerank,fatty acid oxidation (GO:0019395),-0.46321504532582536,-1.6887347067491094,0.004424778761061947,0.35705107572312894,1.0,28/57,28.87%,ABCD2;ECHS1;PPARGC1A;PECR;ABCD4;ECHDC1;ACAD10;HADHB;ACADM;HADH;HADHA;ECI1;ECI2;ABCD3;ACADL;CPT2;ACADS;PHYH;ILVBL;ADIPOR2;PEX13;ACAT2;ADH5;ACAD11;ACOX1;CROT;PPARD;SLC27A2
prerank,peptidyl-proline hydroxylation (GO:0019511),-0.7143107721928752,-1.6885236193855837,0.009592326139088728,0.3461858643354107,1.0,7/11,17.07%,P3H2;P4HA1;EGLN3;EGLN2;P4HB;OGFOD1;CRTAP
prerank,negative regulation of B cell activation (GO:0050869),0.6769910886970659,1.6885132448135969,0.012539184952978056,0.17248960540590835,1.0,8/21,11.69%,LYN;FOXJ1;CD300A;LAPTM5;RC3H1;SAMSN1;ID2;FCGR2B
prerank,positive regulation of chemokine production (GO:0032722),0.603408396444307,1.6882028499020936,0.0041841004184100415,0.1716530080467092,1.0,14/44,12.51%,CD74;IL1B;SYK;EIF2AK2;IL6R;IL33;TIRAP;IL17RA;ADAM17;TLR3;IL6;MBP;APP;TLR2
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),-0.5953216656931805,-1.6866359999957863,0.008875739644970414,0.34162606466143575,1.0,7/20,7.62%,SLC8A1;CACNA1C;PRKACA;ATP2A2;ATP1B1;ANK2;ATP1A2
prerank,fructose 6-phosphate metabolic process (GO:0006002),-0.7183633798582775,-1.6857844590514683,0.021686746987951807,0.33344996590195897,1.0,6/10,18.72%,HK3;HK1;PFKL;PFKP;GFPT1;PFKM
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),0.7681745753045887,1.684276136099234,0.008695652173913044,0.1779204307323833,1.0,2/12,1.13%,IL1B;PAEP
prerank,regulation of defense response (GO:0031347),0.5596145581255288,1.6837566357492122,0.0012437810945273632,0.17734483591746208,1.0,27/76,15.78%,CCR2;FGR;FOXP1;HCK;PTPN22;SAMHD1;BCL6;ACE2;JAK2;DHX58;AKNA;BIRC3;TIRAP;TRAF3;SPATA2;SBNO2;ANXA1;CYLD;FCGR2B;AREL1;ADAMTS12;CASP12;MYD88;XIAP;RELA;CELF1;LRP8
prerank,regulation of interleukin-6 production (GO:0032675),0.5430076311589898,1.6827615079846392,0.002442002442002442,0.1780140065097408,1.0,19/96,8.61%,CD74;IL1B;CD47;PTPN22;PLCG2;SYK;STAT3;FOXJ1;MAPKAPK2;PTPN6;IL6R;IL33;RAB7B;IFIH1;TIRAP;IL17RA;AFAP1L2;TLR3;IL6
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.5322452432610281,1.6826605384427433,0.0,0.17669901985243852,1.0,26/116,13.32%,FGR;HCK;LYN;CRHR2;CYSLTR2;PLCG2;CREB1;FYN;SYK;RXFP2;PTGER2;PTGER4;HTR4;MYH9;DPEP1;MAPK14;ADAM17;CYSLTR1;GNB1;IL6;PRKAR2A;ADCY7;GLP2R;FCGR2B;ADCY5;GNG2
prerank,negative regulation of viral life cycle (GO:1903901),0.7459152935096574,1.682401188988103,0.009389671361502348,0.17576435969036014,1.0,3/15,2.61%,CIITA;PTX3;TRIM26
prerank,membrane depolarization during action potential (GO:0086010),-0.5464103649760632,-1.6800167932160646,0.005797101449275362,0.34167068860857663,1.0,9/26,12.13%,CACNA1D;SLC8A1;SCN1A;KCNJ2;CACNA1C;SCN3A;ATP1A2;HCN2;SCN1B
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.5599391119160912,1.6790833270721932,0.004920049200492005,0.18125024248903612,1.0,16/73,8.61%,CCR2;PTPRC;IFNGR1;PLCG2;OAS2;SYK;JAK2;STAT3;IL33;SPN;IFIH1;TIRAP;CD2;EPHB2;TLR3;IL6
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),0.5915407043328222,1.6785607719591982,0.007989347536617843,0.18087958452870806,1.0,19/47,18.43%,PID1;PLCG2;SYK;ACE2;CD36;CD177;ITGB2;MAPK14;GRB2;DHRS4;RIPK1;ACOD1;TGFB1;GSTP1;THBS1;RNF41;CYBA;MMP8;PRKCD
prerank,hemidesmosome assembly (GO:0031581),-0.6943932934735708,-1.678544274762084,0.012658227848101266,0.33690825097371413,1.0,2/11,0.87%,DST;ITGA6
prerank,acute-phase response (GO:0006953),0.7960746933115888,1.6759881613570369,0.010084033613445379,0.18497938272422085,1.0,4/12,10.22%,PLSCR1;IL6R;IL6;MBL2
prerank,defense response to tumor cell (GO:0002357),0.7857412645644042,1.675232984217776,0.01615798922800718,0.18540609148049483,1.0,4/10,3.78%,KLF4;DAPK1;LAPTM5;SPI1
prerank,negative regulation of synaptic transmission (GO:0050805),0.679268819859429,1.6743907858703675,0.010606060606060607,0.18562242681027946,1.0,5/23,8.42%,LRRK2;IL1B;PTEN;ARF1;SLC30A1
prerank,lymphocyte mediated immunity (GO:0002449),0.7770063141870887,1.6741548516463516,0.009836065573770493,0.18467740800026938,1.0,3/12,6.89%,MYO1G;KLRD1;GNL1
prerank,antigen receptor-mediated signaling pathway (GO:0050851),0.5139201202273356,1.6710042353659194,0.0,0.18970794640337946,1.0,44/163,13.34%,CARD11;GRAP2;VAV3;PTPRC;PTPN22;PLCG2;FYN;SYK;PSME3;PAK1;NFKB1;NFAM1;CD79B;MALT1;PSMB7;IKBKB;ZAP70;PSME2;NFKBIZ;THEMIS2;BCAR1;RC3H1;FBXW11;CD276;DENND1B;UBE2N;PDPK1;PAK2;PSME4;PSMB8;PSMA5;PSMD9;PIK3CA;NFKBID;RNF31;PSMB3;PSMD6;PSMC4;MAP3K7;PSMD10;ICOSLG;PSMB1;BTK;CSK
prerank,negative regulation of secretion (GO:0051048),0.7839317518936151,1.670901058183568,0.012522361359570662,0.18850882499913876,1.0,1/10,0.02%,CD74
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",-0.5781587165941331,-1.6708799101778968,0.008595988538681949,0.351993695047164,1.0,7/22,15.92%,MAN1C1;MAN1A2;DERL2;UBC;TRIM13;RNF103;RNF139
prerank,tRNA modification (GO:0006400),-0.4479028316735484,-1.670756296521421,0.004784688995215311,0.3428083982518978,1.0,45/62,36.77%,ALKBH8;NSUN2;TRMT1;ANKRD16;METTL6;DUS2;QTRT1;ELP5;TYW5;METTL2A;METTL2B;CDKAL1;METTL1;DTWD2;SSB;THUMPD1;OSGEP;THUMPD2;TRMT10A;WDR4;TRMT44;MTO1;TRMT6;TRMT12;TPRKB;NSUN6;LCMT2;TRMT112;GTPBP3;TRMT9B;TRMT5;BCDIN3D;DTWD1;PUS7;QTRT2;FTSJ1;ALKBH1;CTU2;AARS2;THG1L;TRMT61A;PUSL1;WDR6;CTU1;MOCS3
prerank,response to ATP (GO:0033198),-0.6151517863308237,-1.6705266388529096,0.005865102639296188,0.3342662448882551,1.0,7/18,14.65%,RYR3;P2RY12;P2RX7;P2RX4;HSP90B1;DGKQ;TRPC3
prerank,chemokine-mediated signaling pathway (GO:0070098),0.6098909451595238,1.6700091793002871,0.009358288770053475,0.18877080628627327,1.0,8/42,10.85%,CCR2;CCR1;CXCL10;GPR35;PTK2B;CIB1;OXSR1;RBM15
prerank,positive regulation of behavior (GO:0048520),-0.7252423068969833,-1.669360982349569,0.008791208791208791,0.32945593193222256,1.0,4/10,14.35%,MEF2C;NLGN1;CFAP20;NPAS2
prerank,negative regulation of lymphocyte proliferation (GO:0050672),0.6284795373753334,1.6689565439302243,0.01764705882352941,0.18927751054123168,1.0,7/31,5.82%,LYN;LILRB1;CD300A;SPN;RC3H1;LST1;GLMN
prerank,positive regulation of T cell cytokine production (GO:0002726),0.6914799227457031,1.6686152986333598,0.014446227929373997,0.18849760579396893,1.0,9/20,17.32%,IL1B;MALT1;DENND1B;IL6;B2M;NLRP3;MAP3K7;IL18;TRAF2
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",-0.6533312945419919,-1.6671390494282339,0.020151133501259445,0.3283504403870276,1.0,7/14,14.19%,CSTF2;RTRAF;FAM98B;TSEN2;TSEN34;ZBTB8OS;RTCB
prerank,second-messenger-mediated signaling (GO:0019932),0.543461453061144,1.6661936818753764,0.0060901339829476245,0.19180492700755125,1.0,17/82,9.95%,CCR2;LRRK2;FPR1;PLCG2;XCR1;NDNF;CCR1;CD36;MCTP2;ACKR2;CCR9;PPP1R9B;CCRL2;PDPK1;GUCY1A1;HRH1;CAMKK2
prerank,regulation of cytoplasmic translation (GO:2000765),-0.6362858602242097,-1.6661891191495093,0.010126582278481013,0.3233269811668161,1.0,6/14,16.07%,CPEB2;CPEB1;CNBP;CPEB4;DHX9;CPEB3
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),0.6053260414051548,1.6652533361768926,0.012211668928086838,0.19248421876781013,1.0,19/44,16.04%,CD44;NGF;KLF4;NGFR;GPX1;RPS6KA3;DPEP1;CAST;CARD16;HGF;CSNK2A1;RPS6KA1;MAP2K5;SH3RF1;AKT1;DHCR24;XIAP;THBS1;USP47
prerank,myeloid cell activation involved in immune response (GO:0002275),0.6847043748218817,1.6618584703438413,0.02037617554858934,0.1978128458511838,1.0,7/18,13.50%,PLCG2;DOCK2;SYK;DYSF;IFI35;SBNO2;FCER1G
prerank,tight junction assembly (GO:0120192),0.5860729641693978,1.6616952664838962,0.00801068090787717,0.1966811833966324,1.0,13/49,15.91%,PECAM1;MARVELD3;FRMPD2;CLDN1;CLDN12;AFDN;PAK2;F11R;PDCD6IP;CLDN14;TBCD;OCLN;APC
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.5264444384010046,1.6614469850382114,0.0011534025374855825,0.19579659304143654,1.0,23/117,11.26%,FGR;HCK;LYN;CRHR2;CYSLTR2;PLCG2;CREB1;FYN;SYK;RXFP2;PTGER2;PTGER4;HTR4;MYH9;DPEP1;MAPK14;ADAM17;CYSLTR1;GNB1;IL6;PRKAR2A;ADCY7;GLP2R
prerank,B cell mediated immunity (GO:0019724),0.8037984735453377,1.6608721328437543,0.02097902097902098,0.19559029582682416,1.0,1/10,0.02%,CD74
prerank,regulation of neuron apoptotic process (GO:0043523),-0.4241323723450143,-1.6605211064243934,0.006578947368421052,0.3328238140087443,1.0,33/96,14.26%,PRKN;LGMN;APOE;TREM2;MEF2C;NTRK2;GRN;CTNNB1;NF1;RASA1;PPARGC1A;ADAM8;GRID2;NRBP2;FAIM2;ATF4;EGLN3;CDK5R1;KDM2B;NAE1;EGLN2;BACE1;SNX6;CPEB4;PTPRZ1;CDK5;MSH2;SET;EPHA7;SRPK2;MDK;TGFB2;BAX
prerank,cellular response to interleukin-12 (GO:0071349),0.5862500522800004,1.6604061090261146,0.0038910505836575876,0.19517378081705028,1.0,20/48,13.65%,STAT4;CD47;LCP1;CNN2;ANXA2;MSN;JAK2;CDC42;PSME2;TALDO1;PDCD4;PAK2;ARF1;PLCB1;CAPZA1;LMNB1;RPLP0;SNRPA1;HSPA9;TYK2
prerank,regulation of small molecule metabolic process (GO:0062012),-0.5403499127144195,-1.6600010081164478,0.006644518272425249,0.32656565546242833,1.0,8/28,11.53%,PRKN;APOE;TTC39B;PDK1;ARV1;PANK2;DGKQ;FMO5
prerank,lymphocyte migration (GO:0072676),0.6357227131188858,1.6592978452611664,0.009971509971509971,0.19599076174614327,1.0,5/32,5.36%,MYO1G;RET;MSN;ZAP70;CKLF
prerank,cardiac muscle cell contraction (GO:0086003),-0.5958362043826753,-1.6579582754706008,0.01643835616438356,0.3253275060284394,1.0,10/19,22.18%,CACNA1D;CACNA2D1;SCN1A;KCNJ2;CACNA1C;SCN1B;PKP2;FGF12;SCN3B;GSN
prerank,defense response to virus (GO:0051607),0.5330131413929639,1.657786278908847,0.005847953216374269,0.19793111381045994,1.0,32/100,15.44%,PTPRC;IFNLR1;SAMHD1;LILRB1;OAS2;CD40;PLSCR1;MAP3K14;IFIT2;CXCL10;EIF2AK2;IRF2;STAT1;IFIH1;FLNA;OASL;DDIT4;RNASE1;TLR3;IL6;IRF7;SETD2;RNASE6;ACOD1;PQBP1;TLR2;NT5C3A;STAT2;IFIT1;MYD88;RELA;IFITM3
prerank,response to cholesterol (GO:0070723),-0.6019054396849696,-1.6573335668030982,0.008522727272727272,0.3197613222056804,1.0,11/17,24.26%,TGFBR2;LRP6;TGFBR1;GRAMD1A;SMO;GPLD1;CCL3;PMVK;PTCH1;OSBPL7;MLC1
prerank,mesenchymal to epithelial transition (GO:0060231),-0.7265625406633205,-1.6568912893899963,0.009259259259259259,0.3141293058123304,1.0,2/10,1.02%,BASP1;SALL1
prerank,positive regulation of response to cytokine stimulus (GO:0060760),0.7555518553591911,1.6552403208220796,0.01309328968903437,0.2019103878664872,1.0,3/13,5.54%,CD74;TAF9;IFIH1
prerank,bicellular tight junction assembly (GO:0070830),0.5868218786835042,1.6538308140786842,0.012195121951219513,0.20352017345718362,1.0,12/46,15.91%,PECAM1;MARVELD3;FRMPD2;CLDN1;AFDN;PAK2;F11R;PDCD6IP;CLDN14;TBCD;OCLN;APC
prerank,O-glycan processing (GO:0016266),0.5830454524339824,1.6519280266375327,0.008053691275167786,0.2060407803184109,1.0,10/54,12.64%,ST3GAL1;ST3GAL4;MUC3B;MUC3A;GXYLT1;B4GALT5;GALNT2;GALNT10;GALNT5;XXYLT1
prerank,granulocyte differentiation (GO:0030851),0.718106306388939,1.6515988809051123,0.009216589861751152,0.20531089108682,1.0,4/18,6.23%,CBFA2T3;RARA;SPI1;DEK
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),-0.6326720732282304,-1.6497061696422062,0.025380710659898477,0.32881582701306056,1.0,5/15,12.15%,LGMN;FGF2;P2RX4;VEGFA;PRKD1
prerank,positive regulation of cell death (GO:0010942),0.572882060804023,1.6488279705034932,0.00517464424320828,0.2100452468597372,1.0,16/59,11.69%,LRRK2;FYN;MAP3K5;FOS;CD36;PICALM;HP;HPR;ITGB2;FAF1;PRNP;DDIT4;RARG;DAXX;RIPK1;FCGR2B
prerank,protein exit from endoplasmic reticulum (GO:0032527),-0.5614167357658378,-1.648299763195822,0.014450867052023121,0.3255688810152469,1.0,10/23,15.14%,PREB;DERL2;LMAN1;HSP90B1;AUP1;NPLOC4;TMED9;DERL1;SEC13;HERPUD1
prerank,keratan sulfate catabolic process (GO:0042340),-0.6780262956879672,-1.6465487214838213,0.014778325123152709,0.32451870043610515,1.0,3/11,3.81%,HEXB;GALNS;GNS
prerank,regulation of multicellular organismal development (GO:2000026),0.6345561203211186,1.6463171440007947,0.022796352583586626,0.21382839797823583,1.0,7/25,10.69%,SPAAR;OAS2;RACGAP1;NIPBL;SCX;DUSP6;TDG
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.6399988344870698,1.6449591279588485,0.02014388489208633,0.21531085357872978,1.0,8/28,11.17%,ITPR1;MAP3K5;ERN1;ATP2A3;BBC3;ATP2A1;PPP1R15A;AIFM1
prerank,cellular response to interleukin-6 (GO:0071354),0.654006200472228,1.644547371204816,0.008759124087591242,0.2146115773367504,1.0,13/26,9.99%,PID1;NFKB1;JAK2;STAT3;PTGIS;SPI1;CBL;IL6R;STAT1;IL6ST;IL6;SMAD4;SBNO2
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),0.6587495957129004,1.6440837916065771,0.01726844583987441,0.21416531450477913,1.0,3/22,1.27%,CD44;IL1B;KLF4
prerank,regulation of tumor necrosis factor production (GO:0032680),0.5227765315873981,1.6440596990777883,0.0011641443538998836,0.21282177753600173,1.0,23/112,8.61%,CCR2;PTPRC;FOXP1;RARA;CD47;PTPN22;IFNGR1;PLCG2;LILRB1;OAS2;SYK;JAK2;STAT3;MAPKAPK2;PTPN6;IL33;SPN;IFIH1;TIRAP;CD2;EPHB2;TLR3;IL6
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),0.6411520833858808,1.6437567359079857,0.022922636103151862,0.21200294054691288,1.0,7/27,8.94%,CCR2;CD44;CYRIB;CD47;ITGB2;IL6;RHOA
prerank,negative regulation of MAP kinase activity (GO:0043407),0.5896840144260707,1.6433578637587516,0.012517385257301807,0.21155647217718512,1.0,15/44,15.80%,IL1B;LYN;PTPN22;CD300A;RGS2;STK38;SORL1;PDCD4;PAQR3;PTPN1;DUSP1;RGS14;PTPRJ;GSTP1;IRAK3
prerank,lipid droplet organization (GO:0034389),-0.5783205813470649,-1.643184583146964,0.008928571428571428,0.3270911525987123,1.0,12/22,36.10%,PPIA;CDS1;RAB3GAP1;CDS2;AUP1;PPID;BSCL2;ZFYVE1;FITM2;FAF2;PLA2G4C;PNPLA3
prerank,response to lipid (GO:0033993),0.5283654994122661,1.6426722018161959,0.0011587485515643105,0.21161635838612997,1.0,20/105,8.17%,IL1B;FOXP1;RARA;PTPN22;PPARG;MAPKAPK3;JAK2;STAT3;CD36;RPS6KA3;ERBIN;MAPKAPK2;STAT5B;SLPI;PELI1;TIRAP;TRIM16;ADAM17;RARG;IFNAR1
prerank,regulation of leukocyte chemotaxis (GO:0002688),0.6981584438031463,1.6415060907694397,0.02384737678855326,0.2126383627096029,1.0,7/18,8.61%,LYN;CAMK1D;SLC8B1;IL6R;PTK2B;ADAM17;IL6
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),0.62680353605163,1.6404483369499352,0.01585014409221902,0.21345726452098165,1.0,2/33,1.95%,CD74;CCR1
prerank,B cell activation (GO:0042113),0.557923743822219,1.639825068558785,0.0038022813688212928,0.21345991125115396,1.0,21/68,14.69%,ITGA4;PTPRC;FLT3;PLCG2;CD40;NFAM1;CD79B;RABL3;CHRNA4;MALT1;ZAP70;ADAM17;EPHB2;HDAC9;CTPS1;TPD52;SLC25A5;BTK;KIT;PTPRJ;GPS2
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),0.7577351732659515,1.6392561450334084,0.025996533795493933,0.21333739644697675,1.0,4/11,5.41%,STAP1;CD177;SPI1;ITGB2
prerank,cellular response to interleukin-2 (GO:0071352),0.7711838339050531,1.6367748065468426,0.015202702702702704,0.21560548184483347,1.0,5/11,6.44%,STAT5A;SYK;STAT5B;IL2RG;PTK2B
prerank,interleukin-2-mediated signaling pathway (GO:0038110),0.7711838339050531,1.6367748065468426,0.015202702702702704,0.21560548184483347,1.0,5/11,6.44%,STAT5A;SYK;STAT5B;IL2RG;PTK2B
prerank,T cell differentiation in thymus (GO:0033077),0.7231050344351759,1.6364941051229713,0.0165016501650165,0.21490706072900936,1.0,4/14,8.57%,PTPRC;RABL3;ADAM17;ZFP36L2
prerank,protein hydroxylation (GO:0018126),-0.6240988998932036,-1.633854758360159,0.014705882352941176,0.34824528348733114,1.0,9/15,23.37%,ASPH;P3H2;P3H3;EGLN3;VPS33B;OGFOD1;PLOD3;VIPAS39;PLOD1
prerank,regulation of membrane depolarization (GO:0003254),0.687260932392981,1.6336370062710326,0.02280130293159609,0.21975862471126756,1.0,4/18,3.90%,LRRK2;NEDD4L;GJA5;HCN4
prerank,peptidyl-serine phosphorylation (GO:0018105),0.5082780875538081,1.63352978023025,0.0022026431718061676,0.21868552248194703,1.0,60/153,16.11%,LRRK2;MAP4K1;SGK3;PRKCE;VRK1;CAMK1D;LMTK2;AKT3;MAPKAPK3;PKN1;ERN1;PRKCH;RPS6KA3;CSNK1G1;MAPKAPK2;STK38;IKBKB;VRK2;HIPK2;MAPK14;RPS6KA5;HIPK1;STK4;PDPK1;MKNK2;DYRK1A;PKN2;PAK2;MAPK12;STK38L;CSNK1G3;TNKS;LATS1;PIKFYVE;CSNK2A2;CSNK2A1;TLK2;RIPK1;DMPK;NLK;LATS2;RPS6KA1;SMG1;MORC3;EIF2AK3;MAPK8;AKT1;PDK3;MARK3;STK39;ROCK1;TLK1;RPS6KA2;MAP3K13;BRSK1;MAPK1;TAF1;TBK1;DYRK2;RPS6KB1
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),-0.5630530000526356,-1.6330853676430732,0.01791044776119403,0.3438240801090667,1.0,9/21,21.23%,SLC8A1;CACNA1C;PRKACA;ANK2;ATP1A2;AKAP6;CALM1;GSTO1;RYR2
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),0.6619938253678539,1.6313469222681292,0.0343796711509716,0.22218930955523342,1.0,4/23,9.40%,CBFA2T3;SIK1;CRY1;GIT1
prerank,regulation of cellular respiration (GO:0043457),0.7021346596563832,1.6312155135415003,0.022970903522205207,0.2212283527511589,1.0,7/17,14.18%,CBFA2T3;IFNLR1;NOA1;IFNAR1;PRELID1;PNPT1;VCP
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),-0.7072584502561166,-1.6310119546080672,0.01839080459770115,0.343844632599477,1.0,3/10,2.52%,PRKG1;SERPINE2;CD9
prerank,endothelial cell development (GO:0001885),0.6450179046052801,1.6290478923501988,0.012968299711815562,0.22481195596013764,1.0,7/25,9.14%,PECAM1;RAP1A;MSN;RAPGEF2;PDE2A;EZR;ICAM1
prerank,regulation of vascular endothelial growth factor production (GO:0010574),0.6504824331589087,1.6286244291559266,0.009022556390977444,0.2243619766315607,1.0,6/26,8.61%,CCR2;IL1B;SULF2;NOX1;IL6ST;IL6
prerank,regulation of peptide hormone secretion (GO:0090276),0.556461330006115,1.6268367714482748,0.007575757575757576,0.2270134690712646,1.0,10/67,8.61%,DPP4;ITPR1;IL1B;RAP1A;CACNA1A;SLC8B1;RFX3;ADRA2A;CLOCK;IL6
prerank,cardiac muscle tissue development (GO:0048738),0.572028905136045,1.625908497932695,0.013210039630118891,0.22787244026436326,1.0,7/50,9.94%,NOTCH2;SIK1;GJA5;BMPR2;HCN4;SGCD;SMAD4
prerank,epithelial cell migration (GO:0010631),0.6004859894044504,1.62488338616214,0.01440922190201729,0.2288435296892753,1.0,17/37,18.42%,DPP4;PKN1;ZEB2;ADGRA2;STAT1;FAP;PKN2;PLXND1;PXN;RHOA;PIK3CA;KIT;ROCK1;STARD13;KANK1;PKN3;PTP4A3
prerank,T cell migration (GO:0072678),0.7369993850380889,1.624308197930958,0.026016260162601626,0.22872758823912193,1.0,5/13,6.24%,MYO1G;MSN;CXCL10;ZAP70;CXCL16
prerank,positive regulation of lymphocyte activation (GO:0051251),0.6311244922310455,1.623606084627327,0.014044943820224719,0.22899249460142151,1.0,3/28,0.77%,CCR2;CYRIB;CD47
prerank,dendritic cell chemotaxis (GO:0002407),0.7203835334409969,1.62349219711233,0.023064250411861616,0.22786510896766063,1.0,2/14,1.95%,CCR2;CCR1
prerank,rRNA methylation (GO:0031167),-0.5645849943141504,-1.6233370429715905,0.011142061281337047,0.3599543868519237,1.0,13/22,29.05%,METTL15;ZCCHC4;DIMT1;NOP2;NSUN3;EMG1;FTSJ3;NSUN5;MRM1;TRMT112;MRM3;BUD23;FDXACB1
prerank,interleukin-6-mediated signaling pathway (GO:0070102),0.6897380611546935,1.6228698269149135,0.023809523809523808,0.22802391273322137,1.0,9/18,9.94%,JAK2;STAT3;SPI1;CBL;IL6R;STAT1;IL6ST;IL6;SMAD4
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.7090651217400663,1.6224995246649179,0.0214168039538715,0.22747439946376044,1.0,4/15,5.48%,CD74;CD44;TAF9;PTTG1IP
prerank,regulation of phagocytosis (GO:0050764),0.569899182459786,1.6223960975817922,0.015852047556142668,0.22641966020423365,1.0,12/53,5.37%,FGR;PTPRC;IL1B;HCK;CD47;DOCK2;CAMK1D;SYK;PLSCR1;DYSF;SCARB1;IL2RG
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),0.727044461899675,1.621742144111673,0.01680672268907563,0.22657831940766898,1.0,9/14,18.66%,DHX58;ANKRD17;OASL;PUM2;TLR3;USP15;TLR2;PUM1;ZDHHC5
prerank,heterotypic cell-cell adhesion (GO:0034113),0.6385961801332604,1.6211068856034643,0.029239766081871343,0.22658515684806785,1.0,6/25,7.78%,ITGB7;ITGA4;ITGAX;ITGAD;ITGB2;CD2
prerank,ameboidal-type cell migration (GO:0001667),0.5740940072793302,1.6205351791493636,0.011873350923482849,0.22655323283537657,1.0,9/51,7.21%,ITGB7;ITGA4;SRGAP2;PKN1;SEMA4A;PDLIM1;GPC3;GDNF;PKN2
prerank,regulation of calcium-mediated signaling (GO:0050848),0.6540229152677426,1.620484925717721,0.015060240963855422,0.22540048487192754,1.0,3/25,1.21%,ITPR1;LRRK2;PLCG2
prerank,nucleotide catabolic process (GO:0009166),0.6985477507311975,1.6187565579172418,0.029459901800327332,0.2276983716732617,1.0,6/16,14.73%,SAMHD1;GDA;GPX1;DERA;VCP;NT5C2
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),0.7711297378142137,1.6161252969726265,0.02040816326530612,0.23240099183033233,1.0,5/10,3.80%,LYN;STAT5A;JAK2;STAT3;STAT5B
prerank,positive regulation of inflammatory response (GO:0050729),0.5223676248821112,1.6123507143038691,0.008403361344537815,0.23915556907943972,1.0,18/86,12.51%,CCR2;IL1B;CD47;NFKBIA;PTGER4;NFKBIZ;IL33;IL17RA;ABCC1;PDCD4;PDE2A;TLR3;IL6ST;IL6;IFI35;RIPK1;APP;TLR2
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),0.6259034003667718,1.610431767265208,0.029197080291970802,0.2421752965930603,1.0,7/27,10.51%,PID1;IL1B;PIP4K2A;PTPRE;TNS2;PIP4K2B;PTPN1
prerank,neutrophil migration (GO:1990266),0.5608561450707086,1.6099342211026864,0.01015228426395939,0.24186804839450313,1.0,10/58,9.30%,JAML;PECAM1;SYK;CD177;CXCL10;CKLF;ITGB2;IRAK4;GBF1;PIKFYVE
prerank,positive regulation of vasculogenesis (GO:2001214),0.7631698856968321,1.609479035580375,0.021314387211367674,0.24150025079539178,1.0,3/10,3.14%,RIN2;RAP1A;RAPGEF2
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),0.6919733682599855,1.6089377433259817,0.02511773940345369,0.2414220976087887,1.0,4/17,6.89%,MYO1G;BACH2;STAT3;GNL1
prerank,regulation of inflammatory response (GO:0050727),0.4856264334618567,1.6080805686101298,0.0021390374331550803,0.2420132144542279,1.0,48/190,15.91%,CCR2;FFAR4;IL1B;FOXP1;HCK;CD47;KLF4;PPARG;METRNL;BCL6;ACE2;JAK2;PTGIS;AKNA;NFKBIA;PTGER4;SMPDL3B;NFKBIZ;IL33;BIRC3;IL17RA;ABCC1;PDCD4;PDE2A;SPATA2;TLR3;IL6;IFI35;SBNO2;ANXA1;CYLD;RIPK1;ACOD1;NLRP3;APP;TLR2;AREL1;ADAMTS12;TNFRSF1B;CASP12;IL18;GPS2;TNFAIP6;MYD88;XIAP;RELA;CELF1;PROC
prerank,positive regulation of cell division (GO:0051781),0.5928777664690609,1.6064085818889058,0.015406162464985995,0.24433110224232216,1.0,10/38,9.32%,SVIL;CDC14A;PRKCE;RACGAP1;CUL3;KIF23;CDC42;PKN2;RHOA;SPAST
prerank,regulation of plasminogen activation (GO:0010755),-0.6520981131402818,-1.604981088533037,0.041666666666666664,0.41181791082503366,1.0,5/12,12.12%,PLGRKT;SERPINE2;CTSZ;HPN;SERPINE1
prerank,positive regulation of viral life cycle (GO:1903902),0.6558714546859169,1.6049605821760298,0.02321981424148607,0.24628097660512716,1.0,3/22,6.47%,CD74;TSG101;LGALS1
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.5210537142401965,1.6049288580533037,0.008443908323281062,0.2450915228282833,1.0,16/86,8.61%,CD74;CD44;PTPRC;PECAM1;PLCG2;FYN;JAK2;PTPN6;IL6R;ITGB2;PRNP;PTK2B;SAMSN1;PAK2;HGF;IL6
prerank,regulation of interleukin-12 production (GO:0032655),0.5691477140592083,1.6037803236732784,0.0066844919786096255,0.24664614550654948,1.0,11/47,8.52%,FOXP1;CD47;PLCG2;LILRB1;CD40;SYK;LAPTM5;MAPK14;TIRAP;PLCB1;TLR3
prerank,melanosome localization (GO:0032400),-0.5575399339756836,-1.603021615904759,0.021212121212121213,0.41161660080202284,1.0,9/21,17.70%,MLPH;BBS2;SHROOM2;MREG;MYO5A;ARL6;BLOC1S5;VPS33B;RAB11A
prerank,negative regulation of cyclase activity (GO:0031280),0.7260115558171152,1.6028615155030637,0.022187004754358162,0.24751301533358078,1.0,1/14,0.04%,CCR2
prerank,potassium ion export across plasma membrane (GO:0097623),0.7228486448811766,1.6001475269695142,0.023961661341853034,0.2524112888744304,1.0,2/13,3.31%,KCNE3;KCNQ1
prerank,regulation of T cell chemotaxis (GO:0010819),0.7315890541130143,1.5993905319665556,0.032148900169204735,0.25281356929775184,1.0,4/11,9.52%,CCR2;CXCL10;ADAM17;OXSR1
prerank,regulation of B cell apoptotic process (GO:0002902),0.7366042440802153,1.5981318489001968,0.021739130434782608,0.25427722946189224,1.0,3/12,1.98%,FOXP1;LYN;BCL6
prerank,negative regulation of coagulation (GO:0050819),-0.6297083675012736,-1.59811165242211,0.04096385542168675,0.4214838800544585,1.0,4/14,4.74%,APOE;HS3ST5;SERPINE2;CD34
prerank,positive regulation of mRNA catabolic process (GO:0061014),0.5765007040087375,1.597191356018201,0.010680907877169559,0.25526891312548283,1.0,17/44,16.94%,ZC3HAV1;MEX3D;BTG2;RC3H1;GIGYF2;YTHDF3;ZFP36L2;EIF4ENIF1;METTL3;TNRC6B;ROCK1;PNPT1;TNRC6A;CELF1;PABPC1;PUM1;CNOT8
prerank,neuron projection regeneration (GO:0031102),-0.6840863503691207,-1.5968591230291875,0.0387243735763098,0.4186988022387713,1.0,6/10,24.60%,RTN4RL1;PTN;NREP;MTR;OMG;DHFR
prerank,negative regulation of adenylate cyclase activity (GO:0007194),0.7314071277578852,1.5967026574304921,0.022292993630573247,0.2551258907063297,1.0,1/13,0.04%,CCR2
prerank,negative regulation of signaling receptor activity (GO:2000272),0.6231395711878156,1.5964816979557737,0.02878787878787879,0.25433769832007813,1.0,7/25,8.43%,PPARG;ACE2;CBLB;CBL;TSG101;CNRIP1;EPHB2
prerank,branching morphogenesis of an epithelial tube (GO:0048754),-0.46512052087080336,-1.595606873441838,0.014336917562724014,0.41597384651394836,1.0,11/39,11.95%,TGFBR2;LRP6;SALL1;NRP1;NPNT;FGF2;CTNNB1;PKD2;SEMA3E;SLIT2;VEGFA
prerank,positive regulation of cell killing (GO:0031343),0.7147009599314378,1.595245470723441,0.037953795379537955,0.25579929190211176,1.0,7/13,18.67%,SYK;NOX1;RAC1;MAPK8;DVL2;CYBA;FZD7
prerank,B cell receptor signaling pathway (GO:0050853),0.612044364489011,1.5949099737786192,0.02282453637660485,0.255301196624921,1.0,7/32,5.26%,VAV3;PTPRC;PLCG2;SYK;NFAM1;CD79B;BCAR1
prerank,regulation of vasculogenesis (GO:2001212),0.700383298660666,1.5947860205674702,0.030303030303030304,0.25432777512654,1.0,3/14,3.14%,RIN2;RAP1A;RAPGEF2
prerank,lipid catabolic process (GO:0016042),0.6650690722743626,1.591974693440387,0.02631578947368421,0.259561701223011,1.0,3/18,5.81%,PLA1A;HSD17B14;CEL
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),-0.6474907241572749,-1.5917279217187692,0.027227722772277228,0.4216506848907886,1.0,4/12,7.60%,BIN1;CTNNA3;CACNA1C;JUP
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.5008139794598573,1.591520565267193,0.003409090909090909,0.2593922193276006,1.0,31/121,14.64%,CD74;CD44;PTPRC;NEDD9;LYN;FLT3;PECAM1;PLCG2;ACE;CD40;JAK2;STAT3;IL6R;PRNP;PTK2B;PARP14;PAK2;IL6ST;HGF;IL6;PARP9;IL31RA;PTPN1;UNC119;CASS4;KIT;HCLS1;TGFB1;FGFR3;PTPRJ;IL18
prerank,lymphocyte differentiation (GO:0030098),0.5358555764645555,1.5906864730185875,0.011553273427471117,0.26003082225974394,1.0,20/68,14.69%,ITGA4;PTPRC;FLT3;PTPN22;PLCG2;NFAM1;CD79B;RABL3;LFNG;ZAP70;KAT7;ADAM17;HDAC9;PBX1;TPD52;SLC25A5;KIT;NFIL3;PTPRJ;GPS2
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.6629107963144493,1.5893261672870307,0.0392156862745098,0.26187427888488823,1.0,3/20,4.15%,GRK3;RGS2;CRY1
prerank,substrate adhesion-dependent cell spreading (GO:0034446),0.5677646261563264,1.5893216497267186,0.016216216216216217,0.260624833020298,1.0,13/46,12.95%,ITGB7;ITGA4;ATRNL1;SRGAP2;NTNG2;LAMB1;RAC1;PXN;RHOA;FN1;MEGF9;ITGA8;USH2A
prerank,regulation of lymphocyte differentiation (GO:0045619),0.6764949581128081,1.5888869126640475,0.024429967426710098,0.2604201904029208,1.0,7/18,13.39%,CCR2;IKZF3;CD2;ZFP36L2;SLAMF8;PRELID1;METTL3
prerank,regulation of cell communication (GO:0010646),0.5945952827721687,1.5875736384879522,0.029282576866764276,0.26233019775417277,1.0,9/35,10.51%,GRK3;GRK5;CRK;GJA5;CDC42SE2;MTCH1;GRK6;ANXA1;PTPN1
prerank,negative regulation of biosynthetic process (GO:0009890),0.6846734330352435,1.5873599233999935,0.024793388429752067,0.2616479578287137,1.0,2/16,3.48%,CIITA;ABCB7
prerank,cardiac muscle cell action potential (GO:0086001),-0.5032071521083578,-1.5871307792021716,0.009433962264150943,0.43030847843268105,1.0,11/30,12.13%,CACNA1D;SLC8A1;CACNA2D1;SCN1A;KCNJ2;CACNA1C;ATP1B1;ANK2;ATP1A2;HCN2;SCN1B
prerank,B cell differentiation (GO:0030183),0.5674925747533744,1.5862697305241187,0.012162162162162163,0.2627505392704678,1.0,14/46,14.69%,ITGA4;PTPRC;FLT3;PLCG2;NFAM1;CD79B;RABL3;ADAM17;HDAC9;TPD52;SLC25A5;KIT;PTPRJ;GPS2
prerank,positive regulation of T cell migration (GO:2000406),0.6504121483388279,1.586154566554081,0.038580246913580245,0.2617878448722664,1.0,8/20,13.74%,CCR2;CXCL10;SPN;ADAM17;RHOA;OXSR1;APP;STK39
prerank,phospholipid catabolic process (GO:0009395),0.6254363832510665,1.584294581244455,0.02881844380403458,0.26474349888235027,1.0,4/24,5.58%,PLBD1;PRDX6;SMPDL3A;GPCPD1
prerank,negative regulation of interleukin-8 production (GO:0032717),0.6753184886141637,1.5837598315447792,0.03179650238473768,0.26488167693135417,1.0,7/17,12.11%,PTPN22;BCL3;KLF4;ANXA4;ANXA1;CACTIN;MAP2K5
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.557125754717819,1.5834535621730401,0.02193548387096774,0.2644336879165579,1.0,20/50,16.04%,CD44;NGF;KLF4;NGFR;GPX1;RPS6KA3;DPEP1;PAK2;CARD16;HGF;CSNK2A1;RPS6KA1;MAP2K5;SH3RF1;AKT1;DHCR24;CAAP1;XIAP;THBS1;USP47
prerank,ceramide biosynthetic process (GO:0046513),0.5776125682572152,1.58252088712091,0.021768707482993196,0.26534216428389407,1.0,8/40,8.25%,CERS6;ST8SIA4;ST8SIA6;CERS1;SAMD8;SGMS1;SGMS2;ST6GALNAC3
prerank,regulation of insulin receptor signaling pathway (GO:0046626),0.5665055308431898,1.5820815558148509,0.018396846254927726,0.2651973416880479,1.0,9/43,10.51%,PID1;IL1B;PIP4K2A;PTPRE;SORL1;TNS2;SIK2;PIP4K2B;PTPN1
prerank,negative regulation of response to cytokine stimulus (GO:0060761),0.7460441011573131,1.5815873633436026,0.04129263913824058,0.26510380726556876,1.0,2/10,1.27%,PTPRC;KLF4
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.5166642492236903,1.58147258779384,0.01575757575757576,0.26412939562244403,1.0,20/87,8.94%,RND3;IQGAP2;IQGAP1;NOTCH2;EPS8;PAK1;CELSR1;ARHGAP18;CRK;CORO1A;CCDC88A;RAC2;DLC1;ARHGDIB;PTK2B;F11R;RHOBTB3;EZR;RAC1;RHOA
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),-0.6030876799313034,-1.5812676026771122,0.03076923076923077,0.4444621907612596,1.0,8/15,22.60%,RAB3GAP2;ZFAND2A;SPCS3;RAB3GAP1;SEC61G;SRPRB;RYR2;ZFAND2B
prerank,phosphorylation (GO:0016310),0.46640815522785695,1.5810156110490317,0.0,0.26385698999807816,1.0,108/385,14.26%,GRK3;FGR;LRRK2;GRK5;RARA;STK10;MAP4K1;SGK3;RUNX3;HCK;LYN;PRKCE;LIMD1;DGKG;CERKL;SIK1;STK24;NADK;CDK13;VRK1;CREB1;DAPK1;FYN;RET;MAP3K5;LMTK2;AKT3;SYK;PIM1;PKN1;PAK1;STK17B;PRKAG2;JAK2;STAT3;ERN1;PRKCH;IP6K3;BMPR2;MAPKAPK2;BIRC6;STK38;EIF2AK2;BCR;IKBKB;ZAP70;VRK2;GMFG;TAOK3;SIK3;HIPK2;RPS6KA5;CDK14;MAP3K1;HIPK1;STK4;PTK2B;PDPK1;MKNK2;DYRK1A;PKN2;PAK2;SIK2;COQ8A;EPHB2;ACVR2A;STK38L;MINK1;LATS1;OXSR1;CSNK2A1;BRAF;TLK2;CAMKK2;PPP4R1;GRK6;PIK3CA;YWHAZ;PRKG2;PRKAG1;DMPK;NLK;LATS2;MAP4K3;PRKAA1;APP;CCNT1;PIK3R4;CDK12;MORC3;MAP3K20;EIF2AK3;BTK;MAPK8;AKT1;PDK3;LIMK2;CSK;MARK3;TYK2;HCST;STK39;PRKAA2;ROCK1;TLK1;LMTK3;TGFB1;HASPIN
prerank,endocrine system development (GO:0035270),-0.5631840307393335,-1.5804924533886624,0.028481012658227847,0.43986367739496224,1.0,8/21,27.38%,SALL1;TGFBR1;NF1;MDK;DKK3;HOXD3;SOX2;WNT4
prerank,tRNA processing (GO:0008033),-0.42483960061939485,-1.580326311830222,0.0,0.43357556707632444,1.0,43/61,36.26%,NSUN2;TRMT1;ANKRD16;TRNT1;CSTF2;POP1;QTRT1;ELP5;TYW5;RTRAF;FAM98B;RPP30;TSEN2;CDKAL1;METTL1;DTWD2;PTCD1;TSEN34;ZBTB8OS;SSB;THUMPD1;RTCB;KARS1;TRMT10A;WDR4;TRMT6;NSUN6;LCMT2;ELAC2;TRMT9B;DTWD1;RPP40;QTRT2;FTSJ1;POP5;CTU2;AARS2;TSEN54;RPP21;POP7;THG1L;TRMT61A;CTU1
prerank,regulation of T cell cytokine production (GO:0002724),0.702282546652335,1.5787492419401554,0.018456375838926176,0.26787978264514284,1.0,5/15,13.54%,CCR2;MALT1;B2M;MAP3K7;TNFRSF1B
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),0.6386153648387327,1.5786337892720317,0.025954198473282442,0.26693725730796086,1.0,7/23,9.67%,IFNGR1;PPARG;JAK2;SUMO1;STAT1;PARP14;PARP9
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),0.6985354146749292,1.5785014759635134,0.04333868378812199,0.26607420234165097,1.0,3/14,1.94%,CCR2;PTPN22;SYK
prerank,ventricular cardiac muscle cell action potential (GO:0086005),0.6557477387947469,1.576548940152679,0.03064516129032258,0.2693614813971863,1.0,3/17,3.31%,KCNE3;NEDD4L;KCNQ1
prerank,ganglion development (GO:0061548),-0.6583539358697927,-1.5764946350597893,0.014669926650366748,0.43983650709584843,1.0,4/11,12.11%,NRP1;NRP2;CTNNB1;TUBB3
prerank,regulation of protein targeting to membrane (GO:0090313),0.619189355621044,1.5762876727390267,0.021613832853025938,0.2687506322640487,1.0,8/28,10.59%,TCAF2;FYN;C2CD5;MYO1C;ITGB2;PRNP;CIB1;FIS1
prerank,positive regulation of JNK cascade (GO:0046330),0.5295154594805576,1.575396820864877,0.008816120906801008,0.26956939455783296,1.0,25/70,18.67%,IL1B;TRAF1;MAP3K5;AXIN1;TAOK3;TRAF4;HIPK2;TIRAP;PTK2B;TRAF3;PLCB1;MBIP;MINK1;RIPK1;FCGR2B;APP;SH3RF1;NCF1;DUSP22;WNT7A;RASSF2;TRAF2;MMP8;SEMA3A;FZD7
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),0.6755405614071551,1.5753587788419874,0.021035598705501618,0.2684481549911357,1.0,12/18,22.66%,CYRIB;SHTN1;RIPOR2;PTK2B;BCAS3;ARFGEF1;ROCK1;KANK1;KRIT1;KIF20B;LLGL2;RAP1B
prerank,negative regulation of glucose transmembrane transport (GO:0010829),0.754243471436278,1.5744755656017102,0.025597269624573378,0.26936099873366126,1.0,2/10,0.33%,PID1;IL1B
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),0.5928245795041946,1.5737031880609453,0.02608695652173913,0.2700626257146088,1.0,11/33,15.62%,GLI1;PLCG2;PSME3;PTPN6;FBXW7;PSME2;PTEN;ID2;EZH2;TAF1;INO80
prerank,positive regulation of T cell activation (GO:0050870),0.5373785025939682,1.572995506381667,0.017676767676767676,0.2705385535624826,1.0,9/62,8.61%,CCR2;PTPRC;IL1B;CYRIB;CD47;ZAP70;CD276;IL6ST;IL6
prerank,release of sequestered calcium ion into cytosol (GO:0051209),0.6251444542070556,1.5716411997162114,0.03328290468986384,0.27247251827393487,1.0,5/26,4.75%,ITPR1;PTPRC;PLCG2;SLC8B1;IBTK
prerank,positive regulation of cell-substrate adhesion (GO:0010811),0.5308599810209812,1.5703125447030781,0.01373283395755306,0.2742233759428966,1.0,16/67,8.19%,NEDD9;DOCK5;NDNF;UTRN;JAK2;CRK;CD36;CDC42;CARMIL1;RSU1;PTK2B;PLEKHA2;FLNA;CIB1;S100A10;RAC1
prerank,positive regulation of defense response (GO:0031349),0.5054516873997286,1.5696662150607816,0.01570048309178744,0.2745733935242175,1.0,20/89,13.30%,CCR2;IL1B;CD47;POLR3F;PLSCR1;NFKBIA;PTGER4;NFKBIZ;IL33;IL17RA;ABCC1;PDCD4;PDE2A;TLR3;IFI35;SLC15A4;RIPK1;APP;TLR2;GBP5
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),0.6022095231566778,1.5695190119765488,0.02275960170697013,0.2737224757406234,1.0,8/30,6.94%,LYN;NOTCH2;RASGRP4;NGF;JAK2;ERBIN;GRB2;SHOC2
prerank,B cell proliferation (GO:0042100),0.6690857091711933,1.5684399820054622,0.028846153846153848,0.27513807618160596,1.0,3/17,2.31%,PTPRC;CD40;GAPT
prerank,regulation of establishment of cell polarity (GO:2000114),0.6880299037306784,1.5683527695831898,0.029900332225913623,0.2741828256775824,1.0,10/16,19.13%,CYRIB;SHTN1;RIPOR2;PTK2B;BCAS3;ARFGEF1;ROCK1;KANK1;KRIT1;KIF20B
prerank,negative regulation of B cell proliferation (GO:0030889),0.7117324159764106,1.5677537668913952,0.040780141843971635,0.2743097863876295,1.0,4/11,11.69%,LYN;CD300A;RC3H1;FCGR2B
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),0.7488951731495436,1.565825893715625,0.023809523809523808,0.27749491312068936,1.0,3/10,1.35%,PTPRC;KLRD1;LILRB1
prerank,phosphatidylglycerol metabolic process (GO:0046471),-0.5172759480287996,-1.565800750663091,0.02064896755162242,0.46920232356164987,1.0,8/24,9.67%,PLA2G15;LPCAT1;PNPLA8;SLC27A1;PLA2G4A;CDS2;SERAC1;GPAM
prerank,positive regulation of interleukin-12 production (GO:0032735),0.597425060307098,1.5655200964739682,0.024079320113314446,0.27698113963428866,1.0,8/31,8.52%,PLCG2;CD40;SYK;LAPTM5;MAPK14;TIRAP;PLCB1;TLR3
prerank,modulation by host of viral genome replication (GO:0044827),-0.6347131843111983,-1.5651144650610518,0.027918781725888325,0.4646902524981453,1.0,6/13,15.48%,PRKN;EIF2AK4;TBC1D20;IFI27;FBXL2;CCNK
prerank,endothelial cell migration (GO:0043542),0.5762956180462311,1.5643294452130574,0.03418803418803419,0.27872534003857813,1.0,9/37,10.64%,DPP4;MYH9;ADGRA2;STAT1;FAP;PLXND1;PXN;RHOA;PIK3CA
prerank,regulation of response to biotic stimulus (GO:0002831),0.6083827193593395,1.564001598040601,0.027616279069767442,0.27831760426997293,1.0,9/28,7.45%,FGR;FOXP1;PTPN22;SAMHD1;CD36;DHX58;BIRC3;TIRAP;TRAF3
prerank,positive regulation of lipid metabolic process (GO:0045834),0.634757503036451,1.5639070306029002,0.034954407294832825,0.2774096990361606,1.0,8/22,15.05%,IL1B;CREB1;PPARG;ZBTB20;CREBL2;AKT1;SIRT4;ANGPTL3
prerank,cellular response to cytokine stimulus (GO:0071345),0.46041946920140536,1.5636295239259195,0.0,0.2770188511839068,1.0,104/416,14.68%,CCR2;GRAP2;PID1;IL1B;IFNLR1;HCK;STAT4;CD47;FPR1;FLT3;IL27RA;IFNGR1;DAPK1;FYN;ITGAX;CD40;MCL1;STAT5A;SYK;CCR1;BCL6;PIM1;NFKB1;JAK2;STAT3;VIM;FOS;CRK;CD36;PTGIS;ERBIN;SLA;IL10RA;CXCL10;RIPOR2;PTPN6;STAT5B;MMP1;PTPN7;CBL;IL6R;IKBKB;PTPN12;F13A1;STAT1;IL2RG;ITGB2;RC3H1;IRF4;IRAK4;CCND1;GRB2;ZFAND6;CSF2RB;NFE2L2;CIB1;PDE2A;IFNAR1;IL6ST;ZFP36L2;HGF;IL6;SOS1;RHOA;OPRM1;ICAM1;IL1R2;OXSR1;TANK;RPS3;SBNO2;FN1;ANXA1;IL31RA;PIK3CA;RIPK1;YWHAZ;CACTIN;FOXO3;DUSP1;ACOD1;TLR2;EBI3;LIFR;MAPK8;AKT1;KIT;STAT2;GBP5;CSK;ADAMTS12;JUNB;TNFRSF1B;HCLS1;TYK2;STK39;IFIT1;PNPT1;LRCH1;TGFB1;SYNCRIP;PTPRJ;IL18;GBP2
prerank,cellular lipid catabolic process (GO:0044242),0.6048538947860609,1.5631519098957805,0.03367496339677892,0.27698037833108075,1.0,4/27,5.81%,PLBD1;SMPDL3B;NUDT19;CEL
prerank,stress-activated protein kinase signaling cascade (GO:0031098),0.6225439800828034,1.5629452741567282,0.023529411764705882,0.27630330125364466,1.0,11/27,15.12%,MAP3K5;MAP3K8;NFKB1;CCDC88C;IKBKB;KAT7;FBXW11;MAP3K7;MAP3K20;MAPK8;MAPK1
prerank,dopamine metabolic process (GO:0042417),-0.5531336579624384,-1.5628400917911867,0.04607046070460705,0.4658293842035173,1.0,3/18,1.80%,PRKN;SNCAIP;COMT
prerank,regulation of lymphocyte migration (GO:2000401),0.758490391777449,1.5615259659541603,0.04020979020979021,0.2784911655403725,1.0,4/10,5.25%,STK10;MSN;SLC8B1;SPN
prerank,regulation of T cell activation (GO:0050863),0.5656534779799037,1.5610223667128524,0.03230148048452221,0.27861970153343213,1.0,5/42,3.22%,CCR2;CYRIB;CD47;PTPN22;LAPTM5
prerank,transport along microtubule (GO:0010970),0.709132289488277,1.559984615632244,0.04152823920265781,0.27984584615061137,1.0,9/13,17.86%,APBA1;COPG2;CDC42;ARHGAP21;APP;CLIP3;DYNC1I2;BAG3;BORCS5
prerank,blood circulation (GO:0008015),0.5523832445730148,1.5599403534304574,0.018396846254927726,0.2788179815623146,1.0,10/49,9.29%,ACE;TBC1D8;ACE2;GPX1;CXCL10;HCN4;OLR1;STAT1;SGCD;GUCY1A1
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.5252743351440408,1.5596128002695688,0.0189873417721519,0.2785830257195905,1.0,29/67,17.78%,VAV3;CYBB;FYN;MAPKAPK3;WASF2;CRK;MAPKAPK2;ABI1;CDC42;VEGFC;BCAR1;ELMO2;MAPK14;PTK2B;PAK2;RAC1;PXN;RHOA;PGF;NCF2;PIK3CA;NCF1;ROCK1;CYFIP2;ELMO1;SHB;PIK3R2;SH2D2A;CYBA
prerank,regulation of cell size (GO:0008361),0.6278631114785942,1.5595731751378616,0.027906976744186046,0.2776235949525575,1.0,9/23,8.94%,VAV3;RAP1GAP2;MSN;PTEN;MTPN;RARG;EZR;RAC1;RHOA
prerank,positive regulation of protein targeting to membrane (GO:0090314),0.6279797970840448,1.5585455259343097,0.03170028818443804,0.278857882436387,1.0,8/24,10.59%,TCAF2;FYN;C2CD5;MYO1C;ITGB2;PRNP;CIB1;FIS1
prerank,cellular response to interleukin-15 (GO:0071350),0.701299804473267,1.55846995812204,0.044189852700491,0.2768658146378784,1.0,6/13,7.50%,STAT5A;STAT3;STAT5B;IL2RG;GRB2;PLCB1
prerank,interleukin-15-mediated signaling pathway (GO:0035723),0.701299804473267,1.55846995812204,0.044189852700491,0.2768658146378784,1.0,6/13,7.50%,STAT5A;STAT3;STAT5B;IL2RG;GRB2;PLCB1
prerank,cellular response to mechanical stimulus (GO:0071260),0.5535711882759128,1.5581523691889667,0.018944519621109608,0.276542042148617,1.0,12/46,10.48%,IL1B;CD40;CNN2;NFKB1;MAP3K14;PTGER4;MAP3K1;PDE2A;F11R;TLR3;PIEZO1;CASP2
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),0.7074282371332057,1.5573541509006248,0.036605657237936774,0.27724652440301245,1.0,3/13,8.61%,LRRK2;NFE2L2;HGF
prerank,negative regulation of cellular component movement (GO:0051271),0.6800311694410612,1.5555346131152052,0.04612850082372323,0.28025510735896997,1.0,3/15,2.67%,SP100;CCDC125;CRK
prerank,growth hormone receptor signaling pathway (GO:0060396),0.68744667806066,1.5555310272776213,0.032948929159802305,0.279176882116368,1.0,7/14,10.51%,LYN;STAT5A;JAK2;STAT3;STAT5B;PXN;PTPN1
prerank,phosphatidylinositol metabolic process (GO:0046488),0.49777873804216005,1.555390475785149,0.0057405281285878304,0.2783900776250728,1.0,26/109,13.08%,PLBD1;PLCG2;PIP4K2A;PIK3C2A;IP6K3;MTMR14;INPP5F;OCRL;PI4K2B;PTEN;MTMR3;INPP4A;IMPA1;PIK3R6;PLEKHA2;ARF1;PLCB1;MTMR4;SYNJ1;PITPNM1;PIKFYVE;PIP4K2B;PIK3CA;CDIPT;PIK3R4;PIP5K1A
prerank,vitamin D metabolic process (GO:0042359),-0.6265176417499744,-1.5534373577271465,0.04522613065326633,0.49245694616918323,1.0,1/13,0.16%,LGMN
prerank,signal release from synapse (GO:0099643),-0.44798196022008746,-1.553289061999533,0.011235955056179775,0.48607208159653326,1.0,19/43,23.47%,SYT1;PTPRN2;PCLO;NRXN2;SNAP25;GAD2;CDK5;SNPH;STX1A;LIN7A;CPLX1;RIMS1;RAB3A;NRXN1;GAD1;SYN2;PDZD11;SLC32A1;CPLX2
prerank,negative regulation of ATP metabolic process (GO:1903579),0.6705465881914685,1.5530477553997357,0.02593192868719611,0.28254503613736803,1.0,2/17,0.25%,CBFA2T3;PID1
prerank,positive regulation of signaling receptor activity (GO:2000273),0.5833240502203353,1.5529258790641505,0.023054755043227664,0.2817817568795159,1.0,8/36,8.43%,CCR2;JAK2;NCOA3;FBXW7;ADRA2A;ADAM17;BUD31;EPHB2
prerank,positive regulation of lipid transport (GO:0032370),-0.6275265681330586,-1.5516085507888686,0.06088992974238876,0.4851808836094085,1.0,4/12,3.76%,APOE;LRP1;SPP1;ABCB4
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),0.6580757067716941,1.5515269724181846,0.03927492447129909,0.28394050751648525,1.0,4/18,5.25%,ITGB7;ITGA4;SELL;SPN
prerank,negative regulation of extracellular matrix organization (GO:1903054),0.7427150586658962,1.5511561787349564,0.04896421845574388,0.2837240944263243,1.0,2/10,5.83%,DPP4;FAP
prerank,phagolysosome assembly (GO:0001845),0.7106359144136875,1.5509370623253351,0.04628099173553719,0.28316396069418104,1.0,7/12,13.25%,CORO1A;RAB7A;RAB7B;RAB34;RAB39A;PIKFYVE;ARL8B
prerank,camera-type eye development (GO:0043010),-0.5149295809161674,-1.550437213854295,0.034383954154727794,0.48234768197016187,1.0,11/25,24.99%,SKI;CACNA1C;NF1;RAB3GAP1;SHROOM2;VEGFA;EFEMP1;CEP290;CRYBA4;NES;FBN2
prerank,positive regulation of T cell proliferation (GO:0042102),0.5403427840192075,1.5484943029698084,0.019973368841544607,0.28785488677829885,1.0,12/55,12.81%,CCR2;PTPRC;IL1B;IL27RA;SYK;CD276;IL6ST;IL6;RPS3;ANXA1;EBI3;ICOSLG
prerank,organelle transport along microtubule (GO:0072384),0.6049570734596917,1.5478855277690895,0.03698435277382646,0.2882707957399892,1.0,10/31,12.05%,UXT;KIF5B;COPG2;CDC42;FBXW11;RAB6A;PAFAH1B1;PEX14;ARHGAP21;HTT
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),0.6888652279361404,1.5468439401965213,0.04612850082372323,0.2896189812031426,1.0,4/14,9.52%,CCR2;PTK2B;ADAM17;OXSR1
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.5829320159174372,1.546823338077912,0.033381712626995644,0.28858300902311484,1.0,12/33,15.28%,KLF4;NGFR;PPARG;STAT3;FOS;SPI1;KLF5;NR3C1;FOXO3;TEAD1;TGFB1;RELA
prerank,peptidyl-serine modification (GO:0018209),0.4748522943799183,1.5460229439471336,0.001072961373390558,0.28931213687202917,1.0,60/166,16.42%,LRRK2;MAP4K1;SGK3;PRKCE;VRK1;CAMK1D;LMTK2;AKT3;NDNF;MAPKAPK3;PKN1;PRKCH;RPS6KA3;CSNK1G1;MAPKAPK2;STK38;IKBKB;VRK2;HIPK2;MAPK14;RPS6KA5;HIPK1;STK4;PDPK1;MKNK2;DYRK1A;PKN2;PAK2;MAPK12;GALNT2;STK38L;CSNK1G3;TNKS;LATS1;CSNK2A2;CSNK2A1;TLK2;DMPK;LATS2;RPS6KA1;SMG1;MORC3;EIF2AK3;MAPK8;AKT1;PDK3;MARK3;STK39;ROCK1;TLK1;RPS6KA2;MAP3K13;BRSK1;MAPK1;TAF1;TBK1;POGLUT1;DYRK2;RPS6KB1;NTMT1
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),0.6955283008999988,1.5457344942854108,0.04126984126984127,0.2890044068159985,1.0,3/14,7.18%,ITGA4;CD40;PDCD4
prerank,regulation of cell-cell adhesion (GO:0022407),0.5696124010560382,1.545319550841701,0.0226628895184136,0.2889000877305209,1.0,10/39,14.75%,DPP4;CD47;FUT4;AFDN;MINK1;MEGF10;NF2;CITED2;TGFB1;PTPRG
prerank,regulation of mast cell degranulation (GO:0043304),0.6907184400695024,1.544450619994808,0.045454545454545456,0.2899953576996812,1.0,5/14,4.17%,FGR;LYN;SYK;CD300A;UNC13D
prerank,DNA strand elongation involved in DNA replication (GO:0006271),-0.5577940891328352,-1.5436083246578851,0.04456824512534819,0.5003897143336986,1.0,15/18,37.12%,POLD3;PCNA;LIG3;GINS1;POLA1;RFC3;LIG1;GINS3;POLE;POLE3;RFC4;MCM4;GINS4;GINS2;POLD2
prerank,phosphate-containing compound metabolic process (GO:0006796),0.4697487383712058,1.5430833060550122,0.003194888178913738,0.292349693450988,1.0,29/198,8.66%,PLBD1;LGALS13;LRRK2;PTPRC;LIMD1;CERKL;NADK;PLCG2;ITPKC;DUSP16;PIP4K2A;PAK1;STAT3;GPD2;IP6K3;PLD4;OCRL;ITPK1;PPP3CA;PTEN;INPP4A;IMPA1;PAK2;PXYLP1;PLCB1;PLCD4;COQ8A;EPHB2;SYNJ1
prerank,actin-myosin filament sliding (GO:0033275),0.567257840353344,1.5427003671988924,0.029166666666666667,0.29114669371353735,1.0,4/38,3.70%,TNNC1;TPM4;VIM;MYL4
prerank,muscle filament sliding (GO:0030049),0.567257840353344,1.5427003671988924,0.029166666666666667,0.29114669371353735,1.0,4/38,3.70%,TNNC1;TPM4;VIM;MYL4
prerank,response to organic cyclic compound (GO:0014070),0.54353691459834,1.5425602901963256,0.018205461638491547,0.2903901031263225,1.0,12/52,14.64%,LRRK2;HLCS;IL1B;KYNU;STAT3;STAT5B;TIPARP;TLR3;ANXA1;STRN3;TGFB1;IL18
prerank,mucosal immune response (GO:0002385),0.6814469015917207,1.5421219869751097,0.05573248407643312,0.2903546171656786,1.0,1/15,0.53%,IFNLR1
prerank,establishment of melanosome localization (GO:0032401),-0.552744082166883,-1.5420077819127247,0.0469208211143695,0.49902678675353024,1.0,8/19,17.70%,MLPH;BBS2;SHROOM2;MREG;MYO5A;ARL6;BLOC1S5;RAB11A
prerank,regulation of cartilage development (GO:0061035),0.6537171971042067,1.5419381958932799,0.03201219512195122,0.28972751554468024,1.0,3/18,4.20%,TRPS1;BMPR2;SCX
prerank,neurotransmitter secretion (GO:0007269),-0.4420921672794379,-1.5409044288687315,0.00749063670411985,0.49621670557721653,1.0,19/44,23.47%,SYT1;PTPRN2;PCLO;NRXN2;SNAP25;GAD2;CDK5;SNPH;STX1A;LIN7A;CPLX1;RIMS1;RAB3A;NRXN1;GAD1;SYN2;PDZD11;SLC32A1;CPLX2
prerank,negative regulation of lyase activity (GO:0051350),0.6725236582050196,1.5395076037239215,0.04153846153846154,0.294533492629167,1.0,1/16,0.04%,CCR2
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),0.6634493392805941,1.539476656611094,0.0368,0.2935596729401888,1.0,4/17,7.19%,CD74;CD44;PTTG1IP;DYRK1A
prerank,positive regulation of acute inflammatory response (GO:0002675),0.6908068056672685,1.538725391077063,0.04612850082372323,0.2943106773578874,1.0,4/14,10.38%,IL1B;IL6ST;IL6;PTGER3
prerank,establishment of endothelial barrier (GO:0061028),0.5957847493851925,1.53820853954359,0.029871977240398292,0.2945396565847047,1.0,9/29,9.14%,PECAM1;RAP1A;MSN;RAPGEF2;AFDN;PDE2A;F11R;EZR;ICAM1
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),-0.5802439704677523,-1.5377585988987164,0.043478260869565216,0.5011331894020687,1.0,8/16,21.23%,SLC8A1;CACNA1C;PRKACA;ANK2;ATP1A2;CALM1;GSTO1;RYR2
prerank,protein phosphorylation (GO:0006468),0.4515842285447682,1.537584868297177,0.0010070493454179255,0.2948896181175907,1.0,129/479,14.26%,GRK3;FGR;LRRK2;GRK5;RARA;STK10;MAP4K1;SGK3;RUNX3;HCK;LYN;PRKCE;FLT3;SIK1;STK24;CDK13;VRK1;CREB1;DAPK1;FYN;SLK;CAMK1D;RET;MAP3K5;LMTK2;AKT3;MAPKAPK3;SYK;PIM1;PKN1;PAK1;STK17B;PRKAG2;JAK2;ERN1;PRKCH;RPS6KA3;IP6K3;BMPR2;CSNK1G1;MAPKAPK2;BIRC6;STK38;PTPN6;ABI1;EIF2AK2;EIF2AK1;CRY1;BCR;IKBKB;ZAP70;VRK2;GMFG;TAOK3;SIK3;HIPK2;MAPK14;RPS6KA5;CDK14;MAP3K1;HIPK1;STK4;PTK2B;PDPK1;MKNK2;DYRK1A;PKN2;PAK2;MAPK12;CCNH;SIK2;COQ8A;EPHB2;ACVR2A;TLR3;STK38L;MINK1;CSNK1G3;TNKS;LATS1;USP15;OXSR1;CSNK2A2;CSNK2A1;BRAF;TLK2;CAMKK2;PPP4R1;GRK6;RIPK1;YWHAZ;PRKG2;PRKAG1;DMPK;NLK;LATS2;MAP4K3;PRKAA1;CAD;RPS6KA1;APP;CCNT1;MAP3K7;PIK3R4;SMG1;TLR2;CDK12;MORC3;MAP3K20;EIF2AK3;BTK;MAPK8;AKT1;PDK3;KIT;LIMK2;CSK;MARK3;TYK2;HCST;STK39;PRKAA2;ROCK1;TLK1;LMTK3;RPS6KA2;TGFB1;HASPIN;FGFR3
prerank,cellular response to type I interferon (GO:0071357),0.5569483231708507,1.5372472208670926,0.031207598371777476,0.2935822256375317,1.0,20/41,16.77%,SP100;SAMHD1;OAS2;IFIT2;IRF2;STAT1;IRF4;OASL;IFNAR1;IFI35;IRF7;PSMB8;STAT2;TYK2;IFIT1;GBP2;MYD88;IFITM3;IRF5;IFNAR2
prerank,type I interferon signaling pathway (GO:0060337),0.5569483231708507,1.5372472208670926,0.031207598371777476,0.2935822256375317,1.0,20/41,16.77%,SP100;SAMHD1;OAS2;IFIT2;IRF2;STAT1;IRF4;OASL;IFNAR1;IFI35;IRF7;PSMB8;STAT2;TYK2;IFIT1;GBP2;MYD88;IFITM3;IRF5;IFNAR2
prerank,organophosphate catabolic process (GO:0046434),0.741575720422562,1.537185880506856,0.03204047217537943,0.2927187314651111,1.0,1/11,0.01%,PLBD1
prerank,response to retinoic acid (GO:0032526),0.533338781480152,1.5358556521535522,0.022670025188916875,0.2946417527649797,1.0,8/59,7.87%,RARA;LYN;CREB1;RET;TRIM16;SETX;PTK2B;RARG
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),0.7255161073933944,1.5358522848950569,0.04091653027823241,0.29362911534728126,1.0,1/11,0.08%,GRK3
prerank,calcium ion transport into cytosol (GO:0060402),-0.5333779552751613,-1.5356620388796283,0.026737967914438502,0.5021125167742497,1.0,8/21,22.56%,SLC8A1;CACNA2D1;CACNA1C;TRPM2;TRPV4;RYR2;ADRA1A;GRIN2B
prerank,leukocyte tethering or rolling (GO:0050901),0.6602776585193203,1.5347055812382109,0.05167173252279635,0.2952544555177121,1.0,4/17,5.25%,ITGB7;ITGA4;SELL;SPN
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),0.6762829623547526,1.5346672711927307,0.04582651391162029,0.2943526443108713,1.0,2/14,2.21%,ACE;ACE2
prerank,NAD biosynthetic process (GO:0009435),0.6340764369422899,1.5343509219650646,0.04790419161676647,0.2940600037490632,1.0,6/20,12.36%,KYNU;PTGIS;HAAO;NAXE;PARP9;NMNAT3
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.5738833475748021,1.5336566457279923,0.036337209302325583,0.2946385108989934,1.0,9/30,13.29%,PTPRC;CD300A;PTPN6;INPP5F;SAMSN1;PARP14;SH3BP5;NF2;MVP
prerank,membrane protein proteolysis (GO:0033619),0.5773204763022313,1.5320498326935639,0.02244039270687237,0.2974360879933641,1.0,14/37,15.28%,NAPSA;NGFR;RET;NFKB1;MYH9;PARL;ADAM17;SPPL2A;ADAM19;MBTPS1;BACE2;TGFB1;ADAM9;RELA
prerank,integrin-mediated signaling pathway (GO:0007229),0.5071399408805979,1.531253434320263,0.02096177558569667,0.2983769039170662,1.0,14/73,6.44%,ITGB7;FGR;NEDD9;HCK;CD47;SYK;CUL3;ERBIN;RCC2;MYH9;CDC42;BCAR1;ITGB2;PTK2B
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.5591657762044167,1.5312511968580718,0.04456824512534819,0.2973688738362653,1.0,12/40,9.55%,XPO1;RPL5;LAPTM5;FBXW7;AXIN1;HIPK2;GLMN;PTEN;PTK2B;LATS1;CSNK2A2;CSNK2A1
prerank,negative regulation of sequestering of calcium ion (GO:0051283),0.6156292540639278,1.530123072989051,0.043478260869565216,0.2991677238332858,1.0,4/24,4.75%,ITPR1;PTPRC;PLCG2;IBTK
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),0.592181164277499,1.5295359012832468,0.04073033707865169,0.2995491386959274,1.0,4/30,7.19%,CD74;CD44;PTTG1IP;DYRK1A
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),0.5911933626944742,1.529531113181375,0.05370101596516691,0.2985672640419289,1.0,7/28,10.51%,PID1;IL1B;PIP4K2A;PTPRE;TNS2;PIP4K2B;PTPN1
prerank,positive regulation of dendrite morphogenesis (GO:0050775),-0.5534707473176156,-1.5294140563101157,0.03899721448467967,0.5176682989346739,1.0,7/19,10.48%,CUX1;PTPRD;IL1RAPL1;FBXW8;CDKL3;CAPRIN2;SS18L1
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),0.4969702194836174,1.5278233830640209,0.014201183431952662,0.301769967224215,1.0,31/93,18.67%,IL1B;TRAF1;MAP3K5;SPI1;EIF2AK2;AXIN1;TAOK3;TRAF4;HIPK2;TIRAP;PTK2B;TRAF3;PLCB1;MBIP;MINK1;MAP3K4;RELL1;RIPK1;FCGR2B;KLHDC10;APP;EMC10;SH3RF1;NCF1;DUSP22;WNT7A;RASSF2;TRAF2;MMP8;SEMA3A;FZD7
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),0.4946780979412175,1.5270874330801558,0.013095238095238096,0.30246942349724626,1.0,11/90,8.29%,CCR2;PLAC8;FFAR4;SYK;JAK2;CD36;UCP2;IRF4;PRKAB2;THRA;ELOVL6
prerank,outflow tract septum morphogenesis (GO:0003148),-0.5173435253691453,-1.5255877187315963,0.035483870967741936,0.5255706819435121,1.0,7/24,6.22%,TGFBR2;NRP1;ROBO2;NRP2;ROBO1;ACVR1;FGFR2
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),0.7402206620698726,1.524826481251074,0.0391156462585034,0.30689298635909695,1.0,1/10,0.03%,DPP4
prerank,positive regulation of sodium ion transport (GO:0010765),-0.6289188236331087,-1.5246615300862005,0.03800475059382423,0.5228825880880213,1.0,7/12,32.31%,AHCYL1;SCN1B;PKP2;SCN3B;WNK3;SCN4B;NOS1
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),0.6011893963725483,1.5246595759519617,0.03479576399394856,0.3062806724835141,1.0,10/23,20.47%,PTPRC;CBLB;CBL;TSG101;SH3BP5;MVP;DUSP22;ZFYVE28;SOCS5;SH3BP5L
prerank,response to prostaglandin E (GO:0034695),0.7445993664562587,1.5244869968356047,0.05338078291814947,0.30574110462035714,1.0,4/10,13.32%,PTGER2;PTGER4;GNB1;GNG2
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),0.5831434458401771,1.5229164136591542,0.03654970760233918,0.3083818143084661,1.0,1/29,0.01%,PLBD1
prerank,response to lipopolysaccharide (GO:0032496),0.47740857977149015,1.5228336642051685,0.004479283314669653,0.30756908344962697,1.0,39/138,15.80%,IL1B;FOXP1;TNIP3;PTPN22;STAP1;LILRB1;MAPKAPK3;NFKB1;JAK2;VIM;RPS6KA3;ERBIN;MAPKAPK2;CXCL10;SLPI;SCARB1;PELI1;MAPK14;TIRAP;ADAM17;PDCD4;CARD16;IFNAR1;IL6;NFKBIB;RHOA;GIT1;SBNO2;CACTIN;ACOD1;NLRP3;MAPK8;TNFRSF1B;ADAM9;GSTP1;MYD88;RELA;SRR;IRAK3
prerank,phosphatidylcholine catabolic process (GO:0034638),-0.668783628559315,-1.5219428598934053,0.05037783375314862,0.5269790664355529,1.0,4/10,7.25%,PLA2G15;ENPP2;PNPLA8;PLA2G4A
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.5814169486273643,1.5218943036433632,0.04353932584269663,0.3087576668877113,1.0,13/32,17.70%,KLF4;AKT3;PIK3C2A;CIB1;HDAC9;RHOA;ANXA1;MAP2K5;THBS1;STARD13;MAP3K3;JCAD;HDAC7
prerank,response to acidic pH (GO:0010447),-0.6041910247673528,-1.5218307081224163,0.05200945626477541,0.5209472148488533,1.0,4/13,12.14%,LGMN;RAB11FIP5;IMPACT;CHP1
prerank,regulation of chemokine production (GO:0032642),0.5629159499560612,1.521521836228235,0.03281027104136947,0.3085755688113408,1.0,8/36,8.61%,CD74;FOXP1;EIF2AK2;IL6R;IL33;ADAM17;TLR3;IL6
prerank,positive regulation of T cell chemotaxis (GO:0010820),0.7113933556192348,1.5213609667866483,0.059625212947189095,0.3079600413183666,1.0,3/10,9.52%,CCR2;ADAM17;OXSR1
prerank,morphogenesis of an epithelium (GO:0002009),-0.5105949138454685,-1.5213463347592502,0.023880597014925373,0.5165962029754997,1.0,6/25,11.66%,LRP6;ARHGAP12;FGFR2;KDM2B;TRAF3IP1;LAMA3
prerank,prostanoid biosynthetic process (GO:0046457),0.6817020557037501,1.5213227814989028,0.058823529411764705,0.30705005411298986,1.0,2/15,3.17%,CD74;PTGIS
prerank,neurotransmitter uptake (GO:0001504),-0.6261933110503929,-1.521315631708865,0.02544529262086514,0.5106268689165996,1.0,5/12,11.90%,GLUL;SLC1A3;SNAP25;ATP1A2;SLC29A1
prerank,"synaptic transmission, glutamatergic (GO:0035249)",-0.5526863485275942,-1.520709764237869,0.05698005698005698,0.5065234490661793,1.0,6/18,6.91%,NAPA;GRIA2;SLC17A6;GRID2;GRIK4;GRIK1
prerank,tRNA methylation (GO:0030488),-0.46348860976927725,-1.5204937653458814,0.029304029304029304,0.5013981292954974,1.0,20/34,25.13%,ALKBH8;NSUN2;TRMT1;METTL6;DALRD3;TRMT1L;METTL2A;METTL2B;METTL1;THUMPD2;TRMT10A;TRMT44;MTO1;TRMT12;NSUN6;LCMT2;TRMT112;GTPBP3;TRMT5;BCDIN3D
prerank,epithelial tube morphogenesis (GO:0060562),-0.48674860111074925,-1.5198595700951842,0.022435897435897436,0.49763463235248256,1.0,8/32,9.40%,CSF1R;MEF2C;CTNNB1;PKD2;RHOB;ACVR1;SCRIB;SLIT2
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),0.5827054632000651,1.5193015678997808,0.04899135446685879,0.3107423298719991,1.0,4/33,1.94%,DPP4;LYN;RET;SYK
prerank,natural killer cell mediated immunity (GO:0002228),0.6785065973310597,1.5190977714303107,0.05929487179487179,0.3102118619899061,1.0,4/15,4.56%,SLAMF7;KLRD1;KIF5B;KLRK1
prerank,receptor metabolic process (GO:0043112),0.5303891381012146,1.519078892536644,0.032133676092544985,0.3092716206174175,1.0,10/53,6.43%,GRK3;UVRAG;LILRB1;LMTK2;SYK;CD36;PICALM;SNX1;ITGB2;GRB2
prerank,cellular response to fatty acid (GO:0071398),0.7051735144758032,1.5186861967976633,0.0429553264604811,0.3091610625546772,1.0,1/12,0.25%,PID1
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),0.6604792919493704,1.517660337439676,0.043209876543209874,0.31054493973472896,1.0,5/17,11.89%,LYN;EIF2AK2;TAOK3;RNF13;KLHDC10
prerank,regulation of steroid metabolic process (GO:0019218),-0.5165392637303662,-1.516647478367748,0.03927492447129909,0.5029335201307376,1.0,7/23,11.53%,APOE;TTC39B;STUB1;ARV1;PANK2;DGKQ;FMO5
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),0.5768090220836828,1.5161974619060374,0.04678362573099415,0.3130155638779494,1.0,11/34,15.83%,PTPN22;DUSP16;PTPRO;PTPN6;PTPN12;TNS2;DUSP6;PTPN1;DUSP1;PTPRJ;DUSP22
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),0.5975181461201864,1.5157794828104219,0.048558421851289835,0.3130699737153072,1.0,5/23,6.61%,KLRD1;CD226;LILRB1;KLRK1;PIK3R6
prerank,protein dephosphorylation (GO:0006470),0.4701949623993985,1.5153253892120098,0.015873015873015872,0.3131928618856105,1.0,50/135,18.01%,PTPRC;DAPP1;PTPN22;DUSP16;PTPRE;PPP2R5A;PTPRU;PTPRO;PPP1R12A;SDHAF2;PTPN6;PTPN7;PPP3CA;PTPN12;TNS2;FBXW11;PTEN;MTMR3;SSU72;PPTC7;PPP2R2A;PPP4R2;MTMR4;DUSP6;PPP1R15A;PPP4R1;RPRD1B;PTPN1;PDP2;DUSP12;DUSP1;PPP2R3A;PPP1R15B;PPP1CB;PPM1D;TIMM50;PTPRJ;PPP2R5C;PTPRG;DUSP26;ILKAP;PPP2R5E;PPM1G;DUSP22;EYA3;LHPP;MTMR2;TAB1;PTPN4;PTPRA
prerank,superoxide anion generation (GO:0042554),0.6862949244159818,1.5149813317479086,0.05823627287853577,0.31300002122089243,1.0,5/13,17.78%,CYBB;NOX1;NCF2;NCF1;CYBA
prerank,SNARE complex assembly (GO:0035493),0.7297993976439845,1.514478469575418,0.04203152364273205,0.313246706132309,1.0,2/10,1.48%,UVRAG;STXBP6
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),0.5785429983171151,1.5144293943497737,0.04591104734576758,0.3123886205741159,1.0,6/34,11.16%,PTPRC;PTPN22;LAPTM5;EPHB2;IL6;GPI
prerank,regulation of establishment of protein localization (GO:0070201),-0.5946170158286821,-1.5143686403263326,0.0641025641025641,0.5056244185925457,1.0,3/13,6.29%,CTSD;TREM2;CORO2B
prerank,presynapse organization (GO:0099172),-0.642231882818054,-1.513234170508726,0.053763440860215055,0.5040185581666718,1.0,5/10,16.11%,NLGN1;LRRTM3;C5AR1;NLGN2;NLGN3
prerank,negative regulation of viral process (GO:0048525),0.5315978700457049,1.51268857615679,0.02802547770700637,0.3155056748010791,1.0,15/57,10.78%,ZC3HAV1;OAS2;PTX3;PLSCR1;TRIM26;EIF2AK2;SLPI;FAM111A;TRIM62;STAT1;IFIH1;HEXIM1;OASL;MBL2;TRIM14
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),0.5107830680276086,1.5121155155518642,0.022756005056890013,0.31582238540703794,1.0,13/67,8.43%,FGR;HCK;LYN;FLT3;FYN;SYK;JAK2;PTPN6;ABI1;ZAP70;PTK2B;DYRK1A;EPHB2
prerank,intestinal lipid absorption (GO:0098856),0.7046814104577448,1.512082441790052,0.060240963855421686,0.3149458738002322,1.0,3/11,5.81%,LDLR;CD36;CEL
prerank,response to fatty acid (GO:0070542),0.6514848619091638,1.510900343751255,0.05069124423963134,0.31678971170709747,1.0,4/17,13.19%,PID1;CD36;FOXO3;PDK3
prerank,peptidyl-tyrosine modification (GO:0018212),0.5282941389912934,1.5100345763391925,0.029792746113989636,0.3178014002947748,1.0,21/56,17.10%,FGR;HCK;LYN;FLT3;FYN;SYK;JAK2;PTPN6;ABI1;ZAP70;PTK2B;DYRK1A;EPHB2;TPST1;BTK;KIT;FGFR3;INSR;RELN;FES;ABL2
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",-0.6506459846063497,-1.5098659092205873,0.03611738148984198,0.5108510238842888,1.0,3/10,10.11%,TGFBR2;LGALS9;NCKAP1L
prerank,receptor internalization (GO:0031623),0.5412557485938637,1.5091963341003236,0.04144385026737968,0.31877952220691425,1.0,8/44,6.43%,GRK3;LILRB1;SYK;CD36;PICALM;SNX1;ITGB2;GRB2
prerank,regulation of organelle assembly (GO:1902115),0.5001283540700642,1.508672881637213,0.019801980198019802,0.31906322666169634,1.0,21/72,11.37%,HCK;TBC1D1;SDCCAG8;TBC1D8;MSN;USP6NL;TBC1D10C;TBC1D2B;MTMR3;TSG101;ATG5;RABGAP1;IFT140;EZR;PDCD6IP;PIKFYVE;TBC1D5;CYLD;SENP6;STAM;TBC1D2
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),-0.5391727069742993,-1.508580953508587,0.07267441860465117,0.5098719265838105,1.0,7/18,18.40%,NUP133;NXF1;DDX19B;DDX19A;ZC3H11A;IWS1;MCM3AP
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),0.6351035828208649,1.5084588675598807,0.047619047619047616,0.31855906641913634,1.0,4/20,5.23%,PRKCE;TCAF2;NEDD4L;ADRA2A
prerank,positive regulation of cell cycle phase transition (GO:1901989),0.657735818778113,1.508216962431058,0.05263157894736842,0.31810317848979164,1.0,3/15,2.62%,GLI1;PLCG2;CUL3
prerank,cellular response to lipopolysaccharide (GO:0071222),0.48499478306901983,1.5077755635554042,0.016222479721900347,0.3182090395257645,1.0,30/101,15.28%,IL1B;HCK;LYN;PRKCE;TNIP3;PTPN22;STAP1;LILRB1;NFKB1;VIM;CXCL10;MAPK14;PDCD4;CARD16;IL6;NFKBIB;RHOA;GIT1;SBNO2;CACTIN;ACOD1;NLRP3;MAPK8;TNFRSF1B;TGFB1;IL18;ADAM9;GSTP1;MYD88;RELA
prerank,regulation of lymphocyte proliferation (GO:0050670),0.6560315164546454,1.5058010650409523,0.057233704292527825,0.3219787301011293,1.0,6/16,13.54%,PTPN22;LST1;AHR;IKZF3;LGALS3;TNFRSF1B
prerank,regulation of programmed cell death (GO:0043067),0.46071000296548065,1.5040370725775396,0.006600660066006601,0.32511935883043364,1.0,35/161,10.80%,LRRK2;FLT3;BCL3;DAPK1;SLK;ACER3;BCL6;JAK2;CXCL10;MALT1;PTPN6;BCL2L14;BIRC3;BCAR1;STAT1;DDX42;DFFA;LGALS1;WFS1;WRN;IKZF3;RARG;TOX3;TM7SF3;PHLPP1;HIP1;PIDD1;RPS3;NLRC4;RTN4;DAXX;CASP2;RIPK1;USP42;APAF1
prerank,positive regulation of macrophage chemotaxis (GO:0010759),-0.5746420412060719,-1.5038985798816031,0.061068702290076333,0.5205621748251887,1.0,5/14,13.69%,CSF1R;CMKLR1;CSF1;AKIRIN1;MDK
prerank,cardiac conduction system development (GO:0003161),0.6125929672583335,1.5027859427829935,0.04821150855365474,0.32714514791099175,1.0,6/24,16.99%,NOTCH2;GJA5;HCN4;SMAD4;MAML1;SMAD5
prerank,mitochondrial fusion (GO:0008053),-0.547577001369157,-1.5024924734606262,0.03571428571428571,0.5201569827152087,1.0,9/18,15.53%,AFG3L2;GDAP1;MFF;MIGA2;SPG7;USP30;BAX;STOML2;MFN1
prerank,negative regulation of glycolytic process (GO:0045820),0.7309180631369993,1.5020463836092004,0.04152249134948097,0.32700975699883583,1.0,2/10,9.40%,CBFA2T3;GIT1
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),0.7309180631369993,1.5020463836092004,0.04152249134948097,0.32700975699883583,1.0,2/10,9.40%,CBFA2T3;GIT1
prerank,macrophage activation (GO:0042116),0.5631258771919534,1.5019822604531725,0.054519368723098996,0.32618994539283963,1.0,11/34,12.09%,FOXP1;IFNGR1;PLCG2;SYK;JAK2;DYSF;CD93;ITGB2;IFI35;SBNO2;APP
prerank,branching involved in blood vessel morphogenesis (GO:0001569),-0.5929448483562785,-1.5019590228422177,0.04846938775510204,0.5165448915672463,1.0,5/13,11.95%,TGFBR2;NRP1;CTNNB1;SEMA3E;VEGFA
prerank,polyol metabolic process (GO:0019751),0.5382163941006155,1.5004504893536987,0.04240766073871409,0.32888316602674056,1.0,12/46,8.66%,PLCG2;ITPKC;IP6K3;PLD4;OCRL;ITPK1;PTEN;INPP4A;IMPA1;PLCB1;PLCD4;SYNJ1
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.6064433000602633,1.4999606509031038,0.06646058732612056,0.3291043850861748,1.0,9/22,14.69%,PTPN22;CD300A;LAPTM5;PRNP;EZR;FCGR2B;LGALS3;PTPRJ;GPS2
prerank,negative regulation of cell junction assembly (GO:1901889),0.5943110944998027,1.4991756490877122,0.04678362573099415,0.3298275392049963,1.0,13/25,16.87%,IL1B;ACE;RCC2;IKBKB;DLC1;PTEN;PHLDB2;BCAS3;TLR2;ROCK1;THBS1;DUSP22;ARHGAP6
prerank,negative regulation of peptidase activity (GO:0010466),-0.42546257623966377,-1.4989897568305597,0.015267175572519083,0.5218373960816552,1.0,8/47,12.35%,TIMP2;LRP1;SERPINE2;CST3;SPOCK1;TIMP3;SERPINE1;SERPINI1
prerank,negative regulation of neuron apoptotic process (GO:0043524),-0.4014044916091624,-1.4985740898112108,0.013953488372093023,0.517927919163929,1.0,18/69,10.59%,PRKN;LGMN;APOE;CX3CR1;MEF2C;NTRK2;GRN;RASA1;PPARGC1A;HIF1A;ADAM8;NRBP2;KDM2B;SNX6;CPEB4;PTPRZ1;MSH2;SET
prerank,regulation of humoral immune response (GO:0002920),-0.44224473426224176,-1.4983077216827516,0.020242914979757085,0.5133860657207654,1.0,11/44,13.74%,C1QB;C1QA;C1QC;C3AR1;PROS1;C4B;C5AR1;SUSD4;C5AR2;CLU;C3
prerank,atrial septum development (GO:0003283),0.6807144307159957,1.498282112845662,0.07360861759425494,0.33086151092050115,1.0,3/13,2.93%,NOTCH2;GJA5;BMPR2
prerank,negative regulation of inflammatory response (GO:0050728),0.4554378137510699,1.4975315067065642,0.006472491909385114,0.3316247458810012,1.0,39/182,14.87%,FGR;FFAR4;HCK;LYN;CRHR2;CYSLTR2;PLCG2;KLF4;CREB1;FYN;PPARG;SYK;METRNL;RXFP2;PTGER2;PTGIS;PTGER4;HTR4;MYH9;SMPDL3B;DPEP1;MAPK14;ADAM17;CYSLTR1;GNB1;IL6;GIT1;SLAMF8;PRKAR2A;ADCY7;GLP2R;ACOD1;NLRP3;ADCY5;GNG2;TNFRSF1B;GPS2;GSTP1;TNFAIP6
prerank,regulation of stem cell proliferation (GO:0072091),0.6538542481536043,1.4972609706195934,0.0670926517571885,0.3313394575209675,1.0,3/17,4.04%,PTPRC;ACE;EIF2AK2
prerank,negative regulation of Rho protein signal transduction (GO:0035024),0.6314853187450636,1.4969081800404036,0.06677018633540373,0.3312611436173275,1.0,10/18,18.79%,HEG1;CCDC125;CUL3;RIPOR2;DLC1;ITGA3;KCTD13;ABL2;KANK1;SCAI
prerank,inositol phosphate dephosphorylation (GO:0046855),0.6983714833372586,1.4967487053279436,0.07388316151202749,0.3297143465421056,1.0,4/11,8.66%,OCRL;PTEN;IMPA1;SYNJ1
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),0.6983714833372586,1.4967487053279436,0.07388316151202749,0.3297143465421056,1.0,4/11,8.66%,OCRL;PTEN;IMPA1;SYNJ1
prerank,regulation of cytoskeleton organization (GO:0051493),0.4788897999765865,1.4965586894910132,0.020454545454545454,0.32916264226960246,1.0,32/108,15.12%,RND3;IQGAP2;IQGAP1;PAK1;CELSR1;ARHGAP18;CRK;CORO1A;CCDC88A;RAC2;CLIC4;DLC1;DIAPH1;CAPN2;PAK2;PHLDB2;F11R;RHOBTB3;EZR;KATNBL1;RAC1;RHOA;CYLD;PRKAA1;PRKAA2;ROCK1;CLASP1;CAPN6;ARHGAP17;STMN3;RHOG;MAPK1
prerank,positive regulation of biosynthetic process (GO:0009891),0.5424659460691704,1.4955946472992667,0.04477611940298507,0.3305350429666002,1.0,11/40,14.21%,PLCG2;CREB1;VIM;CD36;ZBTB20;SCX;MTPN;CREBL2;AKT1;SIRT4;TGFB1
prerank,ureteric bud morphogenesis (GO:0060675),-0.5592545246771051,-1.4955199370679755,0.04975124378109453,0.5180494690400108,1.0,4/16,3.42%,SALL1;NPNT;FGF2;PKD2
prerank,regulation of dendritic cell apoptotic process (GO:2000668),0.7083230126381627,1.4954992527458286,0.06518010291595197,0.3298131282087585,1.0,3/10,3.14%,LYN;LILRB1;RAPGEF2
prerank,Notch signaling involved in heart development (GO:0061314),0.7006719320389792,1.4954894977536282,0.07586206896551724,0.32889922697173524,1.0,2/11,5.11%,NOTCH2;RBPJ
prerank,positive regulation of lyase activity (GO:0051349),-0.576517596289789,-1.4952817396334084,0.06951871657754011,0.513688270019117,1.0,3/14,4.00%,CACNA1D;CACNA1C;NF1
prerank,response to alcohol (GO:0097305),-0.48646518224101687,-1.4949706718115228,0.03625377643504532,0.5095336067572738,1.0,9/27,22.56%,TGFBR2;TGFBR1;SDF4;SLIT2;SLIT3;CCL3;PMVK;SOD1;GRIN2B
prerank,calcium-mediated signaling (GO:0019722),0.4824597881438268,1.4944619264626058,0.014580801944106925,0.330521385530592,1.0,22/93,13.03%,CCR2;LRRK2;PTPRC;PLCG2;XCR1;CCR1;MCTP2;ACKR2;CCR9;PPP3CA;PPP1R9B;PRNP;CCRL2;PDPK1;CAMKK2;FIS1;DMPK;PRKAA1;FKBP1B;CXCR6;EIF2AK3;BTK
prerank,epiboly involved in wound healing (GO:0090505),0.6511920234980157,1.494048479954738,0.05317324185248713,0.3305376091497402,1.0,4/16,8.94%,CD44;LCP1;FLNA;RHOA
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),-0.6061017307803478,-1.4937666641357918,0.05250596658711217,0.5088617438963607,1.0,8/11,29.26%,TIMM9;TIMM10B;AGK;NDUFA13;TIMM13;TIMM8B;ROMO1;TIMM29
prerank,sensory perception of pain (GO:0019233),0.6155090644244329,1.4928080195286246,0.0581039755351682,0.3326560016597029,1.0,2/21,3.56%,CCR2;CHRNA4
prerank,receptor clustering (GO:0043113),0.5826258577072758,1.4924817528340875,0.043740573152337855,0.3325424599611389,1.0,6/27,6.97%,ITGB7;ITGA4;ITGAL;SYNJ2BP;ITGB2;FLNA
prerank,myotube cell development (GO:0014904),-0.6316862565101614,-1.49172715047656,0.04187192118226601,0.5110507723454263,1.0,2/10,0.72%,IGF1;SKI
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),-0.6579340321668331,-1.4916445763801431,0.046153846153846156,0.506457771769618,1.0,4/10,12.63%,PDE3B;WNK1;SERPINE1;JAM3
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.4953701263557292,1.4914606319936397,0.02804878048780488,0.3340127826711857,1.0,23/80,13.24%,CD44;NGF;KLF4;DAPK1;NGFR;MAP3K5;SYK;GPX1;RPS6KA3;MALT1;DPEP1;CARD16;HGF;CSNK2A1;FIS1;GRAMD4;NLRP3;REST;RPS6KA1;MAP2K5;SH3RF1;AKT1;DHCR24
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",0.6910191837970835,1.4913616974055641,0.059130434782608696,0.33330088252753065,1.0,3/11,5.32%,SP100;MAD2L2;HIPK2
prerank,regulation of macrophage activation (GO:0043030),0.5706522682304289,1.491347016021876,0.06386066763425254,0.33240627717969684,1.0,5/30,11.69%,CD74;IL33;IL6;IL31RA;FCGR2B
prerank,phospholipid metabolic process (GO:0006644),0.5003958474937812,1.4895440575399361,0.02564102564102564,0.33570137047833837,1.0,4/71,2.41%,PLBD1;LGALS13;PIP4K2A;AGPAT4
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),0.6244771844087905,1.489186911912656,0.06818181818181818,0.3356668265372983,1.0,8/19,13.15%,KLF4;NFKB1;WFS1;MTPN;APP;MAP2K5;SLCO1C1;MAPK8
prerank,filopodium assembly (GO:0046847),0.6383265262830271,1.4888491523876561,0.0732899022801303,0.33553023430585494,1.0,6/16,8.71%,SRGAP2;PPP1R9B;FGD4;EZR;FGD1;FGD3
prerank,regulation of catecholamine secretion (GO:0050433),-0.4638273941504756,-1.4857764917594585,0.023728813559322035,0.5220083837140331,1.0,20/29,36.28%,PRKN;DTNBP1;SYT1;SYT9;SYT7;KCNA2;STX1A;SYT6;SYT8;KCNB1;SYT3;SYT12;SYT11;CHGA;SYT13;DRD2;SYT10;SYT5;SYT4;SYT17
prerank,carbohydrate homeostasis (GO:0033500),0.5087811440413197,1.485502233167224,0.026119402985074626,0.34266641204975773,1.0,24/67,20.64%,NGFR;PPARG;STAT3;SLC8B1;CRY1;ADRA2A;WFS1;CRY2;CYB5R4;IL6;SELENOT;PRKAA1;BACE2;PRKAA2;TENT4B;INSR;GCK;PYGL;MBD5;BAD;RPS6;PARK7;ADIPOR1;STK11
prerank,regulation of MAP kinase activity (GO:0043405),0.480072483490937,1.4850643921239683,0.015681544028950542,0.3427887847934018,1.0,25/92,14.82%,LRRK2;IL1B;LYN;FLT3;CD40;CD300A;RGS2;STK38;SORL1;ADRA2A;TSG101;PIK3R6;PAQR3;SNF8;DIRAS1;PTPN1;DUSP1;CDK12;PDGFD;RGS14;KIT;EZH2;TGFB1;PTPRJ;GSTP1
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),0.6292548755691144,1.4844673188131758,0.05069124423963134,0.34328317932746194,1.0,4/20,8.61%,ITGA4;CD40;PDCD4;IL6
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),0.48247644891422137,1.4827319777130217,0.023227383863080684,0.3466853781338361,1.0,26/87,16.37%,GPR132;KLF4;PSME3;PSMB7;PSME2;PTEN;CDKN2C;AVEN;PSME4;ZFP36L2;PSMB8;PSMA5;PSMD9;PSMB3;DCUN1D3;PSMD6;PSMC4;PSMD10;PSMB1;WEE1;APC;RBL2;BRD7;USP47;PSMD12;RB1
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),-0.6212079556159896,-1.481230852039969,0.07481296758104738,0.532570811862186,1.0,4/11,6.12%,TGFBR2;TGFBR1;SMAD7;ACVR1
prerank,protein N-linked glycosylation via asparagine (GO:0018279),-0.46154862383971473,-1.4802200161501258,0.030959752321981424,0.5312140319361742,1.0,8/30,8.10%,ST6GAL1;MCFD2;MGAT5;ALG8;RPN1;TUSC3;LMAN1;OSTC
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.4460950565796725,1.4797415427170637,0.003236245954692557,0.35321676708769845,1.0,44/208,11.55%,CD74;CARD11;IL1B;TRAF1;ALPK1;TNIP3;PLCG2;CD40;SLC44A2;MAP3K14;REL;ANKRD17;MALT1;IKBKB;TRIM62;TRAF4;BIRC3;NLRX1;TRAF3IP2;STAT1;S100A4;PELI1;IRAK4;TIRAP;UBE2N;SHISA5;LGALS1;PDPK1;ZFAND6;FLNA;TRAF3;TRIM25;ZDHHC13;CARD16;RHOA;ZDHHC17;CPNE1;PIDD1;TANK;RIPK1;TRIM14;CACTIN;RNF31;TAB3
prerank,negative regulation of hemostasis (GO:1900047),-0.6094096120986119,-1.4796549884042207,0.06896551724137931,0.5281965840056928,1.0,4/12,12.12%,APOE;SERPINE2;CD34;SERPINE1
prerank,positive regulation of endopeptidase activity (GO:0010950),0.5851057140491258,1.4791207133554058,0.0680786686838124,0.35386615596966237,1.0,6/26,4.74%,LYN;FYN;PSME3;STAT3;PICALM;PSME2
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),0.4642185751152119,1.4790345553738615,0.012127894156560088,0.35307541780517804,1.0,26/138,8.54%,FGR;NEDD9;HCK;LYN;RASGRP4;NGF;FLT3;STAP1;FYN;RET;LMTK2;PTPRU;SYK;JAK2;BMPR2;SLA;ABI1;ZAP70;CLNK;BCAR1;STYK1;POLR1G;PTK2B;EPHB2;ACVR2A;IL6ST
prerank,response to peptide hormone (GO:0043434),0.5427405133097492,1.478506246209045,0.04183535762483131,0.3534405309830991,1.0,13/43,13.81%,STAT4;CREB1;STAT5A;STAT3;STAT5B;CRY1;STAT1;TRIM16;ANXA1;GNAI1;AKT1;STAT2;ROCK1
prerank,carbohydrate transport (GO:0008643),0.6758214761598441,1.4785047967273055,0.0702054794520548,0.3524880892705436,1.0,2/11,2.23%,SLC23A2;SLC23A1
prerank,negative regulation of gluconeogenesis (GO:0045721),0.6992412973070196,1.477417014215036,0.08207705192629816,0.35414870518700076,1.0,2/11,4.15%,SIK1;CRY1
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),-0.551153169252059,-1.477413791145433,0.05037783375314862,0.5305517115002255,1.0,4/16,3.42%,SALL1;NPNT;FGF2;PKD2
prerank,barbed-end actin filament capping (GO:0051016),0.6260435613672154,1.4766595139734258,0.05623100303951368,0.3541887590427686,1.0,5/18,8.86%,SVIL;EPS8;ADD3;CAPZB;CAPZA1
prerank,actin filament capping (GO:0051693),0.6260435613672154,1.4766595139734258,0.05623100303951368,0.3541887590427686,1.0,5/18,8.86%,SVIL;EPS8;ADD3;CAPZB;CAPZA1
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.46157341447898087,1.476496844867608,0.004540295119182747,0.3536205640911359,1.0,29/142,12.62%,CCR2;FPR1;XCR1;FPR3;CCR1;CACNA1A;CD36;LPAR3;PTGER2;ACKR2;CCR9;NPTN;GPR35;SLC8B1;PTGER4;ATP2B1;CAV2;TAC4;CCRL2;CYSLTR1;TACR1;CD52;SELENOT;PTGER3;FIS1;CALB2;FKBP1B;CXCR6;ADCY5
prerank,retinoic acid receptor signaling pathway (GO:0048384),0.7185103577732666,1.4756503003214771,0.05457746478873239,0.35463001606126693,1.0,3/10,7.87%,RARA;PPARG;RARG
prerank,regulation of macrophage migration (GO:1905521),-0.6319625342396313,-1.4745647273329612,0.0481651376146789,0.5359352278508074,1.0,4/10,9.03%,CX3CR1;P2RY12;CSF1;MTUS1
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),0.5806436230903798,1.4744522818149988,0.06119402985074627,0.3566872136247556,1.0,11/26,18.31%,IQGAP1;STAT5B;PTPN12;PDPK1;ZFP36L2;ZPR1;MED1;DUSP22;KNSTRN;FOXC1;SYAP1
prerank,positive regulation of superoxide anion generation (GO:0032930),0.6520259450800417,1.4739201642948578,0.09075907590759076,0.35707992887896145,1.0,6/13,18.43%,SYK;CD177;ITGB2;TGFB1;GSTP1;PRKCD
prerank,positive regulation of metabolic process (GO:0009893),0.4695406887295261,1.473245497949659,0.017341040462427744,0.3577898369236819,1.0,12/103,8.29%,CCR2;PLAC8;FFAR4;CAMK1D;SYK;JAK2;CD36;UCP2;IRF4;PRKAB2;THRA;ELOVL6
prerank,regulation of innate immune response (GO:0045088),0.501556439351402,1.4721754217269272,0.043478260869565216,0.35937233342278335,1.0,21/57,16.77%,FGR;PTPN22;SAMHD1;POLR3F;PLSCR1;DHX58;PTPN6;BIRC3;TIRAP;IFI35;SLC15A4;PARP9;PTPN1;CACTIN;ACOD1;FCGR2B;GBP5;XIAP;LRP8;IRAK3;IFNAR2
prerank,negative regulation of programmed cell death (GO:0043069),0.4328852229072823,1.4721032433053343,0.00102880658436214,0.3586157261454923,1.0,98/355,18.30%,CD74;CD44;FFAR4;GRK5;HCK;NOTCH2;CAPN13;NGF;BCL3;NGFR;MCL1;ITCH;PIM1;NFKB1;HSPA1A;RPS6KA3;LAPTM5;BIRC6;MALT1;TAF9;NFKBIA;NAA16;MRE11;CBL;SCX;IKBKB;DPEP1;GDNF;BIRC3;RAB7A;ARF4;SETX;PTK2B;ANXA4;ZFAND6;SERPINB9;WFS1;FLNA;CIB1;PAK2;TNFAIP8;AVEN;TM7SF3;IL6ST;HGF;IL6;NAA15;ANKLE2;PIDD1;BRAF;UBE2Z;ANXA1;IL31RA;CASP2;RIPK1;YWHAZ;DSTYK;PRKAA1;RPS6KA1;PSMD10;HYPK;SH3RF1;AREL1;HSPA9;CCND2;PRELID1;MAPK8;AKT1;DHCR24;API5;PRKAA2;YME1L1;DNAJC3;CITED2;HDAC3;GSTP1;MYD88;XIAP;RELA;PRDX5;THBS1;MED1;PROC;USP47;RPS6KB1;PPT1;HTATIP2;SEMA4D;NIBAN2;PSEN1;SIRT1;HSPD1;PLAUR;BAG3;HSPA5;HDAC1;AIFM2;HAX1
prerank,negative regulation of DNA binding (GO:0043392),0.5753051796327924,1.4710923589461902,0.05028735632183908,0.36008562555591633,1.0,9/28,14.74%,SP100;JAK2;MAD2L2;NFKBIA;SUMO1;CPNE1;TNKS;RSF1;ILRUN
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),0.6487295223096466,1.4707926816111423,0.08,0.3598167533287116,1.0,6/15,10.06%,IQGAP2;ACTR3;ACTR2;ARPC1B;ARPC2;ARPC4
prerank,peptidyl-asparagine modification (GO:0018196),-0.4521096819824656,-1.4706341178663895,0.030395136778115502,0.5445751062288654,1.0,8/31,8.10%,ST6GAL1;MCFD2;MGAT5;ALG8;RPN1;TUSC3;LMAN1;OSTC
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),0.7135410281731625,1.4701253476437757,0.07867132867132867,0.36045551863861625,1.0,3/10,10.65%,LRRK2;NFE2L2;RIPK1
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.6528217097297724,1.4696583026492216,0.06896551724137931,0.36070394924916327,1.0,5/14,16.89%,KLF4;RHOA;MAP2K5;THBS1;STARD13
prerank,regulation of superoxide anion generation (GO:0032928),0.6450788832012375,1.4692997178225673,0.0859504132231405,0.36060395283476415,1.0,6/14,18.43%,SYK;CD177;ITGB2;TGFB1;GSTP1;PRKCD
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.44365637213214,1.4687549968806184,0.0075107296137339056,0.3610625803430717,1.0,36/214,10.91%,CD74;CD44;FFAR4;PTPRC;IL1B;LYN;NOTCH2;PTPN22;RAP1A;SYK;CCR1;CD36;RAPGEF2;PTPN6;GLIPR2;FBXW7;SYNJ2BP;PRXL2C;LMO3;TIRAP;PTEN;PTK2B;CIB1;EZR;EPHB2;DUSP6;ZDHHC17;OPRM1;ICAM1;BRAF;SPRED3;SMAD4;FN1;PTPN1;YWHAZ;DSTYK
prerank,regulation of establishment of endothelial barrier (GO:1903140),0.6265653239356955,1.467934454545005,0.07255520504731862,0.3621553809541605,1.0,7/17,18.45%,IL1B;PPP1R12A;IKBKB;F11R;ROCK1;PROC;VCL
prerank,positive regulation of T-helper cell differentiation (GO:0045624),0.6637527190360967,1.467297397023314,0.07213114754098361,0.3627747095890648,1.0,8/14,14.64%,RARA;MALT1;NFKBIZ;ANXA1;NFKBID;NLRP3;MYB;IL18
prerank,regulation of response to interferon-gamma (GO:0060330),0.6636422469304452,1.467164857960185,0.0667779632721202,0.36221147987655156,1.0,5/14,9.67%,IFNGR1;JAK2;SUMO1;STAT1;PARP9
prerank,positive regulation of lamellipodium assembly (GO:0010592),0.5922488982001906,1.4659262542827356,0.05688622754491018,0.36441808843021173,1.0,8/24,10.64%,ACTR3;WASF2;RAC2;CDC42;ACTR2;RAC1;ARPC2;PIK3CA
prerank,negative regulation of cell development (GO:0010721),0.5880293137128081,1.465468721344127,0.06134969325153374,0.36456772678847044,1.0,8/25,11.90%,IL1B;LILRB1;SORL1;FBXW7;IL6;FBN1;B2M;REST
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),0.4579960342349586,1.4651436963673914,0.012263099219620958,0.36444437380172123,1.0,30/140,8.94%,ARHGAP15;VAV3;TIAM1;ARHGEF18;CYRIB;SRGAP2;SRGAP3;TIAM2;RACGAP1;ARHGAP18;RABL3;ARHGAP30;SOS2;ARHGAP26;RAC2;OCRL;BCR;CDC42;TAGAP;CD2AP;DLC1;ARAP1;FGD4;ARHGDIB;DEPDC7;RAC1;FGD1;SOS1;FGD3;RHOA
prerank,negative regulation of developmental growth (GO:0048640),-0.45797337998617105,-1.464897845123529,0.03903903903903904,0.5603397168230793,1.0,8/30,10.86%,DIP2B;DCC;ULK2;MAP2;FGF13;CDKL3;BBS2;WWC1
prerank,neuron development (GO:0048666),-0.33676149064194405,-1.4647752190664247,0.0,0.5557837584979518,1.0,29/141,9.04%,OPHN1;PTPRM;ATP8A2;PPP1R9A;APOE;DTNBP1;MEF2C;CAMSAP1;WNK1;NTRK2;NLGN1;TENM4;MAP2;PLP1;ERCC6;HMGB1;TMEM108;TENM2;CNTN4;EPHA5;GPRIN3;RYK;RASGRF1;DCX;SRRM4;CDK5R1;SH3GL2;TBC1D23;GPM6A
prerank,regulation of MAPK cascade (GO:0043408),0.4524466090054751,1.4646387609636866,0.009922822491730982,0.3647809697690781,1.0,34/157,15.32%,CD74;PTPRC;IL1B;IQGAP1;LYN;FLT3;PLCG2;RET;SYK;PAK1;LAPTM5;PTPN6;VRK2;TAOK3;ADRA2A;CAV2;STK4;PAK2;PHLPP1;IL6;MINK1;ZDHHC17;FN1;YWHAZ;DUSP1;PSMD10;KIT;LBH;ROCK1;FGFR3;PTPRJ;GSTP1;MAPK1;SPRED1
prerank,cellular response to sterol (GO:0036315),-0.5795952274477404,-1.4644485840356511,0.06451612903225806,0.5519465562990012,1.0,8/13,28.00%,LRP6;GRAMD1A;SMO;GPLD1;PTCH1;OSBPL7;MLC1;RORA
prerank,cilium-dependent cell motility (GO:0060285),0.5972165734793914,1.4630009595003994,0.06202723146747353,0.36796094424593717,1.0,6/22,15.20%,DNAH2;DNAH8;RFX3;CCDC39;CFAP54;EFHC2
prerank,positive regulation of cell migration (GO:0030335),0.4387887580417266,1.4625032123441912,0.005208333333333333,0.36818086487717355,1.0,37/253,8.61%,CCR2;FGR;PTPRC;IL1B;NEDD9;DOCK5;TIAM1;PRKCE;TCAF2;PECAM1;PLCG2;ITGAX;RET;CCR1;PAK1;SEMA4A;SHTN1;STAT3;CLDN1;NIPBL;BMPR2;MYO1C;RAPGEF2;GLIPR2;LAMB1;CBLL1;PPP3CA;CARMIL1;ADRA2A;BCAR1;CXCL16;PTK2B;ADAM17;CIB1;ARHGEF39;EPHB2;HGF
prerank,cellular response to alkaloid (GO:0071312),-0.5244450779484655,-1.4623429131426235,0.0703125,0.5546055580933027,1.0,5/17,11.74%,SLC8A1;RYR3;BLM;TGM2;CASP3
prerank,zymogen activation (GO:0031638),-0.4433895781807385,-1.4619947612523327,0.04119850187265917,0.5512108955709094,1.0,9/39,9.05%,LGMN;ASPH;VSIR;KLK3;PLAU;FURIN;MMP14;PGK1;TBC1D10A
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),0.46421001205151613,1.4606482270841084,0.020477815699658702,0.3716081185050321,1.0,19/122,8.61%,CIITA;NIBAN1;IL1B;DNA2;GLI1;BCL3;KLF4;RPL5;NFKB1;JAK2;VIM;KAT7;IL33;FAF1;MTPN;YTHDF3;NOX1;HGF;IL6
prerank,T-helper cell differentiation (GO:0042093),0.6566970873896432,1.4605916919012658,0.06735751295336788,0.3707727079798364,1.0,4/14,8.61%,FOXP1;PTGER4;ATP7A;IL6
prerank,hemopoiesis (GO:0030097),0.4813931292143806,1.4597983704144182,0.01694915254237288,0.3716930020366767,1.0,17/87,9.05%,PTPRC;RUNX2;RUNX3;NOTCH2;RASGRP4;FLT3;CDK13;ETV6;TET2;PLD4;GLRX5;TIRAP;HIPK1;MKNK2;ARIH2;ZFP36L2;KAT6A
prerank,muscle cell development (GO:0055001),-0.4506822582649993,-1.4586850293343425,0.055384615384615386,0.5579025718679066,1.0,8/30,14.28%,BIN1;IGF1;SLC8A1;NEBL;ANK2;NRAP;VEGFA;CXADR
prerank,secondary palate development (GO:0062009),-0.5549355354002907,-1.4586479830130856,0.07352941176470588,0.5533117332771877,1.0,2/14,0.65%,TGFBR2;CHD7
prerank,neuron remodeling (GO:0016322),-0.6427140417186771,-1.4569534889353288,0.0660377358490566,0.5543824198797734,1.0,6/10,14.94%,C1QA;ADGRB3;FARP2;ANKS1A;C3;CX3CL1
prerank,neurotrophin signaling pathway (GO:0038179),0.6088613874565213,1.456451616456548,0.059541984732824425,0.3789597000509728,1.0,11/21,15.13%,NGF;RAP1A;NGFR;RAPGEF2;BCAR1;GRB2;DDIT4;SOS1;KIDINS220;ZFYVE27;FRS2
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.45255367364224935,1.456443948454523,0.009988901220865706,0.3780348579336787,1.0,38/149,13.03%,CARD11;IL1B;TRAF1;IL18RAP;CD40;NFKB1;STAT3;HSPA1A;CD36;PRKCH;MALT1;NFKBIA;EIF2AK2;IKBKB;TRIM62;RAB7B;RPS6KA5;TIRAP;UBE2N;CIB1;MTPN;TRIM25;CLOCK;CARD16;IL6;NFKBIB;PIDD1;RPS3;NLRC4;RIPK1;TRIM14;RNF31;TAB3;NLRP3;APP;MAP3K7;TLR2;BTK
prerank,negative regulation of macrophage activation (GO:0043031),0.6354714691423728,1.4553015621427874,0.07526881720430108,0.3799746024115226,1.0,4/16,11.69%,PTPRC;LDLR;IL31RA;FCGR2B
prerank,positive regulation of response to external stimulus (GO:0032103),0.45363769138266774,1.4547454972462575,0.02508551881413911,0.3803542210985459,1.0,28/128,14.64%,CCR2;IL1B;CD47;POLR3F;PLSCR1;DHX58;ANKRD17;NFKBIA;PTGER4;NFKBIZ;IL33;IL17RA;ABCC1;OASL;PDCD4;PUM2;PDE2A;TLR3;IFI35;SLC15A4;USP15;RIPK1;ACOD1;APP;TLR2;GBP5;TGFB1;IL18
prerank,cardiac atrium morphogenesis (GO:0003209),0.6297121151325138,1.4535939327565321,0.08766233766233766,0.3822686473420097,1.0,3/16,8.15%,NOTCH2;BMPR2;ENG
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.54574107103467,1.453445921145217,0.05131761442441054,0.3816804778713322,1.0,8/36,10.65%,CD74;HSPA1A;LAPTM5;ADAM17;PARP14;CPNE1;PARP9;RIPK1
prerank,purine nucleotide catabolic process (GO:0006195),0.652529461622285,1.4530059482737878,0.07357859531772576,0.38188315638818193,1.0,2/13,2.68%,GDA;GPX1
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),0.526186433346102,1.452433707073895,0.04891304347826087,0.38228133170742973,1.0,15/45,14.21%,IQGAP1;PIK3C2A;ERBIN;CBL;BCAR1;RPS6KA5;GRB2;PTK2B;ADAM17;PDPK1;SOS1;BRAF;PIK3CA;AKT1;TGFB1
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),-0.5663389048503742,-1.4516196414668538,0.0654911838790932,0.5686855990766777,1.0,2/13,0.41%,LGMN;ASPH
prerank,amino acid import (GO:0043090),-0.5039697350847455,-1.4515795905969446,0.04065040650406504,0.564144544923719,1.0,9/21,25.44%,SLC1A3;SLC7A1;SLC36A1;SFXN1;SLC7A8;SLC22A4;SLC25A38;SLC1A1;SFXN2
prerank,cardiac cell development (GO:0055006),-0.6006208096614235,-1.450851232345251,0.07399103139013453,0.562123716739513,1.0,3/11,14.28%,SLC8A1;VEGFA;CXADR
prerank,positive regulation of phospholipase C activity (GO:0010863),-0.43730202635919424,-1.4504080061361428,0.03787878787878788,0.5594285365938585,1.0,11/40,8.92%,P2RY12;FLT1;NTRK2;NTRK3;GNA15;FGF2;CD86;PLCG1;HTR2B;C5AR1;P2RY6
prerank,melanosome transport (GO:0032402),-0.5295628922383838,-1.4488709222230314,0.07163323782234957,0.5555188770661587,1.0,8/18,23.53%,MLPH;BBS2;MREG;MYO5A;ARL6;BLOC1S5;RAB11A;BLOC1S6
prerank,pigment granule transport (GO:0051904),-0.5295628922383838,-1.4488709222230314,0.07163323782234957,0.5555188770661587,1.0,8/18,23.53%,MLPH;BBS2;MREG;MYO5A;ARL6;BLOC1S5;RAB11A;BLOC1S6
prerank,dephosphorylation (GO:0016311),0.44661205906711093,1.4488473097650179,0.022099447513812154,0.39057934783378234,1.0,47/147,18.01%,PTPRC;DAPP1;PTPN22;DUSP16;PTPRE;PPP2R5A;PTPRU;PTPRO;PPP1R12A;SDHAF2;PTPN6;PTPN7;PPP3CA;PTPN12;FBXW11;PTEN;MTMR3;PXYLP1;PPP2R2A;PPP4R2;MTMR4;DUSP6;PPP4R1;PTPN1;PDP2;DUSP12;DUSP1;PPP2R3A;PPP1CB;PPM1D;SGPP2;TIMM50;PTPRJ;PPP2R5C;PTPRG;SGPP1;DUSP28;DUSP26;ILKAP;PPP2R5E;PPM1G;LHPP;MTMR2;PLPPR2;TAB1;PTPN4;PTPRA
prerank,phagosome-lysosome fusion (GO:0090385),0.6956855893687107,1.447750683792737,0.0843585237258348,0.39241824650297535,1.0,6/10,13.25%,RAB7A;RAB7B;RAB34;RAB39A;PIKFYVE;ARL8B
prerank,inositol phosphate metabolic process (GO:0043647),0.5184866952881974,1.447713583375875,0.06241519674355495,0.39155152533869697,1.0,12/46,8.66%,PLCG2;ITPKC;IP6K3;PLD4;OCRL;ITPK1;PTEN;INPP4A;IMPA1;PLCB1;PLCD4;SYNJ1
prerank,regulation of intracellular signal transduction (GO:1902531),0.4265429023015082,1.4468987286737365,0.0,0.39265182727723796,1.0,116/420,16.05%,ARHGAP15;LRRK2;VAV3;IL1B;MOB3B;TIAM1;ARHGEF18;DNA2;SRGAP2;SRGAP3;TRAF1;LYN;PTPN22;PLCG2;BCL3;RPL5;PIP4K2A;PAK1;TIAM2;RACGAP1;PRKAG2;ARHGAP18;CRK;ARHGAP30;RBBP8;SOS2;ARHGAP26;TAF13;TAF9;NFKBIA;RAC2;MRE11;OCRL;BCR;VRK2;CDC42;TAGAP;DLC1;ARAP1;TAOK3;TRAF4;BIRC3;RBBP4;HIPK2;FGD4;MAPK14;PTEN;ARHGDIB;HIPK1;STK4;PRKAB2;SGMS1;PDPK1;DEPDC7;ZFAND6;WRN;PAK2;TRAF3;PDE2A;DDIT4;EZR;PHLPP1;RAC1;FGD1;RPF2;SOS1;MINK1;FGD3;BRIP1;RHOA;KAT6A;CPNE1;SLC15A4;NEK8;CSNK2A2;CSNK2A1;PIDD1;ARHGEF6;ARHGAP21;PIP4K2B;DAXX;CYLD;PRKAR2A;PRKAG1;ING2;NET1;PRKAA1;TAF7;RPA3;GNAI1;CASTOR2;NF2;RPL11;PIP5K1A;PEX5L;AKT1;CHD4;LBH;PRKAA2;ARHGAP17;ARHGEF3;MAPKAP1;PPP2R5C;AURKB;USP7;RHOG;MAPK1;XIAP;PHF20;RELA;SPRED1;TAF1;RNF41;DYRK2;BRD7;PRR5
prerank,negative regulation of catabolic process (GO:0009895),0.5127531308360413,1.4458896489626203,0.05151915455746367,0.39432178720007766,1.0,15/47,18.96%,CBFA2T3;IL1B;MAD2L2;ADRA2A;ZDHHC7;FLNA;AZIN1;GIT1;PRKAA1;SNX3;SNX12;IRAK3;SF3B3;PIN1;PRKCG
prerank,regulation of mRNA metabolic process (GO:1903311),-0.597772140866927,-1.4457806678178713,0.07764705882352942,0.5616903585670969,1.0,9/11,24.93%,CDK11B;SAFB2;SRPK1;SRPK2;DHX9;IWS1;PTCD2;SAFB;SRPK3
prerank,morphogenesis of an epithelial sheet (GO:0002011),-0.6377138070246495,-1.445533389876989,0.06947890818858561,0.5580799664979834,1.0,2/10,1.99%,LRP6;ARHGAP12
prerank,regulation of T cell differentiation in thymus (GO:0033081),0.6494836197491449,1.445446391099287,0.07855973813420622,0.3944999377829944,1.0,2/13,2.49%,TESPA1;FOXJ1
prerank,cellular response to tumor necrosis factor (GO:0071356),0.443779461958822,1.4448022647490708,0.011013215859030838,0.3952567009504958,1.0,43/175,15.28%,PID1;TRAF1;TNFSF13B;CD40;PSME3;JAK2;MAP3K14;ERBIN;NFKBIA;PSMB7;IKBKB;PSME2;BIRC3;STAT1;PTK2B;ADAM17;ZFAND6;NFE2L2;CIB1;TRAF3;PSME4;ZFP36L2;TANK;PSMB8;RPS3;PSMA5;PSMD9;RIPK1;CACTIN;PSMB3;FOXO3;PSMD6;PSMC4;ACOD1;PSMD10;PSMB1;AKT1;ADAMTS12;TNFRSF1B;GBP2;GBP3;TNFRSF4;RELA
prerank,ventricular septum morphogenesis (GO:0060412),-0.4806365981087283,-1.4445789644296887,0.06624605678233439,0.5566990800641536,1.0,11/27,16.72%,TGFBR2;TGFBR1;ROBO2;ROBO1;SMAD7;ACVR1;SLIT2;SLIT3;SOX4;TGFB2;SOX11
prerank,prostanoid metabolic process (GO:0006692),-0.5849057588104783,-1.4445482038975945,0.07161803713527852,0.5525090377238352,1.0,3/13,6.89%,HPGDS;PTGS1;PLAA
prerank,regulation of signal transduction (GO:0009966),0.4424569558744422,1.4444432500608806,0.008639308855291577,0.39525589417204277,1.0,42/190,13.66%,GRK3;LRRK2;GRK5;SP100;RASGRP4;GLI1;FYN;PLSCR1;CRK;CD36;RGS2;CD177;RSPO3;CDC42SE2;RGS3;LFNG;AXIN1;GDNF;SYNJ2BP;ZDHHC7;PRNP;CBFB;PLCB1;MTCH1;SIK2;PXN;ELF1;ZDHHC17;RGS12;GIT1;GSKIP;GRK6;PTPN1;FBXL17;APP;CASTOR2;RGS14;SNX3;LIFR;CSK;SREBF2;ITGA3
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),0.5040697429569825,1.4443724948229173,0.047879616963064295,0.3944405336364909,1.0,14/55,12.96%,GPR132;PSME3;PSMB7;PSME2;AVEN;PSME4;PSMB8;PSMA5;PSMD9;PSMB3;PSMD6;PSMC4;PSMD10;PSMB1
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),-0.56832367100657,-1.4436088087064234,0.06553398058252427,0.5514256665646022,1.0,10/14,37.14%,WNK1;ATP1B1;WNK2;CHP1;GLRX;WNK3;DMD;TESC;ACTN4;FXYD2
prerank,actin filament organization (GO:0007015),0.4448467372361663,1.4435746274975911,0.026578073089700997,0.39555392165442194,1.0,38/151,15.50%,MYO1G;RND3;NEDD9;SVIL;LCP1;EPS8;TPM4;MAD2L2;MYO1E;MYO1C;CORO1A;SHROOM3;ABI1;RAC2;CDC42;CD2AP;CARMIL1;PPP1R9B;BCAR1;ELMO2;BIN3;MYO5B;FLNA;RHOBTB3;RAC1;RHOA;HIP1;ARPC4;CASS4;TMOD3;ARHGAP17;TRIOBP;MYO1F;ENAH;FHOD1;RHOG;ELMO1;SHROOM1
prerank,RNA transport (GO:0050658),-0.3755716458616448,-1.4430259050927354,0.0223463687150838,0.5492006566423122,1.0,25/71,19.07%,TGFBR2;SRSF5;SRSF3;DDX39B;RBFOX1;RNPS1;CKAP5;SRSF7;NUP155;NUP188;KIF5C;RTRAF;THOC5;DHX38;NXF1;FLOT1;SIDT1;ZC3H11A;SRSF2;DDX39A;TPR;ATXN2;CASC3;SRSF1;HNRNPA2B1
prerank,skeletal muscle organ development (GO:0060538),-0.47622880863014555,-1.442658455110302,0.04153354632587859,0.5462967280781406,1.0,8/26,13.25%,LARGE1;BASP1;MEF2C;CFLAR;IGSF8;FXR1;MYL6;DISP1
prerank,regulation of monocyte chemotaxis (GO:0090025),0.582563166073927,1.4415779816561676,0.08076358296622614,0.3998806101644127,1.0,4/24,3.59%,CCR2;LYN;CCR1;CXCL10
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.6045304631878567,1.4415167399911384,0.07154742096505824,0.39907433831654576,1.0,3/17,3.31%,KCNE3;GJA5;KCNQ1
prerank,nerve growth factor signaling pathway (GO:0038180),0.7080691088881228,1.4413681545127113,0.07958477508650519,0.39849324854888574,1.0,3/10,3.14%,NGF;RAP1A;RAPGEF2
prerank,protein localization to synapse (GO:0035418),-0.5925089598322283,-1.4390403716179183,0.08647450110864745,0.5544334186765059,1.0,6/12,19.15%,NLGN1;PCLO;DLG4;NRXN2;NLGN2;NRXN1
prerank,positive regulation of neuroinflammatory response (GO:0150078),0.6447999496320125,1.4388084560461403,0.1044776119402985,0.40393578096521393,1.0,4/12,8.61%,IL1B;STAP1;IL33;IL6
prerank,cellular response to retinoic acid (GO:0071300),0.5306748968176973,1.4382559171923364,0.06460296096904442,0.4044922368809262,1.0,5/42,6.44%,LYN;CREB1;RET;SETX;PTK2B
prerank,positive regulation of protein transport (GO:0051222),-0.3854258017812632,-1.4382379998749673,0.015151515151515152,0.5529981577639879,1.0,26/67,21.38%,FRMD4A;IGF1;TREM2;PPIA;CD33;IL1A;ADAM8;PLK3;CHP1;TGFB2;TENM1;MYOM1;BMP6;ATP2C1;APBB1;TPR;IER3IP1;APBB3;EXOC1;OAZ1;RIPOR1;CEP290;ANG;PPID;MYH10;RACK1
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),0.6129124808171184,1.4380939053426158,0.08077544426494346,0.4039236846345587,1.0,6/17,14.36%,PTPN22;LAPTM5;PRNP;EZR;LGALS3;PTPRJ
prerank,regulation of extracellular matrix disassembly (GO:0010715),0.6406624759082217,1.4378251451792936,0.08517887563884156,0.40367370163191385,1.0,5/15,14.21%,DPP4;FAP;IL6;CLASP1;TGFB1
prerank,cranial nerve development (GO:0021545),-0.6076132634943382,-1.4375383488368387,0.09312638580931264,0.5513743723332449,1.0,2/11,1.02%,CHD7;SALL1
prerank,pinocytosis (GO:0006907),0.6898603497344368,1.4371770473899002,0.09380530973451327,0.4044408354161055,1.0,5/10,6.57%,DOCK2;MAPKAPK3;MAPKAPK2;CARMIL1;RAB34
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.44344270769014077,1.4368820812096992,0.014755959137343927,0.4042541580559143,1.0,22/140,10.59%,CCR2;FPR1;XCR1;FPR3;CCR1;CACNA1A;CD36;LPAR3;PTGER2;ACKR2;CCR9;NPTN;GPR35;PTGER4;TAC4;CCRL2;CYSLTR1;TACR1;CD52;SELENOT;PTGER3;FIS1
prerank,neutrophil mediated immunity (GO:0002446),0.42072735627230734,1.43518179445703,0.00101010101010101,0.4076986827853483,1.0,84/432,10.80%,ATP8B4;PLAC8;FGR;ITGAL;CD44;PTPRC;IQGAP2;IQGAP1;STK10;CYBB;CD47;FPR1;PECAM1;CDK13;RAP1A;ACE;LILRB3;MCEMP1;DOCK2;ITGAX;CLEC12A;CNN2;ANXA2;NFKB1;SLC44A2;PTX3;ADGRE5;NFAM1;HSPA1A;CD36;GM2A;CD300A;RAB3D;SELL;CD177;PRDX6;PTPN6;TBC1D10C;SLPI;UNC13D;PSMB7;OLR1;ERP44;CPPED1;CD93;HP;GMFG;DIAPH1;RAB7A;PRCP;ITGB2;GLIPR1;MAPK14;IRAK4;AP2A2;RAB6A;CYSTM1;ACTR2;ADAM17;OSTF1;SVIP;NBEAL2;PSAP;PTGES2;RAC1;TSPAN14;TMEM179B;IL6;RHOA;DERA;IDH1;PGM1;CPNE1;SLC15A4;FUCA1;KCMF1;PSMA5;PRG2;MAGT1;STOM;RAB44;TMC6;B2M;APAF1
prerank,regulation of wound healing (GO:0061041),0.5185165301153204,1.4349995386412673,0.057534246575342465,0.40723435810695063,1.0,8/42,10.39%,PRKCE;CASK;CLDN1;CRK;ADRA2A;EPHB2;ARFGEF1;ANXA1
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.5409379784913317,1.4349082575687366,0.06578947368421052,0.40653225213645816,1.0,9/34,8.19%,NEDD9;DOCK5;CRK;CDC42;CARMIL1;FLNA;CIB1;S100A10;RAC1
prerank,negative regulation of hormone secretion (GO:0046888),0.705192441857101,1.4332461406700865,0.09577922077922078,0.4100611975164976,1.0,2/10,1.63%,IL1B;RAB11FIP1
prerank,T cell differentiation (GO:0030217),0.5169010927828854,1.4329464345901364,0.05446927374301676,0.4098473631353861,1.0,11/40,13.50%,PTPRC;PTPN22;RABL3;SPI1;LFNG;ZAP70;ADAM17;ZFP36L2;ANXA1;KIT;FCER1G
prerank,digestive tract morphogenesis (GO:0048546),0.6375341884889628,1.432834165926306,0.0929853181076672,0.40917183983276284,1.0,3/14,9.19%,GLI1;NIPBL;ID2
prerank,myeloid cell development (GO:0061515),0.6089184197642875,1.4327903394119992,0.08372827804107424,0.40834942796279905,1.0,7/18,15.78%,FOXP1;ANXA2;NRROS;APP;TLR2;KIT;MED1
prerank,lipoprotein transport (GO:0042953),0.6889647860236027,1.431432141509017,0.10207612456747404,0.41077533804781546,1.0,6/10,13.93%,PPARG;CD36;ZDHHC17;UNC119B;UNC119;VMP1
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),0.6766333035871506,1.4311776950437534,0.09090909090909091,0.4104975028590628,1.0,2/11,1.94%,LYN;SYK
prerank,cellular response to cAMP (GO:0071320),0.5490200460905746,1.4311662478508664,0.06489675516224189,0.40957228493940034,1.0,7/30,7.99%,RAP1A;RAPGEF2;KCNQ1;HCN4;AHR;PDE2A;EZR
prerank,regulation of T cell differentiation (GO:0045580),0.5447341819344206,1.431082466671376,0.06837606837606838,0.40882969336179337,1.0,7/33,13.44%,CCR2;ZAP70;CBFB;CD2;PRELID1;METTL3;FANCA
prerank,negative regulation of blood coagulation (GO:0030195),-0.4273287891554414,-1.4308845382029336,0.04150943396226415,0.5697808690681685,1.0,7/38,14.53%,APOE;SERPINE2;PLAU;CD34;PDGFA;SERPINE1;F8
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),0.6608885792172196,1.4307569671233678,0.09212730318257957,0.4086974088411165,1.0,3/11,11.00%,MALT1;NFKBIZ;NFKBID
prerank,toxin transport (GO:1901998),0.6820710129076965,1.4307238220981475,0.1076923076923077,0.40783729439142746,1.0,3/10,14.50%,ANTXR2;RAB40B;RAB29
prerank,myeloid cell differentiation (GO:0030099),0.5139878375264053,1.4306312225822053,0.06084656084656084,0.4071037502231374,1.0,14/47,14.94%,LYN;RASGRP4;TET2;JAK2;SPI1;HIPK2;TIRAP;RPS14;KAT6A;SLC25A5;HSPA9;KIT;HCLS1;KMT2E
prerank,positive regulation of fibroblast proliferation (GO:0048146),0.5605603301497964,1.430406019448099,0.060650887573964495,0.4067315743311486,1.0,1/27,0.02%,CD74
prerank,interleukin-1-mediated signaling pathway (GO:0070498),0.4660689403177573,1.4301058445467316,0.032648125755743655,0.40657134825192043,1.0,32/94,17.53%,IL1B;MAP3K8;PSME3;NFKB1;NFKBIA;PSMB7;IKBKB;PSME2;PELI1;FBXW11;IRAK4;RPS6KA5;UBE2N;PLCB1;PSME4;IL1R2;PSMB8;PSMA5;PSMD9;PSMB3;PSMD6;TAB3;PSMC4;MAP3K7;PSMD10;PSMB1;MYD88;RELA;IRAK3;PSMD12;MAP3K3;TAB1
prerank,regulation of Ras protein signal transduction (GO:0046578),0.4745983765178583,1.4293986993188204,0.03033980582524272,0.40738631692776023,1.0,16/86,6.94%,ARHGEF18;LYN;NOTCH2;RASGRP4;NGF;EPS8;DENND3;JAK2;RABL3;DENND1A;ERBIN;BCR;DLC1;ARHGDIB;GRB2;SHOC2
prerank,extracellular transport (GO:0006858),0.6513272854094039,1.4290563513699195,0.08319738988580751,0.407283850389739,1.0,4/12,9.20%,TSG101;ADCY10;CABYR;WWP2
prerank,glucosamine-containing compound metabolic process (GO:1901071),-0.5728258277372915,-1.429007691365425,0.08674698795180723,0.5719712968579336,1.0,3/13,2.96%,LARGE1;RENBP;NAGK
prerank,positive regulation of Ras protein signal transduction (GO:0046579),0.4846136115097003,1.4287509600567554,0.05263157894736842,0.4071953196310098,1.0,16/62,15.30%,LYN;NOTCH2;RASGRP4;NGF;JAK2;ERBIN;GPR35;GRB2;SHOC2;F11R;RAC1;NET1;LRRC59;ARHGEF3;LPAR6;RASGEF1A
prerank,fatty acid beta-oxidation (GO:0006635),-0.40038446652643106,-1.4274325586270808,0.029850746268656716,0.5735509458777003,1.0,26/51,28.87%,ABCD2;ECHS1;IVD;ABCD4;ECHDC1;ACAD10;HADHB;ACADM;HADH;HADHA;ECI1;ECI2;ABCD3;ACADL;CPT2;ACADS;AMACR;GCDH;ACAT2;ACAD11;ACOX1;ACOT8;CROT;PPARD;DECR2;SLC27A2
prerank,positive regulation of MAPK cascade (GO:0043410),0.42685971825758395,1.427086020727192,0.005252100840336135,0.41050822400867865,1.0,33/245,9.62%,CD74;LRRK2;CD44;FFAR4;PTPRC;IQGAP1;NOTCH2;FLT3;PTPN22;PLCG2;RAP1A;RET;CD40;CCR1;CD36;RAPGEF2;LAPTM5;GLIPR2;EIF2AK2;FBXW7;PRXL2C;TAOK3;ADRA2A;CAV2;TIRAP;PTK2B;PIK3R6;CIB1;IL6;OPRM1;ICAM1;DIRAS1;BRAF
prerank,regulation of T cell proliferation (GO:0042129),0.4917477354866605,1.4264158212873794,0.05012853470437018,0.4112287799118505,1.0,11/61,13.54%,PTPRC;IL1B;LILRB1;SPN;CD276;GLMN;IL6ST;IL6;ANXA1;LGALS3;TNFRSF1B
prerank,regulation of cell killing (GO:0031341),0.6068550513705651,1.4259643052727047,0.10371517027863777,0.4114085722111072,1.0,8/16,18.67%,NOX1;RAC1;ICAM1;CR1L;MAPK8;DVL2;CYBA;FZD7
prerank,regulation of endothelial cell apoptotic process (GO:2000351),0.530026305141786,1.4254470217921404,0.058091286307053944,0.4117544677089793,1.0,7/39,9.14%,ITGA4;CD40;NDNF;PDPK1;NFE2L2;PDCD4;ICAM1
prerank,peptide hormone secretion (GO:0030072),0.5684780016007557,1.4251903572191653,0.07658321060382917,0.41153704070498476,1.0,4/26,10.39%,FFAR4;CYB5R4;IL6;ANXA1
prerank,positive regulation of mRNA metabolic process (GO:1903313),0.644047131088836,1.425070150559424,0.09771986970684039,0.4109107105648468,1.0,5/13,16.94%,ZC3HAV1;RC3H1;NUDT21;PNPT1;CNOT8
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),0.5718458392853523,1.424813646347468,0.08759124087591241,0.4107049673147463,1.0,4/22,6.71%,AHNAK;HPCA;GPR35;CACNB1
prerank,negative regulation of phosphorylation (GO:0042326),0.4700276026126533,1.4241388222705564,0.047841306884480746,0.41155445980628574,1.0,16/85,9.58%,CBFA2T3;NIBAN1;LRRK2;PID1;LYN;STAP1;IBTK;PRKRIP1;PTEN;CDKN2C;PRNP;CIB1;PAQR3;EPHB2;GIT1;ANKLE2
prerank,chromatin organization (GO:0006325),0.4473238570612928,1.4241381958124455,0.021889400921658985,0.4106439410899001,1.0,48/132,20.04%,JARID2;BAZ1A;PADI1;KDM6A;PAK1;BAZ2B;SPI1;INO80C;RBBP4;SMARCA5;FAM47E;SETD7;PHF19;SETDB2;EZH1;SETD5;SMARCE1;DAXX;TADA2A;SETD2;BAZ2A;ATRX;MYB;EZH2;SMARCC2;KAT2B;CHRAC1;HDAC3;RSF1;INO80;KDM4B;NPM3;HMGN1;RB1;BPTF;SIRT1;SUPT4H1;LRWD1;PADI2;SMARCD3;HCFC2;HDAC1;GATAD1;HP1BP3;EHMT1;PBRM1;SATB1;SUPV3L1
prerank,secretory granule organization (GO:0033363),-0.6108660407758573,-1.4238716152973718,0.07311320754716981,0.5818534659714553,1.0,2/10,0.60%,ABCA1;DTNBP1
prerank,response to cAMP (GO:0051591),0.5258255079689145,1.4229212444487342,0.06022408963585434,0.4128579003703027,1.0,8/37,7.99%,RAP1A;RAPGEF2;KCNQ1;HCN4;STAT1;AHR;PDE2A;EZR
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.5362585187354115,1.4224875120738818,0.08180535966149506,0.4130506562529802,1.0,10/35,13.20%,PTPRC;BCL3;JAK2;IL10RA;CRLF3;DOT1L;IL6;NLK;NF2;KIT
prerank,regulation of protein metabolic process (GO:0051246),0.5116089026598843,1.4224226192580187,0.07927677329624479,0.4122893351583124,1.0,16/44,13.15%,ACE;KLF4;LDLR;NEDD4L;SPOP;FAF1;PARL;NEDD8;WFS1;GSAP;MTPN;TRAF3;SNF8;APP;MAP2K5;MAPK8
prerank,regulation of insulin secretion (GO:0050796),0.45541611570744384,1.4223415580533028,0.04410011918951132,0.41160770611532543,1.0,16/101,12.62%,DPP4;ITPR1;IL1B;RAP1A;CACNA1A;SLC8B1;RFX3;ADRA2A;CLOCK;TM7SF3;IL6;PSMD9;CACNA2D2;GLUD1;REST;ADCY5
prerank,regulation of dendrite morphogenesis (GO:0048814),-0.4476000634771258,-1.4219022905919982,0.04304635761589404,0.5849583234707232,1.0,10/32,6.61%,CUX1;PTPRD;RAP2A;IL1RAPL1;TNIK;HECW1;ADGRB3;FBXW8;CDKL3;CAPRIN2
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.5237286176441003,1.4210257623175209,0.0674931129476584,0.4139481965238618,1.0,4/37,1.81%,JAML;ITGAL;ALCAM;NECTIN1
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),0.48083935748317563,1.4199769595018465,0.05078125,0.41566813842288,1.0,19/65,16.30%,GPR132;PSME3;PSMB7;PSME2;NABP1;AVEN;PSME4;PSMB8;PSMA5;PSMD9;PSMB3;PSMD6;PSMC4;PSMD10;PSMB1;PABIR1;AURKB;USP47;PSMD12
prerank,protein mono-ADP-ribosylation (GO:0140289),0.6763379254244523,1.41913085482637,0.1048252911813644,0.4168626123474152,1.0,5/11,9.67%,PARP8;PARP4;TIPARP;PARP14;PARP9
prerank,microvillus organization (GO:0032528),0.649546918902868,1.4190062188774728,0.0967741935483871,0.4163218589504325,1.0,5/13,8.69%,FXYD5;RAP1A;RAPGEF2;EZR;MINK1
prerank,regulation of immunoglobulin production (GO:0002637),0.5820388621259044,1.4183343268149586,0.08728943338437979,0.4171493715321002,1.0,7/23,17.47%,PTPRC;EPHB2;IL6;GPI;FCGR2B;TNFRSF4;SASH3
prerank,dorsal/ventral pattern formation (GO:0009953),-0.5096341774549946,-1.4181875522970748,0.08450704225352113,0.5942027746830254,1.0,16/20,48.19%,ACVR1;BMPR1B;PTCH1;MDFI;LMX1B;AIDA;NBL1;GLI2;GREM1;LHX1;ACVRL1;FBXL15;SFRP1;SHH;NOG;WNT8B
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),0.688225305635326,1.4180296852315062,0.08941605839416059,0.41700006409105994,1.0,3/10,4.62%,RACGAP1;RCC2;CDC42
prerank,negative regulation of neurogenesis (GO:0050768),0.5334600974112149,1.4174606967267305,0.06843575418994413,0.4175217430575818,1.0,11/34,13.27%,IL1B;NGFR;RAPGEF2;SORL1;PTEN;IL6;RHOA;RTN4;B2M;REST;LRP4
prerank,positive regulation of monocyte chemotaxis (GO:0090026),0.6117313657334614,1.4171267791518392,0.08188976377952756,0.4175244935467914,1.0,3/17,3.59%,CCR2;CCR1;CXCL10
prerank,regulation of sodium ion transport (GO:0002028),-0.4427326220960275,-1.4163934299252023,0.0625,0.5962438124821497,1.0,16/34,22.16%,WNK1;AHCYL1;SLMAP;P2RX7;WNK2;P2RX4;SNTA1;SCN1B;PER1;NKAIN3;PKP2;FGF12;YWHAH;SCN3B;WNK3;SPTBN4
prerank,histone H2B ubiquitination (GO:0033523),0.6713424008950628,1.4163755514475798,0.10562180579216354,0.4185647875170255,1.0,4/10,5.34%,DTX3L;UBE2E1;WAC;RNF20
prerank,intestinal absorption (GO:0050892),0.6416011953382845,1.416130408092002,0.09747899159663866,0.4183069893839813,1.0,4/13,7.54%,CD36;KCNQ1;ADRA2A;F11R
prerank,regulation of vasoconstriction (GO:0019229),0.5575912138967012,1.415827381858795,0.07566765578635015,0.4181717125768356,1.0,4/27,4.25%,ACE;ACE2;BMPR2;ATP2B1
prerank,"wound healing, spreading of cells (GO:0044319)",0.5680120573658439,1.4157154519257364,0.0946372239747634,0.41758851735906233,1.0,8/24,16.49%,CD44;LCP1;ADAM17;FLNA;RHOA;MRTFA;ITGA5;WNT7A
prerank,vasodilation (GO:0042311),-0.5650366110532835,-1.415426627616417,0.07710843373493977,0.5955543190977637,1.0,4/13,21.90%,KCNMA1;ADRB1;SOD2;SOD1
prerank,positive regulation of protein ubiquitination (GO:0031398),0.472753124741913,1.4154255568379153,0.04294478527607362,0.4175104964864387,1.0,21/80,15.19%,LRRK2;CUL3;LAPTM5;MALT1;CRY1;FBXW7;AXIN1;BIRC3;PTTG1IP;DCUN1D1;UBE2N;WFS1;MYCBP2;FBXO4;DCUN1D3;RCHY1;PSMD10;FANCI;RPS2;HDAC3;XIAP
prerank,positive regulation of glial cell differentiation (GO:0045687),-0.5166744169233083,-1.4153716782828218,0.06944444444444445,0.5916152011303168,1.0,6/17,13.69%,BIN1;SERPINE2;TENM4;PTN;PTPRZ1;MDK
prerank,neutrophil activation involved in immune response (GO:0002283),0.4156983240933789,1.4152882064657046,0.0010121457489878543,0.41696717081856327,1.0,81/428,10.80%,ATP8B4;PLAC8;FGR;ITGAL;CD44;PTPRC;IQGAP2;IQGAP1;STK10;CYBB;CD47;FPR1;PECAM1;CDK13;RAP1A;LILRB3;MCEMP1;DOCK2;ITGAX;CLEC12A;CNN2;ANXA2;SYK;NFKB1;SLC44A2;PTX3;ADGRE5;NFAM1;HSPA1A;CD36;GM2A;CD300A;RAB3D;SELL;CD177;PRDX6;PTPN6;TBC1D10C;SLPI;UNC13D;PSMB7;OLR1;ERP44;CPPED1;CD93;HP;GMFG;DIAPH1;RAB7A;PRCP;ITGB2;GLIPR1;MAPK14;AP2A2;RAB6A;CYSTM1;ACTR2;OSTF1;SVIP;NBEAL2;PSAP;PTGES2;RAC1;TSPAN14;TMEM179B;RHOA;DERA;IDH1;PGM1;CPNE1;SLC15A4;FUCA1;KCMF1;PSMA5;PRG2;MAGT1;STOM;RAB44;TMC6;B2M;APAF1
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),0.632501922820042,1.4152127787456084,0.12244897959183673,0.41625718928939454,1.0,4/13,8.61%,PTPRC;JAK2;DOT1L;IL6
prerank,ether lipid metabolic process (GO:0046485),0.6259281510831328,1.414614970054948,0.11129296235679215,0.41681264612584046,1.0,7/14,14.47%,AGPS;PAFAH1B1;FAR1;NCEH1;TMEM86B;PLA2G6;GNPAT
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),0.626104083672562,1.414609065687603,0.09950248756218906,0.41593774477795326,1.0,3/16,13.49%,CLDN1;CLDN12;CLDN14
prerank,receptor-mediated endocytosis (GO:0006898),0.4439986483149813,1.4133567507178133,0.024943310657596373,0.41827120390994904,1.0,28/132,11.69%,GRK3;CLEC9A;HPX;LILRB1;LDLR;SYK;CD36;EPS15;SORL1;INPP5F;PICALM;HP;HPR;SCARB1;SNX1;ITGB2;CAV2;HSPG2;AP2A2;CXCL16;GRB2;PIKFYVE;SNX9;AP1G1;SCARB2;LMBRD1;AP2B1;FCGR2B
prerank,cell part morphogenesis (GO:0032990),0.6423734524489685,1.4130796292172323,0.09375,0.4180859244960763,1.0,6/13,14.07%,PID1;FIS1;PACSIN2;DNM1L;PNPT1;MYH14
prerank,embryonic hemopoiesis (GO:0035162),-0.586234064468641,-1.4128196329941478,0.09022556390977443,0.5961989125701747,1.0,5/12,9.62%,TGFBR2;KITLG;TAL1;ATF4;THOC5
prerank,regulation of lysosomal lumen pH (GO:0035751),0.6427827325810147,1.412000914183941,0.1054421768707483,0.4199264901002965,1.0,1/12,0.22%,LRRK2
prerank,cellular protein modification process (GO:0006464),0.4083363140265039,1.4118490001930823,0.0,0.4194027565545632,1.0,241/983,15.91%,GRK3;FGR;LRRK2;PTPRC;HLCS;ST3GAL1;ST8SIA4;GRK5;RARA;DAPP1;STK10;ST3GAL4;MAP4K1;SGK3;RUNX3;HCK;LYN;PRKCE;ZC3HAV1;PTPN22;SIK1;STK24;CDK13;VRK1;CREB1;FEM1C;DAPK1;DUSP16;ST8SIA1;FYN;DTL;PARP8;RET;MAP3K5;LMTK2;AKT3;TNC;PTPRE;PPP2R5A;PTPRU;PTPRO;SYK;PSME3;PIM1;PKN1;PAK1;PPP1R12A;STK17B;PRKAG2;JAK2;ASB5;CUL3;ERN1;SDHAF2;PRKCH;IP6K3;CUL5;BMPR2;NOTUM;FUT4;MAPKAPK2;BIRC6;STK38;ST8SIA6;UBE2E1;PTPN6;KLHL11;LAMB1;PTPN7;EIF2AK2;BCR;B4GALT5;PSMB7;GPC3;IKBKB;ZAP70;FBXW7;VRK2;PSME2;PPP3CA;PARP4;GMFG;TAOK3;SIK3;PTPN12;F13A1;HIPK2;DCAF5;UBE2D3;FBXW11;FBXL8;RPS6KA5;CEL;CDK14;DCUN1D1;PTEN;TIPARP;SHISA5;ARF4;MAP3K1;HIPK1;STK4;MTMR3;PTK2B;LGALS1;FBXW2;PDPK1;NEDD8;WFS1;ATG5;MKNK2;PARP14;ELOB;DYRK1A;PKN2;PAK2;UBXN7;PPP2R2A;FBXO4;ZDHHC6;PPP4R2;MTMR4;COP1;SIK2;PSME4;COQ8A;SERP2;ACVR2A;STK38L;DUSP6;IL6;MINK1;CSNK1G3;COPS3;SUMF2;TNKS;LATS1;WWP2;OXSR1;CSNK2A1;BRAF;FBN1;PARP9;TLK2;FBXO32;PSMB8;CAMKK2;PPP4R1;GRK6;PSMA5;PSMD9;FN1;ANXA1;MBTPS1;PTPN1;PDP2;KLHL5;SUMF1;YWHAZ;PRKG2;PRKAG1;DMPK;PTP4A2;PRSS23;NLK;PSMB3;UBE2S;LATS2;MAP4K3;DUSP12;DUSP1;DCUN1D3;PSMD6;PSMC4;PRKAA1;PPP2R3A;PIGS;APP;CCNT1;PIK3R4;PSMD10;PPP1CB;WIPI2;CDK12;B3GALT2;PPM1D;MORC3;MAP3K20;PSMB1;EIF2AK3;BTK;ATG10;UST;MAPK8;AKT1;PDK3;FBXL12;LIMK2;CSK;MARK3;DCAF10;TYK2;HCST;SLC35A1;KTN1;STK39;PRKAA2;SIRT4;ROCK1;TLK1;DNAJC3;LMTK3;FBXO30;TIMM50;TGFB1;HASPIN;PTPRJ;STT3B;TRIOBP;PPP2R5C;MAP3K13;AURKB;PTPRG;BRSK1;FBXO7;DUSP26;MAPK1;PMM2;PTAR1;TAF1;TBK1;MAML1;PIGH;THBS1;ILKAP;PPP2R5E;PPM1G;IRAK3;SEPHS1;DYRK2;PROC
prerank,inositol phosphate catabolic process (GO:0071545),0.648161294251118,1.4112524493810714,0.1095890410958904,0.4200320669721153,1.0,4/12,8.66%,OCRL;PTEN;IMPA1;SYNJ1
prerank,renal filtration (GO:0097205),0.6694074641885259,1.4110638777379036,0.1111111111111111,0.4196079076599885,1.0,5/10,13.66%,SULF2;MYO1E;TBC1D8B;TMEM63C;ITGA3
prerank,synaptic vesicle cycle (GO:0099504),-0.4425091186255175,-1.4107513549181783,0.103125,0.5990987004585607,1.0,12/30,23.47%,NLGN1;PCLO;SLC17A6;SNAP25;SYT7;CDK5;STX1A;CPLX1;RIMS1;RAB3A;SLC32A1;CPLX2
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),0.6176793568629186,1.4093275684638902,0.09473684210526316,0.4231894630167012,1.0,4/15,5.31%,TIAM1;RSPO3;GPC3;RNF213
prerank,natural killer cell mediated cytotoxicity (GO:0042267),0.6181043788816718,1.4091401825506074,0.10076335877862595,0.4228225469651389,1.0,4/16,4.56%,SLAMF7;CORO1A;KIF5B;KLRK1
prerank,cellular response to interleukin-1 (GO:0071347),0.44088532852604695,1.4090909864927237,0.0223463687150838,0.42208566269281317,1.0,40/143,16.30%,IL1B;CD47;CD40;MAP3K8;PSME3;NFKB1;PTGIS;NFKBIA;PSMB7;IKBKB;PSME2;PELI1;RC3H1;FBXW11;IRAK4;RPS6KA5;UBE2N;PLCB1;PSME4;IL1R2;TANK;PSMB8;PSMA5;PSMD9;CACTIN;PSMB3;PSMD6;TAB3;PSMC4;ACOD1;MAP3K7;PSMD10;PSMB1;ADAMTS12;GBP2;GBP3;MYD88;RELA;IRAK3;PSMD12
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),-0.456706887220555,-1.4088777342925032,0.07374631268436578,0.6013879298775741,1.0,7/28,11.82%,CAMSAP1;MAP2;MAP1B;CLASP2;MAP1A;MAPRE1;CAMSAP2
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.4738136099111885,1.4086250838871441,0.05090909090909091,0.4223465992261797,1.0,18/76,12.51%,LRRK2;CUL3;LAPTM5;MALT1;CRY1;FBXW7;AXIN1;BIRC3;PTTG1IP;DCUN1D1;WFS1;MYCBP2;FBXO4;TANK;DCUN1D3;RCHY1;PSMD10;FANCI
prerank,regulation of JUN kinase activity (GO:0043506),0.5261257218766,1.408261454008854,0.07396870554765292,0.42235159920133475,1.0,12/33,17.32%,PTPN22;MAP3K5;PAK1;TAOK3;PDCD4;MAP3K4;RPS3;DVL3;MAP3K7;GSTP1;DVL2;TRAF2
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),-0.585920251630154,-1.4075973085893922,0.08490566037735849,0.6016847801774089,1.0,9/12,32.31%,WNK1;ATP1B3;ATP1B1;WNK2;GLRX;WNK3;FXYD1;DMD;NOS1
prerank,positive regulation of cell-cell adhesion (GO:0022409),0.5104772508160033,1.4068340584478942,0.0748663101604278,0.4251665460824359,1.0,8/41,11.97%,CD44;IL1B;CD47;PTPRU;AFDN;PIEZO1;ADAM19;MEGF10
prerank,nucleocytoplasmic transport (GO:0006913),0.5096103857304551,1.4066251598589226,0.06344827586206897,0.4248136647713417,1.0,15/40,20.41%,BACH2;XPO1;RSRC1;MALT1;SNRPD2;SNRPB;NUP98;RGS14;GEMIN7;NCBP1;HTATIP2;PHAX;DDX20;NEMF;SNUPN
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),0.6079727692243251,1.4065519729335652,0.1147011308562197,0.4241231531141736,1.0,5/16,8.94%,ST3GAL4;FUT4;ITGB2;IL6;RHOA
prerank,negative regulation of small molecule metabolic process (GO:0062014),0.5894490965405723,1.4065240639637764,0.10416666666666667,0.42331927908074696,1.0,2/20,4.15%,SIK1;CRY1
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),0.6147134519397721,1.4064742992922012,0.10174880763116058,0.4225695502133599,1.0,6/16,11.01%,DTX3L;MAD2L2;SMCHD1;WRAP53;PARP9;KMT5B
prerank,regulation of transmembrane transport (GO:0034762),0.5347096538595731,1.4053204470693057,0.08321377331420372,0.4247138035121408,1.0,4/31,2.59%,FFAR4;PIM1;ACE2;NEDD4L
prerank,positive regulation of cell cycle process (GO:0090068),0.4547119235524487,1.405263997144973,0.04042806183115339,0.4240048085017896,1.0,22/91,16.27%,IL1B;SVIL;CDC14A;PRKCE;RACGAP1;PLSCR1;CUL3;RCC2;FEN1;KIF23;CDC42;PKN2;RHOA;SPAST;DYNC1H1;CSPP1;ATRX;MAP3K20;AURKB;INO80;INSR;GPSM2
prerank,neutrophil degranulation (GO:0043312),0.41235350878100546,1.4052513608205195,0.0010111223458038423,0.42316525089259016,1.0,80/425,10.80%,ATP8B4;PLAC8;FGR;ITGAL;CD44;PTPRC;IQGAP2;IQGAP1;STK10;CYBB;CD47;FPR1;PECAM1;CDK13;RAP1A;LILRB3;MCEMP1;DOCK2;ITGAX;CLEC12A;CNN2;ANXA2;NFKB1;SLC44A2;PTX3;ADGRE5;NFAM1;HSPA1A;CD36;GM2A;CD300A;RAB3D;SELL;CD177;PRDX6;PTPN6;TBC1D10C;SLPI;UNC13D;PSMB7;OLR1;ERP44;CPPED1;CD93;HP;GMFG;DIAPH1;RAB7A;PRCP;ITGB2;GLIPR1;MAPK14;AP2A2;RAB6A;CYSTM1;ACTR2;OSTF1;SVIP;NBEAL2;PSAP;PTGES2;RAC1;TSPAN14;TMEM179B;RHOA;DERA;IDH1;PGM1;CPNE1;SLC15A4;FUCA1;KCMF1;PSMA5;PRG2;MAGT1;STOM;RAB44;TMC6;B2M;APAF1
prerank,carboxylic acid catabolic process (GO:0046395),-0.5924575546438796,-1.404546061359504,0.08108108108108109,0.6087253457643725,1.0,5/12,2.96%,PON3;NPL;RENBP;AMDHD2;NAGK
prerank,protein mannosylation (GO:0035268),-0.495739248831125,-1.4044301108600894,0.0955223880597015,0.6051189694663296,1.0,12/22,31.64%,LARGE1;DPY19L4;RXYLT1;POMT1;DPM2;DPY19L3;FKRP;DPM3;TMTC1;POMT2;DPM1;SDF2L1
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.49317806977782314,1.4035787280053489,0.07366984993178717,0.42653618735026994,1.0,10/47,8.19%,NEDD9;DOCK5;CRK;RCC2;CDC42;CARMIL1;FLNA;CIB1;S100A10;RAC1
prerank,regulation of cellular catabolic process (GO:0031329),0.4773474215316718,1.4030316771580182,0.0563564875491481,0.42709040103102497,1.0,13/62,11.08%,ITPR1;LRRK2;DAPK1;PIP4K2A;DRAM1;DCAF12;MTMR3;PSAP;RMC1;MTMR4;DEPDC5;PIP4K2B;SCARB2
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.545594167584684,1.402824249712004,0.07525325615050651,0.42674808770973177,1.0,10/30,10.65%,TNIP3;CD40;IKBKB;BIRC3;UBE2D3;TRAF3;TLR3;TANK;IRF7;RIPK1
prerank,vesicle transport along actin filament (GO:0030050),0.5877971357285035,1.4020762577026196,0.09763779527559055,0.4278130688717262,1.0,4/19,6.49%,MYO1G;MYO1E;MYO1C;MYO5B
prerank,stress-activated MAPK cascade (GO:0051403),0.48577673917763486,1.4018937564448557,0.06435006435006435,0.4274246433969632,1.0,20/61,15.12%,MAP3K5;MAP3K8;NFKB1;SH2D3C;PTGER4;IKBKB;MAPK14;FBXW11;UBE2N;MINK1;ARHGEF6;MAP4K3;TAB3;MAP3K7;MAP2K3;MAP3K20;MAPK8;MAP3K13;GPS2;MAPK1
prerank,transferrin transport (GO:0033572),-0.4274268800024374,-1.4008662592544665,0.053156146179401995,0.6140463962715702,1.0,13/33,13.26%,ATP6V1C1;ATP6V0B;ATP6V0D2;ATP6V0C;TCIRG1;ATP6V1B2;ATP6AP1;ATP6V1D;TFRC;MCOLN1;ATP6V0D1;ATP6V0A1;ARHGAP1
prerank,neutrophil chemotaxis (GO:0030593),0.4918466737759898,1.3997768804015343,0.07653061224489796,0.4321115019475124,1.0,9/53,13.50%,JAML;SYK;CXCL10;CKLF;ITGB2;GBF1;PIKFYVE;LGALS3;FCER1G
prerank,response to UV-A (GO:0070141),0.6267089877625192,1.3996280473953808,0.1253968253968254,0.4316402652020508,1.0,4/14,13.17%,MMP1;CERS1;CCND1;AKT1
prerank,NIK/NF-kappaB signaling (GO:0038061),0.47039041134603776,1.399613973402304,0.06423173803526448,0.4308187649916993,1.0,21/72,13.17%,PSME3;MAP3K14;REL;MALT1;PSMB7;PSME2;BIRC3;FBXW11;TIRAP;PSME4;TLR3;PSMB8;PSMA5;PSMD9;PSMB3;PSMD6;PSMC4;MAP3K7;PSMD10;PSMB1;AKT1
prerank,negative regulation of JUN kinase activity (GO:0043508),0.6662746218963019,1.3988079077809694,0.1065989847715736,0.43200001111299957,1.0,3/10,14.82%,PTPN22;PDCD4;GSTP1
prerank,cell morphogenesis involved in differentiation (GO:0000904),0.46821428249694375,1.3977357915525472,0.056320400500625784,0.4339890122403408,1.0,18/70,13.62%,ITGB7;ITGA4;ATRNL1;SRGAP2;NTNG2;SIPA1L3;SPI1;LAMB1;RAC1;PXN;RHOA;FN1;MEGF9;RILPL2;ITGA8;USH2A;METTL3;TBCD
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.46705590251654683,1.3975036882884924,0.052825552825552825,0.4337373119838869,1.0,20/76,14.18%,CBFA2T3;LRRK2;HSPA1A;LAPTM5;FBXW7;ANKIB1;SUMO1;AXIN1;ARIH1;PTEN;RNF217;HECTD1;ELOB;COP1;ARIH2;SUMO2;RCHY1;PSMD10;PABIR1;VCP
prerank,positive regulation of cell communication (GO:0010647),-0.4552264073450767,-1.397482650662219,0.061046511627906974,0.6223972000048453,1.0,9/28,18.82%,SYT1;WLS;DLG4;ILK;CLSTN2;CD80;SOX11;RIMS1;RIMS3
prerank,microvillus assembly (GO:0030033),0.6329636882558831,1.3971371858584138,0.11774193548387096,0.43389715034196796,1.0,5/14,8.69%,FXYD5;RAP1A;RAPGEF2;EZR;MINK1
prerank,negative regulation of intracellular protein transport (GO:0090317),0.5639016849381475,1.3967064213573526,0.1085972850678733,0.43410954137422825,1.0,2/22,0.53%,LRRK2;SP100
prerank,positive regulation of protein phosphorylation (GO:0001934),0.4137845324813993,1.3961285703859763,0.001017293997965412,0.4347359078762977,1.0,57/348,10.65%,CD74;NIBAN1;LRRK2;CD44;PTPRC;IL1B;IQGAP1;LYN;NGF;PECAM1;PLCG2;RAP1A;CD40;PAK1;SH2D3C;FGF5;FGF22;PRKAG2;JAK2;BMPR2;MAD2L2;RBPMS;RAPGEF2;NPTN;MRE11;IL6R;GDF1;AXIN1;CCND3;VEGFC;TRAF4;RPS6KA5;CCND1;STK4;PRNP;WDFY2;PTK2B;ADAM17;CIB1;PAK2;BMP3;ENG;RAC1;CACUL1;ACVR2A;HGF;IL6;RALB;LATS1;CREBL2;PGF;BRAF;SMAD4;CAMKK2;DAXX;SNX9;RIPK1
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),0.5713692131628719,1.3958598053851574,0.10534591194968554,0.43459459617762136,1.0,4/21,5.19%,NGF;NGFR;FYN;BIRC3
prerank,cell-matrix adhesion (GO:0007160),0.44977212952229567,1.3957662330915728,0.03663003663003663,0.43399170380076174,1.0,9/95,5.41%,ITGB7;ITGA4;ITGAL;CD44;TIAM1;RCC2;BCR;DLC1;ITGB2
prerank,photoreceptor cell development (GO:0042461),-0.5434329268453104,-1.395724369675888,0.08539944903581267,0.624761703792675,1.0,5/14,20.21%,DCX;MYO7A;VEGFA;ARL3;CEP290
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),-0.5771811503329066,-1.3957108057373568,0.11538461538461539,0.6207376497464626,1.0,3/11,2.65%,BIN1;CACNB2;CACNA2D1
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",0.5936939313257805,1.3955954968439737,0.10866141732283464,0.43356316408197504,1.0,2/18,6.44%,CCR2;PTK2B
prerank,positive regulation of RNA metabolic process (GO:0051254),0.5035824236285541,1.3954192590007812,0.08548168249660787,0.43320652393640363,1.0,16/45,15.28%,IL1B;NFKB1;HSPA1A;ERN1;SETX;DYRK1A;RIOK1;IL6;RBM22;RIPK1;NMD3;ZPR1;HNRNPLL;PNPT1;TGFB1;RELA
prerank,negative regulation of immune effector process (GO:0002698),0.6336946884496634,1.3951087725865932,0.08787346221441125,0.4330829382991951,1.0,6/13,12.84%,CD47;LILRB1;CD300A;RC3H1;SLAMF8;LGALS3
prerank,regulation of execution phase of apoptosis (GO:1900117),0.6622145387081662,1.3949844006505165,0.10966542750929369,0.43252268084193884,1.0,4/11,6.11%,PTGIS;DLC1;FAP;DFFA
prerank,negative regulation of protein localization to cell surface (GO:2000009),0.658946500659067,1.3949625648310062,0.10645724258289703,0.43172803475477434,1.0,5/11,16.74%,NEDD4L;PICALM;TAX1BP3;SNX33;GOPC
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.4627357666241997,1.3948688365783106,0.057692307692307696,0.43114356304767965,1.0,24/75,17.17%,IL1B;LYN;HEG1;CD300A;PKIB;RGS2;STK38;SORL1;HEXIM1;PTEN;PAQR3;LATS1;PTPN1;PRKAR2A;LATS2;DUSP1;RGS14;AKT1;PTPRJ;GSTP1;IRAK3;APC;RB1;SIRT1
prerank,hematopoietic progenitor cell differentiation (GO:0002244),0.5205609121293672,1.394569014632853,0.10698365527488855,0.4310944803354027,1.0,4/30,3.33%,PTPRC;FLT3;ACE;PLD4
prerank,positive regulation of protein modification process (GO:0031401),0.4228898484240289,1.3934554523402989,0.017167381974248927,0.43299271426215014,1.0,42/203,13.33%,CD74;NIBAN1;LRRK2;IL1B;LYN;PECAM1;ACE;CD40;PPP2R5A;PAK1;FGF5;FGF22;NPTN;AXIN1;DLC1;CCND3;VEGFC;UBE2N;CCND1;STK4;WDFY2;ADAM17;SVIP;CIB1;DYRK1A;ENG;RAC1;ACVR2A;HGF;RALB;PGF;ANKLE2;CAMKK2;DAXX;RIPK1;DVL3;APP;CLIP3;CCND2;ATG10;AKT1;LIMK2
prerank,ephrin receptor signaling pathway (GO:0048013),0.4597404067345382,1.3929100138470907,0.047961630695443645,0.43349823924131986,1.0,18/82,10.06%,VAV3;TIAM1;LYN;ACTR3;FYN;PAK1;CRK;CDC42;AP2A2;ACTR2;EFNA2;RAC1;EPHB2;ARPC1B;RHOA;GIT1;ARPC2;ARPC4
prerank,oligosaccharide metabolic process (GO:0009311),0.49821509148099263,1.3919365029450637,0.0799475753604194,0.43515213467522595,1.0,5/46,3.54%,ST8SIA4;ST3GAL4;ST8SIA1;FUT4;ST8SIA6
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.42976761038095274,1.3917518321135351,0.028089887640449437,0.43478328380617925,1.0,31/158,12.18%,CD74;CARD11;ALPK1;CD40;SLC44A2;MAP3K14;REL;ANKRD17;MALT1;IKBKB;TRIM62;BIRC3;TRAF3IP2;S100A4;PELI1;IRAK4;TIRAP;UBE2N;SHISA5;LGALS1;FLNA;TRIM25;ZDHHC13;CARD16;RHOA;ZDHHC17;RIPK1;TRIM14;RNF31;TAB3;MAP3K7
prerank,granulocyte chemotaxis (GO:0071621),0.4869429571958587,1.3911955274927592,0.08015267175572519,0.43543357733919186,1.0,10/55,13.50%,JAML;SYK;CXCL10;CKLF;ITGB2;GBF1;PIKFYVE;ANXA1;LGALS3;FCER1G
prerank,ERBB signaling pathway (GO:0038127),0.4788323357206169,1.3906852126459945,0.06201550387596899,0.43592671747758643,1.0,20/64,15.12%,IQGAP1;PIK3C2A;NRG2;CUL5;ERBIN;CBL;PTPN12;BCAR1;RPS6KA5;GRB2;PTK2B;ADAM17;PDPK1;SOS1;BRAF;PIK3CA;AKT1;MVP;TGFB1;MAPK1
prerank,negative regulation of MAPK cascade (GO:0043409),0.45440001447039335,1.3905431190215054,0.05461165048543689,0.43542319866510193,1.0,25/87,15.80%,PTPRC;IL1B;LYN;CD300A;RGS2;STK38;SORL1;SYNJ2BP;LMO3;PTEN;PAQR3;EZR;EPHB2;DUSP6;SPRED3;SMAD4;PTPN1;DUSP1;PSMD10;RGS14;PTPRJ;GSTP1;DUSP26;SPRED1;IRAK3
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.46976136535791796,1.3902616685835254,0.044472681067344345,0.43532103480077783,1.0,28/70,18.38%,CYBB;LNPEP;PSME3;CD36;PSMB7;IKBKB;PSME2;MFSD6;TAP1;PSME4;PSMB8;NCF2;PSMA5;PSMD9;B2M;PSMB3;PSMD6;PSMC4;PSMD10;PSMB1;NCF1;FCER1G;SNAP23;PSMD12;CYBA;PDIA3;FCGR1A;TAPBP
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.5023340446378369,1.389895416806934,0.08356545961002786,0.4353977118965385,1.0,13/43,15.28%,KLF4;NGFR;PPARG;STAT3;FOS;SPI1;KLF5;NR3C1;FOXO3;REST;TEAD1;TGFB1;RELA
prerank,C-terminal protein amino acid modification (GO:0018410),-0.5889458287722298,-1.3898577071872225,0.08851674641148326,0.637517093880935,1.0,8/11,19.60%,FOLH1;ATG12;GPLD1;TTL;ATG7;AGBL1;AGBL4;LCMT1
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.5906943074856879,1.3887385959888514,0.11019736842105263,0.437634167857782,1.0,3/17,4.56%,KLRD1;CD226;KLRK1
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),-0.5491179420908955,-1.3883536373866827,0.1053921568627451,0.6392658850847349,1.0,9/13,40.08%,SYT1;SCAMP5;STX1A;CACNA1I;KCNB1;SYT10;SYT4;CACNA1H;HYAL3
prerank,monosaccharide transmembrane transport (GO:0015749),0.6046797562170636,1.388162661318439,0.1143317230273752,0.43822245254497466,1.0,2/16,2.23%,SLC23A2;SLC23A1
prerank,cellular response to zinc ion (GO:0071294),-0.5328011341102303,-1.3877146930550734,0.10443864229765012,0.637700269361839,1.0,13/15,42.18%,P2RX4;GLRA2;MT2A;MT3;ATP13A2;MT1B;MT1X;MT1G;MT1F;MT1E;MT1M;MT1H;MT1A
prerank,regulation of microtubule nucleation (GO:0010968),0.6735983830477844,1.3873005407598396,0.11036789297658862,0.43960696292424817,1.0,4/10,9.40%,PAK1;HSPA1A;MECP2;GIT1
prerank,actin nucleation (GO:0045010),0.5746331377237852,1.3869202356638415,0.10276073619631902,0.4397710275375687,1.0,6/21,10.06%,IQGAP2;ACTR3;ACTR2;ARPC1B;ARPC2;ARPC4
prerank,regulation of cytokinesis (GO:0032465),0.4617526848609908,1.385700900524063,0.0603448275862069,0.44211769950319485,1.0,17/78,12.24%,SVIL;UVRAG;CDC14A;PRKCE;RACGAP1;CUL3;KIF20A;BIRC6;KIF23;CDC42;PKN2;RHOA;SPAST;GIT1;SETD2;CSPP1;PIK3R4
prerank,protein ADP-ribosylation (GO:0006471),0.5479371447822056,1.3854350332277923,0.1093525179856115,0.4419667153666272,1.0,14/28,21.66%,ZC3HAV1;PARP8;PARP4;TIPARP;ARF4;PARP14;TNKS;PARP9;SIRT4;PARP12;SIRT1;PARP11;SIRT3;PARP1
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),0.6226091197886043,1.3852658957037653,0.11930926216640503,0.4415596456242964,1.0,4/13,6.64%,ITGA4;AKT3;ADAM17;PDPK1
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.4909482591126459,1.3839656634223056,0.071334214002642,0.4441122366491306,1.0,15/46,15.32%,PTPRC;LYN;SYNJ2BP;LMO3;PTEN;EZR;EPHB2;DUSP6;SPRED3;SMAD4;PTPN1;RGS14;GSTP1;DUSP26;SPRED1
prerank,peptidyl-arginine modification (GO:0018195),0.6054742022498913,1.3838078400246896,0.1276595744680851,0.44365227730271994,1.0,3/15,5.90%,PADI1;KRTCAP2;PRMT8
prerank,cell junction organization (GO:0034330),-0.3674220011468915,-1.3834103175382402,0.023474178403755867,0.6496301504492409,1.0,20/71,14.28%,OPHN1;APBB2;TJP1;MYO9A;C1QA;FBLIM1;PPFIA4;ILK;SEMA3E;SDK1;TJP2;CHRNA7;SMAD3;GRM5;PPFIBP1;PPFIBP2;NLGN2;AGRN;TGFB2;CXADR
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),0.6426785675858593,1.382631837664433,0.11150442477876106,0.4459045081766411,1.0,2/12,2.75%,PLCG2;CD36
prerank,cell chemotaxis (GO:0060326),0.4738414259798354,1.3816145872249657,0.08280254777070063,0.4476983489817536,1.0,10/60,8.61%,CCR2;XCR1;CCR1;ACKR2;CCR9;BCAR1;ELMO2;CCRL2;ABCC1;HGF
prerank,regulation of protein phosphorylation (GO:0001932),0.4129100653688414,1.3798574304945819,0.010416666666666666,0.45138409564979065,1.0,54/256,13.33%,CD74;FGR;NIBAN1;LRRK2;PID1;IL1B;LYN;PECAM1;FYN;CD40;PPP2R5A;PAK1;FGF5;FGF22;CCDC88C;NPTN;CCDC88A;AXIN1;IBTK;CCND3;VEGFC;ITGB2;PTEN;CCND1;STK4;PRNP;WDFY2;ADAM17;CIB1;MOB1B;PAQR3;ENG;RAC1;EPHB2;ACVR2A;HGF;RALB;PGF;CAMKK2;FN1;DAXX;RIPK1;CACTIN;DVL3;PPP1R15B;APP;NDUFS4;CLIP3;EIF2AK3;CCND2;AKT1;STAT2;NSD1;LIMK2
prerank,cellular response to leucine starvation (GO:1990253),-0.6005747839806378,-1.3792863224862604,0.12219451371571072,0.6607102067753471,1.0,8/10,30.64%,SESN3;EIF2AK4;IMPACT;LARS1;SESN2;SESN1;RRAGD;MTOR
prerank,calcium ion transmembrane import into cytosol (GO:0097553),0.496269804678326,1.3792096835824914,0.11156462585034013,0.45214960977004853,1.0,4/41,4.75%,ITPR1;PTPRC;PLCG2;IBTK
prerank,small GTPase mediated signal transduction (GO:0007264),0.44035317990240486,1.379045577892935,0.05601907032181168,0.4517252111331875,1.0,25/103,11.29%,GRAP2;RIN2;TIAM1;ARHGEF18;TIAM2;SHTN1;CCDC88C;ARHGAP18;RASGRP2;ARHGAP30;RAPGEF2;CCDC88A;BCR;ADRA2A;MAPK14;GRB2;SHOC2;NUCB2;RAC1;GNB1;SOS1;RALB;RASSF1;RHEB;NTN1
prerank,microtubule nucleation (GO:0007020),-0.4980836853714094,-1.3790170708076095,0.11602209944751381,0.657604887569884,1.0,9/19,24.06%,TUBGCP5;CLASP2;GOLGA2;CCDC57;TUBGCP6;TPPP;NDEL1;TUBGCP2;TPX2
prerank,negative regulation of binding (GO:0051100),0.45164952714482426,1.378954480896848,0.062034739454094295,0.45112890240712045,1.0,22/81,15.25%,LRRK2;SP100;JAK2;IFIT2;SORL1;NFKBIA;SLPI;MITD1;SUMO1;CARD16;TMC8;PEX14;RALB;CPNE1;MAPK8;AKT1;IFIT1;ROCK1;RSF1;AURKB;ILRUN;DISC1
prerank,covalent chromatin modification (GO:0016569),0.5994236431451557,1.3787849966465393,0.11631663974151858,0.4507558621263487,1.0,7/14,19.97%,HLCS;SETD5;MBD2;AURKB;SIRT1;HDAC1;PARK7
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),0.5947582415121941,1.378594890473921,0.11519198664440734,0.4504264924179208,1.0,3/16,4.56%,KLRD1;CD226;KLRK1
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),0.6128585917451824,1.377659939305507,0.11746031746031746,0.4519961087396227,1.0,8/15,15.13%,NGF;NGFR;BCAR1;GRB2;DDIT4;SOS1;ZFYVE27;FRS2
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),0.43736389765871403,1.377499744653648,0.03255813953488372,0.45157223672369096,1.0,27/114,13.54%,TRAF1;TNFSF13B;CD40;PSME3;JAK2;MAP3K14;NFKBIA;PSMB7;IKBKB;PSME2;BIRC3;STAT1;PTK2B;ADAM17;TRAF3;PSME4;PSMB8;PSMA5;PSMD9;RIPK1;PSMB3;FOXO3;PSMD6;PSMC4;PSMD10;PSMB1;TNFRSF1B
prerank,negative regulation of cell-cell adhesion (GO:0022408),0.5033702166280752,1.3772506305558296,0.10014306151645208,0.45133095648535654,1.0,11/39,16.26%,FXYD5;KLF4;MAD2L2;AKNA;MBP;MAP2K5;NF2;AKT1;TGFB1;ASS1;MYADM
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),-0.36964817027906555,-1.3769584288164596,0.039301310043668124,0.6608771463695182,1.0,21/59,20.07%,PTPRM;CD84;CADM1;ROBO2;ROBO1;CNTN4;PLXNB2;HMCN1;PTPRT;SDK1;PVR;NECTIN4;IGSF11;KIRREL3;CNTN6;PLXNB3;PALLD;NECTIN2;NEXN;CELSR2;CDH4
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.42561423526122333,1.376815876093017,0.032329988851727984,0.4516655202119231,1.0,19/151,9.62%,CD74;CD44;FFAR4;PTPRC;NOTCH2;PTPN22;RAP1A;CCR1;CD36;RAPGEF2;GLIPR2;FBXW7;PRXL2C;TIRAP;PTK2B;CIB1;OPRM1;ICAM1;BRAF
prerank,positive regulation of stem cell proliferation (GO:2000648),0.6055929260296185,1.3766966896690322,0.13578274760383385,0.45117534959273714,1.0,2/17,4.59%,PTPRC;KAT7
prerank,lipoprotein localization (GO:0044872),0.6567679091355133,1.376610945033841,0.12629757785467127,0.45056876274340374,1.0,7/11,17.90%,PPARG;CD36;ZDHHC17;UNC119B;UNC119;VMP1;ZDHHC3
prerank,response to muramyl dipeptide (GO:0032495),0.6411206873425316,1.3761471604285465,0.12026359143327842,0.45089925523550334,1.0,3/12,3.20%,PTPN22;VIM;ERBIN
prerank,nitric oxide mediated signal transduction (GO:0007263),0.6054353403980836,1.3759484786223872,0.09492635024549918,0.4506070392902983,1.0,4/16,9.29%,FPR1;NDNF;CD36;GUCY1A1
prerank,positive regulation of DNA repair (GO:0045739),-0.3911537391919432,-1.3751366393719306,0.04417670682730924,0.6635283446866079,1.0,16/46,14.35%,EYA4;SPIRE1;MGMT;SLF2;ERCC6;HMGB1;SLF1;XRCC1;FMN2;CEBPG;TMEM161A;ZCWPW1;TIGAR;PCNA;DHX9;NPAS2
prerank,regulation of stress fiber assembly (GO:0051492),0.4593832553392735,1.3749331944523708,0.07398273736128237,0.4522891469518795,1.0,18/74,8.94%,ARHGEF18;CD47;PAK1;WASF2;ARHGEF10L;PTGER4;CCDC88A;CDC42;DLC1;ARAP1;CARMIL1;PAK2;S100A10;PHLDB2;F11R;RAC1;PXN;RHOA
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.47706517889890915,1.3743500459933145,0.058673469387755105,0.4530263465039232,1.0,20/59,17.53%,CARD11;BCL3;MAP3K14;REL;NFKBIA;IKBKB;BIRC3;TLR3;TANK;RIPK1;RNF31;TAB3;MAP3K7;TLR2;AKT1;ROCK1;RELA;TBK1;TRAF2;TAB1
prerank,response to sterol (GO:0036314),-0.5658094068213863,-1.3737131205992152,0.10975609756097561,0.6645956691973638,1.0,2/11,1.22%,TGFBR2;TGFBR1
prerank,interleukin-7-mediated signaling pathway (GO:0038111),0.5917709563285949,1.3735258188374206,0.12898089171974522,0.45357352965029174,1.0,4/17,5.37%,STAT5A;STAT3;STAT5B;IL2RG
prerank,cellular response to interleukin-7 (GO:0098761),0.5917709563285949,1.3735258188374206,0.12898089171974522,0.45357352965029174,1.0,4/17,5.37%,STAT5A;STAT3;STAT5B;IL2RG
prerank,macrophage migration (GO:1905517),0.6293768693973626,1.3734742342570765,0.13410596026490065,0.45285176796203,1.0,2/13,5.36%,CCR2;CKLF
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),-0.5450830853879443,-1.3734392744638217,0.12941176470588237,0.6615053924162221,1.0,5/13,6.67%,PLXNA4;NRP1;NRP2;PLXNB2;PLXNA2
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.4543677450659265,1.3729589100864432,0.06683480453972257,0.4533872714826323,1.0,18/75,14.08%,GRK5;RASGRP4;RGS2;RGS3;CRY1;PPP1R9B;ZDHHC7;CAMKMT;PLCB1;SYP;RGS12;GIT1;GRK6;NMT2;RGS14;PDE6B;ROCK1;PDE6H
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),-0.533333983236799,-1.3728471774224074,0.10497237569060773,0.6596111734721333,1.0,9/14,38.45%,ENTPD1;ENTPD5;NUDT16;ENTPD7;NUDT1;ENTPD3;ENTPD6;NUDT18;ENTPD2
prerank,positive regulation of cellular respiration (GO:1901857),0.6490226406118118,1.3727441835662488,0.09899328859060402,0.4531032054348996,1.0,6/11,19.97%,IFNLR1;IFNAR1;PRELID1;VCP;PINK1;PARK7
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),-0.4034277514734649,-1.3726852217682801,0.06147540983606557,0.6561860028618637,1.0,14/44,15.01%,KCNMA1;WNK1;ATP1B3;KCNJ2;ATP1B1;ANK2;WNK2;KCNN2;KCNMB2;AKAP6;KCNJ6;KCNN3;KCNJ9;GABBR1
prerank,negative regulation of autophagosome assembly (GO:1902902),0.6152124757561969,1.3719372621419113,0.11892797319932999,0.45434356764026,1.0,3/13,4.67%,LRRK2;CHMP4A;CHMP4B
prerank,sodium ion export across plasma membrane (GO:0036376),-0.5458313696674593,-1.3718045904248748,0.1162227602905569,0.6554547058350375,1.0,3/13,7.62%,ATP1B3;ATP1B1;ATP1A2
prerank,cellular response to molecule of bacterial origin (GO:0071219),0.4504385244431559,1.3715072294036175,0.051682692307692304,0.4546863308196948,1.0,28/95,15.28%,IL1B;CYRIB;TNIP3;STAP1;LILRB1;NFKB1;VIM;CXCL10;MAPK14;TIRAP;PDCD4;CARD16;IL6;NFKBIB;RHOA;GIT1;SBNO2;CACTIN;ACOD1;FCGR2B;NLRP3;TLR2;MAPK8;TNFRSF1B;ADAM9;GSTP1;MYD88;RELA
prerank,regulation of cell junction assembly (GO:1901888),0.5413761747039679,1.3709392160444254,0.1134020618556701,0.4553499665531139,1.0,8/27,9.40%,PDLIM5;RAP1A;PRKCH;MYO1C;RAPGEF2;CBFB;F11R;SETD5
prerank,positive regulation of nervous system development (GO:0051962),-0.4042342652138698,-1.3707295644804174,0.06538461538461539,0.6552258114102322,1.0,16/42,20.55%,CX3CR1;PTPRD;NUMB;IL1RAPL1;NLGN1;GRID2;TGM2;IL1RAP;NLGN2;SNW1;CLSTN2;NLGN3;SOX11;TRIM32;NRXN1;DLG5
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),-0.48891429000912145,-1.3706874845341621,0.12041884816753927,0.6515462427773986,1.0,8/17,19.80%,NRP1;ROBO1;FGF2;SLIT2;VEGFA;GPLD1;EFNB2;PIK3R3
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),0.5361480631375871,1.3705865646774165,0.11356932153392331,0.45551029464807913,1.0,8/26,18.05%,FOXP1;CRY1;CRY2;CLOCK;CNOT2;STRN3;SIRT1;HDAC1
prerank,regulation of long-term synaptic potentiation (GO:1900271),-0.4385750057950214,-1.3704374505634476,0.07165109034267912,0.6486001469030831,1.0,15/28,27.72%,LGMN;APOE;PTN;EIF2AK4;ZDHHC2;CHRNA7;SQSTM1;ADCY8;TYROBP;AKAP5;EPHA4;ADCY1;NSG1;ABL1;CALB1
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),0.6408944210776332,1.3704104364806255,0.1301482701812191,0.45517000658928813,1.0,5/12,19.53%,UVRAG;SETX;FYCO1;INSR;JMJD4
prerank,mitochondrion morphogenesis (GO:0070584),0.6452175228510643,1.3700021559098952,0.1252236135957066,0.4553849559637032,1.0,5/11,14.07%,PID1;FIS1;DNM1L;PNPT1;MYH14
prerank,regulation of monooxygenase activity (GO:0032768),0.5523124548165164,1.369161293617587,0.10426540284360189,0.4568130079401935,1.0,3/23,4.77%,IL1B;NOSTRIN;GDNF
prerank,negative regulation of blood pressure (GO:0045776),0.6258731876661384,1.3691480381200813,0.1430817610062893,0.456041858865036,1.0,2/13,5.35%,BMPR2;PRCP
prerank,positive regulation of hemostasis (GO:1900048),0.6474694173180805,1.3689719923267167,0.13620689655172413,0.45493657601254067,1.0,1/10,0.58%,ST3GAL4
prerank,positive regulation of coagulation (GO:0050820),0.6474694173180805,1.3689719923267167,0.13620689655172413,0.45493657601254067,1.0,1/10,0.58%,ST3GAL4
prerank,regulation of lamellipodium assembly (GO:0010591),0.5187509659361481,1.3686672349393922,0.0968208092485549,0.4549868783285324,1.0,9/34,10.64%,ACTR3;WASF2;RAC2;CDC42;ACTR2;CAPZB;RAC1;ARPC2;PIK3CA
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),0.39842928618494106,1.3672751433129604,0.003036437246963563,0.4577551061696356,1.0,99/476,15.28%,CD74;CIITA;NFE2;IL1B;RUNX2;RARA;SP100;SP3;RUNX3;GLI1;BCL3;KLF4;CREB1;RET;MAP3K5;PPARG;NFKB1;PITX3;ATF7IP;DTX3L;STAT3;EHF;NSD3;ELF4;FOS;MAD2L2;CRLF3;NAA16;MYRF;SCX;ATAD2;TBL1XR1;PICALM;IKBKB;MED30;RYBP;AXIN1;RFX3;WAC;DEAF1;MED13;STAT1;HIPK2;RNF20;IRF4;FBXW11;TRIM16;SEC14L2;AHR;TADA3;DYRK1A;PLCB1;AFAP1L2;CLOCK;CTCF;ELF1;IL6;KAT6A;ID2;CREBL2;NAA15;ZNF496;PARP9;IRF7;SMAD4;CAMKK2;PSMD9;NCOA1;IL31RA;ING2;FOXO3;MED12;DVL3;ETS2;REST;RPS6KA1;MED14;NFYA;TFAM;MAP2K3;TEAD1;MYB;AKT1;NSD1;LBH;NCF1;SMARCC2;CITED2;NFIL3;TGFB1;RSF1;MAZ;KMT2E;GPATCH3;SERTAD3;RHOG;KMT2A;CREBBP;RELA
prerank,B cell homeostasis (GO:0001782),0.656954140599327,1.3672497376694963,0.1258741258741259,0.45702404327663554,1.0,5/10,10.03%,LYN;GAPT;DOCK10;DOCK11;CAMLG
prerank,regulation of microglial cell activation (GO:1903978),0.6083171132942846,1.3671551727820432,0.13036565977742448,0.456443888340506,1.0,3/15,1.75%,PTPRC;STAP1;LDLR
prerank,toll-like receptor 4 signaling pathway (GO:0034142),0.5805390904741556,1.3668954672204519,0.12145110410094637,0.4562908508719548,1.0,4/19,5.91%,PRKCE;TNIP3;ITGB2;TIRAP
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),-0.5951703371031879,-1.36664102241849,0.15873015873015872,0.6587844624619017,1.0,3/10,3.12%,PDE3B;RNF157;UBE2B
prerank,membrane lipid biosynthetic process (GO:0046467),0.467967325758013,1.366204473996435,0.09445843828715365,0.45724094269330934,1.0,16/58,16.42%,CERS6;ST3GAL4;ACER3;ST8SIA6;CERS1;ELOVL5;SAMD8;SGMS1;SGMS2;ELOVL6;SPTSSB;SGPP2;SGPP1;FA2H;VAPA;HACD4
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.4764559154150256,1.3661661581281355,0.07289002557544758,0.45654018553922576,1.0,17/57,14.64%,LYN;FLT3;CD40;JAK2;STAT3;INPP5F;IL6R;PARP14;IL6ST;IL6;PARP9;IL31RA;NF2;KIT;HCLS1;FGFR3;IL18
prerank,actin filament-based transport (GO:0099515),0.5669233422562034,1.3658140622649668,0.10631741140215717,0.45667373306517295,1.0,4/21,6.49%,MYO1G;MYO1E;MYO1C;MYO5B
prerank,Golgi organization (GO:0007030),0.4416944658406073,1.3651780773738917,0.05176470588235294,0.45756111088307644,1.0,34/112,17.54%,ATP8B4;LRRK2;VRK1;FAM174B;USP6NL;GOLPH3L;CDC42;PI4K2B;STX17;STX6;TMED10;GCC2;GBF1;STX5;BCAS3;ATL3;ARFGEF1;LMAN2L;ARHGAP21;FHDC1;YWHAZ;TRAPPC11;HTT;STX16;CLASP1;VMP1;RAB29;TMED7;VCPIP1;HACE1;TJAP1;PI4K2A;BET1;ATP8B2
prerank,regulation of triglyceride biosynthetic process (GO:0010866),0.5939050298303611,1.364874311539655,0.10559006211180125,0.4575801652848488,1.0,4/15,5.03%,SIK1;LDLR;FBXW7;SCARB1
prerank,cellular response to organic substance (GO:0071310),0.4331261326961285,1.3647061554944773,0.046067415730337076,0.45719917698537704,1.0,19/116,9.32%,LRRK2;PID1;IL1B;FLT3;KLF4;STAT3;BMPR2;NCOA3;PTPN6;STAT5B;PTPN7;CERS1;PTPN12;ADRA2A;TIPARP;CIB1;ACVR2A;RHOA;NCOA2
prerank,positive regulation of mitochondrial fission (GO:0090141),-0.494519019641746,-1.3644221219496524,0.10204081632653061,0.6627697375852132,1.0,5/18,11.37%,PRKN;SPIRE1;MFF;VPS35;RALA
prerank,negative regulation of locomotion (GO:0040013),0.6279144645831611,1.3637631785276332,0.13217391304347825,0.45884174607093325,1.0,2/12,2.67%,CCDC125;CRK
prerank,positive regulation of secretion by cell (GO:1903532),-0.3537623624044929,-1.3634134416637445,0.03076923076923077,0.662394088211305,1.0,13/70,5.41%,FRMD4A;IGF1;DTNBP1;TREM2;CADPS;PPIA;CD33;IL1A;ATP6AP1;CLASP2;RAB9A;ADAM8;P2RX4
prerank,negative regulation of protein localization to membrane (GO:1905476),0.5408712202268495,1.3621677846212465,0.11463046757164404,0.4620884842528823,1.0,3/24,4.29%,PID1;PPP2R5A;PICALM
prerank,aromatic amino acid family metabolic process (GO:0009072),0.6568150417583237,1.3614060357867988,0.13705583756345177,0.4632504468621361,1.0,3/10,10.19%,KYNU;ATP7A;KYAT1
prerank,negative regulation of stress fiber assembly (GO:0051497),0.5452132799066951,1.3610283847317521,0.12229102167182662,0.46345473210361426,1.0,7/24,7.54%,ARHGEF18;WASF2;DLC1;ARAP1;PAK2;PHLDB2;F11R
prerank,chondroitin sulfate catabolic process (GO:0030207),-0.5554456048996008,-1.3607370546055748,0.12531328320802004,0.6682834451382624,1.0,6/13,20.22%,HEXB;ARSB;CSPG4;HEXA;BGN;HYAL1
prerank,membrane repolarization during action potential (GO:0086011),0.6108166428451912,1.3603628446810005,0.1320754716981132,0.4643881548308626,1.0,2/13,3.31%,KCNE3;KCNQ1
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),0.6044501277008698,1.3601789499799255,0.13398692810457516,0.4641052002377454,1.0,6/14,20.44%,RAPGEF2;PKIB;PRKAR2A;HTT;SIRT1;PKIA
prerank,canonical glycolysis (GO:0061621),-0.4488486500408454,-1.3598018056470327,0.10682492581602374,0.6639478774017732,1.0,10/24,24.14%,HK3;HK1;PFKL;PGK1;PFKP;ENO2;PGAM1;PFKM;ENO3;ALDOA
prerank,glucose catabolic process to pyruvate (GO:0061718),-0.4488486500408454,-1.3598018056470327,0.10682492581602374,0.6639478774017732,1.0,10/24,24.14%,HK3;HK1;PFKL;PGK1;PFKP;ENO2;PGAM1;PFKM;ENO3;ALDOA
prerank,muscle organ development (GO:0007517),-0.36393879160087783,-1.359419812818378,0.05172413793103448,0.6615339651884026,1.0,10/54,8.59%,LARGE1;IGF1;MEF2C;SGCE;CAPN3;MRAS;MKX;FXR1;POU6F1;SPEG
prerank,intracellular pH reduction (GO:0051452),-0.4234346859130468,-1.3592102083461852,0.09666666666666666,0.6586073428153881,1.0,14/33,16.18%,ATP6V1C1;ATP6V0B;SLC11A1;ATP6V0D2;ATP6V0C;TCIRG1;ATP6V1B2;ATP6V1D;DMXL2;ATP6V0D1;ATP6V0A1;CLCN3;GPR89B;GPR89A
prerank,regulation of cellular component movement (GO:0051270),0.48206896443147307,1.3577607442361885,0.08244680851063829,0.46962490131508255,1.0,12/49,8.94%,SP100;LYN;PKN1;NRG2;ARHGAP18;INPP5F;ARAP1;DIAPH1;ADAM17;MYCBP2;PKN2;RHOA
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),-0.44138256624234357,-1.355959133936977,0.09337349397590361,0.6666249308435116,1.0,8/25,16.74%,CACNB2;CAPN3;ANK2;PLCG1;TRPC1;AKAP6;CX3CL1;CEMIP
prerank,adipose tissue development (GO:0060612),-0.5693424659431628,-1.3550865860798227,0.10256410256410256,0.6659952225941064,1.0,8/11,33.13%,ARID5B;NAMPT;SH3PXD2B;PGRMC2;DYRK1B;SPTLC2;LRP5;DGAT2
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),0.5598477010859144,1.3547875148651827,0.12738853503184713,0.47656092047275683,1.0,8/20,13.80%,MCUB;SLC8B1;MAIP1;PARL;LETM1;PMPCA;MICU3;YME1L1
prerank,peripheral nervous system development (GO:0007422),0.545502081215284,1.3547836807722458,0.1339421613394216,0.47575616437574747,1.0,3/23,4.77%,NGF;ADGRG6;GDNF
prerank,negative regulation of viral genome replication (GO:0045071),0.503557231341951,1.354655513608178,0.09849521203830369,0.4752659689342839,1.0,8/40,7.16%,ZC3HAV1;OAS2;PLSCR1;EIF2AK2;SLPI;FAM111A;IFIH1;OASL
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),0.6364000342956079,1.354581673781994,0.13290113452188007,0.47461841304303654,1.0,3/11,9.90%,STK24;MAP3K5;GSKIP
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),0.4548976121240976,1.3545106772167865,0.0690505548705302,0.47398656728418814,1.0,18/76,12.51%,IL1B;PTPN22;BCL3;LAPTM5;SPI1;NFKBIA;EIF2AK2;PDCD4;EZR;TLR3;IFI35;RHOA;CPNE1;RPS3;CYLD;NLRP3;APP;TLR2
prerank,RNA modification (GO:0009451),-0.3768514807793519,-1.3544122775424223,0.05333333333333334,0.6646851157362487,1.0,36/54,36.26%,NSUN2;TRMT1;ANKRD16;JMJD6;QTRT1;ELP5;TYW5;NOP2;ADAR;NSUN3;CDKAL1;METTL1;DTWD2;SSB;THUMPD1;FTSJ3;NSUN5;WDR4;ADARB1;TRMT6;NSUN6;LCMT2;TRMT9B;NAT10;BCDIN3D;DTWD1;PUS7;QTRT2;FTSJ1;ALKBH1;CTU2;AARS2;THG1L;RBM15B;TRMT61A;CTU1
prerank,positive regulation of TOR signaling (GO:0032008),-0.4004558667639529,-1.3540916856866376,0.07885304659498207,0.6621778573192898,1.0,14/40,15.21%,TREM2;RPTOR;FLCN;GAS6;FNIP1;GPR137B;KLHL22;LARS1;MIOS;NCKAP1L;LAMTOR5;SEC13;PIH1D1;RRAGC
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),-0.5690125062804527,-1.3539863090108477,0.10835214446952596,0.6589297209462769,1.0,3/10,14.16%,CACNB2;CACNA2D1;CALM1
prerank,plasma membrane bounded cell projection organization (GO:0120036),-0.32337728294733764,-1.3537729054959422,0.022900763358778626,0.6560522167308337,1.0,26/124,9.04%,OPHN1;PTPRM;CSF1R;PPP1R9A;APOE;DTNBP1;CAMSAP1;NLGN1;MAP2;PLP1;ERCC6;ODF2;HMGB1;TMEM108;PKD2;CNTN4;WDPCP;LIMA1;CEP78;GPRIN3;RYK;RASGRF1;CDK5R1;SH3GL2;TBC1D23;GPM6A
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.4291856898703236,1.3533776751403666,0.07109557109557109,0.47608320629405504,1.0,25/108,11.90%,NGF;DAPK1;NGFR;MAP3K5;PPARG;SYK;JAK2;LAPTM5;MALT1;ATP2A3;DLC1;BBC3;MTCH1;HIP1;PIDD1;RPS3;NLRC4;CASP2;FIS1;RIPK1;APAF1;GRAMD4;AIFM1;NLRP3;REST
prerank,phosphatidylinositol dephosphorylation (GO:0046856),0.558909813066823,1.3528233400001146,0.1262848751835536,0.4767302501076488,1.0,6/23,8.66%,INPP5F;OCRL;PTEN;MTMR3;MTMR4;SYNJ1
prerank,regulation of cell migration (GO:0030334),0.39904745754403487,1.352795827885807,0.009137055837563452,0.47598881597225134,1.0,58/382,8.94%,CD74;FGR;IL1B;NEDD9;TIAM1;CYRIB;SRGAP2;SRGAP3;SGK3;TCAF2;PECAM1;STK24;ACE;NGFR;SLK;ITGAX;RET;NTNG2;PTPRU;CCR1;PAK1;SEMA4A;FGF5;FGF22;STAT3;DOCK10;CLDN1;MYO1C;RCC2;SORL1;LAMB1;DPEP1;CLIC4;CBLL1;PPP3CA;DLC1;TMSB10;CARMIL1;ADRA2A;BCAR1;RNF20;AFDN;PTEN;CXCL16;PTK2B;ADAM17;FLNA;CIB1;YTHDF3;LMNA;PLXND1;ENG;RAC1;ARHGEF39;EPHB2;HGF;MINK1;RHOA
prerank,protein monoubiquitination (GO:0006513),0.49915099281221514,1.3526937505557501,0.11666666666666667,0.47546125001295586,1.0,11/36,10.20%,DTL;DTX3L;CUL3;UBE2E1;PEX12;WAC;RNF20;UBE2D3;TRIM25;UBE2W;FANCL
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.4458799039693828,1.3523967910666996,0.09316770186335403,0.4754579655751045,1.0,29/73,22.12%,NGF;NGFR;PPARG;JAK2;LAPTM5;ATP2A3;DLC1;BBC3;MTCH1;HIP1;PIDD1;NLRC4;CASP2;RIPK1;APAF1;AIFM1;EIF2AK3;VCP;CASP12;TRAF2;HSPD1;BAD;MUL1;XDH;ANP32B;DIABLO;BID;CASP9;SENP1
prerank,toll-like receptor signaling pathway (GO:0002224),0.44822207740087744,1.3522571063083777,0.06715506715506715,0.47504675307802746,1.0,23/84,13.03%,TNIP3;PLCG2;MAPKAPK3;CD36;RPS6KA3;MAPKAPK2;IKBKB;BIRC3;ITGB2;UBE2D3;IRAK4;TIRAP;MAP3K1;TRAF3;SFTPA1;SFTPA2;TLR3;RIPK1;TAB3;MAP3K7;PIK3R4;TLR2;BTK
prerank,transcription by RNA polymerase III (GO:0006383),-0.4397485142097459,-1.3520704102329473,0.09187279151943463,0.6586295197291328,1.0,11/27,17.94%,IVNS1ABP;GTF3C3;CRCP;GTF3C4;ICE2;GTF3C2;POLR3H;SNAPC4;GTF3C5;SNAPC1;POLR2K
prerank,cell junction assembly (GO:0034329),-0.32821625668324966,-1.3520243025103464,0.03355704697986577,0.655246204074248,1.0,23/100,16.11%,OPHN1;TJP1;MYO9A;ITGA6;PKP4;FLCN;NLGN1;FBLIM1;CDH11;NRXN2;ILK;RYK;SDK1;GPM6A;CDK5;TLN2;NLGN2;TRPV4;ADGRL3;SLITRK1;PKP2;KIRREL3;NLGN3
prerank,positive regulation of multicellular organismal process (GO:0051240),0.3954041706441922,1.352019022176632,0.011258955987717503,0.47490564178653605,1.0,32/308,6.35%,CCR2;CLEC9A;PLAC8;FGR;FFAR4;IL1B;TIAM1;ITGAX;SYK;JAK2;NFAM1;FOXJ1;CD36;PRKCH;BMPR2;MAD2L2;SORL1;NCOA3;GLIPR2;PTGER4;EIF2AK2;UCP2;SCX;B4GALT5;GDNF;RFX3;IL33;ADRA2A;IRF4;GLMN;TRIM16;PRKAB2
prerank,axonal transport (GO:0098930),-0.41303624094605523,-1.351943297829331,0.07553956834532374,0.6520505245856478,1.0,7/36,5.26%,DST;DTNBP1;TMEM108;KIF1B;KIF1A;AP3M2;HIF1A
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),0.6422579233588364,1.3516056051664804,0.1457286432160804,0.47508659538770764,1.0,4/11,7.43%,LIMD1;STAT3;XPO5;PUM2
prerank,glycosphingolipid biosynthetic process (GO:0006688),0.5759541328752237,1.3515855578600393,0.14217252396166133,0.47434370451795715,1.0,4/16,8.25%,ST8SIA4;ST8SIA1;ST8SIA6;ST6GALNAC3
prerank,mitochondrial genome maintenance (GO:0000002),0.640580078087319,1.3514545014691992,0.14922813036020582,0.47389890172366644,1.0,2/11,2.00%,AKT3;LONP1
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.49033687222141864,1.3512265306523707,0.10896551724137932,0.47368603654532926,1.0,12/39,17.17%,ITPKC;PIP4K2A;TTC7A;PIK3C2A;IP6K3;PI4K2B;PIP4K2B;PIK3CA;SMG1;EFR3A;PIK3R2;PI4K2A
prerank,purine-containing compound catabolic process (GO:0072523),0.6122842610264465,1.351215771828677,0.1371900826446281,0.4729160805190903,1.0,2/13,2.68%,GDA;GPX1
prerank,positive regulation of type I interferon production (GO:0032481),0.44920499873998854,1.3507474635456167,0.07645631067961164,0.47336653155601194,1.0,22/73,17.38%,PTPN22;OAS2;POLR3F;NFKB1;DHX58;POLR3A;MRE11;LRRFIP1;STAT1;IFIH1;DDX41;TLR3;IRF7;SETD2;PQBP1;TLR2;MYD88;CREBBP;RELA;TBK1;IRF5;HSPD1
prerank,chromatin remodeling (GO:0006338),0.4406917205637196,1.3502393903606253,0.0683453237410072,0.4738666292814959,1.0,37/100,20.26%,JARID2;BAZ1A;KDM6A;PAK1;BAZ2B;GATAD2B;INO80C;RBBP4;SMARCA5;EZH1;SMARCE1;DAXX;TADA2A;MBD2;BAZ2A;ATRX;MYB;CHD4;SMARCC2;SRCAP;KAT2B;CHRAC1;RSF1;INO80;KDM4B;NPM3;RB1;BPTF;SIRT1;SMARCD3;HCFC2;HDAC1;GATAD1;ACTB;PBRM1;SATB1;HNRNPC
prerank,regulation of JNK cascade (GO:0046328),0.4359199005709451,1.349844261526948,0.06031363088057901,0.4741229665506305,1.0,32/101,18.80%,IL1B;TRAF1;MARVELD3;MAP3K5;ITCH;AXIN1;TAOK3;TRAF4;HIPK2;TIRAP;PTK2B;TRAF3;PLCB1;PHLPP1;MBIP;MINK1;CYLD;RIPK1;FCGR2B;APP;SH3RF1;NCF1;HDAC3;GPS2;DUSP22;WNT7A;RASSF2;TRAF2;MMP8;SEMA3A;FZD7;PINK1
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.4832384419092072,1.3492744778848063,0.09740259740259741,0.47478458546960306,1.0,15/49,14.64%,LYN;FLT3;CD40;JAK2;STAT3;IL6R;PARP14;IL6ST;IL6;PARP9;IL31RA;KIT;HCLS1;FGFR3;IL18
prerank,positive regulation of cellular catabolic process (GO:0031331),0.42442942712470355,1.3492058863653722,0.05221339387060159,0.4741504921384331,1.0,34/132,14.67%,LRRK2;IL1B;ZC3HAV1;DAPK1;ITCH;MSN;PIK3C2A;DTX3L;PLEKHF1;LAPTM5;ZBTB20;ATF6;PRXL2C;ADRA2A;RC3H1;PTTG1IP;FAF1;SVIP;EZR;PTPN1;SNX9;TRIM14;FOXO3;PRKAA1;APP;SH3BP4;PFKFB3;ABCD1;TNFRSF1B;PRKAA2;ROCK1;PNPT1;PFKFB4;ADAM9
prerank,negative regulation of cell motility (GO:2000146),0.432344399480893,1.3490942076985373,0.0675990675990676,0.4736905651775988,1.0,14/108,5.92%,CD74;SRGAP2;SRGAP3;STK24;NGFR;PTPRU;CCDC125;CRK;DPEP1;CLIC4;DLC1;RNF20;AFDN;PTEN
prerank,chromatin assembly or disassembly (GO:0006333),0.6236424032500043,1.3490822824734985,0.15422077922077923,0.4729458276691263,1.0,2/11,5.29%,CHAF1A;RBBP4
prerank,mesoderm development (GO:0007498),0.5701309893589809,1.3490812623994781,0.125,0.47217086698251864,1.0,4/18,13.03%,HCK;JAK2;IKZF3;BTK
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.47741611660842254,1.3487478184627704,0.10204081632653061,0.47224318586206676,1.0,8/53,10.39%,XCR1;CCR1;LPAR3;HTR1D;HTR4;OPRM1;HRH1;ANXA1
prerank,positive regulation of ERBB signaling pathway (GO:1901186),0.533395285194824,1.348688168181767,0.12244897959183673,0.47164774673337545,1.0,9/25,14.08%,CCDC88A;CBL;ARAP1;RBPJ;AFAP1L2;HIP1;RTN4;AKT1;PDE6H
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.39694546466533337,1.3486713099188594,0.007142857142857143,0.4709209673713547,1.0,71/390,10.06%,FGR;VAV3;NEDD9;TIAM1;CYBB;HCK;LYN;RASGRP4;NGF;FLT3;ACTR3;STAP1;NGFR;FYN;RET;LMTK2;SULF2;MAPKAPK3;SYK;PAK1;FGF5;FGF22;PIK3C2A;JAK2;STAT3;WASF2;KL;CRK;ATP6V0E1;GTF2F2;RAPGEF2;SLA;MAPKAPK2;ABI1;POLR2C;CBL;ZAP70;CDC42;CLNK;VEGFC;BCAR1;ELMO2;CAV2;STYK1;MAPK14;AP2A2;POLR1G;GRB2;SETX;PTK2B;ACTR2;EFNA2;SHOC2;PAK2;GIGYF2;PLCB1;DDIT4;RAC1;PXN;EPHB2;ARPC1B;HGF;SOS1;RHOA;ATP6V1H;GIT1;TRIM71;PGF;ARPC2;NCF2;ARPC4
prerank,negative regulation of protein localization to cell periphery (GO:1904376),0.5590703470119627,1.3479625524627397,0.12363067292644757,0.4719718901612771,1.0,3/20,4.29%,PID1;PPP2R5A;PICALM
prerank,RNA interference (GO:0016246),-0.5070605543945051,-1.3479019827387055,0.1359773371104816,0.6626782743176692,1.0,6/17,18.00%,AGO3;TSN;AGO1;DHX9;TSNAX;DROSHA
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.5295333609739661,1.3477188499451982,0.11764705882352941,0.4718431638945637,1.0,5/26,4.77%,IL1B;RET;MCL1;HSPA1A;GDNF
prerank,response to tumor necrosis factor (GO:0034612),0.44478245753158385,1.3475558760547501,0.07073170731707316,0.47149810971919215,1.0,25/91,17.82%,PID1;CD40;JAK2;ERBIN;IKBKB;CXCL16;ZFAND6;NFE2L2;CIB1;ZFP36L2;TANK;RPS3;RIPK1;CACTIN;MAP4K3;ACOD1;AKT1;ADAMTS12;ADAM9;GBP2;GBP3;RELA;AFF3;SIRT1;YBX3
prerank,mitochondrial calcium ion homeostasis (GO:0051560),0.5558118684478981,1.3475120788209034,0.128,0.47083927315902147,1.0,8/21,12.87%,PDZD8;MCUB;SLC8B1;MAIP1;ATP2A1;FIS1;LETM1;MICU3
prerank,lipid droplet formation (GO:0140042),-0.58302982617534,-1.3468817511776667,0.14676616915422885,0.6629396548724745,1.0,6/10,27.88%,CDS1;CDS2;AUP1;BSCL2;ZFYVE1;FITM2
prerank,negative regulation of protein binding (GO:0032091),0.44897656577264056,1.3467711884689149,0.07124681933842239,0.4720528034095341,1.0,24/71,19.97%,ITGA4;LRRK2;IFIT2;SORL1;SLPI;MITD1;ATP2A3;CARD16;TMC8;PEX14;RALB;B2M;MAPK8;AKT1;IFIT1;ROCK1;AURKB;DISC1;TFIP11;PRKCD;PIN1;ACTB;STYX;PARK7
prerank,DNA double-strand break processing (GO:0000729),0.5748680767471278,1.3461782030332639,0.13570274636510501,0.4728342369704555,1.0,6/18,13.55%,DNA2;RBBP8;MRE11;UBE2N;EXD2;RNF138
prerank,reverse cholesterol transport (GO:0043691),-0.5422938906675804,-1.3449939338790369,0.1342925659472422,0.6660410643487716,1.0,2/13,0.41%,ABCA1;APOE
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),0.6388780815586547,1.3448657048442694,0.16460176991150444,0.4754773341532661,1.0,3/10,8.81%,PTPN22;TIRAP;IFI35
prerank,regulation of heart rate by cardiac conduction (GO:0086091),-0.41283306080770316,-1.344768097219948,0.08940397350993377,0.6634330223283177,1.0,9/38,7.60%,CACNA1D;BIN1;CTNNA3;CACNB2;CACNA2D1;KCNJ2;CACNA1C;ANK2;JUP
prerank,regulation of immune effector process (GO:0002697),-0.4033631418978665,-1.344449509054813,0.06513409961685823,0.6611260888655246,1.0,11/41,13.74%,C1QB;C1QA;C1QC;C3AR1;PROS1;C4B;C5AR1;SUSD4;C5AR2;CLU;C3
prerank,microtubule polymerization (GO:0046785),-0.4328029594027176,-1.3422845793442022,0.11464968152866242,0.6651110690017804,1.0,11/28,20.30%,TUBGCP5;FGF13;CLASP2;CKAP5;GOLGA2;CCDC57;TRPV4;TUBGCP6;TPPP;NDEL1;TUBGCP2
prerank,regulation of neuron migration (GO:2001222),0.535090932938898,1.3421883479250405,0.13452914798206278,0.48153102434178674,1.0,5/26,3.14%,SRGAP2;NTNG2;SHTN1;NIPBL;RAPGEF2
prerank,regulation of histone H3-K9 methylation (GO:0051570),0.6484759183827511,1.3413115714794714,0.16835016835016836,0.48310076920547135,1.0,5/10,19.36%,JARID2;ATRX;MYB;SIRT1;DNMT1
prerank,carbohydrate derivative catabolic process (GO:1901136),0.558832365111097,1.3408672734528613,0.1523809523809524,0.48341160925022425,1.0,5/18,15.76%,SAMHD1;DERA;FUCA1;STT3B;BPGM
prerank,nucleoside diphosphate metabolic process (GO:0009132),-0.5144273955483172,-1.3404669308849346,0.10198300283286119,0.6679704976102391,1.0,9/15,34.24%,ENTPD1;ENTPD5;AK1;ENTPD7;CMPK2;AK4;ENTPD3;ENTPD6;NME2
prerank,positive regulation of macromolecule metabolic process (GO:0010604),0.3934995694436204,1.3404499828950138,0.020512820512820513,0.48371825793199213,1.0,77/348,15.16%,CD74;PID1;IL1B;NGF;PTPN22;IFNGR1;PLCG2;KLF4;STAP1;RPL5;LILRB1;ITGAX;ITCH;ANXA2;MSN;FGF5;ATF7IP;FGF22;PLSCR1;DTX3L;STAT3;HSPA1A;CD36;RNF207;LAPTM5;INPP5F;SCX;ATF2;RBPJ;IL33;MAPK14;AFDN;UBR5;TADA3;SERPINB9;WFS1;NFE2L2;MTPN;SETDB2;PDE2A;EZR;MBIP;CTCF;EPHB2;TLR3;IL6;SNF8;ID2;OLFM1;BRAF;TBC1D5;RPS3;ADAM19;FN1;PTPN1;PRKAG1;MED26;PRKAA1;APP;MAP2K5;TLR2;RPL11;EIF2AK3;ZPR1;MAPK8;AKT1;TLE1;TNRC6B;ROCK1;CITED2;TNRC6A;TGFB1;RAB29;MAZ;MYD88;MAPK1;OCLN
prerank,positive regulation of gene expression (GO:0010628),0.39083786780839047,1.3402407012535715,0.010080645161290322,0.4835376982764087,1.0,93/442,15.16%,CD74;CLEC9A;FGR;NIBAN1;PID1;IL1B;NGF;PTPN22;IFNGR1;PLCG2;BCL3;KLF4;STAP1;RPL5;LILRB1;ITGAX;MSN;FGF5;FGF22;PLSCR1;STAT3;VIM;NFAM1;HSPA1A;CD36;ERN1;MYO1C;TAF1A;RNF207;PTGER4;EIF2AK2;SCX;ATF2;RBPJ;IL33;ADRA2A;MAPK14;GLMN;SMARCA5;AFDN;UBR5;POLR1G;DEK;SETX;TADA3;SERPINB9;NFE2L2;DYRK1A;PDE2A;YTHDF3;EZR;MBIP;CTCF;EPHB2;TLR3;IL6;SNF8;RBM22;ID2;OLFM1;BRAF;RPS3;ADAM19;FN1;RIPK1;PRKAG1;MED26;PRKAA1;APP;TLR2;RPL11;EIF2AK3;ZPR1;HNRNPLL;MAPK8;AKT1;METTL3;TLE1;AGPAT1;TNRC6B;ROCK1;CITED2;KAT2B;TNRC6A;LARP4B;TGFB1;POLR1B;EIF3E;TENT4B;MAZ;MYD88;MAPK1;OCLN
prerank,positive regulation of innate immune response (GO:0045089),0.5039189961953692,1.339797001575245,0.11407407407407408,0.48395139486427974,1.0,6/30,9.23%,POLR3F;PLSCR1;SPI1;TRIM62;IFI35;SLC15A4
prerank,positive regulation of cell population proliferation (GO:0008284),0.39507565792252847,1.3397652783769793,0.006054490413723511,0.4832466403829912,1.0,74/423,15.87%,CD74;DPP4;PID1;PTPRC;IL1B;FOXP1;GRK5;RARA;TIAM1;HCK;LYN;CD47;GLI1;FLT3;CDK13;ITGAX;ACER3;TBC1D8;PIM1;PAK1;FGF5;FGF22;CUL3;PRKCH;PTPN6;LAMB1;SCX;IL6R;GDNF;VEGFC;RBPJ;ADRA2A;STAT1;PTEN;PTK2B;ADAM17;CIB1;MECP2;CNOT6;NOX1;DOT1L;CACUL1;IL6ST;IL6;ID2;PGF;CSNK2A1;RPRD1B;FN1;IL31RA;GLP2R;MCTS1;NAP1L1;SLC25A5;MEGF10;NDUFS4;PDGFD;CCND2;LIFR;AKT1;HCLS1;EZH2;GNAI2;TGFB1;COX17;FGFR3;IL18;MAZ;RHOG;RELA;RPS15A;THBS1;CDCA7L;RPS4X
prerank,calcium ion transmembrane transport (GO:0070588),-0.34005296496326565,-1.3390647289471505,0.042328042328042326,0.6695401438696269,1.0,27/86,16.27%,CACNA1D;SLC8A1;RYR3;SLC24A3;GAS6;CACNA2D1;TRPV2;TRPM3;PKD2;CACNA1C;ATP2A2;TRPC4;P2RX7;P2RX4;AFG3L2;TRPC1;MCOLN1;MCOLN3;ATP2B3;TRPC7;TRPM2;SPG7;TRPV4;TRPC3;STOML2;MCOLN2;ATP2C1
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),-0.5813211426015787,-1.3390617983783888,0.13986013986013987,0.6661241227274349,1.0,2/10,2.09%,DLGAP1;DLGAP4
prerank,cellular biogenic amine catabolic process (GO:0042402),-0.5859970909450687,-1.3382939614354028,0.15566037735849056,0.6653664586784815,1.0,4/10,11.72%,COMT;SMOX;HNMT;ALDH7A1
prerank,copper ion homeostasis (GO:0055070),0.5709933337482855,1.3380058542062057,0.11451612903225807,0.4870007648568224,1.0,8/17,16.64%,PRNP;ARF1;ATP7A;ATOX1;APP;CUTC;XIAP;SLC31A1
prerank,myelin assembly (GO:0032288),-0.5748806961881526,-1.3379593880209275,0.14685314685314685,0.6632831383508037,1.0,7/10,29.26%,TENM4;CD9;EPB41L3;TPPP;CNTNAP1;NCMAP;ABCA2
prerank,regulation of calcium ion transmembrane transport (GO:1903169),0.5326063914834716,1.3377933618017734,0.1299093655589124,0.4867622713920756,1.0,5/23,6.71%,FYN;DIAPH1;PRNP;PTK2B;CACNB1
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),0.5904196786147187,1.3375573955121247,0.13379073756432247,0.48658779663628265,1.0,2/14,1.13%,IL1B;PAEP
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.46995686691492183,1.337541837405681,0.1193029490616622,0.48585017303773514,1.0,15/48,15.80%,PTPRC;SAMHD1;STAP1;PPARG;PARP14;YTHDF3;CARD16;IL6;CACTIN;OTUD4;STAT2;METTL3;GPS2;GSTP1;IRAK3
prerank,DNA packaging (GO:0006323),0.5814604791629918,1.3372458086083725,0.14862681744749595,0.48588579435987245,1.0,4/16,11.17%,CHAF1A;RBBP4;KAT6A;AIFM1
prerank,cellular response to lipid (GO:0071396),0.40742079773960826,1.3360317013148717,0.030010718113612004,0.4883421186676113,1.0,39/191,15.28%,PID1;IL1B;MAP4K1;LYN;TNIP3;STAP1;CREB1;LILRB1;RET;NFKB1;MSN;VIM;NCOA3;CXCL10;MAPK14;SETX;PTK2B;AHR;PDCD4;CARD16;IL6;NFKBIB;RHOA;GIT1;SBNO2;NR3C1;CACTIN;ACOD1;NLRP3;GNAI1;ADCY5;MAPK8;NRIP1;PDK3;TNFRSF1B;ADAM9;GSTP1;MYD88;RELA
prerank,regulation of cytoplasmic transport (GO:1903649),0.62953421238198,1.335879516101995,0.1543859649122807,0.4879179511263332,1.0,1/11,0.22%,LRRK2
prerank,DNA replication (GO:0006260),0.42748471237871594,1.33528446056463,0.07502930832356389,0.4886844517791861,1.0,33/105,18.19%,DNA2;BAZ1A;RBBP8;POLL;CDC45;MRE11;FEN1;FAM111A;KAT7;ORC5;MCM6;RBMS1;POLD4;WRN;ORC4;BRIP1;RECQL5;NAP1L1;RPA3;POLA2;MCM2;RNASEH2A;PCLAF;DONSON;MCMBP;ORC6;MCM9;POLG2;POLB;HUS1;POLD1;ORC2;RAD17
prerank,positive regulation of cell differentiation (GO:0045597),0.4031186470079533,1.3352525592089803,0.02631578947368421,0.4879978979729642,1.0,39/237,10.60%,FFAR4;IL1B;RUNX2;RIN2;TIAM1;NGF;RAP1A;CREB1;PPARG;NFKB1;CD36;PRKCH;RPS6KA3;BMPR2;RAPGEF2;CTNNA1;RIPOR2;GLIPR2;IL6R;CDC42;GDNF;BTG1;LMO3;MAPK14;WDFY2;PLCB1;MAPK12;ACVR2A;IL6ST;HGF;IL6;RHOA;CPNE1;ID2;CREBL2;OLFM1;SMAD4;NUDT21;CCDC71L
prerank,regulation of interferon-beta production (GO:0032648),0.4783719749568422,1.335244535244172,0.1032171581769437,0.48725563132898314,1.0,13/46,12.51%,LILRB1;OAS2;POLR3F;DHX58;REL;POLR3A;IFIH1;TIRAP;TRAF3;TLR3;IRF7;CACTIN;TLR2
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.4500580345546537,1.3351643359534364,0.0946969696969697,0.48672339432412465,1.0,23/66,16.37%,KLF4;PSME3;ANKRD17;PTPN6;PSME2;CCND3;PTEN;CDKN2C;CCND1;ADAM17;PLCB1;ID2;ANXA1;DCUN1D3;CCND2;AKT1;WEE1;KMT2E;INO80;APC;RBL2;BRD7;RB1
prerank,regulation of protein tyrosine kinase activity (GO:0061097),0.48978201991028597,1.3348771995182616,0.13150684931506848,0.48667617773741473,1.0,16/38,18.84%,PTPRC;NEDD9;ACE;PRNP;PTPN1;UNC119;APP;SH3BP5;CASS4;MVP;LRP8;RELN;EFNA1;LILRA5;FCGR1A;NCK2
prerank,cell-cell junction maintenance (GO:0045217),-0.566801682211781,-1.3347626103977313,0.1391509433962264,0.6709492248744562,1.0,2/11,0.35%,CSF1R;TJP1
prerank,regulation of neurotransmitter receptor activity (GO:0099601),-0.37281710240898336,-1.3347199583985443,0.06018518518518518,0.6676905689829272,1.0,10/57,3.97%,DLGAP1;MEF2C;GRIA4;LRRC7;NLGN1;DLGAP4;DLG2;DLG4;GRIA2;GRIA1
prerank,energy reserve metabolic process (GO:0006112),0.559561462756546,1.333579464696882,0.14913657770800628,0.4892569195098239,1.0,3/19,9.07%,PID1;PRKAG2;UGP2
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.40111382992932265,1.3327321816977222,0.029535864978902954,0.49072291536756346,1.0,60/234,15.80%,CARD11;IL1B;TRAF1;PLCG2;IL18RAP;CAMK1D;PPARG;CD40;NFKB1;STAT3;NFAM1;HSPA1A;TRIM26;CD36;PRKCH;MALT1;NFKBIA;EIF2AK2;IKBKB;ATF2;TRIM62;RAB7B;HIPK2;RPS6KA5;TIRAP;PTEN;UBE2N;BUD31;CIB1;MTPN;TRIM25;CLOCK;CARD16;IL6;NFKBIB;PIDD1;RPS3;NLRC4;RIPK1;TRIM14;RNF31;TAB3;NLRP3;APP;MAP3K7;TLR2;BTK;AKT1;KIT;HCLS1;LPAR5;CRTC3;MAP3K13;IL18;MYD88;RELA;TAF1;DVL2;LRP8;IRAK3
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),0.6045367149950771,1.3318305708071936,0.16363636363636364,0.4922821069949807,1.0,5/13,5.41%,PPARG;LDLR;SYK;CD36;ITGB2
prerank,GPI anchor metabolic process (GO:0006505),-0.4424246306226287,-1.3317497392520505,0.12094395280235988,0.6748910964939004,1.0,19/26,39.09%,PIGN;PIGG;PGAP2;PIGP;PIGB;PIGA;DPM2;GPLD1;PIGV;DPM3;PIGU;DPM1;PIGO;PGAP3;MPPE1;PIGZ;PIGW;PIGQ;PGAP1
prerank,regulation of response to cytokine stimulus (GO:0060759),0.5650685595874876,1.3316332766425085,0.1406003159557662,0.4920653796965411,1.0,8/19,13.07%,KLF4;TAF9;IFIH1;CBFB;ELF1;PARP9;MAP2K5;LIFR
prerank,regulation of mitochondrial depolarization (GO:0051900),0.6376711470273048,1.3306560627574113,0.18530884808013356,0.49382339480646126,1.0,1/10,0.22%,LRRK2
prerank,myeloid leukocyte differentiation (GO:0002573),0.45376336172811205,1.3305807910000529,0.103831891223733,0.4932249576689228,1.0,10/65,6.69%,CBFA2T3;FOXP1;RARA;PPARG;SPI1;MYH9;CDC42;MAPK14;DEK;EFNA2
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.4420707536396479,1.330349799467585,0.08220858895705521,0.49306329864044235,1.0,25/79,17.19%,CD74;AP1S3;RACGAP1;AP1S2;KIF23;RAB7A;AP2A2;MFSD6;CAPZB;ARF1;DCTN3;CAPZA1;PIKFYVE;KIF3B;AP1G1;AP2B1;FCGR2B;DYNC1H1;FCER1G;CANX;KIF5A;AP2S1;SEC24C;DYNC1I2;AP1M1
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),-0.5077466024839965,-1.3303060209410968,0.15968586387434555,0.6766074321377175,1.0,10/15,32.35%,DERL2;HSP90B1;AUP1;NPLOC4;DERL1;HERPUD1;SEC61B;FAF2;TMEM129;SYVN1
prerank,maintenance of protein location in nucleus (GO:0051457),0.5598485705837284,1.3299304631409539,0.14330218068535824,0.4933687270487275,1.0,2/20,1.24%,SP100;BCL3
prerank,regulation of aerobic respiration (GO:1903715),0.5975313166970847,1.3297084578635514,0.17517006802721088,0.49321349557322597,1.0,6/15,18.80%,CBFA2T3;ATP7A;ABCD1;VCP;COX7A2;PINK1
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),0.637620959047916,1.3296617022843031,0.15342960288808663,0.49256135844468607,1.0,4/11,11.47%,RIN3;STAP1;SLAMF8;DUSP1
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),0.6024813215762377,1.3282410101944888,0.14893617021276595,0.4954718621188807,1.0,5/14,17.32%,MALT1;TIRAP;TLR3;MAP3K7;TRAF2
prerank,cellular biogenic amine biosynthetic process (GO:0042401),-0.5147297105616794,-1.328065692713752,0.13533834586466165,0.6809227446272916,1.0,8/15,39.24%,SMOX;PAOX;DDC;ASMT;SAT2;MOXD1;SRM;AANAT
prerank,mitochondrion distribution (GO:0048311),0.6272527644028126,1.3279512953466566,0.15344827586206897,0.4954457271641664,1.0,3/12,12.86%,LRRK2;CLUH;DNM1L
prerank,keratan sulfate biosynthetic process (GO:0018146),0.5320771475630598,1.3268134249103352,0.15086206896551724,0.49763536499170774,1.0,4/26,8.98%,ST3GAL1;ST3GAL4;B4GALT5;ACAN
prerank,organelle fusion (GO:0048284),-0.44626084769235563,-1.3265244918073689,0.14423076923076922,0.6834306251114349,1.0,8/22,15.53%,AFG3L2;GDAP1;MFF;MIGA2;SPG7;USP30;BAX;MFN1
prerank,nuclear migration (GO:0007097),0.6189200274660835,1.3259231963181115,0.15397923875432526,0.49924461536974274,1.0,4/13,11.89%,SYNE3;FBXW11;PAFAH1B1;DYNC1H1
prerank,response to leucine (GO:0043201),-0.5634122735953134,-1.3258853394746286,0.14925373134328357,0.6791669441554901,1.0,5/10,8.49%,RPTOR;KLHL22;SESN3;LARS1;UBR1
prerank,cellular response to leucine (GO:0071233),-0.5634122735953134,-1.3258853394746286,0.14925373134328357,0.6791669441554901,1.0,5/10,8.49%,RPTOR;KLHL22;SESN3;LARS1;UBR1
prerank,presynaptic endocytosis (GO:0140238),-0.43663592328493517,-1.3257501976217565,0.10787172011661808,0.6763354893742449,1.0,7/24,16.11%,OPHN1;SYT1;NLGN1;CDK5;STX1A;NLGN2;NLGN3
prerank,negative regulation of amyloid-beta formation (GO:1902430),-0.4971232847771351,-1.3253456294815908,0.1322314049586777,0.6745475991209702,1.0,9/17,13.29%,BIN1;APOE;IGF1;NTRK2;RTN3;GGA3;CHRNA7;CLU;ABCA7
prerank,positive regulation of gene silencing by miRNA (GO:2000637),0.5208997766867776,1.3250169734555202,0.14265335235378032,0.5008763578621652,1.0,12/27,18.98%,LIMD1;STAT3;PUM2;IL6;RIPK1;EIF4ENIF1;TNRC6B;TGFB1;PUM1;AJUBA;DDX6;MAP2K1
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),0.6222783287538096,1.3246335594914525,0.15306122448979592,0.501085487690456,1.0,1/12,0.38%,FOXP1
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),-0.5347662173370221,-1.3245057417411286,0.16831683168316833,0.6710758832763577,1.0,5/12,12.86%,IGF1;SPPL3;CAMTA1;AKAP6;PTBP1
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),-0.5347662173370221,-1.3245057417411286,0.16831683168316833,0.6710758832763577,1.0,5/12,12.86%,IGF1;SPPL3;CAMTA1;AKAP6;PTBP1
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",-0.3395492037175023,-1.3244689532838243,0.04371584699453552,0.6680488280775416,1.0,29/84,14.06%,QKI;SON;DDX5;SRSF3;SFSWAP;RBFOX1;RNPS1;RBFOX2;SRPK1;KHDRBS3;SRSF7;TIA1;TRA2A;SRRM4;JMJD6;FXR1;NOVA1;RBFOX3;RBM5;RBM3;THRAP3;FXR2;NOVA2;PTBP1;RBM25;SRPK2;SNW1;KHDRBS2;WTAP
prerank,regulation of p38MAPK cascade (GO:1900744),0.4981462392464005,1.323222530353283,0.13861386138613863,0.5040459215183724,1.0,12/35,13.43%,IL1B;PTPN22;SPI1;EZR;PHLPP1;MINK1;MAP3K4;RELL1;CYLD;DUSP1;EMC10;NCF1
prerank,regulation of protein kinase C signaling (GO:0090036),0.5895236344025347,1.3226738464006078,0.15875613747954173,0.5047530325341748,1.0,2/14,1.72%,DGKG;CD40
prerank,regulation of apoptotic process (GO:0042981),0.38199763473336207,1.322438592674036,0.004004004004004004,0.5046176605843141,1.0,166/676,17.38%,CD74;CD44;VAV3;FFAR4;GRK5;TIAM1;ARHGEF18;HCK;NOTCH2;CAPN13;NGF;FLT3;BCL3;LILRB1;DAPK1;NGFR;SLK;MAP3K5;MCL1;ITCH;BCL6;PIM1;TIAM2;NFKB1;STK17B;JAK2;HSPA1A;RPS6KA3;IFIT2;PHLDA1;SOS2;BIRC6;CXCL10;MALT1;TAF9;PTPN6;NFKBIA;NAA16;MRE11;CBL;BCL2L14;SCX;IKBKB;DPEP1;ATF6;RYBP;GDNF;BIRC3;BCAR1;STAT1;FGD4;DDX42;FAF1;ARF4;DFFA;STK4;SETX;PTK2B;LGALS1;ANXA4;ZFAND6;SERPINB9;WFS1;FLNA;WRN;IKZF3;CIB1;PAK2;PAWR;MTCH1;TNFAIP8;SAP18;RARG;TOX3;AVEN;PHLPP1;FGD1;IL6ST;DUSP6;HGF;IL6;SOS1;FGD3;LATS1;NAA15;ING3;OLFM1;HIP1;ANKLE2;PIDD1;BRAF;ARHGEF6;RPS3;NLRC4;RTN4;UBE2Z;DAXX;ANXA1;IL31RA;CASP2;CALHM2;RIPK1;USP42;APAF1;YWHAZ;DSTYK;AIFM1;NET1;LATS2;FOXO3;DCUN1D3;PRKAA1;REST;RPS6KA1;HTT;PSMD10;HYPK;SH3RF1;CLIP3;NF2;AREL1;DNM1L;MAP3K20;ERCC3;HSPA9;CCND2;PRELID1;MAPK8;AKT1;DHCR24;API5;PRKAA2;YME1L1;DNAJC3;CITED2;ARHGEF3;HDAC3;RPS6KA2;VCP;GSTP1;MYD88;CASP6;XIAP;CREBBP;RELA;RNF122;PRDX5;THBS1;TRIM35;LRP8;MED1;PROC;APC;USP47;RPS6KB1;PPT1;DAPK3;IRF5;HTATIP2;SEMA4D;NIBAN2;PSEN1;RASSF2;SIRT1;TRAF2;HSPD1
prerank,positive regulation of protein secretion (GO:0050714),-0.3510404027326236,-1.321936579791435,0.057971014492753624,0.67349043039549,1.0,24/69,21.35%,FRMD4A;IGF1;TREM2;WLS;PPIA;CD33;IL1A;ADAM8;TLR4;SOX4;NLGN2;TGFB2;MYOM1;BMP6;LRRC8A;APBB1;IER3IP1;APBB3;CAPN10;EXOC1;TCF7L2;ANG;PPID;MYH10
prerank,regulation of intracellular pH (GO:0051453),0.4985492912529341,1.3219174483002079,0.1394700139470014,0.5051856907211604,1.0,5/34,7.86%,LRRK2;SLC9A7;SLC4A7;SLC4A8;NOX1
prerank,cartilage development (GO:0051216),0.4725527346396575,1.3215538539200375,0.12016021361815754,0.5053791470598825,1.0,5/49,4.20%,CD44;RUNX2;RUNX3;SULF2;SCX
prerank,fat cell differentiation (GO:0045444),0.46444727303121797,1.3211638043099319,0.09881422924901186,0.5056654652135689,1.0,5/57,1.96%,PID1;FFAR4;KLF4;PPARG;METRNL
prerank,superoxide metabolic process (GO:0006801),0.5121222026920256,1.3206439921211326,0.1326530612244898,0.5062579261006973,1.0,7/29,13.43%,CYBB;ATP7A;NOX1;CYB5R4;NRROS;NCF2;NCF1
prerank,cellular response to ketone (GO:1901655),0.4929664680764105,1.3204705788503328,0.12805755395683452,0.5059650253526136,1.0,12/35,13.32%,MAP4K1;MSN;PTGER2;PTGER4;AHR;GNB1;NR3C1;ACOD1;GNAI1;ADCY5;KLF9;GNG2
prerank,positive regulation of kinase activity (GO:0033674),0.4255013469809928,1.3202778782007434,0.07249712313003452,0.5056520024750355,1.0,18/107,11.04%,CD74;PTPRC;IQGAP1;FLT3;RAP1A;RET;LMTK2;PRKAG2;RAPGEF2;MRE11;TRAF4;PTK2B;CACUL1;EPHB2;DAXX;SNX9;DSTYK;PRKAG1
prerank,polyol biosynthetic process (GO:0046173),0.5730429810739678,1.3195694770900606,0.17028380634390652,0.5067317008844112,1.0,4/16,7.75%,ITPKC;ACER3;IP6K3;CYP27A1
prerank,positive regulation of protein metabolic process (GO:0051247),0.4164488029973521,1.3195407699550372,0.07390300230946882,0.506068427332185,1.0,33/110,16.94%,IL1B;PAEP;KLF4;DTL;ITCH;ASB5;NEDD4L;SORL1;NFKBIA;GPC3;AXIN1;RAB7A;TIPARP;WFS1;MTPN;STX5;SNF8;WWP2;CSNK2A1;APP;MAP2K5;AREL1;MAPK8;AKT1;VCP;TGFB1;SLC6A9;IL18;RNF41;APC;HACE1;WNT7A;PSEN1
prerank,postsynaptic membrane organization (GO:0001941),-0.4838970140649458,-1.3190279846040134,0.12011173184357542,0.6804195212729062,1.0,8/17,19.15%,APOE;NLGN1;DLG4;NRXN2;NLGN2;NLGN3;LHFPL4;NRXN1
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),-0.43450014840494655,-1.318744183763175,0.13109756097560976,0.6783176382708085,1.0,10/25,24.14%,HK3;HK1;PFKL;PGK1;PFKP;ENO2;PGAM1;PFKM;ENO3;ALDOA
prerank,cytoplasmic translational initiation (GO:0002183),-0.4908741208372259,-1.3184271975048656,0.13279132791327913,0.6761882622670934,1.0,8/17,15.07%,EIF4A1;DENR;EIF2S2;DHX29;EIF3M;EIF5;EIF4G1;EIF4H
prerank,cardiolipin metabolic process (GO:0032048),-0.5287132557796813,-1.3172917807001838,0.14153132250580047,0.6769772310767669,1.0,6/13,13.56%,PNPLA8;SLC27A1;PLA2G4A;HADHB;TAMM41;HADHA
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",0.6290502243994865,1.3171113632731704,0.16756756756756758,0.5115266211842849,1.0,2/10,5.32%,SP100;HIPK2
prerank,cellular response to oxidative stress (GO:0034599),0.41453369070670093,1.3166531173538343,0.06908267270668177,0.5120557487646359,1.0,29/118,15.36%,LRRK2;CYBB;DAPK1;LONP1;HSPA1A;FOS;GPX1;GSR;PRDX6;VRK2;SETX;NFE2L2;PXN;FANCC;CAMKK2;RPS3;NCF2;MGAT3;ERMP1;FOXO3;PRKAA1;MAPK8;AKT1;NCF1;PRKAA2;PNPT1;GSTP1;MAPK1;PRDX5
prerank,chondrocyte differentiation (GO:0002062),0.504338245605007,1.3166526977416337,0.13661971830985917,0.5112891982425332,1.0,5/32,4.20%,RUNX2;RUNX3;SULF2;BMPR2;SCX
prerank,calcium ion homeostasis (GO:0055074),0.42735144716225937,1.3151116724484584,0.09904534606205251,0.5145367303507143,1.0,16/95,12.60%,CCR2;CD40;CCR1;NPTN;SLC8B1;ATP2B1;ATP2A3;STIM2;WFS1;ATP2A1;SLC30A1;DMPK;TMEM203;ATP13A3;SLC10A7;SLC24A4
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),0.4710624980478189,1.3150057753793858,0.12624113475177304,0.5140568028246116,1.0,17/41,18.26%,NEDD9;ACE;STAP1;FYN;FBXW7;ADRA2A;PRNP;ADAM17;PTPN1;UNC119;CASS4;NCF1;LRP8;RELN;EFNA1;LILRA5;FCGR1A
prerank,neuron differentiation (GO:0030182),-0.3033400207250299,-1.3145785259196476,0.020618556701030927,0.6829701279119076,1.0,35/165,17.14%,OPHN1;ATP8A2;MEF2C;LRP6;PTPRD;WNK1;TGFBR1;NTRK2;IL1RAPL1;TENM4;ERCC6;CTNNB1;TENM2;ATP2B2;SPOCK1;LDB1;EPHA5;NRBP2;RYK;CDK5R1;MYO7A;CDK5;SNPH;CASP3;VEGFA;ITM2C;SOX4;ERCC2;TGFB2;MANF;TENM1;HS6ST1;MYEF2;SOX11;VXN
prerank,nucleosome organization (GO:0034728),0.45815980752474966,1.314434336126439,0.10668380462724936,0.5148028655857712,1.0,19/55,18.54%,NFE2;CHAF1A;H3-3A;SMARCA5;CTCF;ACTR6;SMARCE1;DAXX;ARID2;SETD2;NAP1L1;ATRX;SMARCC2;SRCAP;RSF1;INO80;BPTF;SMARCD3;BRD2
prerank,intrinsic apoptotic signaling pathway (GO:0097193),0.4321011394914317,1.314360970260437,0.08313253012048193,0.5142455138557829,1.0,18/94,11.17%,ITPR1;STK24;MAP3K5;MCL1;CUL3;ERN1;CUL5;ATP2A3;BBC3;HIPK2;CRIP1;ATP2A1;MSH6;PPP1R15A;GSKIP;CASP2;APAF1;AIFM1
prerank,monocarboxylic acid biosynthetic process (GO:0072330),-0.3636378570761137,-1.3142243861624519,0.08035714285714286,0.6812152576561297,1.0,22/59,32.05%,ACACA;OSBPL1A;CH25H;ELOVL4;HOGA1;CBR4;HSD17B8;PER2;LIPH;ABCD3;MLYCD;OSBPL6;AMACR;OXSM;OSBPL7;NDUFAB1;ACOT8;OSBP;ALDH1A2;SLC27A2;OSBPL2;HSD17B10
prerank,positive regulation of MAP kinase activity (GO:0043406),0.4387846083571957,1.3139559478111165,0.1065989847715736,0.5145574703199567,1.0,17/66,14.21%,LRRK2;FLT3;MAP3K5;CD40;PAK1;TAOK3;ADRA2A;PIK3R6;DIRAS1;MAP3K4;RPS3;DVL3;MAP3K7;PDGFD;KIT;EZH2;TGFB1
prerank,atrial septum morphogenesis (GO:0060413),0.6364579073574245,1.3133726497258922,0.15469613259668508,0.5153171805269944,1.0,2/10,2.93%,NOTCH2;BMPR2
prerank,regulation of nervous system process (GO:0031644),-0.47414701234955026,-1.313049819077884,0.1548223350253807,0.6820813110567919,1.0,5/18,13.27%,DLGAP1;DLGAP4;TMEM108;CHRNA7;HTR2C
prerank,regulation of sodium ion transmembrane transport (GO:1902305),0.5198974225637477,1.3128988873103495,0.13484848484848486,0.5158137890653656,1.0,3/27,2.59%,FXYD5;UTRN;NEDD4L
prerank,cellular response to DNA damage stimulus (GO:0006974),0.38652156377513736,1.3127882468249576,0.01443298969072165,0.5153465329787856,1.0,87/336,16.47%,VAV3;FOXP1;UVRAG;LYN;SAMHD1;BCL3;DTL;MCL1;BCL6;PAK1;DTX3L;POLI;NIPBL;BTG2;RBBP8;MAPKAPK2;CHRNA4;TAF9;USP3;MRE11;FEN1;CRY1;FAM111A;SUMO1;ATF2;PARP4;TAOK3;WAC;MAPK14;UBR5;CCND1;GRB2;SETX;SETD7;CRIP1;CEP63;GNL1;MBD4;WRN;CIB1;USP45;MSH3;MAPK12;NABP1;DOT1L;PSME4;BACH1;MSH6;PPP1R15A;PIDD1;TLK2;TANK;IRF7;FANCC;RPS3;FANCL;CASP2;KMT5B;RECQL5;SUSD6;NUPR2;RAD54L;SPIDR;ERCC3;ERCC4;METTL3;FANCA;TNFRSF1B;PCLAF;SIRT4;VCP;XRCC2;BRSK1;XIAP;VCPIP1;TAF1;INO80;ENDOV;MCM9;DYRK2;APC;INIP;USP47;POLB;NSMCE4A;HUS1;UBA6
prerank,heme biosynthetic process (GO:0006783),-0.4493600793655324,-1.312114202226379,0.12804878048780488,0.6821395055741591,1.0,13/22,32.66%,ABCG2;FLVCR1;FECH;ALAS1;CPOX;COX10;FXN;SLC25A38;PGRMC1;ABCB10;HMBS;UROD;ATP5IF1
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),0.49536652571275525,1.311857263153689,0.13687150837988826,0.5170950112887208,1.0,6/38,3.17%,IL1B;CD47;KLF4;JAK2;CD36;PTGIS
prerank,central nervous system development (GO:0007417),-0.28953635012277157,-1.3103165655580575,0.0,0.6852819468158946,1.0,66/250,17.08%,PRKN;ZFHX3;ATXN1;TGFBR2;CX3CR1;WWP1;CHD7;MARCKS;C1QA;ADAM23;ROBO2;PKD2;TPP1;CNTN4;PLXNB2;SMO;NF1;MTF1;APOD;NFIB;AFF2;SPOCK1;CAPG;RAB3GAP1;GRIK1;DCX;JRKL;CDK5R1;NCOA6;POU6F1;SH3GL2;TBC1D23;AATK;LOXL3;ZFHX2;PTPRZ1;UFC1;CDK5;SHROOM2;PHF8;EPHA7;SERPINI1;DHX30;MEIS3;ROGDI;EIF2B5;SOX4;SETD1A;UFM1;C3;ADGRL3;RNF103;NPAS2;TAGLN3;POU3F3;TPPP;PAFAH1B2;ADGRL2;CNTNAP2;ADGRG1;CNTN6;SOX11;SCYL2;PHGDH;IER3IP1;HAPLN2
prerank,negative regulation of defense response (GO:0031348),0.42923549147885554,1.3094606063721348,0.0925700365408039,0.5225180987612432,1.0,9/77,4.32%,FFAR4;KLF4;PPARG;ITCH;METRNL;DHX58;PTGIS;PTGER4;SMPDL3B
prerank,activation of phospholipase C activity (GO:0007202),-0.41930029595092455,-1.3091717176449296,0.1523809523809524,0.6860131858000199,1.0,8/29,8.92%,P2RY12;NTRK2;GNA15;CD86;PLCG1;HTR2B;C5AR1;P2RY6
prerank,regulation of cell motility (GO:2000145),0.41219031846070286,1.3090901358026807,0.05821917808219178,0.5227154916740256,1.0,22/121,8.94%,CYRIB;SGK3;SLK;PKN1;FGF5;CCDC125;FGF22;NRG2;DOCK10;ARHGAP18;CRK;RCC2;INPP5F;TMSB10;DIAPH1;FLNA;PKN2;LMNA;PLXND1;RAC1;MINK1;RHOA
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),0.4968119039005991,1.3088697346311355,0.15028901734104047,0.5225187848984743,1.0,12/33,14.94%,GLI1;PLCG2;ANKRD17;CCND3;CCND1;ADAM17;PLCB1;ANXA1;CCND2;AKT1;EZH2;KMT2E
prerank,fat-soluble vitamin metabolic process (GO:0006775),-0.4578041219926732,-1.3088114032024438,0.1069364161849711,0.6841434076213712,1.0,1/22,0.16%,LGMN
prerank,histone ubiquitination (GO:0016574),0.5386117147236895,1.3088109448848118,0.1642651296829971,0.521897578096136,1.0,6/21,7.92%,DTX3L;UBE2E1;WAC;RNF20;UBE2N;UBR2
prerank,synaptic vesicle recycling (GO:0036465),-0.40849431313641477,-1.3083965856853834,0.11418685121107267,0.6824212739261059,1.0,8/31,16.11%,OPHN1;SYT1;NLGN1;SYT7;CDK5;STX1A;NLGN2;NLGN3
prerank,protein catabolic process (GO:0030163),-0.3594017217069847,-1.3081409235905352,0.05855855855855856,0.6801749941471399,1.0,8/59,8.12%,PRKN;CTSD;APOE;CAPN3;LAMP2;TPP1;UCHL3;IDE
prerank,positive regulation of interleukin-4 production (GO:0032753),0.562915405304743,1.308005462485302,0.16614420062695925,0.5231802156842447,1.0,5/17,13.50%,RARA;SYK;IRF4;NLRP3;FCER1G
prerank,protein localization to endoplasmic reticulum (GO:0070972),0.5741858177082259,1.3079632372972863,0.16470588235294117,0.5225350995127891,1.0,7/16,19.05%,LRRK2;GBF1;PPP1R15A;TAPT1;VAPA;HSPA5;UBAC2
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),-0.4136867775904258,-1.3077508285023083,0.11073825503355705,0.6784901354828479,1.0,9/31,9.99%,OPHN1;PARD3B;MYO9A;RAP2A;LRRC7;DLG2;SCRIB;MTCL1;PARD3
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.5052935142082874,1.307729412728781,0.14842578710644677,0.5223848913842264,1.0,11/26,19.83%,CBLB;CBL;FBXW7;ADRA2A;TSG101;ADAM17;APP;NCF1;ZFYVE28;NCK2;SOCS5
prerank,extracellular structure organization (GO:0043062),0.39279494174001023,1.307520980180164,0.045989304812834225,0.5221683197784437,1.0,28/204,10.32%,ITGB7;ITGA4;ITGAL;CD44;CD47;PECAM1;ITGAE;ITGAX;TNC;NDNF;COL5A2;MMP1;LAMB1;ITGAD;ITGB2;HSPG2;TEX14;F11R;ATP7A;ADAMTS6;TGFBI;PXDN;ACAN;ICAM1;FBN1;ADAM19;NCAN;FN1
prerank,body fluid secretion (GO:0007589),-0.49979815506796105,-1.30750244523126,0.14323607427055704,0.6762096710335652,1.0,4/15,16.03%,ERBB4;VEGFA;SLC22A4;GPAT4
prerank,regulation of supramolecular fiber organization (GO:1902903),-0.4534301822272801,-1.3072121805102708,0.1392757660167131,0.6742819330712915,1.0,7/22,11.82%,APOE;CAMSAP1;MAP2;MAP1B;MAP1A;CHRNA7;CAMSAP2
prerank,regulation of protein kinase activity (GO:0045859),0.41940733524294777,1.3071996558189996,0.09101123595505618,0.5222482002518507,1.0,29/106,17.53%,FGR;PTPRC;IQGAP1;UVRAG;RAP1A;PRKAG2;RAPGEF2;TRAF4;PRKRIP1;PTK2B;PDPK1;PAK2;CACUL1;GSKIP;CAMKK2;DAXX;SNX9;DBNDD2;PRKAG1;TAF7;MAP2K3;AKT1;GSTP1;SPRED1;RELN;RB1;RASSF2;SIRT1;TAB1
prerank,negative regulation of cellular protein localization (GO:1903828),0.4989815247468002,1.3063918041547298,0.12262773722627737,0.5236455195998706,1.0,13/34,19.08%,NEDD4L;CTNNA1;RIPOR2;SPI1;PICALM;LATS1;LATS2;TAX1BP3;ILRUN;SNX33;GOPC;LZTFL1;ANKRD13A
prerank,aerobic respiration (GO:0009060),-0.4669306364515211,-1.3061015693398794,0.13314447592067988,0.6749991024293862,1.0,12/20,26.05%,UQCRC2;ME3;SDHB;OXA1L;SLC25A14;NDUFS7;MTFR1L;ATP5F1D;UQCRC1;UQCR10;NDUFS8;SURF1
prerank,positive regulation of phosphorylation (GO:0042327),0.3934041139954359,1.3049401983511675,0.04439746300211417,0.5266682904247046,1.0,52/240,14.28%,CD74;NIBAN1;LRRK2;IL1B;LYN;FLT3;PECAM1;RET;LMTK2;CD40;PAK1;FGF5;FGF22;NPTN;ZBTB20;MRE11;AXIN1;CCND3;PRXL2C;VEGFC;GLMN;CCND1;STK4;WDFY2;ADAM17;CIB1;ENG;RAC1;EPHB2;ACVR2A;HGF;RALB;PGF;CAMKK2;DAXX;RIPK1;DSTYK;PRKAA1;DVL3;APP;BTBD10;PFKFB3;CLIP3;CCND2;AKT1;KIT;LIMK2;PRKAA2;HDAC3;TGFB1;FGFR3;PFKFB4
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.4711504309720902,1.304908731551034,0.14285714285714285,0.5260193982209023,1.0,9/51,8.69%,LRRK2;SRGAP2;NGF;PAK1;SHTN1;TAOK3;SNX1;ATP7A;MINK1
prerank,regulation of systemic arterial blood pressure (GO:0003073),0.5637208883435835,1.3048825142343177,0.16124031007751938,0.5253204858453687,1.0,3/16,5.35%,ACE;BMPR2;PRCP
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.4348467230284689,1.304769245176512,0.10740740740740741,0.5240911617165344,1.0,24/78,17.19%,CD74;AP1S3;RACGAP1;AP1S2;KIF23;RAB7A;AP2A2;CAPZB;ARF1;DCTN3;CAPZA1;PIKFYVE;KIF3B;AP1G1;AP2B1;FCGR2B;DYNC1H1;FCER1G;CANX;KIF5A;AP2S1;SEC24C;DYNC1I2;AP1M1
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.4348467230284689,1.304769245176512,0.10740740740740741,0.5240911617165344,1.0,24/78,17.19%,CD74;AP1S3;RACGAP1;AP1S2;KIF23;RAB7A;AP2A2;CAPZB;ARF1;DCTN3;CAPZA1;PIKFYVE;KIF3B;AP1G1;AP2B1;FCGR2B;DYNC1H1;FCER1G;CANX;KIF5A;AP2S1;SEC24C;DYNC1I2;AP1M1
prerank,regulation of cell-substrate adhesion (GO:0010810),0.4722919453321151,1.3045967919718788,0.14285714285714285,0.5238416126265345,1.0,9/42,8.94%,NDNF;PTPRO;JAK2;RAC2;RSU1;RAC1;ATXN3;MINK1;RHOA
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),0.5061639289354312,1.3045446339619873,0.1527165932452276,0.5232315695565124,1.0,8/26,12.51%,TREML4;PTPN22;TIRAP;TLR3;IFI35;SLC15A4;RTN4;TLR2
prerank,regulation of myeloid cell differentiation (GO:0045637),0.45093119144912147,1.3037916056239391,0.1172069825436409,0.5244310430279187,1.0,25/62,20.60%,NFE2;LYN;SPI1;H3-3A;KMT2C;PTK2B;CBFB;PURB;RBM15;LGALS3;HSPA9;TNRC6B;KAT2B;TNRC6A;KMT2E;KMT2A;CREBBP;THBS1;FES;ASH2L;HDAC1;HOXA9;WDR5;RUNX1;ZBTB16
prerank,response to cadmium ion (GO:0046686),0.5153806655865782,1.3034304911483576,0.15203761755485892,0.5245722710159366,1.0,8/26,15.12%,FOS;SUMO1;HAAO;DAXX;MAPK8;AKT1;NCF1;MAPK1
prerank,external encapsulating structure organization (GO:0045229),0.3910970698660184,1.303415971848425,0.052406417112299465,0.5238524825339573,1.0,27/205,10.32%,ITGB7;ITGA4;ITGAL;CD44;CD47;PECAM1;ITGAE;ITGAX;TNC;NDNF;COL5A2;MMP1;LAMB1;ITGAD;ITGB2;HSPG2;F11R;ATP7A;ADAMTS6;TGFBI;PXDN;ACAN;ICAM1;FBN1;ADAM19;NCAN;FN1
prerank,regulation of dopamine secretion (GO:0014059),-0.42878393566573225,-1.303173390444576,0.125,0.681559006227005,1.0,6/25,9.19%,PRKN;DTNBP1;SYT1;SYT9;SYT7;KCNA2
prerank,cell cycle G1/S phase transition (GO:0044843),0.4508406343031085,1.3030534275808592,0.12352168199737187,0.5241380770356562,1.0,11/61,9.42%,GPR132;CUL3;CUL5;EIF4EBP1;CRLF3;CDKN2C;CCND1;CCNH;CACUL1;LATS1;TRIM71
prerank,regulation of protein neddylation (GO:2000434),0.6316073394601188,1.3029095655400718,0.17398945518453426,0.523773906026008,1.0,4/10,12.90%,RPL5;DCUN1D1;DCUN1D3;RPL11
prerank,cellular response to UV-A (GO:0071492),0.6174744319008219,1.3020880825367491,0.19137931034482758,0.5251061469955279,1.0,2/11,4.65%,MMP1;CERS1
prerank,negative regulation of nervous system development (GO:0051961),0.558426008312233,1.3020700762767672,0.153125,0.5243811896987098,1.0,6/17,12.51%,IL1B;SORL1;IL6;B2M;REST;TLR2
prerank,Golgi localization (GO:0051645),0.6272043061410739,1.3013204651866461,0.1917808219178082,0.5256931824767946,1.0,4/11,10.87%,UVRAG;CDC42;ARHGAP21;YWHAZ
prerank,protein export from nucleus (GO:0006611),0.5133691330024353,1.3010741261853818,0.16975748930099857,0.5256514994192254,1.0,5/27,5.77%,XPO1;DUSP16;XPO5;XPO6;XPO4
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.49324241016683296,1.3009352494456194,0.15527065527065528,0.5252792869543418,1.0,11/33,14.08%,CCDC88A;CBL;FBXW7;ARAP1;ADRA2A;ADAM17;AFAP1L2;HIP1;AKT1;NCF1;PDE6H
prerank,synaptic membrane adhesion (GO:0099560),-0.5089217928318748,-1.300927698616165,0.14545454545454545,0.6859866178355469,1.0,6/14,24.01%,PTPRD;GPC6;SLITRK1;PTPRF;GPC4;SLITRK3
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),0.5453245130245816,1.3003702727390722,0.1626865671641791,0.5260016713786108,1.0,5/18,6.64%,ITGA4;AKT3;PPARG;ADAM17;PDPK1
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),0.6114257547994806,1.2992915222261372,0.18166939443535188,0.5280014013551562,1.0,4/11,8.61%,PAK1;BCAR1;RAC1;HGF
prerank,alpha-amino acid metabolic process (GO:1901605),0.4582229919546102,1.298962310558698,0.13278008298755187,0.5281902561398953,1.0,12/45,17.44%,KMO;DPEP1;SLC25A13;ATP7A;KYAT1;SLC25A12;MTRR;GLUD1;ASS1;SRR;PYCR2;DDAH1
prerank,defense response to Gram-positive bacterium (GO:0050830),0.4784143050497291,1.298595183975065,0.13399153737658676,0.5283645270195216,1.0,9/40,14.98%,FGR;TIRAP;ADAM17;IL6;MBL2;RNASE6;TLR2;GBP2;MYD88
prerank,inorganic cation transmembrane transport (GO:0098662),-0.27368752856410716,-1.298435718561751,0.0,0.6915314102743004,1.0,57/268,16.27%,CACNA1D;KCNK13;SLC8A1;RYR3;SLC24A3;KCNQ5;SLC11A1;KCND2;GAS6;SLC1A3;KCNQ3;SCN1A;ATP6V0C;TRPV2;ATP1B3;TRPM3;PKD2;KCNJ2;CACNA1C;ATP2A2;ATP1B1;TRPC4;P2RX7;SLC11A2;P2RX4;SLC6A15;SCN3A;SLC36A1;ATP5PO;SLC9A9;SLC9A6;KCNN2;ATP1A2;HPN;TRPC1;MCOLN1;KCNA2;ATP6V0D1;KCNK6;HCN1;MCOLN3;HCN2;SLC39A7;SCN1B;SLC25A14;SLC25A27;KCNN3;TRPC7;TRPM2;TRPV4;SLC6A8;TRPC3;KCNA1;SLC39A6;CCDC51;MCOLN2;ATP2C1
prerank,negative regulation of lipid catabolic process (GO:0050995),0.5534258823214373,1.2982839837764235,0.15348101265822786,0.5283895819451058,1.0,5/17,13.17%,IL1B;SORL1;ADRA2A;PRKAA1;AKT1
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),-0.40527773445300336,-1.2979165367937788,0.10067114093959731,0.6902347875351373,1.0,9/32,16.74%,CAPN3;P2RX7;P2RX4;PLCG1;TRPC1;AKAP6;TRPC3;CX3CL1;CEMIP
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",-0.4811736737405144,-1.2978344686439829,0.16531165311653118,0.6875660318139938,1.0,11/17,32.35%,DERL2;HSP90B1;AUP1;NPLOC4;DERL1;HERPUD1;HM13;SEC61B;FAF2;TMEM129;SYVN1
prerank,phosphatidylinositol biosynthetic process (GO:0006661),0.4104722210413241,1.297099896464539,0.09154113557358054,0.5308944846868977,1.0,28/119,13.08%,PLCG2;ITPKC;PIP4K2A;TTC7A;PIK3C2A;IP6K3;MTMR14;INPP5F;OCRL;PI4K2B;PTEN;MTMR3;INPP4A;IMPA1;PIK3R6;PLEKHA2;ARF1;MTMR4;SYNJ1;PITPNM1;PIKFYVE;PIGF;PIP4K2B;PIK3CA;CDIPT;PIK3R4;SMG1;PIP5K1A
prerank,cellular senescence (GO:0090398),0.504324437320062,1.2966461374822473,0.1554559043348281,0.5312936714046733,1.0,11/27,19.85%,SPI1;MAPK14;KAT6A;ID2;SIRT1;ECRG4;SMC6;PRKCD;SMC5;MAP2K1;TERF2
prerank,membrane protein intracellular domain proteolysis (GO:0031293),0.5428272594351802,1.2962996820049546,0.17220543806646527,0.5314779731354123,1.0,9/20,16.94%,NGFR;NFKB1;ADAM17;SPPL2A;MBTPS1;TGFB1;ADAM9;RELA;PSEN1
prerank,negative regulation of phagocytosis (GO:0050765),0.5517862844136213,1.296001375990389,0.1819620253164557,0.531520843834605,1.0,9/17,18.12%,CD47;PLSCR1;CD300A;DYSF;FCGR2B;TLR2;SNX3;CD300LF;APPL1
prerank,negative regulation of T cell activation (GO:0050868),0.48988834024528033,1.2957561118218865,0.1324599708879185,0.5314047657001064,1.0,6/35,5.82%,PTPN22;LILRB1;LAPTM5;RIPOR2;SPN;GLMN
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.4196609236020018,1.2955604160943095,0.10501750291715285,0.5311401446524436,1.0,26/100,15.44%,CBFA2T3;LRRK2;XPO1;HSPA1A;TAF9;ANKIB1;SUMO1;RYBP;ARIH1;WAC;GLMN;RNF217;HECTD1;ELOB;COP1;ARIH2;TLK2;CAMLG;SUMO2;RCHY1;PSMD10;RPL11;PABIR1;VCP;USP7;TAF1
prerank,actin filament bundle organization (GO:0061572),0.4915429824211123,1.2955008899537694,0.16058394160583941,0.5305706073290569,1.0,5/33,7.99%,NEDD9;LCP1;EPS8;PAWR;EZR
prerank,regulation of protein secretion (GO:0050708),0.4088234720315083,1.2942760399194806,0.07611241217798595,0.5330854730172927,1.0,15/119,8.61%,DPP4;ITPR1;IL1B;RAP1A;DNAJC1;CACNA1A;SLC8B1;GOLPH3L;CD2AP;RFX3;ADRA2A;TMED10;CLOCK;EZR;IL6
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),0.6235662604874084,1.293519042896298,0.16928446771378708,0.5342757488034255,1.0,2/10,2.59%,PRKCE;NEDD4L
prerank,divalent inorganic cation homeostasis (GO:0072507),-0.4281822338338932,-1.2933822988108632,0.13803680981595093,0.7000404810901919,1.0,4/25,10.31%,PRKN;SLC8A1;CNNM2;CNNM4
prerank,dendrite self-avoidance (GO:0070593),0.5686914147639597,1.2918729890046314,0.1907051282051282,0.5379876849952119,1.0,3/16,6.69%,EMB;NPTN;IGSF9
prerank,actin filament polymerization (GO:0030041),0.5024824582332672,1.2914989184876327,0.17210682492581603,0.5382380126509051,1.0,7/29,11.45%,PSTPIP1;JAK2;PSTPIP2;MSRB1;DIAPH1;RAC1;TTC17
prerank,negative regulation of cellular biosynthetic process (GO:0031327),0.45993818559100585,1.2914689536430832,0.15364238410596026,0.5375756588761171,1.0,8/47,7.71%,SIK1;FYN;NFKB1;RAPGEF2;PTGIS;CRY1;FBXW7;ERLIN1
prerank,C4-dicarboxylate transport (GO:0015740),0.5838182240709493,1.291314673983392,0.184640522875817,0.5372251442297064,1.0,5/14,11.49%,LRRC8D;SLC25A13;SLC25A30;SLC25A12;SLC25A18
prerank,endoplasmic reticulum mannose trimming (GO:1904380),-0.46704201043680077,-1.2905562596138385,0.16111111111111112,0.7067903790452442,1.0,6/18,23.19%,DERL2;UBC;TRIM13;RNF103;RNF139;UBA52
prerank,regulation of microtubule-based movement (GO:0060632),-0.5544083376543008,-1.2905246958376355,0.17330210772833723,0.7038934977948587,1.0,8/11,27.31%,MAP2;TTC21B;LAMP1;NEFH;HDAC6;IGBP1;CFAP298;HAP1
prerank,prostaglandin metabolic process (GO:0006693),0.5082312814415613,1.29025968420674,0.14814814814814814,0.5392558914196014,1.0,2/26,3.17%,CD74;PTGIS
prerank,cotranslational protein targeting to membrane (GO:0006613),0.4241534414665835,1.2901967467806739,0.11561382598331346,0.5386594538744177,1.0,43/91,24.60%,RPL5;RPS10;RPL37A;RPL6;RPS18;RPS14;TRAM1;RPL35A;RPL13;SEC63;RPS3;RPS21;SRP72;SRP19;RPL34;RPLP0;RPL19;RPL11;RPL30;RPS2;RPL4;RPL7;RPS15A;RPS4X;RPL32;RPSA;RPS13;RPS6;RPL18A;RPS27;RPLP2;RPL22;RPS7;RPS12;RPL10A;RPS25;RPL9;RPS16;RPL23;RPL17;SSR2;RPL37;RPL36
prerank,positive regulation of transforming growth factor beta production (GO:0071636),-0.5329321569170962,-1.2899696609452642,0.1864406779661017,0.702903665663764,1.0,2/11,4.92%,CD34;LGALS9
prerank,G1/S transition of mitotic cell cycle (GO:0000082),0.4247526707352038,1.2896977603296687,0.12239902080783353,0.539208989651981,1.0,14/83,9.42%,GPR132;CUL3;CUL5;EIF4EBP1;CRLF3;CDC45;CDK14;CDKN2C;CCND1;CCNH;CACUL1;BACH1;LATS1;TRIM71
prerank,negative regulation of cytokine production (GO:0001818),0.39368805323733297,1.289198752892172,0.07407407407407407,0.5397049437304984,1.0,35/163,12.11%,FFAR4;PTPRC;RARA;PTPN22;BCL3;KLF4;LILRB1;ITCH;FOXJ1;DHX58;LAPTM5;NPTN;PTPN6;PTGER4;ATP2B1;NLRX1;SRGN;IFIH1;RPS6KA5;PRNP;ANXA4;PDCD4;TRIM25;EZR;RAC1;HDAC9;IL6;FN1;ANXA1;CYLD;ADCY7;CACTIN;ACOD1;FCGR2B;MAP2K5
prerank,intracellular sterol transport (GO:0032366),-0.5206560953952882,-1.288951922521808,0.1700507614213198,0.7035260892627965,1.0,4/13,13.00%,ABCA1;ARV1;SERAC1;NPC1
prerank,regulation of gene expression by genetic imprinting (GO:0006349),-0.5476704794400893,-1.2887118857487427,0.1848101265822785,0.7013322652394463,1.0,1/10,0.23%,DNMT3A
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),-0.5558454482885224,-1.2885602106570657,0.16784869976359337,0.6988628574757776,1.0,3/11,6.98%,PRKN;HIF1A;ATF4
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),0.5593056101987584,1.2883254862235765,0.18781725888324874,0.541359869816024,1.0,8/15,21.95%,SAMHD1;YTHDF3;CACTIN;STAT2;METTL3;TTLL12;MUL1;PTPN2
prerank,prostaglandin biosynthetic process (GO:0001516),0.5506786182202071,1.2876737297540852,0.17701863354037267,0.5422983332989011,1.0,2/18,3.17%,CD74;PTGIS
prerank,positive regulation of protein catabolic process (GO:0045732),0.4239604596218031,1.2873409065119226,0.11363636363636363,0.5423663573511819,1.0,28/84,16.05%,IL1B;DTL;ITCH;MSN;ASB5;NEDD4L;SORL1;GPC3;AXIN1;ADRA2A;RAB7A;PTTG1IP;FAF1;TIPARP;EZR;STX5;SNF8;WWP2;CSNK2A1;SNX9;AREL1;TNFRSF1B;VCP;ADAM9;SNX33;RNF41;APC;HACE1
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",0.40992920698621055,1.2873218897308152,0.09954751131221719,0.541679260355533,1.0,52/110,23.83%,RPL5;RPS10;RPL37A;RPL6;RPS18;HELZ2;RPS14;RPL35A;PPP2R2A;MAGOHB;RPL13;ETF1;DHX34;RPS3;RPS21;UPF2;DCP1A;RPL34;RPLP0;SMG1;RPL19;RPL11;RPL30;RPS2;RPL4;RPL7;EIF3E;RPS15A;NCBP1;RPS4X;PABPC1;SMG6;GSPT1;RPL32;RPSA;RPS13;UPF3B;RPS6;RPL18A;RPS27;RPLP2;UPF3A;RPL22;RPS7;RPS12;PPP2CA;RPL10A;RPS25;RPL9;RPS16;RPL23;RPL17
prerank,regulation of astrocyte differentiation (GO:0048710),-0.5230810173180908,-1.2869934649703099,0.16,0.7013458491131629,1.0,2/12,1.66%,BIN1;SERPINE2
prerank,regulation of autophagosome assembly (GO:2000785),0.47559471145170373,1.2868634429871821,0.14857142857142858,0.5421262569834716,1.0,8/33,10.35%,LRRK2;PIP4K2A;CHMP4A;CHMP4B;MTMR3;RALB;PIKFYVE;PIP4K2B
prerank,positive regulation of DNA replication (GO:0045740),0.5520474814240212,1.2868504458106682,0.173015873015873,0.5414345704341802,1.0,4/16,5.79%,DNA2;GLI1;KAT7;FAF1
prerank,regulation of mast cell activation (GO:0033003),0.6305557917268119,1.2865406029468427,0.18629173989455183,0.5415359725700314,1.0,3/10,2.32%,CD226;LYN;PLSCR1
prerank,protein O-linked mannosylation (GO:0035269),-0.4730866320600933,-1.286486471819538,0.15748031496062992,0.7000954963231121,1.0,10/18,31.64%,LARGE1;RXYLT1;POMT1;DPM2;FKRP;DPM3;TMTC1;POMT2;DPM1;SDF2L1
prerank,protein localization to Golgi apparatus (GO:0034067),0.5003063630237885,1.2862279973544781,0.1555232558139535,0.5417007961819126,1.0,8/27,13.30%,SORL1;RAB6A;TMED10;GCC2;PAQR3;GBF1;VPS13A;GBP5
prerank,regulation of developmental growth (GO:0048638),0.487923846911927,1.2860052243797482,0.1544011544011544,0.5415795980019412,1.0,11/29,16.27%,SPAAR;STAT5A;NIPBL;STAT5B;PLCB1;LATS1;OLFM1;LATS2;APP;FGFR3;INSR
prerank,regulation of TOR signaling (GO:0032006),-0.3389142409217,-1.2857869366983201,0.09405940594059406,0.6995062191839032,1.0,21/67,18.14%,TREM2;GNA12;RPTOR;EPM2A;FLCN;GAS6;FNIP1;RFFL;LARS1;UBR1;MIOS;DGKQ;LAMTOR5;FBXO9;SEC13;TSC2;PIH1D1;RRAGC;AKT1S1;SMCR8;ITFG2
prerank,V(D)J recombination (GO:0033151),-0.551560760299052,-1.2842261304207323,0.1568627450980392,0.7018983822396029,1.0,6/11,20.36%,HMGB1;DCAF1;HMGB2;LIG3;LIG1;TCF3
prerank,activin receptor signaling pathway (GO:0032924),-0.49579069396733916,-1.283762450936006,0.16094986807387862,0.700702148500754,1.0,5/15,17.01%,TGFBR1;ACVR1;ACVR2B;SMAD3;ACVR1B
prerank,fatty acid biosynthetic process (GO:0006633),-0.3440155237270709,-1.2832886237968053,0.07142857142857142,0.6994746504142362,1.0,20/63,25.55%,ACACA;LTA4H;HACD2;LTC4S;ELOVL7;ABHD3;ELOVL4;CBR4;HSD17B8;FADS3;LIPH;ABCD3;ACOT7;ELOVL1;MLYCD;OXSM;TECR;NDUFAB1;ACSBG1;SCD
prerank,positive regulation of blood coagulation (GO:0030194),0.5466030033798548,1.2832394368027713,0.18396226415094338,0.548250464033646,1.0,1/17,0.58%,ST3GAL4
prerank,MAPK cascade (GO:0000165),0.3765880471875992,1.2826103618669826,0.038262668045501554,0.5492423543256342,1.0,69/295,15.32%,LRRK2;IL1B;RASGRP4;FLT3;FYN;RET;MAP3K5;MAP3K8;PSME3;PAK1;NFKB1;FGF5;FGF22;JAK2;NRG2;KL;CUL3;RAPGEF2;MAPKAPK2;RASA3;PTGER4;PTPN7;PSMB7;IKBKB;PSME2;GDNF;TAOK3;IL2RG;FBXW11;GRB2;SETX;CSF2RB;SHOC2;MAPK12;PAQR3;PSME4;DUSP6;ZFP36L2;HGF;SOS1;MINK1;ABHD17B;BRAF;PSMB8;CAMKK2;PSMA5;MBP;PSMD9;IL31RA;PIK3CA;PRKG2;PSMB3;PSMD6;PSMC4;MAP3K7;PSMD10;PPP1CB;MAP3K20;PSMB1;MAPK8;KIT;MARK3;TGFB1;FGFR3;IL18;MAPK1;FRS2;RASGEF1A;SPRED1
prerank,sympathetic nervous system development (GO:0048485),-0.49242859050553,-1.2824859298504803,0.165,0.6992644491082252,1.0,4/15,4.00%,NRP1;NRP2;CTNNB1;NF1
prerank,hematopoietic stem cell differentiation (GO:0060218),0.5993137325189276,1.2820884595164916,0.20540540540540542,0.5499053584311064,1.0,1/10,1.25%,ACE
prerank,positive regulation of cyclase activity (GO:0031281),-0.503799220281739,-1.2819679453177166,0.17543859649122806,0.6983653701300424,1.0,3/14,4.00%,CACNA1D;CACNA1C;NF1
prerank,receptor recycling (GO:0001881),0.622240369068922,1.2819139437419973,0.20517241379310344,0.549590644114548,1.0,2/10,3.50%,LMTK2;SORL1
prerank,cellular response to peptide (GO:1901653),0.441666033038729,1.2817977160475116,0.13506493506493505,0.5491571391775881,1.0,10/56,6.93%,ITGA4;PTPN22;NGFR;FYN;VIM;CACNA1A;CD36;PRNP;CACNB1;ABCC1
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",-0.4484465866222954,-1.281644284889612,0.13109756097560976,0.6965307880256851,1.0,11/22,31.22%,GTF2H2;GTF2H1;UBC;ERCC2;GTF2H3;GTF2H5;UBA52;XPC;GTF2H4;DDB1;CHD1L
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),0.548062518442668,1.2815082404006215,0.19155844155844157,0.5491476820277648,1.0,5/17,11.81%,PTPRC;PPP1R12A;CD300A;PPP1R15A;PPP1R15B
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.5468949029527121,1.2810485479993368,0.17236024844720496,0.5497160747156787,1.0,8/18,17.70%,AKT3;PIK3C2A;CIB1;HDAC9;ANXA1;MAP3K3;JCAD;HDAC7
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),0.5738769741693304,1.280672337122599,0.19734660033167495,0.5500084720630631,1.0,2/13,10.04%,CYRIB;STX7
prerank,neutrophil activation (GO:0042119),0.5823859585578485,1.2806168488530285,0.19270833333333334,0.5494015818895659,1.0,5/12,19.48%,SYK;FCER1G;KMT2E;PRKCD;PREX1
prerank,regulation of establishment of planar polarity (GO:0090175),0.42075414559595237,1.280468969056222,0.11714975845410629,0.5490380032118848,1.0,29/88,19.82%,TIAM1;PSME3;CELSR1;PSMB7;CDC42;PSME2;AP2A2;RAC1;PSME4;RHOA;PSMB8;PSMA5;PSMD9;PSMB3;AP2B1;PSMD6;PSMC4;DVL3;PSMD10;PSMB1;DVL2;AP2S1;PSMD12;WNT7A;VANGL1;SMURF2;FZD7;FZD3;PSMF1
prerank,embryonic skeletal system morphogenesis (GO:0048704),-0.39810411277915836,-1.2802544593367904,0.12987012987012986,0.6984343458142644,1.0,3/31,6.22%,TGFBR2;TGFBR1;FGFR2
prerank,iron ion transport (GO:0006826),-0.36286466238558307,-1.279981446917683,0.09465020576131687,0.6968267812642315,1.0,16/47,13.26%,ATP6V1C1;ATP6V0B;SLC11A1;ATP6V0D2;ATP6V0C;TCIRG1;ATP6V1B2;ATP6AP1;SLC11A2;ATP6V1D;TFRC;FTH1;MCOLN1;ATP6V0D1;ATP6V0A1;ARHGAP1
prerank,cAMP-mediated signaling (GO:0019933),0.5004649314386627,1.2798879883245475,0.1738484398216939,0.549862188655732,1.0,5/24,7.49%,ADGRG6;RAPGEF2;PDE7A;AHR;PDE2A
prerank,glucose transmembrane transport (GO:1904659),-0.47073532535495954,-1.2797711769721403,0.16581632653061223,0.6947921525016645,1.0,8/18,32.64%,SORT1;SLC2A3;SLC2A9;SLC2A5;RAB4B;SLC2A8;PPARD;SLC45A1
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),0.5192886484713372,1.2794726251369222,0.17099236641221374,0.550256696203418,1.0,7/24,14.21%,IL1B;SULF2;NOX1;IL6ST;IL6;EIF2AK3;TGFB1
prerank,negative regulation of lipid metabolic process (GO:0045833),0.5217611212518753,1.2792610828955775,0.17018072289156627,0.5500995679242713,1.0,3/22,5.23%,IL1B;PPP2R5A;ADRA2A
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.3712843237458395,1.2789672871046214,0.029322548028311426,0.5501168442704134,1.0,75/417,14.21%,CIITA;CBFA2T3;JARID2;FOXP1;RUNX2;RARA;SP3;LIMD1;BCL3;KLF4;PPARG;SCML4;BCL6;ATF7IP;NIPBL;NAB1;CIART;SPI1;CRY1;MTA3;MBD1;SUMO1;KAT7;RFX3;RBPJ;DEAF1;HEXIM1;MBTD1;FBXW11;RPS6KA5;KLF10;AHR;ARID4A;PDCD4;SETDB2;MECP2;PLCB1;THRA;CRY2;CLOCK;SAP18;GATAD2A;CTCF;PHF12;UIMC1;HDAC9;PEX14;CBFA2T2;KAT6A;RBAK;ID2;WWP2;SMARCE1;RCOR3;SMAD4;SBNO2;DAXX;NR3C1;SPEN;RBM15;EIF4A2;DEDD2;TAF7;REST;MBD2;L3MBTL2;MYB;LBH;TLE1;EZH2;SMARCC2;CITED2;HDAC3;NFIL3;TGFB1
prerank,negative regulation of actin filament polymerization (GO:0030837),0.5159631513389568,1.2789327573987983,0.19753086419753085,0.5494934429721596,1.0,8/22,19.09%,CYRIB;TMSB10;KANK3;ARFGEF1;MYADM;KANK1;PRKCD;TMSB4X
prerank,regulation of histone H3-K4 methylation (GO:0051569),-0.47806860606097457,-1.278659457291431,0.16804407713498623,0.6957402756219472,1.0,7/16,17.62%,AUTS2;CTNNB1;CTR9;BCOR;SNW1;PIH1D1;BRCA1
prerank,positive regulation of response to biotic stimulus (GO:0002833),0.46607076683582205,1.2786260598684598,0.17496443812233287,0.5496028773336002,1.0,11/38,13.30%,POLR3F;PLSCR1;DHX58;ANKRD17;OASL;PUM2;IFI35;SLC15A4;USP15;ACOD1;GBP5
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.43284241115405203,1.2785462651128225,0.11944091486658195,0.5491101321702724,1.0,25/67,18.38%,CYBB;PSME3;CD36;PSMB7;IKBKB;PSME2;TAP1;PSME4;PSMB8;NCF2;PSMA5;PSMD9;B2M;PSMB3;PSMD6;PSMC4;PSMD10;PSMB1;NCF1;SNAP23;PSMD12;CYBA;PDIA3;FCGR1A;TAPBP
prerank,rhodopsin mediated signaling pathway (GO:0016056),0.6168770714974645,1.2784387841467642,0.19725557461406518,0.5486477594105009,1.0,3/10,21.15%,GNB1;PDE6B;SAG
prerank,positive regulation of catabolic process (GO:0009896),0.43429316470819807,1.2782985298009355,0.13015463917525774,0.5482670918053029,1.0,20/65,16.05%,IL1B;DTL;ITCH;ASB5;NEDD4L;SORL1;GPC3;AXIN1;RAB7A;TIPARP;STX5;SNF8;WWP2;CSNK2A1;AREL1;VCP;ANGPTL3;RNF41;APC;HACE1
prerank,activation of GTPase activity (GO:0090630),0.41758585179355756,1.2780487473276647,0.1187648456057007,0.5481931101140448,1.0,18/89,9.64%,RAP1GAP2;TIAM1;TBC1D1;TBC1D8;TIAM2;CCDC125;FOXJ1;SIPA1L3;TBC1D9;USP6NL;TBC1D10C;TBC1D2B;BCR;TBC1D8B;RABGAP1L;RABGAP1;BCAS3;TBC1D5
prerank,positive regulation of cell motility (GO:2000147),0.3867143920818188,1.277753255020723,0.07293868921775898,0.548271960735339,1.0,27/205,8.61%,FGR;IL1B;NEDD9;TIAM1;TCAF2;PECAM1;ITGAX;RET;CCR1;PAK1;SEMA4A;STAT3;CLDN1;MYO1C;LAMB1;CBLL1;PPP3CA;CARMIL1;ADRA2A;BCAR1;CXCL16;PTK2B;ADAM17;CIB1;ARHGEF39;EPHB2;HGF
prerank,positive regulation of dendritic spine development (GO:0060999),-0.4500701130854314,-1.2773897910306997,0.18126888217522658,0.6970855529365405,1.0,4/20,6.61%,APOE;NLGN1;CAMK1;CAPRIN2
prerank,cellular response to chemical stress (GO:0062197),0.41557664432475877,1.2772100107753426,0.1100811123986095,0.5489761120074744,1.0,24/96,15.36%,LRRK2;CYBB;LONP1;HSPA1A;GPX1;GSR;PRDX6;LRRC8D;VRK2;SETX;NFE2L2;NOX1;FANCC;NCF2;MGAT3;PIK3CA;ERMP1;FOXO3;PRKAA1;NCF1;PRKAA2;PNPT1;GSTP1;PRDX5
prerank,positive regulation of programmed cell death (GO:0043068),0.375844453543565,1.2769627119370566,0.049689440993788817,0.5488975506543382,1.0,55/272,13.15%,LRRK2;VAV3;TIAM1;ARHGEF18;NGF;LILRB1;DAPK1;NGFR;MAP3K5;SYK;BCL6;TIAM2;STK17B;IFIT2;LAPTM5;PHLDA1;SOS2;ATF6;RYBP;FGD4;FAF1;STK4;PAWR;MTCH1;TNFAIP8;SAP18;RARG;FGD1;DUSP6;IL6;SOS1;FGD3;LATS1;ING3;OLFM1;PIDD1;ARHGEF6;NLRC4;UBE2Z;CASP2;CALHM2;RIPK1;APAF1;AIFM1;NET1;LATS2;FOXO3;DCUN1D3;REST;HTT;CLIP3;DNM1L;MAP3K20;ERCC3;MAPK8
prerank,cytoplasmic translation (GO:0002181),0.416493775253731,1.2766532509217565,0.1154299175500589,0.5489751614964438,1.0,45/91,24.60%,RPL5;RPS10;RPL37A;RPL6;RPS18;RPS14;RPL35A;RPL22L1;RPL13;ETF1;RWDD1;RPS3;RPS21;EIF4A2;RPL34;RPLP0;RPL19;RPL11;RPL30;TMA7;RPS2;RPL4;RPL7;DRG2;RPS15A;RPS4X;GSPT1;RPL32;RPSA;EIF2B3;RPS13;RPS6;RPL18A;RPS27;RPL22;RPS7;RPS12;RPL10A;RPS25;RPL9;RPS16;RPL23;RPL17;RPL37;RPL36
prerank,negative regulation of endothelial cell proliferation (GO:0001937),-0.38792912725699813,-1.2766050738105275,0.12751677852348994,0.6970176873502637,1.0,7/35,4.00%,PTPRM;APOE;MEF2C;SPARC;FLT1;ATP5F1A;NF1
prerank,response to hydrogen peroxide (GO:0042542),0.4527234854392249,1.2765053320655053,0.15521628498727735,0.5486494246603875,1.0,12/45,11.32%,STK24;FYN;MAP3K5;GPX1;HP;SETX;NFE2L2;IL6;RPS3;ANXA1;RIPK1;NET1
prerank,positive regulation of phospholipase activity (GO:0010518),-0.4331126208470931,-1.275571709900217,0.1295774647887324,0.6978870476447204,1.0,7/22,7.26%,FLT1;NTRK3;FGF2;FGFR2;PLAA;GNA13;PLCG1
prerank,regulation of activin receptor signaling pathway (GO:0032925),-0.488477940636443,-1.2755073160242527,0.16085790884718498,0.6954016042955967,1.0,5/15,7.64%,SKI;MAGI2;SMAD7;ACVR1;ACVR2B
prerank,regulation of mitochondrial membrane potential (GO:0051881),0.470559312609947,1.2753238451959534,0.15912208504801098,0.5510997025094527,1.0,2/40,0.25%,LRRK2;PID1
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.5029275889681959,1.2753202151698946,0.1880597014925373,0.5503830019124918,1.0,7/26,12.18%,ALPK1;ITCH;IFIH1;UBE2N;CYLD;TAB3;MAP3K7
prerank,negative regulation of apoptotic process (GO:0043066),0.37127566702387543,1.2743897674548539,0.03323262839879154,0.5521479330820588,1.0,107/444,16.94%,CD74;CD44;FFAR4;GRK5;HCK;NOTCH2;CAPN13;NGF;BCL3;KLF4;NGFR;MCL1;ITCH;NDNF;PIM1;NFKB1;HSPA1A;GPX1;PRKCH;RPS6KA3;BIRC6;MALT1;TAF9;NFKBIA;NAA16;MRE11;CBL;SCX;IKBKB;DPEP1;GDNF;BIRC3;RNF213;ARF4;DFFA;SETX;PTK2B;ANXA4;ZFAND6;SERPINB9;WFS1;FLNA;CIB1;PAK2;TNFAIP8;TOX3;AVEN;CARD16;IL6ST;HGF;IL6;NAA15;CSNK2A2;CSNK2A1;ANKLE2;PIDD1;BRAF;UBE2Z;ANXA1;IL31RA;CASP2;PIK3CA;RIPK1;YWHAZ;DSTYK;PRKAA1;RPS6KA1;MAP2K5;PSMD10;HYPK;SH3RF1;AREL1;HSPA9;CCND2;PRELID1;MAPK8;AKT1;DHCR24;TLE1;HCLS1;API5;PRKAA2;YME1L1;DNAJC3;CITED2;HDAC3;GSTP1;UNC5B;MAZ;MYD88;MAPK1;XIAP;RELA;PRDX5;ITGA5;THBS1;MED1;PROC;USP47;RPS6KB1;PPT1;RB1;MAEA;HTATIP2;SEMA4D;NIBAN2;PSEN1
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.5543662323952464,1.2740449702707368,0.1875968992248062,0.5523184356489569,1.0,4/16,9.42%,ZC3H12D;RC3H1;ZFP36L2;TRIM71
prerank,response to interleukin-1 (GO:0070555),0.4272584954573053,1.2740125852555657,0.12864077669902912,0.5516757722572965,1.0,18/73,15.80%,IL1B;CD47;CD40;NFKB1;PTGIS;TAF9;RC3H1;TANK;ANXA1;CACTIN;ACOD1;APP;ADAMTS12;GBP2;GBP3;MYD88;RELA;IRAK3
prerank,determination of heart left/right asymmetry (GO:0061371),-0.3737402307894474,-1.2739013275699034,0.10740740740740741,0.6983676443084488,1.0,4/42,4.00%,TGFBR2;MEF2C;PKD2;SMO
prerank,negative regulation of osteoclast differentiation (GO:0045671),0.5455330323447696,1.2738900941633422,0.18454258675078863,0.5513062056770214,1.0,5/18,9.63%,LILRB3;LILRB1;FBXW7;TLR3;FBN1
prerank,vascular process in circulatory system (GO:0003018),0.5813721597807759,1.2737098726104201,0.19185059422750425,0.5503355153751243,1.0,2/13,2.21%,ACE;ACE2
prerank,regulation of tube diameter (GO:0035296),0.5813721597807759,1.2737098726104201,0.19185059422750425,0.5503355153751243,1.0,2/13,2.21%,ACE;ACE2
prerank,regulation of interleukin-4 production (GO:0032673),0.5219128469566973,1.273440804918191,0.1691616766467066,0.5503287509854735,1.0,5/21,13.50%,RARA;SYK;IRF4;NLRP3;FCER1G
prerank,phosphatidylcholine metabolic process (GO:0046470),0.4259804303560254,1.2732342093119366,0.13350125944584382,0.5501488884301357,1.0,11/70,13.79%,PLBD1;SLC44A2;ABCA3;CEPT1;PCYT1A;CSNK2A2;CSNK2A1;SLC44A1;TMEM86B;SLC44A5;PLA2G6
prerank,endodermal cell fate commitment (GO:0001711),-0.5417351659706486,-1.272772539717712,0.18032786885245902,0.6995524562707895,1.0,5/10,31.87%,CTR9;RTF1;SOX2;LEO1;CDC73
prerank,presynapse assembly (GO:0099054),-0.4794287860090084,-1.2726533665223543,0.16786570743405277,0.6972984712845842,1.0,5/16,3.61%,PTPRD;IL1RAPL1;NLGN1;PCLO;LRRTM3
prerank,neurogenesis (GO:0022008),-0.37798925922344556,-1.2723593860160798,0.116,0.6954516124801611,1.0,11/43,17.14%,ERCC6;BTBD3;DAGLA;SPOCK1;RYK;METTL14;WDR62;FAT4;ROGDI;TGFB2;VXN
prerank,aorta development (GO:0035904),-0.5048897947516396,-1.272174562039023,0.1683673469387755,0.6933688136332334,1.0,4/14,3.42%,LRP1;ROBO2;ROBO1;PKD2
prerank,response to interleukin-6 (GO:0070741),0.6148879073431743,1.2721523151815108,0.20034246575342465,0.5523448111157173,1.0,3/10,3.17%,PID1;NFKB1;PTGIS
prerank,cobalamin metabolic process (GO:0009235),0.5426059485517386,1.2721057440702654,0.1884297520661157,0.5517504633491889,1.0,5/17,13.51%,MMAB;ABCC1;MTRR;LMBRD1;MMAA
prerank,organonitrogen compound catabolic process (GO:1901565),-0.3534806629726166,-1.272043635247421,0.09623430962343096,0.6912213352365133,1.0,18/57,14.45%,NPL;LTA4H;CAPN3;RENBP;AMDHD2;NAGK;PLA2G15;TPP1;ENPP2;PNPLA8;PLA2G4A;UCHL3;IDE;TRHDE;TXN2;RIDA;SGPL1;PDXDC1
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),0.5233612119067867,1.2718695165700098,0.18396226415094338,0.5509712232256844,1.0,8/21,16.45%,IL1B;MCL1;HSPA1A;GDNF;MAP2K5;AKT1;UNC5B;EYA3
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),0.5233612119067867,1.2718695165700098,0.18396226415094338,0.5509712232256844,1.0,8/21,16.45%,IL1B;MCL1;HSPA1A;GDNF;MAP2K5;AKT1;UNC5B;EYA3
prerank,protein-containing complex subunit organization (GO:0043933),0.4087674324280123,1.2715251968352865,0.12142038946162657,0.5511510926800933,1.0,24/109,16.20%,CD74;TRAF1;WIPF1;CD40;SKAP2;PICALM;CD2AP;PTK2B;ELOB;NUP98;PEX14;CAPZA1;FANCC;SNX9;TEAD1;DNM1L;FANCA;CLDN14;KMT2A;OCLN;SLC2A1;CREBBP;APC;SEH1L
prerank,regulation of phospholipase C activity (GO:1900274),-0.49449843927994447,-1.2715054123768512,0.18441558441558442,0.690303835586151,1.0,5/15,13.92%,FLT1;NTRK3;FGF2;PLCG1;ESR1
prerank,nervous system development (GO:0007399),-0.26288719353632184,-1.2713922522945778,0.0,0.6881231854476169,1.0,100/429,17.14%,NAV2;MERTK;OPHN1;NAV3;PRKN;RAPGEF5;ATXN1;WWP1;CHD7;MEF2C;EVL;ERBB4;MYLIP;MARCKS;TGFBR1;NELL1;ADAM23;NLGN1;ROBO2;FEZ2;ROBO1;ERCC6;FGF13;FGF2;GFRA1;CHRM3;PTN;PKD2;TPP1;RBFOX1;DLG4;CNTN4;CHRM2;SMO;NF1;MTF1;WDPCP;BTBD3;LIMK1;NRXN2;RBFOX2;DAGLA;SPOCK1;LDB1;CAPG;LSAMP;RYK;IGSF8;GRIK1;DCX;DPF2;SDK1;SRRM4;JRKL;EFNB3;SH3GL2;NAB2;GPM6A;FEZ1;RBFOX3;PTPRZ1;CDK5;WDR62;EFNA5;MOBP;RBM45;FAT4;VEGFA;SERPINI1;DHX30;ROGDI;NLGN2;SPG7;DPF3;MDK;CYP51A1;ATXN10;ADGRL3;RNF103;NPAS2;PPP2R5D;TAGLN3;MTR;NFASC;NINJ1;IRF2BPL;IGF2BP2;TENM1;SLITRK1;POU3F3;ADGRB1;CRMP1;KIRREL3;ADGRV1;NLGN3;CNTN6;CNTFR;ACVR1B;HAPLN2;VXN
prerank,regulation of interleukin-10 production (GO:0032653),0.4530435044709187,1.2711261412124861,0.1510204081632653,0.5515138130406556,1.0,7/44,8.61%,CD47;PLCG2;LILRB1;SYK;STAT3;IRF4;IL6
prerank,regulation of Rac protein signal transduction (GO:0035020),-0.4865978393262727,-1.271022034984039,0.1868421052631579,0.6867885074959152,1.0,9/16,30.45%,AUTS2;ARHGAP24;RASGRF1;PIK3CG;ALS2;GABARAP;KBTBD7;CADM4;PIK3CB
prerank,histone H4 deacetylation (GO:0070933),0.6070144729773154,1.2709130457412867,0.20598591549295775,0.5513532497371945,1.0,7/10,26.21%,HDAC9;REST;HDAC3;HDAC1;RCOR1;SIRT2;HDAC2
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),0.513197722294096,1.270302341396971,0.19097744360902255,0.5521980977104752,1.0,3/25,2.75%,IL1B;KLF4;CD36
prerank,regulation of interleukin-1 beta production (GO:0032651),0.42972129324589503,1.270129567000616,0.15315315315315314,0.5519796040004792,1.0,16/66,14.98%,FFAR4;FOXP1;JAK2;STAT3;CD36;MALT1;TRIM16;CARD16;IL6;GIT1;NLRC4;NLRP3;APP;GBP5;GSTP1;MYD88
prerank,regulation of protein sumoylation (GO:0033233),-0.46329361052206297,-1.2699785474619283,0.16216216216216217,0.6875886445442773,1.0,4/17,14.65%,CAPN3;CTNNB1;SAE1;PIAS4
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),0.5337919944389413,1.2696788099633118,0.19047619047619047,0.5524312269418643,1.0,4/18,5.26%,LYN;FPR1;FPR3;BCAR1
prerank,long-term synaptic potentiation (GO:0060291),0.5224260322637918,1.2692574375847419,0.18153364632237873,0.5528485768313487,1.0,4/21,12.70%,CRHR2;NPTN;PTK2B;RGS14
prerank,regulation of oligodendrocyte differentiation (GO:0048713),-0.4689147052910889,-1.2692004237068213,0.15776081424936386,0.6875180017220405,1.0,6/18,13.69%,TENM4;PTN;NF1;DAAM2;PTPRZ1;MDK
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),0.5098081885691912,1.2687849104555498,0.1781437125748503,0.5533450006086847,1.0,3/26,2.75%,IL1B;KLF4;CD36
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),0.45248875144358713,1.2684166387756535,0.14420485175202155,0.5536305306194947,1.0,20/48,19.43%,AKT3;CD40;STAT5A;PIK3C2A;MAPK14;ADAM17;PDPK1;CIB1;HDAC9;ANXA1;MAP2K3;AKT1;TGFB1;THBS1;MAP3K3;SIRT1;JCAD;HDAC7;TMSB4X;FGFR1
prerank,protein O-linked glycosylation (GO:0006493),0.407789837496147,1.268109189196267,0.12709832134292565,0.5536958231457929,1.0,8/96,4.27%,ST3GAL1;ST3GAL4;MUC3B;MUC3A;TET2;GXYLT1;ST8SIA6;B4GALT5
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),0.4172982583889528,1.2679558060067249,0.13064133016627077,0.5533845842912049,1.0,42/87,24.60%,RPL5;RPS10;RPL37A;RPL6;RPS18;RPS14;RPL35A;RPL13;SEC63;RPS3;RPS21;SRP72;SRP19;RPL34;RPLP0;RPL19;RPL11;RPL30;RPS2;RPL4;RPL7;RPS15A;RPS4X;RPL32;RPSA;RPS13;RPS6;RPL18A;RPS27;RPLP2;RPL22;RPS7;RPS12;RPL10A;SEC61A2;RPS25;RPL9;RPS16;RPL23;RPL17;RPL37;RPL36
prerank,regulation of mRNA catabolic process (GO:0061013),0.3968314266811137,1.2677671769433594,0.11737629459148446,0.5531437459475423,1.0,32/121,16.94%,ZC3HAV1;XPO1;PSME3;VIM;HSPA1A;MAPKAPK2;PSMB7;PSME2;RC3H1;DCP2;PUM2;YTHDF3;PSME4;ZFP36L2;PSMB8;PSMA5;IGF2BP3;PSMD9;YWHAZ;DCP1A;PSMB3;PSMD6;PSMC4;PSMD10;PSMB1;AKT1;PNPT1;PABPC1;PUM1;TNPO1;PSMD12;CNOT8
prerank,vascular transport (GO:0010232),-0.3247668040156676,-1.2671574212464216,0.07650273224043716,0.6916661122845141,1.0,17/81,12.90%,SLCO2B1;SLC24A3;LRP1;ABCC3;SLC1A3;ABCG2;SLC7A1;ATP8A1;SLC2A3;SLC27A1;ATP1A2;TFRC;SLC22A5;SLC7A2;SLC29A1;SLC7A8;SLC15A2
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),0.4722891613372465,1.266843128266959,0.1596045197740113,0.5549233947420443,1.0,15/37,19.97%,RPL5;TAF9;RYBP;WAC;HIPK2;CSNK2A2;CSNK2A1;TLK2;CAMLG;RPL11;USP7;TAF1;EIF3H;N4BP1;PARK7
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),0.5316191635440272,1.2668325919986456,0.19162640901771336,0.5542507371828876,1.0,3/20,4.29%,PID1;PPP2R5A;PICALM
prerank,positive regulation of cellular metabolic process (GO:0031325),0.40910000079482456,1.266634469173434,0.1276595744680851,0.5540878862570872,1.0,26/98,17.13%,PID1;IFNLR1;KLF4;PPARG;ANXA2;ACE2;NFKBIA;INPP5F;MAPK14;GRB2;IFNAR1;TBC1D5;DHRS4;RIPK1;ACOD1;SLCO1C1;PRELID1;AKT1;AGPAT1;TGFB1;RAB29;THBS1;RNF41;INSR;WNT7A;CHCHD2
prerank,response to thyroid hormone (GO:0097066),-0.5032500666672639,-1.2659452841090046,0.18518518518518517,0.6930216451305012,1.0,4/13,8.19%,CTSB;LMO2;THRB;HPN
prerank,negative regulation of T cell proliferation (GO:0042130),0.4879183921649931,1.2656043646231732,0.17569546120058566,0.5561668270483258,1.0,5/28,6.34%,LILRB1;SPN;RC3H1;GLMN;PRNP
prerank,embryonic heart tube morphogenesis (GO:0003143),-0.3693260944952679,-1.2655218560580583,0.11904761904761904,0.6919166123927233,1.0,5/43,6.12%,TGFBR2;MEF2C;PKD2;SMO;ACVR1
prerank,fatty acid catabolic process (GO:0009062),-0.33955129953184016,-1.2653844424048428,0.10810810810810811,0.689811904038473,1.0,30/67,28.87%,ABCD2;PCCA;ECHS1;AIG1;PLA2G15;PECR;ABCD4;ECHDC1;ACAD10;ABHD3;HADHB;ACADM;HADH;HADHA;ECI1;ECI2;ABCD3;ACADL;CPT2;ACADS;PHYH;ILVBL;PEX13;ACAT2;ACAD11;ACOX1;ACOT8;CROT;PPARD;SLC27A2
prerank,regulation of erythrocyte differentiation (GO:0045646),0.47344126473695053,1.265335836202488,0.18353576248313092,0.55617174287078,1.0,10/35,12.99%,LYN;STAT3;HSPA1A;SPI1;STAT5B;STAT1;MAPK14;ACVR2A;FOXO3;HSPA9
prerank,protein heterooligomerization (GO:0051291),-0.4672594339442197,-1.2651627626605182,0.15733333333333333,0.6879957309058022,1.0,8/17,22.56%,PKD2;MAT2A;CPSF6;CBR4;HSD17B8;TMEM120A;FARSA;GRIN2B
prerank,tRNA wobble uridine modification (GO:0002098),-0.4904169647167744,-1.2648220336778424,0.20551378446115287,0.6865458634285636,1.0,10/14,38.79%,ALKBH8;TRMU;ELP1;MTO1;GTPBP3;TRMT9B;CTU2;CTU1;MOCS3;KTI12
prerank,positive regulation of GTPase activity (GO:0043547),0.3861566614230674,1.2647611112538089,0.08378672470076169,0.5570319973484386,1.0,30/188,7.54%,RAP1GAP2;TIAM1;SRGAP2;TBC1D1;RAP1A;CD40;TBC1D8;TIAM2;CCDC125;DOCK10;FOXJ1;SIPA1L3;TBC1D9;RASGRP2;RAPGEF2;USP6NL;TBC1D10C;TBC1D2B;DOCK11;BCR;PICALM;ARAP1;RSU1;TBC1D8B;CAV2;AFDN;RABGAP1L;S100A10;RABGAP1;F11R
prerank,non-canonical Wnt signaling pathway (GO:0035567),0.3994040530307592,1.264453112794165,0.10817031070195628,0.5570746973491171,1.0,40/124,19.82%,TIAM1;PSME3;CELSR1;CCDC88C;PSMB7;CDC42;PSME2;PPP3CA;AP2A2;PLCB1;RAC1;PSME4;GNB1;RHOA;PSMB8;PSMA5;PSMD9;NLK;PSMB3;AP2B1;PSMD6;PSMC4;DVL3;MAP3K7;PSMD10;PDE6B;PSMB1;GNG2;TNRC6B;TNRC6A;DVL2;AP2S1;PSMD12;WNT7A;VANGL1;SMURF2;FZD7;FZD9;FZD3;PSMF1
prerank,positive regulation of neuron migration (GO:2001224),0.5884714612692332,1.2643801943927928,0.21654929577464788,0.5565660321218001,1.0,3/11,3.14%,SHTN1;NIPBL;RAPGEF2
prerank,regulation of response to oxidative stress (GO:1902882),-0.5301247680207999,-1.2642704825499174,0.2054794520547945,0.686037353463258,1.0,1/11,0.12%,PRKN
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.5093547401086224,1.263968294198679,0.18440779610194902,0.5569883493945779,1.0,8/25,14.18%,LONP1;CUL3;KLHL15;ATXN3;UBE2W;FBXL17;YME1L1;VCP
prerank,regulation of phospholipid metabolic process (GO:1903725),0.6092622143318327,1.2639607524954166,0.20238095238095238,0.556302362102343,1.0,4/10,8.04%,ABCA3;MTMR3;MTMR4;DNAJC19
prerank,potassium ion homeostasis (GO:0055075),-0.42931661664225695,-1.2632845516606137,0.16997167138810199,0.6867776896424702,1.0,5/23,7.62%,KCNMA1;ATP1B3;KCNJ2;ATP1B1;ATP1A2
prerank,regulation of endocytic recycling (GO:2001135),0.6040714424636644,1.2629239277734998,0.20508474576271185,0.5582554212104084,1.0,3/11,4.34%,SORL1;INPP5F;EHD2
prerank,regulation of axon guidance (GO:1902667),-0.5347981305095376,-1.262892299012131,0.20654911838790932,0.6854861089883697,1.0,5/10,14.51%,NRP1;ZSWIM8;VEGFA;ZSWIM6;ZSWIM5
prerank,regulation of fatty acid metabolic process (GO:0019217),0.5416269850407569,1.2628450134882168,0.19751166407465007,0.5577465795012906,1.0,3/17,6.35%,PPARG;PRKAG2;PRKAB2
prerank,Rac protein signal transduction (GO:0016601),0.5380144502473994,1.2627453586031956,0.19478527607361965,0.5573236727247416,1.0,7/18,16.05%,TIAM1;EPS8;RAC2;RAC1;RHOG;ELMO1;HACE1
prerank,cellular response to oxygen-containing compound (GO:1901701),0.37588390512820985,1.2627367985785491,0.06101344364012409,0.5566444266005242,1.0,60/291,15.44%,PID1;IL1B;LYN;SPAAR;TNIP3;RAP1A;STAP1;CREB1;LILRB1;DAPK1;RET;NFKB1;VIM;FOS;RAPGEF2;KCNQ1;NCOA3;CXCL10;HCN4;DPEP1;CERS1;MAPK14;TIRAP;CAPN2;SETX;PTK2B;AHR;PDCD4;PDE2A;EZR;CARD16;PXN;GNB1;IL6;NFKBIB;RHOA;GIT1;CAMKK2;RPS3;SBNO2;CACTIN;ACOD1;NLRP3;SH3BP4;TLR2;MAPK8;AKT1;NRIP1;PDK3;GNG2;NCF1;TNFRSF1B;VCP;ADAM9;GSTP1;MYD88;MAPK1;RELA;PRDX5;TAF1
prerank,heart looping (GO:0001947),-0.37727870617149994,-1.262665360656887,0.12681159420289856,0.6838267492778108,1.0,4/39,4.00%,TGFBR2;MEF2C;PKD2;SMO
prerank,positive regulation of interleukin-13 production (GO:0032736),0.6089957986457619,1.2619516965272006,0.23652173913043478,0.55799118898829,1.0,2/10,5.53%,RARA;IRF4
prerank,heart contraction (GO:0060047),0.45436484679176276,1.2616376854401643,0.1728395061728395,0.5581190390826198,1.0,6/41,7.07%,ACE;TNNC1;GPX1;KCNQ1;MYL4;SGCD
prerank,regulation of hippo signaling (GO:0035330),0.5486390554461013,1.2613188555874537,0.210016155088853,0.5582849740525265,1.0,7/17,13.42%,MOB3B;LIMD1;MAPK14;NEK8;MAP2K3;NF2;MARK3
prerank,regulation of mRNA stability (GO:0043488),0.3867274808564878,1.2609085329497745,0.12044198895027625,0.5587041377322562,1.0,39/145,16.30%,TENT5A;XPO1;PSME3;FASTKD1;MEX3D;VIM;HSPA1A;MAPKAPK2;PSMB7;PSME2;GDNF;RC3H1;GIGYF2;DCP2;PUM2;YTHDF3;PSME4;ZFP36L2;PSMB8;PSMA5;IGF2BP3;PSMD9;YWHAZ;DCP1A;PSMB3;PSMD6;PSMC4;PSMD10;EIF4ENIF1;PSMB1;AKT1;METTL3;ROCK1;PAIP1;CELF1;PABPC1;PUM1;TNPO1;PSMD12
prerank,glucose homeostasis (GO:0042593),0.41767091080741486,1.2608644248791947,0.1573301549463647,0.5581262547479376,1.0,27/83,20.64%,NGFR;PPARG;STAT3;SLC8B1;CRY1;LRRC8D;ADRA2A;WFS1;CRY2;CYB5R4;IL6;SELENOT;PRKAA1;BACE2;PRKAA2;INSR;GCK;FOXK1;PIK3R2;SIRT1;PYGL;MBD5;BAD;RPS6;PARK7;ADIPOR1;STK11
prerank,mRNA polyadenylation (GO:0006378),0.5053029308299091,1.2606272638262492,0.19416058394160585,0.5573421227525027,1.0,15/26,19.38%,SSU72;FIP1L1;TUT1;SCAF8;TENT2;PAPOLG;MTPAP;APP;PNPT1;TENT4B;CPSF3;PAPOLA;PABPC1;CSTF3;WDR33
prerank,RNA polyadenylation (GO:0043631),0.5053029308299091,1.2606272638262492,0.19416058394160585,0.5573421227525027,1.0,15/26,19.38%,SSU72;FIP1L1;TUT1;SCAF8;TENT2;PAPOLG;MTPAP;APP;PNPT1;TENT4B;CPSF3;PAPOLA;PABPC1;CSTF3;WDR33
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.39414993221456135,1.2604390925949545,0.10822998872604284,0.5571558834121533,1.0,36/136,17.17%,SP100;SIK1;KLF4;ITCH;PIM1;FOXJ1;MAD2L2;PTGIS;ERBIN;SPI1;NFKBIA;SUMO1;NFKBIE;PRNP;ANXA4;WFS1;FLNA;TRAF3;PEX14;ID2;WWP2;CYLD;CACTIN;ACOD1;NLRP3;MAP2K5;PSMD10;ZNF431;USP7;TNFRSF4;TAF1;BHLHE40;IRAK3;RB1;PROX1;SIRT1
prerank,calcium ion import (GO:0070509),-0.40052639103965937,-1.260293382302981,0.13071895424836602,0.6886996507938395,1.0,7/28,6.81%,CACNA1D;SLC8A1;CACNB2;CACNA1C;ATP2A2;TRPC4;AFG3L2
prerank,peptidyl-lysine acetylation (GO:0018394),0.6040582103478748,1.2599614318128933,0.20954003407155025,0.5577337038415736,1.0,4/10,17.17%,KAT7;KAT2B;CREBBP;SIRT1
prerank,regulation of cation channel activity (GO:2001257),-0.3086680550418059,-1.2592837279504179,0.08,0.6895855537352277,1.0,14/89,5.04%,MEF2C;GRIA4;FGF14;LRRC7;CACNB2;NLGN1;SLMAP;FGF13;DLG2;DLG4;GRIA2;GRIA1;PRKACA;ANK2
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.47962873840591,-1.2590526217376257,0.1770573566084788,0.6878468134689079,1.0,8/16,15.43%,ATP5F1A;ATP5PO;ATP5MG;ATP5PD;ATP5PF;STOML2;ATP5F1D;ATP5MC3
prerank,positive regulation of protein acetylation (GO:1901985),-0.5269767383439786,-1.258899674431569,0.1547911547911548,0.6859452292093305,1.0,7/12,22.33%,DIP2B;CAMK1;TERF2IP;DDX3X;FAM161A;RAPGEF3;DIP2A
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),-0.47305301553691614,-1.258736953865852,0.20347394540942929,0.6840036133528917,1.0,7/16,16.58%,PIGN;PIGG;PIGP;PIGB;PIGA;DPM2;PIGV
prerank,ventricular septum development (GO:0003281),-0.39417960351304226,-1.2585185008699806,0.15613382899628253,0.6822317805900014,1.0,12/37,13.75%,TGFBR2;SALL1;TGFBR1;ROBO2;ROBO1;SMAD7;MATR3;ACVR1;SLIT2;SLIT3;SOX4;TGFB2
prerank,cellular response to growth factor stimulus (GO:0071363),0.3879922622051912,1.258511538630451,0.11086717892425905,0.5608657955559249,1.0,45/151,18.31%,CD44;RUNX2;IQGAP1;RAP1A;KLF4;NDNF;ERN1;BMPR2;RAPGEF2;MAPKAPK2;STAT5B;PTPN12;BCAR1;MAPK14;SETX;PDPK1;CIB1;PDE2A;ACVR2A;ZFP36L2;HGF;SMAD4;ANXA1;NR3C1;DSTYK;MAP2K5;MAP2K3;ZPR1;AKT1;KIDINS220;ADAMTS12;TGFB1;EHD1;RELA;STMN2;MED1;DUSP22;RPS6KB1;WNT7A;RAB35;KNSTRN;NR4A1;FOXC1;APPL1;SYAP1
prerank,"regulation of gene expression, epigenetic (GO:0040029)",0.4210821291429651,1.2584243934342954,0.14213197969543148,0.5603937831631136,1.0,20/73,14.23%,JARID2;GPX1;MYO1C;TAF1A;SPI1;H3-3A;RBBP4;GLMN;SMARCA5;POLR1G;DEK;PHF19;CGGBP1;MECP2;CTCF;TDG;PPM1D;EZH2;KAT2B;POLR1B
prerank,mRNA catabolic process (GO:0006402),0.45462479113358845,1.2584152192287044,0.1711590296495957,0.5597465210328353,1.0,14/44,14.59%,ZC3H12D;HSPA1A;ERN1;RC3H1;XRN2;DCP2;LSM5;ZFP36L2;DHX34;TUT7;METTL3;RNH1;PNPT1;MRTO4
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),0.5604350690786841,1.2580843817290752,0.18864774624373956,0.5599757099907237,1.0,3/15,2.88%,NFKB1;CD36;PRKCH
prerank,positive regulation of protein kinase activity (GO:0045860),0.38759033481727084,1.25807268662843,0.10753880266075388,0.5593244414105777,1.0,28/148,11.04%,PTPRC;NEDD9;IQGAP1;RAP1A;ACE;PAK1;PRKAG2;RAPGEF2;CCDC88A;IL6R;AXIN1;TAOK3;TRAF4;ADRA2A;STK4;PRNP;PTK2B;CIB1;PAK2;CACUL1;MINK1;RALB;RHOA;DAXX;PTPN1;SNX9;UNC119;PRKAG1
prerank,glutamate receptor signaling pathway (GO:0007215),-0.3718452447947149,-1.2579814832421419,0.12666666666666668,0.681490887660892,1.0,15/37,25.22%,GRIA4;GRIA2;DAGLA;GRID2;GRIK4;GRIK1;CDK5R1;CPEB4;GRM5;GRIA3;GRM7;GRIN2B;CLN3;HOMER3;KCNB1
prerank,positive regulation of intracellular signal transduction (GO:1902533),0.3667114030958217,1.257940999300693,0.028282828282828285,0.5589506212351238,1.0,107/509,16.32%,CD74;CARD11;FGR;FFAR4;PTPRC;IL1B;IQGAP1;ALPK1;LYN;FLT3;PLCG2;FYN;RET;CD40;SLC44A2;FGF5;FGF22;JAK2;NRG2;MAP3K14;KL;DHX58;REL;RAPGEF2;LAPTM5;ANKRD17;MALT1;PTPN6;RAC2;EIF2AK2;CBL;IKBKB;TRIM62;BBC3;BIRC3;ADRA2A;TRAF3IP2;S100A4;PELI1;CAV2;HEXIM1;IRAK4;TIRAP;UBE2N;SHISA5;GRB2;LGALS1;PDPK1;FLNA;OASL;PDCD4;PUM2;TRIM25;ZDHHC13;CARD16;ENG;RAC1;TLR3;HGF;IL6;IFI35;RHOA;ZDHHC17;CPNE1;RNF13;USP15;HIP1;RPS3;RTN4;FN1;FIS1;PIK3CA;RIPK1;TRIM14;RNF31;RHEB;TAB3;APP;MAP3K7;TLR2;PDGFD;CASS4;DNM1L;KIT;NCF1;HCLS1;HCST;ROCK1;HDAC3;TGFB1;FGFR3;PTPRJ;IL18;UNC5B;MAZ;MYD88;RHOG;FRS2;RELA;MIER1;TBK1;THBS1;VAPA;PUM1;SEH1L;INSR;RELN
prerank,apoptotic process (GO:0006915),0.3771452915683557,1.2574953131853497,0.08110992529348986,0.5593774339626004,1.0,52/203,15.27%,IL1B;PRKCE;NOTCH2;PAEP;DAPK1;NGFR;PLSCR1;JAK2;IFIT2;NFKBIA;BCL2L14;DLC1;BBC3;ITGB2;FAP;STK4;PTK2B;AHR;ATP2A1;CIB1;PDCD4;DDX41;PAWR;KREMEN1;CD2;DDIT4;PPP1R15A;HIP1;PIDD1;ARHGEF6;RTN4;CSRNP1;CASP2;PIK3CA;RIPK1;APAF1;DMPK;AIFM1;NLRP3;APP;MAP3K7;TLR2;MCM2;ERCC3;AKT1;DHCR24;CASP7;CYFIP2;CASP12;MYD88;CASP6;ELMO1
prerank,actin polymerization or depolymerization (GO:0008154),0.4441442785477264,1.2571955884854848,0.16666666666666666,0.5594939344687544,1.0,7/50,5.12%,SVIL;PSTPIP1;JAK2;PSTPIP2;MSRB1;ABI1;DIAPH1
prerank,regulation of neuronal synaptic plasticity (GO:0048168),-0.3986881056457438,-1.2566766685000037,0.16838487972508592,0.6830812004289452,1.0,6/29,7.75%,APOE;SYNGR1;DLG4;ZDHHC2;RAB3GAP1;NETO1
prerank,positive regulation of immunoglobulin production (GO:0002639),0.48750791218646244,1.2565932640701718,0.1685878962536023,0.5604030471134509,1.0,6/31,11.16%,PTPRC;MAD2L2;EPHB2;IL6;KMT5B;GPI
prerank,mitotic cell cycle phase transition (GO:0044772),0.3789352930779547,1.2564638359389417,0.0876068376068376,0.5600601010687973,1.0,45/203,15.04%,GPR132;EPS8;SDCCAG8;CNTRL;PPP1R12A;CUL3;CUL5;HAUS8;PHLDA1;EIF4EBP1;CRLF3;CCNJL;CHMP4B;CCND3;FBXW11;FBXL8;CDK14;CDKN2C;CCND1;CEP63;PAFAH1B1;PLCB1;HAUS1;PPP2R2A;CCNH;CACUL1;DCTN3;LATS1;SPAST;TRIM71;CEP250;UBE2S;FBXL17;LATS2;DYNC1H1;PPP1CB;CCND2;HAUS3;FBXL12;CLASP1;WEE1;USP37;BCAT1;BRSK1;ANAPC7
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),-0.3753152482887414,-1.2552149750466226,0.16037735849056603,0.6852821057330852,1.0,13/37,12.54%,SIRPA;TREM2;ABCD2;APPL2;PLD3;APOD;HIF1A;NLRC3;PYCARD;CUEDC2;CHID1;PER1;TLR4
prerank,tetrapyrrole metabolic process (GO:0033013),0.5325066205043139,1.2545062414341974,0.2,0.5644334416534159,1.0,5/18,13.51%,MMAB;ABCC1;MTRR;LMBRD1;MMAA
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.4929088797335643,1.2543987216478096,0.2027231467473525,0.5640573421726454,1.0,13/27,19.09%,CD36;IRAK4;TIRAP;MAP3K1;TAB3;MAP3K7;TLR2;BTK;MYD88;IRAK3;HSPD1;TAB1;TLR1
prerank,positive regulation of p38MAPK cascade (GO:1900745),0.5134932763181338,1.254136805533954,0.23511450381679388,0.5640585243479035,1.0,7/22,13.43%,IL1B;SPI1;MINK1;MAP3K4;RELL1;EMC10;NCF1
prerank,regulation of keratinocyte differentiation (GO:0045616),0.5016800541589792,1.2528575659734498,0.21921921921921922,0.5666487635806721,1.0,9/24,20.23%,PRKCH;NCOA3;TRIM16;CBFB;ROCK1;SGPP1;MED1;FOXC1;RUNX1
prerank,epithelial cell development (GO:0002064),0.5214371090630663,1.2527538837459922,0.1858678955453149,0.5662387492932733,1.0,7/20,21.17%,SIPA1L3;SLC4A7;PDZD7;RILPL2;WNT7A;WNT5B;DACT2
prerank,N-glycan processing (GO:0006491),0.5247135241359139,1.2526274078750168,0.20098846787479407,0.5658864006983021,1.0,3/18,3.54%,ST8SIA4;ST8SIA1;ST8SIA6
prerank,regulation of vesicle-mediated transport (GO:0060627),0.40851494187588777,1.2526089847416768,0.14709371293001186,0.5652675458837502,1.0,10/91,5.03%,FGR;LRRK2;PTPRC;HCK;SYK;RAB3D;CD177;INPP5F;PICALM;SCARB1
prerank,positive regulation of interferon-beta production (GO:0032728),0.46830877214730476,1.2524218970594874,0.19577464788732393,0.565103667877635,1.0,10/33,16.50%,OAS2;POLR3F;DHX58;POLR3A;IFIH1;TLR3;IRF7;TLR2;TBK1;IRF5
prerank,negative regulation of cell activation (GO:0050866),-0.48376785830231706,-1.2521204059323534,0.208955223880597,0.693011649056386,1.0,3/14,8.54%,APOE;TREM2;PDGFA
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",0.6045086716185933,1.2513455381411982,0.2013888888888889,0.5672685230787436,1.0,4/10,12.53%,RUNX3;IRF4;CBFB;SH3RF1
prerank,regulation of myotube differentiation (GO:0010830),0.5007445400256254,1.2510330661393507,0.19271623672230653,0.5674206169700452,1.0,9/24,19.28%,SIK1;MAPK14;HDAC9;PIEZO1;DMPK;HDAC3;MAML1;HDAC1;ATP11A
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),0.5994474689459931,1.2507308643685386,0.22283609576427257,0.5674884481450374,1.0,1/10,0.33%,IL1B
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.4886218622269379,1.2506552979038368,0.17971014492753623,0.5670162351345269,1.0,9/29,10.65%,CD40;IKBKB;BIRC3;UBE2D3;TRAF3;TLR3;TANK;IRF7;RIPK1
prerank,Golgi inheritance (GO:0048313),0.5890382755456919,1.250407335339652,0.2170940170940171,0.5670258031036988,1.0,5/11,15.27%,VRK1;GBF1;STX5;YWHAZ;VCPIP1
prerank,protein localization to lysosome (GO:0061462),0.4900305602022746,1.2504049772148005,0.18385650224215247,0.5663474882608973,1.0,8/28,12.46%,LAPTM5;SORL1;RAB7A;GCC2;RTN4;SCARB2;LMBRD1;SH3BP4
prerank,dendritic spine morphogenesis (GO:0060997),0.5500820335370483,1.250363810902652,0.20195439739413681,0.5657924625322949,1.0,4/15,8.43%,DOCK10;CDC42;PTEN;EPHB2
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),0.5998149299888682,1.2498445957732514,0.23478260869565218,0.5664753779036575,1.0,4/10,11.00%,MALT1;NFKBIZ;RC3H1;NFKBID
prerank,N-acetylglucosamine metabolic process (GO:0006044),-0.4879529171531117,-1.2494941896932052,0.17054263565891473,0.6988776916872323,1.0,4/15,2.96%,LARGE1;RENBP;AMDHD2;NAGK
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),0.5694297793294237,1.249440086367277,0.22749590834697217,0.5668603704969305,1.0,1/13,0.22%,LRRK2
prerank,mRNA destabilization (GO:0061157),0.46632305790049816,1.2492872485313025,0.1745152354570637,0.5665931484128793,1.0,12/38,16.02%,ZC3H12D;MEX3D;RC3H1;GIGYF2;YTHDF3;ZFP36L2;TRIM71;TUT7;METTL3;ROCK1;CELF1;PUM1
prerank,internal peptidyl-lysine acetylation (GO:0018393),0.48657744732075975,1.2492614175701506,0.1988388969521045,0.5659918087131968,1.0,8/27,15.26%,ATAT1;KAT7;KAT6A;MORF4L1;MSL3;KAT2B;CREBBP;PHF20
prerank,GTP metabolic process (GO:0046039),0.5538443117190677,1.2490732968044613,0.24390243902439024,0.5657879132337406,1.0,1/15,0.22%,LRRK2
prerank,amide biosynthetic process (GO:0043604),0.44526034314565177,1.2489917666091819,0.1783783783783784,0.5653334423395769,1.0,11/47,15.21%,CERS6;CERS1;SAMD8;SGMS1;SGMS2;ARG2;SPTSSB;PCSK5;ASL;ASS1;FA2H
prerank,negative regulation of endopeptidase activity (GO:0010951),-0.3621837689535212,-1.2488928960375638,0.11788617886178862,0.6984190575562552,1.0,7/47,12.35%,BIN1;TIMP2;SERPINE2;SPOCK1;TIMP3;SERPINE1;SERPINI1
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),0.4376199230185885,1.2484682967145055,0.18133333333333335,0.5660534307922022,1.0,15/55,15.85%,PID1;ACE2;RAC2;MAPK14;PARL;ARF4;GRB2;RAC1;PIKFYVE;DHRS4;RIPK1;ACOD1;PDK3;THBS1;RNF41
prerank,eye photoreceptor cell development (GO:0042462),-0.48285172694923445,-1.248323692190182,0.19889502762430938,0.697814614502157,1.0,3/15,20.21%,MYO7A;VEGFA;CEP290
prerank,cellular copper ion homeostasis (GO:0006878),0.5536320244853459,1.247933434998728,0.20757825370675453,0.5668473209938756,1.0,6/14,16.64%,PRNP;ARF1;ATP7A;ATOX1;APP;SLC31A1
prerank,striated muscle cell differentiation (GO:0051146),-0.46730687337637766,-1.2477881009005014,0.21671018276762402,0.6971590631475302,1.0,4/16,4.55%,SKI;MEF2C;PLD3;SORT1
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),-0.49777735948860474,-1.247693968869091,0.21534653465346534,0.6950905285786508,1.0,3/14,5.04%,ATP1B3;ATP1B1;ANK2
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),0.5506742926561916,1.2474727043891927,0.19765494137353434,0.5673950604575999,1.0,3/15,2.97%,RPL5;DTX3L;MAD2L2
prerank,negative regulation of axonogenesis (GO:0050771),-0.4101922575666543,-1.247295794946715,0.18095238095238095,0.6940372079101582,1.0,8/27,8.24%,DIP2B;DCC;ULK2;MAP2;FGF13;CDKL3;ARHGDIA;EFNB3
prerank,positive regulation of epidermal cell differentiation (GO:0045606),0.5508129652944778,1.2471235854358595,0.2146422628951747,0.5676397709197328,1.0,4/15,7.77%,PRKCH;NCOA3;TRIM16;SULT2B1
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),0.5479173781916877,1.2470321970117493,0.2098976109215017,0.5672258238843111,1.0,3/13,6.32%,CBLB;CBL;TSG101
prerank,positive regulation of fatty acid oxidation (GO:0046321),-0.506809697300568,-1.2468220539085966,0.18446601941747573,0.6932336218596916,1.0,3/12,8.94%,ABCD2;PPARGC1A;IRS1
prerank,negative regulation of multicellular organismal process (GO:0051241),0.3788311127623534,1.2467216315070206,0.10775862068965517,0.567416066754832,1.0,35/199,14.21%,FFAR4;IL1B;PAEP;IFNGR1;MARVELD3;LNPEP;RAB11FIP1;PTPRO;SDHAF2;BMPR2;MAD2L2;RGS2;NPTN;ACOT11;SPI1;PTGER4;ATP2B1;RBPJ;SRGN;RPS6KA5;PTEN;ARHGDIB;ADAM17;HDAC9;SLAMF8;SPRED3;RHEB;FCGR2B;PGAM5;SLC6A4;USF3;LRP4;TIFAB;ROCK1;TGFB1
prerank,chromatin assembly (GO:0031497),0.4629297981089464,1.2466269472711462,0.19699042407660738,0.5669998378890214,1.0,15/38,22.70%,CHAF1A;H3-3A;RBBP4;SMARCA5;CTCF;EZH1;DAXX;NAP1L1;ATRX;RSF1;SIRT1;BRD2;PRDM9;ANP32B;ASF1A
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),-0.5321623320806653,-1.2463082013557873,0.2237442922374429,0.6924933431034984,1.0,6/10,24.96%,IVD;ACADM;ACADL;ACADS;GCDH;ACAD11
prerank,sensory perception of taste (GO:0050909),0.5981234980414293,1.2459836971790845,0.20930232558139536,0.5679828988010468,1.0,1/10,2.75%,CD36
prerank,regulation of mitochondrion organization (GO:0010821),0.4453764154255402,1.2457851285266415,0.18230563002680966,0.5678821689080594,1.0,11/47,13.62%,LRRK2;PID1;CYRIB;FBXW7;PARL;PDE2A;CSNK2A2;FIS1;DNM1L;STAT2;SREBF2
prerank,mesoderm formation (GO:0001707),0.5331287980343877,1.245083489601153,0.19937205651491366,0.5690959421167544,1.0,4/17,13.66%,BMPR2;SCX;ITGA8;ITGA3
prerank,actin filament bundle assembly (GO:0051017),0.4765809097149295,1.2450102999385075,0.20802377414561665,0.5686364448228286,1.0,5/33,7.99%,NEDD9;LCP1;EPS8;PAWR;EZR
prerank,histone mRNA catabolic process (GO:0071044),0.5408247032082961,1.2445456367239167,0.2310126582278481,0.5691938119436815,1.0,7/15,14.80%,DCP2;TUT1;ERI1;TENT2;MTPAP;TUT7;TENT4B
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),0.4646646491724996,1.2441750341165352,0.1857541899441341,0.5695329588231473,1.0,12/34,16.19%,LYN;CD300A;SMPDL3B;RAB7B;TLR3;CACTIN;GRAMD4;ACOD1;OTUD4;GPS2;IRAK3;CD300LF
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.3820288866552283,1.2441642951839749,0.13439635535307518,0.5688870254421496,1.0,23/152,12.62%,GRK5;GNA14;CRHR2;FPR1;ADGRG5;ADGRG6;ADGRE5;WASF2;RXFP2;LPAR3;PTGER2;CXCL10;HTR1D;PTGER4;ADRA2A;PDE2A;PSAP;PTGER3;S1PR5;ADCY7;GLP2R;GNAI1;ADCY5
prerank,regulation of GTPase activity (GO:0043087),0.38036884393951587,1.244086502055377,0.11413043478260869,0.5684462108139563,1.0,36/177,12.49%,ARHGAP15;LRRK2;VAV3;SRGAP2;RAP1A;CD40;DOCK10;CRK;RASGRP2;RAPGEF2;RCC2;USP6NL;DOCK11;OCRL;PICALM;KLRK1;ARAP1;RSU1;FGD4;CAV2;AFDN;S100A10;RABGAP1;F11R;PLXND1;FGD1;FGD3;BCAS3;ARFGEF1;SNX9;ADAP1;NET1;TBC1D2;DVL3;SH3BP4;PLXNC1
prerank,negative regulation of lymphocyte activation (GO:0051250),0.5088535888303719,1.2437604840404515,0.22325581395348837,0.5685991042313677,1.0,7/21,12.84%,PTPN22;FOXJ1;LAPTM5;LST1;SAMSN1;FCGR2B;LGALS3
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.4255882733226613,1.243570748554893,0.1613722998729352,0.5684637728774256,1.0,20/60,16.53%,RUNX2;NFKB1;ATF7IP;MED30;MED13;PTEN;CCND1;CBFB;MECP2;MED6;IL6;MED26;MED12;MED14;PPM1D;TNRC6B;TNRC6A;RELA;MED1;MED7
prerank,stem cell development (GO:0048864),0.5339293175630081,1.2433977909603382,0.20707070707070707,0.568242961008161,1.0,4/16,16.56%,PTPRC;TAPT1;WNT7A;KLHL12
prerank,positive regulation of small molecule metabolic process (GO:0062013),0.5590748678333536,1.2433889772380688,0.20735785953177258,0.5675999730586765,1.0,2/15,1.70%,PRKCE;PPARG
prerank,ESCRT complex disassembly (GO:1904896),-0.5369748580425897,-1.2433073967211317,0.2263681592039801,0.6971540061709505,1.0,6/10,27.54%,VPS4B;CHMP5;CHMP1B;CHMP7;CHMP2A;IST1
prerank,ESCRT III complex disassembly (GO:1904903),-0.5369748580425897,-1.2433073967211317,0.2263681592039801,0.6971540061709505,1.0,6/10,27.54%,VPS4B;CHMP5;CHMP1B;CHMP7;CHMP2A;IST1
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.41110164400004645,1.2431876782139424,0.1608643457382953,0.5674639621537859,1.0,20/87,15.48%,CD44;NDNF;FGF5;FGF22;KL;GTF2F2;POLR2C;CBL;GRB2;SETX;SHOC2;ZFP36L2;TRIM71;DSTYK;FLRT1;FGFR3;MAPK1;FRS2;SPRED1;NCBP1
prerank,regulation of cilium assembly (GO:1902017),0.4240321295003849,1.2430444282819768,0.1791044776119403,0.5671642053130662,1.0,18/62,15.02%,TBC1D1;SDCCAG8;TBC1D8;USP6NL;TBC1D10C;CCDC88A;TBC1D2B;ATG5;RABGAP1;IFT140;TBC1D5;CYLD;TAPT1;TBC1D2;HTT;LIMK2;EVI5;DYNLT2B
prerank,regulation of type I interferon production (GO:0032479),0.4113826295752164,1.2429294894472613,0.1414752116082225,0.5668005185654765,1.0,24/84,15.47%,PTPN22;ITCH;POLR3F;NFKB1;DHX58;POLR3A;MRE11;LRRFIP1;NLRX1;IFIH1;TIRAP;DDX41;TRAF3;TRIM25;IRF7;CYLD;ACOD1;PQBP1;ILRUN;GPATCH3;MYD88;CREBBP;RELA;TBK1
prerank,negative regulation of BMP signaling pathway (GO:0030514),0.44135471874164467,1.2428421225552972,0.17670682730923695,0.5663984832774962,1.0,10/51,10.52%,PPARG;BMPR2;SORL1;LEMD3;HIPK2;UBE2D3;ACVR2A;FBN1;SMAD4;LEMD2
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),0.4567790013600565,1.2426916119372144,0.18614718614718614,0.5661217248173894,1.0,9/35,9.13%,IQGAP2;HCK;NOTCH2;STAP1;CDC42;ARHGDIB;PTK2B;F11R;BCAS3
prerank,carbohydrate catabolic process (GO:0016052),-0.3705867633543978,-1.2426740363145894,0.14685314685314685,0.6967587073148154,1.0,14/38,24.14%,HK3;HK1;PFKL;NEU1;PGK1;MAN2B2;ENO2;PGAM1;PGAM4;PFKM;MAN2C1;ENO3;LDHA;ALDOA
prerank,regulation of microtubule depolymerization (GO:0031114),-0.42169427174532365,-1.24236207174246,0.21052631578947367,0.6953478381222974,1.0,8/25,13.66%,NAV3;CAMSAP1;MAP1B;FGF13;CLASP2;MAP1A;CAMSAP2;TRPV4
prerank,calcium-ion regulated exocytosis (GO:0017156),-0.40122250283512373,-1.242225208323984,0.13915857605177995,0.693443923625495,1.0,16/27,36.28%,SYT1;SDF4;SYT9;SYT7;SYT6;RIMS1;RIMS3;SYT8;SYT3;SYT12;SYT11;SYT13;SYT10;SYT5;SYT4;SYT17
prerank,arachidonic acid metabolic process (GO:0019369),-0.37827364954387527,-1.2419229101377391,0.14093959731543623,0.6921000418520101,1.0,6/35,7.25%,HPGDS;PTGS1;MGLL;DAGLA;PNPLA8;PLA2G4A
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.3601562500767155,1.241549826453069,0.029116465863453816,0.5684159067103837,1.0,106/497,17.17%,CIITA;CBFA2T3;JARID2;FOXP1;RUNX2;RARA;SP3;LIMD1;BCL3;KLF4;DAPK1;PPARG;SCML4;BCL6;ATF7IP;NIPBL;NAB1;BTG2;CIART;BMPR2;SPI1;EIF2AK2;EIF2AK1;CRY1;MTA3;MBD1;SUMO1;KAT7;RFX3;RBPJ;DEAF1;HEXIM1;MBTD1;FBXW11;RPS6KA5;KLF10;AHR;ARID4A;PDCD4;GIGYF2;SETDB2;MECP2;PLCB1;THRA;CRY2;CLOCK;SAP18;GATAD2A;CTCF;PHF12;UIMC1;MRPL13;HDAC9;PEX14;CBFA2T2;KAT6A;RBAK;ID2;WWP2;TRIM71;SMARCE1;RCOR3;SMAD4;RPS3;SBNO2;IGF2BP3;DAXX;NR3C1;SPEN;RBM15;S100A11;DEDD2;PAIP2;TAF7;REST;MBD2;L3MBTL2;EIF4ENIF1;MYB;EIF2AK3;LBH;TLE1;EZH2;SMARCC2;CITED2;HDAC3;NFIL3;TGFB1;SYNCRIP;RSF1;TNFRSF4;RELA;BHLHE40;PHC3;ZNF148;BRD7;USP47;RB1;DAPK3;PROX1;SCMH1;NIBAN2;CNOT8;CAPRIN1;FOXK1;SIRT1
prerank,regulation of protein binding (GO:0043393),0.39014303447349413,1.2415034861426706,0.13043478260869565,0.567898529349901,1.0,29/114,15.44%,LRRK2;TIAM1;DTX3L;CRK;IFIT2;RAPGEF2;SORL1;SLPI;MITD1;HIPK2;PRMT8;STK4;CARD16;TMC8;PEX14;RALB;SNAPIN;B2M;APP;NMD3;RPL11;MAPK8;AKT1;MARK3;IFIT1;ROCK1;AURKB;DISC1;TAF1
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),-0.4734424990748656,-1.2413745251879997,0.19072164948453607,0.6916467158001477,1.0,9/16,24.21%,DDX5;RBFOX2;EGLN2;PPARGC1B;ESR1;AR;NCOA4;ARID1A;SAFB
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),-0.4789449950454009,-1.2411734335466824,0.22058823529411764,0.6900290194286646,1.0,6/14,18.84%,BFAR;TMEM33;BAX;DAB2IP;UFL1;DNAJB9
prerank,glycerophospholipid biosynthetic process (GO:0046474),0.3787031061814985,1.2406575088471605,0.11314655172413793,0.5695130110006756,1.0,36/172,13.61%,DGKG;PLCG2;PIP4K2A;SLC44A2;PLSCR1;PIK3C2A;AGPAT4;MTMR14;INPP5F;OCRL;PI4K2B;PTEN;MTMR3;INPP4A;IMPA1;PIK3R6;PLEKHA2;CEPT1;ARF1;MTMR4;SYNJ1;PCYT1A;CPNE1;PITPNM1;PIKFYVE;FAR1;CSNK2A2;CSNK2A1;PIP4K2B;PIK3CA;CDIPT;SLC44A1;PIK3R4;SLC44A5;PIP5K1A;AGPAT1
prerank,cellular defense response (GO:0006968),0.45236096607632725,1.2401679131159606,0.17812061711079943,0.5700430495345903,1.0,9/40,15.72%,CD300C;LSP1;CCR9;SPN;PTK2B;NCF2;NCF1;RELA;ZNF148
prerank,N-terminal protein amino acid modification (GO:0031365),-0.49181074606438,-1.2399828918497875,0.2116788321167883,0.6917075409366745,1.0,4/14,3.63%,METAP1D;NAA50;NAA40;METAP2
prerank,cellular response to corticosteroid stimulus (GO:0071384),0.5533589720109034,1.2397807512835706,0.22537562604340566,0.5703772642522469,1.0,4/15,11.90%,ZFP36L2;ANXA1;NR3C1;REST
prerank,pattern recognition receptor signaling pathway (GO:0002221),0.4348353029575231,1.2392152092950977,0.1837270341207349,0.5712446846466487,1.0,14/56,12.51%,ALPK1;PLCG2;MAPKAPK3;CD36;RPS6KA3;MAPKAPK2;IRAK4;TRAF3;SFTPA1;SFTPA2;TLR3;TAB3;MAP3K7;TLR2
prerank,monovalent inorganic cation homeostasis (GO:0055067),0.5004960800856395,1.2388689895743479,0.21951219512195122,0.571507084202909,1.0,4/23,11.21%,SLC9A7;SLC12A7;SLC12A6;SLC12A9
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),0.5634677826131459,1.2388674738578498,0.22569444444444445,0.5708551085427854,1.0,3/12,3.03%,IQGAP1;PTPRO;MYO1E
prerank,plasma membrane tubulation (GO:0097320),0.559248520064091,1.2385926086436385,0.23785594639865998,0.5709213619577866,1.0,6/13,15.66%,EHD2;CHMP4A;BIN3;SNX9;PACSIN2;SNX33
prerank,positive regulation of wound healing (GO:0090303),0.4599082343827235,1.238094669560587,0.2059659090909091,0.5715554157002198,1.0,6/36,10.39%,ST3GAL4;PRKCE;CLDN1;ADRA2A;ARFGEF1;ANXA1
prerank,response to glucagon (GO:0033762),0.523036112075698,1.2379498372879372,0.2231012658227848,0.5712364520712688,1.0,6/19,12.62%,CYSLTR2;CREB1;CRY1;PRKAR2A;ADCY7;ADCY5
prerank,heterochromatin assembly (GO:0031507),0.5067926705028566,1.2375695884492737,0.20806451612903226,0.5715666337917105,1.0,8/20,18.05%,H3-3A;SMCHD1;EZH1;MBD2;BAZ2A;RRP8;SIRT1;HDAC1
prerank,regulation of viral genome replication (GO:0045069),0.437549937005752,1.2372187982482,0.17091836734693877,0.5718495567733056,1.0,10/56,7.21%,ZC3HAV1;OAS2;PLSCR1;EIF2AK2;SLPI;FAM111A;STAU1;IFIH1;OASL;PKN2
prerank,negative regulation of cell communication (GO:0010648),0.516456525966778,1.2371289763862547,0.2111801242236025,0.5714203144841696,1.0,3/21,10.51%,IL1B;OPRM1;PTPN1
prerank,T cell mediated immunity (GO:0002456),0.5621868711835771,1.2371131263286077,0.22333333333333333,0.5707973954331086,1.0,2/13,6.89%,MYO1G;GNL1
prerank,BMP signaling pathway (GO:0030509),0.42898034411860547,1.2371078820357129,0.17843388960205392,0.5701623270681855,1.0,10/62,9.94%,RUNX2;BMPR2;SCX;GDF1;HIVEP1;PDCD4;ENG;ACVR2A;USP15;SMAD4
prerank,cellular component maintenance (GO:0043954),0.5761030958247004,1.2370147126672295,0.22296173044925124,0.5697398489846657,1.0,7/12,20.04%,FYN;CLDN1;PRNP;ITGA3;INSR;MTMR2;SUPV3L1
prerank,positive regulation of mononuclear cell migration (GO:0071677),0.4864350684193321,1.2366788080742055,0.20178041543026706,0.5699612071658307,1.0,3/29,3.59%,CCR2;CCR1;CXCL10
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.380275986085937,1.2357045182836073,0.1191827468785471,0.5717649078909923,1.0,28/145,13.12%,GPR132;SDCCAG8;DTL;CNTRL;PSME3;HAUS8;RCC2;PSMB7;PSME2;CCND1;CEP63;PAFAH1B1;MECP2;HAUS1;AVEN;PSME4;DCTN3;PSMB8;PSMA5;PSMD9;CEP250;PSMB3;PSMD6;PSMC4;DYNC1H1;PSMD10;PSMB1;HAUS3
prerank,regulation of blood circulation (GO:1903522),0.45886635880864934,1.2356421061106542,0.19941775836972345,0.5712599034252307,1.0,5/34,11.05%,ACE;ACE2;KCNQ1;CELF2;DMPK
prerank,regulation of cell population proliferation (GO:0042127),0.3573327035813402,1.2338199121344937,0.014,0.5752948869268472,1.0,127/691,15.99%,DPP4;CBFA2T3;IL1B;GRK5;RARA;IFNLR1;TIAM1;SGK3;HCK;STAT4;LYN;CD47;GLI1;NGF;FLT3;CDK13;KLF4;ITGAX;ACER3;TBC1D8;STAT5A;PTPRU;BCL6;PAK1;ACE2;FGF5;FGF22;JAK2;STAT3;HSPA1A;CUL3;BTG2;BMPR2;RAPGEF2;FABP7;BIRC6;CXCL10;PTPN6;STAT5B;CCDC88A;ABI1;EIF2AK2;SCX;IL6R;GDNF;DLC1;VEGFC;BTG1;ADRA2A;PPP1R9B;RBBP4;STAT1;TNS2;KCNH1;GLMN;PTEN;CDKN2C;KLF10;PTK2B;ADAM17;CIB1;MECP2;CNOT6;SULT2B1;NOX1;RARG;LMNA;DOT1L;ENG;CACUL1;CTCF;IL6ST;IL6;IFI35;RHOA;OPRM1;ID2;TRIM71;PGF;CSNK2A1;RPRD1B;FN1;IL31RA;ARID2;GLP2R;MCTS1;S100A11;NAP1L1;REST;SLC25A5;APP;NUPR2;UTP20;SH3BP4;PDGFD;PPM1D;NF2;CCND2;LIFR;AKT1;KIT;STAT2;JUNB;HCLS1;EZH2;GNAI2;CD164;KAT2B;RPS6KA2;TGFB1;COX17;FGFR3;PTPRJ;PPP2R5C;MAZ;RHOG;XIAP;RELA;RPS15A;THBS1;CELF1;CDCA7L;DUSP22;RNF41;RPS4X;APC;BRD7
prerank,regulation of epithelial cell differentiation (GO:0030856),-0.4486393473179663,-1.2337890957670248,0.20365535248041775,0.7090381813492168,1.0,6/17,28.43%,MAFG;KLF7;AJAP1;CD24;MAFF;CAV1
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),0.5679174028310405,1.2337727820896376,0.23580034423407917,0.5747556008394082,1.0,2/11,2.59%,KCNE3;NEDD4L
prerank,synaptic vesicle endocytosis (GO:0048488),-0.3836662262910588,-1.2336943757030159,0.15488215488215487,0.7070448065938887,1.0,9/33,13.30%,OPHN1;SYT1;NLGN1;ITSN1;DNM1;CDK5;STX1A;DNAJC6;NLGN2
prerank,relaxation of cardiac muscle (GO:0055119),-0.48540559601590305,-1.2336798403629818,0.21359223300970873,0.7048221034097785,1.0,5/13,7.62%,SLC8A1;KCNJ2;ATP1B1;P2RX4;ATP1A2
prerank,synaptic vesicle exocytosis (GO:0016079),-0.3610074711740334,-1.2335675236079642,0.15384615384615385,0.7029661254804073,1.0,17/40,23.53%,SYT1;PCLO;STX2;SNAP25;SYT7;CDK5;SNPH;STX1A;CPLX1;RIMS1;STX1B;RIMS3;RAB3A;SNAP29;CPLX2;SYT8;BLOC1S6
prerank,mismatch repair (GO:0006298),0.4745787061002525,1.2333735156843437,0.17553956834532375,0.5751472533184303,1.0,11/27,16.82%,MLH1;POLD4;MSH3;MSH6;TDG;SETD2;RPA3;RNASEH2A;MCM9;PMS1;POLD1
prerank,positive regulation of lamellipodium organization (GO:1902745),0.47958709077670025,1.2331103191206112,0.19096209912536444,0.5751952314960708,1.0,9/32,10.64%,ACTR3;WASF2;RAC2;CDC42;CARMIL1;ACTR2;RAC1;ARPC2;PIK3CA
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),-0.4275837274926777,-1.2329607177993154,0.20710059171597633,0.7024750543937983,1.0,8/21,18.89%,IGF1;FGF2;FOXJ2;P2RY6;GJA1;IGFBP5;ADAMTS1;FGF9
prerank,cardiocyte differentiation (GO:0035051),0.5920130778579493,1.232716526032199,0.2537313432835821,0.5756123637647291,1.0,1/10,1.18%,SIK1
prerank,regulation of megakaryocyte differentiation (GO:0045652),0.4377516855616912,1.2326601121093115,0.19143576826196473,0.5750829687494109,1.0,19/49,21.35%,NFE2;H3-3A;RAB7B;KMT2C;CBFB;CIB1;RBM15;TNRC6B;KAT2B;TNRC6A;KMT2E;KMT2A;THBS1;ASH2L;HDAC1;WDR5;RUNX1;MTURN;RBBP5
prerank,negative regulation of response to external stimulus (GO:0032102),0.3983034472124305,1.2326412875382893,0.13028169014084506,0.5744743766344587,1.0,13/105,5.92%,FFAR4;KLF4;CASK;PPARG;ITCH;METRNL;CRK;DHX58;PTGIS;PTGER4;INPP5F;SMPDL3B;PTEN
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),0.4740640353807604,1.232628665393586,0.20539730134932535,0.5738537665261536,1.0,13/29,22.84%,SAMHD1;PTPN6;YTHDF3;PTPN1;CACTIN;STAT2;METTL3;IFNAR2;ABCE1;TTLL12;MUL1;PTPN2;UBE2K
prerank,stem cell differentiation (GO:0048863),0.45742200778079933,1.2325416635316124,0.20583941605839415,0.5734406296343691,1.0,3/39,1.25%,PTPRC;JARID2;ACE
prerank,positive regulation of cell-matrix adhesion (GO:0001954),0.45378293936565106,1.2325409524194293,0.1778975741239892,0.5728014225979214,1.0,8/42,8.19%,RIN2;UTRN;CD36;PTK2B;PLEKHA2;CIB1;S100A10;RAC1
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),0.3856831390051213,1.232353314023856,0.14238042269187987,0.5726849254177047,1.0,42/148,16.36%,DNA2;RPL5;PIP4K2A;PRKAG2;RBBP8;TAF13;TAF9;MRE11;RBBP4;HIPK2;HEXIM1;MAPK14;HIPK1;PRKAB2;PDPK1;WRN;RPF2;BRIP1;KAT6A;CSNK2A2;CSNK2A1;PIP4K2B;DAXX;PRKAG1;ING2;PRKAA1;TAF7;RPA3;RPL11;AKT1;CHD4;PRKAA2;MAPKAP1;PPP2R5C;AURKB;USP7;PHF20;TAF1;DYRK2;BRD7;PRR5;HUS1
prerank,tricarboxylic acid metabolic process (GO:0072350),0.5695898338491862,1.2319980542334643,0.2356020942408377,0.5730427581276237,1.0,5/12,15.00%,IDH1;GLUD1;IREB2;SIRT4;ASS1
prerank,negative regulation of focal adhesion assembly (GO:0051895),0.5297029518606081,1.2318948751066268,0.23557692307692307,0.5720367873568661,1.0,8/16,16.87%,RCC2;DLC1;PTEN;PHLDB2;BCAS3;THBS1;DUSP22;ARHGAP6
prerank,negative regulation of cell-substrate junction organization (GO:0150118),0.5297029518606081,1.2318948751066268,0.23557692307692307,0.5720367873568661,1.0,8/16,16.87%,RCC2;DLC1;PTEN;PHLDB2;BCAS3;THBS1;DUSP22;ARHGAP6
prerank,ATP synthesis coupled proton transport (GO:0015986),-0.4587128870539072,-1.2315607592969386,0.20100502512562815,0.7042726782350235,1.0,8/17,15.43%,ATP5F1A;ATP5PO;ATP5MG;ATP5PD;ATP5PF;STOML2;ATP5F1D;ATP5MC3
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.5436799515164706,1.2314197927843191,0.22698412698412698,0.5726265179980355,1.0,6/15,16.00%,BTG2;EIF4ENIF1;TNRC6B;TNRC6A;TENT4B;PABPC1
prerank,transport across blood-brain barrier (GO:0150104),-0.3134114533589335,-1.2314136816123833,0.11299435028248588,0.7025331911779163,1.0,18/83,12.90%,SLCO2B1;SLC24A3;LRP1;ABCC3;SLC1A3;ABCG2;SLC7A1;ATP8A1;SLC2A3;FABP5;SLC27A1;ATP1A2;TFRC;SLC22A5;SLC7A2;SLC29A1;SLC7A8;SLC15A2
prerank,regulation of filopodium assembly (GO:0051489),-0.35863406401169917,-1.2313545179078,0.17905405405405406,0.7004536661443066,1.0,15/38,15.16%,NRP1;NLGN1;TENM2;MYO10;RHOQ;FXR1;GPM6A;PIK3R1;FXR2;RALA;DPYSL3;TRPM2;AGRN;PALM;TENM1
prerank,peptidyl-threonine phosphorylation (GO:0018107),0.42855265777643764,1.2310007021521683,0.18123393316195371,0.5730425114089915,1.0,20/59,15.88%,LRRK2;LMTK2;HIPK2;HIPK1;PDPK1;DYRK1A;TNKS;OXSR1;CSNK2A2;CSNK2A1;NLK;CAD;MAPK8;AKT1;STK39;ROCK1;MAPK1;TAF1;TBK1;DYRK2
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.42547687680816226,1.230677779387354,0.17647058823529413,0.5732279342893873,1.0,18/54,14.82%,TRAF1;SYK;HSPA1A;LAPTM5;IKBKB;BIRC3;HIPK1;ADAM17;CARD16;SPATA2;SPPL2A;CPNE1;CYLD;RIPK1;RNF31;CLIP3;GPS2;GSTP1
prerank,positive regulation of ossification (GO:0045778),-0.36181814097676185,-1.2304285307745353,0.1732283464566929,0.7011841562339359,1.0,14/39,16.72%,SLC8A1;MEF2C;NELL1;PTN;TMEM119;P2RX7;ACVR1;ACVR2B;TGFB2;BMPR1B;PKDCC;BMP6;ADGRV1;SOX11
prerank,intracellular protein transmembrane transport (GO:0065002),0.44354756901170844,1.2302538850916112,0.18604651162790697,0.5736897610556254,1.0,11/42,11.17%,C2CD5;PEX16;PEX12;GRPEL2;RTN2;DNAJC19;TIMM21;PEX14;SEC63;TOMM40;AIFM1
prerank,cellular sodium ion homeostasis (GO:0006883),-0.47808659117770413,-1.2300554123889038,0.20155038759689922,0.7001655467227443,1.0,4/15,7.62%,SLC8A1;ATP1B3;ATP1B1;ATP1A2
prerank,positive regulation of epithelial cell differentiation (GO:0030858),0.5346741421459541,1.2299452878953534,0.22429906542056074,0.5738531255568591,1.0,4/17,7.77%,FOXJ1;RFX3;BTG1;SULT2B1
prerank,protein complex oligomerization (GO:0051259),0.4086785620928031,1.2297747012315823,0.16971916971916973,0.5736794035496066,1.0,19/85,14.89%,CARD11;LRRC8C;CLDN1;UPB1;LRRC8D;RNF213;PRMT8;PDCD6IP;SPAST;ATL3;NLRC4;NUDT21;LETM1;DNM1L;YME1L1;PNPT1;CUTC;EHD1;ATL1
prerank,central nervous system neuron axonogenesis (GO:0021955),0.5629071187565237,1.2297157514095172,0.23460898502495842,0.5732169777400596,1.0,4/12,8.43%,B4GALT5;PTEN;MYCBP2;EPHB2
prerank,positive regulation of phagocytosis (GO:0050766),0.44239746297408117,1.2294577209062063,0.1989100817438692,0.573221116091931,1.0,6/47,1.56%,PTPRC;IL1B;CD47;STAP1;DOCK2;CAMK1D
prerank,cellular response to amyloid-beta (GO:1904646),0.4589378176447623,1.2290642156548603,0.19599427753934193,0.5736080177156248,1.0,11/35,12.09%,ITGA4;NGFR;FYN;CACNA1A;CD36;PRNP;CACNB1;ABCC1;ICAM1;FCGR2B;APP
prerank,cellular amino acid catabolic process (GO:0009063),0.40040257498906695,1.228980106297087,0.15878787878787878,0.5732019764209628,1.0,23/87,18.37%,KMO;KYNU;HGD;HIBADH;HAAO;DLD;BCKDHA;KYAT1;MTRR;BCKDHB;GLUD1;CARNS1;ACAT1;OGDH;GCSH;HIBCH;AMT;BCAT1;SARDH;DDAH1;AUH;HMGCLL1;SHMT1
prerank,heme catabolic process (GO:0042167),-0.48436612431613724,-1.2283878906368002,0.21241050119331742,0.7009084312928601,1.0,3/14,4.06%,SLCO2B1;ABCG2;BLVRB
prerank,porphyrin-containing compound catabolic process (GO:0006787),-0.48436612431613724,-1.2283878906368002,0.21241050119331742,0.7009084312928601,1.0,3/14,4.06%,SLCO2B1;ABCG2;BLVRB
prerank,carboxylic acid metabolic process (GO:0019752),0.46894538623751386,1.228224886311008,0.21285714285714286,0.5744788535450125,1.0,9/33,15.17%,ST3GAL1;SLC23A2;SLC23A1;PTGIS;GLUD1;SIRT4;GNE;CSGALNACT1;SLC2A1
prerank,cellular calcium ion homeostasis (GO:0006874),0.3842750363992527,1.228172303454852,0.14365256124721604,0.5739743638871686,1.0,25/133,12.87%,CCR2;CD40;CCR1;PDZD8;MCUB;NPTN;SLC8B1;ATP2B1;ATP2A3;MAIP1;CAV2;STIM2;WFS1;ATP2A1;SLC30A1;DMPK;CALB2;LETM1;TMEM203;FKBP1B;ATP13A3;SLC10A7;PACS2;SLC24A4;MICU3
prerank,regulation of cardiac muscle cell action potential (GO:0098901),-0.3998738568626165,-1.2280162000937713,0.18823529411764706,0.6998685578071315,1.0,9/25,15.55%,CTNNA3;FGF13;CACNA1C;ATP2A2;ANK2;JUP;CALM1;CXADR;PKP2
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.4715876699554311,1.227738850821503,0.21865889212827988,0.5744231651241318,1.0,11/31,18.80%,FBXW7;AXIN1;DCUN1D1;PTEN;UBE2N;UBE2S;DCUN1D3;RPS2;FZR1;PIN1;PINK1
prerank,regulation of adenylate cyclase activity (GO:0045761),0.5016371517063096,1.227385783155368,0.1985185185185185,0.5746681015210344,1.0,1/22,0.04%,CCR2
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),-0.46128094898439154,-1.2269421811693402,0.20334261838440112,0.7009434790999816,1.0,3/15,1.56%,PRKN;IGF1;BCL2L1
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),0.40345288664754564,1.226834548403097,0.16448152562574495,0.5754507446787108,1.0,20/85,15.90%,CBFA2T3;LRRK2;HSPA1A;FBXW7;ANKIB1;SUMO1;ARIH1;RNF217;HECTD1;ELOB;COP1;ARIH2;ATXN3;SUMO2;RCHY1;PSMD10;PABIR1;VCP;TAF1;TMTC3
prerank,regulation of cell development (GO:0060284),0.45361146490455745,1.2268057889663355,0.21666666666666667,0.5749005996356592,1.0,8/36,13.17%,IL1B;NOTCH2;ADGRA2;CLOCK;HDAC9;SLAMF8;RHEB;AKT1
prerank,proteolysis (GO:0006508),0.36554708611063824,1.2267582731453897,0.10564853556485355,0.5743962314675951,1.0,45/252,13.94%,DPP4;NAPSA;CAPN13;ACE;RET;LNPEP;LONP1;RSPRY1;ATG4C;TINAGL1;MALT1;MMP1;FAM111A;OLR1;PRCP;SRGN;RNPEPL1;FAP;PARL;CAPN2;FBXW2;ADAM17;NEDD8;CPQ;HGF;SPPL2A;ACAN;CPNE1;LACTB;ADAM19;MBTPS1;CASP2;SENP6;RNPEP;ERMP1;PSMD6;PSMC4;CAPN7;ATG4D;BACE2;CASP7;PCSK5;ADAMTS12;YME1L1;CAPN6
prerank,cell differentiation in hindbrain (GO:0021533),-0.5176405590081194,-1.2265118833305213,0.21513002364066194,0.7001778117533675,1.0,3/11,6.92%,OPHN1;GRID2;FAIM2
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.4048180893086375,1.2262600069234342,0.1548780487804878,0.5750278271532704,1.0,29/85,19.82%,TIAM1;PSME3;CELSR1;PSMB7;CDC42;PSME2;AP2A2;RAC1;PSME4;RHOA;PSMB8;PSMA5;PSMD9;PSMB3;AP2B1;PSMD6;PSMC4;DVL3;PSMD10;PSMB1;DVL2;AP2S1;PSMD12;WNT7A;VANGL1;SMURF2;FZD7;FZD3;PSMF1
prerank,positive regulation of organelle assembly (GO:1902117),0.4447657707706553,1.2256968492895932,0.20972222222222223,0.5757925615845686,1.0,11/44,12.05%,LCP1;PIP4K2A;CCDC88A;CNOT6;PDCD6IP;RALB;CNOT2;PIP4K2B;TAPT1;DYNC1H1;HTT
prerank,regulation of lipid biosynthetic process (GO:0046890),0.468681490216105,1.2256234303562563,0.21022727272727273,0.5753322151197265,1.0,8/32,13.78%,CREB1;PRKAG2;ZBTB20;PRKAB2;CREBL2;AKT1;PRKAA2;SIRT4
prerank,regulation of synapse assembly (GO:0051963),-0.3485884984667901,-1.2255710202270071,0.145748987854251,0.7008681484724439,1.0,21/46,24.01%,MEF2C;PTPRD;IL1RAPL1;NLGN1;ROBO2;GRID2;VPS35;GPC6;IL1RAP;SLIT1;NLGN2;CLSTN2;EIF4G1;SLITRK1;NLGN3;LHFPL4;NRXN1;DLG5;CUX2;GPC4;SLITRK3
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),-0.44721766877892344,-1.225505391783224,0.18384401114206128,0.6988830368424253,1.0,9/19,13.29%,BIN1;APOE;IGF1;NTRK2;RTN3;GGA3;CHRNA7;CLU;ABCA7
prerank,pre-replicative complex assembly (GO:0036388),0.41925147500462995,1.2246839086189845,0.18604651162790697,0.5771503406610421,1.0,16/64,12.96%,PSME3;PSMB7;PSME2;ORC5;MCM6;ORC4;PSME4;PSMB8;PSMA5;PSMD9;PSMB3;PSMD6;PSMC4;PSMD10;MCM2;PSMB1
prerank,negative regulation of phosphate metabolic process (GO:0045936),0.4978022141777735,1.2245306599520305,0.20757575757575758,0.576942536568719,1.0,6/22,17.17%,STAP1;PRKRIP1;CDKN2C;ANKLE2;ROCK1;SIRT1
prerank,negative regulation of signal transduction (GO:0009968),0.365237599719207,1.224495789340059,0.10819327731092437,0.5764068341838509,1.0,50/249,16.84%,LRRK2;PID1;PTPRC;IL1B;LYN;CD47;PIP4K2A;SULF2;PTPRE;HERC4;NOTUM;RGS2;CRY1;SMPDL3B;GPC3;FBXW7;APCDD1;PTPN12;TNS2;PTEN;DDIT4;CARD16;WWP2;CSNK2A2;CSNK2A1;PIP4K2B;PTPN1;CACTIN;NLK;NTN1;RGS14;OTUD4;AKT1;METTL3;TLE1;ADAMTS12;EZH2;TAX1BP3;CNMD;VCP;PTPRJ;GPS2;MAZ;TSPAN15;THBS1;IRAK3;RPS6KB1;RB1;MTMR2;NIBAN2
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",0.49156622748911954,1.2244665818447988,0.22171945701357465,0.5758582678086833,1.0,11/25,19.71%,PRPF6;DBR1;SRSF10;PRPF3;SRSF4;SLU7;DDX23;TXNL4A;SF3B3;SF3B1;SMNDC1
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),-0.4045583874183408,-1.2244101459045444,0.17065868263473055,0.700035140751259,1.0,5/26,7.75%,CACNA1D;ATP1B3;ATP1B1;ANK2;NETO1
prerank,phospholipid homeostasis (GO:0055091),-0.5159571880207269,-1.2242262717072798,0.24056603773584906,0.6985316434328102,1.0,1/11,0.18%,ABCA1
prerank,ERAD pathway (GO:0036503),-0.31537852185019494,-1.2240311204945324,0.10215053763440861,0.6970001377739151,1.0,28/83,21.94%,PRKN;ECPAS;STUB1;ERLIN2;DERL2;CCDC47;HSP90B1;AUP1;NPLOC4;USP19;RNF121;DNAJB2;SGTB;DERL1;TRIM13;ANKZF1;RNF103;HERPUD1;TMUB2;RNF139;GET4;FAM8A1;UBQLN2;DNAJB9;UBE2G2;SEC61B;BRSK2;FBXO44
prerank,negative regulation of cation channel activity (GO:2001258),0.48525776834106005,1.223807546561319,0.22366522366522368,0.5769038146413067,1.0,5/26,14.60%,KCNE3;GPR35;EPHB2;FKBP1B;SLC6A9
prerank,positive regulation of interleukin-1 beta production (GO:0032731),0.43285452344939596,1.223659577305667,0.18533333333333332,0.5766745685385537,1.0,11/45,14.98%,JAK2;STAT3;CD36;MALT1;TRIM16;IL6;NLRC4;NLRP3;APP;GBP5;MYD88
prerank,positive regulation of keratinocyte differentiation (GO:0045618),0.5815485039794323,1.2234762560257073,0.2535211267605634,0.5764952877226747,1.0,5/10,18.10%,PRKCH;NCOA3;TRIM16;MED1;FOXC1
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),-0.4347680015024362,-1.2226777149579309,0.208,0.698945475414314,1.0,6/19,6.22%,MEF2C;ERBB4;TGFBR1;VGLL4;FGF2;FGFR2
prerank,regulation of sensory perception of pain (GO:0051930),-0.512222356739862,-1.2225481273638084,0.22033898305084745,0.6972493554742162,1.0,4/11,19.93%,MGLL;ZFHX2;CCL3;TMEM100
prerank,icosanoid secretion (GO:0032309),0.5777171650110235,1.2220251626096954,0.24479166666666666,0.5795252241130484,1.0,3/12,11.59%,ACE;ANXA1;ABCC4
prerank,miRNA metabolic process (GO:0010586),0.5142215073046166,1.2218452990527682,0.22929936305732485,0.5793207197222298,1.0,6/20,14.80%,SND1;XPO5;DGCR8;TRIM71;TUT7;TENT4B
prerank,regulation of cell communication by electrical coupling (GO:0010649),-0.4772537701120532,-1.221785013814622,0.21148825065274152,0.697417406808895,1.0,5/13,34.73%,SLC8A1;CALM1;CAV1;PDE4D;CALM2
prerank,positive regulation of stress fiber assembly (GO:0051496),0.4422205082779086,1.221548730961206,0.2058432934926959,0.5793782118539289,1.0,10/44,8.94%,CD47;PAK1;ARHGEF10L;CCDC88A;CDC42;CARMIL1;S100A10;RAC1;PXN;RHOA
prerank,very-low-density lipoprotein particle assembly (GO:0034379),-0.5062510501971033,-1.221269252046663,0.2283653846153846,0.6968212349304455,1.0,8/12,31.81%,MTTP;P4HB;APOC4;APOC1;DGAT1;SOAT2;ACSL3;LPCAT3
prerank,positive regulation of cation channel activity (GO:2001259),0.4535917904757883,1.2212489447770754,0.19615912208504802,0.5795094651405966,1.0,1/40,0.04%,CCR2
prerank,regulation of primary metabolic process (GO:0080090),0.38417057338022154,1.2212240912577326,0.14475138121546963,0.5789291224694804,1.0,37/126,16.93%,PPARG;LDLR;PSME3;TBL1XR1;PSMB7;PSME2;HELZ2;PRKAB2;AZIN1;PSAP;PSME4;ELOVL6;NFYC;ID2;NCOA2;LACTB;PSMB8;OPA3;PSMA5;PSMD9;NCOA1;IDI1;FDPS;PSMB3;PSMD6;PSMC4;NFYA;PSMD10;PSMB1;SREBF2;HDAC3;GPS2;CREBBP;MED1;PSMD12;MVD;MVK
prerank,pre-miRNA processing (GO:0031054),-0.46832854738608787,-1.2211788725189758,0.2367758186397985,0.6949971701857545,1.0,5/14,18.79%,AGO3;AGO1;ADAR;DROSHA;LIN28B
prerank,retinoic acid metabolic process (GO:0042573),-0.49196383726770476,-1.2209489405907954,0.22527472527472528,0.6936471792423852,1.0,11/14,50.83%,BCO2;SCPEP1;ALDH1A2;CYP26B1;CYP26C1;ALDH1A3;ALDH8A1;CYP2S1;UGT1A1;UGT1A7;UGT1A8
prerank,detection of visible light (GO:0009584),0.533062690679265,1.220932030806969,0.2427843803056027,0.5790253158082256,1.0,3/16,14.71%,CEP250;PDE6B;GNA11
prerank,sodium ion homeostasis (GO:0055078),-0.43023918255937144,-1.2209199563227817,0.18786127167630057,0.691640091326882,1.0,4/21,7.62%,SLC8A1;ATP1B3;ATP1B1;ATP1A2
prerank,endoplasmic reticulum organization (GO:0007029),0.4103121627971078,1.220819361032122,0.17417783191230207,0.578701834458101,1.0,19/72,15.93%,LRRK2;SHTN1;TMCC1;CAV2;PRNP;TRAM2;TRAM1;STX5;ATL3;LMAN2L;RTN4;SPTSSB;APP;DNM1L;EIF2AK3;UBE2J2;ATL1;VCPIP1;VAPA
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.5010126903235061,1.2207883851564785,0.23100303951367782,0.5781658054742015,1.0,7/22,12.96%,PSMB7;NFE2L2;PSME4;PSMB8;PSMA5;PSMB3;PSMB1
prerank,regulation of urine volume (GO:0035809),-0.5337202913359336,-1.220639153191586,0.25121951219512195,0.690468738994024,1.0,7/10,45.91%,NPR3;ADCY6;HAS2;NPR1;TFAP2B;HYAL2;ADM
prerank,regulation of sequestering of triglyceride (GO:0010889),-0.45960613440174286,-1.2200299277023727,0.21204188481675393,0.6902131986652221,1.0,3/15,2.20%,TREM2;OSBPL11;OSBPL8
prerank,positive regulation of neuroblast proliferation (GO:0002052),-0.5317076339449202,-1.2193360265437556,0.22588235294117648,0.690296338121537,1.0,4/10,14.94%,CX3CR1;CTNNB1;VEGFA;CX3CL1
prerank,regulation of DNA replication (GO:0006275),0.42771729623398747,1.219331507272315,0.18977119784656796,0.5812691820101924,1.0,7/49,5.79%,DNA2;GLI1;ANKRD17;CCDC88A;KAT7;ORC5;FAF1
prerank,rRNA catabolic process (GO:0016075),-0.45962232006798165,-1.2186582060143734,0.21428571428571427,0.6903369643885185,1.0,6/16,19.78%,XRN1;TRIR;EXOSC9;EXOSC5;EXOSC10;EXOSC3
prerank,clathrin coat assembly (GO:0048268),0.545485614577154,1.2182819960263738,0.25588697017268447,0.5833530640639046,1.0,4/15,9.45%,PIK3C2A;EPS15;PICALM;HIP1
prerank,histone deubiquitination (GO:0016578),0.511395580041547,1.2180611459002655,0.26066350710900477,0.583314356985614,1.0,6/18,14.86%,USP3;USP49;ATXN7;UIMC1;USP15;USP7
prerank,negative regulation of fatty acid metabolic process (GO:0045922),-0.4593032828308189,-1.2178752351686482,0.2210242587601078,0.6905688723718267,1.0,6/16,18.03%,APPL2;ERLIN2;WDTC1;APOC1;BRCA1;ACADL
prerank,positive regulation of histone modification (GO:0031058),0.46535987046863425,1.217788233901374,0.2109704641350211,0.5834328572753762,1.0,7/33,11.12%,IL1B;NIPBL;RPS6KA5;UBE2N;FAM47E;TADA2A;ING2
prerank,regulation of granulocyte chemotaxis (GO:0071622),-0.42741420529041974,-1.2176494661029318,0.18867924528301888,0.6891494230727505,1.0,6/19,13.69%,CSF1R;CMKLR1;CSF1;AKIRIN1;JAM3;MDK
prerank,negative regulation of gene expression (GO:0010629),0.36176828759951707,1.2173899782607156,0.09285714285714286,0.5837982064977183,1.0,80/302,17.17%,FFAR4;JARID2;FOXP1;ZC3H12D;NOTCH2;PTPN22;KLF4;DAPK1;PTBP3;CCR1;NFKB1;HSPA1A;ERN1;BTG2;REL;NPTN;SPI1;PTGER4;EIF2AK2;ATP2B1;PICALM;FBXW7;H3-3A;RBBP4;SRGN;RPS6KA5;TIPARP;PHF19;PARP14;GIGYF2;SETDB2;DCP2;MECP2;ENG;LSM5;MRPL13;HDAC9;ZFP36L2;CPNE1;ID2;WWP2;OLFM1;TRIM71;PARP9;RPS3;IGF2BP3;PRKAA1;FCGR2B;PAIP2;REST;APP;PPM1D;EIF4ENIF1;EIF2AK3;METTL3;EZH2;RNH1;TNRC6B;PRKAA2;PNPT1;CITED2;KAT2B;TNRC6A;TGFB1;SYNCRIP;OCLN;TAF1;ZNF148;CELF1;SNX12;PTBP2;PPHLN1;RBL2;MYADM;RB1;DAPK3;CNOT8;PSEN1;CAPRIN1;SIRT1
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.4067241158400319,1.2171984782615233,0.17554479418886199,0.5836500316001727,1.0,17/78,14.18%,CBFA2T3;LRRK2;HSPA1A;ANKIB1;SUMO1;ARIH1;RNF217;HECTD1;NFE2L2;ELOB;COP1;ARIH2;SUMO2;RCHY1;PSMD10;PABIR1;VCP
prerank,negative regulation of interferon-gamma production (GO:0032689),0.4956069381239365,1.216637669238401,0.2280431432973806,0.5844133385227048,1.0,4/23,6.34%,RARA;LILRB1;LAPTM5;PRNP
prerank,regulation of histone methylation (GO:0031060),0.5455609460882679,1.216290042982436,0.2495755517826825,0.5846771097808915,1.0,2/13,5.97%,JARID2;FAM47E
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),0.3792956675390665,1.2156562572255454,0.16496018202502843,0.5857777437682261,1.0,40/129,20.12%,LRRK2;PSME3;NFKB1;CSNK1G1;TBL1XR1;PSMB7;GPC3;ZEB2;ADGRA2;RNF146;AXIN1;PSME2;UBR5;PSME4;CSNK1G3;TNKS;GSKIP;PSMB8;PSMA5;PSMD9;PSMB3;PSMD6;PSMC4;PSMD10;PSMB1;VCP;TGFB1;XIAP;LYPD6;USP47;PSMD12;DAPK3;LRRK1;KANK1;SMURF2;PIN1;FZD9;PSMF1;SCEL;USP8
prerank,mitochondrial fission (GO:0000266),-0.46253077509259716,-1.215586079797602,0.21818181818181817,0.693233018833379,1.0,5/16,14.29%,PRKN;GDAP1;MFF;DNM1;MTFR1L
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.3496030444339134,1.215325733834808,0.008,0.5859962578702205,1.0,233/1082,17.41%,CD74;CIITA;PLAC8;NFE2;PID1;IL1B;RUNX2;RARA;SP100;SP3;RUNX3;GLI1;TNIP3;HNF4G;ACTR3;BCL3;KLF4;CREB1;LILRB1;RET;MAP3K5;PPARG;IER2;CD40;PPP1R12A;NFKB1;PITX3;ATF7IP;TET2;FOSL2;PLSCR1;DTX3L;STAT3;EHF;NSD3;FOXJ1;ELF4;FOS;TCF20;RPS6KA3;BMPR2;MAD2L2;REL;AKNA;NCOA3;CXCL10;CRLF3;TAF9;SPI1;STAT5B;NFKBIA;NAA16;MYRF;SCX;ATAD2;TBL1XR1;PICALM;IKBKB;MED30;ZEB2;CAMTA2;KAT7;ATF6;RYBP;AXIN1;GDNF;ATF2;PPP3CA;IRF2;PRPF6;RFX3;RBPJ;IL33;WAC;HIVEP1;DEAF1;MED13;STAT1;HIPK2;RNF20;NUFIP1;KLF5;IRF4;FBXW11;HELZ2;RFX5;RPS6KA5;SMARCA5;ARF4;TRIM16;KMT2C;KLF10;CDC5L;SEC14L2;SETX;AHR;ACTR2;CREBRF;TADA3;NFE2L2;DYRK1A;PLCB1;AFAP1L2;THRA;CLOCK;MED6;ZBED4;RARG;TOX3;DOT1L;E2F2;ENG;GABPB1;GABPB2;CTCF;ACVR2A;ELF1;ELOF1;TLR3;HGF;IL6;SCAF8;KAT6A;TNKS;BCAS3;ID2;CREBL2;NAA15;NCOA2;E4F1;ZNF496;PARP9;IRF7;MEF2B;SMAD4;CAMKK2;SBNO2;RPRD1B;PSMD9;NCOA1;IL31RA;CSRNP1;NR3C1;RIPK1;PBX1;ING2;CCNT2;FOXO3;MED12;ZNF507;DVL3;TAF7;NLRP3;ETS2;REST;RPS6KA1;ATF6B;APP;MAP2K5;MED14;CCNT1;BCLAF3;NFYA;TFAM;TLR2;MAP2K3;TEAD1;ATRX;NFATC2IP;MYB;EIF2AK3;ZPR1;AKT1;NRIP1;NSD1;LBH;NCF1;JUNB;HCLS1;SREBF2;SMARCC2;CITED2;KAT2B;HDAC3;MRTFA;NFIL3;TGFB1;CRTC3;RSF1;FHOD1;IL18;GPS2;MAZ;KMT2E;GPATCH3;SERTAD3;RHOG;KMT2A;ASXL2;CREBBP;RELA;TBK1;DVL2;PHF5A;MAML1;INO80;ZMIZ2;MED1;ELF2;BRD7;HMGN1;ELL;WNT7A;IRF5;PAXBP1;BPTF;RAI1;HTATIP2;PROX1;NIBAN2;PSEN1;CREB3L4;CREB3;SMAD5;ELK4;FOXK1;PIK3R2;CHCHD2;SIRT1;SUPT4H1;ATF1;NR4A1;SS18
prerank,ureteric bud development (GO:0001657),-0.4465768169531183,-1.215138541986251,0.2032520325203252,0.6925852954794252,1.0,6/17,9.40%,SALL1;ROBO2;NPNT;PKD2;FGFR2;SLIT2
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),-0.46765244814605633,-1.2151255697465415,0.22305764411027568,0.6905897676018593,1.0,3/15,6.22%,TGFBR2;TGFBR1;FGFR2
prerank,photoperiodism (GO:0009648),0.4688550026733338,1.2146137377589925,0.2227204783258595,0.5871837877930332,1.0,11/28,15.58%,SIK1;CRY1;FBXL8;CRY2;CLOCK;ID2;FBXL17;PPP1CB;PDE6B;FBXL12;BHLHE40
prerank,regulation of B cell differentiation (GO:0045577),0.5171712543043616,1.2144518910158462,0.2418831168831169,0.5869992857455277,1.0,6/17,13.03%,SYK;IKZF3;ZFP36L2;ID2;SLAMF8;BTK
prerank,positive regulation of glucose import (GO:0046326),-0.41977480861721883,-1.214438777681561,0.20441988950276244,0.6906524190058652,1.0,5/21,10.54%,IGF1;OSBPL8;RHOQ;IRS1;PIK3R1
prerank,regulation of defense response to virus (GO:0050688),0.5435306154220763,1.2143431376375113,0.263986013986014,0.5866763687157676,1.0,3/14,7.45%,IFNLR1;ITCH;TRAF3
prerank,cellular response to estrogen stimulus (GO:0071391),0.5385813297826022,1.2142072919840141,0.2469775474956822,0.5864192611312168,1.0,3/14,9.13%,RARA;SERPINB9;BCAS3
prerank,"phototransduction, visible light (GO:0007603)",0.5371115707638119,1.2138484812839354,0.23202614379084968,0.586746126195509,1.0,4/14,21.15%,GNB1;PDE6B;GNA11;SAG
prerank,positive regulation of cardiocyte differentiation (GO:1905209),-0.5080998836103818,-1.2133873520250267,0.24153498871331827,0.6917203016175105,1.0,3/11,19.05%,MEF2C;TGFB2;EFNB2
prerank,regulation of protein export from nucleus (GO:0046825),0.48672529435400486,1.2131988455075766,0.2583732057416268,0.5877945323268601,1.0,4/23,8.99%,IL1B;SP100;XPO4;RBM22
prerank,phasic smooth muscle contraction (GO:0014821),0.5925444914630708,1.213171239833511,0.23642732049036777,0.5872407230407833,1.0,4/10,13.67%,HTR1D;GDNF;PTGER3;TIFAB
prerank,kinetochore organization (GO:0051383),-0.4839901990664669,-1.2126834230835029,0.2233502538071066,0.6918408810273581,1.0,12/13,40.20%,POGZ;CENPE;CENPA;CENPF;DLGAP5;CENPT;NDC80;MIS12;CENPH;CDT1;CENPW;NUF2
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),0.5051852289018233,1.2122423820167485,0.2558139534883721,0.5889370316279495,1.0,4/18,10.75%,LRRK2;RAP1A;SLC4A8;SNAPIN
prerank,regulation of amyloid-beta clearance (GO:1900221),-0.4433661443591672,-1.210980877290088,0.20476190476190476,0.6951735156792792,1.0,6/16,13.96%,APOE;TREM2;LRP1;CLU;ABCA7;CYP51A1
prerank,macromolecule catabolic process (GO:0009057),-0.39885585464307094,-1.2108516793382507,0.20833333333333334,0.6936336055634763,1.0,6/26,8.12%,LGMN;CAPN3;SNX25;TPP1;UCHL3;IDE
prerank,retrograde axonal transport (GO:0008090),-0.4520120537427803,-1.2105089464436392,0.2141057934508816,0.6926867601701028,1.0,5/16,8.14%,DST;DLG2;TMEM108;KIF1A;MAP1A
prerank,amino sugar metabolic process (GO:0006040),0.5814107991268828,1.2101822352224634,0.2795138888888889,0.5934771998145044,1.0,4/10,14.99%,ST3GAL1;GNE;SLC35A3;CSGALNACT1
prerank,collagen fibril organization (GO:0030199),-0.30234547531865547,-1.2099310180793725,0.08074534161490683,0.6924322171687851,1.0,34/88,30.35%,DST;P3H2;ITGA6;COL27A1;TGFBR1;NF1;P4HA1;COL15A1;LOXL3;LAMA3;P4HB;COL19A1;TGFB2;COL12A1;CRTAP;COL4A2;SERPINH1;ADAMTS2;COL23A1;PLOD3;PLEC;PLOD1;COLGALT1;CD151;COL11A2;COL26A1;ITGB4;COL6A2;COL24A1;COLGALT2;COL6A3;P3H4;COL4A6;P4HA3
prerank,base-excision repair (GO:0006284),0.4262948981307593,1.2097068659295969,0.20707732634338138,0.5940078851506831,1.0,14/48,16.82%,DNA2;POLL;FEN1;APEX2;POLD4;MBD4;WRN;SMUG1;TDG;PARG;RPA3;USP47;POLB;POLD1
prerank,regulation of proteasomal protein catabolic process (GO:0061136),-0.34039781493634813,-1.209418366619618,0.1589958158995816,0.6920635314263099,1.0,5/53,0.75%,OPHN1;PRKN;APOE;TREM2;GNA12
prerank,positive regulation of histone acetylation (GO:0035066),0.4887771300193735,1.2089575843709754,0.2308868501529052,0.5953195094524004,1.0,5/23,10.53%,IL1B;KAT7;RPS6KA5;SMAD4;TADA2A
prerank,neuropeptide signaling pathway (GO:0007218),0.4178205604258706,1.2085798825317073,0.19818652849740934,0.5956502836675878,1.0,6/58,9.06%,CYSLTR2;LTB4R;RAPGEF2;SORL1;CYSLTR1;OPRM1
prerank,phospholipid biosynthetic process (GO:0008654),0.4512933540952508,1.2085616397646988,0.22993197278911565,0.5950771651043402,1.0,11/36,16.43%,AGPAT4;SAMD8;SGMS1;SGMS2;CPNE1;FAR1;IDI1;FDPS;PIP5K1A;GNPAT;MVD
prerank,positive regulation by host of viral transcription (GO:0043923),-0.46951402928030656,-1.2081571883498698,0.22894736842105262,0.6940570574394131,1.0,11/15,34.32%,HPN;SMARCB1;SNW1;SP1;RRP1B;CHD1;TAF11;CTDP1;LEF1;TFAP4;SMARCA4
prerank,positive regulation of Wnt signaling pathway (GO:0030177),0.3713677822007256,1.2080999150516725,0.1583610188261351,0.5955790132668135,1.0,47/152,20.12%,LRRK2;SULF2;PSME3;NFKB1;RSPO2;CSNK1G1;RSPO3;TBL1XR1;PSMB7;GPC3;ZEB2;ADGRA2;RNF146;AXIN1;PSME2;UBR5;PSME4;CSNK1G3;TNKS;CSNK2A1;GSKIP;PSMB8;PSMA5;PSMD9;PSMB3;PSMD6;PSMC4;PSMD10;TLR2;PSMB1;VCP;TGFB1;XIAP;DISC1;LYPD6;USP47;PSMD12;DAPK3;LRRK1;KANK1;SMURF2;WNT5B;PIN1;FZD9;PSMF1;SCEL;USP8
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),0.5858893407889435,1.2080630660541185,0.2816399286987522,0.595055969521108,1.0,2/10,2.59%,PRKCE;NEDD4L
prerank,glycolytic process (GO:0006096),-0.3956548871197261,-1.208003590762215,0.16560509554140126,0.6925249517327232,1.0,13/28,28.60%,HK3;HK1;PFKL;PGK1;ENO2;PGAM1;PGAM4;PFKM;ENO3;LDHA;ALDOA;PFKFB1;GAPDHS
prerank,synapse assembly (GO:0007416),-0.3211463968992801,-1.2080006981141944,0.11165048543689321,0.690565990045478,1.0,19/67,17.13%,NLGN1;FGF13;LRRTM3;PLXNB2;NRXN2;GABRG2;GRID2;RYK;SDK1;LGI2;GPM6A;CDK5;NLGN2;ADGRL3;GABRB3;SLITRK1;KIRREL3;NLGN3;GABRA2
prerank,carbohydrate biosynthetic process (GO:0016051),0.5002640610995834,1.207986227467519,0.2383107088989442,0.5946263361770935,1.0,3/21,3.54%,ST3GAL4;FUT4;ST8SIA6
prerank,JNK cascade (GO:0007254),0.44411165196304675,1.2077661512007432,0.23076923076923078,0.594551984545849,1.0,14/40,17.53%,MAP3K5;SH2D3C;PTGER4;UBE2N;MINK1;ARHGEF6;MAP4K3;TAB3;MAP3K7;MAPK8;MAP3K13;GPS2;MAP2K4;TAB1
prerank,cytoplasmic microtubule organization (GO:0031122),-0.33371136948700525,-1.2072220701187937,0.12389380530973451,0.6910982125636624,1.0,19/54,15.45%,DST;CAMSAP1;NUMA1;TUBGCP5;VPS4B;CLIP1;PLK3;CLIP2;KATNAL1;FIGNL2;CEP126;FIGN;CAMSAP2;CHP1;TRPV4;HOOK1;CCDC88B;TUBGCP6;TPPP
prerank,mRNA export from nucleus (GO:0006406),-0.2959760215118484,-1.2070012482725567,0.0962962962962963,0.6898381211158254,1.0,35/102,19.43%,SRSF5;SRSF3;DDX39B;NUP54;RNPS1;NUP133;SRSF7;SYMPK;NUP155;ALKBH5;NUP188;UPF1;THOC5;DHX38;NXF1;DDX19B;RANBP2;DDX19A;ZC3H11A;SEC13;IWS1;SRSF2;DDX39A;NUP85;GLE1;NUP42;SMG7;TPR;NUP35;CASC3;SRSF1;MCM3AP;FYTTD1;HNRNPA2B1;NUP37
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),0.5386755075253491,1.206693307849183,0.2721311475409836,0.59676855243825,1.0,1/13,0.25%,PID1
prerank,positive regulation of leukocyte activation (GO:0002696),0.5073747715376086,1.2065250868363013,0.2282958199356913,0.5965721771293487,1.0,3/18,7.78%,CD226;IL33;CD2
prerank,DNA replication initiation (GO:0006270),0.4495954638571113,1.206464692770286,0.2315202231520223,0.5960859394259256,1.0,19/37,26.14%,CDC45;ORC5;MCM6;ORC4;RPA3;POLA2;MCM2;ORC6;LRWD1;ORC2;CDC34;NOC3L;POLE2;ORC1;DBF4;PRIM1;RPA1;MCM3;MCM7
prerank,outer dynein arm assembly (GO:0036158),0.5373233066554063,1.2063978737461238,0.22259136212624583,0.5956285723164688,1.0,3/14,11.62%,DNAH8;DNAAF5;ODAD1
prerank,artery morphogenesis (GO:0048844),-0.38225828435533715,-1.2063519840955768,0.20860927152317882,0.6897897882753409,1.0,6/30,4.15%,NRP1;TGFBR1;LRP1;PKD2;NF1;SMAD7
prerank,regulation of anatomical structure morphogenesis (GO:0022603),0.38387461059342826,1.2048224889070003,0.1693181818181818,0.5991254599871462,1.0,18/118,8.61%,LRRK2;PID1;SP100;CYRIB;PDLIM5;BCL6;PAK1;NEDD4L;PDZD8;LFNG;ADGRA2;GDNF;RC3H1;CAPZB;PAK2;PHLDB2;PLXND1;IL6
prerank,metanephric mesenchyme development (GO:0072075),-0.5191660944587267,-1.2047298108894324,0.24881516587677724,0.6927789878791362,1.0,2/10,3.42%,BASP1;PKD2
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.49321121677205726,1.2045211764714683,0.25149700598802394,0.5993002390900036,1.0,4/22,6.88%,LYN;IFNGR1;PICALM;GSAP
prerank,cellular response to thyroid hormone stimulus (GO:0097067),-0.48690779134014955,-1.2040622326897252,0.2517985611510791,0.6929911188145202,1.0,3/12,5.33%,CTSB;LMO2;THRB
prerank,energy derivation by oxidation of organic compounds (GO:0015980),0.4789727438974079,1.2038186785434628,0.23600605143721634,0.60051366106991,1.0,2/24,5.18%,PID1;SLC25A13
prerank,lamellipodium assembly (GO:0030032),0.4907010782677156,1.2037292960463057,0.2248062015503876,0.6001245179728738,1.0,6/26,9.69%,SRGAP2;PTPRO;CCDC88A;CARMIL1;RAC1;ARHGEF6
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),0.5173826071708818,1.2036069763579311,0.2431561996779388,0.5998357576726642,1.0,2/17,5.11%,NOTCH2;RBPJ
prerank,positive regulation of integrin activation (GO:0033625),-0.503908149739221,-1.203280327086437,0.24281984334203655,0.6934697287776832,1.0,4/11,16.72%,P2RY12;SKAP1;SRC;PLEK
prerank,sterol biosynthetic process (GO:0016126),0.4647654974341684,1.202832973748957,0.24647887323943662,0.601193577381036,1.0,11/33,18.92%,PRKAG2;HSD17B7;ACAA2;MSMO1;IDI1;FDPS;NSDHL;DHCR24;MVD;MVK;LBR
prerank,regulation of ossification (GO:0030278),-0.36388581829809347,-1.2028261622114376,0.18702290076335878,0.6929117264139646,1.0,9/36,7.87%,MEF2C;LRP6;ANKH;ENPP1;PTN;ACVR1;BMP2K;NBR1;S1PR1
prerank,negative regulation of oxidoreductase activity (GO:0051354),-0.5267791871204899,-1.2027078678440521,0.2534883720930233,0.6913621505785948,1.0,5/10,22.55%,PRKN;OXA1L;HDAC6;MT3;ETFBKMT
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.5037164112356128,1.2025737770929674,0.23882896764252695,0.6012075567724952,1.0,8/20,19.45%,RUNX2;RBPJ;NFE2L2;SMAD4;RELA;CREB3;SMAD5;CARF
prerank,defense response to bacterium (GO:0042742),0.3893612960093936,1.202060845275896,0.19098457888493475,0.6018928744866472,1.0,21/105,14.98%,FGR;OAS2;SYK;ANKRD17;SLPI;IL6R;SPN;TIRAP;ADAM17;TLR3;IL6;SLAMF8;NLRC4;MBL2;RNASE6;TLR2;RPL30;FCER1G;PLA2G6;GBP2;MYD88
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),-0.40527360935599316,-1.2016320490405907,0.209366391184573,0.6926990928949366,1.0,8/25,17.38%,WNK1;ATP1B3;ATP1B1;ANK2;WNK2;TCAF1;GLRX;ACTN2
prerank,negative regulation of endocytosis (GO:0045806),0.4805217463760434,1.2007141006902822,0.22865853658536586,0.6046982087774427,1.0,8/24,16.70%,LILRB1;CD300A;PICALM;RAC1;UNC119;LGALS3;SNX33;MTMR2
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.39882305909968785,1.2004950111529464,0.20446096654275092,0.6046564594057101,1.0,24/72,19.43%,FGR;LYN;FLT3;JAK2;PTPN6;CBL;HGF;FN1;PIK3CA;PDGFD;KIT;NCF1;HCLS1;HCST;IL18;UNC5B;MAZ;INSR;SEMA4D;SIRT1;BECN1;HAX1;PIK3R5;FGFR1
prerank,metanephros development (GO:0001656),-0.39400251684618126,-1.2001803719856599,0.2072072072072072,0.695042931708737,1.0,4/26,4.00%,BASP1;ROBO2;PKD2;NF1
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),-0.5070961366330355,-1.2000305897266912,0.2557544757033248,0.6935391750714552,1.0,2/11,2.21%,MERTK;GAS6
prerank,neuronal action potential (GO:0019228),-0.4094207004408548,-1.2000237745485074,0.2222222222222222,0.6916584659149482,1.0,5/22,14.98%,SCN1A;SCN3A;KCNMB2;KCNA2;KCNA1
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.39581140014943894,1.1993524513100629,0.21894218942189422,0.6069083771017533,1.0,17/76,12.26%,KLF4;ITCH;FOXJ1;PTGIS;ERBIN;SPI1;NFKBIA;FAF1;ANXA4;TRAF3;NFKBIB;CYLD;CACTIN;ACOD1;NLRP3;MAP2K5;PSMD10
prerank,regulation of RIG-I signaling pathway (GO:0039535),0.49837544396851496,1.199292994352224,0.25,0.6064587947991239,1.0,8/18,16.02%,DHX58;ANKRD17;BIRC3;OASL;PUM2;USP15;GPATCH3;PUM1
prerank,positive regulation of myeloid cell differentiation (GO:0045639),0.4557467032410778,1.1991467379330443,0.22268326417704012,0.606221915900607,1.0,8/33,11.42%,STAT3;HSPA1A;STAT5B;STAT1;RAB7B;MAPK14;ACVR2A;FOXO3
prerank,positive regulation of transmembrane transport (GO:0034764),0.5411860074366299,1.199104686779482,0.24433656957928804,0.6057047889130105,1.0,5/13,12.69%,C2CD5;ACSL5;AZIN1;BRAF;CLIP3
prerank,regulation of cell cycle (GO:0051726),0.3578320549820101,1.1990456935904101,0.11838006230529595,0.6052344432151003,1.0,67/271,16.73%,PTPRC;GRK5;RARA;IQGAP1;RUNX3;CDC14A;NOTCH2;SIK1;LILRB1;DTL;STAT3;ERN1;ANKRD17;SND1;CRLF3;BIRC3;PPP1R9B;RBBP4;HIPK2;RNF20;FBXL8;FAP;CDKN2C;CCND1;LIN52;PDCD4;AFAP1L2;MAPK12;GBF1;PPP1R15A;ID2;E4F1;CSNK2A2;CSNK2A1;RASSF1;RPRD1B;LIN37;CYLD;FBXL17;DUSP1;DCUN1D3;TXLNG;NUPR2;LIN9;NF2;MAP3K20;DHCR24;FBXL12;METTL3;JUNB;PCLAF;PNPT1;CITED2;KAT2B;RPS6KA2;TGFB1;UHRF2;RRP8;XIAP;RPS15A;THBS1;APC;PUM1;RB1;DAPK3;MAEA;PROX1
prerank,cellular protein-containing complex assembly (GO:0034622),0.3693102119083575,1.1989774507964832,0.15444444444444444,0.604774193044865,1.0,38/159,18.85%,TESPA1;TIAM1;UVRAG;STXBP6;LONP1;PIK3C2A;HSPA1A;EPS15;PICALM;CHMP4A;CHMP4B;AXIN1;NUP98;PXN;HIP1;SMAD4;RTN4;SNX9;IMMP2L;DNAJB12;AIFM1;SRP19;CCDC39;NUP153;POMP;TBCD;TGFB1;CENPC;AP2S1;TCP1;COX7A2;TRAF2;HSPD1;BBS10;CYBA;NUP93;NCK2;SHQ1
prerank,response to amyloid-beta (GO:1904645),0.4314078329866601,1.1986341405650751,0.22982216142270862,0.605017608298899,1.0,11/44,12.09%,ITGA4;NGFR;FYN;CACNA1A;CD36;PRNP;CACNB1;ABCC1;ICAM1;FCGR2B;APP
prerank,positive regulation of intracellular protein transport (GO:0090316),0.37158912323222,1.1981693141083976,0.15783540022547915,0.6055968449906235,1.0,40/144,19.13%,IL1B;TCAF2;FYN;C2CD5;MYO1C;SORL1;RAC2;FBXW7;BBC3;ITGB2;UBE2D3;XPO4;UBR5;PRNP;FLNA;CIB1;ARIH2;RBM22;BCAS3;CSNK2A2;FIS1;YWHAZ;RNF31;ZPR1;MAPK8;HCLS1;SREBF2;HDAC3;UBE2J2;TGFB1;RAB29;PSEN1;TMEM30A;PIK3R2;BAG3;ATG13;PRKCD;PINK1;BAD;KIF20B
prerank,positive regulation of apoptotic process (GO:0043065),0.35325348423491804,1.1973628653728274,0.11191709844559586,0.6070816310425431,1.0,59/293,13.15%,VAV3;TIAM1;ARHGEF18;NGF;SIK1;LILRB1;DAPK1;NGFR;MAP3K5;BCL6;TIAM2;STK17B;IFIT2;PTGIS;PHLDA1;SOS2;ATF6;RYBP;DLC1;BTG1;FGD4;FAF1;FAP;STK4;PRNP;PAWR;MTCH1;TNFAIP8;SAP18;RARG;FGD1;DUSP6;IL6;SOS1;FGD3;LATS1;ING3;OLFM1;PIDD1;ARHGEF6;RPS3;NLRC4;UBE2Z;CASP2;CALHM2;RIPK1;APAF1;AIFM1;NET1;LATS2;FOXO3;DCUN1D3;REST;HTT;CLIP3;DNM1L;MAP3K20;ERCC3;MAPK8
prerank,glycoprotein biosynthetic process (GO:0009101),0.40209665866783156,1.197241087781862,0.21706398996235884,0.6067912132839579,1.0,11/79,8.27%,ST8SIA4;ST3GAL4;ST8SIA1;BMPR2;FUT4;ST8SIA6;B4GALT5;CHST12;ATP7A;XYLT1;SERP2
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.4792492122226641,1.1972372415103931,0.23969465648854962,0.606190330369838,1.0,6/22,15.78%,MED30;MED13;MED12;PSMC4;MED14;MED1
prerank,mRNA transport (GO:0051028),-0.29273308699659234,-1.1968520299090695,0.12949640287769784,0.6994219295059705,1.0,34/101,19.43%,SRSF5;SRSF3;DDX39B;NUP54;RNPS1;NUP133;SRSF7;SYMPK;NUP155;ALKBH5;NUP188;KIF5C;UPF1;THOC5;DHX38;NXF1;DDX19B;RANBP2;ZC3H11A;SEC13;SRSF2;DDX39A;NUP85;GLE1;NUP42;SMG7;TPR;NUP35;CASC3;SRSF1;MCM3AP;FYTTD1;HNRNPA2B1;NUP37
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),0.3521592489305983,1.196781248312409,0.13270637408568442,0.6068346326385062,1.0,64/248,18.76%,LRRK2;LIMD1;GLI1;PTPRU;PTPRO;PSME3;NFKB1;CUL3;CCDC88C;SDHAF2;MAD2L2;NOTUM;CSNK1G1;TBL1XR1;PSMB7;GPC3;ZEB2;ADGRA2;RNF146;AXIN1;PSME2;CDK14;UBR5;TMEM131L;STK4;KREMEN1;PSME4;CSNK1G3;TNKS;LATS1;GSKIP;PSMB8;PSMA5;PSMD9;CYLD;PSMB3;LATS2;PSMD6;PSMC4;DVL3;PSMD10;PSMB1;LRP4;TLE1;VCP;TGFB1;INVS;XIAP;DVL2;APC;LYPD6;USP47;IGFBP6;PSMD12;DAPK3;KLHL12;PSEN1;LRRK1;KANK1;HDAC1;SMURF2;PIN1;FZD7;STK3
prerank,histone monoubiquitination (GO:0010390),0.48626390353132587,1.1965781514353058,0.24702380952380953,0.6067751426442513,1.0,5/24,5.34%,DTX3L;UBE2E1;RYBP;WAC;RNF20
prerank,negative regulation of cilium assembly (GO:1902018),-0.48511183180288936,-1.1962100476699926,0.2518891687657431,0.6994371255188412,1.0,7/12,28.32%,EVI5L;ODF2L;TCHP;CDK10;CEP97;TBC1D7;CCP110
prerank,response to amino acid starvation (GO:1990928),-0.3133455297882806,-1.1961349232860643,0.15469613259668508,0.6977398758136387,1.0,19/72,12.15%,LARP1;ATP6V1C1;RPTOR;ATP6V0B;FLCN;ATP6V0D2;ATP6V0C;TCIRG1;ATP6V1B2;SESN3;EIF2AK4;IMPACT;ATF4;LARS1;ATP6V1D;MIOS;ATP6V0D1;LAMTOR5;PRKD1
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),-0.4559431713158527,-1.1960862073358418,0.2182254196642686,0.696021672888716,1.0,6/15,21.33%,AAK1;SMAP1;BMP2K;SCYL2;UBQLN2;SNAP91
prerank,potassium ion transport (GO:0006813),-0.2863362650474299,-1.1959662764348669,0.08490566037735849,0.6944986504585039,1.0,21/120,10.51%,KCNMA1;KCNK13;SLC24A3;KCNQ5;KCND2;SLC1A3;KCNQ3;ATP1B3;PKD2;KCNJ2;SLC9A9;SLC9A6;KCNN2;ATP1A2;KCNMB2;HPN;KCNA2;KCNJ6;KCNK6;HCN1;HCN2
prerank,regulation of potassium ion transmembrane transport (GO:1901379),-0.33588359430011594,-1.1958368126295482,0.1888412017167382,0.6930274600040965,1.0,13/54,15.01%,CACNA1D;KCNMA1;BIN1;KCNJ2;CD63;KCNN2;DPP10;KCNMB2;AKAP6;KCNJ6;KCNN3;KCNJ9;GABBR1
prerank,necroptotic process (GO:0070266),0.5298325111281598,1.195446380145974,0.2478920741989882,0.6089993128350447,1.0,7/16,15.45%,ITPK1;TLR3;CYLD;RIPK1;PGAM5;DNM1L;IPMK
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),0.39669129828852245,1.1951275356506152,0.21894218942189422,0.6091841836430465,1.0,18/79,16.99%,CASK;SULF2;PPARG;BMPR2;SORL1;LEMD3;HIPK2;UBE2D3;ACVR2A;SMAD4;PTPN1;LEMD2;ADAMTS12;CNMD;VWC2L;THBS1;NIBAN2;SMAD5
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),-0.5254123166236282,-1.1950970304826498,0.2465753424657534,0.6933097912155567,1.0,3/10,1.35%,OPHN1;MYO9A;RAP2A
prerank,protein localization to mitochondrion (GO:0070585),0.5640553960335011,1.1947738264414491,0.2703180212014134,0.6094510760262394,1.0,2/11,5.27%,LRRK2;MAIP1
prerank,positive regulation of oxidoreductase activity (GO:0051353),0.50726914009816,1.1941992407654338,0.24878836833602586,0.6103187082285496,1.0,8/18,22.73%,GDNF;ATP7A;PDP2;ABL2;POR;PARK7;SIRT3;TNF
prerank,hydrogen peroxide metabolic process (GO:0042743),0.49862512412157545,1.1940646808243172,0.24096385542168675,0.6100755033752928,1.0,8/19,19.97%,GPX1;NOX1;PXDN;MAOB;PRDX5;CYBA;CAT;PARK7
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),-0.40861291254351423,-1.1939323878536205,0.24397590361445784,0.6950332501522173,1.0,9/22,21.23%,PKD2;ATP1B1;ANK2;P2RY6;AKAP6;CALM1;STAC2;GSTO1;RYR2
prerank,regulation of lipid metabolic process (GO:0019216),0.39278367463947683,1.193920374041601,0.1955241460541814,0.6098598364745871,1.0,23/88,16.93%,IL1B;PPARG;PRKAG2;TBL1XR1;HELZ2;PSAP;ELOVL6;NFYC;ID2;NCOA2;LACTB;OPA3;NCOA1;IDI1;FDPS;NFYA;SREBF2;HDAC3;GPS2;CREBBP;MED1;MVD;MVK
prerank,glycoprotein metabolic process (GO:0009100),0.4199160545557238,1.193798891865422,0.2002652519893899,0.6095385214492786,1.0,6/53,4.46%,ST8SIA4;ST3GAL4;ST8SIA1;ST8SIA6;B4GALT5;ERP44
prerank,cellular response to BMP stimulus (GO:0071773),0.40782498497146924,1.193751703039346,0.2075,0.6090438925874775,1.0,13/66,15.33%,RUNX2;BMPR2;SCX;GDF1;HIVEP1;PDCD4;ENG;ACVR2A;USP15;SMAD4;ADAMTS12;TGFB1;USP9X
prerank,positive regulation of establishment of protein localization (GO:1904951),-0.4308124155528941,-1.1926620877411753,0.23204419889502761,0.696793468918891,1.0,6/18,13.17%,TREM2;CORO2B;CCT2;DKC1;CHP1;CCT8
prerank,protein homotetramerization (GO:0051289),-0.3408266471722837,-1.1924715499386884,0.1762295081967213,0.6955179632556453,1.0,13/49,13.22%,RYR3;ACACA;APPL2;PKD2;KCNJ2;ALDH9A1;GOLGA2;MCOLN1;HCN1;USP16;TRPM2;CBR4;AQP4
prerank,positive regulation of cell aging (GO:0090343),0.5570013086822183,1.19220095291304,0.27692307692307694,0.6123485586669738,1.0,4/11,17.17%,LMNA;ARG2;B2M;SIRT1
prerank,epidermal cell differentiation (GO:0009913),0.4307766196999867,1.1920818441880798,0.22893258426966293,0.6120376874302152,1.0,12/41,20.54%,GLI1;BCR;CLIC4;ANXA1;USH2A;ERCC3;PIP5K1A;ADAM9;MED1;HDAC1;SCEL;UGCG
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.3969807591702069,1.1917061090849588,0.21604938271604937,0.6124062348197495,1.0,20/74,16.30%,LIMD1;PSME3;PSMB7;PSME2;RBPJ;NFE2L2;ELOB;PSME4;BACH1;PSMB8;PSMA5;PSMD9;PSMB3;PSMD6;PSMC4;PSMD10;PSMB1;CITED2;CREBBP;PSMD12
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.36247061773708833,1.1913340945399429,0.16722783389450055,0.6127342137650582,1.0,37/161,16.56%,LIMD1;GLI1;PTPRU;PTPRO;PSME3;CUL3;CCDC88C;SDHAF2;MAD2L2;NOTUM;PSMB7;AXIN1;PSME2;TMEM131L;STK4;KREMEN1;PSME4;LATS1;PSMB8;PSMA5;PSMD9;CYLD;PSMB3;LATS2;PSMD6;PSMC4;DVL3;PSMD10;PSMB1;LRP4;TLE1;INVS;DVL2;APC;IGFBP6;PSMD12;KLHL12
prerank,positive regulation of JUN kinase activity (GO:0043507),0.47967187633089875,1.1909873353369043,0.23981191222570533,0.6129590754913948,1.0,9/23,17.32%,MAP3K5;PAK1;TAOK3;MAP3K4;RPS3;DVL3;MAP3K7;DVL2;TRAF2
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),0.5559375601904177,1.1909294172292615,0.2862129144851658,0.6124838698160373,1.0,3/11,9.94%,RGS2;LMNA;SMAD4
prerank,beta-catenin-TCF complex assembly (GO:1904837),-0.39012529954843334,-1.1908671781713285,0.20557491289198607,0.6984565525040174,1.0,19/29,35.69%,BCL9;CTNNB1;TCF7L2;RUVBL1;TCF7L1;BCL9L;PYGO2;MEN1;PYGO1;MYC;KAT5;LEO1;TRRAP;AXIN2;CDC73;TLE3;LEF1;SMARCA4;TCF7
prerank,replication fork processing (GO:0031297),0.44354530067343606,1.1907819607684167,0.22558459422283356,0.6122627725640742,1.0,7/38,12.73%,DNA2;SAMHD1;MRE11;FAM111A;WRN;EXD2;ATRX
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.46433839928728027,1.190292410012141,0.25036603221083453,0.6128325761156785,1.0,7/27,14.26%,FGR;FLT3;PTK2B;PIK3R4;KIT;TGFB1;FGFR3
prerank,calcium ion transport (GO:0006816),-0.2856190090532987,-1.1900905751392314,0.09285714285714286,0.6988843990886594,1.0,34/113,16.59%,CACNA1D;SLC8A1;RYR3;SLC24A3;CACNB2;GAS6;CACNA2D1;TRPV2;TRPM3;PKD2;CDH23;CACNA1C;PSEN2;ATP2A2;TRPC4;P2RX7;ANK2;ATP2B2;P2RX4;TRPC1;MCOLN1;CRACR2A;CHRNA7;MCOLN3;CRACR2B;SELENOK;SLC3A2;TRPC7;TRPM2;TRPV4;TRPC3;MCOLN2;ATP2C1;CAMK2A
prerank,tRNA 5'-leader removal (GO:0001682),-0.48121345749919725,-1.190035559948218,0.24484536082474226,0.6972281606829589,1.0,10/13,34.66%,POP1;RPP30;RPP14;SSB;RPP40;POP4;POP5;RPP21;POP7;RPP25L
prerank,DNA-dependent DNA replication (GO:0006261),0.3752978321686824,1.1898975363387128,0.17505720823798626,0.6131941660837757,1.0,33/128,17.74%,DNA2;BAZ1A;PSME3;CDC45;PSMB7;PSME2;ORC5;MCM6;POLD4;WRN;ORC4;PSME4;PSMB8;PSMA5;PSMD9;RECQL5;PSMB3;PSMD6;PSMC4;RPA3;POLA2;PSMD10;DDX23;MCM2;PSMB1;MCMBP;ORC6;POLG2;POLB;PSMD12;POLD1;LRWD1;ORC2
prerank,response to chemokine (GO:1990868),0.5440530004321487,1.1898869497944096,0.24268502581755594,0.6126147070680474,1.0,7/13,18.10%,RIPOR2;RHOA;OXSR1;DUSP1;STK39;LRCH1;FOXC1
prerank,negative regulation of interleukin-17 production (GO:0032700),-0.5123052537312294,-1.1897542866559374,0.26128266033254155,0.696239856531095,1.0,3/10,12.54%,VSIR;NCKAP1L;TLR4
prerank,negative regulation of GTPase activity (GO:0034260),0.4849588736181095,1.1893589921017842,0.2593167701863354,0.6133535302843404,1.0,8/22,13.88%,LRRK2;RCC2;KLRK1;F11R;BCAS3;ARFGEF1;SH3BP4;LRCH1
prerank,mononuclear cell differentiation (GO:1903131),0.47060342063191307,1.1892173779597164,0.25339366515837103,0.613100068018936,1.0,5/24,4.25%,LYN;FLT3;LILRB1;PPARG;MYH9
prerank,DNA integrity checkpoint signaling (GO:0031570),0.43854304796755345,1.1887994095319387,0.24964336661911554,0.613545815821264,1.0,13/36,18.77%,DNA2;CDC45;CDC5L;CEP63;CLOCK;DOT1L;BRIP1;MAP3K20;DONSON;HUS1;RAD17;CHEK2;SETMAR
prerank,tRNA wobble base modification (GO:0002097),-0.4671670143153575,-1.1884286398544825,0.25304136253041365,0.6983098148407315,1.0,10/14,38.79%,ALKBH8;MTO1;GTPBP3;TRMT9B;ALKBH1;CTU2;CTU1;MOCS3;ADAT2;KTI12
prerank,histone mRNA metabolic process (GO:0008334),0.46207129414244047,1.1880915251756137,0.2450532724505327,0.6147084127005396,1.0,10/27,15.48%,SNRPB;DCP2;TUT1;ERI1;TENT2;MTPAP;TUT7;TENT4B;CPSF3;NCBP1
prerank,brain development (GO:0007420),-0.2870191376772723,-1.1876986656204258,0.11578947368421053,0.6986937328408507,1.0,37/136,16.85%,ZFHX3;ATXN1;TGFBR2;CX3CR1;ROBO2;CTNNA2;CNTN4;PLXNB2;NF1;APOD;NFIB;AFF2;RAB3GAP1;CDK5R1;BBS2;NCOA6;POU6F1;TBC1D23;AATK;ZFHX2;UFC1;SHROOM2;PHF8;EPHA7;MEIS3;ROGDI;SETD1A;UFM1;ADGRL3;VPS51;PAFAH1B2;ADGRL2;CNTNAP2;ADGRG1;SCYL2;PHGDH;IER3IP1
prerank,connective tissue development (GO:0061448),0.4439713037326211,1.1873573773873698,0.24581005586592178,0.6159947772089729,1.0,4/35,7.73%,CD44;SULF2;SCX;ATP7A
prerank,regulation of ion transport (GO:0043269),-0.304587369522598,-1.1861394890169077,0.14659685863874344,0.7014772346593465,1.0,18/76,14.40%,PRKN;DTNBP1;WNK1;SYT1;KCNJ2;P2RX7;P2RX4;SYT9;ITGB3;SYT7;KCNA2;KCNJ6;SNX6;CA2;PER1;KCNJ9;SYT6;NKAIN3
prerank,positive regulation of erythrocyte differentiation (GO:0045648),0.47146935502957815,1.1861384315638306,0.24358974358974358,0.618415054746515,1.0,7/25,11.42%,STAT3;HSPA1A;STAT5B;STAT1;MAPK14;ACVR2A;FOXO3
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),-0.2897614935259167,-1.1857357935751738,0.14285714285714285,0.7008658110034713,1.0,33/96,19.43%,SRSF5;SRSF3;DDX39B;NUP54;RNPS1;NUP133;SRSF7;SYMPK;NUP155;ALKBH5;NUP188;UPF1;THOC5;DHX38;NXF1;DDX19B;RANBP2;ZC3H11A;SEC13;SRSF2;DDX39A;NUP85;GLE1;NUP42;SMG7;TPR;NUP35;CASC3;SRSF1;MCM3AP;FYTTD1;HNRNPA2B1;NUP37
prerank,peptide catabolic process (GO:0043171),0.4818820152908862,1.1849317962560317,0.2571001494768311,0.6209258975892508,1.0,4/23,7.39%,ACE;LNPEP;DPEP1;CPQ
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),-0.41443478131955247,-1.1847725801643798,0.256198347107438,0.7019565356666359,1.0,2/21,0.92%,PRKN;ABCD2
prerank,double-strand break repair via homologous recombination (GO:0000724),0.3828252958063882,1.1846834171633294,0.18640093786635403,0.6209659724526038,1.0,24/95,16.36%,SAMHD1;NIPBL;RBBP8;POLL;CDC45;MRE11;FEN1;MCM6;UBE2N;WRN;NABP1;MORF4L1;RECQL5;RPA3;EXD2;RAD54L;SPIDR;MCM2;ERCC4;RNF138;XRCC2;INO80;MCM9;HUS1
prerank,estrogen metabolic process (GO:0008210),0.5122946398629138,1.184286500931511,0.2652733118971061,0.6213434443247284,1.0,4/15,17.80%,HSD17B14;HSD17B7;HSD17B11;HSD17B2
prerank,vacuolar acidification (GO:0007035),-0.4152501100680573,-1.1839864396304303,0.23809523809523808,0.7025108976580203,1.0,7/21,12.66%,SLC11A1;GRN;ATP6V0D2;TCIRG1;DMXL2;ATP6V0D1;ATP6V0A1
prerank,protein localization to cell junction (GO:1902414),0.4797354411370464,1.1836414642249038,0.27699530516431925,0.62236995782382,1.0,4/22,1.81%,ARHGEF18;MARVELD3;HEG1;NECTIN1
prerank,inner ear morphogenesis (GO:0042472),-0.40656571249105805,-1.1836092097263908,0.24169184290030213,0.7017548054643166,1.0,4/22,8.19%,CHD7;MYO6;FGFR2;HPN
prerank,positive regulation of peptide hormone secretion (GO:0090277),0.4338049641357516,1.1835038957294723,0.23300970873786409,0.622125532020276,1.0,5/39,10.99%,FFAR4;TM7SF3;SELENOT;PSMD9;GLUD1
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),-0.3994022279050758,-1.1830513389776038,0.23127035830618892,0.7016063700448169,1.0,11/24,34.73%,PKD2;PRKACA;AKAP6;CALM1;GSTO1;FKBP1A;PDE4D;DMD;NOS1;JPH3;CALM2
prerank,inorganic cation import across plasma membrane (GO:0098659),-0.304353074293113,-1.182439541095664,0.13903743315508021,0.7016646446395419,1.0,15/75,13.66%,SLC8A1;CACNA2D1;TRPV2;ATP1B3;KCNJ2;SLC39A10;ATP1B1;SLC9A9;SLC9A6;ATP1A2;KCNJ6;HCN2;TRPM2;KCNJ9;TRPV4
prerank,cellular response to cadmium ion (GO:0071276),0.4714973705435755,1.1815079512433688,0.25,0.6267644673973747,1.0,7/24,15.12%,FOS;SUMO1;DAXX;MAPK8;AKT1;NCF1;MAPK1
prerank,RNA methylation (GO:0001510),-0.3210504897983136,-1.1814899213913563,0.17567567567567569,0.7026794916470219,1.0,30/60,26.25%,ALKBH8;NSUN2;METTL6;ZCCHC4;METTL14;DIMT1;NOP2;NSUN3;METTL2A;METTL2B;METTL1;TGS1;ZC3H13;WTAP;FTSJ3;METTL8;NSUN5;THUMPD2;TRMT10A;TRMT44;MTO1;TRMT6;TRMT12;NSUN6;LCMT2;TRMT112;GTPBP3;TRMT5;BCDIN3D;BUD23
prerank,regulation of microtubule polymerization (GO:0031113),-0.34724848481393567,-1.1811339920020867,0.1972318339100346,0.7019592507668385,1.0,9/40,11.82%,NAV3;CAMSAP1;NUMA1;MAP2;CLIP1;CDK5R1;EML2;MAPRE1;CAMSAP2
prerank,RNA destabilization (GO:0050779),0.4970021356822433,1.1811307444618966,0.28639240506329117,0.6272041399117843,1.0,8/18,19.50%,MEX3D;GIGYF2;YTHDF3;METTL3;ROCK1;CELF1;PUM1;FTO
prerank,positive regulation of protein localization to membrane (GO:1905477),0.383700474736598,1.1807134889086814,0.20734597156398105,0.6276497830264359,1.0,20/98,13.66%,PRKCE;TCAF2;FYN;C2CD5;PRKCH;MYO1C;KIF5B;BBC3;ITGB2;PRNP;PDPK1;CIB1;EPHB2;FIS1;YWHAZ;CLIP3;LGALS3;MAPK8;AKT1;ITGA3
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),-0.48541440481151155,-1.180485929081792,0.26884422110552764,0.7018971785412949,1.0,6/12,18.03%,PIBF1;ERLIN2;WDTC1;APOC1;BRCA1;ACADL
prerank,intracellular protein transport (GO:0006886),0.3497782285483794,1.1796513932728558,0.1282051282051282,0.629780784202462,1.0,61/304,14.84%,CD74;AP1S3;TBC1D1;XPO1;STX11;NGFR;RAB19;TBC1D8;SYK;STAT3;TBC1D9;C2CD5;RABL3;MYO1C;LAPTM5;SORL1;USP6NL;TBC1D10C;TBC1D2B;XPO5;XPO6;MAIP1;RAB7A;SNX1;TBC1D8B;PTTG1IP;XPO4;ARF4;STX17;RAB6A;RABGAP1L;KATNB1;RTN2;STX6;TMED10;RABGAP1;ARF1;STX5;STX12;SNF8;TBC1D5;SLU7;STX7;HIKESHI;SNX9;STAM;TBC1D2;NUP153;CLIP3;RPL11;EIF4ENIF1;AKT1;STX16;SGSM1;TLK1;TGFB1;EVI5;FAM53C;RAB29;SCFD2;EHD1
prerank,regulation of protein localization to plasma membrane (GO:1903076),0.391433999108412,1.1795290538208067,0.2134969325153374,0.6294659925947895,1.0,17/78,15.03%,PID1;PRKCE;PPP2R5A;PRKCH;KIF5B;PICALM;ZDHHC7;PDPK1;CIB1;EPHB2;STX7;CLIP3;LGALS3;AKT1;ITGA3;TGFB1;RHOG
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.40519803808552707,1.1791459940706512,0.23582474226804123,0.6298438729201252,1.0,21/59,16.53%,RUNX2;NFKB1;MED30;MED13;PTEN;CCND1;SETX;CBFB;MECP2;THRA;MED6;IL6;MED26;MED12;MED14;PPM1D;TNRC6B;TNRC6A;RELA;MED1;MED7
prerank,positive regulation of interleukin-1 production (GO:0032732),0.4135902238551782,1.179133573639645,0.2303595206391478,0.6292641687163198,1.0,12/51,14.98%,JAK2;STAT3;CD36;MALT1;TRIM16;TMED10;IL6;NLRC4;NLRP3;APP;GBP5;MYD88
prerank,peptidyl-threonine modification (GO:0018210),0.40272273131864184,1.178611161292975,0.21706398996235884,0.6300417473888751,1.0,21/66,15.88%,LRRK2;LMTK2;HIPK2;HIPK1;PDPK1;DYRK1A;GALNT2;TNKS;OXSR1;CSNK2A2;CSNK2A1;NLK;CAD;MAPK8;AKT1;STK39;ROCK1;MAPK1;TAF1;TBK1;DYRK2
prerank,artery development (GO:0060840),-0.4102829688356229,-1.1782051196487657,0.2282958199356913,0.7066683179118421,1.0,8/23,7.64%,NRP1;TGFBR1;ROBO2;ROBO1;PKD2;NF1;SMAD7;ACVR2B
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),-0.3050963345138581,-1.1777100303930876,0.1774193548387097,0.7064607452238967,1.0,29/72,24.76%,GTF2H2;ERCC6;COPS4;POLD3;TCEA1;GTF2H1;UBC;XRCC1;POLR2A;COPS7A;ERCC2;COPS2;PCNA;LIG3;PPIE;ISY1;POLR2K;RFC3;LIG1;GTF2H3;COPS7B;XAB2;CDK7;POLR2H;GTF2H5;POLR2J;UBA52;COPS6;ERCC1
prerank,negative regulation of autophagy (GO:0010507),0.4110335165211237,1.1764765909475674,0.24761904761904763,0.6349599320864228,1.0,12/54,13.17%,LRRK2;PTPN22;MCL1;STAT3;EIF4G3;IL10RA;HGF;TLK2;PIK3CA;TAB3;SMG1;AKT1
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),-0.4810838022624468,-1.1762854722332878,0.27790973871733965,0.7087726477491496,1.0,5/12,23.52%,SYT1;SYT7;RIMS1;RIMS3;SYT8
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.3396086783463215,1.1758777954932937,0.0531062124248497,0.6358758777258825,1.0,172/834,17.41%,CIITA;PLAC8;PID1;RUNX2;RARA;SP3;GLI1;TNIP3;HNF4G;ACTR3;CDK13;KLF4;CREB1;LILRB1;NGFR;PPARG;IER2;CD40;PPP1R12A;NFKB1;TET2;FOSL2;PLSCR1;STAT3;EHF;FOXJ1;ELF4;FOS;TCF20;RPS6KA3;BMPR2;REL;AKNA;NCOA3;CXCL10;CRLF3;TAF9;SPI1;STAT5B;NFKBIA;SCX;ATAD2;TBL1XR1;IKBKB;MED30;ZEB2;CAMTA2;KAT7;ATF6;GDNF;ATF2;PPP3CA;IRF2;PRPF6;RFX3;RBPJ;IL33;HIVEP1;MED13;STAT1;HIPK2;NUFIP1;KLF5;IRF4;HELZ2;RFX5;RPS6KA5;SMARCA5;ARF4;KMT2C;KLF10;CDC5L;SETX;AHR;ACTR2;CREBRF;NFE2L2;THRA;CLOCK;MED6;ZBED4;RARG;TOX3;DOT1L;PLXND1;E2F2;ENG;GABPB1;GABPB2;ACVR2A;ELF1;TLR3;HGF;IL6;KAT6A;TNKS;BCAS3;NCOA2;E4F1;IRF7;MEF2B;SMAD4;SBNO2;RPRD1B;NCOA1;CSRNP1;NR3C1;RIPK1;PBX1;CCNT2;FOXO3;MED12;ZNF507;DVL3;TAF7;NLRP3;REST;RPS6KA1;ATF6B;APP;MAP2K5;MED14;CCNT1;BCLAF3;TLR2;CDK12;TEAD1;ATRX;NFATC2IP;MYB;NRIP1;JUNB;HCLS1;SREBF2;CITED2;KAT2B;HDAC3;MRTFA;TGFB1;CRTC3;RSF1;FHOD1;IL18;GPS2;KMT2A;ASXL2;CREBBP;RELA;TBK1;DVL2;MAML1;INO80;ZMIZ2;MED1;ELL;WNT7A;IRF5;PAXBP1;BPTF;HTATIP2;PROX1;CREB3L4;CREB3;SMAD5;ELK4;PIK3R2;CHCHD2;SIRT1;SUPT4H1;ATF1;NR4A1;SS18
prerank,membrane raft organization (GO:0031579),0.5117565636137864,1.175667582459758,0.26953748006379585,0.6358020504278141,1.0,6/15,16.31%,ANXA2;S100A10;NAXE;FA2H;MYADM;PPT1
prerank,lytic vacuole organization (GO:0080171),-0.37514834682177717,-1.1754141225537624,0.21103896103896103,0.7096106852661858,1.0,9/32,8.05%,ABCA1;HPS4;GRN;ZKSCAN3;TPP1;ARSB;TPCN2;GAA;MYO7A
prerank,adenine nucleotide transport (GO:0051503),0.5167462941359179,1.175061178556193,0.26625386996904027,0.6367521665267408,1.0,4/17,11.95%,LRRC8C;LRRC8D;ABCC4;SLC25A5
prerank,negative regulation of protein processing (GO:0010955),0.5520835685587359,1.17502999632903,0.28338762214983715,0.6362193991032266,1.0,2/12,6.34%,LRRK2;PRNP
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.4737587679611193,1.1749881835386036,0.25948406676783003,0.6357011873187393,1.0,6/22,11.67%,LYN;PTPN22;RAB7B;TIRAP;IFI35;ACOD1
prerank,leukotriene metabolic process (GO:0006691),0.5036369180703747,1.1745559707048994,0.29133858267716534,0.63624629044275,1.0,7/19,17.22%,ALOX5AP;MAPKAPK2;DPEP1;ABCC1;DPEP2;ABCC10;MGST3
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.40156079276251877,1.1740846535696563,0.22692307692307692,0.6368693789299461,1.0,15/67,11.37%,TBC1D1;SDCCAG8;TBC1D8;USP6NL;TBC1D10C;TBC1D2B;CDC42;CAPZB;ATG5;RABGAP1;IFT140;RAC1;TBC1D5;CYLD;TBC1D2
prerank,detection of calcium ion (GO:0005513),-0.4685687528593912,-1.173938857224161,0.296875,0.7123192970463472,1.0,4/13,21.23%,SYT1;KCNMB2;CALM1;RYR2
prerank,exit from mitosis (GO:0010458),0.5387309366777812,1.1733130421144886,0.31399317406143346,0.6382886174556478,1.0,5/12,13.91%,EPS8;CHMP4B;SPAST;UBE2S;CLASP1
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),0.5316719219343623,1.173022376826791,0.30130293159609123,0.63842941993949,1.0,3/13,9.67%,PTGIS;NAXE;PARP9
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.3753715352261131,1.1729651745571719,0.22479721900347624,0.637960593936514,1.0,30/100,19.43%,FGR;LYN;FLT3;PIP4K2A;JAK2;PTPN6;CBL;PTEN;HGF;FN1;PIP4K2B;PIK3CA;PDGFD;PIP5K1A;KIT;NCF1;HCLS1;HCST;PPP2R5C;IL18;UNC5B;MAZ;MAPK1;INSR;SEMA4D;SIRT1;BECN1;HAX1;PIK3R5;FGFR1
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),-0.3650137902586228,-1.1728716157260137,0.2028985507246377,0.713607878473393,1.0,10/32,20.34%,CAPN3;PKD2;PLCG1;TRPC1;P2RY6;AKAP6;CALM1;CX3CL1;CEMIP;GSTO1
prerank,lipoxygenase pathway (GO:0019372),0.5308536643489603,1.1726150290683086,0.2859504132231405,0.6382070634727772,1.0,2/14,2.68%,ALOX5AP;GPX1
prerank,mitochondrion transport along microtubule (GO:0047497),0.5436901414931716,1.1724066116189669,0.28547008547008546,0.6381211480575034,1.0,2/13,9.32%,UXT;SPAST
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),0.5350726403576577,1.172383826007144,0.3128205128205128,0.6375552637585831,1.0,2/14,2.97%,CD226;MAD2L2
prerank,positive regulation of collagen biosynthetic process (GO:0032967),0.5134529646527155,1.1718031400693067,0.26134585289514867,0.6384007627888382,1.0,2/16,4.20%,VIM;SCX
prerank,DNA metabolic process (GO:0006259),0.34671600790095924,1.171751845818064,0.15970772442588727,0.6379236967112372,1.0,80/270,20.37%,SP100;UVRAG;DNA2;SAMHD1;LONP1;POLI;BTG2;RBBP8;POLL;CHRNA4;CDC45;USP3;MRE11;FEN1;SUMO1;PARP4;DNTT;ORC5;MCM6;UBE2N;POLD4;MBD4;WRN;USP45;MSH3;NABP1;ORC4;DOT1L;PSME4;SMUG1;BACH1;MSH6;FANCC;FANCL;TDG;KMT5B;RECQL5;DFFB;PARG;RPA3;POLA2;DDX23;EXD2;RAD54L;MCM2;ERCC3;ERCC4;FANCA;RNASEH2A;RNASEH1;VCP;XRCC2;USP7;UHRF2;ORC6;STN1;INO80;ENDOV;INIP;POLB;NSMCE4A;KPNA2;HUS1;POLD1;LRWD1;LTO1;ORC2;RAD17;RAD21;PRIMPOL;SETMAR;FANCG;DNMT1;DNASE1L1;TERF2;PARK7;APEX1;SUPV3L1;PDS5B;XPA
prerank,positive regulation of fat cell differentiation (GO:0045600),0.4193851952002949,1.1715146326595895,0.23945578231292516,0.6379157864448132,1.0,9/47,10.60%,CREB1;PPARG;METRNL;PIM1;LMO3;WDFY2;ID2;CREBL2;CCDC71L
prerank,midbody abscission (GO:0061952),0.5079102206236882,1.1714790830365516,0.2895174708818636,0.6374047785592197,1.0,5/17,8.00%,KIF20A;MITD1;CHMP4A;CHMP4B;PDCD6IP
prerank,regulation of autophagy (GO:0010506),0.3512372629715796,1.1713974291200044,0.18642241379310345,0.6370254153914641,1.0,44/216,13.81%,ITPR1;LRRK2;PTPN22;DAPK1;PIP4K2A;DRAM1;MCL1;PRKAG2;PIK3C2A;STAT3;PLEKHF1;ATP6V0E1;ERN1;EIF4G3;IL10RA;FBXW7;ATF6;DCAF12;MTMR3;PRKAB2;SVIP;PSAP;RMC1;MTMR4;HGF;ATP6V1H;CSNK2A2;DEPDC5;TLK2;EXOC7;PIP4K2B;TRIM14;PRKAG1;RHEB;FOXO3;TAB3;PRKAA1;SH3BP4;DNM1L;MAPK8;AKT1;SREBF2;PRKAA2;ROCK1
prerank,neuron cell-cell adhesion (GO:0007158),-0.4557647321167527,-1.170433066939219,0.2733644859813084,0.7191442837382754,1.0,10/14,19.15%,NLGN1;NCAM2;CNTN4;NRXN2;CDK5R1;ASTN1;ASTN2;NLGN2;NLGN3;NRXN1
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),0.5218040705742868,1.1699257658825177,0.2586490939044481,0.6402123226155811,1.0,2/13,7.44%,SORL1;GCC2
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),0.5732971004407895,1.1695116384302093,0.3121597096188748,0.6406944016885047,1.0,5/10,18.98%,LYN;RNF13;GSTP1;MAPK1;MAP2K1
prerank,ion homeostasis (GO:0050801),0.4486881893281106,1.1689422784673387,0.2633802816901408,0.6415721353826564,1.0,5/30,7.51%,NEDD4L;SLC30A4;HCN4;SLC4A7;SLC4A8
prerank,"synaptic transmission, cholinergic (GO:0007271)",-0.4197063247493741,-1.1686227588645905,0.2717948717948718,0.7228023672256625,1.0,4/19,12.06%,APOE;CHRFAM7A;CHRNA7;SLC5A7
prerank,regulation of embryonic development (GO:0045995),0.4365401832948386,1.168571573262921,0.2711864406779661,0.6419132781408025,1.0,10/34,16.84%,RACGAP1;NIPBL;B4GALT5;PHLDB2;PLCB1;TDG;CLASP1;POGLUT1;INSR;NIBAN2
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),0.557209674382532,1.1681199860948608,0.2831215970961887,0.6417666924631935,1.0,4/10,16.26%,KLF4;MBP;MAP2K5;MYADM
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),0.557209674382532,1.1681199860948608,0.2831215970961887,0.6417666924631935,1.0,4/10,16.26%,KLF4;MBP;MAP2K5;MYADM
prerank,regulation of cholesterol storage (GO:0010885),-0.4274620030629457,-1.16811339718604,0.257985257985258,0.7223911983741645,1.0,4/15,4.30%,ABCA1;TREM2;TTC39B;MSR1
prerank,gene silencing by miRNA (GO:0035195),0.4374161944474374,1.1677237085257692,0.26713286713286716,0.6421294128244316,1.0,10/32,16.94%,LIMD1;XPO5;PUM2;CNOT6;TRIM71;TNRC6B;TNRC6A;PUM1;AJUBA;CNOT8
prerank,positive regulation of biomineral tissue development (GO:0070169),-0.34678270060232963,-1.1675729809482267,0.19140625,0.7221157666121137,1.0,12/40,15.97%,SLC8A1;MEF2C;NELL1;PTN;TMEM119;P2RX7;ACVR1;ACVR2B;BMPR1B;PKDCC;BMP6;ADGRV1
prerank,positive regulation of bone mineralization (GO:0030501),-0.3588363212758042,-1.1672769280809876,0.23228346456692914,0.7212403549177567,1.0,12/35,15.97%,SLC8A1;MEF2C;NELL1;PTN;TMEM119;P2RX7;ACVR1;ACVR2B;BMPR1B;PKDCC;BMP6;ADGRV1
prerank,nucleosome assembly (GO:0006334),0.44491512065275834,1.1662431926692785,0.26227208976157085,0.6454038176651098,1.0,13/31,22.70%,CHAF1A;H3-3A;RBBP4;SMARCA5;DAXX;NAP1L1;ATRX;RSF1;BRD2;HAT1;CABIN1;ANP32B;ASF1A
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.4730998223436733,1.1659811270057567,0.266025641025641,0.6454531804211963,1.0,4/21,6.97%,KCNE3;GJA5;KCNQ1;FLNA
prerank,hexose transmembrane transport (GO:0008645),-0.41381508488569807,-1.1656302535670686,0.22054380664652568,0.7242068733328264,1.0,8/21,32.64%,SLC2A3;SLC2A9;SLC2A5;SLC50A1;SLC2A8;SLC45A3;PPARD;SLC45A1
prerank,protein targeting to ER (GO:0045047),0.37957939554168274,1.1655437255244654,0.21841794569067297,0.6459549609142173,1.0,42/99,23.83%,RPL5;RPS10;CHMP4A;CHMP4B;RPL37A;RPL6;RPS18;RPS14;RPL35A;RPL13;SEC63;RPS3;RPS21;SRP72;SRP19;RPL34;RPLP0;RPL19;RPL11;RPL30;RPS2;RPL4;RPL7;RPS15A;RPS4X;SPCS2;RPL32;RPSA;RPS13;RPS6;RPL18A;RPS27;RPLP2;RPL22;RPS7;RPS12;RPL10A;RPS25;RPL9;RPS16;RPL23;RPL17
prerank,negative regulation of macroautophagy (GO:0016242),0.4593160749359836,1.16543685419424,0.2767857142857143,0.6456526119700341,1.0,7/26,13.17%,LRRK2;CHMP4A;CHMP4B;CLEC16A;PIK3CA;SMG1;AKT1
prerank,cristae formation (GO:0042407),-0.3883576625738283,-1.1647852822604654,0.23809523809523808,0.7249730162457828,1.0,11/27,15.43%,ATP5F1A;ATP5PO;APOO;AFG3L2;ATP5MG;ATP5PD;CHCHD6;ATP5PF;SPG7;ATP5F1D;ATP5MC3
prerank,regulation of cellular amine metabolic process (GO:0033238),0.4100032351110196,1.1646726860572152,0.25906040268456376,0.6469820696384052,1.0,13/50,12.96%,PSME3;PSMB7;PSME2;AZIN1;PSME4;PSMB8;PSMA5;PSMD9;PSMB3;PSMD6;PSMC4;PSMD10;PSMB1
prerank,histone modification (GO:0016570),0.3700469683963963,1.1645161861715352,0.22538552787663108,0.6467537399950214,1.0,32/109,20.00%,HLCS;PADI1;NSD3;USP3;TBL1XR1;MTA3;RPS6KA5;PRMT8;UBE2N;ATXN7;HDAC9;KAT6A;RCOR3;MORF4L1;BAZ2A;MSL3;NSD1;EZH2;AURKB;CREBBP;PHF20;MIER1;NTMT1;EYA3;SIRT1;PADI2;HDAC1;PRKCD;MIDEAS;EHMT1;PARK7;RCOR1
prerank,positive regulation of interleukin-10 production (GO:0032733),0.4459652455034668,1.1643832541920713,0.2647482014388489,0.6464703159876907,1.0,5/30,8.61%,PLCG2;SYK;STAT3;IRF4;IL6
prerank,positive regulation of signal transduction (GO:0009967),0.34945883653703946,1.1643028586946884,0.16913319238900634,0.6460717787444734,1.0,48/238,16.49%,CD74;LRRK2;PTPRC;IL1B;CD226;GLI1;SULF2;JAK2;STAT3;ERN1;MYO1C;PTGIS;RSPO2;RSPO3;SORL1;NPTN;RBPJ;LMO3;CAV2;PTEN;TRIM16;PTK2B;RAB34;FLNA;TSPAN14;IL6ST;IL6;CSNK2A1;RPS3;DSTYK;HTT;TLR2;TUBD1;AGPAT1;CITED2;KAT2B;PDE6H;TXNDC15;GPS2;ASXL2;DISC1;CREBBP;POGLUT1;MAML1;ITGA5;TSPAN5;RELN;WNT7A
prerank,regulation of chromosome segregation (GO:0051983),0.5040833373515133,1.1639715562003812,0.2996742671009772,0.6463362345037631,1.0,8/16,18.87%,IHO1;PUM2;CSNK2A2;CSNK2A1;AURKB;PUM1;SMC6;SMC5
prerank,nuclear transport (GO:0051169),0.5085129805134487,1.1635179258304378,0.2847571189279732,0.646875160602038,1.0,4/16,12.70%,XPO1;RSRC1;NUP98;RGS14
prerank,cellular metal ion homeostasis (GO:0006875),0.3753086229842588,1.1632006738580254,0.23832335329341317,0.647050228398338,1.0,17/102,12.60%,CCR2;CD40;CCR1;NEDD4L;NPTN;SLC8B1;ATP2B1;ATP2A3;STIM2;ATP2A1;SLC30A1;DMPK;LETM1;TMEM203;ATP13A3;SLC10A7;SLC24A4
prerank,regulation of kinase activity (GO:0043549),0.37938029283465124,1.1630142833360813,0.24047619047619048,0.6469374012984174,1.0,5/89,1.59%,CD74;FGR;FLT3;RET;LMTK2
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),-0.42840622850870824,-1.16285559317209,0.2698412698412698,0.7291544148210931,1.0,12/17,29.80%,SLC8A1;CACNA1C;PRKACA;ATP1B1;ATP1A2;GJA1;PKP2;RYR2;ATP1A1;ATP1A3;GJC1;GJD3
prerank,regulation of gene expression (GO:0010468),0.3374015060429884,1.1627073002169879,0.056,0.6471504495032202,1.0,186/903,16.38%,CD74;PID1;PTPRC;IL1B;FOXP1;MBNL1;AHNAK;SP3;RUNX3;LYN;NOTCH2;LIMD1;NGF;KDM6A;PTPN22;IFNGR1;PLCG2;KLF4;STAP1;RPL5;LILRB1;PTBP3;ITGAX;CCR1;BCL6;SAP30;NFKB1;MSN;PITX3;ACE2;FGF5;FGF22;PLSCR1;STAT3;NSD3;HSPA1A;TRIM26;GPX1;CD36;NAB1;REL;RNF207;PRX;SPI1;SCX;PICALM;FBXW7;MBNL3;KAT7;RYBP;GDNF;ATF2;NFKBIZ;IRF2;RFX3;RPL6;RBPJ;BTG1;IL33;RNF20;RC3H1;MAPK14;CD276;RPS6KA5;GLMN;AFDN;TIPARP;UBR5;AHR;PHF19;CRIP1;TADA3;SERPINB9;CGGBP1;CREM;SRSF10;NFE2L2;PARP14;SETDB2;MECP2;PUM2;TRAF3;PDE2A;CLOCK;TOB2;EZR;ENG;MBIP;CTCF;PHF12;EPHB2;NFYC;TLR3;ZBTB11;IL6;BACH1;NKAPL;AFF1;SNF8;CPNE1;RBAK;ASCC1;ID2;WWP2;CREBL2;NCOA2;OLFM1;TRIM71;BRAF;PARP9;METTL4;RPS3;SBNO2;ADAM19;IGF2BP3;BNC2;FN1;DAXX;NR3C1;YTHDC1;NUDT21;TDG;TRIM14;NFKBID;CACTIN;PRKAG1;ING2;SRRT;NLK;MED26;PRKAA1;ZNF507;REST;APP;BAZ2A;NFYA;TRIM17;PQBP1;MSL3;TLR2;ATRX;ICOSLG;RPL11;MYB;EIF2AK3;ZPR1;HNRNPLL;MAPK8;AKT1;NSD1;TLE1;HCLS1;EZH2;TNRC6B;RBM38;PRKAA2;ROCK1;CITED2;TNRC6A;NFIL3;TGFB1;ZNF431;MAZ;MYD88;SERTAD3;MAPK1;OCLN;CREBBP;RELA;MARF1;TAF1;DVL2;BHLHE40;ZNF148;CELF1;SNX12;MED1;PTBP2;FOXN2;RBL2;PUM1;AFF3;MYADM;INSR;RB1;DAPK3
prerank,dendritic cell differentiation (GO:0097028),0.4717135545406119,1.1624736550779824,0.27531645569620256,0.6471190795290281,1.0,3/22,1.35%,LYN;FLT3;LILRB1
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),-0.4296837955638176,-1.162429541551232,0.2777777777777778,0.7285268973151434,1.0,10/17,44.93%,LPCAT1;PLA2G4A;SERAC1;LPGAT1;PLA2G3;CRLS1;LPCAT4;PLA2G5;PLA2G4F;PLA2G2D
prerank,regulation of hydrolase activity (GO:0051336),0.3963394450469267,1.162168456132663,0.2543859649122807,0.6472960629295188,1.0,15/71,11.08%,ARHGAP15;VAV3;CRK;OCRL;FGD4;FBXW11;WRN;PAFAH1B1;RABGAP1;PLXND1;FGD1;FGD3;TDG;ADAP1;SCARB2
prerank,telomere organization (GO:0032200),0.42428544932257106,1.1618627142341813,0.272,0.6474848456142729,1.0,13/43,17.54%,SP100;DNA2;MRE11;H3-3A;POLD4;WRN;DOT1L;RPA3;ERCC4;STN1;HUS1;POLD1;LTO1
prerank,response to estradiol (GO:0032355),0.4501473087004079,1.1616673089998963,0.2887624466571835,0.6474075674930176,1.0,7/31,14.21%,STAT3;NCOA3;STAT5B;ANXA1;NRIP1;STRN3;TGFB1
prerank,mitotic cytokinetic process (GO:1902410),0.48446159014292667,1.1613672618786024,0.2893481717011129,0.6475362805901903,1.0,6/20,8.94%,KIF20A;MITD1;CHMP4A;CHMP4B;PDCD6IP;RHOA
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",-0.45015488285380023,-1.1613573620935467,0.2650918635170604,0.7299999716841686,1.0,7/15,14.19%,CSTF2;RTRAF;FAM98B;TSEN2;TSEN34;ZBTB8OS;RTCB
prerank,lipoprotein catabolic process (GO:0042159),-0.4945669950850874,-1.1613075059020272,0.2755344418052256,0.7283247950433223,1.0,4/11,7.31%,CTSD;APOE;ABHD17C;ABHD10
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),0.4559347435615819,1.1609744823007981,0.2627627627627628,0.6479281015913837,1.0,5/27,3.83%,PPARG;NFKB1;CD36;PRKCH;NFKBIA
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.3563907474505809,1.1606484946929103,0.20310765815760268,0.648170439633687,1.0,41/166,18.05%,RARA;NOTCH2;HNF4G;PPARG;GTF2F2;TAF1A;TAF13;TAF9;GTF2E2;POLR2C;TBL1XR1;RBPJ;SMARCA5;POLR1G;THRA;RARG;CCNH;GTF2A1;E2F2;HDAC9;NR3C1;MED26;TAF7;TFAM;TEAD1;ERCC3;KAT2B;HDAC3;POLR1B;RSF1;MAZ;CREBBP;TAF1;MAML1;MED1;TFB1M;MED7;TAF1C;NR4A1;HDAC7;HDAC1
prerank,arachidonic acid secretion (GO:0050482),0.5618579632474583,1.1604745226863147,0.31261101243339257,0.6473898823961041,1.0,2/10,10.39%,ACE;ANXA1
prerank,arachidonate transport (GO:1903963),0.5618579632474583,1.1604745226863147,0.31261101243339257,0.6473898823961041,1.0,2/10,10.39%,ACE;ANXA1
prerank,negative regulation of Ras protein signal transduction (GO:0046580),0.43736420694025513,1.1599912416571896,0.28055555555555556,0.6480102979512625,1.0,13/35,18.79%,HEG1;CCDC125;CUL3;RIPOR2;DLC1;EPHB2;ITGA3;MAPKAP1;STMN3;KCTD13;ABL2;KANK1;SCAI
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),0.3576556295764734,1.1598610692977387,0.19607843137254902,0.6477385262492333,1.0,70/168,23.83%,RPL5;RPS10;RPL37A;RPL6;RC3H1;RPS18;HELZ2;XRN2;PNLDC1;RPS14;RPL35A;DCP2;PPP2R2A;CNOT6;TUT1;MAGOHB;RPL13;ERI1;ETF1;TENT2;DHX34;RPS3;CNOT2;RPS21;UPF2;MTPAP;DCP1A;TUT7;RPL34;RPLP0;SMG1;RPL19;RPL11;RPL30;RPS2;RPL4;RPL7;MRTO4;EIF3E;TENT4B;RPS15A;NCBP1;RPS4X;PABPC1;SMG6;CNOT8;GSPT1;RPL32;RPSA;RPS13;UPF3B;TNKS1BP1;RPS6;RPL18A;RPS27;CNOT6L;RPLP2;UPF3A;PARN;RPL22;RPS7;RPS12;CNOT3;PPP2CA;RPL10A;RPS25;RPL9;RPS16;RPL23;RPL17
prerank,steroid hormone mediated signaling pathway (GO:0043401),-0.46384636556053527,-1.1596418046890002,0.27634660421545665,0.7314456285516577,1.0,6/13,15.74%,PLPP1;PGR;NR3C2;CALCOCO1;ESR1;AR
prerank,negative regulation of cholesterol transport (GO:0032375),0.5515580026604541,1.1595938080679702,0.3127208480565371,0.6477976161879957,1.0,2/10,13.62%,NFKB1;SREBF2
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),0.44634773118259463,1.159554938503268,0.28347578347578345,0.6473083636469824,1.0,12/29,21.53%,DTX3L;FBXW7;AXIN1;DCUN1D1;UBE2N;DCUN1D3;RPS2;PIN1;PINK1;PARK7;FEM1B;ARRDC4
prerank,positive regulation of transferase activity (GO:0051347),0.3589518662467232,1.1594709821911546,0.22111111111111112,0.6469151554570954,1.0,30/142,16.27%,CD74;FLT3;KLF4;RET;LMTK2;DTX3L;PKIB;SORL1;MRE11;FBXW7;AXIN1;DCUN1D1;UBE2N;EPHB2;PARM1;WRAP53;TNKS;MAP3K4;CHTF18;DSTYK;DCUN1D3;KIT;RPS2;TGFB1;FGFR3;AURKB;MAPK1;TCP1;POLG2;INSR
prerank,regulation of chondrocyte differentiation (GO:0032330),0.46993334092557737,1.159298242871587,0.30434782608695654,0.6467626026409523,1.0,1/24,0.16%,TRPS1
prerank,positive regulation of chemotaxis (GO:0050921),-0.33658845222454514,-1.1588707722420324,0.20481927710843373,0.7319016644106908,1.0,9/43,5.41%,LGMN;TREM2;P2RY12;NRP1;NTRK3;FGF2;AIF1;PTN;P2RX4
prerank,negative regulation of cell growth (GO:0030308),-0.28088316429702015,-1.1585126597745168,0.13513513513513514,0.7311594290448533,1.0,39/121,21.87%,APBB2;DIP2B;DCC;ULK2;FLCN;VGLL4;MAP2;FGF13;ENPP1;NDRG3;IP6K2;ADAM15;CDKL3;CAPRIN2;PRDM11;RERG;SLIT2;DNAJB2;SMAD3;DCBLD2;GJA1;SLIT3;TCHP;TGFB2;APBB1;CGRRF1;ACVR1B;SPHK2;DDX3X;ING1;SESN2;HYAL1;NDUFA13;MT3;PPP2R1A;RACK1;GNG4;CCDC85B;DACT3
prerank,negative regulation of histone methylation (GO:0031061),0.5588906133768102,1.1583745151760612,0.30256410256410254,0.6484671127804218,1.0,1/10,0.35%,JARID2
prerank,negative regulation of cell migration (GO:0030336),0.36860529388831165,1.1582310366933586,0.21436716077537057,0.6482212971826146,1.0,17/137,8.19%,CD74;SRGAP2;SRGAP3;STK24;MARVELD3;NGFR;PTPRU;DPEP1;CLIC4;DLC1;RNF20;AFDN;PTEN;ARHGDIB;PHLDB2;ENG;RAC1
prerank,eye development (GO:0001654),0.4033313136571562,1.158105792203843,0.25432756324900135,0.6479648936078368,1.0,9/54,10.94%,MAB21L2;SIPA1L3;NIPBL;COL5A2;ATF6;HIPK2;HIPK1;FBN1;PBX1
prerank,glycosaminoglycan biosynthetic process (GO:0006024),0.3757154669313263,1.1577699268460582,0.23647058823529413,0.6482219782050866,1.0,17/95,13.15%,IL1B;ST3GAL1;ST3GAL4;EXT1;B4GALT5;GPC3;HSPG2;CHST12;PXYLP1;XYLT1;ACAN;NCAN;GALNT5;SDC3;SLC10A7;CHST15;UST
prerank,regulation of DNA binding (GO:0051101),0.42059970722821616,1.156986862916953,0.257516339869281,0.6496625750355864,1.0,13/44,14.74%,SP100;NGF;BCL3;PPARG;JAK2;NFKBIA;SUMO1;DOT1L;CPNE1;MAPK8;TGFB1;RSF1;ILRUN
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),-0.36436313099760875,-1.156326955568568,0.24067796610169492,0.7357335015122424,1.0,19/31,36.28%,SYT1;SCAMP5;RAB3GAP1;SYT9;SYT7;STX1A;SYT6;CBARP;SYT8;CACNA1I;KCNB1;SYT3;SYT12;SYT11;SYT13;SYT10;SYT5;SYT4;SYT17
prerank,production of siRNA involved in RNA interference (GO:0030422),-0.4956305985127901,-1.1561612868355235,0.2975609756097561,0.7344271888456932,1.0,4/10,28.15%,TSN;TSNAX;DROSHA;MRPL44
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),-0.3038692866197346,-1.1561451156644351,0.17010309278350516,0.7326971873519438,1.0,15/75,10.40%,OPHN1;DCC;MEF2C;MAP2;MAP1B;CTNNA2;CNTN4;BTBD3;FGFR2;RYK;AFG3L2;MAP1A;PARD3;CDK5;KLF7
prerank,positive regulation of exosomal secretion (GO:1903543),0.5007481749685906,1.1560906664333657,0.29510703363914376,0.651318005061454,1.0,5/15,11.10%,RAB7A;TSG101;PDCD6IP;SNF8;STAM
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),0.4630190172093137,1.1560880266433522,0.273542600896861,0.6507268803519508,1.0,9/24,18.80%,PSME3;GPX1;PSME2;PTK2B;LATS1;EFNA1;USP14;CTSC;PINK1
prerank,peptidyl-proline modification (GO:0018208),-0.3787567203209292,-1.1560663010787373,0.25732899022801303,0.731141259063449,1.0,8/25,20.70%,P3H2;FKBP5;PPIA;CWC27;PPIE;OGFOD1;FKBP7;PPID
prerank,positive regulation of vacuole organization (GO:0044090),0.5408193520270612,1.1559535647566397,0.2904929577464789,0.6504675181175549,1.0,4/10,10.35%,PIP4K2A;ANXA2;RALB;PIP4K2B
prerank,negative regulation of protein catabolic process (GO:0042177),-0.34272485023819366,-1.155760562770781,0.23076923076923078,0.7302468666810694,1.0,12/40,15.47%,TIMP2;NELL1;SNRNP70;CTSA;CST3;TIMP3;FMN2;RIC1;CYP51A1;DAB2IP;PTPN3;ADGRB1
prerank,programmed necrotic cell death (GO:0097300),0.490511427712915,1.1556274087017877,0.2922824302134647,0.6506890875530079,1.0,7/18,15.45%,ITPK1;TLR3;CYLD;RIPK1;PGAM5;DNM1L;IPMK
prerank,positive regulation of RNA splicing (GO:0033120),0.45281089281726283,1.1556013207352989,0.2763744427934621,0.6501422291025027,1.0,10/29,15.48%,HSPA1A;ERN1;PRDX6;SETX;DYRK1A;NUP98;RBM22;ZPR1;HNRNPLL;NCBP1
prerank,regulation of interleukin-13 production (GO:0032656),0.5296946571751211,1.155548956665806,0.31270903010033446,0.6496868085765909,1.0,2/13,5.53%,RARA;IRF4
prerank,regulation of RNA export from nucleus (GO:0046831),-0.48636995616415557,-1.155320300328134,0.28087167070217917,0.7298321819899669,1.0,6/11,16.52%,NSUN2;CPSF6;AKAP8L;DHX9;IWS1;TPR
prerank,nucleotide-sugar metabolic process (GO:0009225),0.5447595454209443,1.1548362420448266,0.28929765886287623,0.6509589245483561,1.0,6/12,16.29%,GMDS;UGP2;PARG;SLC35A3;CSGALNACT1;FUT8
prerank,DNA geometric change (GO:0032392),0.46936213944414656,1.15466632999636,0.2897897897897898,0.6507825999163718,1.0,6/24,11.18%,DNA2;MRE11;WRN;ASCC3;ANXA1;RECQL5
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),-0.4700775912980333,-1.1545761214912895,0.2823834196891192,0.7302881894087124,1.0,6/13,17.65%,LGMN;EIF2AK4;ZDHHC2;CHRNA7;SQSTM1;ADCY8
prerank,protein kinase A signaling (GO:0010737),0.5313481832159859,1.1541202376279276,0.31069609507640067,0.6515877033317821,1.0,2/12,7.99%,LCP1;EZR
prerank,acylglycerol catabolic process (GO:0046464),-0.3674043939904411,-1.1534787009685918,0.2603550295857988,0.7319611023965154,1.0,4/30,6.30%,ABHD12;MGLL;DAGLA;FABP5
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),0.48529684718578137,1.1532361133228515,0.29505582137161085,0.6532541345632285,1.0,7/17,18.30%,HCK;STAP1;CDC42;BCAS3;HCLS1;FES;HAX1
prerank,C21-steroid hormone biosynthetic process (GO:0006700),-0.4795754780289394,-1.1528749621624295,0.3125,0.7318222500242345,1.0,6/12,38.72%,STARD3;AKR1B1;FDX1;TSPOAP1;STAR;CACNA1H
prerank,negative regulation of innate immune response (GO:0045824),0.4313750288257614,1.1527919457526492,0.2805232558139535,0.6538309109090156,1.0,11/34,15.80%,SAMHD1;DHX58;YTHDF3;USP15;SLAMF8;FAM3A;CACTIN;ACOD1;STAT2;METTL3;IRAK3
prerank,action potential (GO:0001508),0.4093798758995465,1.152491901347797,0.2699468085106383,0.6540514238420259,1.0,4/44,3.56%,KCNE3;GNA14;KCNQ1;CHRNA4
prerank,membrane repolarization (GO:0086009),0.49799061348626483,1.1523271317133188,0.288,0.6538685438051517,1.0,2/15,3.31%,KCNE3;KCNQ1
prerank,entrainment of circadian clock by photoperiod (GO:0043153),0.44722466610177236,1.152213179826712,0.30118694362017806,0.6535436281663077,1.0,10/27,15.58%,SIK1;CRY1;FBXL8;CRY2;ID2;FBXL17;PPP1CB;PDE6B;FBXL12;BHLHE40
prerank,axon extension (GO:0048675),-0.39270562261667963,-1.1521572505707411,0.24183006535947713,0.732224632414811,1.0,14/23,20.69%,ULK2;NRP1;AUTS2;NRP2;MAP1B;SLC9A6;SLIT2;CDK5;SLIT1;SLIT3;NLGN3;HSP90AB1;SEMA5B;CYFIP1
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",-0.4442429020548709,-1.1521384004970971,0.26288659793814434,0.7305566151147412,1.0,10/15,36.94%,NLGN1;USP46;NLGN2;CNTNAP4;ADRA1A;CLN3;HAP1;DRD2;BAIAP3;SYN3
prerank,cellular response to glucocorticoid stimulus (GO:0071385),0.4950044400719516,1.1521210177719758,0.2980769230769231,0.6531848769986163,1.0,5/18,12.90%,ZFP36L2;ANXA1;NR3C1;REST;KLF9
prerank,endomembrane system organization (GO:0010256),0.35482256642629145,1.1519797805791736,0.20588235294117646,0.6529625525198189,1.0,39/178,16.10%,ATP8B4;LRRK2;FAM174B;PLEKHF1;DYSF;USP6NL;GOLPH3L;TMCC1;LEMD3;CDC42;SRGN;CAV2;PI4K2B;STX17;TMED10;GBF1;SYP;BCAS3;ATL3;ARFGEF1;LMAN2L;ARHGAP21;LEMD2;DMPK;TRAPPC11;SPTSSB;HTT;DNM1L;EIF2AK3;SYNGR2;CLASP1;VMP1;RAB29;ATL1;TMED7;SNX33;VAPA;HACE1;TJAP1
prerank,regulation of protein acetylation (GO:1901983),-0.47377480252428084,-1.1519502321404211,0.27954545454545454,0.7293699413356369,1.0,6/12,27.14%,CAMK1;TERF2IP;DDX3X;FAM161A;RAPGEF3;KAT5
prerank,positive chemotaxis (GO:0050918),-0.4166403103597822,-1.1519359427612494,0.2845528455284553,0.7277069825759884,1.0,9/17,21.06%,NRP1;SCRIB;SCG2;VEGFA;TSC2;CX3CL1;PLXNB3;ANGPT1;FGF10
prerank,cellular response to drug (GO:0035690),0.4581699389036259,1.151904040739384,0.30600292825768666,0.6525742344558817,1.0,7/25,11.90%,IL1B;KCNQ1;DPEP1;CERS1;RBM22;SLAMF8;REST
prerank,negative regulation of actin filament bundle assembly (GO:0032232),0.4527591602447603,1.1518136321201589,0.2854984894259819,0.6521875252980779,1.0,7/27,7.54%,ARHGEF18;WASF2;DLC1;ARAP1;PAK2;PHLDB2;F11R
prerank,anterograde synaptic vesicle transport (GO:0048490),-0.4406280679494169,-1.1516748516590678,0.2659279778393352,0.7250764300773895,1.0,5/15,15.46%,DTNBP1;AP3M2;AP3B1;AP3B2;BLOC1S5
prerank,synaptic vesicle transport along microtubule (GO:0099517),-0.4406280679494169,-1.1516748516590678,0.2659279778393352,0.7250764300773895,1.0,5/15,15.46%,DTNBP1;AP3M2;AP3B1;AP3B2;BLOC1S5
prerank,heterochromatin organization (GO:0070828),0.5058257572133097,1.1514869767320788,0.30807248764415157,0.6524776362787376,1.0,6/14,18.89%,SMCHD1;SETD7;SETDB2;EZH1;SIRT1;HP1BP3
prerank,negative regulation of protein depolymerization (GO:1901880),-0.3963904580698324,-1.15143522073559,0.26273458445040215,0.724062941021168,1.0,7/24,11.82%,NAV3;CAMSAP1;FGF13;CLASP2;LIMA1;PLEKHH2;CAMSAP2
prerank,positive regulation of response to wounding (GO:1903036),0.46006264655260143,1.1513265642868877,0.3073394495412844,0.652270287395145,1.0,9/24,20.74%,PRKCE;CLDN1;ADRA2A;ARFGEF1;ANXA1;OCLN;KANK1;PTK2;INSL3
prerank,protein tetramerization (GO:0051262),-0.30243603545687137,-1.1509498900978377,0.21,0.7238506071884803,1.0,16/67,13.61%,RYR3;ACACA;APPL2;PKD2;KCNJ2;ALDH9A1;GOLGA2;MCOLN1;CPSF6;OXA1L;HCN1;USP16;TRPM2;CBR4;AQP4;HSD17B8
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.45703521432794475,1.150948570699328,0.2809667673716012,0.6525859285679863,1.0,11/25,19.84%,CDK13;HEXIM1;RECQL5;NELFA;CDK12;EAF1;ELL;SUPT4H1;BRD4;RNF168;LARP7
prerank,cyclooxygenase pathway (GO:0019371),-0.48787276244512323,-1.1507932914691388,0.28354430379746837,0.7225994940831707,1.0,2/10,0.82%,HPGDS;PTGS1
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),-0.39205525968301713,-1.1507493748149498,0.25770308123249297,0.7210695754286804,1.0,14/22,36.29%,ATF4;SMARCB1;UTP15;PWP1;PHF8;PIH1D1;DDX11;WDR43;LYAR;IPPK;WDR75;MTOR;SMARCA4;NCL
prerank,phagosome acidification (GO:0090383),-0.3836783209507272,-1.1507413200469798,0.27631578947368424,0.7194176814838731,1.0,9/26,12.66%,ATP6V1C1;ATP6V0B;ATP6V0D2;ATP6V0C;TCIRG1;ATP6V1B2;ATP6V1D;ATP6V0D1;ATP6V0A1
prerank,neuron projection morphogenesis (GO:0048812),0.3628894622424552,1.1505992961983804,0.23595505617977527,0.6528811930784771,1.0,18/137,9.08%,LRRK2;ALCAM;IQGAP1;SRGAP2;NGF;LMTK2;NTNG2;PAK1;SHTN1;DOCK10;CDC42;TAOK3;PTEN;ATP7A;EPHB2;MINK1;ZDHHC17;CPNE1
prerank,regulation of Rho protein signal transduction (GO:0035023),0.38687919594044506,1.1505919705716365,0.2490613266583229,0.6523124709044472,1.0,22/72,17.50%,ARHGEF18;EPS8;HEG1;CCDC125;CUL3;GPR35;RIPOR2;BCR;DLC1;ARHGDIB;F11R;RAC1;NET1;ITGA3;ARHGEF3;LPAR6;KCTD13;STARD13;ARHGEF28;ABL2;GPR65;KANK1
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),0.4704507763850151,1.1504693732981244,0.30340557275541796,0.6520530020198881,1.0,5/21,12.90%,RPL5;MAD2L2;PTEN;UBE2S;RPL11
prerank,negative regulation of type I interferon production (GO:0032480),0.4174359975186143,1.1503272368211923,0.29379310344827586,0.6518460742636889,1.0,13/40,15.47%,LILRB1;ITCH;DHX58;REL;NLRX1;IFIH1;TRIM25;CYLD;CACTIN;ACOD1;ILRUN;GPATCH3;TBK1
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.35733155534886846,1.1501072294607695,0.23852183650615902,0.6518251980378775,1.0,33/138,18.05%,RARA;NOTCH2;HNF4G;PPARG;GTF2F2;TAF13;TAF9;GTF2E2;POLR2C;TBL1XR1;RBPJ;THRA;RARG;CCNH;GTF2A1;E2F2;HDAC9;NR3C1;MED26;TAF7;TEAD1;ERCC3;KAT2B;HDAC3;MAZ;CREBBP;TAF1;MAML1;MED1;MED7;NR4A1;HDAC7;HDAC1
prerank,regulation of fibroblast proliferation (GO:0048145),0.4062334689404455,1.1494160696706812,0.27800269905533065,0.6529936019131545,1.0,2/45,2.92%,CD74;CD300A
prerank,amino acid transmembrane transport (GO:0003333),-0.32983312596642045,-1.1487519585899277,0.23529411764705882,0.7234629884566786,1.0,8/45,6.04%,SLC38A6;MFSD12;SLC7A6;SLC7A1;SLC36A4;SLC7A7;SLC36A1;SFXN1
prerank,peptidyl-amino acid modification (GO:0018193),-0.5071658792584507,-1.148697212594773,0.30616740088105726,0.7219299956241604,1.0,2/10,3.63%,METAP1D;METAP2
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",0.47225188404446566,1.148681849594274,0.30265210608424337,0.6542503360443096,1.0,10/22,18.94%,CDK13;KAT7;SCAF8;CCNT2;CCNT1;CDK12;HMGN1;ELL;SUPT4H1;BRD4
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.44715674112788967,1.1486615821393378,0.2960812772133527,0.6537210235016925,1.0,7/28,11.01%,DTX3L;MAD2L2;SMCHD1;ACTR2;WRAP53;PARP9;KMT5B
prerank,regulation of actin filament polymerization (GO:0030833),0.38763310756060376,1.1486603495298693,0.25798212005108556,0.6531363543957387,1.0,12/69,10.61%,CYRIB;HCK;PRKCE;ARHGAP18;CARMIL1;PTK2B;KANK3;MTPN;LATS1;ARFGEF1;SNX9;VASP
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),0.5215993487937144,1.1485752006023549,0.3135048231511254,0.6527527604350504,1.0,5/13,16.00%,BTG2;EIF4ENIF1;TNRC6B;TNRC6A;PABPC1
prerank,regulation of T cell migration (GO:2000404),0.47764756626047683,1.148054575839755,0.3,0.6534859591772977,1.0,6/18,13.88%,CXCL10;RIPOR2;SPN;RHOA;APP;LRCH1
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),0.5252324238282955,1.148015208684241,0.30976430976430974,0.6530037972648692,1.0,5/12,13.58%,SMCHD1;YTHDC1;RBM15;METTL3;CDYL
prerank,TOR signaling (GO:0031929),0.4460731737623763,1.1473298930098672,0.3035971223021583,0.6541531369855762,1.0,13/26,21.55%,CARD11;EIF4EBP1;CCDC88A;SMG1;AKT1;MAPKAP1;PRR5;RPS6KB1;SYAP1;PINK1;RPS6;RICTOR;TIPRL
prerank,regulation of biomineral tissue development (GO:0070167),-0.37196690595568316,-1.1465271268378028,0.2608695652173913,0.7264799158564194,1.0,6/26,7.87%,GAS6;ANKH;ENPP1;BMP2K;NBR1;S1PR1
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),0.5186180669940021,1.1461603882412346,0.3187919463087248,0.6565069568463028,1.0,5/14,15.48%,ERN1;FIP1L1;TUT1;NUDT21;NCBP1
prerank,positive regulation of lipid biosynthetic process (GO:0046889),0.4402608624926375,1.1460702902440765,0.29004329004329005,0.6561620688695115,1.0,8/29,13.78%,CREB1;LDLR;ZBTB20;SCARB1;ELOVL5;CREBL2;AKT1;SIRT4
prerank,atrial cardiac muscle cell action potential (GO:0086014),-0.4644845914119055,-1.1458334467194016,0.2949061662198391,0.7268723283071316,1.0,5/13,12.22%,CACNB2;CACNA1C;ANK2;KCNN2;GJA1
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),-0.37004554493288727,-1.1455420885358922,0.24749163879598662,0.7259777164372052,1.0,7/29,10.38%,NAPA;COPA;RAB6B;GOLGA5;VTI1B;GOSR2;COPE
prerank,negative regulation of JNK cascade (GO:0046329),0.43459719575270894,1.1452696291654563,0.3042212518195051,0.6575408796914456,1.0,9/31,14.82%,PTPN22;MARVELD3;ITCH;TAOK3;PDCD4;CYLD;HDAC3;GPS2;GSTP1
prerank,skeletal system development (GO:0001501),0.35713189242701565,1.144930927320952,0.23464912280701755,0.6577787030715442,1.0,25/148,14.26%,TRPS1;CD44;EXT1;SULF2;ANKRD11;RPS6KA3;NOTUM;PTGER4;DEAF1;PAPSS1;ATP7A;BMP3;XYLT1;PAPSS2;RPL13;ACAN;FBN1;TLL1;NCAN;ETS2;SLC10A7;EIF2AK3;PCSK5;CNMD;FGFR3
prerank,synapse organization (GO:0050808),-0.2787233158752407,-1.1448491833608376,0.14655172413793102,0.7263579091941915,1.0,28/125,16.11%,APBB2;CX3CR1;C1QB;PTPRD;C1QA;CACNB2;NLGN1;C1QC;NRXN2;PPFIA4;RYK;SEMA3E;SDK1;C5AR1;GPM6A;CHRNA7;GPC6;CDK5;GRM5;PPFIBP1;PPFIBP2;NLGN2;AGRN;ADGRL3;CX3CL1;SLITRK1;KIRREL3;NLGN3
prerank,actin crosslink formation (GO:0051764),0.5343335991733179,1.1443579818941427,0.3184931506849315,0.6586881482459713,1.0,3/12,6.97%,LCP1;EPS8;FLNA
prerank,epithelial cell morphogenesis (GO:0003382),0.4845408734630403,1.1441154168502554,0.3213728549141966,0.6587252182347488,1.0,4/17,13.95%,SIPA1L3;CCDC88C;RILPL2;CNMD
prerank,phagosome maturation (GO:0090382),-0.35250034864194474,-1.1438819231955872,0.23487544483985764,0.7274730346032614,1.0,13/35,12.66%,ATP6V1C1;ATP6V0B;ATP6V0D2;ATP6V0C;TCIRG1;ATP6V1B2;RAB31;ATP6V1D;RAB32;MCOLN1;ATP6V0D1;MREG;ATP6V0A1
prerank,insulin secretion (GO:0030073),-0.4130318830609132,-1.1438143927214042,0.25936599423631124,0.7260002442985055,1.0,4/19,7.30%,PTPRN2;RAB11FIP2;RAB11FIP5;SNX19
prerank,regulation of glycolytic process (GO:0006110),0.38618171741528806,1.1437609676528266,0.26763990267639903,0.6590348103531896,1.0,18/68,16.97%,CBFA2T3;NUP210;PRKAG2;ZBTB20;PRXL2C;NUP98;GIT1;PRKAG1;PRKAA1;APP;NUP153;PFKFB3;PRKAA2;PFKFB4;SEH1L;INSR;PSEN1;GCK
prerank,histone H3 acetylation (GO:0043966),0.4257871219320279,1.1437496809288226,0.2868965517241379,0.6584781815389441,1.0,11/40,13.96%,TAF9;SPI1;KAT7;TRIM16;TADA3;MBIP;KAT6A;TADA2A;JADE3;MAP3K7;KAT2B
prerank,vesicle transport along microtubule (GO:0047496),0.4745470205123593,1.1437287576362425,0.3071528751753156,0.6579313759510567,1.0,8/23,14.70%,KIF5B;FBXW11;PAFAH1B1;KIF3B;DYNC1H1;HTT;KIF5A;FYCO1
prerank,microtubule-based transport (GO:0099111),0.5314507602896908,1.1433564573219672,0.3203252032520325,0.6582929258937272,1.0,4/12,17.12%,ADCY10;CABYR;HTT;DYNC1I2
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),-0.42924556345658754,-1.1430002501729977,0.2732732732732733,0.7266927305200128,1.0,7/16,31.56%,IGF1;IGFBP5;IGFBP2;IGFBP4;ZFAND2B;IGFBP3;BMP5
prerank,regulation of protein processing (GO:0070613),0.47426849724263903,1.1429910177858995,0.2996987951807229,0.6585806380966235,1.0,3/21,10.12%,LRRK2;PRNP;NLRC4
prerank,positive regulation of interferon-alpha production (GO:0032727),0.4720812474089336,1.1427920518358152,0.30340557275541796,0.658464293730092,1.0,10/19,21.92%,STAT1;IFIH1;TLR3;IRF7;SETD2;TBK1;IRF5;HSPD1;RIPK2;TLR8
prerank,RNA export from nucleus (GO:0006405),-0.2786817047868632,-1.1427007327548682,0.1597222222222222,0.7259164679369137,1.0,34/100,19.43%,SRSF5;SRSF3;DDX39B;NUP54;RNPS1;NUP133;SRSF7;SYMPK;NUP155;ALKBH5;NUP188;UPF1;THOC5;DHX38;NXF1;DDX19B;RANBP2;ZC3H11A;SEC13;SRSF2;DDX39A;NUP85;GLE1;NUP42;SMG7;TPR;RAN;NUP35;CASC3;SRSF1;MCM3AP;FYTTD1;HNRNPA2B1;NUP37
prerank,COPII-coated vesicle cargo loading (GO:0090110),-0.4479991647770269,-1.1425164457257555,0.2898936170212766,0.7247386697186043,1.0,9/14,31.43%,SEC23B;TBC1D20;SEC23A;SEC13;SAR1A;SEC24A;SEC24D;SEC31B;SEC24B
prerank,protein import into peroxisome matrix (GO:0016558),0.518618822737991,1.1424308205430997,0.3164128595600677,0.6588543433154572,1.0,4/12,13.10%,PEX16;PEX12;PEX14;PEX5L
prerank,regulation of anoikis (GO:2000209),0.4750092938070497,1.1421824021223927,0.3037974683544304,0.6588795700161664,1.0,5/19,15.59%,SIK1;MCL1;PIK3CA;TLE1;ITGA5
prerank,acyl-CoA biosynthetic process (GO:0071616),-0.43715086444747414,-1.142110047806069,0.2896174863387978,0.7242534446676306,1.0,10/16,27.20%,ACACA;CBR4;HSD17B8;MLYCD;DIP2A;GCDH;PPCS;ACSS1;SCD;FASN
prerank,negative regulation of protein phosphorylation (GO:0001933),0.35553797898283335,1.1417536692263517,0.22430939226519336,0.659382803932628,1.0,38/150,17.53%,NIBAN1;LRRK2;PID1;PTPRC;LYN;PRKAG2;PTPN6;IBTK;PRKRIP1;PTEN;PRNP;PDPK1;SAMSN1;CIB1;PAK2;DDIT4;PAQR3;ENG;EPHB2;SPRED3;GSKIP;PMEPA1;DBNDD2;CACTIN;TAF7;PPP1R15B;AKT1;MVP;DNAJC3;TGFB1;GSTP1;OCLN;SPRED1;MYADM;RB1;SEMA4D;RASSF2;TAB1
prerank,response to endoplasmic reticulum stress (GO:0034976),0.3593484507940337,1.141629563342712,0.2502883506343714,0.6591125130036468,1.0,18/107,13.09%,ITPR1;NIBAN1;MAP3K5;ERN1;ERP44;ATF6;ATP2A3;BBC3;WFS1;ATP2A1;PPP1R15A;MBTPS1;DNAJB12;AIFM1;PPP1R15B;ATF6B;EIF2AK3;ATG10
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),-0.44051541348943685,-1.1412959155737068,0.2913165266106443,0.7251327087584303,1.0,6/15,16.47%,WHRN;SCN1A;HPN;KCNA1;ADGRV1;TMEM120A
prerank,regulation of presynapse assembly (GO:1905606),-0.41357731676398246,-1.1411764974886622,0.28346456692913385,0.7221803532255349,1.0,6/18,15.30%,PTPRD;IL1RAPL1;VPS35;GPC6;EIF4G1;SLITRK1
prerank,regulation of presynapse organization (GO:0099174),-0.41357731676398246,-1.1411764974886622,0.28346456692913385,0.7221803532255349,1.0,6/18,15.30%,PTPRD;IL1RAPL1;VPS35;GPC6;EIF4G1;SLITRK1
prerank,neuron projection extension (GO:1990138),-0.3499552631005743,-1.1410421277032219,0.23411371237458195,0.7209426265171494,1.0,13/32,10.32%,ULK2;NRP1;AUTS2;NRP2;MAP1B;TMEM108;CTNNB1;CDKL3;EIF2AK4;IMPACT;SLC9A6;SH3GL2;CDK5
prerank,macrophage activation involved in immune response (GO:0002281),0.5129240271866495,1.1410156719898625,0.3356401384083045,0.6600348432090715,1.0,5/13,9.99%,PLCG2;SYK;DYSF;IFI35;SBNO2
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),0.456189431223756,1.140781441596162,0.29154078549848944,0.6600773463444324,1.0,8/26,19.97%,PLCG2;CD36;ABCB7;PIKFYVE;ABCD1;CYBA;MMP8;PARK7
prerank,cognition (GO:0050890),0.41669223648071557,1.140548849223224,0.2673942701227831,0.6600698610385969,1.0,11/42,12.09%,ST3GAL4;NIPBL;CHRNA4;DGCR2;PTCHD1;RP9;SETD5;MGAT3;MAGT1;SLC1A4;APP
prerank,protein polyubiquitination (GO:0000209),0.33866285538298435,1.1402634745993787,0.2032854209445585,0.6601848759122866,1.0,82/297,18.60%,TRAF1;DTL;LNPEP;ITCH;PSME3;DTX3L;NEDD4L;CUL3;UBE2E1;PSMB7;FBXW7;ANKIB1;RNF146;PSME2;TRIM62;ARIH1;TRAF3IP2;RNF213;RNF20;PELI1;RC3H1;UBE2QL1;UBE2D3;SPOP;FBXW11;FBXL8;UBE2N;RNF217;UBR5;FBXO38;FBXW2;HECTD1;CBFB;TRAF3;FBXO4;UBR2;PSME4;ARIH2;TNKS;WWP2;TRIM71;UBE2W;FBXO32;PSMB8;PSMA5;PSMD9;TRIM14;HERC6;RNF31;PSMB3;UBE2S;FBXL17;PSMD6;PSMC4;LONRF1;TPP2;PSMD10;UBE2G1;AREL1;PSMB1;FBXL12;HECTD2;FBXO30;UBE2J2;FBXO7;ANAPC7;RNF166;TAF1;RNF41;HACE1;FBXL16;PSMD12;TRIM36;RNF144A;UBE2Q2;TRAF2;RNF19B;SMURF2;ANAPC11;FZR1;FBXL14;ANAPC4
prerank,negative regulation of histone modification (GO:0031057),0.5150364665434193,1.1401190163005646,0.3310580204778157,0.6599753832960421,1.0,1/14,0.35%,JARID2
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),0.44709334333702905,1.139673778871172,0.2946298984034833,0.6605007635119391,1.0,4/27,6.71%,AHNAK;HPCA;ADRA2A;CACNB1
prerank,regulation of mitotic sister chromatid separation (GO:0010965),-0.43628419545426605,-1.1396305449552384,0.3010204081632653,0.7232663961622143,1.0,6/15,24.18%,NEK6;TPR;CDC16;CENPE;TACC3;ANAPC1
prerank,fluid transport (GO:0042044),-0.46692657574102203,-1.1391817805123663,0.29974811083123426,0.7229756581200336,1.0,3/12,27.22%,AQP4;SLC26A6;PDPN
prerank,"regulation of transcription, DNA-templated (GO:0006355)",0.3275349563834888,1.1383158985373514,0.039,0.6633864907229101,1.0,252/1646,13.62%,CD74;CIITA;CBFA2T3;BCL11A;TRPS1;NFE2;ZBTB46;IL1B;BACH2;JARID2;FOXP1;RUNX2;HIVEP2;RARA;SP100;SP3;BAZ1A;RUNX3;STAT4;LIMD1;TOX4;GLI1;HNF4G;BCL3;KLF4;UXT;CREB1;RET;MAP3K5;PPARG;MED13L;ETV6;STAT5A;SCML4;BCL6;SAP30;PKN1;POLR3F;NFKB1;PITX3;ATF7IP;FOSL2;DTX3L;STAT3;BAZ2B;EHF;NSD3;FOXJ1;ELF4;RFX7;NIPBL;FOS;KDM7A;CRK;NAB1;TCF20;RPS6KA3;CIART;MAD2L2;REL;RBBP8;ZBTB20;CRLF3;CDC45;SPI1;STAT5B;NAA16;MYRF;CRY1;SCX;ATAD2;TBL1XR1;MTA3;PICALM;IKBKB;MED30;ZEB2;MBD1;SUMO1;PGBD1;CAMTA2;KAT7;ATF6;LRRFIP1;KLF8;RYBP;AXIN1;ATF2;IRF2;RFX3;RPL6;ZNF319;RBPJ;BTG1;WAC;HIVEP1;DEAF1;MED13;STAT1;HIPK2;RNF20;KLF5;IRF4;HEXIM1;MBTD1;MAPK14;FBXW11;BBX;RFX5;RPS6KA5;SMARCA5;CDK14;KLF13;FAM47E;TSHZ1;TRIM16;DEK;KLF10;CDC5L;SEC14L2;ELOA;AHR;ANXA4;CREBRF;PHF19;TADA3;ARID4A;CBFB;CREM;SRSF10;IKZF3;NFE2L2;PDCD4;DYRK1A;KDM3B;SETDB2;PURB;HTATSF1;MECP2;PLCB1;AFAP1L2;THRA;CRY2;CLOCK;ZFP3;SAP18;MED6;GATAD2A;CCNH;TOX3;E2F2;ENG;CTCF;PHF12;UIMC1;NFYC;HDAC9;ELF1;ZBTB11;IL6;PEX14;CBFA2T2;BRIP1;BACH1;NFE2L1;ZNF182;SNF8;KAT6A;RBAK;ASCC1;ID2;WWP2;CREBL2;NAA15;EPC2;NCOA2;E4F1;SETD5;PKNOX1;SMARCE1;ZNF496;ZFX;PARP9;IRF7;METTL4;MEF2B;RCOR3;SMAD4;CAMKK2;SBNO2;CNOT2;PSMD9;BNC2;NCOA1;DAXX;IL31RA;CSRNP1;NR3C1;TADA2A;GMEB2;SP140;SPEN;RBM15;PBX1;ING2;CCNT2;SRRT;NLK;MED26;FOXO3;MED12;IKZF5;DEDD2;DVL3;TAF7;ZNF260;ETS2;REST;RPS6KA1;ZNF418;MBD2;ATF6B;NUPR2;BAZ2A;MED14;CCNT1;NFYA;LIN9;TFAM;PQBP1;MSL3;MAP2K3;TEAD1;RGS14;ATRX;L3MBTL2;KLF9;CCNL1;MYB;IFRD1;AKT1;KIT;STAT2;NSD1;CHD4;LBH;NCF1;TLE1;JUNB;HCLS1;EZH2;SREBF2
prerank,regulation of myoblast fusion (GO:1901739),0.5327064013913441,1.1381458016303967,0.3141891891891892,0.6632314125520355,1.0,3/11,5.65%,RIPOR2;EHD2;MAPK14
prerank,regulation of stem cell differentiation (GO:2000736),0.36943563606785024,1.1378770080529115,0.2762691853600944,0.6633335735810164,1.0,23/89,16.30%,ITCH;PSME3;EIF2AK2;PSMB7;PSME2;GDNF;CBFB;PSME4;ZFP36L2;PSMB8;PSMA5;PSMD9;NUDT21;PSMB3;PSMD6;PSMC4;PSMD10;PSMB1;MYB;METTL3;KMT2A;OCIAD1;PSMD12
prerank,positive regulation of phosphate metabolic process (GO:0045937),-0.3791274293355733,-1.1373172834066565,0.2815533980582524,0.7265792715050499,1.0,10/25,21.48%,ITGA6;NRP1;KCTD20;ILK;NCKAP1L;PTGES3;SRC;AR;ANG;MIF
prerank,fibrinolysis (GO:0042730),-0.4483938833517894,-1.1371699144619993,0.30412371134020616,0.7253988372399768,1.0,3/13,21.44%,PLAU;SERPINE1;PLAT
prerank,cellular response to nerve growth factor stimulus (GO:1990090),0.464282483700594,1.1371059196723297,0.3076923076923077,0.664675754077324,1.0,9/22,16.57%,NGF;RAP1A;RAPGEF2;CIB1;AKT1;KIDINS220;EHD1;STMN2;RAB35
prerank,regulation of calcium ion transport (GO:0051924),-0.32116918630472396,-1.1368742826632328,0.21739130434782608,0.7246488041567991,1.0,9/54,5.41%,CACNA1D;CD84;CACNB2;CACNA2D1;CD33;CTNNB1;PKD2;ANK2;P2RX4
prerank,positive regulation of monooxygenase activity (GO:0032770),0.4443643761564931,1.1367588999896263,0.2934947049924357,0.6650069057186808,1.0,4/26,7.73%,IL1B;GDNF;SCARB1;ATP7A
prerank,extracellular matrix assembly (GO:0085029),0.4669124427099848,1.1366948017562184,0.3001531393568147,0.6645746774942849,1.0,4/23,8.30%,NTNG2;LAMB1;ATP7A;PXDN
prerank,visual system development (GO:0150063),0.420003674155669,1.1366761575773792,0.29814550641940085,0.6640329629930706,1.0,5/37,6.12%,MAB21L2;SIPA1L3;ATF6;HIPK2;HIPK1
prerank,positive regulation of actin filament bundle assembly (GO:0032233),0.40367190365875283,1.136547785992692,0.2866666666666667,0.663766253373218,1.0,10/51,8.94%,CD47;PAK1;ARHGEF10L;CCDC88A;CDC42;CARMIL1;S100A10;RAC1;PXN;RHOA
prerank,semaphorin-plexin signaling pathway (GO:0071526),-0.34477202878202506,-1.1362110891821504,0.2627986348122867,0.7248689018301446,1.0,9/35,8.32%,PLXNA4;NRP1;NRP2;PLXNB2;SEMA3D;ARHGDIA;SEMA3E;PLXNA2;SEMA6D
prerank,protein K48-linked ubiquitination (GO:0070936),0.4000203115938418,1.1360666648840507,0.3055555555555556,0.6643544010451339,1.0,11/54,8.23%,ITCH;DTX3L;NEDD4L;CUL3;UBE2E1;RNF146;PELI1;UBE2D3;UBR5;FBXO38;ARIH2
prerank,carnitine metabolic process (GO:0009437),-0.455735796160063,-1.1358439325861813,0.30049261083743845,0.724223596561196,1.0,8/12,32.52%,ALDH9A1;ACADM;ACADL;CPT2;CPT1C;CROT;BBOX1;TMLHE
prerank,positive regulation of binding (GO:0051099),0.37124002162514824,1.1357789554507889,0.27817745803357313,0.6644956535031677,1.0,25/84,18.76%,LRRK2;RARA;TIAM1;NGF;PPARG;DTX3L;RAPGEF2;HIPK2;STK4;RALB;PARP9;B2M;APP;NMD3;RPL11;MARK3;TAF1;NCBP1;DPH3;PSEN1;PLAUR;MMP8;FOXC1;PIN1;STK3
prerank,DNA replication checkpoint signaling (GO:0000076),0.48685546000983637,1.135738090186126,0.3069466882067851,0.664020768216193,1.0,2/16,3.73%,DNA2;CDC45
prerank,ATP transport (GO:0015867),0.5595896037920854,1.1355164032136706,0.31551724137931036,0.6639969903950143,1.0,2/10,11.95%,CD47;SLC25A5
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),-0.4206063714289131,-1.1351908943373763,0.2857142857142857,0.7244214310496996,1.0,5/18,7.72%,GNA15;CHRM3;CHRM2;RGS10;CDK5R1
prerank,cellular response to insulin stimulus (GO:0032869),-0.27097553109739175,-1.1348128042840022,0.168,0.7239263352242619,1.0,26/124,12.66%,PDE3B;BCAR3;ATP6V1C1;ATP6V0B;ATP6V0D2;CPEB2;ATP6V0C;TCIRG1;ENPP1;ATP6V1B2;GAB1;ATP6AP1;CPEB1;GOT1;RAB31;RHOQ;SLC27A1;ATP6V1D;PCK2;IDE;IRS1;ATP6V0D1;PIK3R1;MYO5A;NAMPT;ATP6V0A1
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),0.45920385920884094,1.1346059052338364,0.2993827160493827,0.6651229206338453,1.0,8/23,15.64%,ZEB2;HIPK2;ADAM17;SMAD4;ING2;CITED2;CREBBP;THBS1
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),0.45920385920884094,1.1346059052338364,0.2993827160493827,0.6651229206338453,1.0,8/23,15.64%,ZEB2;HIPK2;ADAM17;SMAD4;ING2;CITED2;CREBBP;THBS1
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),-0.49988976304791477,-1.134369475390989,0.3132530120481928,0.7235994032977091,1.0,3/10,8.54%,TGFBR2;FGFR2;PDGFA
prerank,pyruvate metabolic process (GO:0006090),-0.3225616725978802,-1.134270511197712,0.21487603305785125,0.7223088006130204,1.0,19/52,24.14%,HK3;HK1;ME3;PFKL;PGK1;PCK2;LDHB;ENO2;VDAC1;HOGA1;DLAT;PDHB;PGAM1;PGAM4;PFKM;ENO3;PDHA1;LDHA;ALDOA
prerank,regulation of cellular ketone metabolic process (GO:0010565),0.38920662180380355,1.1338098964533374,0.2765685019206146,0.6665817836564069,1.0,14/61,12.96%,PSME3;PRKAG2;PSMB7;PSME2;AZIN1;PSME4;PSMB8;PSMA5;PSMD9;PSMB3;PSMD6;PSMC4;PSMD10;PSMB1
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),-0.3565446797640439,-1.1335338169059839,0.2822822822822823,0.7227823355345482,1.0,8/32,11.82%,NAV3;CAMSAP1;MAP2;FGF13;CLASP2;EML2;MAPRE1;CAMSAP2
prerank,negative regulation of microtubule depolymerization (GO:0007026),-0.4064382771842574,-1.1335260670326661,0.2975871313672922,0.7212286604770417,1.0,4/21,4.39%,NAV3;CAMSAP1;FGF13;CLASP2
prerank,axon guidance (GO:0007411),-0.25572630077386094,-1.133512382396579,0.14285714285714285,0.7197146372463094,1.0,46/201,13.16%,OPHN1;PTPRM;DCC;PLXNA4;EVL;RHOH;NRP1;EPHA6;ROBO2;NRP2;FEZ2;ROBO1;CHN1;GFRA1;GAB1;CNTN4;PLXNB2;SMO;NFIB;SPTAN1;SEMA3D;EPHA5;SPTB;RYK;SEMA3E;PLXNA2;PLCG1;CDK5R1;KIF5C;EFNB3;SEMA6D;ARHGAP35;FEZ1;SLIT2;KLF7;PIK3R1;EFNA5;LAMA3;EPHA7;VEGFA;TUBB3;SCN1B;SLIT1;SLIT3;RAP1GAP;DOK1
prerank,negative regulation of Wnt signaling pathway (GO:0030178),0.3390357851892402,1.1333708720991043,0.23318872017353579,0.6671656516530531,1.0,41/186,16.56%,LIMD1;GLI1;PTPRU;PTPRO;PSME3;CUL3;CCDC88C;SDHAF2;MAD2L2;NOTUM;PSMB7;APCDD1;AXIN1;PSME2;RNF213;TMEM131L;STK4;KREMEN1;PSME4;LATS1;PSMB8;PSMA5;PSMD9;CYLD;NLK;PSMB3;LATS2;PSMD6;PSMC4;DVL3;PSMD10;PSMB1;LRP4;TLE1;TAX1BP3;INVS;DVL2;APC;IGFBP6;PSMD12;KLHL12
prerank,negative regulation of transmembrane transport (GO:0034763),0.5421417397101879,1.1324555628387747,0.35431654676258995,0.6688663344222437,1.0,1/10,0.33%,IL1B
prerank,cellular response to nutrient levels (GO:0031669),0.38772655818379265,1.1323976160038514,0.2794307891332471,0.6684404120985736,1.0,12/62,13.77%,LRRK2;STK24;BMPR2;KLF10;WRN;CLEC16A;RALB;PRKAA1;NUPR2;WIPI2;SREBF2;PRKAA2
prerank,endothelial cell proliferation (GO:0001935),0.4899904839366875,1.1323844770190081,0.32248062015503876,0.6679001138925971,1.0,2/17,2.93%,ERN1;BMPR2
prerank,vesicle cytoskeletal trafficking (GO:0099518),0.4188843553382773,1.132358899697833,0.3012211668928087,0.6673830638350791,1.0,7/39,7.27%,MYO1G;MYO1E;MYO1C;KIF5B;FBXW11;MYO5B;PAFAH1B1
prerank,cardiac ventricle development (GO:0003231),0.4746788169746403,1.1322911964861082,0.31191222570532917,0.6669655246357482,1.0,4/20,8.15%,GJA5;HECTD1;PDE2A;ENG
prerank,positive regulation of bone resorption (GO:0045780),-0.4776318681076176,-1.131510443137262,0.32325581395348835,0.7239651384355318,1.0,4/11,5.35%,SPP1;TNFRSF11A;ATP6AP1;ADAM8
prerank,glycosphingolipid metabolic process (GO:0006687),-0.33574351728029705,-1.1311254783229767,0.2339622641509434,0.7235265748743847,1.0,10/42,11.42%,HEXB;LARGE1;CERK;B3GALNT1;CTSA;GALC;NEU1;ST6GALNAC6;ST6GALNAC5;HEXA
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.4075385164470552,1.1303601903829203,0.30612244897959184,0.6712877833016313,1.0,11/43,14.36%,EPS15;CBLB;CBL;CDC42;RAB7A;TSG101;GRB2;EPS15L1;STAM;MVP;PTPRJ
prerank,regulation of cholesterol esterification (GO:0010872),-0.49344683869497247,-1.1301542443001793,0.29777777777777775,0.7247052116220742,1.0,5/10,32.49%,APOE;APOC1;LAMTOR1;ABCA2;STARD4
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.37681632880535293,1.129932724262123,0.2679245283018868,0.6717682027075472,1.0,18/73,13.39%,ITCH;PSME3;SPI1;EIF2AK2;PSMB7;PSME2;CBFB;PSME4;PSMB8;PSMA5;PSMD9;PSMB3;PSMD6;PSMC4;PSMD10;PSMB1;MYB;METTL3
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),0.3794445503367392,1.129723924325586,0.27340823970037453,0.6717217570259957,1.0,17/70,13.39%,ITCH;PSME3;EIF2AK2;PSMB7;PSME2;CBFB;PSME4;PSMB8;PSMA5;PSMD9;PSMB3;PSMD6;PSMC4;PSMD10;PSMB1;MYB;METTL3
prerank,intraciliary transport involved in cilium assembly (GO:0035735),-0.3422306209153161,-1.129519782418398,0.25773195876288657,0.7249325593540558,1.0,12/37,20.96%,IFT74;DYNLL2;IFT172;DYNLL1;TRAF3IP1;IFT80;IFT20;DYNC2H1;TTC21B;KIF3A;CLUAP1;IFT27
prerank,nuclear pore complex assembly (GO:0051292),0.5518515279982117,1.129463380548989,0.33815551537070526,0.6718078561620967,1.0,4/10,18.20%,NUP98;RTN4;NUP153;NUP93
prerank,eye morphogenesis (GO:0048592),0.4753888026454818,1.1293184958880997,0.2931854199683043,0.6716103195208653,1.0,5/19,9.63%,STAT3;NIPBL;COL5A2;RARG;FBN1
prerank,regulation of catabolic process (GO:0009894),0.4718602468416656,1.1292493945397006,0.3102362204724409,0.6712186041674282,1.0,5/18,8.94%,NEDD4L;ZDHHC7;FAF1;FAP;SNF8
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),0.3918351251455342,1.129160192931871,0.30423280423280424,0.6708497229514019,1.0,19/56,16.57%,RACGAP1;KIF20A;MITD1;KIF23;CHMP4B;BIN3;PDCD6IP;DCTN3;RHOA;SPAST;SNX9;UNC119;ROCK1;AURKB;EFHC2;SNX33;APC;TRIM36;RAB35
prerank,negative regulation of mitochondrion organization (GO:0010823),-0.34874100264045854,-1.1289752798652992,0.24914675767918087,0.7249635818765279,1.0,9/33,12.13%,PRKN;IGF1;FLCN;BCL2L1;SLC35F6;TFRC;MPV17L;VAT1;CLU
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.3493229421669419,1.1284320792706033,0.249728555917481,0.6721175626429743,1.0,13/159,5.41%,JAML;ITGAL;ALCAM;EMB;PECAM1;NECTIN1;PCDHB11;CLDN1;SELL;CD177;NPTN;CLDN12;ITGB2
prerank,ruffle organization (GO:0031529),-0.4206598904662133,-1.128237546462119,0.31851851851851853,0.7255272833801831,1.0,3/16,4.50%,CSF1R;AIF1;LIMA1
prerank,positive regulation of lipid catabolic process (GO:0050996),0.46007771464430314,1.1280740311804491,0.3130841121495327,0.6724259058460288,1.0,1/19,0.33%,IL1B
prerank,peptidyl-threonine dephosphorylation (GO:0035970),0.46533752360050673,1.127571275604363,0.3142414860681115,0.6731630883001517,1.0,5/22,15.79%,DUSP16;DUSP6;DUSP1;PPM1D;PPM1G
prerank,regulation of protein kinase A signaling (GO:0010738),0.47101457625346566,1.1272246641503643,0.3343558282208589,0.6734555704494152,1.0,1/20,0.22%,LRRK2
prerank,actin filament network formation (GO:0051639),0.5401318756880994,1.1271945702615873,0.3368237347294939,0.672938666658677,1.0,4/11,16.33%,LCP1;CARMIL1;FHOD1;PLS1
prerank,secondary alcohol biosynthetic process (GO:1902653),0.4434375909030547,1.1271372891022309,0.32336182336182334,0.6725049056228513,1.0,11/30,21.30%,HSD17B7;ACAA2;MSMO1;IDI1;FDPS;NSDHL;DHCR24;MVD;MVK;LBR;SQLE
prerank,positive regulation of osteoblast differentiation (GO:0045669),0.41415921542526574,1.1261931170090174,0.32570659488559894,0.6743037599627354,1.0,8/43,8.61%,FFAR4;RUNX2;BMPR2;IL6R;ACVR2A;IL6ST;HGF;IL6
prerank,mitochondrial RNA metabolic process (GO:0000959),0.5062601747312995,1.1260847759514059,0.33895446880269814,0.6739931808668472,1.0,5/14,15.90%,FASTKD1;FOXO3;TFAM;PNPT1;TFB1M
prerank,sodium ion transmembrane transport (GO:0035725),-0.28591434995774545,-1.1260663835686238,0.19760479041916168,0.7300177716589958,1.0,15/84,13.80%,SLC8A1;SLC24A3;SCN1A;ATP1B3;PKD2;ATP1B1;SLC6A15;SCN3A;SLC9A9;SLC9A6;ATP1A2;HCN1;HCN2;SCN1B;SLC6A8
prerank,amino acid transport (GO:0006865),-0.3179631750693326,-1.1258545866766112,0.21839080459770116,0.7290650969174074,1.0,10/49,12.68%,SLC38A6;SLC7A6;SLC7A1;SLC36A4;SLC7A7;SLC6A15;SLC36A1;SLC7A2;SLC7A8;SLC3A2
prerank,cortical cytoskeleton organization (GO:0030865),0.4087294293919934,1.1257939978054696,0.28879892037786775,0.6741500626009128,1.0,8/41,8.94%,RND3;LCP1;RAC2;IKBKB;RHOBTB3;EZR;RAC1;RHOA
prerank,positive regulation of viral genome replication (GO:0045070),-0.35336839435047085,-1.1255007623789026,0.2857142857142857,0.7285167624112,1.0,19/29,34.21%,LARP1;PPIA;SRPK1;ADAR;SRPK2;PPIE;VAPB;DDX3X;PPID;ADARB1;RAD23A;CNOT7;PDE12;CD28;DDB1;CCL5;PPIH;TOP2B;HACD3
prerank,DNA methylation or demethylation (GO:0044728),0.4761862174472806,1.1255005661761524,0.3322884012539185,0.6737359501339998,1.0,10/19,19.45%,ATF7IP;FOS;GATAD2A;MTRR;BAZ2A;ATRX;PPM1D;KMT2E;DNMT1;EHMT1
prerank,DNA alkylation (GO:0006305),0.4761862174472806,1.1255005661761524,0.3322884012539185,0.6737359501339998,1.0,10/19,19.45%,ATF7IP;FOS;GATAD2A;MTRR;BAZ2A;ATRX;PPM1D;KMT2E;DNMT1;EHMT1
prerank,negative regulation of peptide hormone secretion (GO:0090278),0.47084752555548964,1.1253484770655806,0.32682926829268294,0.6735340613314915,1.0,5/18,13.78%,FFAR4;ADRA2A;PSMD9;REST;SIRT4
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.3461356754072774,1.1253421879265189,0.2440347071583514,0.6729792872294955,1.0,49/190,17.84%,ITPR1;CYRIB;LYN;LIMD1;DGKG;TNIP3;MCL1;SPI1;CD2AP;NLRX1;STAT1;MAPK14;PTEN;CIB1;PDE2A;DDIT4;UBR2;PHLPP1;IFI35;CPNE1;DEPDC5;TANK;CYLD;RIPK1;CACTIN;DUSP1;PRKAA1;NLRP3;PSMD10;SH3BP4;MAP2K3;AKT1;MARK3;CARD19;TLE1;PRKAA2;PTPRJ;PPP2R5C;GSTP1;RELA;SPRED1;THBS1;MYADM;AJUBA;PIK3R2;SIRT1;PLAUR;HDAC7;CGNL1
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),0.42691543516365704,1.125330304293515,0.31196581196581197,0.6724262949376003,1.0,13/30,19.97%,TAF9;RYBP;WAC;SVIP;TLK2;CAMLG;RPL11;USP7;EIF3H;USP14;N4BP1;STYX;PARK7
prerank,L-amino acid transport (GO:0015807),-0.3716418318548308,-1.1252352701627577,0.2884012539184953,0.7277452679789144,1.0,8/28,12.68%,SLC1A3;SLC7A1;SLC36A4;SLC36A1;SFXN1;SLC7A2;SLC7A8;SLC3A2
prerank,positive regulation of developmental process (GO:0051094),-0.26062220331242686,-1.1248624187979717,0.16304347826086957,0.727232054582545,1.0,36/164,16.07%,PRKN;RREB1;BASP1;APOE;NLGN1;NUMA1;SPIRE1;CAMK1;PTN;GRIP1;DLG4;CLASP2;TMEM119;ENPP2;ACVR1;ADGRL1;TFRC;MFF;RBM19;RIF1;VPS35;SHLD2;CFL1;RALA;PHLDB1;PA2G4;VEGFA;GJA1;MDK;BMPR1B;SRC;DAB2IP;HMCES;SOX5;AR;CPEB3
prerank,negative regulation of immune system process (GO:0002683),0.48808085513958493,1.1246160832930483,0.3177257525083612,0.6736811504924822,1.0,1/16,0.76%,LYN
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",-0.4845326086971579,-1.124547562199003,0.34649122807017546,0.7266311972730989,1.0,6/10,15.43%,ATP5F1A;ATP5PO;ATP5MG;ATP5PD;ATP5F1D;ATP5MC3
prerank,response to purine-containing compound (GO:0014074),-0.41830819824337917,-1.1244255542056458,0.30526315789473685,0.7254588518502604,1.0,6/17,14.65%,P2RX7;P2RX4;P2RY6;DGKQ;TRPM2;TRPC3
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),-0.4261293109110505,-1.124055695900918,0.298050139275766,0.7249984112015898,1.0,2/16,5.33%,PRKN;PDK1
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),-0.48369025848861325,-1.1240537449354238,0.345372460496614,0.7234859300450233,1.0,7/10,38.92%,HTR2B;PLPP1;PARD3;PICK1;DGKH;DGKD;GAP43
prerank,microtubule anchoring at centrosome (GO:0034454),0.5445049497684524,1.1240071375238914,0.33907056798623064,0.6746353696209005,1.0,2/10,7.37%,CCDC120;NIN
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.36740688417324285,1.1239559112527877,0.27904191616766466,0.6742033652564489,1.0,20/88,13.29%,PSME3;CUL5;PSMB7;FBXW7;PSME2;FBXW11;FBXL8;FBXO38;FBXO4;PSME4;PSMB8;PSMA5;PSMD9;PSMB3;FBXL17;PSMD6;PSMC4;PSMD10;PSMB1;FBXL12
prerank,cholesterol biosynthetic process (GO:0006695),0.43775794802577006,1.123804992898201,0.31966053748231965,0.6739979068928159,1.0,11/31,21.30%,HSD17B7;ACAA2;MSMO1;IDI1;FDPS;NSDHL;DHCR24;MVD;MVK;LBR;SQLE
prerank,negative regulation of anoikis (GO:2000811),0.5003056009571266,1.123512633618432,0.34523809523809523,0.6741392029394511,1.0,6/14,22.11%,MCL1;PIK3CA;TLE1;ITGA5;PTK2;BCL2
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",0.4485710743526237,1.1234773534074745,0.3358208955223881,0.6736475305079777,1.0,2/25,3.56%,LRRK2;CHRNA4
prerank,protein auto-ADP-ribosylation (GO:0070213),0.5177098347434628,1.123408486544188,0.3322314049586777,0.6732529808376534,1.0,6/12,21.66%,PARP8;TIPARP;TNKS;PARP12;PARP11;PARP1
prerank,protein-DNA complex assembly (GO:0065004),0.3565335808668982,1.1231354449992488,0.2848904267589389,0.673355224630493,1.0,25/116,12.97%,PSME3;CHAF1A;PSMB7;PSME2;H3-3A;ORC5;MCM6;SMARCA5;ORC4;CCNH;PSME4;PSMB8;PSMA5;PSMD9;DAXX;PSMB3;PSMD6;PSMC4;NAP1L1;RPA3;PSMD10;ATRX;MCM2;PSMB1;ERCC3
prerank,regulation of cellular amino acid metabolic process (GO:0006521),0.39346441965070716,1.123082234318645,0.29733333333333334,0.6729298179545097,1.0,13/53,12.96%,PSME3;PSMB7;PSME2;AZIN1;PSME4;PSMB8;PSMA5;PSMD9;PSMB3;PSMD6;PSMC4;PSMD10;PSMB1
prerank,positive regulation of isotype switching (GO:0045830),0.5001023417491026,1.123079393544209,0.3311367380560132,0.6723731579018616,1.0,4/15,14.21%,CD40;MAD2L2;KMT5B;TGFB1
prerank,negative regulation of protein modification process (GO:0031400),0.37181698632333604,1.1229439822559752,0.28381642512077293,0.672132887279229,1.0,17/79,14.21%,NIBAN1;LRRK2;PID1;LYN;IBTK;PTEN;PRNP;CIB1;PAQR3;EPHB2;PPP1R15A;CACTIN;PRKAA1;PPP1R15B;CDYL;PRKAA2;TGFB1
prerank,cGMP metabolic process (GO:0046068),0.514509611872084,1.122880922597683,0.3089700996677741,0.6717420946592864,1.0,5/12,24.91%,PDE2A;GUCY1A1;NPR2;NPPC;PDE9A
prerank,gland development (GO:0048732),-0.3019895293459587,-1.1228435084598154,0.18269230769230768,0.72527291932927,1.0,12/59,16.05%,SALL1;TGFBR1;PKD2;NF1;FGFR2;ARID5B;CEBPG;ARHGAP35;PHF2;PRKCSH;MDK;DKK3
prerank,peptide cross-linking (GO:0018149),0.43795056956992073,1.1227500448346273,0.31555555555555553,0.6715119195720505,1.0,4/25,10.39%,NDNF;F13A1;FN1;ANXA1
prerank,sulfur compound catabolic process (GO:0044273),-0.34243123347636,-1.1220100597116793,0.244,0.7261996599502295,1.0,7/38,11.42%,HEXB;GALNS;GNS;ARSB;TXN2;CSPG4;HEXA
prerank,response to muscle stretch (GO:0035994),-0.44122306399715816,-1.121732099540053,0.3117206982543641,0.7254817858774795,1.0,2/15,3.17%,SLC8A1;CTNNB1
prerank,protein transmembrane import into intracellular organelle (GO:0044743),0.42165779569308326,1.1216128120459457,0.31,0.6736803983357571,1.0,9/31,14.19%,PEX16;PEX12;GRPEL2;DNAJC19;TIMM21;PEX14;TOMM40;AIFM1;TIMM50
prerank,cellular response to misfolded protein (GO:0071218),0.47141580400158034,1.120609276799416,0.331306990881459,0.675610698200137,1.0,6/20,14.18%,CUL3;KLHL15;ATXN3;UBE2W;DNAJB12;VCP
prerank,DNA repair (GO:0006281),0.3307068413555475,1.1205004032558061,0.2218782249742002,0.6753047354800819,1.0,85/284,20.37%,UVRAG;DNA2;MLH1;DTX3L;POLI;BTG2;MAD2L2;RBBP8;POLL;CHRNA4;USP3;MRE11;FEN1;FAM111A;SUMO1;PARP4;APEX2;SMARCA5;UBE2N;POLD4;SETX;MBD4;WRN;CIB1;USP45;MSH3;NABP1;DOT1L;PSME4;SMUG1;UIMC1;ATXN3;ASCC3;BRIP1;BACH1;MSH6;ASCC1;PARP9;FANCC;FANCL;TDG;SETD2;KMT5B;RECQL5;RPA3;XRCC4;EXD2;FANCI;RAD54L;ERCC3;MAPK8;ERCC4;FANCA;RNASEH2A;VCP;XRCC2;VCPIP1;INO80;ENDOV;INIP;KDM4B;USP47;POLB;NSMCE4A;KPNA2;HUS1;EYA3;MDC1;PMS1;POLD1;SIRT1;RAD17;RAD21;CHEK2;PRIMPOL;FANCG;ALKBH2;WDR33;TNKS1BP1;FTO;RNF168;PARK7;APEX1;PDS5B;XPA
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),0.5303785195992491,1.1204685810775143,0.34464285714285714,0.6748174350300197,1.0,4/10,13.43%,FBXW7;ADRA2A;ADAM17;NCF1
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),0.4125058655963672,1.1201902128745442,0.31721194879089615,0.6749473892572059,1.0,4/39,2.59%,FXYD5;PRKCE;UTRN;NEDD4L
prerank,negative regulation of supramolecular fiber organization (GO:1902904),-0.30134506050812104,-1.11995909295049,0.23829787234042554,0.7288865609556623,1.0,16/72,12.13%,NAV3;PRKN;APOE;TREM2;CAMSAP1;MAP2;FGF13;CLASP2;LIMA1;PFN1;PLEKHH2;SLIT2;EML2;MAPRE1;CAMSAP2;CLU
prerank,regulation of cAMP-mediated signaling (GO:0043949),0.4501623890612927,1.1196762809875727,0.3257229832572298,0.6756748175836546,1.0,6/24,13.10%,FFAR4;RAPGEF2;PDE2A;PRKAR2A;GNAI1;PEX5L
prerank,regulation of RNA metabolic process (GO:0051252),0.3883442143726816,1.1187039502481118,0.29197994987468673,0.6774943699037985,1.0,17/59,15.86%,MBNL1;AHNAK;PTBP3;OAS2;PRX;MBNL3;RC3H1;OASL;METTL4;IGF2BP3;PQBP1;HNRNPLL;TNFRSF1B;RBM38;CELF1;MED1;PTBP2
prerank,neuromuscular junction development (GO:0007528),0.4447866193300048,1.1186564423831356,0.32978723404255317,0.6770341800707942,1.0,2/24,6.71%,LRRK2;CACNB1
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),-0.41200822653799424,-1.1185370540993231,0.2864583333333333,0.7314023887939354,1.0,8/17,22.29%,TREM2;PPIA;P4HB;HTRA2;MAPK7;SOD2;SOD1;BAG5
prerank,positive regulation of synapse assembly (GO:0051965),-0.3640795048432637,-1.1184493480714646,0.3161094224924012,0.7301430717313521,1.0,13/27,23.47%,PTPRD;IL1RAPL1;NLGN1;GRID2;IL1RAP;NLGN2;AGRN;CLSTN2;NLGN3;NRXN1;DLG5;VSTM5;CUX2
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),0.5104247219879375,1.118415790424691,0.33620689655172414,0.6759603391395562,1.0,5/12,18.60%,CUL3;ANAPC7;RB1;ANAPC11;ANAPC4
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.5104247219879375,1.118415790424691,0.33620689655172414,0.6759603391395562,1.0,5/12,18.60%,CUL3;ANAPC7;RB1;ANAPC11;ANAPC4
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.5104247219879375,1.118415790424691,0.33620689655172414,0.6759603391395562,1.0,5/12,18.60%,CUL3;ANAPC7;RB1;ANAPC11;ANAPC4
prerank,neurotransmitter biosynthetic process (GO:0042136),-0.43631827402188655,-1.118372855852447,0.3417085427135678,0.7288784984647297,1.0,7/14,34.91%,DAGLA;ALDH9A1;SLC5A7;CHAT;NOS1;MOXD1;ACHE
prerank,selective autophagy (GO:0061912),-0.3109045363615662,-1.1183434620648465,0.24313725490196078,0.7274624137030531,1.0,13/56,14.34%,PRKN;WDFY3;ULK2;UBC;DYNLL2;NBR1;AUP1;DYNLL1;UFC1;MAP1LC3B;UFM1;USP30;SQSTM1
prerank,pyroptosis (GO:0070269),-0.432739055188489,-1.1183107611405732,0.30310880829015546,0.7260417408771445,1.0,3/15,14.03%,TREM2;CASP4;DHX9
prerank,cellular component assembly (GO:0022607),0.33534350409024904,1.1182648510755533,0.24761904761904763,0.6757413293918247,1.0,51/253,16.49%,CD74;NEDD9;TRAF1;WIPF1;LCP1;EPS8;CD40;FOXJ1;CHAF1A;SKAP2;RAC2;PICALM;ABCA3;CDC42;CD2AP;RBBP4;PTK2B;FLNA;ELOB;PAWR;YTHDF3;EZR;RAC1;PEX14;CAPZA1;RHOA;FANCC;STX7;RTN4;SNX9;VASP;YWHAZ;TEAD1;DNM1L;FANCA;CLDN14;VMP1;TGFB1;BSN;RHOG;KMT2A;ZFYVE27;OCLN;SLC2A1;CREBBP;VCPIP1;SHROOM1;APC;STAG3;PLS1;WNT7A
prerank,regulation of protein polymerization (GO:0032271),-0.33307080257639443,-1.1182599491525504,0.247557003257329,0.7246893512399345,1.0,16/35,28.64%,CAMSAP1;COTL1;MAP2;RASA1;PFN1;FCHSD2;CAMSAP2;PFN2;TPPP;CTTN;GBA2;MAPRE3;ABITRAM;HSP90AA1;ABL1;DBN1
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.35372180674078874,1.1182289075811438,0.3070588235294118,0.6752836741239837,1.0,16/110,13.32%,ADGRG5;ADGRG6;ADGRE5;RXFP2;LPAR3;PTGER2;RAPGEF2;CXCL10;PTGER4;ADRA2A;GNB1;PTGER3;S1PR5;ADCY7;ADCY5;GNG2
prerank,neuromuscular process controlling balance (GO:0050885),-0.4538588723894368,-1.1179669113182542,0.33251833740831294,0.7240362178828661,1.0,4/12,8.05%,CDH23;TPP1;PCDH15;MYO7A
prerank,ceramide metabolic process (GO:0006672),0.39933776953264594,1.1177074461913041,0.3229166666666667,0.6760117710557279,1.0,7/49,8.25%,CERS6;ACER3;CERS1;SAMD8;SGMS1;SGMS2;ST6GALNAC3
prerank,positive regulation of ATP metabolic process (GO:1903580),0.4213280141240766,1.117682494760156,0.3071528751753156,0.6755168002136261,1.0,13/32,19.09%,PID1;ZBTB20;PRXL2C;PRKAA1;APP;PFKFB3;PRKAA2;VCP;PFKFB4;INSR;PSEN1;PINK1;TMSB4X
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),0.40990310096899896,1.117563296204754,0.30567081604426005,0.6752742173189237,1.0,8/35,13.87%,ADGRG6;CD36;RAPGEF2;PDE7A;AHR;PDE2A;IRAG1;PDE7B
prerank,regulation of dendrite development (GO:0050773),-0.3403505406311053,-1.1175095443921979,0.29044117647058826,0.723833463853494,1.0,8/37,4.17%,CSMD3;DCC;RAP2A;TNIK;HECW1;PTN;ADGRB3;MARK1
prerank,glutathione metabolic process (GO:0006749),0.41859396316436853,1.1170474017022822,0.3219645293315143,0.6760621267035081,1.0,6/38,6.34%,GPX1;GSR;ETHE1;DPEP1;GSTA3;GSS
prerank,spinal cord development (GO:0021510),-0.4668300499486925,-1.1168767337314285,0.3404255319148936,0.7240555730465622,1.0,5/12,16.72%,PKD2;NF1;LOXL3;SOX4;SOX11
prerank,regulation of angiogenesis (GO:0045765),0.33958141364150574,1.1166341653913843,0.2449197860962567,0.6765549013449067,1.0,25/192,9.47%,CCR2;IL1B;SP100;KLF4;ITGAX;PPARG;CD40;PTGIS;CXCL10;ADGRA2;ATF2;SYNJ2BP;VEGFC;BTG1;STAT1;HIPK2;HSPG2;HIPK1;PIK3R6;PDPK1;MECP2;PLXND1;IL6;NAXE;PGF
prerank,endoderm formation (GO:0001706),0.41129388830743063,1.1161329480612916,0.3224431818181818,0.6772043208334025,1.0,6/35,11.47%,ITGA4;LAMB1;ITGB2;FN1;SETD2;DUSP1
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.3820445919032287,1.1159609424712404,0.3200992555831266,0.6770684905076804,1.0,16/65,14.36%,EPS15;CCDC88A;CBL;CDC42;ARAP1;PTPN12;TSG101;GRB2;AFAP1L2;HIP1;EPS15L1;STAM;AKT1;MVP;PDE6H;PTPRJ
prerank,regulation of bone mineralization (GO:0030500),-0.3101036189277542,-1.1147803139422954,0.2608695652173913,0.7286096091567404,1.0,14/55,7.87%,SLC8A1;MEF2C;NELL1;ANKH;ENPP1;PTN;BCOR;TMEM119;P2RX7;ACVR1;BMP2K;NBR1;ACVR2B;S1PR1
prerank,reticulophagy (GO:0061709),-0.4624295144317615,-1.1141907620042428,0.2966507177033493,0.7288231462773969,1.0,6/12,25.50%,ULK2;UFC1;UFM1;UFL1;ATG2A;UBA5
prerank,positive regulation of neurogenesis (GO:0050769),-0.2957080939208509,-1.11386360072249,0.25,0.7281908627358467,1.0,16/68,6.67%,CX3CR1;PLXNA4;CUX1;PTPRD;NTRK2;NUMB;IL1RAPL1;ROBO2;ROBO1;CTNNB1;PLXNB2;FBXW8;CDKL3;ARHGDIA;CAPRIN2;PLXNA2
prerank,nitric oxide metabolic process (GO:0046209),0.49915594664504587,1.113217531060869,0.34039087947882735,0.6833968388329962,1.0,4/14,19.18%,CYB5B;ARG2;AKT1;CYB5R3
prerank,protein deacetylation (GO:0006476),0.4030633886462485,1.1129686419001474,0.3204951856946355,0.6834770174829471,1.0,18/41,21.54%,TBL1XR1;MTA3;FLNA;HDAC9;RCOR3;MORF4L1;BAZ2A;MSL3;SIRT4;HDAC3;MIER1;SIRT1;HDAC7;HDAC1;MIDEAS;RCOR1;SIRT3;HDAC5
prerank,regulation of acrosome reaction (GO:0060046),0.5328286879992417,1.112719776158421,0.3487972508591065,0.6835431686561305,1.0,1/10,7.50%,PLCB1
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),0.500134902766578,1.1125135253507874,0.3474714518760196,0.6834891528157422,1.0,4/13,14.82%,JAK2;IL33;TLR2;GSTP1
prerank,monocarboxylic acid transport (GO:0015718),-0.3129371530121743,-1.112494847155497,0.27876106194690264,0.7307617583788486,1.0,7/51,7.18%,SLCO2B1;SLC16A6;ABCC3;ABCG2;ABCB4;ATP8B1;SLC27A1
prerank,cholesterol efflux (GO:0033344),-0.3995652999678676,-1.1124043788008506,0.3290155440414508,0.7295363763593852,1.0,2/20,0.41%,ABCA1;APOE
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),0.47058065567736185,1.1121009516865394,0.33878887070376434,0.6839607642155674,1.0,5/19,14.36%,PTPRC;PRNP;FIS1;FKBP1B;PTPRJ
prerank,melanosome organization (GO:0032438),-0.3717516815989939,-1.111963648218963,0.28187919463087246,0.7293029008799968,1.0,7/26,15.46%,DTNBP1;HPS4;RAB32;AP3B1;SHROOM2;LYST;BLOC1S5
prerank,organic substance transport (GO:0071702),-0.26708543494218345,-1.1118514778640212,0.17073170731707318,0.7281221079572497,1.0,30/121,20.25%,SLCO2B1;ABCA1;LRP1B;ABCD2;MFSD12;SCAMP1;ABCG2;FLVCR1;ATP8A1;SCAMP2;PLEKHA8;SCAMP5;HSP90B1;SLC22A5;CHKA;SPNS2;TOM1;DISP1;ABCA7;SLC22A4;TXNIP;CHMP1B;VPS33B;ARRDC2;ABCD3;KIF3A;SLC50A1;ABCB9;CEP290;CHMP2A
prerank,regulation of lipid storage (GO:0010883),0.44578798289560023,1.111681617626035,0.3081570996978852,0.6844691101853542,1.0,4/22,8.61%,NFKB1;NFKBIA;FBXW7;IL6
prerank,regulation of transcription by RNA polymerase II (GO:0006357),0.3203233631831353,1.1114832172853584,0.082,0.6843778064476392,1.0,291/1668,15.83%,CIITA;PLAC8;BCL11A;TRPS1;NFE2;ZBTB46;PID1;BACH2;FOXP1;RUNX2;HIVEP2;RARA;SP100;SP3;BAZ1A;RUNX3;STAT4;TOX4;GLI1;TNIP3;HNF4G;ACTR3;CDK13;KLF4;UXT;CREB1;LILRB1;PPARG;IER2;CD40;MED13L;ETV6;STAT5A;BCL6;SAP30;PKN1;PPP1R12A;NFKB1;PITX3;TET2;FOSL2;PLSCR1;STAT3;BAZ2B;EHF;FOXJ1;ELF4;RFX7;NIPBL;NEDD4L;FOS;KDM7A;CRK;TCF20;RPS6KA3;BMPR2;MAD2L2;REL;RBBP8;AKNA;NCOA3;CXCL10;ZBTB20;CRLF3;TAF9;SPI1;STAT5B;NFKBIA;CRY1;SCX;ATAD2;TBL1XR1;MTA3;GATAD2B;IKBKB;MED30;ZEB2;SUMO1;PGBD1;CAMTA2;KAT7;ATF6;LRRFIP1;KLF8;GDNF;ATF2;PPP3CA;IRF2;PRPF6;RFX3;ZNF319;RBPJ;IL33;KCNIP3;HIVEP1;DEAF1;MED13;STAT1;HIPK2;NUFIP1;KLF5;UBE2D3;IRF4;HEXIM1;MAPK14;HELZ2;BBX;RFX5;RPS6KA5;SMARCA5;PTEN;KLF13;TSHZ1;ARF4;CCND1;DEK;KMT2C;KLF10;CDC5L;ELOA;SETX;AHR;ACTR2;RPS14;ANXA4;CREBRF;BUD31;TADA3;SSU72;CGGBP1;WFS1;ARID4A;CBFB;CREM;IKZF3;NFE2L2;KDM3B;PURB;HTATSF1;MECP2;PDE2A;THRA;CRY2;CLOCK;ZFP3;SAP18;MED6;ZBED4;GATAD2A;RARG;CCNH;TOX3;EZR;DOT1L;E2F2;ENG;GABPB1;GABPB2;CTCF;PHF12;NFYC;ACVR2A;HDAC9;ELF1;TLR3;HGF;IL6;BRIP1;BACH1;NFE2L1;ZNF182;SNF8;KAT6A;TNKS;BCAS3;RBAK;ID2;WWP2;EZH1;EPC2;NCOA2;E4F1;PKNOX1;SMARCE1;ZNF496;ZFX;PARP9;IRF7;MEF2B;RCOR3;SMAD4;SBNO2;CNOT2;RPRD1B;NCOA1;LIN37;CSRNP1;NR3C1;TADA2A;RIPK1;GMEB2;SP140;SPEN;PBX1;CCNT2;MED26;FOXO3;MED12;IKZF5;ZNF507;DVL3;TAF7;ZNF260;NLRP3;ETS2;REST;RPS6KA1;ZNF418;MBD2;ATF6B;APP;MAP2K5;NUPR2;MED14;CCNT1;BCLAF3;NFYA;PSMD10;LIN9;TLR2;CDK12;TEAD1;ATRX;PPM1D;NFATC2IP;KLF9;CCNL1;MYB;IFRD1;NRIP1;KIT;STAT2;NSD1;CHD4;JUNB;HCLS1;EZH2;SREBF2;TNRC6B;SMARCC2;SRCAP;CITED2;KAT2B;TNRC6A;HDAC3;MRTFA;NFIL3;TGFB1;CRTC3;ZNF431;SLTM;RSF1;FHOD1;IL18;GPS2;ZNF436;MAFK;AURKB;SP4;MAZ;KMT2A;HOMEZ;DUSP26;ASXL2;CREBBP;PHF20;RELA;ZBTB25;USP9X;MIER1;TAF1;TBK1;DVL2;HSF5;MAML1;BHLHE40;INO80;ZNF148;ZMIZ2;MED1;DUSP22
prerank,protein modification process (GO:0036211),0.36813048852546604,1.1113901827362729,0.3054862842892768,0.6840359246360753,1.0,12/76,11.46%,ST3GAL1;ST8SIA4;STK38;PARP4;UBE2D3;FBXW2;NEDD8;PPP4R2;CSNK1G3;WWP2;UBE2S;DUSP12
prerank,positive regulation of organelle organization (GO:0010638),0.42065925297036677,1.1111943091626864,0.3333333333333333,0.6839882337993032,1.0,7/32,10.39%,UVRAG;ANXA2;C2CD5;KATNBL1;SYNJ1;ATL3;ANXA1
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),0.5097832793521542,1.1108423279550514,0.33500837520938026,0.6842900905748265,1.0,5/13,18.20%,JAK2;RBPMS;SMAD4;TGFB1;NUP93
prerank,P-body assembly (GO:0033962),0.5090687591530431,1.1104866722476692,0.33500837520938026,0.6845979509770026,1.0,6/12,20.36%,LIMD1;RC3H1;DYNC1H1;EIF4ENIF1;DDX6;EDC3
prerank,acylglycerol metabolic process (GO:0006639),-0.34660909220397007,-1.1102750083955633,0.2872727272727273,0.7309573734818081,1.0,4/37,2.13%,APOE;ABHD12;DGKZ;MGLL
prerank,regulation of cell cycle process (GO:0010564),0.35909240867180764,1.1101620392404636,0.284037558685446,0.6848541913132054,1.0,20/104,12.24%,UVRAG;CDK13;RACGAP1;KIF20A;BIRC6;SND1;CDC42;CAV2;IHO1;E4F1;GIT1;CSNK2A2;CSNK2A1;RPRD1B;CEP250;SETD2;DCUN1D3;TXLNG;DYNC1H1;PIK3R4
prerank,cardiac muscle cell differentiation (GO:0055007),-0.37939231876047624,-1.109834114091155,0.29362880886426596,0.7306980781544147,1.0,5/21,14.28%,SLC8A1;MEF2C;ACVR1;VEGFA;CXADR
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",0.40701458164547244,1.1097484192918379,0.3178717598908595,0.6852875645306764,1.0,2/46,0.22%,CCR2;LRRK2
prerank,chromatin disassembly (GO:0031498),0.4965781056343692,1.109425388254276,0.3445378151260504,0.6849445498828711,1.0,4/14,13.76%,NFE2;SMARCE1;ARID2;SMARCC2
prerank,nucleosome disassembly (GO:0006337),0.4965781056343692,1.109425388254276,0.3445378151260504,0.6849445498828711,1.0,4/14,13.76%,NFE2;SMARCE1;ARID2;SMARCC2
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),0.5027929940072602,1.1093141121753824,0.33389544688026984,0.6846440599556853,1.0,3/13,5.11%,GLI1;PIM1;RBPJ
prerank,hyaluronan metabolic process (GO:0030212),0.4528029945251231,1.1092583059877945,0.3448275862068966,0.6842301163134881,1.0,2/23,0.33%,CD44;IL1B
prerank,DNA methylation (GO:0006306),0.45119900600204005,1.1090327907600757,0.3288084464555053,0.684220566055881,1.0,11/23,19.45%,ATF7IP;FOS;GATAD2A;METTL4;MTRR;BAZ2A;ATRX;PPM1D;KMT2E;DNMT1;EHMT1
prerank,myoblast differentiation (GO:0045445),0.49037757534478077,1.1089921102905558,0.348993288590604,0.6837834336832963,1.0,4/14,11.90%,MBNL1;PLEKHM3;MAPK12;REST
prerank,lipid transport (GO:0006869),-0.2761995836872393,-1.1084818306743047,0.2138728323699422,0.7331316864306104,1.0,13/97,7.18%,SLCO2B1;ABCA1;APOE;ABCD2;PITPNC1;OSBPL8;ABCC3;ATP8A1;PRELID2;PLEKHA8;FABP5;ATP8B1;SLC27A1
prerank,mitochondrion localization (GO:0051646),0.46225473393162014,1.108315198489688,0.32926829268292684,0.6849334817726775,1.0,2/19,6.98%,LRRK2;ATP2A1
prerank,polarized epithelial cell differentiation (GO:0030859),-0.44227151762233513,-1.1082551174774513,0.3469879518072289,0.7322925382615689,1.0,3/13,1.35%,OPHN1;MYO9A;RAP2A
prerank,negative regulation of hydrolase activity (GO:0051346),0.39296427839378995,1.1082356977304766,0.3311081441922563,0.6845617240402211,1.0,11/49,14.41%,LRRK2;PTX3;RCC2;KLRK1;F11R;BCAS3;ARFGEF1;GPATCH2;SH3BP4;LRCH1;ZCCHC9
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),0.5291359991616882,1.1082255337692113,0.36925795053003535,0.6840287970852142,1.0,3/10,12.38%,MMGT1;EMC9;EMC10
prerank,epithelial cell-cell adhesion (GO:0090136),-0.46787689671479415,-1.1081981071252829,0.34005037783375314,0.7309944085783134,1.0,2/11,7.60%,ITGB5;JUP
prerank,regulation of NMDA receptor activity (GO:2000310),0.4181642456019769,1.107584760968221,0.340941512125535,0.6850592517317466,1.0,5/32,9.06%,CCR2;DAPK1;PTK2B;EPHB2;OPRM1
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.4508747016235853,1.1075403122654846,0.335832083958021,0.6846264215031743,1.0,7/23,16.08%,JAK2;IL10RA;CRLF3;PTK2B;IL6;KIT;OCIAD1
prerank,regulation of endothelial cell migration (GO:0010594),-0.2809912155663743,-1.1073502191680271,0.23809523809523808,0.7318694752712218,1.0,18/85,9.40%,PTPRM;ANXA3;APOE;SASH1;SPARC;NRP1;GRN;GLUL;NRP2;ETS1;FGF2;PTN;NF1;RHOB;PIK3CG;ITGB3;AAMP;SLIT2
prerank,positive regulation of cellular biosynthetic process (GO:0031328),0.3407372683540839,1.1073075271991974,0.2800875273522976,0.6846944847972578,1.0,38/166,18.12%,NIBAN1;IL1B;DNA2;GLI1;BCL3;KLF4;RPL5;LDLR;VIM;CD36;ZEB2;KAT7;SCARB1;ELOVL5;FAF1;ATP7A;YTHDF3;HGF;IL6;NMD3;AKT1;METTL3;LARP4B;SLC6A9;EIF3E;ASS1;STN1;THBS1;RPS4X;DYRK2;RPS6KB1;INSR;GCK;SIRT1;DDAH1;ATAD5;MMP8;APPL1
prerank,cellular response to virus (GO:0098586),0.42876309545028723,1.1072400120664092,0.3303964757709251,0.6843155942590449,1.0,6/30,8.61%,CXCL10;IFIH1;MAPK14;ARF1;GBF1;IL6
prerank,pore complex assembly (GO:0046931),0.46784649127867595,1.1071784281668786,0.3365695792880259,0.6838828064229853,1.0,7/19,18.89%,AFDN;NUP98;TSPAN33;RTN4;NUP153;NUP93;BAD
prerank,regulation of glycogen biosynthetic process (GO:0005979),-0.374325316990921,-1.1069460177502972,0.31384615384615383,0.7315546392739718,1.0,4/24,8.94%,IGF1;ENPP1;PPP1R3B;IRS1
prerank,regulation of cell differentiation (GO:0045595),0.3458439032073593,1.1067125024689102,0.288268156424581,0.6844871339984406,1.0,14/148,7.31%,TRPS1;RUNX2;TIAM1;RUNX3;NGF;SIK1;KLF4;BCL6;RPS6KA3;EIF2AK2;GDNF;CBFB;PURB;PHLDB2
prerank,monoacylglycerol metabolic process (GO:0046462),-0.44157488797672684,-1.1064854914700148,0.3279445727482679,0.73134741817188,1.0,3/13,7.25%,ABHD12;MGLL;PLA2G4A
prerank,regulation of neurotransmitter transport (GO:0051588),-0.42096727645637133,-1.106474866921516,0.3283208020050125,0.7299352580773484,1.0,6/16,17.69%,MEF2C;SNCAIP;FLOT1;CPLX1;CAMK2A;RIMS1
prerank,cellular response to amino acid starvation (GO:0034198),-0.292998970411033,-1.1063107339044058,0.25,0.7289404663702455,1.0,18/71,12.15%,ATP6V1C1;RPTOR;ATP6V0B;FLCN;ATP6V0D2;ATP6V0C;TCIRG1;ATP6V1B2;SESN3;EIF2AK4;IMPACT;ATF4;LARS1;ATP6V1D;MIOS;ATP6V0D1;LAMTOR5;PRKD1
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),-0.47428672775812314,-1.1059997641274106,0.3611738148984199,0.7268909530532356,1.0,4/10,12.16%,MYLIP;AP2A1;CLTA;AP2M1
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),-0.47428672775812314,-1.1059997641274106,0.3611738148984199,0.7268909530532356,1.0,4/10,12.16%,MYLIP;AP2A1;CLTA;AP2M1
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),0.422389010673279,1.10531890064637,0.3209700427960057,0.6873833409255855,1.0,9/31,16.37%,KLF4;PTEN;CDKN2C;DCUN1D3;WEE1;APC;RBL2;BRD7;RB1
prerank,nitric oxide biosynthetic process (GO:0006809),0.49916797973172233,1.1052137643123126,0.34039087947882735,0.6870914691605087,1.0,4/13,19.18%,CYB5B;ARG2;AKT1;CYB5R3
prerank,negative regulation of cell cycle (GO:0045786),0.37114515693932076,1.1051945297653496,0.3242909987669544,0.6865979163140581,1.0,19/73,18.81%,RUNX3;LILRB1;BTG2;BTG1;HEXIM1;PTEN;PDCD4;LATS1;LATS2;DUSP1;NUPR2;RPS6KA2;TGFB1;TRIM35;APC;RB1;NR4A1;FOXC1;HPGD
prerank,cellular macromolecule biosynthetic process (GO:0034645),0.32619539257114377,1.104840771603569,0.24692622950819673,0.6869298723159873,1.0,57/306,14.11%,ZAR1;ST3GAL4;DNA2;EXT1;BCL3;RPL5;RBBP8;POLL;CDC45;RPS10;POLR3A;MRE11;FEN1;POLR2C;SCX;FAM111A;B4GALT5;KAT7;RPL37A;MRPL55;RPL6;ORC5;MRPL18;MCM6;RBMS1;RPS18;RPS14;WRN;RPL35A;ORC4;MRPL13;RPL13;NFKBIB;BRIP1;CREBL2;EEF1G;RPS3;IGF2BP3;RPS21;FARSB;RECQL5;NAP1L1;RPA3;RPL34;RPLP0;BAZ2A;POLA2;RPL19;RPL11;MCM2;RPL30;RNASEH2A;PCLAF;RPS2;RPL4;DONSON;RPL7
prerank,inositol phosphate biosynthetic process (GO:0032958),0.5211612473038382,1.1047779835633933,0.3616636528028933,0.6865545069777336,1.0,2/11,2.90%,ITPKC;IP6K3
prerank,plasma membrane bounded cell projection assembly (GO:0120031),0.33096732328729117,1.1047601033291903,0.27887617065556713,0.6860450348133108,1.0,46/259,13.28%,FXYD5;SRGAP2;CDC14A;ATAT1;ACTR3;RAP1A;PTPRO;SHTN1;FOXJ1;EXOC6;RAPGEF2;CCDC88A;OCRL;EHD2;RP2;CD2AP;RFX3;CARMIL1;PPP1R9B;FGD4;ARF4;ACTR2;FLNA;IFT140;EZR;GBF1;RAC1;FGD1;MINK1;FGD3;KIF24;ARHGEF6;EXOC7;UNC119B;CEP250;KIF3B;RILPL2;FHDC1;PTPDC1;NTN1;ABCC4;IQCB1;CFAP54;PIP5K1A;KIT;CFAP70
prerank,positive regulation of hydrolase activity (GO:0051345),0.3422475127979623,1.104519321279806,0.3091517857142857,0.6861161960824937,1.0,25/137,11.71%,SRGAP2;RAP1A;CD40;DOCK10;RASGRP2;RAPGEF2;USP6NL;DOCK11;PICALM;ARAP1;RSU1;CAV2;AFDN;WRN;S100A10;F11R;PSAP;MAPK12;RHOA;BCAS3;RPS3;SNX9;NET1;TBC1D2;DVL3
prerank,regulation of mitochondrial fission (GO:0090140),0.4463562477526959,1.103933318945229,0.33796296296296297,0.6870817402505813,1.0,2/24,0.59%,LRRK2;CYRIB
prerank,placenta development (GO:0001890),0.5009275959762792,1.1038684714403126,0.3657331136738056,0.6866971163908189,1.0,2/12,10.02%,PPARG;ADAM19
prerank,regulation of intracellular transport (GO:0032386),0.4033715166742696,1.103479758112294,0.32357043235704325,0.6870965276743711,1.0,8/38,15.02%,LRRK2;LCP1;INPP5F;RINT1;PTPN1;DYNC1H1;GRIPAP1;DYNLT2B
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.49170800419322347,1.1034557162626382,0.3515358361774744,0.6866204123504336,1.0,6/15,18.12%,STAT3;IL17RA;IL6;GBP5;MYD88;APPL1
prerank,negative regulation of bone remodeling (GO:0046851),-0.46342797325540536,-1.1031582401517948,0.3470319634703196,0.7333460313936234,1.0,3/11,4.94%,GPR137B;TMEM119;P2RX7
prerank,establishment of apical/basal cell polarity (GO:0035089),-0.43343589187813425,-1.1029175519695638,0.35731414868105515,0.7326062148606712,1.0,5/14,7.66%,OPHN1;MYO9A;RAP2A;PATJ;SCRIB
prerank,positive regulation of DNA binding (GO:0043388),-0.3413603638327229,-1.102768833289795,0.3211920529801324,0.7315981153581385,1.0,4/31,2.97%,PRKN;IGF1;SKI;HMGB1
prerank,regulation of focal adhesion assembly (GO:0051893),0.38462134822803956,1.102626319579476,0.3263707571801567,0.6881663265165313,1.0,19/54,18.45%,SLK;RCC2;DLC1;PTEN;S100A10;PHLDB2;RAC1;RHOA;BCAS3;ROCK1;CLASP1;PTPRJ;COL16A1;THBS1;DUSP22;DAPK3;ARHGAP6;PTPRA;VCL
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.3548552270766842,1.102545349101476,0.3096385542168675,0.687845475940576,1.0,21/101,14.21%,LRRK2;IL1B;FLT3;CD40;RAPGEF2;CCND3;ADRA2A;CCND1;PIK3R6;ADAM17;CIB1;RALB;RHOA;DIRAS1;PSMD10;PDGFD;CCND2;AKT1;KIT;EZH2;TGFB1
prerank,establishment of protein localization to extracellular region (GO:0035592),-0.33101111611123996,-1.1024390412351266,0.2807570977917981,0.731095740733231,1.0,9/39,12.57%,ABCA1;TANGO2;RAB3C;PREB;SCG2;ARFGAP3;OLFM2;TANGO6;MTTP
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),0.5038347489576608,1.1022739031114461,0.353518821603928,0.6880082647845566,1.0,6/13,19.17%,PRPF6;SRSF10;PRPF3;USP4;AAR2;DDX20
prerank,regulation of ion transmembrane transporter activity (GO:0032412),0.39933788844609175,1.1022018799296045,0.3379501385041551,0.6876437329591824,1.0,4/39,2.59%,FXYD5;TCAF2;UTRN;NEDD4L
prerank,positive regulation of neuron apoptotic process (GO:0043525),-0.3794281142987145,-1.1016746335452705,0.3146417445482866,0.7317980545912038,1.0,13/24,19.65%,GRN;CTNNB1;NF1;ATF4;CDK5R1;BACE1;CDK5;EPHA7;SRPK2;TGFB2;BAX;CCL3;TYROBP
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.49670896438694034,1.1009505553424457,0.3492822966507177,0.6901075198025446,1.0,2/14,2.48%,LRRK2;HSPA1A
prerank,vasculature development (GO:0001944),0.48633088535379343,1.1009163816319514,0.3729903536977492,0.689634442427706,1.0,3/16,10.64%,BMPR2;FBXW7;PIK3CA
prerank,cellular response to organonitrogen compound (GO:0071417),-0.27280773718689716,-1.1007292483899642,0.2236024844720497,0.7329955023684137,1.0,24/99,10.51%,RYR3;MEF2C;P2RY12;LARP1;RPTOR;CTNNB1;PKD2;GABRG2;CPEB1;P2RX7;P2RX4;GABRB1;IMPACT;LARS1;IPO5;JUP;HSP90B1;GLRA2;P2RY6;SLIT2;AKAP6;CPEB4;HCN1;HCN2
prerank,regulation of complement activation (GO:0030449),-0.33478491315122083,-1.100635037396317,0.2943396226415094,0.731825570172436,1.0,11/40,13.74%,C1QB;C1QA;C1QC;C3AR1;PROS1;C4B;C5AR1;SUSD4;C5AR2;CLU;C3
prerank,ncRNA metabolic process (GO:0034660),0.4090862704364909,1.1006325465248252,0.34497206703910616,0.6897652936813569,1.0,10/37,22.58%,XPO5;DGCR8;EXD1;TRIM71;TUT7;TENT4B;DTD1;PARN;TARBP2;ZCCHC8
prerank,regulation of adaptive immune response (GO:0002819),0.46569979575483783,1.1006097946770363,0.34554140127388533,0.6892703606876793,1.0,8/18,17.47%,AHR;SAMSN1;IL6ST;IRF7;ADCY7;FCGR2B;SIRT1;SASH3
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",0.3179451296426122,1.1005450457142798,0.157,0.6888708018691165,1.0,158/807,17.20%,CIITA;CBFA2T3;BCL11A;TRPS1;JARID2;FOXP1;RUNX2;RARA;SP100;SP3;RUNX3;LIMD1;BCL3;KLF4;UXT;CREB1;PPARG;ETV6;SCML4;BCL6;SAP30;NFKB1;ATF7IP;STAT3;FOXJ1;NIPBL;NEDD4L;NAB1;CIART;MAD2L2;SPI1;CRY1;TBL1XR1;MTA3;GATAD2B;ZEB2;MBD1;SUMO1;KAT7;LRRFIP1;KLF8;IRF2;RFX3;RBPJ;IL33;KCNIP3;HIVEP1;DEAF1;STAT1;UBE2D3;HEXIM1;MBTD1;FBXW11;RPS6KA5;CCND1;KLF10;AHR;RPS14;CGGBP1;WFS1;ARID4A;CBFB;FLNA;CREM;PDCD4;SETDB2;MECP2;PDE2A;PLCB1;THRA;CRY2;CLOCK;SAP18;GATAD2A;RARG;EZR;CTCF;PHF12;UIMC1;HDAC9;PEX14;CBFA2T2;BACH1;KAT6A;RBAK;ID2;WWP2;EZH1;E4F1;SMARCE1;PARP9;IRF7;RCOR3;SMAD4;SBNO2;CNOT2;DAXX;LIN37;NR3C1;SPEN;RBM15;FOXO3;IKZF5;DEDD2;TAF7;ETS2;REST;MBD2;MAP2K5;NUPR2;PSMD10;L3MBTL2;MYB;NRIP1;NSD1;LBH;TLE1;EZH2;SREBF2;SMARCC2;CITED2;HDAC3;NFIL3;TGFB1;ZNF431;RSF1;GPS2;ZNF436;MAFK;AURKB;MAZ;DUSP26;TNFRSF4;CREBBP;RELA;USP9X;PRDX5;MIER1;TAF1;BHLHE40;PHC3;ZNF148;MED1;DUSP22;BRD7;USP47;RB1;BPTF;NCOA5;SEMA4D;PROX1;SCMH1;NIBAN2;PSEN1;ELK4;FOXK1;SIRT1;SUPT4H1
prerank,regulation of lipid catabolic process (GO:0050994),0.4686505433454563,1.0996461415096985,0.35691318327974275,0.6906102758123739,1.0,5/19,15.05%,IL1B;ADRA2A;PRKAA1;ABCD1;ANGPTL3
prerank,"phagocytosis, engulfment (GO:0006911)",0.41022752453427486,1.0996414772900023,0.350354609929078,0.6900741379389668,1.0,14/36,18.26%,CD36;RAC2;MYH9;CDC42;ITGB2;XKR4;RAC1;FCGR2B;MEGF10;RHOG;ELMO1;THBS1;GULP1;FCGR1A
prerank,positive regulation of protein export from nucleus (GO:0046827),0.4769557693816917,1.0992221725919886,0.341421143847487,0.6905344036185039,1.0,3/15,8.99%,IL1B;XPO4;RBM22
prerank,amino acid import across plasma membrane (GO:0089718),-0.37317006391947183,-1.0991471611686883,0.30484330484330485,0.7344884921555743,1.0,7/24,14.59%,SLC1A3;SLC7A1;SLC36A1;SLC7A2;SLC7A8;SLC3A2;SLC22A4
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.4013888024085479,1.0987664596908155,0.34395750332005315,0.6910835185827947,1.0,7/45,9.94%,BMPR2;RBPMS;GDF1;BMP3;ENG;ACVR2A;SMAD4
prerank,mitotic nuclear membrane organization (GO:0101024),0.38205699039020913,1.0983072245248802,0.33636363636363636,0.6911153430178674,1.0,10/51,10.52%,VRK1;SUMO1;CHMP4A;CHMP4B;NUP98;PPP2R2A;LMNA;SPAST;ANKLE2;LEMD2
prerank,mitotic nuclear membrane reassembly (GO:0007084),0.38205699039020913,1.0983072245248802,0.33636363636363636,0.6911153430178674,1.0,10/51,10.52%,VRK1;SUMO1;CHMP4A;CHMP4B;NUP98;PPP2R2A;LMNA;SPAST;ANKLE2;LEMD2
prerank,regulation of autophagosome maturation (GO:1901096),0.4942192517599271,1.0982070618933215,0.35960591133004927,0.6908333354905843,1.0,2/13,7.31%,UVRAG;CLEC16A
prerank,relaxation of muscle (GO:0090075),-0.43962515906962163,-1.0981761810714985,0.34673366834170855,0.7358694309049761,1.0,5/13,7.62%,SLC8A1;KCNJ2;ATP1B1;P2RX4;ATP1A2
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),0.3685891271913575,1.0979243819733655,0.32885085574572126,0.6909567294274833,1.0,16/74,15.32%,IL1B;TIAM1;SDHAF2;MAD2L2;GLIPR2;PTEN;PHLDB2;IL6;OLFM1;SPRED3;SMAD4;USF3;EZH2;CLASP1;TGFB1;SPRED1
prerank,transepithelial transport (GO:0070633),0.48497190955643105,1.0971478445390312,0.3517915309446254,0.6923924614490827,1.0,3/15,6.93%,SLC23A2;SLC23A1;ABCC1
prerank,positive regulation of protein localization to cell surface (GO:2000010),-0.4386037398518748,-1.096736484242866,0.3604060913705584,0.7385923709203712,1.0,5/13,21.60%,MAP1A;ABCA7;HSP90AB1;TYROBP;TMEM35A
prerank,cell-substrate junction assembly (GO:0007044),-0.33979359395408526,-1.0962091235817677,0.31788079470198677,0.7386816061997342,1.0,11/33,19.48%,DST;ITGA6;PTPRK;PEAK1;LAMA3;TESK2;SRC;WHAMM;CTTN;ACTN2;THSD1
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),-0.4638686731378841,-1.096145445769527,0.3617021276595745,0.7374789210476993,1.0,5/11,21.75%,RASA1;NOVA1;NOVA2;IGF2BP2;PCBP4
prerank,regulation of protein ubiquitination (GO:0031396),0.3552117229040772,1.0955277598622584,0.305978898007034,0.6957536930109598,1.0,27/108,15.37%,LRRK2;HSPA1A;CUL3;LAPTM5;MALT1;CRY1;FBXW7;AXIN1;BIRC3;PTTG1IP;DCUN1D1;UBE2N;WFS1;MYCBP2;FBXO4;RPS3;CAMLG;DAXX;RCHY1;PSMD10;USP4;FANCI;AKT1;HDAC3;PRMT3;XIAP;SVBP
prerank,positive regulation of smooth muscle cell migration (GO:0014911),-0.39619919798204417,-1.0953199854535018,0.31865284974093266,0.7382960393479377,1.0,4/17,3.16%,IGF1;DOCK4;NRP1;AIF1
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),0.44900701038866475,1.0949782669413972,0.3297045101088647,0.6966410837301088,1.0,1/21,0.54%,PLA1A
prerank,pulmonary valve morphogenesis (GO:0003184),0.47253255494662494,1.0947830184222185,0.3665644171779141,0.6965822845695384,1.0,2/17,2.90%,NOTCH2;GJA5
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),-0.41973634055354936,-1.09461394327277,0.327319587628866,0.7388910675334688,1.0,6/16,9.54%,IGF1;MEF2C;ERBB4;FGF2;FGFR2;AKAP6
prerank,negative regulation of neuroinflammatory response (GO:0150079),0.49411599332473244,1.0942186952207618,0.37735849056603776,0.6974387656060018,1.0,2/14,1.75%,PTPRC;LDLR
prerank,negative regulation of neuron death (GO:1901215),-0.28021448479372224,-1.0940723342574925,0.26627218934911245,0.7389597093155422,1.0,21/93,10.59%,PRKN;LGMN;APOE;MEF2C;NTRK2;GRN;CSF1;RASA1;CD34;PPARGC1A;ADAM8;NRBP2;ATF4;KDM2B;SNX6;CPEB4;VPS35;PTPRZ1;CDK5;MSH2;SET
prerank,modulation of chemical synaptic transmission (GO:0050804),-0.2663637784905832,-1.0940417224464936,0.2191780821917808,0.7376479260590142,1.0,21/107,10.34%,OPHN1;DLGAP1;CX3CR1;MEF2C;DGKZ;SNCAIP;SYT1;NLGN1;DLGAP4;ABR;TMEM108;DLG4;USP46;NRG3;GRID2;GRIK4;GRIK1;ATP1A2;CHRNA7;CDK5;GRM5
prerank,mesenchymal cell differentiation (GO:0048762),-0.3076397702884882,-1.0935588744769098,0.2834008097165992,0.7375741776463653,1.0,10/51,10.02%,MEF2C;LRP6;TGFBR1;DDX5;CTNNB1;HIF1A;FGFR2;HTR2B;LOXL3;HNRNPAB
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),0.35047798606751496,1.0934016285020896,0.32941176470588235,0.6988575549532384,1.0,15/107,12.60%,CCR2;CD40;CCR1;NPTN;SLC8B1;ATP2B1;ATP2A3;STIM2;ATP2A1;SLC30A1;DMPK;TMEM203;ATP13A3;SLC10A7;SLC24A4
prerank,macroautophagy (GO:0016236),0.3442267309517904,1.092981566862918,0.3383545770567787,0.6993486827699602,1.0,38/118,19.01%,UVRAG;PIP4K2A;PRKAG2;VPS37C;MTMR14;CHMP4A;CHMP4B;STX17;MTMR3;TSG101;PRKAB2;ATG5;SNF8;CSNK2A2;CSNK2A1;TBC1D5;TOMM40;PIP4K2B;PRKAG1;STAM;PRKAA1;PGAM5;PIK3R4;WIPI2;ATG10;ARL8B;PRKAA2;VCP;ILRUN;RB1CC1;FUNDC1;AMBRA1;BECN1;ATG13;STAM2;SNX14;PINK1;VPS37B
prerank,regulation of mesenchymal cell proliferation (GO:0010464),-0.46123220589936886,-1.0929571840339847,0.34306569343065696,0.7378295355377912,1.0,3/11,8.54%,TGFBR2;FGFR2;PDGFA
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),0.43987577263855515,1.0926261600562701,0.3468208092485549,0.6996934849553673,1.0,10/23,16.94%,NFKB1;ZBTB20;PRXL2C;PRKAA1;APP;PFKFB3;PRKAA2;PFKFB4;INSR;PSEN1
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),0.5250186846602116,1.0925764621613736,0.38636363636363635,0.6992747542960084,1.0,3/10,12.51%,JAK2;IL33;TLR2
prerank,double-strand break repair (GO:0006302),0.3366642092350945,1.0925361426851392,0.292896174863388,0.6988201512098061,1.0,45/158,19.64%,DNA2;SAMHD1;DTX3L;MAD2L2;RBBP8;POLL;MRE11;FEN1;SUMO1;DNTT;SMARCA5;UBE2N;SETX;WRN;CIB1;NABP1;UIMC1;BRIP1;PARP9;MORF4L1;RECQL5;RPA3;XRCC4;EXD2;SPIDR;MAPK8;ERCC4;RNF138;VCP;XRCC2;INO80;MCM9;KDM4B;POLB;KPNA2;HUS1;EYA3;MDC1;SMC6;RAD21;CHEK2;SETMAR;SMC5;TNKS1BP1;RNF168
prerank,negative regulation of protein polymerization (GO:0032272),0.4325216432893629,1.0922862043134751,0.37422360248447206,0.6988686902694956,1.0,10/27,18.43%,CYRIB;DYRK1A;KANK3;ARFGEF1;CLIP3;TBCD;STMN2;MYADM;KANK1;PRKCD
prerank,purine ribonucleotide transport (GO:0015868),0.491982645396984,1.0922229896469409,0.3670886075949367,0.6984756373339593,1.0,3/16,11.59%,LRRC8C;LRRC8D;ABCC4
prerank,positive regulation of T cell differentiation (GO:0045582),0.4038133643481413,1.0921388787913409,0.33709449929478136,0.6981297178959873,1.0,3/36,4.42%,TESPA1;BCL6;ZAP70
prerank,positive regulation of protein binding (GO:0032092),0.3767827305950089,1.0919126339228546,0.3603723404255319,0.698159312701789,1.0,12/56,13.42%,LRRK2;TIAM1;DTX3L;RAPGEF2;HIPK2;STK4;RALB;B2M;APP;NMD3;RPL11;MARK3
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),0.41279034046078616,1.0914766704927186,0.3427362482369535,0.6986951488148114,1.0,6/33,9.14%,NDNF;CAST;PDPK1;WFS1;NFE2L2;ICAM1
prerank,positive regulation of lipid kinase activity (GO:0090218),0.42330149101872094,1.0914760804751817,0.3522561863173217,0.6981541606031165,1.0,7/29,14.26%,FGR;FLT3;PTK2B;PIK3R4;KIT;TGFB1;FGFR3
prerank,negative regulation of signaling (GO:0023057),0.44095782485285967,1.0912744318863368,0.3535660091047041,0.6980839585978403,1.0,3/25,10.51%,IL1B;OPRM1;PTPN1
prerank,negative regulation of cell population proliferation (GO:0008285),0.3207309441561463,1.0912365734138194,0.28249744114636643,0.6976338760007009,1.0,56/351,14.46%,CBFA2T3;IL1B;IFNLR1;RUNX3;LYN;NGF;MARVELD3;KLF4;PPARG;PTPRU;PAK1;JAK2;HSPA1A;BTG2;CD300A;BMPR2;RAPGEF2;FABP7;PTPN6;ABI1;EIF2AK2;DLC1;BTG1;RBBP4;TNS2;GLMN;FAP;PTEN;CDKN2C;KLF10;PTK2B;CIB1;SULT2B1;RARG;LMNA;CTCF;IL6;IFI35;OPRM1;ARID2;B2M;S100A11;REST;APP;NUPR2;UTP20;SH3BP4;PPM1D;NF2;MORC3;CD164;KAT2B;RPS6KA2;TGFB1;PTPRJ;PPP2R5C
prerank,cellular response to organic cyclic compound (GO:0071407),0.3372233249346482,1.090814515902984,0.3192436040044494,0.6980835658332674,1.0,29/141,15.78%,LRRK2;IL1B;RAP1A;MSN;RAPGEF2;KCNQ1;NCOA3;CTNNA1;HCN4;GABRB2;DIAPH1;TIPARP;AHR;PDE2A;EZR;GNB1;HRH1;NR3C1;GNAI1;ADCY5;SPIDR;NRIP1;GNG2;CASP7;TGFB1;IL18;CASP6;TAF1;MED1
prerank,negative regulation of bone mineralization (GO:0030502),0.5058977889474864,1.0907165309403757,0.3644067796610169,0.6977729863930814,1.0,3/13,6.44%,CCR1;SRGN;PTK2B
prerank,regulation of bicellular tight junction assembly (GO:2000810),0.47068821383747583,1.0902486426404925,0.36728395061728397,0.6984006375267763,1.0,7/19,15.16%,PRKCH;MYO1C;IKBKB;CBFB;F11R;ROCK1;OCLN
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),-0.40307610546537065,-1.0900028969541542,0.3423180592991914,0.7447458477925416,1.0,3/18,5.26%,PRKN;PPIA;HIF1A
prerank,acetylcholine receptor signaling pathway (GO:0095500),-0.392373059926931,-1.0900004897756908,0.33518005540166207,0.7433410913164299,1.0,6/20,13.71%,CHRM3;CHRM2;RGS10;CDK5R1;CHRNA7;AGRN
prerank,regulation of sequestering of calcium ion (GO:0051282),0.5026260610256238,1.0897286265760724,0.37823834196891193,0.6991035416641195,1.0,5/12,21.94%,DIAPH1;PTK2B;FKBP1B;ANXA6;UBASH3B
prerank,regulation of protein localization to nucleus (GO:1900180),0.398685947639148,1.0895132856074299,0.3451568894952251,0.6990883243740598,1.0,12/43,14.74%,NGFR;DTX3L;CTNNA1;KAT7;LATS1;PARP9;LATS2;EIF2AK3;AKT1;LIMK2;TGFB1;ILRUN
prerank,regulation of melanin biosynthetic process (GO:0048021),0.5201465637433889,1.0893609776610331,0.37153419593345655,0.6989470547134204,1.0,5/10,18.35%,RAPGEF2;ZEB2;ATP7A;APPL1;CTNS
prerank,bone development (GO:0060348),0.4136615771692329,1.0884227172796563,0.352773826458037,0.7006772453634924,1.0,4/39,3.91%,PTPRC;SULF2;NOTUM;PTGER4
prerank,regulation of keratinocyte proliferation (GO:0010837),0.44005705135235,1.0881350088804,0.3543913713405239,0.7008427628925765,1.0,2/22,1.57%,NOTCH2;CASK
prerank,negative regulation of metabolic process (GO:0009892),0.37329751321142984,1.087465009525203,0.34935064935064936,0.7019260969879214,1.0,9/54,11.72%,IL1B;LNPEP;ACOT11;RBPJ;ZDHHC7;ADAM17;FIS1;RHEB;PGAM5
prerank,bile acid metabolic process (GO:0008206),-0.3643265354434659,-1.087234598131396,0.3,0.7491864153492,1.0,13/27,34.28%,OSBPL1A;CH25H;NPC1;GBA2;OSBPL6;AMACR;OSBPL7;ACOT8;OSBP;SLC27A2;OSBPL2;HSD17B10;CYP7B1
prerank,ERBB2 signaling pathway (GO:0038128),0.415264079425099,1.0870794663671122,0.3583815028901734,0.7023647636720821,1.0,7/31,10.64%,NRG2;CUL5;ERBIN;PTPN12;GRB2;SOS1;PIK3CA
prerank,regulation of fatty acid beta-oxidation (GO:0031998),-0.42407315555666136,-1.0866875600500998,0.3308270676691729,0.7492690773768267,1.0,3/14,8.94%,ABCD2;LONP2;IRS1
prerank,endocardial cushion morphogenesis (GO:0003203),-0.38878747292113347,-1.086544560376547,0.3333333333333333,0.7482732821227687,1.0,3/18,13.75%,TGFBR2;ACVR1;TGFB2
prerank,cellular response to starvation (GO:0009267),0.3340130703059258,1.0865047192244566,0.3094972067039106,0.7032185824107001,1.0,39/147,17.98%,LRRK2;SIK1;STK24;MAP3K5;PRKAG2;ATP6V0E1;BMPR2;EIF2AK2;ATF2;KLF10;MTMR3;WRN;ATG5;CLEC16A;SIK2;RALB;ATP6V1H;DEPDC5;PRKAG1;RHEB;FOXO3;PRKAA1;NUPR2;PIK3R4;WIPI2;CASTOR2;EIF2AK3;MAPK8;SREBF2;PRKAA2;BRSK1;RRP8;MAPK1;SEH1L;XPR1;SIRT1;ATP6V1E1;BECN1;HSPA5
prerank,innate immune response in mucosa (GO:0002227),-0.4751152803768204,-1.0864604342801696,0.3497536945812808,0.7471044122633259,1.0,5/10,44.08%,RNASE3;CAMP;LTF;DEFA6;RPL39
prerank,protein targeting to membrane (GO:0006612),0.35881959065685803,1.0864453515357753,0.3353733170134639,0.7028375733709518,1.0,17/83,13.43%,VPS37C;MYO1C;PEX16;CHMP4A;CHMP4B;PEX12;ZDHHC7;TRAM1;ZDHHC6;ZDHHC23;PEX14;SEC63;PIKFYVE;FIS1;SRP19;ABCD1;NCF1
prerank,regulation of cell adhesion (GO:0030155),0.3417342133633386,1.0862995616312405,0.33860045146726864,0.7026628326020113,1.0,30/129,17.64%,CYTIP;LYN;RET;PPP1R12A;RIPOR2;RAC2;CBLL1;PPP3CA;SPN;RSU1;ARHGDIB;PTK2B;TGFBI;PLXND1;EPHB2;ATXN3;MINK1;DUSP1;PPP1CB;PLXNC1;ROCK1;CD164;PTPRJ;IL18;DUSP26;MYADM;FES;SEMA4D;ABL2;EFNA1
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.3677461298377126,1.0862725147729717,0.3378212974296206,0.7021812194309688,1.0,23/63,20.89%,SP100;TRAF1;PSME3;BIRC6;BCL2L14;PAK2;TMC8;CYLD;RIPK1;DEDD2;HTT;SH3RF1;LGALS3;GSTP1;RELA;THBS1;TRAF2;DEPTOR;FGFR1;PARK7;FEM1B;ITGAV;PHIP
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),0.4391468904216751,1.0862304584582645,0.35222052067381315,0.701737754328284,1.0,9/23,20.41%,SPI1;IFI35;CPNE1;CYLD;NLRP3;RELA;HDAC7;TMSB4X;ADIPOR1
prerank,maintenance of protein localization in organelle (GO:0072595),0.45204413838471513,1.0861156285816937,0.3558282208588957,0.7014757672222593,1.0,7/19,21.24%,BCL3;TAPT1;MORC3;AKT1;HSPA5;PINK1;TAF3
prerank,negative regulation of amyloid fibril formation (GO:1905907),-0.4544051332373794,-1.085725752513743,0.36496350364963503,0.74778070111093,1.0,2/12,0.70%,APOE;TREM2
prerank,positive regulation of neuron death (GO:1901216),0.3920248908486224,1.0856109350665852,0.353494623655914,0.7021327236042892,1.0,11/46,11.90%,FYN;MAP3K5;FOS;PICALM;ITGB2;PRNP;DDIT4;DAXX;FOXO3;FCGR2B;REST
prerank,bone morphogenesis (GO:0060349),-0.43031555363116314,-1.0855668160234473,0.35789473684210527,0.7468539002358127,1.0,3/14,6.22%,SKI;LRP6;FGFR2
prerank,respiratory system development (GO:0060541),-0.3457896755687857,-1.0848202932187256,0.32323232323232326,0.7476150971891199,1.0,7/32,13.25%,BASP1;CHD7;FGF2;FGFR2;LOXL3;VEGFA;DISP1
prerank,regulation of early endosome to late endosome transport (GO:2000641),0.46447072048162374,1.08452837190324,0.3864734299516908,0.7041978038060738,1.0,9/18,23.52%,MSN;EZR;SNX3;MAPK1;SNX12;MTMR2;MAP2K1;RAB21;CHMP3
prerank,positive regulation of chondrocyte differentiation (GO:0032332),-0.47277657396794326,-1.0843508225265301,0.3592233009708738,0.7474884122369941,1.0,3/10,15.29%,BMPR1B;PKDCC;SOX5
prerank,excitatory postsynaptic potential (GO:0060079),0.4532428819937694,1.0841272276068832,0.357032457496136,0.7046454116872318,1.0,1/19,0.22%,LRRK2
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),-0.4475458805357493,-1.0838398934778488,0.36228287841191065,0.7475354873860638,1.0,3/12,0.72%,PRKG1;DOCK4;MEF2C
prerank,bicarbonate transport (GO:0015701),0.4274692023256704,1.0837024582435735,0.3838526912181303,0.70513492467362,1.0,5/25,13.59%,SLC4A7;SLC4A8;CYB5R4;CYB5R1;SLC26A7
prerank,regulation of RNA splicing (GO:0043484),0.37099592548946275,1.0831946112927602,0.3487241798298906,0.7058091166043492,1.0,20/69,15.86%,MBNL1;AHNAK;PTBP3;HSPA1A;ERN1;PRX;MBNL3;SETX;SRSF10;DYRK1A;RBM22;METTL4;YTHDC1;PQBP1;ZPR1;HNRNPLL;RBM38;CELF1;RBM39;PTBP2
prerank,dendritic spine organization (GO:0097061),0.4315570404650215,1.083187615299363,0.3542600896860987,0.7052915932685456,1.0,11/26,16.70%,FYN;DOCK10;CDC42;PTEN;PRNP;ARF1;EPHB2;ITGA3;INSR;WNT7A;MTMR2
prerank,chromatin organization involved in regulation of transcription (GO:0034401),0.48641883682341774,1.083060272788126,0.3789649415692821,0.7050806505317287,1.0,5/13,17.80%,SPI1;FAM47E;ELOF1;ZMIZ2;PADI2
prerank,double-strand break repair via break-induced replication (GO:0000727),0.4968884644815937,1.08294133521181,0.38047138047138046,0.704826811470632,1.0,3/12,12.94%,CDC45;MCM6;MCM2
prerank,negative regulation of cell adhesion (GO:0007162),0.3587507930275456,1.082923332574205,0.3431013431013431,0.7043316747702572,1.0,16/72,14.21%,PTPRC;PTPRO;RIPOR2;CBLL1;SPN;ARHGDIB;TGFBI;PLXND1;EPHB2;RHOA;DUSP1;PLXNC1;NF2;TBCD;CD164;TGFB1
prerank,snRNA transcription by RNA polymerase II (GO:0042795),0.3646649087343844,1.0822539448506268,0.3411330049261084,0.7054528458627908,1.0,22/69,18.69%,GTF2F2;TAF13;TAF9;GTF2E2;POLR2C;NABP1;GTF2A1;RPRD2;SNAPC3;RPRD1B;INTS2;CCNT2;SRRT;INTS11;INTS14;CCNT1;INTS4;NCBP1;ELL;INTS6;POU2F2;PHAX
prerank,cilium movement (GO:0003341),0.37840141822374573,1.0818929020945807,0.340878828229028,0.7058044858449651,1.0,9/47,13.28%,DNAH9;ADCY10;DNAAF5;CABYR;CFAP61;ODAD1;CCDC39;CFAP54;CFAP70
prerank,extracellular matrix organization (GO:0030198),0.32045945524833735,1.081780000968711,0.31704781704781704,0.7055372620342333,1.0,31/276,10.32%,ITGB7;ITGA4;ITGAL;CD44;CD47;LCP1;PECAM1;ITGAE;ITGAX;TNC;NDNF;COL5A2;MMP1;LAMB1;SCX;ITGAD;ITGB2;HSPG2;CAPN2;F11R;ATP7A;ADAMTS6;TGFBI;PXDN;ACAN;ICAM1;FBN1;TLL1;ADAM19;NCAN;FN1
prerank,protein glycosylation (GO:0006486),0.336991887331879,1.0816944689774113,0.33182844243792325,0.7052107729654465,1.0,14/125,10.27%,ST3GAL1;ST8SIA4;ST3GAL4;ST8SIA1;TET2;KRTCAP2;FUT4;ST8SIA6;B4GALT5;GALNT2;SERP2;GALNT10;MGAT3;MAGT1
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),0.47689179681539634,1.0813953692614948,0.38556067588325654,0.7053995234977443,1.0,4/17,9.27%,RET;SYK;CIB1;PIEZO1
prerank,respiratory electron transport chain (GO:0022904),0.4871879373454043,1.0812495648116698,0.3680672268907563,0.7052365377906613,1.0,4/14,11.49%,GPD2;SLC25A13;SLC25A12;SLC25A18
prerank,protein processing (GO:0016485),-0.27259848755396204,-1.081200903220157,0.23129251700680273,0.7536268034725823,1.0,36/102,25.04%,LGMN;VSIR;MMP16;KLK3;METAP2;PSEN2;SPCS3;FURIN;SPPL3;LONP2;MMP14;AFG3L2;SEC11C;CASP4;PCSK1;BACE1;PCSK7;SPG7;STOML2;HTRA2;ZMPSTE24;HM13;PSENEN;SPRTN;AEBP1;TMEM208;ECE1;FXN;PTCH1;CLN3;CPE;PCSK2;EEF1AKMT4-ECE2;CTSH;APH1A;TYSND1
prerank,protein secretion (GO:0009306),-0.29640230553055313,-1.0811246189565311,0.2833333333333333,0.7524294029957604,1.0,11/56,12.57%,ABCA1;TANGO2;WLS;RAB3C;PREB;SNX19;SCG2;ARFGAP3;OLFM2;TANGO6;MTTP
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),-0.28844867871553914,-1.0807050036900006,0.3080568720379147,0.7522198169114017,1.0,26/69,25.21%,ECPAS;STUB1;ERLIN2;DERL2;HSP90B1;AUP1;NPLOC4;USP19;RNF121;DNAJB2;SGTB;DERL1;TRIM13;ANKZF1;RNF103;HERPUD1;TMUB2;FAM8A1;UBQLN2;DNAJB9;UBE2G2;SEC61B;FBXO44;UBE4A;UBE4B;FBXO17
prerank,regulation of ion transmembrane transport (GO:0034765),-0.3390403168327357,-1.0806126696493308,0.3256578947368421,0.7510724455263068,1.0,7/33,9.57%,WNK1;AHCYL1;CHRM3;KCNJ2;P2RX7;AKAP6;KCNJ6
prerank,response to estrogen (GO:0043627),0.4072425185342649,1.0805597925733408,0.34107402031930334,0.7064024192381976,1.0,4/31,9.13%,RARA;SERPINB9;TRIM25;BCAS3
prerank,activation of protein kinase B activity (GO:0032148),-0.34651000669386534,-1.0804387562785767,0.3258785942492013,0.7502017720351388,1.0,5/29,2.78%,IGF1;NTRK3;OSBPL8;GAS6;PPIA
prerank,protein polymerization (GO:0051258),0.37986692755006085,1.0801779911035545,0.36,0.7068082214467998,1.0,11/55,11.45%,PSTPIP1;JAK2;PSTPIP2;MSRB1;CHMP4A;CHMP4B;DIAPH1;TPPP3;RAC1;UBE2S;TTC17
prerank,positive regulation of growth (GO:0045927),0.36632934729246147,1.0797037428082654,0.3630653266331658,0.7074353893176379,1.0,20/64,16.27%,RPS6KA3;CDC42;H3-3A;CXCL16;ADAM17;WFS1;CIB1;MTPN;PLCB1;DDX49;CSNK2A1;RPS6KA1;PSMD10;ZPR1;PABIR1;AKT1;NCBP1;INO80;USP47;INSR
prerank,signal transduction in response to DNA damage (GO:0042770),0.3833446631030072,1.0794267777389568,0.3684210526315789,0.7075187341099908,1.0,20/49,23.15%,BCL3;MAD2L2;MAPK14;CDC5L;GRB2;CEP63;CLOCK;DOT1L;BRIP1;ATRX;MAP3K20;DONSON;HUS1;RAD17;CHEK2;TIPRL;BID;CASP9;BATF;STK33
prerank,ketone body metabolic process (GO:1902224),-0.467623059225392,-1.0793850041017374,0.38799076212471134,0.7517409853094434,1.0,2/10,4.03%,OXCT1;HMGCL
prerank,DNA replication-independent nucleosome organization (GO:0034724),0.5114450306200442,1.079039966268632,0.38640429338103754,0.7079145089875708,1.0,6/11,22.70%,H3-3A;RBBP4;ATRX;HAT1;CABIN1;ASF1A
prerank,regulation of actomyosin structure organization (GO:0110020),0.48882995724973305,1.0788549119093036,0.37603993344425957,0.7078044186273235,1.0,7/13,21.30%,PTGER4;CDC42;RAC1;ROCK1;FHOD1;ALMS1;WAS
prerank,protein-DNA complex disassembly (GO:0032986),0.4720681107475793,1.0788321403075534,0.3806343906510851,0.7073208930915403,1.0,4/16,13.76%,NFE2;SMARCE1;ARID2;SMARCC2
prerank,thymus development (GO:0048538),-0.4245624467533442,-1.078419714950321,0.37755102040816324,0.7529714687370846,1.0,9/13,48.98%,TGFBR1;FGF10;SOD1;EPHB3;HES1;ZBTB1;SHH;FADD;RIPK3
prerank,smooth muscle cell differentiation (GO:0051145),-0.43828981233970943,-1.0783123054416883,0.37644341801385683,0.7518608339609397,1.0,1/12,0.72%,MEF2C
prerank,central nervous system neuron development (GO:0021954),0.46677251978549245,1.0775881651871013,0.3723916532905297,0.7098493918460689,1.0,4/15,7.73%,RAPGEF2;B4GALT5;PTEN;ATP7A
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),0.3971313988099817,1.077479348537446,0.3477088948787062,0.7095777914781851,1.0,8/40,14.21%,IL1B;TIAM1;GLIPR2;IL6;OLFM1;SMAD4;EZH2;TGFB1
prerank,regulation of BMP signaling pathway (GO:0030510),0.36326484629415384,1.0769959005438483,0.3639751552795031,0.710211548188206,1.0,14/73,15.19%,PPARG;BMPR2;SORL1;LEMD3;RBPJ;HIPK2;UBE2D3;ENG;ACVR2A;SMAD4;LEMD2;ITGA3;VWC2L;XIAP
prerank,negative regulation of interleukin-2 production (GO:0032703),0.45686664143793576,1.0763781613933123,0.373015873015873,0.711211593863178,1.0,4/18,7.99%,PTPRC;LAPTM5;PRNP;EZR
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),-0.4557577056169091,-1.0759974825385625,0.3544600938967136,0.75687869986703,1.0,6/11,13.99%,IGF1;GHR;GIGYF1;IRS1;PIK3R1;TSC2
prerank,transcription by RNA polymerase II (GO:0006366),0.31879520351392876,1.0759862172912222,0.3047520661157025,0.711596533699363,1.0,73/305,17.37%,RARA;NOTCH2;HNF4G;CDK13;PPARG;NFKB1;GTF2F2;TAF1A;TAF13;TAF9;GTF2E2;POLR2C;TBL1XR1;MBD1;RBPJ;DEAF1;KLF13;SNRPB;DEK;ELOA;SETX;SSU72;CBFB;ELOB;NABP1;THRA;FIP1L1;RARG;CCNH;GTF2A1;E2F2;HDAC9;ELOF1;SCAF8;RPRD2;SNAPC3;PKNOX1;RPRD1B;NR3C1;NUDT21;GMEB2;INTS2;SETD2;CCNT2;SRRT;MED26;NELFA;TAF7;INTS11;INTS14;CCNT1;NFYA;CDK12;TEAD1;ERCC3;EAF1;KAT2B;INTS4;HDAC3;MAZ;CREBBP;CPSF3;TAF1;PAPOLA;NCBP1;MAML1;MED1;ELL;MED7;INTS6;TAF1C;SUPT4H1;NR4A1
prerank,telomere maintenance via telomere trimming (GO:0090737),0.5049343267428856,1.0759429662387165,0.3874538745387454,0.7100946746110647,1.0,2/10,7.01%,DNA2;WRN
prerank,t-circle formation (GO:0090656),0.5049343267428856,1.0759429662387165,0.3874538745387454,0.7100946746110647,1.0,2/10,7.01%,DNA2;WRN
prerank,formation of extrachromosomal circular DNA (GO:0001325),0.5049343267428856,1.0759429662387165,0.3874538745387454,0.7100946746110647,1.0,2/10,7.01%,DNA2;WRN
prerank,lipid oxidation (GO:0034440),-0.43520249612524686,-1.0757294137829363,0.35083532219570407,0.7562365119883196,1.0,3/12,25.50%,PPARGC1A;ADIPOR2;ACOX1
prerank,cellular response to glucose starvation (GO:0042149),0.397546406264099,1.0754840846709797,0.34334763948497854,0.7107251957979446,1.0,14/41,17.98%,SIK1;PRKAG2;MTMR3;SIK2;PRKAG1;FOXO3;PRKAA1;PIK3R4;EIF2AK3;PRKAA2;BRSK1;RRP8;BECN1;HSPA5
prerank,skin development (GO:0043588),0.3659997567720539,1.0750576584178153,0.3504492939666239,0.7111649031590279,1.0,12/65,15.78%,CLDN1;COL5A2;BCR;CLIC4;ATP7A;ANXA1;PIP5K1A;DHCR24;ITGA3;ADAM9;FA2H;MED1
prerank,chondroitin sulfate metabolic process (GO:0030204),-0.3524033336838971,-1.0748653013600236,0.3610223642172524,0.757401820525624,1.0,12/30,22.19%,HEXB;CHST11;ARSB;CHST9;CHPF2;CSPG4;HEXA;DSE;CHST3;BGN;HYAL1;CHSY1
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),0.4273744125100635,1.0748073086279966,0.38563049853372433,0.7111880394062506,1.0,4/26,13.17%,ACER3;CYB5B;ARG2;AKT1
prerank,protein localization to membrane (GO:0072657),0.3259713781454949,1.0740628656769913,0.3435114503816794,0.7124356443644462,1.0,22/187,8.37%,ITGB7;ITGA4;ITGAL;RAP1A;SYNE3;TTC7A;PLEKHF1;C2CD5;RAB3D;RAPGEF2;IKBKB;EHD2;SYNJ2BP;KCNIP3;ITGB2;RAB34;FLNA;S100A10;F11R;EZR;ZDHHC23;TSPAN14
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),0.5011274539467427,1.0740374496088556,0.38562091503267976,0.7119659841670906,1.0,2/12,7.37%,CCDC120;NIN
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),0.37836611116278596,1.0733651545542302,0.3577981651376147,0.7131198355385252,1.0,8/51,9.47%,CCR2;CCR1;CXCL10;IL6R;VEGFC;ADAM17;IL6;PGF
prerank,regulation of ERBB signaling pathway (GO:1901184),-0.4033261603271133,-1.0733073431958007,0.33421750663129973,0.7603168461187192,1.0,5/15,17.90%,LGMN;MVB12B;FER;PTPN18;RHBDF2
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),-0.35816954820873215,-1.0731637315235867,0.34626865671641793,0.7593243299269777,1.0,4/23,9.54%,IGF1;MEF2C;MMP14;AKAP6
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),0.3124214218314918,1.073079135639832,0.2799597180261833,0.713274229256007,1.0,120/572,18.13%,CIITA;BCL11A;TRPS1;FOXP1;RARA;SP100;RUNX3;KLF4;UXT;PPARG;ETV6;BCL6;SAP30;NFKB1;STAT3;HSPA1A;FOXJ1;NIPBL;NEDD4L;MAD2L2;SPI1;CRY1;TBL1XR1;MTA3;GATAD2B;ZEB2;SUMO1;LRRFIP1;KLF8;IRF2;RBPJ;IL33;KCNIP3;HIVEP1;DEAF1;STAT1;UBE2D3;HEXIM1;CCND1;KLF10;RPS14;CGGBP1;WFS1;CBFB;CREM;MECP2;PDE2A;THRA;CRY2;GATAD2A;RARG;EZR;CTCF;PHF12;HDAC9;BACH1;ID2;WWP2;EZH1;E4F1;PARP9;IRF7;SMAD4;CNOT2;LIN37;NR3C1;SPEN;FOXO3;IKZF5;TAF7;ETS2;REST;MBD2;MAP2K5;NUPR2;PSMD10;ATRX;MYB;NRIP1;NSD1;EZH2;SREBF2;CITED2;HDAC3;NFIL3;ZNF431;GPS2;ZNF436;MAFK;AURKB;MAZ;DUSP26;CREBBP;RELA;USP9X;MIER1;TAF1;BHLHE40;ZNF148;MED1;DUSP22;RB1;BPTF;NCOA5;SEMA4D;PROX1;PSEN1;ELK4;SIRT1;SUPT4H1;MCPH1;NFATC3;EFNA1;ORC2;BAG3;HCFC2;HDAC1;SMURF2;FOXC1;CBX8
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),0.4770617337400026,1.0727277424998125,0.37966101694915255,0.7135959174036149,1.0,5/14,12.26%,NFKBIA;NFKBIE;FAF1;NFKBIB;PSMD10
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),0.4610758340972677,1.071827217592229,0.3769968051118211,0.7152378071051239,1.0,4/17,15.19%,CASK;ZDHHC17;ITGA3;XIAP
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),-0.4320415955241334,-1.0718061871011701,0.38144329896907214,0.7617847151697392,1.0,5/12,34.73%,CALM1;CAV1;PDE4D;GJD3;CALM2
prerank,sphingolipid biosynthetic process (GO:0030148),0.3591694720096318,1.0714980889649615,0.35653235653235654,0.7155642169577772,1.0,15/71,16.42%,CERS6;ST8SIA1;ACER3;CERS1;ELOVL5;SAMD8;SGMS1;SGMS2;ELOVL6;SPTSSB;SGPP2;SGPP1;FA2H;VAPA;HACD4
prerank,snRNA transcription (GO:0009301),0.35949991054897773,1.071357881345306,0.3614163614163614,0.7153605838367137,1.0,22/70,18.69%,GTF2F2;TAF13;TAF9;GTF2E2;POLR2C;NABP1;GTF2A1;RPRD2;SNAPC3;RPRD1B;INTS2;CCNT2;SRRT;INTS11;INTS14;CCNT1;INTS4;NCBP1;ELL;INTS6;POU2F2;PHAX
prerank,positive regulation of transport (GO:0051050),0.3467251795755444,1.071267391070949,0.35424354243542433,0.7150530463792522,1.0,10/85,5.37%,IL1B;CD47;DOCK2;CAMK1D;ANXA2;NEDD4L;C2CD5;GPC3;CBLL1;IL2RG
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.5140097059854216,1.0709367180615053,0.39827586206896554,0.7152769523987277,1.0,1/10,0.80%,PRKCE
prerank,translational elongation (GO:0006414),-0.2659276870842191,-1.0707981011475862,0.2543352601156069,0.7634610874130947,1.0,46/101,29.96%,EEF2K;GFM2;MRPL24;MRPS9;DAP3;EEF1A1;MRPS21;MRPL1;MRPS5;LTN1;OXA1L;MRPL45;MRPS31;MRPS17;MRPL10;MRPL43;CHCHD1;MRPS7;MRPL4;MRPL2;MRPL37;MRPS24;MRPS26;MRPS22;MRPS18B;GTPBP2;MRPL3;MRPL32;MRPL47;EEF1D;RACK1;MRPS30;MRPL17;MRPL50;MRPS14;MRPL51;MRPL16;MRPL11;EEF1B2;MRPS18C;MRPL44;MRPL35;MRPS11;MRPL28;MRPL46;MRPL52
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),0.4574364340281612,1.0705287150775302,0.3918032786885246,0.715710844696099,1.0,6/16,14.36%,PIK3C2A;BCAR1;PTPN1;PDGFD;RGS14;PTPRJ
prerank,steroid catabolic process (GO:0006706),0.5025110748645208,1.0704522169654296,0.4010507880910683,0.715353587463848,1.0,2/10,12.83%,HSD17B14;HSD17B11
prerank,telomere maintenance (GO:0000723),0.38191857516363165,1.0698994265851915,0.36774193548387096,0.716155950214846,1.0,16/50,19.99%,SP100;DNA2;MRE11;TEP1;POLD4;WRN;RPA3;ERCC4;STN1;HUS1;POLD1;LTO1;SMC6;SMC5;TERF2;APEX1
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",-0.29214728122104183,-1.0697551560881555,0.3,0.7649978746612317,1.0,17/52,14.06%,DDX5;RBFOX1;RNPS1;RBFOX2;KHDRBS3;SRRM4;FXR1;NOVA1;RBFOX3;RBM5;THRAP3;FXR2;NOVA2;PTBP1;RBM25;KHDRBS2;WTAP
prerank,positive regulation of leukocyte migration (GO:0002687),-0.3423483247967228,-1.0693989930907566,0.3696369636963696,0.764639442821966,1.0,8/27,13.69%,AIF1;PTN;CSF1;ADAM8;NCKAP1L;VEGFA;JAM3;MDK
prerank,regulation of lamellipodium morphogenesis (GO:2000392),0.4990697429769267,1.069114501468395,0.3996447602131439,0.7175741620676199,1.0,1/11,0.26%,CD44
prerank,positive regulation of cellular component organization (GO:0051130),-0.2550157439917604,-1.0689195830717202,0.2413793103448276,0.7646012365454704,1.0,27/107,15.74%,APOE;PLEKHM2;FNIP2;TREM2;TGFBR1;LRP1;CAMK1;SLF2;FNIP1;FRMPD4;ABCB4;SLF1;TAL1;LMAN1;ADGRL1;TFRC;TMED9;FLOT1;VEGFA;CLU;TGFB2;WARS1;BAX;DAB2IP;PIH1D1;TPPP;AR
prerank,regulation of exocytosis (GO:0017157),-0.3086411399537805,-1.0686453537812597,0.33210332103321033,0.7640355992138433,1.0,8/46,5.27%,SYT1;IL1RAPL1;CADPS;RAB3C;STXBP5L;ATP6AP1;CLASP2;RAB9A
prerank,regulation of gene silencing by miRNA (GO:0060964),0.36845492943721475,1.06825872959287,0.3700887198986058,0.7191160937170508,1.0,15/62,16.80%,LIMD1;PPARG;NUP210;STAT3;POLR2C;H3-3A;NUP98;PUM2;TRIM71;NUP153;TNRC6A;TGFB1;PUM1;SEH1L;AJUBA
prerank,dopaminergic neuron differentiation (GO:0071542),0.45383022668837214,1.068213156684011,0.39456869009584666,0.7186794412226057,1.0,2/19,2.15%,CDNF;PITX3
prerank,UV protection (GO:0009650),0.5140709159947772,1.0681992993494966,0.4094076655052265,0.7181861279320263,1.0,2/10,4.13%,GPX1;FEN1
prerank,apical protein localization (GO:0045176),0.5237056980024375,1.0681900650613463,0.38120567375886527,0.7176729866561181,1.0,6/10,19.20%,CELSR1;SHROOM3;INSC;GOPC;MAL;ACTB
prerank,regulation of cell death (GO:0010941),0.3467566631062442,1.0680795191801322,0.3624401913875598,0.7173726143147929,1.0,11/94,7.08%,LRRK2;SRGAP2;ACER3;HSPA1A;CD36;NOA1;CHMP4B;HP;HPR;FAF1;ATG5
prerank,regulation of heart contraction (GO:0008016),0.3457210805293296,1.0679419777143553,0.36778846153846156,0.717195839633669,1.0,8/90,4.80%,ITPR1;ACE2;GJA5;RNF207;KCNQ1;HCN4;ATP2B1;ATP2A3
prerank,regulation of mitochondrial translation (GO:0070129),-0.361938540714403,-1.0678532963009588,0.3582474226804124,0.7648975023504206,1.0,10/21,30.78%,RMND1;RCC1L;NSUN3;C1QBP;MTG1;SHMT2;FASTKD3;MPV17L2;COA3;ALKBH1
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.4354301306629344,1.0678118746587721,0.3864353312302839,0.7169805014507289,1.0,6/21,15.78%,MED30;MED13;SETX;MED12;MED14;MED1
prerank,defense response to Gram-negative bacterium (GO:0050829),-0.3117731032024652,-1.0663718546784073,0.3382899628252788,0.7677085739302412,1.0,10/42,18.00%,TREM2;SLC11A1;PYCARD;OPTN;SERPINE1;TLR4;HMGB2;ADGRB1;MR1;DROSHA
prerank,tRNA 5'-end processing (GO:0099116),-0.41197153571197165,-1.0663504516514763,0.36623376623376624,0.7663858776115562,1.0,11/15,34.66%,POP1;RPP30;RPP14;SSB;RPP40;POP4;POP5;HSD17B10;RPP21;POP7;RPP25L
prerank,positive regulation of lipid localization (GO:1905954),-0.4445543512249911,-1.06622160306467,0.3804878048780488,0.7654092784039229,1.0,4/11,13.74%,LRP1;IKBKE;VSTM2A;C3
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),0.3567976825444844,1.0660999184615365,0.3617283950617284,0.7206750195663313,1.0,9/75,7.38%,CCR2;KLF4;PPARG;CXCL10;ATF2;SYNJ2BP;STAT1;HSPG2;MECP2
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),0.4980563590569764,1.065797290622347,0.3989455184534271,0.7208750967475408,1.0,3/11,10.39%,LYN;RAPGEF2;ANXA1
prerank,positive regulation of cell adhesion (GO:0045785),0.3592326308048445,1.065673692288478,0.38268506900878296,0.7206392571092801,1.0,10/74,8.19%,CD47;RET;NDNF;SYK;JAK2;PPP3CA;RSU1;AFDN;CIB1;RAC1
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.4795364991413781,1.0653959121057321,0.3903654485049834,0.7207346232523184,1.0,4/13,17.59%,PPARG;REST;RELA;NFATC3
prerank,bile acid and bile salt transport (GO:0015721),-0.36373321664402164,-1.0652747595821837,0.3619047619047619,0.7666610477332655,1.0,3/24,7.06%,SLCO2B1;ABCC3;ATP8B1
prerank,import into cell (GO:0098657),0.37908073297372796,1.0652512065303896,0.3643835616438356,0.7205532407656544,1.0,5/41,4.52%,NEURL1B;LRRC8C;IL10RA;LRRC8D;SLC12A7
prerank,negative regulation of response to stimulus (GO:0048585),0.36306446116090935,1.064995969149387,0.37738246505717915,0.7206383198930818,1.0,9/60,12.11%,LYN;KLF4;CASK;AKT3;ADRA2A;WFS1;PTPN1;FCGR2B;MAP2K5
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.3817189112575958,1.064878888191405,0.383989145183175,0.7204142763561276,1.0,9/48,8.19%,NEDD9;DOCK5;CRK;CDC42;CARMIL1;FLNA;CIB1;S100A10;RAC1
prerank,anterior/posterior pattern specification (GO:0009952),-0.2960618751804095,-1.0643764172903856,0.3346938775510204,0.7678741665550859,1.0,4/53,1.74%,BASP1;SKI;TGFBR1;WLS
prerank,fatty-acyl-CoA metabolic process (GO:0035337),-0.37459881275890206,-1.0643406524478858,0.36056338028169016,0.7666054881689583,1.0,12/20,33.13%,ACACA;CBR4;HSD17B8;GCDH;DGAT1;ACSL4;SCD;ACSL3;FASN;FITM2;FAR2;DGAT2
prerank,regulation of epithelial cell migration (GO:0010632),0.3806428586930282,1.0643096961736669,0.3910690121786198,0.7212537844982829,1.0,6/51,3.77%,DOCK5;PRKCE;PLCG2;MARVELD3;BMPR2;GLIPR2
prerank,thyroid hormone generation (GO:0006590),0.5086919833122133,1.0637535191588225,0.39347079037800686,0.7220876981755995,1.0,1/10,7.39%,CPQ
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),-0.3282781421421169,-1.063568060202805,0.3333333333333333,0.7673642609127419,1.0,12/35,16.61%,DDX5;RBFOX2;PLPP1;PGR;EGLN2;NR3C2;PPARGC1B;CALCOCO1;ESR1;SRC;AR;NCOA4
prerank,regulation of endothelial cell proliferation (GO:0001936),-0.2700091088242069,-1.0632964176555237,0.30128205128205127,0.766795582531693,1.0,13/88,8.34%,PTPRM;APOE;SPARC;NRP1;TGFBR1;NRP2;FGF2;ATP5F1A;NF1;HIF1A;HTR2B;ITGB3;SCG2
prerank,regulation of neural precursor cell proliferation (GO:2000177),0.4340776338043619,1.0631160216891418,0.3774145616641902,0.7231058212107638,1.0,4/22,11.69%,LRRK2;ID2;TRIM71;NAP1L1
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.4199345026972081,1.0627909789305285,0.3793103448275862,0.723340592708283,1.0,10/26,14.94%,ANKRD17;CCND3;CCND1;ADAM17;PLCB1;ANXA1;MTBP;CCND2;AKT1;KMT2E
prerank,negative regulation of calcium ion transport (GO:0051926),0.47274648053380586,1.0625522333439783,0.402555910543131,0.7233913158606667,1.0,3/15,8.42%,LILRB1;ADRA2A;SLC30A1
prerank,nucleoside phosphate catabolic process (GO:1901292),-0.4175232590725897,-1.0624836595398055,0.3723404255319149,0.7677800819635586,1.0,8/13,31.66%,ENTPD1;ENPP1;ENTPD5;ITPA;ENTPD7;ENPP3;ENTPD3;ENTPD6
prerank,cellular protein localization (GO:0034613),0.31572357957532093,1.06243531578937,0.3419421487603306,0.7231444774145238,1.0,36/285,10.56%,CD74;LRRK2;TBC1D1;STX11;NGFR;RAB19;TBC1D8;PTPRU;CELSR1;FOXJ1;TBC1D9;NIPBL;RABL3;LAPTM5;CD177;USP6NL;TBC1D10C;TBC1D2B;SNX1;TBC1D8B;ARF4;STX17;RAB6A;RABGAP1L;FLNA;STX6;TMED10;RABGAP1;ARF1;STX5;STX12;TBC1D5;SLU7;STX7;CEP250;SNX9
prerank,negative regulation of inclusion body assembly (GO:0090084),0.5199397761066373,1.062171450889368,0.4136690647482014,0.7232257216959466,1.0,2/10,3.50%,HSPA1A;SORL1
prerank,positive regulation of cellular protein metabolic process (GO:0032270),0.3434748532565322,1.0620719050156788,0.3722543352601156,0.722943861810859,1.0,25/101,16.49%,NIBAN1;BCL3;KLF4;RPL5;MSN;VIM;NFKBIA;PTTG1IP;FBXW11;FAF1;YTHDF3;EZR;IL6;ATG10;AKT1;METTL3;CYFIP2;LARP4B;TGFB1;EIF3E;THBS1;RPS4X;RPS6KB1;AURKAIP1;WNT7A
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.35103062368701576,1.0618386200037866,0.36666666666666664,0.722989658072131,1.0,16/80,12.05%,ACTR3;EPS8;WASF2;RIPOR2;CCDC88A;RAC2;DOCK11;CDC42;ARAP1;ACTR2;RAC1;BCAS3;ARPC2;PIK3CA;TAPT1;HTT
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.46764852629968834,1.0618005943154332,0.3719806763285024,0.7225578983486298,1.0,6/15,18.67%,MRE11;ATF2;HUS1;MDC1;RAD17;CHEK2
prerank,cellular response to decreased oxygen levels (GO:0036294),-0.2852642631387938,-1.0617934511311438,0.32710280373831774,0.7684489247419454,1.0,17/65,13.21%,KCND2;CPEB2;FAM162A;STUB1;CPEB1;HIF1A;ADAM8;PGK1;EGLN3;FMN2;EGLN2;HYOU1;CPEB4;HMOX1;VEGFA;TIGAR;P4HB
prerank,negative regulation of lipid storage (GO:0010888),-0.37652069328522264,-1.061722761340744,0.37057220708446864,0.7673132753823532,1.0,4/19,3.76%,ABCA1;TREM2;OSBPL8;TTC39B
prerank,entry into host (GO:0044409),0.4753009235999671,1.0614078928738018,0.4,0.7229559817680737,1.0,3/13,6.43%,CBL;CBLL1;GRB2
prerank,positive regulation of protein sumoylation (GO:0033235),-0.456270617732336,-1.0609678853937878,0.4073226544622426,0.7680961341006556,1.0,4/10,28.92%,SAE1;PIAS4;HDAC4;UBA2
prerank,substrate-dependent cell migration (GO:0006929),0.4725800801654383,1.0607491486326985,0.4027072758037225,0.7240802394615721,1.0,4/14,5.00%,PTPRC;SHTN1;CD2AP;VEGFC
prerank,negative regulation of DNA metabolic process (GO:0051053),0.42345347448221926,1.0601985152022229,0.38980509745127434,0.7249234925675625,1.0,8/24,16.84%,BMPR2;DFFA;MSH3;MSH6;RPS3;ERCC4;KMT2A;NIBAN2
prerank,blood vessel morphogenesis (GO:0048514),-0.29077359531056524,-1.059963531915464,0.35294117647058826,0.7696037989557869,1.0,7/54,4.43%,TGFBR2;NRP1;TGFBR1;FLT1;NF1;SMAD7;RASA1
prerank,positive regulation of filopodium assembly (GO:0051491),-0.3593043299272121,-1.0599067550484447,0.38935574229691877,0.7684154085060699,1.0,11/24,15.16%,NRP1;NLGN1;TENM2;RHOQ;GPM6A;PIK3R1;RALA;DPYSL3;AGRN;PALM;TENM1
prerank,retinal metabolic process (GO:0042574),-0.4319266147769079,-1.0598199821843817,0.3860045146726862,0.7673142840690338,1.0,8/12,49.40%,BCO2;RDH13;DHRS13;RDH11;ABCA4;CYP1B1;ALDH1A3;ALDH8A1
prerank,microglial cell activation (GO:0001774),-0.37444643654169385,-1.0597958128716416,0.36023054755043227,0.7660387148836898,1.0,5/21,3.16%,CX3CR1;TREM2;C1QA;GRN;AIF1
prerank,urogenital system development (GO:0001655),0.4951816695846092,1.0596613095730465,0.42483660130718953,0.725654431668425,1.0,2/11,10.39%,EPHB2;ANXA1
prerank,regulation of ruffle assembly (GO:1900027),-0.3606296488549515,-1.0595420482850177,0.35511363636363635,0.7653790574706153,1.0,6/23,5.76%,P2RY12;EVL;NLGN1;ARHGAP24;P2RX4;PFN1
prerank,"base-excision repair, gap-filling (GO:0006287)",0.3947894634356438,1.059203758088712,0.3980309423347398,0.7262286083811608,1.0,10/35,16.82%,POLL;FEN1;POLD4;MBD4;SMUG1;TDG;PARG;RPA3;POLB;POLD1
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.4487811216362383,1.0591921548984098,0.41455696202531644,0.7257329905040221,1.0,2/21,2.48%,LRRK2;HSPA1A
prerank,protein deubiquitination (GO:0016579),0.3147283775694096,1.0590626075907288,0.3584905660377358,0.7255044174604773,1.0,69/242,18.08%,TNIP3;PSME3;NFKBIA;USP3;PSMB7;INO80C;PSME2;OTULINL;IL33;BIRC3;EIF3F;IFIH1;OTUD1;PTEN;USP49;NEDD8;TADA3;ATXN7;USP45;TRAF3;JOSD1;PSME4;SPATA2;UIMC1;ATXN3;USP32;USP48;USP31;RHOA;USP15;PSMB8;SMAD4;PSMA5;PSMD9;CYLD;RIPK1;USP42;STAM;PSMB3;PSMD6;PSMC4;NLRP3;USP40;MAP3K7;PSMD10;USP4;SNX3;OTUD4;PSMB1;KAT2B;VCP;USP37;USP7;ASXL2;VCPIP1;USP9X;INO80;APC;USP47;POLB;PSMD12;WDR20;FOXK1;TRAF2;TAB1;USP14;BECN1;USP38;SMURF2
prerank,sterol transport (GO:0015918),0.44276465277889737,1.05874403844482,0.3937908496732026,0.7258091642753258,1.0,2/19,2.75%,LDLR;CD36
prerank,mitotic cytokinesis (GO:0000281),0.3799727168481827,1.058717378498909,0.38409703504043125,0.7253451118734686,1.0,16/47,17.63%,RACGAP1;KIF20A;MITD1;KIF23;CHMP4B;PDCD6IP;SPAST;SNX9;UNC119;ROCK1;EFHC2;SNX33;APC;TRIM36;RAB35;CNTROB
prerank,regulation of cell aging (GO:0090342),-0.45034430116937985,-1.0585732829907186,0.41379310344827586,0.7667499240552864,1.0,3/11,8.08%,NUAK1;NEK6;NEK4
prerank,nuclear membrane reassembly (GO:0031468),0.36806828380738454,1.0582877392941892,0.38341968911917096,0.7258470510575222,1.0,10/54,10.52%,VRK1;SUMO1;CHMP4A;CHMP4B;NUP98;PPP2R2A;LMNA;SPAST;ANKLE2;LEMD2
prerank,regulation of actin filament bundle assembly (GO:0032231),-0.3468483686865692,-1.058206847927826,0.4,0.7664074086734433,1.0,9/26,18.86%,PRKN;ASAP3;LIMK1;PFN1;PFN2;CX3CL1;PLEK;RDX;SYNPO2
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.4921841100666281,1.0581752685032444,0.39666666666666667,0.7255996767545578,1.0,2/11,3.48%,FYN;ABCB7
prerank,basement membrane organization (GO:0071711),0.48318974439398066,1.0580798129444406,0.41118421052631576,0.7253046061216918,1.0,3/14,8.30%,NTNG2;LAMB1;PXDN
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),0.44375346797445114,1.0579682003510396,0.3894736842105263,0.725027161288442,1.0,4/18,8.29%,ACSL5;ELOVL5;HSD17B12;ELOVL6
prerank,positive regulation of immune system process (GO:0002684),-0.3945255767945781,-1.057940202567739,0.39444444444444443,0.7658189087087603,1.0,4/16,13.75%,LGALS9;NCKAP1L;VEGFA;TGFB2
prerank,axon development (GO:0061564),-0.27649897918674243,-1.0577679916942964,0.3172043010752688,0.7650102003197866,1.0,25/78,20.02%,RTN4RL1;DCC;MAP1B;PLP1;CTNNA2;CNTN4;FGFR2;NREP;RYK;AFG3L2;CDK5R1;MAP1A;ARHGAP35;PARD3;CDK5;KLF7;CAMSAP2;MTR;SLITRK1;ADGRB1;APBB1;NEFH;RAB3A;PLPPR4;GRM7
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.3494400041267802,1.057399474724349,0.37394451145958985,0.7259081737710245,1.0,17/86,15.64%,JAK2;BMPR2;RBPMS;ZEB2;GDF1;RBPJ;HIPK2;ADAM17;BMP3;ENG;ACVR2A;SMAD4;ING2;CITED2;TGFB1;CREBBP;THBS1
prerank,2-oxoglutarate metabolic process (GO:0006103),0.4704779966378147,1.057345533027781,0.39087947882736157,0.7255018748424553,1.0,3/13,12.50%,TAT;IDH1;OGDH
prerank,regulation of protein catabolic process (GO:0042176),0.33950757644957347,1.0564941948848563,0.38221153846153844,0.7270499417947811,1.0,31/99,18.96%,DTL;ITCH;ASB5;NEDD4L;MAD2L2;SORL1;GPC3;AXIN1;RAB7A;FAF1;TIPARP;FLNA;AZIN1;STX5;SNF8;WWP2;CSNK2A1;SNX3;AREL1;VCP;SNX12;IRAK3;RNF41;APC;HACE1;SF3B3;SMURF2;FZR1;PIN1;CHEK2;PRKCG
prerank,recombinational repair (GO:0000725),0.34956482417078794,1.0564384053985703,0.38106796116504854,0.7266484088263476,1.0,19/77,16.36%,SAMHD1;RBBP8;POLL;MRE11;FEN1;UBE2N;WRN;NABP1;MORF4L1;RECQL5;RPA3;EXD2;SPIDR;ERCC4;RNF138;XRCC2;INO80;MCM9;HUS1
prerank,cell projection organization (GO:0030030),-0.33417545821259464,-1.0556158233678077,0.39,0.7695761146121539,1.0,11/30,17.46%,P2RY12;RHOH;PARVG;RHOQ;CAPG;PDGFA;NCKAP1L;PARVA;RHOU;PLEK;NEFH
prerank,mitochondrion disassembly (GO:0061726),-0.3315855844227741,-1.0553904295095011,0.35714285714285715,0.768882303788814,1.0,12/34,21.92%,PRKN;ULK2;MAP1LC3B;ATG12;USP30;SQSTM1;ATG9A;FUNDC2;ATG7;WDR45;ATG2A;GABARAP
prerank,regulation of viral release from host cell (GO:1902186),0.4374219885002938,1.0551477750139853,0.3958664546899841,0.7293317377708195,1.0,4/21,7.46%,TRIM26;TRIM62;TSG101;TRIM25
prerank,pyrimidine-containing compound catabolic process (GO:0072529),0.46625398094074555,1.054882392226985,0.41961414790996787,0.7294251015670048,1.0,2/16,2.85%,TET2;UPB1
prerank,sodium ion transport (GO:0006814),-0.26757817470407025,-1.0546234725019676,0.3167701863354037,0.7697594527235733,1.0,14/85,12.13%,SLC8A1;SLC24A3;FGF13;SCN1A;ATP1B3;PKD2;ATP1B1;SGK1;SLC6A15;SCN3A;ATP1A2;HCN1;HCN2;SCN1B
prerank,histone acetylation (GO:0016573),0.354222587106863,1.0545222764717073,0.37995049504950495,0.7298092748532493,1.0,17/69,15.26%,TAF9;SPI1;KAT7;ATF2;TRIM16;TADA3;MBIP;KAT6A;ING3;TADA2A;MORF4L1;JADE3;MAP3K7;MSL3;KAT2B;CREBBP;PHF20
prerank,neural crest cell differentiation (GO:0014033),-0.3877900000894539,-1.0541334164970266,0.3553299492385787,0.7697906906214973,1.0,3/18,7.38%,MEF2C;LRP6;HTR2B
prerank,response to reactive oxygen species (GO:0000302),0.3697399788384044,1.0540138527545246,0.381389252948886,0.7305171242049169,1.0,15/54,15.36%,STK24;FYN;FOS;GPX1;HP;PXN;CAMKK2;RPS3;MAPK8;AKT1;NCF1;ADAM9;GSTP1;MAPK1;PRDX5
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),0.428752533869892,1.053875343493854,0.384251968503937,0.7303160638621272,1.0,2/20,0.65%,IL1B;PSTPIP1
prerank,actin filament depolymerization (GO:0030042),-0.43631078114397936,-1.0537368881254274,0.38636363636363635,0.7695216749221928,1.0,3/11,22.18%,MICAL3;CFL1;GSN
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),0.46044192980756965,1.0537159293401053,0.40836012861736337,0.7301594082627133,1.0,3/16,5.88%,MAD2L2;SMCHD1;KLHL15
prerank,negative regulation of cell death (GO:0060548),0.3446735061717006,1.05370721730783,0.3883374689826303,0.7296588247584168,1.0,10/88,8.09%,LRRK2;SRGAP2;FYN;HSPA1A;SORL1;CHMP4A;CHMP4B;WFS1;ATG5;TM7SF3
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),-0.44333386233755867,-1.0536985886811139,0.39767441860465114,0.7683304353381979,1.0,9/11,36.29%,SMARCB1;PWP1;PIH1D1;DDX11;NOP53;IPPK;MTOR;SMARCA4;NCL
prerank,regulation of Wnt signaling pathway (GO:0030111),0.3360266361043607,1.0536013124668318,0.3793103448275862,0.7293962799601054,1.0,21/108,13.66%,LRRK2;TIAM1;SULF2;NOTUM;RSPO2;RSPO3;GPC3;APCDD1;AXIN1;CDK14;CBFB;KREMEN1;CSNK2A1;GSKIP;NLK;APP;TLR2;SNX3;TLE1;TAX1BP3;ITGA3
prerank,regulation of oxidoreductase activity (GO:0051341),0.4761417572651601,1.0535440630532233,0.3924466338259442,0.7290041721828576,1.0,5/13,17.10%,HP;ATP7A;SLAMF8;SIRT4;ABL2
prerank,zinc ion homeostasis (GO:0055069),-0.33819751090007544,-1.0534805160421723,0.3333333333333333,0.7676412258501063,1.0,6/28,16.46%,PRKN;SLC39A10;SLC39A7;SLC30A9;SLC39A6;MT2A
prerank,positive regulation of hormone secretion (GO:0046887),-0.39330126724981196,-1.0533574892487327,0.37669376693766937,0.7666298677366904,1.0,9/17,39.80%,SPP1;VAMP8;SOX11;HFE;PLA2G3;C1QTNF3;GRP;TFR2;HCAR2
prerank,protein heterotetramerization (GO:0051290),-0.42480336972463006,-1.0533469828470174,0.38141809290953543,0.7653531475093677,1.0,6/13,22.56%,PKD2;CPSF6;CBR4;HSD17B8;FARSA;GRIN2B
prerank,protein sumoylation (GO:0016925),0.37426700715571654,1.0531769367920278,0.39920948616600793,0.7294172376274175,1.0,5/49,7.26%,BCL11A;NUP210;SUMO1;IFIH1;NUP98
prerank,glucan catabolic process (GO:0009251),-0.40852882501771715,-1.0531268142063013,0.35602094240837695,0.7646914399834874,1.0,7/15,22.68%,PYGB;GAA;CALM1;PHKA1;PGM2;AGL;PHKG2
prerank,anion transmembrane transport (GO:0098656),0.36024091944910586,1.0531027817791114,0.3963494132985658,0.7290526170204047,1.0,15/67,14.79%,LRRC8C;SLC23A2;SLC23A1;LRRC8D;SLC25A13;LRRC8B;SLC25A30;ABCC1;SLC25A12;SLC6A5;SLC25A18;SLC25A5;SLC35A1;SLC6A9;SLC35A3
prerank,positive regulation of cellular process (GO:0048522),0.30551559252393035,1.052855490764095,0.34503510531594783,0.7291157565735245,1.0,105/565,16.27%,DPP4;IL1B;GRK5;RARA;TIAM1;HCK;LYN;CD47;GLI1;FLT3;CDK13;DOCK2;ITGAX;CAMK1D;ACER3;TBC1D8;PAK1;FGF5;FGF22;CUL3;CD36;RPS6KA3;ANKRD17;PTPN6;MYRF;SCX;IL6R;CDC42;GDNF;PPP3CA;HP;HPR;VEGFC;H3-3A;ADRA2A;IL2RG;FAF1;PTEN;CCND1;CXCL16;PTK2B;ADAM17;CIB1;MTPN;MECP2;CNOT6;NOX1;LMNA;DOT1L;RAC1;CACUL1;IL6ST;IL6;DDX49;PGF;CSNK2A1;RPRD1B;FN1;IL31RA;GLP2R;MCTS1;PRKAA1;FKBP1B;NAP1L1;FCGR2B;DYNC1H1;RPS6KA1;SLC25A5;CSPP1;PSMD10;TLR2;PDGFD;CCND2;LIFR;PABIR1;MAPK8;AKT1;FCER1G;TNFRSF1B;HCLS1;EZH2;AGPAT1;GNAI2;PRKAA2;CITED2;TGFB1;COX17;FGFR3;PTPRJ;MAZ;RHOG;DUSP26;RELA;RPS15A;NCBP1;DVL2;INO80;THBS1;CELF1;CDCA7L;RPS4X;APC;USP47;NSMCE4A;INSR
prerank,regulation of cholesterol metabolic process (GO:0090181),-0.377128111127465,-1.052638104389735,0.3848314606741573,0.7647858639319731,1.0,8/20,18.03%,APOE;TTC39B;ARV1;DGKQ;FMO5;MBTPS2;RAN;ACADL
prerank,plasma membrane invagination (GO:0099024),0.4012947828636535,1.0526343480121192,0.40117994100294985,0.7291030479997489,1.0,12/29,18.26%,CD36;MYH9;CDC42;ITGB2;RHOA;SNX9;FCGR2B;AURKB;ELMO1;SNX33;GULP1;FCGR1A
prerank,calcineurin-NFAT signaling cascade (GO:0033173),0.4951352799963151,1.0525127122687425,0.42980935875216636,0.728367135385784,1.0,5/10,24.95%,PPP3CA;NFATC3;NFAT5;NFATC2;PPP3CC
prerank,calcineurin-mediated signaling (GO:0097720),0.4951352799963151,1.0525127122687425,0.42980935875216636,0.728367135385784,1.0,5/10,24.95%,PPP3CA;NFATC3;NFAT5;NFATC2;PPP3CC
prerank,protein insertion into mitochondrial membrane (GO:0051204),-0.3566950680462869,-1.052319034120537,0.3614457831325301,0.764384515929666,1.0,13/23,29.26%,TIMM9;BAX;COX18;TIMM10B;AGK;NDUFA13;TIMM13;SAMM50;TIMM8B;HSP90AA1;BMF;ROMO1;TIMM29
prerank,protein insertion into ER membrane (GO:0045048),0.3839711351045706,1.0521587029504436,0.3941908713692946,0.728699763655147,1.0,11/37,15.93%,MMGT1;PRNP;TRAM2;TRAM1;EMC9;STX5;CAMLG;APP;EMC10;UBE2J2;VAPA
prerank,inner mitochondrial membrane organization (GO:0007007),-0.30176046821174024,-1.0518097813512144,0.3333333333333333,0.7644209498401826,1.0,24/47,30.12%,ATP5F1A;ATP5PO;APOO;AFG3L2;TMEM11;TIMM9;ATP5MG;ATP5PD;CHCHD6;ATP5PF;SPG7;ATP5F1D;ATP5MC3;TIMM10B;AGK;NDUFA13;ATP5MF;TIMM13;SAMM50;TIMM8B;ROMO1;TIMM29;APOOL;UQCC3
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),-0.38820547769913677,-1.0518042861819525,0.38402061855670105,0.7631365325339335,1.0,9/18,19.15%,NLGN1;DLG4;CHRNA7;NLGN2;PRKCZ;NLGN3;RIMS1;STX1B;NRXN1
prerank,regulation of protein transport (GO:0051223),0.41058327953981144,1.051340740036293,0.41384388807069217,0.7300365734558256,1.0,11/27,23.13%,LCP1;DNAJC1;WWP2;PTPN1;SNX3;SNX12;NDFIP2;LLGL2;HSPA8;TNF;SCFD1
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),0.36549128395943314,1.0512882040393166,0.38181818181818183,0.7296366372410947,1.0,15/57,18.67%,DTL;MRE11;ATF2;TAOK3;WAC;CCND1;UIMC1;RINT1;DONSON;BRSK1;HUS1;MDC1;RAD17;FZR1;CHEK2
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.4527150255304328,1.0512136504700293,0.39197530864197533,0.7292837985891445,1.0,7/17,16.73%,CCND3;CCND1;ADAM17;PSMD10;CCND2;AKT1;PROX1
prerank,nucleoside catabolic process (GO:0009164),0.5022542192212772,1.0508975752084544,0.4102112676056338,0.7295309985654741,1.0,3/11,13.21%,UPB1;DERA;NT5C3A
prerank,regulation of secretion (GO:0051046),0.47105542496350455,1.0507832950544274,0.4169435215946844,0.729291376077706,1.0,2/13,3.31%,OAS2;KCNQ1
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.4896051878242583,1.050697515002252,0.42424242424242425,0.7289585250879169,1.0,3/12,10.51%,ERN1;ATF6;PTPN1
prerank,Rap protein signal transduction (GO:0032486),0.5025026837662016,1.0506512151758238,0.40033500837520936,0.7285677941203184,1.0,2/10,3.14%,RAP1A;RAPGEF2
prerank,negative regulation of protein metabolic process (GO:0051248),0.36857812562556014,1.050631783290328,0.4,0.7281150906768755,1.0,8/48,7.12%,LDLR;NFKB1;PTX3;MAD2L2;EIF2AK1;PRNP;FLNA;AZIN1
prerank,positive regulation of protein localization to nucleus (GO:1900182),0.36265308346424885,1.0502334203309998,0.40533672172808133,0.7285482798078784,1.0,22/66,19.97%,NGFR;DTX3L;KAT7;UBR5;FLNA;RBM22;PARP9;NMD3;EIF2AK3;ZPR1;AKT1;LIMK2;HCLS1;HDAC3;TGFB1;TCP1;PSEN1;PIK3R2;BAG3;PRKCD;LARP7;PARK7
prerank,cell-cell junction organization (GO:0045216),-0.2696499190650026,-1.0500458770022008,0.3707865168539326,0.7667364357292017,1.0,18/79,14.28%,CSF1R;TJP1;CADM1;PKP4;FLCN;CADM2;CDH11;SDK1;JUP;TJP2;SMAD3;PVR;NECTIN4;TLN2;NLGN2;TRPV4;TGFB2;CXADR
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.353246222842581,1.0495760836809434,0.38875305623471884,0.7295827706837618,1.0,15/73,14.21%,CD44;NGF;PAK1;SH2D3C;MAD2L2;AXIN1;STK4;IL6;LATS1;CREBL2;BRAF;APP;AKT1;HCLS1;TGFB1
prerank,protein K63-linked ubiquitination (GO:0070534),0.38575349394096514,1.0494376560347014,0.4153846153846154,0.7294226409018536,1.0,11/41,12.37%,TRAF1;ITCH;TRAF3IP2;PELI1;UBE2N;HECTD1;TRAF3;ARIH2;WWP2;UBE2S;UBE2G1
prerank,regulation of androgen receptor signaling pathway (GO:0060765),0.40505083824853527,1.049064056830057,0.4096045197740113,0.7297510143724324,1.0,4/30,9.32%,FOXP1;PKN1;H3-3A;NCOA2
prerank,cellular response to exogenous dsRNA (GO:0071360),0.4773874210973663,1.04889746920257,0.4205298013245033,0.7296546960209646,1.0,4/12,13.79%,IFIH1;RALB;PQBP1;IFIT1
prerank,COPII vesicle coating (GO:0048208),-0.2784711470416382,-1.0488690068878348,0.3382352941176471,0.7659725484194776,1.0,16/61,16.05%,TGFA;NAPA;PREB;MCFD2;GRIA1;TBC1D20;GOLGA2;LMAN1;CTSZ;SEC23A;GOSR2;SEC13;CNIH1;SEC23IP;F8;TRAPPC4
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",-0.2784711470416382,-1.0488690068878348,0.3382352941176471,0.7659725484194776,1.0,16/61,16.05%,TGFA;NAPA;PREB;MCFD2;GRIA1;TBC1D20;GOLGA2;LMAN1;CTSZ;SEC23A;GOSR2;SEC13;CNIH1;SEC23IP;F8;TRAPPC4
prerank,vesicle coating (GO:0006901),-0.2784711470416382,-1.0488690068878348,0.3382352941176471,0.7659725484194776,1.0,16/61,16.05%,TGFA;NAPA;PREB;MCFD2;GRIA1;TBC1D20;GOLGA2;LMAN1;CTSZ;SEC23A;GOSR2;SEC13;CNIH1;SEC23IP;F8;TRAPPC4
prerank,lysosome organization (GO:0007040),-0.32771036085744015,-1.0488143851362077,0.386986301369863,0.7648470789590981,1.0,9/36,8.05%,ABCA1;HPS4;GRN;ZKSCAN3;TPP1;ARSB;TPCN2;GAA;MYO7A
prerank,positive regulation of myoblast differentiation (GO:0045663),0.4533350469303328,1.0478098496983268,0.4110032362459547,0.7317061519864035,1.0,4/16,7.50%,RIPOR2;BTG1;MAPK14;PLCB1
prerank,sensory organ development (GO:0007423),0.369779097189891,1.0477885766728017,0.3880794701986755,0.731236692462593,1.0,6/51,6.12%,MAB21L2;SIPA1L3;ATF6;HIPK2;SMCHD1;HIPK1
prerank,Rho protein signal transduction (GO:0007266),0.37041434890077146,1.0476773715504433,0.41301460823373176,0.7310172832474162,1.0,13/53,15.03%,EPS8;NGFR;CELSR1;SHTN1;CDC42;ADRA2A;ARHGDIB;RHOA;NTN1;TAX1BP3;ROCK1;ARHGEF3;RHOG
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),0.34100528676005176,1.0476241900669259,0.3958333333333333,0.7306180763346707,1.0,19/93,14.21%,CD44;NGF;PAK1;SH2D3C;MAD2L2;AXIN1;PTEN;STK4;DDIT4;PAQR3;IL6;LATS1;CREBL2;BRAF;APP;AKT1;NSD1;HCLS1;TGFB1
prerank,homeostasis of number of cells (GO:0048872),-0.42652750438264503,-1.0475302004584495,0.38402061855670105,0.7670541111257765,1.0,6/12,36.48%,CX3CR1;NAPEPLD;OCIAD2;LPCAT3;UBAP2L;CCN3
prerank,receptor catabolic process (GO:0032801),-0.3523146986901195,-1.0472632362954053,0.39465875370919884,0.7665587560201653,1.0,7/24,12.16%,LGMN;MYLIP;AP2A1;SNX25;CLTA;ZNRF3;AP2M1
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.440472553020198,1.0471673524101157,0.4012841091492777,0.7312295459199015,1.0,3/18,11.69%,ERN1;ATXN3;FCGR2B
prerank,myeloid dendritic cell activation (GO:0001773),-0.4249514663725893,-1.04674950055217,0.39344262295081966,0.7667393695217017,1.0,4/12,10.75%,TGFBR2;HMGB1;PYCARD;CAMK4
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),0.41473878147426524,1.0465171035874905,0.41358024691358025,0.7323051278625575,1.0,9/25,20.76%,RIN3;PICALM;RAC1;UNC119;APP;MTMR2;PSEN1;ANKRD13A;ITGAV
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),-0.3735465276286237,-1.0464198353293854,0.3971830985915493,0.766387557589421,1.0,10/19,24.73%,CTC1;XRN1;SRC;TEN1;TERF1;EXOSC10;HNRNPU;TINF2;PINX1;NAT10
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.45628734383363395,1.0459437462730852,0.4290375203915171,0.7331054327833405,1.0,4/16,12.78%,BCL3;INPP5F;PARP14;NF2
prerank,establishment of skin barrier (GO:0061436),0.46471780964050313,1.0457780466794402,0.40789473684210525,0.7324703662364823,1.0,3/15,20.54%,CLDN1;FA2H;UGCG
prerank,regulation of water loss via skin (GO:0033561),0.46471780964050313,1.0457780466794402,0.40789473684210525,0.7324703662364823,1.0,3/15,20.54%,CLDN1;FA2H;UGCG
prerank,regulation of axonogenesis (GO:0050770),0.3707285584119658,1.0457326635158284,0.3880597014925373,0.7320593048911975,1.0,12/51,13.27%,TIAM1;NGF;NGFR;PAK1;TIAM2;PTEN;PAK2;PLXND1;RHOA;RTN4;PLXNC1;LRP4
prerank,blood vessel endothelial cell migration (GO:0043534),-0.35516732134521195,-1.0455403150022435,0.39941690962099125,0.7675121238474458,1.0,8/22,19.80%,NRP1;ROBO1;FGF2;SLIT2;VEGFA;GPLD1;EFNB2;PIK3R3
prerank,erythrocyte differentiation (GO:0030218),0.37734773458460136,1.0454821226365736,0.40877914951989025,0.7321621798599567,1.0,12/44,16.72%,LYN;JAK2;HIPK2;RPS14;ID2;SLC25A5;HSPA9;KIT;HCLS1;KMT2E;MED1;ACIN1
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),0.4740155332540219,1.0454606218170337,0.3993453355155483,0.7317067851510558,1.0,7/14,20.26%,MAPKAPK2;MAPK14;TIRAP;MYD88;BOLL;YBX3;HNRNPC
prerank,detection of light stimulus involved in sensory perception (GO:0050962),0.5050032251912385,1.045217525432558,0.4185639229422067,0.7312630498932327,1.0,1/10,10.53%,CEP250
prerank,detection of light stimulus involved in visual perception (GO:0050908),0.5050032251912385,1.045217525432558,0.4185639229422067,0.7312630498932327,1.0,1/10,10.53%,CEP250
prerank,aggrephagy (GO:0035973),-0.34309611456520195,-1.0447592539728188,0.3746312684365782,0.768240447073711,1.0,5/27,8.44%,PRKN;WDFY3;UBC;DYNLL2;DYNLL1
prerank,response to light stimulus (GO:0009416),0.364492122946102,1.0445614339906903,0.39405684754521964,0.7322709065854272,1.0,13/55,14.85%,DTL;CRY1;CRY2;CLOCK;MSH6;COPS3;GPR88;MAP4K3;ERCC3;MAPK8;ERCC4;PCLAF;BRSK1
prerank,extrinsic apoptotic signaling pathway (GO:0097191),0.35065734252478287,1.0443668421530679,0.3945409429280397,0.7322029817770791,1.0,27/70,22.11%,NGF;MCL1;JAK2;IL6R;HIPK1;PDPK1;CIB1;SIVA1;TLR3;DAXX;CASP2;RIPK1;DEDD2;TNFRSF1B;TGFB1;FGFR3;RNF41;TRAF2;BAG3;APPL1;BAD;ITGAV;DIABLO;BID;GSK3B;CASP9;BCL2
prerank,neuron projection organization (GO:0106027),-0.39502471840577613,-1.0443172160674712,0.3640897755610973,0.7681977037560915,1.0,4/15,9.50%,LGMN;ABCD2;MAP1A;CHRNA7
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),-0.44645625103955705,-1.044218551496521,0.4019138755980861,0.7671937814449173,1.0,3/10,7.23%,LRP1;APOD;HGS
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",-0.35465385276944417,-1.0441776771062112,0.38968481375358166,0.766014578437632,1.0,8/23,24.02%,COPS4;UBC;COPS7A;COPS2;COPS7B;UBA52;XPC;COPS6
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),0.4738534653841233,1.0436184804523714,0.4241935483870968,0.7334239244755503,1.0,4/13,19.09%,MAD2L2;TAF1;PSEN1;TMSB4X
prerank,positive regulation of axonogenesis (GO:0050772),0.3783058145833579,1.04312536045514,0.42191780821917807,0.7340445111670025,1.0,5/43,2.36%,TIAM1;NGF;NGFR;TIAM2;SHTN1
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),0.49619082099762435,1.0429598711352293,0.43485617597292725,0.7339568442702286,1.0,2/10,5.34%,TAF9;NUFIP1
prerank,calcium import into the mitochondrion (GO:0036444),0.492520864804127,1.0429369156948938,0.4344262295081967,0.7335068743430149,1.0,4/10,18.72%,MCUB;MAIP1;MICU3;MICU2
prerank,protein transport (GO:0015031),0.30716435022521105,1.0429089001212741,0.3824130879345603,0.7330602879233981,1.0,65/332,15.66%,CD74;NEURL1B;TBC1D1;STX11;NGFR;RAB19;LMTK2;PPARG;TBC1D8;TBC1D9;RABL3;ATP6V0E1;CD36;RAB3D;LAPTM5;IL10RA;USP6NL;TBC1D10C;GOLPH3L;TBC1D2B;MYH9;COPG2;RAB7A;SNX1;TBC1D8B;ARF4;STX17;RAB6A;RABGAP1L;RAB34;STX6;TMED10;GCC2;RABGAP1;ARF1;STX5;STX12;ZDHHC17;ATP6V1H;TBC1D5;UNC119B;SLU7;STX7;LMAN2L;HIKESHI;SNX9;KIF3B;UNC119;TBC1D2;SLC10A7;TMEM167A;STX16;SGSM1;TLK1;VMP1;CANX;EVI5;RAB29;SCFD2;ABCG1;EHD1;TMED7;SVBP;CALCRL;SNX33
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.42921589437695945,1.0427916747477919,0.40217391304347827,0.732807345744846,1.0,4/20,15.64%,SULF2;NPTN;DSTYK;THBS1
prerank,cellular response to interleukin-4 (GO:0071353),-0.43833077119826835,-1.0423868966010845,0.38620689655172413,0.7695983643069956,1.0,5/10,35.69%,STAT6;JAK3;SHPK;LEF1;TCF7
prerank,somite development (GO:0061053),-0.4323733929440311,-1.0417435006370463,0.4129353233830846,0.7701459146738596,1.0,5/11,27.17%,SMO;LOXL3;SOX11;PTCH1;MTHFD1
prerank,macrophage differentiation (GO:0030225),-0.41221147120429874,-1.041304288378386,0.4071246819338422,0.7700439235079503,1.0,2/13,3.39%,CSF1R;CSF1
prerank,cellular response to metal ion (GO:0071248),0.32818569161364103,1.0412957352964034,0.40344827586206894,0.7357650212055897,1.0,23/123,13.77%,LRRK2;IQGAP1;PLCG2;ALOX5AP;FOS;HPCA;RASGRP2;DPEP1;SUMO1;CLIC4;KCNH1;PRNP;CPNE1;BRAF;DAXX;B2M;ADCY7;PRKAA1;CPNE2;MAPK8;AKT1;NCF1;PRKAA2
prerank,cellular macromolecule catabolic process (GO:0044265),0.36624330971640456,1.0412227386209514,0.3997308209959623,0.7354100477470488,1.0,18/49,21.11%,DENND3;SND1;XRN2;RNASEH2C;RIPK1;RNASE6;DFFB;UBE2G1;RNASEH2A;RNASEH1;PNPT1;STT3B;NCBP1;SIDT2;CHEK2;DNASE1L1;SUPV3L1;NGLY1
prerank,oligosaccharide biosynthetic process (GO:0009312),0.43554437755085185,1.0411610576183767,0.4175491679273828,0.735039054563968,1.0,2/20,3.36%,ST3GAL4;FUT4
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),-0.4246616965434261,-1.0409663507275553,0.42997542997543,0.769713440990689,1.0,11/13,44.97%,ANAPC15;TPR;LCMT1;GEN1;NDC80;CDK5RAP2;MAD2L1;XRCC3;PCID2;DYNC1LI1;CCNB1
prerank,negative regulation of response to biotic stimulus (GO:0002832),0.40828200823803656,1.0407653110460864,0.4236526946107784,0.7354639772944064,1.0,7/26,15.80%,ITCH;DHX58;CARD16;CACTIN;ACOD1;ILRUN;IRAK3
prerank,sphingosine biosynthetic process (GO:0046512),0.48986454345343927,1.0405729487325714,0.44387755102040816,0.7348779200125393,1.0,1/11,1.59%,ACER3
prerank,sphingoid biosynthetic process (GO:0046520),0.48986454345343927,1.0405729487325714,0.44387755102040816,0.7348779200125393,1.0,1/11,1.59%,ACER3
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),-0.4442910049588852,-1.0403932420551933,0.41496598639455784,0.7699617901202636,1.0,6/11,55.58%,RTP4;PKD1L3;PKD2L1;LPO;RTP2;TAS1R3
prerank,positive regulation of vascular permeability (GO:0043117),-0.4219679164649519,-1.0402360239736428,0.38902147971360385,0.7691003399279859,1.0,6/12,18.27%,TJP1;TJP2;VEGFA;TRPV4;BMP6;ANGPT1
prerank,regulation of regulated secretory pathway (GO:1903305),0.38883829947276954,1.0401646868046261,0.41843971631205673,0.7352979584320878,1.0,3/34,4.17%,LRRK2;RAB3D;UNC13D
prerank,cell projection assembly (GO:0030031),-0.34995419017062074,-1.039990991332829,0.39465875370919884,0.7685189075025873,1.0,11/22,22.18%,RHOH;PARVG;RHOQ;CAPG;PDGFA;NCKAP1L;PARVA;RHOU;NEFH;CYFIP1;GSN
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),0.36120393121436695,1.0398337954156922,0.399734395750332,0.7355604211810105,1.0,18/56,18.94%,DTL;CUL3;ANKRD17;RCC2;CCND3;CCND1;ADAM17;MECP2;PLCB1;ANXA1;CCND2;AKT1;KMT2E;ANAPC7;RB1;ANAPC11;ANAPC4;BRD4
prerank,gonad development (GO:0008406),-0.31058787364737017,-1.0396958688002274,0.38333333333333336,0.7680760994812147,1.0,17/41,33.12%,BASP1;SALL1;KITLG;MSH2;TGFB2;AR;NCOA4;NR2F2;FGF9;WNT4;INHBA;MEA1;BIK;WNT5A;MKKS;WNT2B;MAMLD1
prerank,regulation of cellular response to stress (GO:0080135),-0.253450057068932,-1.0394331709663296,0.3237410071942446,0.7675936145698631,1.0,35/115,19.43%,PRKN;NUAK1;RPTOR;NEK6;NUP54;ATF3;NUP133;CORO2B;BAG4;NUP155;BAG1;ATF4;NUP188;NEK4;DNAJC2;USP19;RANBP2;PTGES3;NPM1;SEC13;NPAS2;NUP85;EIF4G1;MANF;HSBP1;MBTPS2;NUP42;TPR;CAMK2A;NUP35;ADCY8;AKT1S1;HSP90AB1;CRYAB;NUP37
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",0.47618487877210425,1.0393051815423007,0.4103448275862069,0.7363548474254393,1.0,6/13,19.84%,HEXIM1;RECQL5;NELFA;SUPT4H1;RNF168;LARP7
prerank,anterograde trans-synaptic signaling (GO:0098916),-0.22848612037463814,-1.039057333227238,0.2777777777777778,0.7673458611212064,1.0,48/224,16.11%,DLGAP1;LRP6;GRIA4;SYT1;CACNB2;NLGN1;CAMK1;KCND2;SLC1A3;PLP1;KCNQ3;CHRM3;DLG2;DLG4;CHRM2;GRIA2;GRIA1;PRKACA;GABRG3;NRXN2;GABRG2;GRIK4;SNAP25;GLRA3;GABRB1;GRIK1;HTR2B;GLRA2;NOVA1;GABRA4;GAD2;CHRFAM7A;CHRNA7;RIT2;CDK5;GRM5;CAMK4;PRKAR1A;HTR2C;NLGN2;SST;CALM1;GIPC1;KCNA1;GABRB3;HTR7;CPLX1;NLGN3
prerank,regulation of protein targeting to mitochondrion (GO:1903214),0.3851606501870975,1.0390181411606292,0.40883190883190884,0.7365210577459556,1.0,10/38,14.20%,LRRK2;RAC2;FBXW7;UBE2D3;PARL;ARIH2;CSNK2A2;RNF31;SREBF2;UBE2J2
prerank,chemical synaptic transmission (GO:0007268),-0.23236669432566298,-1.0388910380197955,0.30434782608695654,0.7665431726596922,1.0,60/284,16.11%,APOE;DLGAP1;LRP6;GRIA4;SYT1;PTPRN2;CACNB2;NLGN1;CAMK1;KCND2;SLC1A3;PLP1;KCNQ3;CHRM3;DLG2;NAPA;DLG4;CHRM2;KIF1B;GRIA2;GRIA1;PRKACA;GABRG3;NRXN2;GABRG2;SLC17A6;GRID2;GRIK4;SNAP25;GLRA3;GABRB1;GRIK1;HTR2B;GLRA2;FCHSD2;NOVA1;GABRA4;GAD2;CHRFAM7A;CHRNA7;RIT2;CDK5;GRM5;CAMK4;SNPH;STX1A;SLC5A7;PRKAR1A;HTR2C;NLGN2;SST;CALM1;ERC1;GIPC1;LIN7A;KCNA1;GABRB3;HTR7;CPLX1;NLGN3
prerank,pentose-phosphate shunt (GO:0006098),0.4992761920790204,1.038845690748366,0.44884488448844884,0.7364113227162372,1.0,5/11,15.35%,TALDO1;RPE;DERA;RBKS;H6PD
prerank,cellular polysaccharide catabolic process (GO:0044247),-0.3959570789434482,-1.0384895640674638,0.38544474393531,0.7663224711379535,1.0,7/16,22.68%,PYGB;GAA;CALM1;PHKA1;PGM2;AGL;PHKG2
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),0.4180424338564927,1.0378394253917234,0.4270676691729323,0.7382830732904279,1.0,4/26,9.63%,RARA;LILRB3;TLR3;FBN1
prerank,negative regulation of transforming growth factor beta production (GO:0071635),0.4891165525955303,1.0374433363928375,0.4200743494423792,0.7387058742865256,1.0,2/10,10.32%,LILRB1;FN1
prerank,regulation of telomerase activity (GO:0051972),0.3711352311461585,1.0371009332111427,0.4186046511627907,0.7389970065449403,1.0,13/45,16.35%,KLF4;PKIB;CERS1;PARP4;PARM1;WRAP53;TNKS;MAP3K4;ERCC4;AURKB;MAPK1;TCP1;SMG6
prerank,regulation of neuron death (GO:1901214),0.33950563854093324,1.0361084117310913,0.40636042402826855,0.7408078673611876,1.0,19/82,14.50%,LRRK2;FYN;MAP3K5;FOS;SORL1;PICALM;CHMP4A;CHMP4B;ITGB2;PRNP;DDIT4;DAXX;FCGR2B;REST;BTBD10;AKT1;DHCR24;TNFRSF1B;RAB29
prerank,regulation of platelet activation (GO:0010543),0.41893214545134605,1.0359915164970614,0.4153846153846154,0.7405701160689074,1.0,2/21,1.94%,LYN;SYK
prerank,positive regulation of mitochondrion organization (GO:0010822),-0.28752546064886564,-1.0353600273364334,0.36585365853658536,0.7736256428463799,1.0,11/57,15.27%,PRKN;TREM2;SPIRE1;FAM162A;PPARGC1A;PYCARD;MFF;VPS35;RALA;BAX;HTRA2
prerank,regulation of cell projection organization (GO:0031344),-0.40725999822393455,-1.0351695904491665,0.40298507462686567,0.7729423284914289,1.0,2/13,0.70%,MYO9A;TREM2
prerank,regulation of smooth muscle cell migration (GO:0014910),-0.3698491252781997,-1.0351248476529586,0.39714285714285713,0.7718214425941394,1.0,7/20,12.12%,IGF1;NRP1;LRP1;PLAU;PDGFA;SLIT2;SERPINE1
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),-0.28446177365727626,-1.0350086959258131,0.37209302325581395,0.7708570205690408,1.0,8/65,5.49%,LDLRAD4;TGFBR2;SKI;TGFBR1;SNX25;SMAD7;STUB1;UBC
prerank,positive regulation of endothelial cell migration (GO:0010595),0.3374147764465195,1.034855341829162,0.39486552567237165,0.7427289948603433,1.0,18/84,13.17%,FOXP1;RIN2;AKT3;CD40;STAT5A;BMPR2;SCARB1;BCAR1;MAPK14;PTK2B;ADAM17;PDPK1;RAC1;BCAS3;GPI;EMC10;MAP2K3;AKT1
prerank,phospholipid translocation (GO:0045332),0.40412652693927253,1.034737640171693,0.415929203539823,0.7424875305612083,1.0,2/28,2.32%,ATP8B4;PLSCR1
prerank,lung epithelium development (GO:0060428),0.501204833127317,1.0346304998061453,0.4358523725834798,0.7422314274105322,1.0,1/10,2.49%,FOXJ1
prerank,regulation of cardiac conduction (GO:1903779),0.35927633012536386,1.0345931885756836,0.42745098039215684,0.741805686409573,1.0,6/54,6.98%,ITPR1;ACE2;GJA5;ATP2B1;ATP2A3;ATP2A1
prerank,response to exogenous dsRNA (GO:0043330),0.4358745666245803,1.0345886835123554,0.4226646248085758,0.7413085013596696,1.0,6/18,15.80%,IFIH1;TLR3;RALB;PQBP1;IFIT1;IRAK3
prerank,autophagy of mitochondrion (GO:0000422),-0.3106547175466296,-1.0345422085249492,0.40070921985815605,0.7707740390466542,1.0,12/38,21.92%,PRKN;ULK2;MAP1LC3B;ATG12;USP30;SQSTM1;ATG9A;FUNDC2;ATG7;WDR45;ATG2A;GABARAP
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.38929385391044097,1.0344325049803884,0.4011220196353436,0.7411616921974838,1.0,9/33,16.37%,KLF4;PTEN;CDKN2C;DCUN1D3;WEE1;APC;RBL2;BRD7;RB1
prerank,negative regulation of response to wounding (GO:1903035),0.4420816777613191,1.0344123526961444,0.42391304347826086,0.7407002313018027,1.0,4/19,9.40%,CASK;CRK;INPP5F;GIT1
prerank,embryonic limb morphogenesis (GO:0030326),-0.3238775544286868,-1.034211416161389,0.4052044609665427,0.7705259860455098,1.0,6/34,4.23%,SKI;LRP6;SALL1;CTNNB1;CACNA1C;WDPCP
prerank,regulation of gluconeogenesis (GO:0006111),0.4021231050830607,1.0339855447576642,0.41863905325443784,0.74121314802015,1.0,8/27,23.33%,SIK1;CRY1;USP7;GCK;SIRT1;CLK2;PTPN2;SELENOS
prerank,Ras protein signal transduction (GO:0007265),0.32175562740773,1.0339535118826413,0.40465631929046564,0.7407848072901171,1.0,20/137,8.94%,GRAP2;TIAM1;RAP1A;EPS8;NGFR;CELSR1;SHTN1;RASGRP2;RAPGEF2;RAC2;ADRA2A;MAPK14;ARHGDIB;GRB2;SHOC2;RAC1;GNB1;SOS1;RALB;RHOA
prerank,termination of RNA polymerase II transcription (GO:0006369),0.39378510566119895,1.0335996500966547,0.4238505747126437,0.741070791788726,1.0,13/33,21.01%,SNRPB;SETX;SSU72;FIP1L1;SCAF8;NUDT21;MAZ;CPSF3;PAPOLA;NCBP1;CSTF3;WDR33;SLBP
prerank,positive regulation of Notch signaling pathway (GO:0045747),-0.3119918718460901,-1.0334161184083706,0.38735177865612647,0.7713533190599982,1.0,7/39,6.52%,MAML2;ROBO2;MAML3;ROBO1;AAK1;EPN2;BMP2K
prerank,wound healing (GO:0042060),0.35143352521913,1.0329359445469033,0.4120667522464698,0.7420676135674998,1.0,8/62,5.35%,JAML;PAK1;CLDN1;DYSF;MYH9;PPP3CA;SCARB1;PRCP
prerank,positive regulation of cellular protein localization (GO:1903829),0.3481473171952221,1.0327778469745263,0.42162818955042525,0.741958081133148,1.0,17/69,15.91%,NGFR;FYN;DTX3L;CCDC88A;KAT7;PARP9;RTN4;CEP250;CENPQ;PRKAA1;EIF2AK3;AKT1;LIMK2;PRKAA2;TGFB1;SNX33;APC
prerank,negative regulation by host of viral process (GO:0044793),-0.44720077381942386,-1.0327047749603602,0.40093240093240096,0.7720745991372957,1.0,2/10,5.15%,PRKN;EIF2AK4
prerank,phospholipid transport (GO:0015914),0.36164061521184176,1.0323782234808259,0.41392904073587383,0.7423724382686271,1.0,18/52,19.75%,ATP8B4;LDLR;ABCA3;SCARB1;PITPNB;ABCC1;PITPNM1;ATP10B;SCARB2;PRELID1;ATP11C;ABCG1;TMEM30A;PITPNA;ATP8B2;ATP11A;ATP11B;PRELID3A
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),0.4387184652866823,1.031162611504259,0.43375394321766564,0.7446960822354728,1.0,4/18,12.32%,RFX3;ADCY10;CABYR;CCDC39
prerank,organic hydroxy compound transport (GO:0015850),-0.31439998600222524,-1.0309888589564147,0.39285714285714285,0.7753779242041063,1.0,3/36,7.06%,SLCO2B1;ABCC3;ATP8B1
prerank,homocysteine metabolic process (GO:0050667),0.47182873664426367,1.0302907015041227,0.42158516020236086,0.7462998533912267,1.0,2/11,10.44%,DPEP1;MTRR
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),-0.3447554962163206,-1.0301685592426413,0.411214953271028,0.7764319523313439,1.0,11/25,19.50%,EVL;ARHGAP24;EVI5L;SLIT2;ODF2L;RAP1GAP;TCHP;PFN2;CDK10;PLXNB3;CEP97
prerank,response to amino acid (GO:0043200),-0.3243473173393411,-1.030083631310706,0.38095238095238093,0.7754403799054024,1.0,12/31,19.38%,RPTOR;CPEB1;GLRA3;LARS1;IPO5;GLRA2;CPEB4;LAMTOR5;RRAGC;CPEB3;NSMF;SESN2
prerank,mitotic G2/M transition checkpoint (GO:0044818),0.36968074268821866,1.0299106046660378,0.4076086956521739,0.7466746799311176,1.0,12/43,18.47%,DTL;MRE11;TAOK3;NABP1;UIMC1;RINT1;PABIR1;DONSON;BRSK1;HUS1;RAD17;FZR1
prerank,anterograde axonal transport (GO:0008089),-0.30825985370694975,-1.0295913455874879,0.4,0.7755067804408476,1.0,10/37,15.46%,DTNBP1;DLG2;KIF1B;KIF1A;AP3M2;KIF5C;MAP1A;AP3B1;AP3B2;BLOC1S5
prerank,regulation of AMPA receptor activity (GO:2000311),-0.3419363360979417,-1.0290308502678476,0.39263803680981596,0.7758791384101298,1.0,6/25,17.67%,MEF2C;NLGN1;CACNG2;NLGN2;NLGN3;PRRT1
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),0.43703646599120005,1.0286879527114183,0.44907407407407407,0.7490553867034123,1.0,4/18,7.38%,DTL;RCC2;CCND1;MECP2
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),-0.39015238101896305,-1.0286367274970991,0.40896358543417366,0.7757141716622784,1.0,5/16,18.23%,BCL2L1;TMEM161A;CLU;FBH1;TRIM32
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.3668221962840429,1.0283336276499233,0.45646437994722955,0.7493955117378225,1.0,10/50,12.51%,IL1B;LAPTM5;EIF2AK2;PDCD4;TLR3;IFI35;RHOA;RPS3;APP;TLR2
prerank,neurotransmitter transport (GO:0006836),-0.2694313358021325,-1.0283085936618077,0.39487179487179486,0.7753707603747023,1.0,25/73,22.61%,SYT1;PTPRN2;GLUL;SLC1A3;NRXN2;PPFIA4;SLC6A15;SLC17A6;SNAP25;ATP1A2;GAD2;SNPH;STX1A;SLC29A1;SLC5A7;LIN7A;CPLX1;GABRA2;RIMS1;RAB3A;NRXN1;GAD1;SYN2;PDZD11;SLC32A1
prerank,regulation of cell morphogenesis (GO:0022604),0.3985261432201736,1.0280371520163774,0.44396551724137934,0.7495931627398532,1.0,4/30,6.68%,CD44;NTNG2;PDZD8;CAPZB
prerank,regulation of mononuclear cell migration (GO:0071675),0.41991224635735375,1.0279878948279058,0.42255639097744363,0.749203370133106,1.0,3/23,2.13%,STK10;LYN;MSN
prerank,regulation of histone H3-K9 acetylation (GO:2000615),-0.4629384987406862,-1.027959246239655,0.4624413145539906,0.7751161787559127,1.0,6/10,21.27%,CAMK1;SMARCB1;PIH1D1;BRCA1;SPHK2;RAPGEF3
prerank,cation transport (GO:0006812),-0.2340323995754071,-1.0277550934982396,0.32954545454545453,0.7744864802793784,1.0,26/167,13.03%,KCNMA1;SLC8A1;SLC7A6;FGF13;SCN1A;TRPM3;KCNJ2;SLC7A1;ANO10;ATP1B1;SLC36A4;SGK1;SLC11A2;SCN3A;SLC36A1;KCNN2;ATP1A2;KCNMB2;MCOLN1;KCNA2;KCNJ6;KCNK6;SLC7A8;CHP1;SLC3A2;TRPM2
prerank,regulation of acute inflammatory response (GO:0002673),0.4365350317032234,1.0275692584872227,0.43084260731319557,0.7496361334144424,1.0,4/18,14.82%,IL6ST;IL6;NLRP3;GSTP1
prerank,insulin receptor signaling pathway (GO:0008286),-0.2713067136511111,-1.0273899201349486,0.37185929648241206,0.7742722585199875,1.0,17/69,12.66%,BCAR3;ATP6V1C1;ATP6V0B;ATP6V0D2;ATP6V0C;TCIRG1;ATP6V1B2;GAB1;ATP6AP1;RHOQ;ATP6V1D;IDE;IRS1;ATP6V0D1;PIK3R1;NAMPT;ATP6V0A1
prerank,response to histamine (GO:0034776),0.49626527276624466,1.0272901522054603,0.4482758620689655,0.749799637184241,1.0,3/10,9.66%,GABRB2;DIAPH1;HRH1
prerank,membrane organization (GO:0061024),0.30887370623027355,1.0272162275494823,0.4196242171189979,0.7494782889940976,1.0,51/227,16.31%,ACTR3;STX11;FNBP1;LDLR;PIK3C2A;EPS15;REPS1;KIF20A;DYSF;CCDC88A;OCRL;CBL;PICALM;TMCC1;MITD1;LEMD3;CHMP4A;CHMP4B;AP2A2;GRB2;ACTR2;MTCH1;PDCD6IP;SYP;SYNJ1;SPAST;HIP1;ARPC2;EPS15L1;ARPC4;LEMD2;SNX9;ATP10B;DMPK;SCARB2;STAM;AP2B1;TOR1AIP1;AGFG1;SNX3;PACSIN2;DNM1L;SYNGR2;TIMM50;SNAP23;DVL2;AP2S1;VAPA;HACE1;MYADM;PPT1
prerank,rRNA modification (GO:0000154),-0.3600003647744576,-1.0269137491541083,0.4075067024128686,0.7742841875529297,1.0,9/21,26.25%,ZCCHC4;DIMT1;NSUN3;DKC1;THUMPD1;FTSJ3;TRMT112;NAT10;BUD23
prerank,regulation of neuroinflammatory response (GO:0150077),0.4305158365240842,1.0257814476110219,0.4333843797856049,0.7523382218452366,1.0,5/19,14.64%,IL1B;IL33;IL6;TNFRSF1B;IL18
prerank,peptidyl-serine dephosphorylation (GO:0070262),0.4613771327768662,1.025702209367042,0.44873949579831934,0.7520176070919494,1.0,5/14,11.81%,PPP3CA;PPTC7;PPP2R2A;DUSP1;PPP1R15B
prerank,protein ubiquitination (GO:0016567),0.3005946181934883,1.025224686648852,0.4171717171717172,0.7526097986165345,1.0,111/471,17.32%,DTL;LNPEP;ITCH;PSME3;DTX3L;ASB5;NEDD4L;TRIM26;CUL3;CUL5;BIRC6;UBE2E1;RNF38;TRIM7;CBL;PSMB7;FBXW7;ANKIB1;RNF146;CBLL1;PSME2;TRIM62;PEX12;ARIH1;WAC;RNF213;RNF20;PELI1;RC3H1;UBE2QL1;UBE2D3;SPOP;FBXW11;FBXL8;UBE2N;RNF217;UBR5;HLTF;FBXW2;NEDD8;CBFB;NFE2L2;ELOB;MYCBP2;TRIM25;FBXO4;UBR2;PCNP;PSME4;ARIH2;PEX14;RNF141;TNKS;WWP2;RNF13;TRIM71;UBE2W;FBXO32;PSMB8;PSMA5;UBE2Z;FANCL;PSMD9;TRIM14;HERC6;RNF31;PSMB3;UBE2S;FBXL17;PSMD6;PSMC4;LONRF1;KLHL8;TPP2;RCHY1;PSMD10;TRIM17;UBE2G1;SH3RF1;AREL1;PSMB1;FBXL12;RNF138;HECTD2;FBXO30;VCP;UBE2J2;USP7;UHRF2;FBXO7;ANAPC7;KCTD13;VCPIP1;RNF166;RNF122;USP9X;TAF1;TRIM35;RNF41;HACE1;FBXL16;PSMD12;TRIM36;UBR3;UBA6;KLHL12;MSL2;SIRT1;RNF144A;UBE2Q2;TRAF2
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.33672000172469974,1.025189130850467,0.42398022249690975,0.7521776381984087,1.0,10/76,10.38%,GNA14;FPR1;LTB4R;FPR3;GPR35;ADRA2A;TACR1;OPRM1;HRH1;PTGER3
prerank,DNA unwinding involved in DNA replication (GO:0006268),0.4452426121454487,1.0250753334833367,0.4424920127795527,0.7519454143231913,1.0,4/16,12.94%,MCM6;WRN;RECQL5;MCM2
prerank,IRE1-mediated unfolded protein response (GO:0036498),-0.29168081268694246,-1.0250346422717485,0.42081447963800905,0.7780899073906541,1.0,20/52,22.11%,PREB;TPP1;ATP6V0D1;HYOU1;GOSR2;ARFGAP1;SRPRB;PARP16;TATDN2;DNAJB11;GFPT1;PDIA6;EXTL3;CXXC1;VAPB;DNAJB9;FKBP14;DDX11;HDGF;PDIA5
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.33676087849859987,1.0250202772664914,0.4289185905224787,0.7515644208536605,1.0,20/86,16.30%,LIMD1;PSME3;HSPA1A;PSMB7;PSME2;NFE2L2;ELOB;PSME4;BACH1;PSMB8;PSMA5;PSMD9;PSMB3;PSMD6;PSMC4;PSMD10;PSMB1;CREBBP;INO80;PSMD12
prerank,regulation of viral transcription (GO:0046782),0.3816598526524129,1.0244339349922857,0.4603825136612022,0.7524519529351745,1.0,13/39,19.84%,GTF2F2;POLR2C;TRIM62;HEXIM1;TRIM14;NELFA;CCNT1;RSF1;IFITM3;SUPT4H1;MDFIC;MID2;LARP7
prerank,sensory perception (GO:0007600),0.3680631223989652,1.024406940456077,0.430327868852459,0.7520030325909933,1.0,2/45,3.56%,CCR2;CHRNA4
prerank,regulation of smooth muscle cell proliferation (GO:0048660),0.3706454840305491,1.0241563567662306,0.43953185955786733,0.7521138135899977,1.0,7/46,9.19%,FOXP1;PPARG;IL6R;STAT1;NOX1;IL6;ID2
prerank,negative chemotaxis (GO:0050919),-0.31584399115660866,-1.0236797794742132,0.42207792207792205,0.7804021168962717,1.0,10/33,12.71%,ROBO1;SEMA3D;SEMA3E;ITGB3;SEMA6D;PDGFA;SLIT2;EPHA7;SLIT1;SLIT3
prerank,actomyosin structure organization (GO:0031032),-0.26429895320562863,-1.0235029823539656,0.4097560975609756,0.7796758332045279,1.0,5/75,3.21%,ITGB5;EPB41L2;TJP1;CAPN3;EPB41L4B
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),0.36382134095924046,1.0234397123578522,0.43691899070385126,0.7532825554966929,1.0,12/52,16.33%,PRKCE;PRKCH;KIF5B;PDPK1;CIB1;EPHB2;CLIP3;LGALS3;AKT1;ITGA3;RHOG;PLS1
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),0.4503475646141938,1.023410613703805,0.43025210084033616,0.7528493055192548,1.0,6/15,15.66%,IL1B;ADRA2A;SNX9;TNFRSF1B;ADAM9;SNX33
prerank,regulation of osteoblast differentiation (GO:0045667),0.340887560398593,1.0234071932459057,0.45465393794749404,0.7523540462811734,1.0,10/82,8.61%,FFAR4;RUNX2;LIMD1;PPARG;BMPR2;IL6R;ACVR2A;IL6ST;HGF;IL6
prerank,regulation of SMAD protein signal transduction (GO:0060390),0.4273726156231184,1.0232627127567442,0.4268104776579353,0.75219214843507,1.0,5/21,18.20%,JAK2;RBPMS;SMAD4;TGFB1;NUP93
prerank,positive regulation of keratinocyte migration (GO:0051549),-0.43573597921006696,-1.02306460807785,0.44819277108433736,0.7796792578836225,1.0,2/10,4.10%,EPB41L4B;IQSEC1
prerank,regulation of cardiac muscle contraction (GO:0055117),0.3861798944994256,1.0228966439693805,0.4444444444444444,0.7525823779295369,1.0,5/34,3.90%,GJA5;RNF207;RGS2;KCNQ1;HCN4
prerank,eosinophil chemotaxis (GO:0048245),-0.39662006132326677,-1.0228579978112828,0.42278481012658226,0.7777999790393688,1.0,6/14,31.87%,SCG2;CCL13;CX3CL1;CCL3;CCL2;CCL5
prerank,eosinophil migration (GO:0072677),-0.39662006132326677,-1.0228579978112828,0.42278481012658226,0.7777999790393688,1.0,6/14,31.87%,SCG2;CCL13;CX3CL1;CCL3;CCL2;CCL5
prerank,negative regulation of fibroblast proliferation (GO:0048147),-0.37064698650396904,-1.0228570542096649,0.43523316062176165,0.7765953563269944,1.0,7/18,18.23%,SKI;NF1;NLRC3;FTH1;MED25;DAB2IP;TRIM32
prerank,negative regulation of endothelial cell migration (GO:0010596),-0.3071983465233007,-1.022793075210617,0.38380281690140844,0.7755387414438645,1.0,5/36,2.97%,PTPRM;APOE;MEF2C;FGF2;HMGB1
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),-0.42760745544102224,-1.022603842295408,0.43387470997679817,0.7748596126692133,1.0,6/11,18.00%,RENBP;AMDHD2;NAGK;UAP1L1;GFPT1;GNPDA2
prerank,cellular respiration (GO:0045333),-0.30977479696241605,-1.022406629763759,0.4317343173431734,0.7741716398831294,1.0,16/41,26.05%,UQCRC2;ME3;PPARGC1A;SDHB;OXA1L;SLC25A14;NDUFS7;MTFR1L;ATP5F1D;COX10;NDUFA5;UQCRC1;UQCR10;LYRM7;NDUFS8;SURF1
prerank,positive regulation of receptor internalization (GO:0002092),-0.355512059490003,-1.0219883662587326,0.463768115942029,0.7740711354554861,1.0,8/22,28.53%,MAGI2;CD63;VEGFA;SCYL2;ANGPT1;ARRB2;PICK1;EGF
prerank,spliceosomal snRNP assembly (GO:0000387),0.37123293660804674,1.0217541653409863,0.4178272980501393,0.7547596144804007,1.0,9/38,15.56%,SNRPD2;PRPF6;SNRPB;SRSF10;COIL;PRPF3;USP4;GEMIN7;AAR2
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",0.3637921357629663,1.0216701609182826,0.4385245901639344,0.7544848720716328,1.0,14/48,19.20%,MYO1C;TAF1A;ATAD2;SMARCA5;POLR1G;DEK;ELOF1;KAT2B;POLR1B;ZMIZ2;TAF1C;PADI2;SF3B1;ACTB
prerank,protein methylation (GO:0006479),0.3713668951567653,1.0211111843064162,0.4397260273972603,0.7552822459188968,1.0,13/40,19.45%,NSD3;PRMT8;SNRPB;RAB6A;CAMKMT;ETF1;NSD1;EZH2;PRMT3;EEF1AKMT1;NTMT1;GSPT1;EHMT1
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.3435381395431237,1.0209327160707071,0.4315659679408138,0.7551952012627766,1.0,16/72,15.48%,FGF5;FGF22;KL;GTF2F2;POLR2C;CBL;GRB2;SETX;SHOC2;TRIM71;FLRT1;FGFR3;MAPK1;FRS2;SPRED1;NCBP1
prerank,lamellipodium organization (GO:0097581),0.40472316539492803,1.0209212099454794,0.43157894736842106,0.7547165945147183,1.0,7/29,13.20%,PTPRO;CCDC88A;CARMIL1;SNX1;RAC1;ARHGEF6;KIT
prerank,regulation of chromosome organization (GO:0033044),-0.35659658983106785,-1.020895339209295,0.4257703081232493,0.7757944031187999,1.0,5/22,11.59%,WAPL;YLPM1;UPF1;TERF2IP;XRCC5
prerank,regulation of potassium ion transport (GO:0043266),-0.3222146489410878,-1.0208548310070467,0.4144736842105263,0.7746973525299741,1.0,5/31,7.56%,CACNA1D;CD63;ANK2;KCNN2;DPP10
prerank,central nervous system myelination (GO:0022010),0.4773098893618368,1.0204075520227616,0.4425956738768719,0.7553877096970713,1.0,3/11,5.92%,MYRF;B4GALT5;PTEN
prerank,amino sugar biosynthetic process (GO:0046349),-0.4116834111334754,-1.0202767885791109,0.4341801385681293,0.7750579605643713,1.0,6/12,18.00%,RENBP;AMDHD2;NAGK;UAP1L1;GFPT1;GNPDA2
prerank,regulation of macroautophagy (GO:0016241),-0.24936515350590316,-1.0194648691891965,0.41007194244604317,0.7760891942896733,1.0,34/105,18.04%,LARP1;SCOC;ATP6V1C1;RPTOR;EPM2A;ATP6V0B;SNX5;ATP6V0D2;ATP6V0C;ATP6V1B2;PRKACA;SESN3;NRBP2;ATP6V1D;CDK5R1;CAPNS1;SNX6;ATP6V0D1;VPS35;CDK5;LAMTOR5;CASP3;ATP6V0A1;TRIM13;TSC2;SNX32;UCHL1;RRAGC;PAFAH1B2;GPSM1;UBQLN2;EXOC1;HDAC6;SMCR8
prerank,mitochondrial translational termination (GO:0070126),-0.2559198190487841,-1.0194297174220266,0.385,0.7750060261164778,1.0,49/88,35.85%,GFM2;MRPL24;MRPS9;DAP3;MRRF;MRPS21;MRPL1;MRPS5;OXA1L;MRPL45;MRPS31;MRPS17;MRPL10;MRPL43;CHCHD1;MRPS7;MRPL4;MRPL2;MRPL37;MRPS24;MRPS26;MRPS22;MRPS18B;MRPL3;MRPL32;MRPL47;MRPS30;MRPL17;MRPL50;MRPS14;MRPL51;MRPL16;MRPL11;MRPS18C;MRPL44;MRPL35;MRPS11;MRPL28;MRPL46;MRPL52;MRPS35;MRPS28;MRPL23;MRPL9;MRPS16;MRPL54;MRPL49;MRPL42;MRPS23
prerank,regulation of glucose metabolic process (GO:0010906),-0.31955247750374643,-1.0192740988245548,0.43157894736842106,0.7742200243072475,1.0,4/34,9.25%,PRKN;PDK1;IRS1;DGKQ
prerank,negative regulation of angiogenesis (GO:0016525),0.335697030794937,1.0191243614677568,0.451338199513382,0.7577992749060856,1.0,11/84,9.45%,CCR2;KLF4;PPARG;CXCL10;ATF2;SYNJ2BP;STAT1;HSPG2;MECP2;E2F2;NAXE
prerank,metal ion export (GO:0070839),0.3880249686863426,1.0189091735283065,0.4447592067988669,0.7577881738563945,1.0,3/31,7.73%,KCNE3;KCNQ1;ATP7A
prerank,positive regulation of chromosome organization (GO:2001252),0.44286047812196894,1.0180714985704449,0.4548335974643423,0.7591763746583011,1.0,4/15,18.32%,MRE11;FEN1;ATRX;RAD21
prerank,negative regulation of leukocyte activation (GO:0002695),-0.3950759058302235,-1.017933140751816,0.45038167938931295,0.7765758591185755,1.0,2/15,1.61%,CD84;GRN
prerank,protein modification by small protein conjugation or removal (GO:0070647),-0.4098467100492396,-1.0177356127410464,0.4268867924528302,0.7759286302099301,1.0,6/13,18.23%,UBA3;SAE1;NAE1;UBA7;UBA1;ATG7
prerank,positive regulation of cellular amide metabolic process (GO:0034250),0.3422966182438717,1.017569596680924,0.4576271186440678,0.7598810571657407,1.0,18/80,16.11%,NIBAN1;IFNGR1;BCL3;RPL5;VIM;PICALM;GSAP;YTHDF3;IL6;METTL3;PLA2G6;LARP4B;EIF3E;ABCG1;RELA;THBS1;RPS4X;RPS6KB1
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),0.47664130306896846,1.0175626976952872,0.44905008635578586,0.7593939854673238,1.0,6/11,21.31%,LYN;TIRAP;ACOD1;CYBA;TLR1;TNFAIP3
prerank,regulation of platelet aggregation (GO:0090330),0.4348498968394712,1.0167961043691758,0.43709677419354837,0.7606266375923202,1.0,3/17,7.54%,LYN;SYK;F11R
prerank,glycerophospholipid catabolic process (GO:0046475),-0.3381771096134558,-1.0167120890051502,0.43050847457627117,0.7775387939890702,1.0,6/27,7.25%,ABHD12;PLA2G15;GDE1;ENPP2;PNPLA8;PLA2G4A
prerank,positive regulation of BMP signaling pathway (GO:0030513),0.4055408547391005,1.0163054626579002,0.43870014771048743,0.7612511695931901,1.0,5/25,9.94%,BMPR2;RBPJ;ENG;ACVR2A;SMAD4
prerank,regulation of secretion by cell (GO:1903530),-0.28445807046032673,-1.016139841983675,0.4396887159533074,0.7779235286209433,1.0,16/54,18.87%,MEF2C;SNCAIP;SYT1;RAB3C;STXBP5L;RIC1;RALA;DISP1;SCG5;VAMP8;CPLX1;CAMK2A;RIMS1;RHBDF2;VAMP3;RAB3A
prerank,Notch signaling pathway (GO:0007219),0.35297410625135095,1.0157738938281236,0.4346153846153846,0.7619512937800902,1.0,8/59,8.05%,NOTCH2;ITCH;DTX3L;RBPJ;STAT1;GMDS;ADAM17;PLXND1
prerank,cardiac right ventricle morphogenesis (GO:0003215),-0.4282982791559113,-1.0157337772957773,0.4582392776523702,0.777861984727066,1.0,6/11,44.30%,SOX4;TGFB2;JAG1;BMP4;HEY2;ISL1
prerank,cellular response to reactive oxygen species (GO:0034614),0.34655596973325253,1.0155947588903058,0.44601542416452444,0.7618742945266056,1.0,17/59,15.36%,MAP3K5;FOS;SETX;NFE2L2;PXN;IL6;CAMKK2;RPS3;ANXA1;RIPK1;NET1;MAPK8;AKT1;NCF1;MAPK1;RELA;PRDX5
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",-0.38174675904877703,-1.0153981771023624,0.43636363636363634,0.7775033146476737,1.0,7/16,18.34%,PSIP1;SFSWAP;SNRNP200;PRPF39;CWC15;SNRPC;SRSF1
prerank,negative regulation of ossification (GO:0030279),0.4085083542498557,1.0150549839451977,0.4418262150220913,0.7626500567168952,1.0,4/23,6.44%,CCR1;RBPJ;SRGN;PTK2B
prerank,response to iron ion (GO:0010039),-0.4142965685954297,-1.0143418008449114,0.4433497536945813,0.7791518496414993,1.0,5/12,22.04%,HIF1A;SLC11A2;BMP6;FXN;HFE
prerank,regulation of programmed necrotic cell death (GO:0062098),0.4123058328062285,1.0140378274492268,0.4539877300613497,0.7644649291942082,1.0,6/20,10.65%,BIRC3;PELI1;PDCD6IP;SPATA2;CYLD;RIPK1
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),0.48560446550527814,1.0139353562703883,0.45955882352941174,0.7642142758765098,1.0,3/10,11.57%,ATF7IP;THRA;PSMC4
prerank,erythrocyte development (GO:0048821),-0.4246285038294587,-1.0137562696063398,0.452914798206278,0.7795012647614633,1.0,7/10,41.96%,ALAS1;NCKAP1L;LYAR;ABCB10;ZBTB7A;SH2B3;DMTN
prerank,phospholipid dephosphorylation (GO:0046839),0.3785291094940507,1.013657120900342,0.44173441734417346,0.7643323136546496,1.0,10/37,17.28%,INPP5F;OCRL;PTEN;MTMR3;MTMR4;SYNJ1;SGPP2;SGPP1;MTMR2;PLPPR2
prerank,regulation of metal ion transport (GO:0010959),-0.377928019257025,-1.0135753803589982,0.4297520661157025,0.7788061119980009,1.0,2/16,5.04%,CACNA2D1;ANK2
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),0.4123229509297654,1.0134896353336937,0.44393939393939397,0.7642126583960951,1.0,9/24,18.38%,ACE;MFSD6;TAP1;B2M;FCER1G;CANX;SEC24C;PDIA3;TAPBP
prerank,negative regulation of chemotaxis (GO:0050922),-0.3203622638092191,-1.0134063183649245,0.46078431372549017,0.7780886801492429,1.0,7/31,9.40%,ROBO2;ROBO1;AIF1;SEMA3D;SEMA3E;SEMA6D;SLIT2
prerank,cell differentiation in spinal cord (GO:0021515),-0.4390686512534418,-1.0129712492206937,0.45080091533180777,0.7780441743746468,1.0,6/10,38.08%,MDGA2;SOX4;SOX13;ZC4H2;SOX6;LHX1
prerank,negative regulation of viral transcription (GO:0032897),0.46086256766810413,1.0127753316684707,0.4409448818897638,0.7653692462530888,1.0,6/13,19.84%,TRIM62;HEXIM1;TRIM14;IFITM3;MID2;LARP7
prerank,organic anion transport (GO:0015711),0.340636322208584,1.012625369928447,0.4542168674698795,0.7652307167067983,1.0,16/76,17.23%,LRRC8C;SLC23A1;SLC4A7;LRRC8D;SLCO1B1;SLC4A8;CYB5R4;CYB5R1;ABCC4;SLCO1C1;SLC26A7;SLC35A1;SLC35A3;SLCO4C1;SLC52A1;SLCO3A1
prerank,regulation of cardiac muscle cell contraction (GO:0086004),-0.33160078293975404,-1.0113848653260678,0.43354430379746833,0.7809734813391754,1.0,6/27,7.60%,CTNNA3;FGF13;CACNA1C;ATP2A2;ANK2;JUP
prerank,protein modification by small protein removal (GO:0070646),0.3012446390972003,1.0112341163387895,0.45855194123819515,0.7679548696181353,1.0,70/252,18.08%,TNIP3;PSME3;NFKBIA;USP3;PSMB7;INO80C;PSME2;OTULINL;IL33;BIRC3;EIF3F;IFIH1;OTUD1;PTEN;USP49;NEDD8;TADA3;ATXN7;USP45;TRAF3;JOSD1;PSME4;UIMC1;ATXN3;USP32;USP48;USP31;RHOA;COPS3;USP15;PSMB8;SMAD4;PSMA5;PSMD9;CYLD;RIPK1;USP42;SENP6;STAM;PSMB3;PSMD6;PSMC4;NLRP3;USP40;MAP3K7;PSMD10;USP4;SNX3;OTUD4;PSMB1;KAT2B;VCP;USP37;USP7;ASXL2;VCPIP1;USP9X;INO80;APC;USP47;POLB;PSMD12;WDR20;FOXK1;TRAF2;TAB1;USP14;BECN1;USP38;SMURF2
prerank,neuron maturation (GO:0042551),-0.3682809405583083,-1.0110799022200514,0.4182825484764543,0.7805957130293805,1.0,7/18,14.94%,C1QA;ADGRB3;SRRM4;FARP2;ANKS1A;C3;CX3CL1
prerank,response to UV (GO:0009411),0.3299236497884136,1.0110740521728838,0.4597156398104265,0.7677807896905452,1.0,34/95,22.08%,BCL3;DTL;GPX1;FEN1;CCND1;WRN;MSH6;MAP3K4;MAP4K3;DCUN1D3;ERCC3;MAPK8;AKT1;ERCC4;METTL3;PCLAF;AURKB;BRSK1;CREBBP;RELA;TAF1;INO80;USP47;POLD1;PRKCD;PRIMPOL;CAT;N4BP1;RHBDD1;XPA;POLK;PARP1;CASP9;SDE2
prerank,negative regulation of organelle assembly (GO:1902116),0.37908965464228256,1.0104557268874295,0.4487004103967168,0.7687612898889173,1.0,7/35,13.96%,LRRK2;CHMP4A;CHMP4B;SMAD4;MDM1;LIMK2;KAT2B
prerank,circulatory system development (GO:0072359),-0.24559556611715752,-1.009997021190649,0.4,0.782238999661153,1.0,16/118,8.16%,ADAP2;TGFBR2;MEF2C;ERBB4;SALL1;TGFBR1;NTRK3;TCF25;PKD2;CACNA1C;NF1;BCOR;ACVR1;NXN;NCOA6;POU6F1
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.3965278023253962,1.0099789756976412,0.4588235294117647,0.7693738356168845,1.0,6/29,13.75%,PAK1;AXIN1;CBFB;LATS1;CNOT2;STRN3
prerank,xenobiotic transport (GO:0042908),-0.3623259715117174,-1.009527398775844,0.4365079365079365,0.7823170696340573,1.0,6/17,17.09%,ABCC3;ABCG2;GJA1;SLC15A2;SLC22A4;ABCC5
prerank,glutathione derivative metabolic process (GO:1901685),-0.3576980201470802,-1.0093501860520437,0.4331395348837209,0.7804435295533281,1.0,2/20,6.13%,HPGDS;AKR1A1
prerank,glutathione derivative biosynthetic process (GO:1901687),-0.3576980201470802,-1.0093501860520437,0.4331395348837209,0.7804435295533281,1.0,2/20,6.13%,HPGDS;AKR1A1
prerank,serine family amino acid catabolic process (GO:0009071),0.4746881427298444,1.0090318749554132,0.48184818481848185,0.7710332528003623,1.0,4/10,18.37%,DLD;GCSH;AMT;SHMT1
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.38116858067566123,1.008920887862387,0.4281767955801105,0.7707877670967528,1.0,7/32,14.85%,DTL;MRE11;TAOK3;UIMC1;RINT1;DONSON;BRSK1
prerank,maturation of 5.8S rRNA (GO:0000460),-0.36979788270002656,-1.0089107637863883,0.43010752688172044,0.7804938193736807,1.0,8/17,18.86%,RPF1;WDR12;C1D;LAS1L;PES1;FTSJ3;RRP15;EXOSC10
prerank,negative regulation of fat cell differentiation (GO:0045599),-0.3191705281268949,-1.0088231892840172,0.4370860927152318,0.7795535247174615,1.0,6/34,9.98%,FLCN;TRIO;ANKRD26;ENPP1;RUNX1T1;SMAD3
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),-0.440884337541838,-1.0087704970800446,0.4430693069306931,0.7785289792800423,1.0,2/10,1.53%,DIP2B;FLCN
prerank,acidic amino acid transport (GO:0015800),0.4372665656260102,1.0085422244972038,0.44878048780487806,0.7711114158175766,1.0,4/17,11.49%,LRRC8D;SLC25A13;SLC25A12;SLC25A18
prerank,positive regulation of epithelial cell migration (GO:0010634),0.3282814904701641,1.0078016550873938,0.43577430972388953,0.7722788255066264,1.0,19/92,14.67%,FOXP1;RIN2;DOCK5;PRKCE;PLCG2;BMPR2;GLIPR2;SCARB1;BCAR1;PTK2B;RAC1;BCAS3;RTN4;GPI;EMC10;CAPN7;AKT1;CLASP1;ADAM9
prerank,protein localization to chromosome (GO:0034502),-0.3108902883926047,-1.00775277451906,0.4357142857142857,0.7800773681577801,1.0,17/34,24.04%,WAPL;SLF2;TPP1;SLF1;IFFO1;TERF2IP;MSH2;XRCC5;ESR1;MRNIP;TNKS2;CHMP7;CENPA;BOD1;PARP3;TINF2;PINX1
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),0.2977672659103287,1.0076869228645904,0.4606741573033708,0.7720460354643829,1.0,80/341,16.55%,FEM1C;DTL;ITCH;PSME3;RNF149;DTX3L;VPS37C;NEDD4L;CUL3;BIRC6;UBE2E1;CBL;TBL1XR1;PSMB7;FBXW7;ANKIB1;RNF146;PSME2;KCTD2;ARIH1;RNF213;RNF20;PELI1;RC3H1;UBE2D3;SPOP;FBXW11;FAF1;KLHL15;RNF217;TSG101;NEDD8;NFE2L2;TRIM25;CLOCK;COP1;PCNP;PSME4;ARIH2;RNF130;ATXN3;COPS3;WWP2;RNF13;TRIM71;UBE2W;PSMB8;KCTD5;PSMA5;PSMD9;PSMB3;UBE2S;FBXL17;PSMD6;PSMC4;KLHL8;RCHY1;PSMD10;UBE2G1;AREL1;PSMB1;UBAP1;VCP;RNF150;PPP2R5C;AURKB;FBXO7;ANAPC7;KCTD13;UBXN11;RMND5B;RNF166;RNF122;USP9X;TAF1;HACE1;PSMD12;UBR3;UBA6;MAEA
prerank,positive regulation of cholesterol transport (GO:0032376),-0.31733706596650285,-1.007613950799056,0.434640522875817,0.7792840077737915,1.0,4/27,3.76%,APOE;TREM2;LRP1;ABCB4
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),0.36762802105209436,1.007257029503272,0.4395750332005312,0.7725446536398936,1.0,7/43,9.19%,FOXP1;ERN1;IL6R;STAT1;NOX1;IL6;ID2
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",0.40192388518351907,1.0067339278482843,0.473604826546003,0.7732644746745899,1.0,5/24,6.67%,JARID2;SPI1;H3-3A;RBBP4;PHF19
prerank,histone lysine demethylation (GO:0070076),0.4025389275944209,1.0066872481032307,0.4425981873111782,0.7728552991288609,1.0,3/25,7.20%,KDM6A;KDM7A;KDM3B
prerank,negative regulation of TORC1 signaling (GO:1904262),0.4508494573269535,1.0064765943873133,0.4570957095709571,0.7728228642141586,1.0,3/13,12.67%,SPAAR;DEPDC5;CASTOR2
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),0.3949137608040584,1.0063805940310513,0.4636627906976744,0.7725411299340553,1.0,9/26,19.97%,LRRK2;FYN;NFE2L2;REST;AKT1;FBXO7;SIRT1;PINK1;PARK7
prerank,hydrogen peroxide catabolic process (GO:0042744),0.470907093864941,1.0062837799673432,0.4768211920529801,0.772242891714558,1.0,4/11,19.34%,GPX1;PXDN;PRDX5;CAT
prerank,lipoprotein biosynthetic process (GO:0042158),-0.4276783327010542,-1.006152199038574,0.4363207547169811,0.7819128860814201,1.0,4/11,20.24%,APOE;PORCN;ATG7;WDR45
prerank,intracellular cholesterol transport (GO:0032367),-0.3926166825856864,-1.0059460282922845,0.4087193460490463,0.781289229948547,1.0,2/15,0.76%,ABCA1;LRP6
prerank,GPI anchor biosynthetic process (GO:0006506),-0.318223434551952,-1.0058860338859352,0.4339622641509434,0.7802964865617751,1.0,18/30,39.09%,PIGN;PIGG;PGAP2;PIGP;PIGB;PIGA;DPM2;PIGV;DPM3;PIGU;DPM1;PIGO;PGAP3;MPPE1;PIGZ;PIGW;PIGQ;PGAP1
prerank,ganglioside metabolic process (GO:0001573),0.41860141570870735,1.0058151731996468,0.4416403785488959,0.7727854734304702,1.0,4/20,8.25%,ST8SIA4;GM2A;ST8SIA6;ST6GALNAC3
prerank,triglyceride metabolic process (GO:0006641),-0.29482844614625237,-1.005643363653853,0.43373493975903615,0.7797722395236636,1.0,13/48,25.38%,APOE;AGMO;FABP5;GPAM;GK5;GPAT4;APOC1;LIPH;LPGAT1;LMF1;PLAAT3;DGAT1;FABP4
prerank,protein targeting to lysosome (GO:0006622),0.41991927785640937,1.0053210730226863,0.45754716981132076,0.7734070593731909,1.0,5/20,11.08%,LAPTM5;SORL1;RAB7A;GCC2;SCARB2
prerank,regulation of cell-substrate junction assembly (GO:0090109),0.4139050623680061,1.0049852345715324,0.4525316455696203,0.7736742264796036,1.0,10/21,22.76%,SLK;RHOA;ROCK1;CLASP1;DAPK3;PTPRA;VCL;PTK2;LIMCH1;CORO1C
prerank,positive regulation of catalytic activity (GO:0043085),0.37362740481248014,1.0048259107658757,0.45179063360881544,0.7735242394491573,1.0,11/37,17.10%,MAPK14;WRN;CIB1;MSH3;ATP7A;MSH6;BCAS3;XRCC4;MAPK8;PSEN1;ABL2
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),0.34895009606094474,1.0045387865412643,0.4723684210526316,0.7736849086905512,1.0,9/54,7.38%,AKT3;PPARG;CD40;STAT5A;PRCP;MAPK14;ADAM17;PDPK1;MECP2
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),0.42422302431070336,1.0044668500965628,0.44925373134328356,0.7733502466813409,1.0,4/20,9.41%,RBPJ;PDCD4;ENG;OLFM1
prerank,cellular response to alcohol (GO:0097306),0.36024988882904024,1.0044575266637186,0.43922651933701656,0.7728719715032538,1.0,12/42,13.32%,MAP4K1;PTGER2;CTNNA1;PTGER4;AHR;GNB1;ADCY7;GNAI1;ADCY5;SPIDR;KLF9;GNG2
prerank,carbohydrate derivative biosynthetic process (GO:1901137),0.39826139449375636,1.0044147931691898,0.47781065088757396,0.7724582250294739,1.0,3/26,4.27%,ST3GAL4;ST8SIA6;B4GALT5
prerank,embryonic organ development (GO:0048568),-0.27859982866543387,-1.0042545428974334,0.41818181818181815,0.7821770203218832,1.0,12/61,14.89%,TGFBR2;SALL1;KITLG;TAL1;FGFR2;RPL10;ATF4;PDGFA;TBC1D23;GLI3;TGFB2;PKDCC
prerank,negative regulation of cell-matrix adhesion (GO:0001953),0.37387461953083734,1.0042522089690404,0.45092460881934565,0.7722998361791354,1.0,10/32,16.87%,CASK;RCC2;DLC1;PTEN;PHLDB2;BCAS3;NF2;THBS1;DUSP22;ARHGAP6
prerank,positive regulation of cellular component movement (GO:0051272),-0.34214431110191745,-1.0041453543181238,0.4550561797752809,0.781307473425929,1.0,6/24,11.95%,CSF1R;TGFBR1;ETS1;CFAP20;CCDC25;VEGFA
prerank,positive regulation of myelination (GO:0031643),0.4746279976063585,1.0039815784986186,0.46519524617996605,0.7724543313193061,1.0,2/11,4.08%,ITGAX;MYRF
prerank,detection of mechanical stimulus (GO:0050982),-0.3518185860854155,-1.0035509308548316,0.4638888888888889,0.7817214784344166,1.0,3/19,7.60%,CTNNB1;PKD2;JUP
prerank,neuron projection development (GO:0031175),0.30607268936480847,1.0032333353247542,0.4653679653679654,0.7736330327772016,1.0,22/168,8.69%,LRRK2;SRGAP2;LYN;CDNF;NGF;PAK1;SHTN1;DOCK10;BTG2;FRY;RAPGEF2;LAMB1;CDC42;GDNF;TAOK3;PPP1R9B;PTEN;FRYL;ATP7A;EPHB2;IL6;MINK1
prerank,phosphate ion homeostasis (GO:0055062),-0.4403108498954932,-1.0018273292840274,0.46539379474940334,0.7851997553993928,1.0,1/10,3.14%,ENPP1
prerank,positive regulation of exocytosis (GO:0045921),0.3703612340538427,1.001246578964314,0.45391061452513964,0.7777507342467733,1.0,8/35,13.91%,RAB3D;UNC13D;RAB7A;TSG101;PDCD6IP;SNF8;STAM;CLASP1
prerank,negative regulation of RNA metabolic process (GO:0051253),0.4303560961328987,1.001170063939217,0.4766355140186916,0.7774188183084937,1.0,6/18,19.18%,PTBP3;KAT2B;TGFB1;PTBP2;SHQ1;RPS13
prerank,AMP metabolic process (GO:0046033),-0.4044093797762164,-1.000601423828081,0.4793187347931874,0.7872355675394536,1.0,6/13,30.73%,ADSS2;AK3;AMPD2;NUDT2;ADSS1;AK4
prerank,keratinocyte differentiation (GO:0030216),0.38614738107992796,1.0003927845072107,0.4726443768996961,0.7786814062386714,1.0,8/29,20.54%,BCR;CLIC4;ANXA1;PIP5K1A;ADAM9;MED1;SCEL;UGCG
prerank,glycerolipid catabolic process (GO:0046503),-0.3588845043769216,-1.0000938570219398,0.45776566757493187,0.7874076310576142,1.0,4/19,7.25%,ABHD12;MGLL;GDE1;PLA2G4A
prerank,negative regulation of osteoblast differentiation (GO:0045668),0.3851973038962634,0.999934414133701,0.48194444444444445,0.7791712237515792,1.0,2/31,1.70%,LIMD1;PPARG
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),0.4654404726273177,0.9996035002214222,0.4828150572831424,0.7794465558630208,1.0,3/12,14.21%,STAT3;IL6;TGFB1
prerank,hepaticobiliary system development (GO:0061008),-0.3636102154548949,-0.9993292627382685,0.4613003095975232,0.7883006249676358,1.0,6/20,13.67%,PKD2;NF1;ARID5B;CEBPG;PHF2;PRKCSH
prerank,platelet degranulation (GO:0002576),0.3174443038030319,0.9989583148466633,0.47995418098510884,0.780441617486008,1.0,18/118,12.50%,CYRIB;PHACTR2;LYN;PECAM1;CD36;TOR4A;VEGFC;F13A1;SRGN;NHLRC2;FLNA;PSAP;HGF;FN1;CYB5R1;ABCC4;APP;TLN1
prerank,regulation of interleukin-1 production (GO:0032652),0.43378394119717584,0.998871698446779,0.441747572815534,0.7801321260476345,1.0,3/15,10.39%,FOXP1;TMED10;ANXA1
prerank,maintenance of blood-brain barrier (GO:0035633),0.38342645758895766,0.9984615592786955,0.46075581395348836,0.780524243400043,1.0,10/30,19.20%,PECAM1;CLDN1;CLDN12;F11R;IL6;MBP;OCLN;TJP3;VCL;ACTB
prerank,regulation of telomere capping (GO:1904353),0.396139300897801,0.9982277104619732,0.4642857142857143,0.7805398546700847,1.0,7/23,16.35%,PKIB;TNKS;MAP3K4;AURKB;USP7;MAPK1;SMG6
prerank,modulation by symbiont of host process (GO:0044003),-0.4343705725203034,-0.9975248835755459,0.48717948717948717,0.7920343294265569,1.0,3/10,7.23%,UBC;PGK1;HGS
prerank,mesenchyme development (GO:0060485),-0.3839207713708704,-0.9970838670540761,0.47368421052631576,0.7920166425917345,1.0,3/15,6.22%,TGFBR1;PKD2;FGFR2
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),0.4046260951049972,0.9969915570572137,0.46131386861313867,0.7828791352795297,1.0,5/23,9.47%,ACSL5;ELOVL5;HSD17B12;ELOVL6;FAR1
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),0.3840439291008502,0.9965007482878143,0.48121387283236994,0.78346960264453,1.0,10/26,15.80%,CD36;SMPDL3B;BIRC3;TLR3;IRF7;CACTIN;TLR2;OTUD4;GPS2;IRAK3
prerank,cardiac myofibril assembly (GO:0055003),-0.38231659508707166,-0.9961851809021687,0.5,0.793206914755562,1.0,8/15,41.44%,NEBL;NRAP;FHOD3;MEF2A;NEB;PDGFRB;OBSL1;MYL2
prerank,COPII-coated vesicle budding (GO:0090114),-0.2588465158496764,-0.9961457743144557,0.46113989637305697,0.7921702508937952,1.0,17/68,16.05%,TGFA;NAPA;PREB;MCFD2;GRIA1;SEC23B;TBC1D20;GOLGA2;LMAN1;CTSZ;SEC23A;GOSR2;SEC13;CNIH1;SEC23IP;F8;TRAPPC4
prerank,intracellular lipid transport (GO:0032365),-0.35086426212461397,-0.9958921026527359,0.4583333333333333,0.7916774013351282,1.0,6/21,8.47%,ABCD2;ACACA;PLEKHA8;ABCD4;ARV1;SLC25A20
prerank,water-soluble vitamin metabolic process (GO:0006767),0.33299839115104896,0.9954502008038367,0.4850455136540962,0.7853775724683649,1.0,16/68,19.18%,HLCS;SLC23A2;SLC23A1;MMAB;ABCC1;TPK1;MTRR;LMBRD1;ACP5;MMAA;PCCB;SLC2A1;SLC52A1;SHMT1;MTHFD1L;CYB5R3
prerank,regulation of store-operated calcium entry (GO:2001256),-0.43507320053088283,-0.9950257115600224,0.475,0.7928586316466607,1.0,1/10,0.17%,CD84
prerank,RNA splicing (GO:0008380),0.32245703267021597,0.9949289796903974,0.4834123222748815,0.7860755677629682,1.0,30/95,20.93%,MBNL1;RSRC1;RNPC3;SNRPD2;PRPF6;PPP1R9B;SNRPB;DBR1;SRSF10;MAGOHB;PRPF3;RP9;SRSF4;DHX8;SLU7;DDX23;SNRPA1;CDK12;SYNCRIP;NCBP1;TXNL4A;SF3B3;SF3B2;SF3B1;PDCD7;SMNDC1;HNRNPC;LUC7L3;PRPF18;NONO
prerank,protein autoprocessing (GO:0016540),0.4267449566266248,0.9948391691684632,0.4755905511811024,0.7857951367844916,1.0,3/17,9.61%,MYRF;FAM111A;PIDD1
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.46802224357362765,0.994345017048771,0.47130434782608693,0.7853632114968878,1.0,4/11,11.96%,SLC25A16;PANK1;PANK4;ACAT1
prerank,coenzyme A biosynthetic process (GO:0015937),0.46802224357362765,0.994345017048771,0.47130434782608693,0.7853632114968878,1.0,4/11,11.96%,SLC25A16;PANK1;PANK4;ACAT1
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.46802224357362765,0.994345017048771,0.47130434782608693,0.7853632114968878,1.0,4/11,11.96%,SLC25A16;PANK1;PANK4;ACAT1
prerank,endocytic recycling (GO:0032456),0.35421060888784633,0.9942805314072988,0.45992115637319314,0.7850075319506601,1.0,9/50,8.94%,LMTK2;EPS15;DENND1A;EHD2;RAB7A;VPS53;DENND1B;STX6;SNF8
prerank,positive regulation of smoothened signaling pathway (GO:0045880),0.40895889311814215,0.9940910316197299,0.47147147147147145,0.7849234347312197,1.0,4/21,14.27%,GLI1;RAB34;TUBD1;TXNDC15
prerank,regulation of translation (GO:0006417),0.3073217193266776,0.993748136271507,0.492972972972973,0.7852363351959719,1.0,43/173,18.37%,NIBAN1;BCL3;RPL5;DAPK1;VIM;RPS6KA3;BTG2;EIF4G3;EIF2AK2;MTPN;GIGYF2;YTHDF3;MRPL13;IL6;ETF1;TRIM71;RPS3;IGF2BP3;FOXO3;EIF4A2;PAIP2;RPS6KA1;APP;EIF4ENIF1;EIF2AK3;METTL3;MTRF1;LARP4B;SYNCRIP;PAIP1;EIF3E;NCBP1;THBS1;RPS4X;RPS6KB1;DAPK3;EIF1;CNOT8;CAPRIN1;EIF3H;DDX6;GSPT1;SHMT1
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.4177416526933758,0.9935393178381241,0.4704968944099379,0.7851941511904916,1.0,4/19,7.83%,BCL3;HIPK2;HIPK1;DDIT4
prerank,regulation of organelle organization (GO:0033043),0.3261777366741701,0.9933542616553923,0.4583333333333333,0.7851272471061695,1.0,26/80,20.81%,MSN;USP6NL;ZEB2;CLIC4;DIAPH1;PARL;CAPN2;PAK2;CLEC16A;PDE2A;F11R;EZR;STX5;FIS1;SCARB2;DNM1L;CAPN6;STMN3;MAPK1;EHD3;TBC1D25;PINK1;AKAP9;PTK2;MUL1;ARMH3
prerank,cochlea morphogenesis (GO:0090103),0.48364937677429665,0.9932530609990398,0.49471830985915494,0.7848566498441982,1.0,2/10,13.67%,MYO3B;TIFAB
prerank,negative regulation of cellular process (GO:0048523),0.2881588200439997,0.9932039996788073,0.5035246727089627,0.7844563417671035,1.0,75/521,13.00%,CBFA2T3;IL1B;IFNLR1;SP100;SRGAP2;RUNX3;LYN;NGF;KLF4;LILRB1;CASK;PTPRU;BCL6;PLSCR1;JAK2;HSPA1A;BTG2;BMPR2;RAPGEF2;FABP7;DYSF;CRLF3;RIPOR2;PTPN6;ABI1;EIF2AK2;MYH9;CHMP4B;CBLL1;DLC1;BTG1;PPP1R9B;SPN;RBBP4;TNS2;GLMN;PTEN;ARHGDIB;CDKN2C;OSGIN2;KLF10;PTK2B;WFS1;ATG5;CIB1;PDCD4;SULT2B1;RARG;TGFBI;LMNA;UBR2;PLXND1;CTCF;EPHB2;IL6;IFI35;OPRM1;SMAD4;RTN4;ARID2;DUSP1;DCUN1D3;S100A11;FCGR2B;REST;APP;NUPR2;UTP20;SH3BP4;PLXNC1;TLR2;SNX3;PPM1D;NF2;EIF2AK3
prerank,negative regulation of defense response to virus (GO:0050687),0.46799930190462596,0.9930694562726831,0.4782608695652174,0.7842854233743308,1.0,4/10,22.54%,ITCH;ILRUN;MUL1;TARBP2
prerank,negative regulation of programmed necrotic cell death (GO:0062099),0.46865043847955334,0.9930236784972257,0.49665551839464883,0.7838682479697983,1.0,5/11,19.49%,BIRC3;PELI1;RIPK1;YBX3;FZD9
prerank,nucleobase-containing compound catabolic process (GO:0034655),0.3724759890743873,0.9929741547370878,0.4792243767313019,0.7834680670646039,1.0,10/37,15.75%,SND1;XRN2;RNASEH2C;RNASE6;DFFB;RNASEH2A;RNASEH1;PNPT1;NCBP1;SIDT2
prerank,positive regulation of cell projection organization (GO:0031346),0.31683484993024397,0.9928269398089229,0.4797687861271676,0.7832696272985826,1.0,30/115,17.10%,TIAM1;LYN;NGF;RAP1A;NGFR;CAMK1D;RET;NDNF;TIAM2;RAPGEF2;NPTN;CARMIL1;SETX;PTK2B;PLXND1;CBFA2T2;RHOA;SCARB2;DVL3;PLXNC1;SNX3;KIDINS220;MAP3K13;STMN2;DVL2;RETREG3;RELN;FES;CAPRIN1;ABL2
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.32645040366462136,0.9928019477288336,0.5024449877750611,0.7828222731566286,1.0,14/80,12.10%,UVRAG;RACGAP1;GOLPH3L;COPG2;KIF23;ARF4;RAB6A;PITPNB;TMED10;GBF1;RINT1;KIF3B;HTT;KDELR1
prerank,cellular response to acid chemical (GO:0071229),-0.3241607889800275,-0.9927534891512699,0.4506578947368421,0.7976174331448593,1.0,12/27,19.38%,RPTOR;CPEB1;LARS1;IPO5;GLRA2;CPEB4;LAMTOR5;VEGFA;RRAGC;CPEB3;NSMF;SESN2
prerank,alanine transport (GO:0032328),-0.43123092470220153,-0.9925660052751635,0.47297297297297297,0.7969267656244359,1.0,2/10,5.89%,SLC36A4;SLC36A1
prerank,regulation of double-strand break repair (GO:2000779),-0.28447209973924903,-0.9925413482452976,0.44360902255639095,0.7958224474723683,1.0,9/39,10.76%,SPIRE1;MGMT;SLF2;SLF1;RNF169;FMN2;ZCWPW1;TERF2IP;SHLD2
prerank,regulation of ATP biosynthetic process (GO:2001169),0.42482037771617315,0.9920489707818766,0.47471451876019577,0.7839725538927649,1.0,1/16,0.25%,PID1
prerank,motile cilium assembly (GO:0044458),0.45491379253553327,0.9918254736151356,0.46987951807228917,0.78401607448266,1.0,2/12,12.32%,SPATA6;CCDC39
prerank,negative regulation of mononuclear cell migration (GO:0071676),0.4582357257978986,0.9917088682258862,0.4726027397260274,0.7837515147620161,1.0,4/12,13.17%,PLCB1;SLAMF8;DUSP1;AKT1
prerank,negative regulation of gene silencing by miRNA (GO:0060965),0.46526009768541354,0.9916964239804679,0.47684391080617494,0.7832822809917819,1.0,1/12,1.70%,PPARG
prerank,membrane lipid metabolic process (GO:0006643),-0.3446432901880924,-0.9914316427196133,0.4658385093167702,0.7976541435319638,1.0,10/22,22.14%,ST3GAL6;CERK;AGMO;ARV1;B4GALT4;SERINC1;AGK;SPHK2;TECR;ST6GALNAC4
prerank,vesicle organization (GO:0016050),0.35571665863237195,0.9913827380407901,0.47761194029850745,0.783515275959782,1.0,6/46,5.49%,PLEKHF1;EPS15;CORO1A;SRGN;CAV2;PI4K2B
prerank,regulation of mitochondrial fusion (GO:0010635),0.46685300208233854,0.991151666316183,0.5156794425087108,0.7835514159045047,1.0,2/11,7.67%,PID1;ZDHHC6
prerank,sodium-independent organic anion transport (GO:0043252),-0.42807552974389423,-0.9907691494343025,0.4701670644391408,0.7982401562622694,1.0,1/10,0.11%,SLCO2B1
prerank,primary alcohol metabolic process (GO:0034308),-0.3280270858916174,-0.9906371710459103,0.45058139534883723,0.7974830925937417,1.0,4/25,8.63%,IGF1;GDE1;PECR;DHRS3
prerank,cellular iron ion homeostasis (GO:0006879),-0.2717725516105704,-0.9904155725801901,0.4386792452830189,0.796918927464046,1.0,13/55,10.86%,FRRS1;SLC11A1;ABCG2;ATP6AP1;FLVCR1;SLC22A17;SLC11A2;TFRC;FTH1;ATP6V0D1;CAND1;FTL;HMOX1
prerank,homotypic cell-cell adhesion (GO:0034109),-0.30263878142721645,-0.9903617202653433,0.47924528301886793,0.7959134002184519,1.0,8/39,9.10%,P2RY12;PPIA;PLPP3;ILK;MEGF11;PIK3CG;ITGB3;TJP2
prerank,regulation of axon extension (GO:0030516),-0.30032696054195485,-0.9901071393827964,0.4910394265232975,0.7954568195679137,1.0,6/37,7.70%,APOE;DIP2B;MAP2;LIMK1;CDKL3;GOLGA4
prerank,cellular glucan metabolic process (GO:0006073),0.46551700116978545,0.9897361325281827,0.46757679180887374,0.7862431669737968,1.0,2/11,9.07%,PRKAG2;UGP2
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.4023221281595377,0.9895490375902789,0.4720121028744327,0.786182526166345,1.0,3/24,6.83%,LRRK2;HSPA1A;WFS1
prerank,protein-containing complex assembly (GO:0065003),0.2949451464638848,0.9892091128806861,0.5284384694932782,0.7864130987417747,1.0,27/259,10.98%,CD74;LRRK2;TIAM1;TRAF1;WIPF1;CD40;TRAPPC5;CLDN1;CUL3;SKAP2;PICALM;AXIN1;CD2AP;AFDN;PTK2B;ELOB;TMED10;STX5;PEX14;CAPZA1;FANCC;TSPAN33;FN1;SNX9;RIPK1;DNAJB12;TRAPPC2L
prerank,base conversion or substitution editing (GO:0016553),-0.4192731323415503,-0.9891627145740204,0.4634146341463415,0.7967338526130705,1.0,4/11,26.72%,ADARB2;ADAR;ADARB1;NUDT16
prerank,myoblast fusion (GO:0007520),-0.40702288379360585,-0.9890823505460273,0.4572127139364303,0.7958305725745514,1.0,4/12,15.76%,CD9;ADGRB3;JAM2;ADAMTS5
prerank,glycine metabolic process (GO:0006544),0.45792359443476127,0.9890564809159905,0.46688741721854304,0.7862682205581314,1.0,5/12,19.33%,DLD;GCSH;AMT;SHMT1;GLYAT
prerank,cytoskeleton organization (GO:0007010),0.31149499652639046,0.9886553867603576,0.48092485549132946,0.786684967192526,1.0,16/114,8.94%,RND3;NEDD9;LIMD1;CNN2;SYNE3;SIPA1L3;PDZD8;RAC2;DIAPH1;FGD4;CAPZB;RHOBTB3;RAC1;FGD1;FGD3;RHOA
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),0.4600366959586788,0.9884659137319499,0.4983277591973244,0.7866348701358233,1.0,2/11,5.03%,LDLR;SCARB1
prerank,heart trabecula morphogenesis (GO:0061384),0.41905750360237815,0.9884303504022659,0.46801872074882994,0.7862072503426933,1.0,3/18,8.15%,ADGRG6;RBPJ;ENG
prerank,smoothened signaling pathway (GO:0007224),0.37389621535748335,0.9880406097191927,0.4604519774011299,0.7866188598275208,1.0,4/32,7.94%,GLI1;HIPK2;HIPK1;PTCHD1
prerank,G2/M transition of mitotic cell cycle (GO:0000086),0.3095291425418664,0.9880100857187526,0.4709236031927024,0.7861892829637324,1.0,26/128,14.85%,SDCCAG8;CNTRL;PPP1R12A;HAUS8;PHLDA1;FBXW11;FBXL8;CDK14;CEP63;PAFAH1B1;PLCB1;HAUS1;PPP2R2A;CCNH;DCTN3;BACH1;LATS1;CEP250;FBXL17;DYNC1H1;PPP1CB;HAUS3;FBXL12;CLASP1;WEE1;BRSK1
prerank,regulation of fibroblast migration (GO:0010762),-0.34167131190667643,-0.9879117076141503,0.45738636363636365,0.7978093339025707,1.0,4/20,3.67%,GNA12;APPL2;FGF2;RFFL
prerank,negative regulation of hippo signaling (GO:0035331),0.46042862555161423,0.9874149120430276,0.5,0.7870498787716582,1.0,5/12,16.80%,LIMD1;MAPK14;MAP2K3;MARK3;AJUBA
prerank,limb morphogenesis (GO:0035108),0.4048023994982032,0.9870416871013505,0.47058823529411764,0.7873919867878598,1.0,2/20,2.57%,MBNL1;NIPBL
prerank,positive regulation of cartilage development (GO:0061036),0.42600369375975333,0.9870410385076284,0.4679186228482003,0.7868977082100705,1.0,3/17,10.82%,BMPR2;SCX;TAPT1
prerank,protein localization to plasma membrane (GO:0072659),0.30980020660475077,0.9870146280240778,0.502844141069397,0.7864590378454477,1.0,33/129,17.90%,RAP1A;TTC7A;PLEKHF1;C2CD5;RAB3D;RAPGEF2;CCDC88A;IKBKB;EHD2;KCNIP3;AFDN;RAB34;FLNA;S100A10;F11R;EZR;ZDHHC23;TSPAN14;TSPAN33;PACS2;PACS1;RAB40B;PIP5K1A;ROCK1;EFR3A;EHD1;ZFYVE27;TSPAN15;TSPAN5;MYADM;TSPAN17;EHD3;ZDHHC3
prerank,regulation of centriole replication (GO:0046599),-0.3653854054392254,-0.9869393777711296,0.4627659574468085,0.7991864924049574,1.0,11/17,33.57%,TRIM37;NPM1;RBM14;CEP76;BRCA1;SPICE1;PLK2;CDK5RAP2;CEP295NL;STIL;PLK4
prerank,translesion synthesis (GO:0019985),0.3617397468214729,0.9863983317018858,0.4903047091412742,0.7873947367814301,1.0,9/42,14.18%,DTL;POLI;MAD2L2;POLD4;TRIM25;RPA3;RCHY1;PCLAF;VCP
prerank,positive regulation of lymphocyte migration (GO:2000403),0.4607690580101027,0.9862748417901015,0.47920133111480867,0.7871672410790587,1.0,4/12,12.09%,CXCL10;SPN;RHOA;APP
prerank,ovarian follicle development (GO:0001541),-0.3915884672578014,-0.9861640443502306,0.47911547911547914,0.8001720464524051,1.0,6/13,29.39%,VEGFA;EIF2B5;EIF2B4;ANG;SOD1;INHBA
prerank,brain morphogenesis (GO:0048854),0.4592676059613325,0.9860129381591969,0.4759535655058043,0.7872618494935124,1.0,4/12,12.04%,FBXW11;PTEN;PAFAH1B1;SLC6A4
prerank,lipid translocation (GO:0034204),0.40324280189476375,0.9856895586029263,0.5117004680187207,0.7874672848244024,1.0,1/21,0.05%,ATP8B4
prerank,cellular response to fluid shear stress (GO:0071498),0.46267667439078153,0.9852853890339468,0.48663101604278075,0.7878811340064092,1.0,6/12,15.00%,KLF4;NFE2L2;MAP2K5;SREBF2;HDAC3;ASS1
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),-0.22085793370642992,-0.9850264533575406,0.4918032786885246,0.8019677118174093,1.0,40/173,16.85%,TGFA;GAS6;NAPA;COPA;PREB;MCFD2;GRIA1;PROS1;GOLT1A;ANK2;SPTAN1;TBC1D20;CAPZA2;ERGIC3;GOLGA2;NRBP2;DYNLL2;SPTB;LMAN1;CTSZ;SEC23A;VTI1B;DYNLL1;HYOU1;GOSR2;DCTN5;ARFGAP1;ARFGAP3;COPE;ZW10;TMED9;TEX261;SEC13;BCAP31;CNIH1;F8;TMED4;TRAPPC4;WHAMM;IER3IP1
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),0.3738541443101516,0.9849068225374056,0.4801699716713881,0.7882409294477909,1.0,12/34,18.92%,ERN1;MAPKAPK2;VEGFC;MAPK14;PGF;ANXA1;PIK3CA;MAP2K3;RELA;NR4A1;FOXC1;SEMA6A
prerank,endodermal cell differentiation (GO:0035987),0.3750138896835509,0.984867494730337,0.46449704142011833,0.7878350675366343,1.0,5/31,10.79%,ITGA4;LAMB1;ITGB2;FN1;SETD2
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",0.42189629776919346,0.9844497752948607,0.4761171032357473,0.7883100839825462,1.0,4/16,12.34%,CDK13;RSRC1;SLU7;PQBP1
prerank,long-term memory (GO:0007616),-0.3611188285680189,-0.9842221875365356,0.45821325648414984,0.8028923513082353,1.0,7/19,16.16%,APOE;EIF2AK4;SGK1;RASGRF1;CAMK4;CPEB3;PJA2
prerank,myelin maintenance (GO:0043217),0.4726281387822212,0.9839415923430848,0.4991243432574431,0.7889802299521947,1.0,4/10,13.06%,PRX;MYRF;PTEN;ABCD1
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),0.29507974097039474,0.9838341229550049,0.5016465422612514,0.7887125185527691,1.0,32/184,13.12%,CDC14A;SDCCAG8;CNTRL;PSME3;CUL3;HAUS8;UBE2E1;PTPN6;PSMB7;PSME2;PPP1R9B;CEP63;MAD2L1BP;PAFAH1B1;HAUS1;PSME4;ZFP36L2;DCTN3;ID2;PSMB8;PSMA5;PSMD9;CEP250;PSMB3;UBE2S;PSMD6;PSMC4;DYNC1H1;PSMD10;PSMB1;ERCC3;HAUS3
prerank,inhibitory synapse assembly (GO:1904862),-0.4133603511330912,-0.9837443137766795,0.4930232558139535,0.8029909591298738,1.0,5/11,17.13%,FGF13;GABRG2;LGI2;GABRB3;GABRA2
prerank,regulation of amyloid fibril formation (GO:1905906),-0.38275932545627867,-0.9836510213795073,0.48267326732673266,0.8020991525974509,1.0,4/15,12.13%,APOE;TREM2;CHRNA7;CLU
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.46845930554609577,0.9836451310629516,0.4875,0.7886443432982864,1.0,6/10,24.12%,HSPA1A;CITED2;BAG3;NCK1;HIF1AN;SIRT2
prerank,striated muscle tissue development (GO:0014706),0.387810429660323,0.9834896223286599,0.5029673590504451,0.788483846155571,1.0,3/29,7.07%,SVIL;BMPR2;SGCD
prerank,response to nutrient levels (GO:0031667),-0.3686732508360482,-0.9831829611204655,0.49859154929577465,0.8021616615476744,1.0,4/17,14.53%,RPTOR;CD68;ATF4;EIF4G1
prerank,lipid homeostasis (GO:0055088),-0.27271705992999945,-0.9830207279967303,0.4721030042918455,0.8014650334008029,1.0,7/57,5.92%,ABCA1;APOE;TREM2;USF2;ABCB4;PNPLA8;NR1D2
prerank,N-acetylneuraminate metabolic process (GO:0006054),0.46063695120039705,0.982544742403669,0.5191956124314442,0.7900750871263191,1.0,2/10,3.16%,ST3GAL1;GNPDA1
prerank,pyrimidine nucleobase metabolic process (GO:0006206),-0.39486143490301207,-0.9823593883924515,0.45652173913043476,0.802100575208049,1.0,4/12,15.61%,DPYD;DPYSL3;UMPS;CRMP1
prerank,protein N-linked glycosylation (GO:0006487),-0.25802321839950004,-0.9818933246616646,0.48095238095238096,0.8021925275839756,1.0,19/66,17.24%,MAN1C1;ST6GAL1;MCFD2;MGAT5;ALG8;RPN1;TUSC3;LMAN1;MPDU1;OSTC;MGAT4C;ENTPD5;ALG2;ALG9;MGAT4A;ALG10B;DPM2;GFPT1;ALG1
prerank,positive regulation of cellular senescence (GO:2000774),0.4692805110834626,0.9815717972732404,0.4991394148020654,0.7918191985200586,1.0,3/10,17.17%,ARG2;B2M;SIRT1
prerank,adherens junction organization (GO:0034332),-0.2746405676767951,-0.9813220605546492,0.4641509433962264,0.8025625203144849,1.0,10/48,12.63%,TJP1;CADM1;CTNNB1;CADM2;CDH11;SMAD7;JUP;PVR;NECTIN4;JAM3
prerank,organelle organization (GO:0006996),0.2874647755787652,0.9812800744423157,0.5391658189216684,0.7919919166537991,1.0,65/388,13.93%,ATP8B4;LRRK2;NEDD9;LIMD1;FAM174B;CNN2;SYNE3;TSGA10IP;LONP1;SIPA1L3;PLEKHF1;PDZD8;EPS15;USP6NL;GOLPH3L;TMCC1;ABCA3;PEX16;CDC42;CHMP4A;CHMP4B;PEX12;DIAPH1;RAB7A;FGD4;CAV2;PI4K2B;STX17;HPS3;CLUH;PITPNB;RAB34;CAPZB;ATXN7;TMED10;ATP7A;YTHDF3;PDCD6IP;GBF1;GABPB1;FGD1;PEX14;FGD3;BCAS3;PIKFYVE;ATL3;ARFGEF1;STX7;LMAN2L;ARHGAP21;CFAP61;STRIP2;TTC17;TRAPPC11;SPTSSB;HTT;TFAM;PACSIN2;DNM1L;EIF2AK3;ABCD1;SIRT4;YME1L1;CLASP1;VMP1
prerank,mitochondrial translation (GO:0032543),-0.24556591986168064,-0.9810563677084182,0.4966887417218543,0.8021118608553036,1.0,50/104,31.53%,GFM2;MRPL24;MRPS9;DAP3;MRRF;LARS2;MRPS21;MRPL1;MRPS5;OXA1L;NDUFA7;MRPL45;MRPS31;MRPS17;GATB;MRPL10;MRPL43;GATC;CHCHD1;MRPS7;MRPL4;MRPL2;MRPL37;MRPS24;MRPS26;MRPS22;MRPS18B;MRPL3;MRPL32;MRPL47;MRPS30;MRPL17;EARS2;MRPL50;MRPS14;MRPL51;MRPL16;MRPL11;QRSL1;MRPS18C;MRPL44;MTIF2;MRPL35;MRPS11;MRPL28;MRPL46;MRPL52;HARS1;MRPS35;MRPS28
prerank,icosanoid metabolic process (GO:0006690),0.36252645590805416,0.9810519831294384,0.48770491803278687,0.7919899641144458,1.0,6/40,6.93%,ALOX5AP;GPX1;PTGIS;MAPKAPK2;DPEP1;ABCC1
prerank,purine ribonucleotide biosynthetic process (GO:0009152),0.35198942752137596,0.9808587382587483,0.5102599179206566,0.791913823608698,1.0,12/48,15.82%,SLC25A16;PANK1;ADCY10;PANK4;PAPSS1;PAPSS2;GUCY1A1;ADCY7;ACAT1;ADCY5;ADSL;GMPS
prerank,negative regulation of cellular amide metabolic process (GO:0034249),-0.24810355511036045,-0.9798221258609285,0.45962732919254656,0.8041263449607057,1.0,22/84,16.07%,BIN1;APOE;IGF1;LARP1;NTRK2;SAMD4A;RTN3;LSM14A;FXR1;GGA3;CHRNA7;CNOT10;PAIP2B;FXR2;RPL13A;CLU;RIDA;TOB1;ABCA7;IGF2BP2;RNF139;CPEB3
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),0.40888897833034643,0.9797266711898761,0.49765258215962443,0.7939267936900584,1.0,6/20,15.99%,IL1B;RPS6KA5;TADA2A;PRKAA1;PRKAA2;BRD7
prerank,negative regulation of lymphocyte migration (GO:2000402),0.46580433362457707,0.9796808765821832,0.5008605851979346,0.7935296878444311,1.0,5/10,22.05%,RIPOR2;AKT1;LRCH1;PADI2;MIA3
prerank,mitotic nuclear membrane disassembly (GO:0007077),0.4505812072578235,0.9796263597354131,0.5188356164383562,0.7931701008469396,1.0,1/12,1.25%,VRK1
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),-0.3800358766986167,-0.9791535842971852,0.5070422535211268,0.8046806130827971,1.0,6/13,18.00%,RENBP;AMDHD2;NAGK;UAP1L1;GFPT1;GNPDA2
prerank,protein oxidation (GO:0018158),-0.4082997713764078,-0.9789581958214248,0.4682926829268293,0.8040659295318475,1.0,4/11,22.36%,LOXL3;TMX3;PRDX3;CHCHD4
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),0.32096541375484555,0.978882245288799,0.4963054187192118,0.7943589271674266,1.0,23/84,18.60%,PSME3;CUL3;UBE2E1;PSMB7;PSME2;PSME4;PSMB8;PSMA5;PSMD9;PSMB3;UBE2S;PSMD6;PSMC4;PSMD10;PSMB1;AURKB;ANAPC7;PSMD12;RB1;ECRG4;ANAPC11;FZR1;ANAPC4
prerank,cellular response to ionizing radiation (GO:0071479),0.3415877260261099,0.9787456377762493,0.47651006711409394,0.7941626015446646,1.0,13/47,17.17%,NIPBL;MAPK14;GRB2;WRN;CLOCK;TLK2;TANK;NET1;SPIDR;MAP3K20;INO80;HUS1;SIRT1
prerank,regulation of vasculature development (GO:1901342),0.3890342688674153,0.9787233252269765,0.4847161572052402,0.7937262960683246,1.0,4/26,8.61%,SP100;ADGRA2;PLXND1;IL6
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),0.3623024160524185,0.9782882218291634,0.49572649572649574,0.7941917326684961,1.0,10/36,14.82%,PTPN22;MARVELD3;ITCH;TAOK3;EZR;CYLD;DUSP1;HDAC3;GPS2;GSTP1
prerank,neutral amino acid transport (GO:0015804),-0.32039831929970997,-0.9771139890597235,0.49014084507042255,0.8078074891025915,1.0,6/28,12.68%,SLC38A6;SLC36A4;SLC6A15;SLC36A1;SLC7A8;SLC3A2
prerank,mRNA modification (GO:0016556),0.3939933413947772,0.9770554974676248,0.48673946957878317,0.7964578831191186,1.0,10/22,21.47%,VIRMA;CBLL1;CMTR1;PUS3;METTL3;TRMT10C;PUS1;TRMT61B;PCIF1;TRUB2
prerank,peptide biosynthetic process (GO:0043043),0.3024280979661037,0.9768019079309167,0.5286975717439294,0.7965337231426278,1.0,52/153,23.83%,ZAR1;RPL5;RPS10;RPL37A;MRPL55;RPL6;MRPL18;RPS18;RPS14;GGTA1;RPL35A;MRPL13;RPL13;RPS3;IGF2BP3;RPS21;FARSB;CARNS1;RPL34;RPLP0;RPL19;RPL11;RPL30;PCSK5;RPS2;RPL4;RPL7;RPS15A;MRPS6;RPS4X;MRPS33;HARS2;GSPT1;RPL32;RPSA;RPS13;MRPS15;RPS6;RPL18A;RPS27;RPLP2;RPL22;RPS7;MRPS12;RPS12;RPL10A;MRPS18A;RPS25;RPL9;RPS16;RPL23;RPL17
prerank,diterpenoid metabolic process (GO:0016101),-0.2728166041219308,-0.9765784349155643,0.4805194805194805,0.8080951823860142,1.0,8/55,15.75%,APOE;LRP1;BCO2;PECR;DHRS3;GPC6;AGRN;AKR1B1
prerank,regulation of macromolecule metabolic process (GO:0060255),0.29883648759269194,0.9760056100314664,0.5224043715846994,0.7977984003192848,1.0,26/170,12.31%,PTPRC;FOXP1;KDM6A;LDLR;TRIM26;GDNF;NFKBIZ;MTMR3;AHR;CRIP1;CGGBP1;ARF1;MTMR4;TOB2;CTCF;NKAPL;AFF1;IGF2BP3;TRIM14;NFKBID;CACTIN;SCARB2;ZNF507;REST;APP;TRIM17
prerank,ceramide catabolic process (GO:0046514),-0.3749616482447078,-0.9759686383094716,0.5037406483790524,0.8085331717082114,1.0,2/14,6.07%,HEXB;NEU1
prerank,negative regulation of translation (GO:0017148),0.3214928727685693,0.9758785120037725,0.5029797377830751,0.7975767305416508,1.0,25/87,18.37%,DAPK1;MEX3D;BTG2;EIF4EBP1;EIF2AK2;GIGYF2;YTHDF3;MRPL13;TRIM71;RPS3;IGF2BP3;PAIP2;EIF4ENIF1;EIF2AK3;METTL3;ROCK1;SYNCRIP;EIF3E;CELF1;PUM1;DAPK3;CNOT8;CAPRIN1;DDX6;SHMT1
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",-0.3116770262260965,-0.9756897019955133,0.4966887417218543,0.8081372994900503,1.0,13/29,31.37%,GTF2H2;GTF2H1;UBC;ERCC2;GTF2H3;CDK7;GTF2H5;UBA52;XPC;GTF2H4;DDB1;CHD1L;MNAT1
prerank,mitochondrial translational elongation (GO:0070125),-0.24823801965958364,-0.9751967239462745,0.5255102040816326,0.8082810431789524,1.0,51/88,37.78%,GFM2;MRPL24;MRPS9;DAP3;MRPS21;MRPL1;MRPS5;OXA1L;MRPL45;MRPS31;MRPS17;MRPL10;MRPL43;CHCHD1;MRPS7;MRPL4;MRPL2;MRPL37;MRPS24;MRPS26;MRPS22;MRPS18B;MRPL3;MRPL32;MRPL47;MRPS30;MRPL17;MRPL50;MRPS14;MRPL51;MRPL16;MRPL11;MRPS18C;MRPL44;MRPL35;MRPS11;MRPL28;MRPL46;MRPL52;MRPS35;MRPS28;MRPL23;MRPL9;MRPS16;MRPL54;MRPL49;MRPL42;MRPS23;MRPS2;MRPL14;MRPL36
prerank,sarcomere organization (GO:0045214),-0.31896469732530264,-0.9750895228094948,0.4956268221574344,0.80745471127905,1.0,15/27,56.61%,CAPN3;ACTN2;FHOD3;CSRP2;TNNT3;MYPN;TTN;CSRP1;TNNT2;MYH6;SIX4;MYOM2;SYNPO2L;MYOZ2;TNNT1
prerank,protein palmitoylation (GO:0018345),0.376188479681804,0.9750678540290388,0.49853372434017595,0.7989588708248069,1.0,7/30,12.69%,HHAT;ZDHHC7;ZDHHC13;ZDHHC6;ZDHHC23;ZDHHC17;CLIP3
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.42931774889560603,0.9748232610736735,0.49498327759197325,0.7990023169987149,1.0,4/16,11.10%,CHMP4A;CHMP4B;SNF8;STAM
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),-0.34080486437362684,-0.974809500721167,0.463855421686747,0.8070800430042742,1.0,5/21,14.94%,CX3CR1;CTNNB1;VEGFA;MDK;CX3CL1
prerank,multivesicular body organization (GO:0036257),0.37451592960603985,0.9747376287065288,0.4964131994261119,0.7987079905905794,1.0,7/31,11.10%,VPS37C;CHMP4A;CHMP4B;TSG101;PDCD6IP;SNF8;STAM
prerank,positive regulation of Rho protein signal transduction (GO:0035025),0.3758428169106214,0.974657349625322,0.48691860465116277,0.7983901374837611,1.0,7/30,17.34%,GPR35;F11R;RAC1;NET1;ARHGEF3;LPAR6;GPR65
prerank,positive regulation of chromatin organization (GO:1905269),0.44152434798123125,0.9741753575805709,0.5083892617449665,0.7989743958948682,1.0,5/12,15.43%,H3-3A;UBE2N;DAXX;ATRX;MIER1
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),-0.2930059456090752,-0.9741607335518373,0.4714828897338403,0.8075886668756483,1.0,5/37,5.04%,IGF1;PRKG1;MEF2C;FGF2;FOXJ2
prerank,positive regulation of cell junction assembly (GO:1901890),-0.2670647627829503,-0.9740713911932152,0.5064935064935064,0.8067389355920686,1.0,22/56,28.43%,PTPRD;NRP1;IL1RAPL1;NLGN1;GRID2;PPM1F;IL1RAP;FLOT1;VEGFA;NLGN2;CLSTN2;CNTNAP2;NLGN3;NRXN1;DLG5;CUX2;KDR;TSC1;NPHP4;NPHP1;ABL1;CAV1
prerank,anion transport (GO:0006820),0.37001981155716923,0.9740508641156329,0.49230769230769234,0.7987723981024076,1.0,4/33,5.66%,LRRC8C;LRRC8D;LRRC8B;SLCO1B1
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",0.3812165930421994,0.9732794599459764,0.4985507246376812,0.7999793449819363,1.0,11/29,23.69%,DHX37;RPS14;UTP6;RPS21;UTP20;RRP36;TBL3;NOP9;HEATR1;DCAF13;RPS16
prerank,regulation of nitric-oxide synthase activity (GO:0050999),0.3603704561989982,0.9731233627002072,0.48667601683029454,0.7998411370215576,1.0,3/36,5.03%,IL1B;NOSTRIN;SCARB1
prerank,cellular response to catecholamine stimulus (GO:0071870),0.39366226091826234,0.9726110017877245,0.5052631578947369,0.8004352833131554,1.0,3/23,8.38%,LRRK2;KCNQ1;GNB1
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.32268085298216426,0.9726068917791117,0.5030599755201959,0.7999570347712617,1.0,20/74,17.32%,IL1B;MCL1;PSME3;HSPA1A;GPX1;BIRC6;GDNF;ICAM1;RIPK1;HTT;MAP2K5;SH3RF1;LGALS3;AKT1;GSTP1;UNC5B;RELA;THBS1;EYA3;TRAF2
prerank,central nervous system projection neuron axonogenesis (GO:0021952),0.4447690159914052,0.9724116849229104,0.49261083743842365,0.7998825257469334,1.0,3/12,8.43%,MYCBP2;PAFAH1B1;EPHB2
prerank,female gonad development (GO:0008585),-0.34386346811377866,-0.9719165713457901,0.5068119891008175,0.8111221109837224,1.0,6/19,21.90%,VEGFA;EIF2B5;EIF2B4;NR2F2;ANG;SOD1
prerank,long-chain fatty acid import into cell (GO:0044539),0.46032901571264,0.971687187407856,0.5017482517482518,0.8010594939609628,1.0,5/10,22.20%,CD36;SLC2A1;RPS6KB1;ACSL1;SLC27A4
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),0.4309525431838621,0.9715621912429694,0.5040783034257749,0.8008321093564713,1.0,6/13,27.73%,SORL1;TMEM30A;CD81;EDEM2;SAR1B;SEC16A
prerank,regulation of nuclear division (GO:0051783),0.40770673052888357,0.9715149330819749,0.49242424242424243,0.8004290615796826,1.0,2/20,5.44%,CDK13;CAV2
prerank,Golgi ribbon formation (GO:0090161),0.4401221257597019,0.9713392907592101,0.4940577249575552,0.8003264587395356,1.0,4/13,13.81%,STX6;GCC2;FHDC1;STX16
prerank,positive regulation of amyloid-beta formation (GO:1902004),0.41035715031776987,0.9711378235406702,0.49923195084485406,0.8002957312109027,1.0,6/18,17.64%,IFNGR1;PICALM;GSAP;ABCG1;RELA;EFNA1
prerank,negative regulation of catalytic activity (GO:0043086),0.38461524341149533,0.9711264243260462,0.5,0.7998323742095843,1.0,6/24,17.17%,PPP1R12A;APBA3;HP;PARP9;IFIT1;SIRT1
prerank,cellular response to topologically incorrect protein (GO:0035967),0.37020083190714526,0.9710415811782166,0.508100147275405,0.7995250536627336,1.0,13/31,20.02%,HSPA1A;ERN1;TM7SF3;ATXN3;UBE2W;DAXX;PTPN1;DNAJB12;HSPA9;BAG3;HSPA5;DNAJB14;RHBDD1
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.3635962070085351,0.9709206816807346,0.4908579465541491,0.7992824434336074,1.0,9/34,17.09%,FGR;FLT3;PTK2B;PIK3R4;KIT;TGFB1;FGFR3;AMBRA1;PIK3R2
prerank,positive regulation of triglyceride metabolic process (GO:0090208),0.418293277748372,0.9708429464326602,0.4944,0.7989697673237197,1.0,2/16,5.03%,LDLR;SCARB1
prerank,ear morphogenesis (GO:0042471),-0.3372011084800547,-0.9707997751667596,0.511049723756906,0.8128421473523764,1.0,3/20,6.22%,CHD7;MYO6;FGFR2
prerank,histone deacetylation (GO:0016575),0.3500282369858264,0.970683545194492,0.5366847826086957,0.7988211455246097,1.0,15/43,20.00%,TBL1XR1;MTA3;HDAC9;RCOR3;MORF4L1;REST;BAZ2A;MSL3;HDAC3;MIER1;ELK4;SIRT1;HDAC1;MIDEAS;RCOR1
prerank,T cell proliferation (GO:0042098),0.4371076022917039,0.9705445257352379,0.5160202360876898,0.7986175744056567,1.0,3/13,9.26%,LILRB1;MSN;CTPS1
prerank,UV-damage excision repair (GO:0070914),-0.40081846485400047,-0.9704949682388172,0.5228426395939086,0.8124903143617596,1.0,6/12,28.18%,POLD3;ACTR5;POLA1;XPC;ERCC1;DDB1
prerank,positive regulation of protein localization to cell periphery (GO:1904377),0.3441037589046044,0.970299529848817,0.528476821192053,0.7986406928452008,1.0,14/52,16.33%,PRKCE;PRKCH;KIF5B;PDPK1;CIB1;EPHB2;GNAI1;CLIP3;LGALS3;AKT1;ITGA3;RHOG;GPSM2;PLS1
prerank,steroid hormone biosynthetic process (GO:0120178),0.37175730643379185,0.9699530360087116,0.5211678832116788,0.7989167111780519,1.0,5/29,17.80%,HSD17B14;HSD17B7;HSD17B11;MED1;HSD17B2
prerank,inner dynein arm assembly (GO:0036159),0.46551375377970483,0.9699508174998162,0.5171821305841925,0.7984346758625336,1.0,3/10,19.26%,DNAAF5;CCDC39;CFAP73
prerank,histone H2A monoubiquitination (GO:0035518),-0.36087102855846187,-0.9698546801854484,0.45231607629427795,0.8129936074198001,1.0,4/17,8.10%,BCOR;TRIM37;PCGF6;KDM2B
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),-0.3745989522023775,-0.969738960341853,0.4883720930232558,0.8122304949216781,1.0,3/14,3.41%,AUTS2;CTNNB1;CTR9
prerank,positive regulation of endothelial cell proliferation (GO:0001938),0.32252499433943216,0.9697286059348234,0.5176184690157959,0.7984264367856264,1.0,7/75,6.64%,ITGA4;AKT3;STAT5A;BMPR2;VEGFC;ADAM17;PDPK1
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",0.4495446386817399,0.9696056577739476,0.4965986394557823,0.7982351991125202,1.0,2/10,2.92%,STAP1;CD300A
prerank,nucleus organization (GO:0006997),-0.28145815995863477,-0.9691131191123787,0.483739837398374,0.812739652760671,1.0,9/47,6.90%,BIN1;NUMA1;IRAG2;VPS4B;NUP54;CHMP5;NUP133;SUN1;NUP155
prerank,negative regulation of macromolecule metabolic process (GO:0010605),0.29591719964450147,0.9687359564754034,0.5505376344086022,0.7996389635999471,1.0,51/182,20.23%,FOXP1;NOTCH2;PTPN22;RIN3;KLF4;LDLR;CCR1;NFKB1;REL;SPI1;PICALM;FBXW7;TIPARP;PARP14;SETDB2;MECP2;ENG;CPNE1;ID2;WWP2;OLFM1;PARP9;PRKAA1;REST;APP;TNRC6B;PRKAA2;CITED2;TNRC6A;TGFB1;OCLN;TAF1;ZNF148;CELF1;SNX12;RBL2;MYADM;RB1;MTMR2;PSEN1;SIRT1;MMP8;HDAC1;PINK1;MAP2K1;ANKRD13A;DNMT1;TERF2;NDFIP2;PARK7;RUNX1
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),0.3836454081389962,0.9685065332115299,0.48439821693907875,0.7996722371344697,1.0,10/27,18.55%,ZC3H12D;ERN1;NHP2;RNASE1;KHNYN;RNASE6;RNASEH1;CPSF3;NYNRIN;CSTF3
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.3185015328182378,0.9684423565792533,0.5054811205846529,0.799317811667972,1.0,18/78,16.73%,CCNJL;CCND3;HEXIM1;PTEN;CDKN2C;CCND1;ADAM17;CCNH;LATS1;CCNT2;LATS2;CCNT1;PSMD10;CCND2;AKT1;CDK5R2;APC;PROX1
prerank,pulmonary valve development (GO:0003177),0.4157259653428206,0.9683224677921057,0.5122324159021406,0.799098178724201,1.0,2/18,2.93%,NOTCH2;BMPR2
prerank,lymphocyte chemotaxis (GO:0048247),-0.30361239276853874,-0.9680527336478457,0.5159235668789809,0.8143564776179012,1.0,9/34,17.37%,GAS6;ADAM8;PIK3CG;CH25H;CCL13;GPR183;CX3CL1;CCL14;CCL3
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),-0.3172279866977139,-0.9679408287809464,0.4957983193277311,0.8135026698229518,1.0,6/26,13.66%,NAV3;NUMA1;CLIP1;CDK5R1;MAPRE1;TRPV4
prerank,regulation of cell-matrix adhesion (GO:0001952),0.32924479320860034,0.9679269652700805,0.5267080745341615,0.7994851875344398,1.0,18/64,20.18%,SLK;CASK;UTRN;CD36;PTK2B;PLEKHA2;CIB1;MINK1;RHOA;NF2;ROCK1;CLASP1;THBS1;DAPK3;PTPRA;VCL;NEXMIF;PTK2
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.30695523661818874,0.9678952390012661,0.5144175317185697,0.7990653208569578,1.0,29/128,18.12%,RUNX2;ARHGEF18;FOS;BMPR2;CBL;SCX;GDF1;HIVEP1;PDCD4;ZFYVE9;F11R;ENG;PXN;ACVR2A;RHOA;USP15;NRROS;SMAD4;NLK;MAP3K7;TGFB1;ADAM9;USP9X;ZMIZ2;DUSP22;SMAD5;SIRT1;SMURF2;APPL1
prerank,in utero embryonic development (GO:0001701),-0.3266734268057725,-0.9678113372128868,0.5173501577287066,0.8127430036494767,1.0,6/25,12.58%,CHD7;TGFBR1;FLCN;FGFR2;VEGFA;HINFP
prerank,multivesicular body assembly (GO:0036258),0.3749955191614621,0.967652980223013,0.5158959537572254,0.7991090649821675,1.0,7/30,11.10%,VPS37C;CHMP4A;CHMP4B;TSG101;PDCD6IP;SNF8;STAM
prerank,proteasomal protein catabolic process (GO:0010498),0.2918494044264878,0.9676001375214003,0.5554371002132196,0.7987476356039682,1.0,47/201,16.55%,FEM1C;ITCH;PSME3;NEDD4L;CUL3;TBL1XR1;PSMB7;FBXW7;PSME2;KCTD2;PELI1;UBE2D3;SPOP;FBXW11;FAF1;NFE2L2;CLOCK;COP1;PCNP;PSME4;ATXN3;WWP2;TRIM71;UBE2W;PSMB8;KCTD5;PSMA5;PSMD9;DNAJB12;PSMB3;FBXL17;PSMD6;PSMC4;PSMD10;UBE2G1;AREL1;PSMB1;VCP;PPP2R5C;KCTD13;UBXN11;RMND5B;RNF122;RNF41;HACE1;PSMD12;MAEA
prerank,positive regulation of fatty acid metabolic process (GO:0045923),0.42181310945194084,0.9673713854641298,0.4984076433121019,0.7987578791878731,1.0,2/15,5.11%,PPARG;ELOVL5
prerank,glycogen catabolic process (GO:0005980),-0.3689887060232629,-0.9670608501177279,0.47745358090185674,0.8135416158224986,1.0,7/15,22.68%,PYGB;GAA;CALM1;PHKA1;PGM2;AGL;PHKG2
prerank,global genome nucleotide-excision repair (GO:0070911),-0.32444549185732474,-0.9667227426533702,0.5454545454545454,0.8133019899754905,1.0,11/26,28.18%,GTF2H2;GTF2H1;UBC;ERCC2;GTF2H3;GTF2H5;UBA52;XPC;ERCC1;GTF2H4;DDB1
prerank,protein acylation (GO:0043543),0.35412731362139044,0.9665876736954457,0.49657064471879286,0.8000012163851202,1.0,8/38,9.05%,HHAT;ZDHHC7;ZDHHC13;ZDHHC6;CLOCK;ZDHHC23;ZDHHC17;KAT6A
prerank,positive regulation of muscle cell differentiation (GO:0051149),-0.32825262747600087,-0.9665311215878937,0.5041095890410959,0.8126657915189718,1.0,4/24,3.17%,MEF2C;CAMK1;CTNNA2;CTNNB1
prerank,protein K48-linked deubiquitination (GO:0071108),-0.33266546569603,-0.9663367881774915,0.5072886297376094,0.8120544818646248,1.0,9/23,20.01%,MINDY2;OTUD5;USP20;OTUD7A;MINDY1;OTUD7B;OTUB1;OTUD3;USP5
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),0.4493602124280968,0.9662900500747672,0.5121527777777778,0.8001552871026746,1.0,5/12,19.84%,HEXIM1;RECQL5;NELFA;RNF168;LARP7
prerank,mammary gland epithelium development (GO:0061180),-0.38289303347996384,-0.9662535887796817,0.5037037037037037,0.8111711882481446,1.0,2/14,0.93%,CSF1R;ERBB4
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),-0.30409611628730504,-0.9658047738763186,0.47440273037542663,0.8112772740152435,1.0,10/30,19.92%,BCL2L1;CFLAR;RFFL;FAIM2;HMOX1;SERPINE1;TRADD;BRCA1;DDX3X;TNFSF10
prerank,cellular response to glucose stimulus (GO:0071333),-0.30226133719444315,-0.9654673144706686,0.494949494949495,0.8110803109908229,1.0,6/30,7.43%,PTPRN2;RAB11FIP2;GAS6;RAB11FIP5;PRKACA;PCK2
prerank,resolution of meiotic recombination intermediates (GO:0000712),-0.3659366501406715,-0.9653753656026492,0.5092348284960422,0.8102018753525237,1.0,9/16,38.85%,RMI1;FANCM;SLX4;HFM1;CENPX;TOP2B;MUS81;MSH4;EME1
prerank,cell-cell junction assembly (GO:0007043),-0.26016798463165813,-0.9652144026718,0.48130841121495327,0.8095302533255913,1.0,20/63,21.50%,TJP1;PKP4;FLCN;CD9;CTNNB1;CDH11;SMAD7;PATJ;JUP;EPB41L3;GJA1;JAM3;TLN2;TRPV4;PKP2;RHOC;ARVCF;CDH22;CLDN11;CNTNAP1
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),0.4446863849282625,0.9651907424541436,0.49575551782682514,0.802111629701422,1.0,3/12,8.81%,CHMP4A;CHMP4B;SEC63
prerank,regulation of histone acetylation (GO:0035065),0.3666011941444465,0.9650956671020026,0.5093525179856115,0.8018333764170061,1.0,8/33,15.99%,IL1B;SPI1;RPS6KA5;SETD5;TADA2A;TAF7;KMT2A;BRD7
prerank,negative regulation of protein localization to nucleus (GO:1900181),-0.3501081239931677,-0.9644182145790935,0.49877750611246946,0.810561546034122,1.0,7/18,13.59%,FLCN;APOD;SUFU;OTUD7B;MFHAS1;CHP1;UFM1
prerank,skeletal muscle contraction (GO:0003009),0.3960024213032933,0.9640275060822746,0.521875,0.8036156671860399,1.0,1/19,1.85%,TNNC1
prerank,inorganic anion transport (GO:0015698),-0.2701798817988509,-0.9635396885212455,0.4909090909090909,0.8117521372083486,1.0,19/53,30.05%,SLC11A1;TTYH3;CLCN6;ENPP1;ANO10;CLCN4;SLC26A11;SLC25A11;SLC25A14;ANO8;CLCN2;SLC26A8;SLC4A10;SLC26A6;SLC25A10;CLCN1;CLIC5;FXYD1;ENPP3
prerank,metal ion transport (GO:0030001),0.31915533932283463,0.9633973215569559,0.5500618046971569,0.8044974082326579,1.0,12/86,10.58%,ITPR1;FYN;CCR1;CACNA1A;CHRNA4;ATP2A3;MMGT1;ATP2A1;KCNN4;SLC30A1;MAGT1;NIPA2
prerank,dicarboxylic acid catabolic process (GO:0043649),-0.3872008020181748,-0.9631559853171475,0.5049261083743842,0.8116772312560564,1.0,6/13,29.86%,GLUL;GOT1;MTHFS;GAD1;ACOT8;DDO
prerank,regulation of cellular component biogenesis (GO:0044087),0.34630330331665715,0.9631117752733319,0.5094339622641509,0.8045861015743604,1.0,6/39,9.15%,RAP1A;MSN;CD36;RAPGEF2;EZR;LATS1
prerank,hematopoietic stem cell proliferation (GO:0071425),0.44355201961714263,0.9630048212161968,0.5086505190311419,0.8043249646523343,1.0,2/11,8.23%,ETV6;ARIH2
prerank,modification-dependent protein catabolic process (GO:0019941),0.2927084566263411,0.9629990152142854,0.5612353567625133,0.8038508484830992,1.0,49/193,18.80%,FEM1C;DTL;ITCH;LONP1;RNF149;DTX3L;NEDD4L;CUL3;BIRC6;UBE2E1;CBL;ANKIB1;RNF146;ARIH1;RNF213;RNF20;RC3H1;KLHL15;RNF217;NEDD8;TRIM25;ARIH2;RNF130;ATXN3;COPS3;RNF13;PSMD9;UBE2S;KLHL8;RCHY1;UBE2G1;AREL1;RNF150;AURKB;FBXO7;ANAPC7;RNF166;TAF1;HACE1;UBR3;UBA6;RNF144A;RNF19B;SMURF2;ANAPC11;FZR1;FBXL14;ANAPC4;PINK1
prerank,mRNA stabilization (GO:0048255),0.3573492221462522,0.9626810192253029,0.5142857142857142,0.8040430686000478,1.0,12/40,17.82%,TENT5A;MAPKAPK2;GDNF;MAPK14;TIRAP;EIF4ENIF1;SYNCRIP;PAIP1;MYD88;PABPC1;BOLL;YBX3
prerank,response to organonitrogen compound (GO:0010243),0.35691326647223676,0.9624899882223971,0.5234806629834254,0.8039623468374602,1.0,8/38,16.50%,HLCS;KYNU;KAT7;IL6;DNAJB12;VCP;IRAK3;IRF5
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.40003437412088555,0.9624880218631948,0.5052631578947369,0.8034857224842755,1.0,7/20,16.73%,CCND3;CCND1;ADAM17;PSMD10;CCND2;AKT1;PROX1
prerank,coenzyme A metabolic process (GO:0015936),0.4334268162598397,0.9623870462915951,0.4957841483979764,0.8032194708821562,1.0,4/14,11.96%,SLC25A16;PANK1;PANK4;ACAT1
prerank,regulation of membrane repolarization (GO:0060306),0.4374042510020145,0.9621101162413666,0.49391304347826087,0.8033300018207812,1.0,2/13,3.31%,NEDD4L;KCNQ1
prerank,skeletal system morphogenesis (GO:0048705),-0.28503538695063185,-0.9620723238994497,0.5196850393700787,0.813298195165432,1.0,3/42,1.22%,SKI;LRP6;TGFBR1
prerank,positive regulation of signaling (GO:0023056),-0.2894173199000696,-0.9617965930243407,0.5351170568561873,0.8128744101055171,1.0,12/37,20.71%,SYT1;WLS;DLG4;ILK;SCRIB;CLSTN2;CD80;SOX11;RIMS1;VAMP3;RIMS3;ECE1
prerank,positive regulation of peptidase activity (GO:0010952),0.40551102200901135,0.9614516017185442,0.502495840266223,0.8043006290501523,1.0,6/20,14.18%,PSME3;PSME2;MAPK12;TANK;PRELID1;VCP
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),-0.3663696106639305,-0.9613026485452242,0.5102564102564102,0.8130400993050101,1.0,3/16,7.38%,APOE;HIF1A;HTR2B
prerank,regulation of interferon-alpha production (GO:0032647),0.38693730251466624,0.9612872639668477,0.5114155251141552,0.80417596775617,1.0,10/23,21.92%,STAT1;IFIH1;TLR3;IRF7;SETD2;TBK1;IRF5;HSPD1;RIPK2;TLR8
prerank,post-transcriptional gene silencing by RNA (GO:0035194),0.40122980864218727,0.961024762307001,0.5,0.804255998655379,1.0,7/20,16.94%,LIMD1;CNOT6;TNRC6B;TNRC6A;CELF1;AJUBA;CNOT8
prerank,liver development (GO:0001889),-0.3139129271167349,-0.9607640210252948,0.5381818181818182,0.8132912037488714,1.0,7/32,13.67%,PKD2;NF1;PCK2;ARID5B;CEBPG;PHF2;PRKCSH
prerank,regulation of Golgi organization (GO:1903358),0.4094975330508784,0.9604807740389844,0.5074875207986689,0.8049337464485029,1.0,7/17,20.81%,USP6NL;STX5;MAPK1;EHD3;MAP2K1;AKAP9;ARMH3
prerank,histone H3-K4 methylation (GO:0051568),0.3840228766083363,0.9596061896997778,0.533724340175953,0.8063619586915469,1.0,9/26,21.35%,KDM6A;TET2;KMT2C;KMT2A;ASH2L;SETMAR;WDR5;PRDM9;RBBP5
prerank,glucose import (GO:0046323),-0.38755039172003725,-0.959065487124026,0.5127020785219399,0.8165345406127766,1.0,3/13,7.18%,SORT1;SLC2A3;SLC27A1
prerank,regulation of cellular protein localization (GO:1903827),0.34363592762041445,0.9589468864594917,0.5161725067385444,0.8073249135219662,1.0,13/45,15.27%,LCP1;GPC3;TRIM46;GBF1;RALB;PTPN1;SETD2;PRKAA1;DVL3;SPIDR;PRKAA2;VCP;VCPIP1
prerank,bile acid biosynthetic process (GO:0006699),-0.3307023016972668,-0.9582374244397912,0.5105740181268882,0.8175844552511556,1.0,11/24,34.28%,OSBPL1A;CH25H;OSBPL6;AMACR;OSBPL7;ACOT8;OSBP;SLC27A2;OSBPL2;HSD17B10;CYP7B1
prerank,muscle contraction (GO:0006936),0.2968792775262105,0.9576867750875379,0.5584562996594779,0.8095988428781907,1.0,8/126,3.90%,LTB4R;TNNC1;UTRN;TPM4;VIM;DYSF;MYL4;HCN4
prerank,phosphatidylcholine biosynthetic process (GO:0006656),0.3679897910974575,0.9574898183070515,0.5110132158590308,0.8095455736846665,1.0,7/32,12.61%,SLC44A2;CEPT1;PCYT1A;CSNK2A2;CSNK2A1;SLC44A1;SLC44A5
prerank,negative regulation of axon extension (GO:0030517),-0.2996511354649435,-0.9567782603256372,0.5017182130584192,0.8201120656999931,1.0,6/30,8.32%,DIP2B;MAP2;CDKL3;SEMA3D;SEMA3E;SEMA6D
prerank,response to glucocorticoid (GO:0051384),0.37296673123594565,0.9565902078247792,0.49777117384843983,0.8109753388327836,1.0,6/26,14.67%,ZFP36L2;IL6;ANXA1;NR3C1;REST;ADAM9
prerank,acylglycerol biosynthetic process (GO:0046463),-0.3284944003216786,-0.9562387281582809,0.5047923322683706,0.8204112289377566,1.0,9/23,26.77%,PLA2G15;AGMO;PLA2G4A;GPAM;GPAT4;LPGAT1;ANG;DGAT1;AWAT2
prerank,antibacterial humoral response (GO:0019731),0.4150477231108638,0.9559850809363759,0.522508038585209,0.8117485119422017,1.0,3/16,13.79%,SLPI;RNASE6;PLA2G6
prerank,negative regulation of neuron projection development (GO:0010977),0.3316831086892973,0.9558192802212075,0.515748031496063,0.8116579608911448,1.0,16/56,18.50%,BCL11A;NGFR;PTPRO;PTEN;CIB1;PAQR3;CBFA2T2;RHOA;RTN4;LRP4;RAB29;STMN2;DENND5A;KANK1;EFNA1;SEMA3A
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),0.3832589370103404,0.9552120056683286,0.5151057401812689,0.8124700254152045,1.0,4/24,9.14%,NDNF;PDPK1;NFE2L2;ICAM1
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),-0.2826077017873145,-0.9546271490974431,0.4883720930232558,0.823320251757032,1.0,8/40,14.26%,PRKN;IGF1;BCL2L1;FAM162A;PYCARD;MFF;CLU;BAX
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),-0.3989089973572272,-0.9544517283820759,0.5345622119815668,0.822645518759331,1.0,6/11,23.67%,SMARCAL1;BLM;LIG3;FBH1;FBXO5;TIMELESS
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),0.39339838817679224,0.9541443721613425,0.5221374045801527,0.8142995372135557,1.0,4/21,7.38%,DTL;RCC2;CCND1;MECP2
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.32802639867725886,0.9539023773690118,0.5255570117955439,0.8143523585862055,1.0,12/57,15.05%,HTR1D;HTR4;ADRA2A;FLNA;PDE2A;PSAP;OPRM1;ADCY7;GNAI1;ADCY5;GNAI2;GRM8
prerank,signal peptide processing (GO:0006465),-0.4078651022845503,-0.953388999558042,0.5168269230769231,0.8243038719733566,1.0,4/11,7.28%,SPCS3;FURIN;SPPL3;SEC11C
prerank,ribosomal large subunit assembly (GO:0000027),0.38331917170139995,0.9533834556429621,0.5163690476190477,0.8149559302995893,1.0,5/24,12.90%,RPL5;RPL6;RPF2;RPLP0;RPL11
prerank,positive regulation of protein deacetylation (GO:0090312),0.42770274139071673,0.9531560949586471,0.5238879736408567,0.8149569681701563,1.0,3/14,11.12%,NIPBL;DYRK1A;ING2
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),-0.377155303094163,-0.953096794873403,0.5311720698254364,0.8239787243684833,1.0,6/13,28.72%,SYNGR1;RAB3GAP1;RAB3A;CLN3;SLC4A10;SLC8A2
prerank,negative regulation of protein-containing complex assembly (GO:0031333),-0.26925040278150625,-0.9530960529604239,0.5572519083969466,0.822904107304489,1.0,16/49,19.60%,LDLRAD4;TREM2;HMGB1;NLRC3;IMPACT;PYDC1;TRAF3IP1;RPL13A;CLU;JAM3;PRKCZ;SRC;HDAC6;DDX3X;CRYAB;LCMT1
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),-0.3006550844985031,-0.9528586899977097,0.5065359477124183,0.8224108571321274,1.0,7/33,10.54%,IGF1;NYAP2;NF1;HTR2B;PIK3CG;IRS1;PIK3R1
prerank,positive regulation of telomere capping (GO:1904355),0.4074453613745472,0.9523590516330027,0.5213946117274167,0.8161715410773772,1.0,5/17,15.12%,PKIB;TNKS;MAP3K4;AURKB;MAPK1
prerank,positive regulation of neuron projection development (GO:0010976),0.3140231213842412,0.9521080988183074,0.5497572815533981,0.8162148778157229,1.0,20/85,17.10%,LYN;RAP1A;CAMK1D;RET;NDNF;RAPGEF2;NPTN;SETX;PTK2B;CBFA2T2;SCARB2;SNX3;KIDINS220;STMN2;LRP8;RETREG3;RELN;FES;CAPRIN1;ABL2
prerank,neuromuscular synaptic transmission (GO:0007274),-0.3421478969134925,-0.952079134175394,0.4986225895316804,0.8232833976419405,1.0,8/18,31.95%,KIF1B;FCHSD2;SLC5A7;ERC1;DTNA;TSPOAP1;STAC3;CHAT
prerank,regulation of phospholipase activity (GO:0010517),0.45485697261380087,0.9517871060679164,0.5190311418685121,0.8164566459670165,1.0,5/10,19.43%,RGS2;PDPK1;FGFR3;ANGPTL3;FGFR1
prerank,inorganic ion transmembrane transport (GO:0098660),-0.39434132107777,-0.9517688169319038,0.5199004975124378,0.8229916508410627,1.0,6/12,41.44%,PKD2;ABCC9;ABCC8;PKD2L1;CACNA1H;P2RX3
prerank,negative regulation of insulin secretion (GO:0046676),-0.34434472119114706,-0.9516292151329431,0.5265822784810127,0.8222681169753326,1.0,3/17,10.40%,PRKN;IRS1;KLF7
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",-0.37422130845024426,-0.9514411266009279,0.5473145780051151,0.8216663166981886,1.0,7/14,24.04%,TPP1;NABP2;TERF2IP;XRCC5;TNKS2;TINF2;PINX1
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),0.39401741356581477,0.9509804327825566,0.5329249617151608,0.8176775933806767,1.0,4/19,10.02%,PTPRU;MAD2L2;AFDN;ADAM19
prerank,telomere maintenance via recombination (GO:0000722),0.4399024700891204,0.9509510475491885,0.5084745762711864,0.8172593449027945,1.0,4/11,18.87%,TEP1;ERCC4;SMC6;SMC5
prerank,pyrimidine-containing compound metabolic process (GO:0072527),0.45219478715086275,0.9509501056004372,0.5371329879101899,0.8167804465823293,1.0,4/11,17.58%,TPK1;NT5C3A;DCK;ERH
prerank,ion transport (GO:0006811),-0.2308395695454925,-0.9507007080776742,0.6011904761904762,0.8224353229974947,1.0,19/111,12.90%,SLC8A1;SLC24A3;WNK1;SLC1A3;TRPM3;ANO10;SLC25A26;SLC36A1;SLC17A6;SLC9A9;GABRB1;SLC9A6;KCNN2;MCOLN1;CHRNA7;VDAC1;SLC26A11;KCNN3;SLC15A2
prerank,mitotic DNA replication (GO:1902969),0.4619106587586269,0.9505556587273756,0.5329768270944741,0.8171482262965535,1.0,3/10,12.94%,CDC45;MCM6;MCM2
prerank,positive regulation of glycolytic process (GO:0045821),0.3927649969650458,0.9504570382849625,0.5181422351233672,0.8163959049667326,1.0,9/20,16.94%,ZBTB20;PRXL2C;PRKAA1;APP;PFKFB3;PRKAA2;PFKFB4;INSR;PSEN1
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),0.3927649969650458,0.9504570382849625,0.5181422351233672,0.8163959049667326,1.0,9/20,16.94%,ZBTB20;PRXL2C;PRKAA1;APP;PFKFB3;PRKAA2;PFKFB4;INSR;PSEN1
prerank,positive regulation of secretion (GO:0051047),-0.3972300103889494,-0.9501111774920878,0.5364077669902912,0.822820072715061,1.0,7/11,53.80%,GPLD1;ACSL3;NPR1;AQP1;ABCB11;SCIN;TRH
prerank,female gamete generation (GO:0007292),0.37179382839606584,0.9499047514197628,0.5236111111111111,0.8170858571109433,1.0,9/29,20.95%,DIAPH2;IHO1;TOB2;METTL3;USP9X;MARF1;MCM9;PRDM9;PARN
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",-0.402913835725503,-0.9495027828146825,0.5344036697247706,0.8232904098846215,1.0,8/11,45.10%,UQCRC2;UQCRC1;UQCR10;UQCC3;CYC1;UQCRQ;UQCR11;UQCRH
prerank,"synaptic transmission, GABAergic (GO:0051932)",-0.41495036301724486,-0.9494404002904038,0.5344418052256532,0.8223877468108061,1.0,5/10,18.60%,GABRG3;GABRG2;GABRA4;GABRA2;GABRA5
prerank,angiogenesis involved in wound healing (GO:0060055),0.4484689553399159,0.948671299396005,0.5388692579505301,0.81911972285928,1.0,2/11,5.35%,NDNF;PRCP
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),-0.3701242653893907,-0.9485214926454508,0.518918918918919,0.8237288922049508,1.0,2/13,3.14%,TPST2;ENPP1
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),-0.34145229920703607,-0.9482792688484833,0.5170454545454546,0.823284074111768,1.0,6/20,18.00%,AGO3;TSN;AGO1;ZC3H7B;TSNAX;DROSHA
prerank,translational termination (GO:0006415),-0.2385147984149886,-0.9481834550409597,0.5513513513513514,0.8224514750481322,1.0,52/95,35.85%,GFM2;MRPL24;MRPS9;DAP3;MRRF;MRPS21;MRPL1;MRPS5;OXA1L;MRPL45;MRPS31;MRPS17;MRPL10;MRPL43;CHCHD1;MRPS7;MRPL4;MRPL2;MRPL37;MRPS24;MRPS26;MRPS22;MRPS18B;MRPL3;MRPL32;MRPL47;MRPS30;MRPL17;N6AMT1;MRPL50;MRPS14;TRMT112;MRPL51;MRPL16;MRPL11;GSPT2;MRPS18C;MRPL44;MRPL35;MRPS11;MRPL28;MRPL46;MRPL52;MRPS35;MRPS28;MRPL23;MRPL9;MRPS16;MRPL54;MRPL49;MRPL42;MRPS23
prerank,regulation of striated muscle contraction (GO:0006942),0.3658790189971462,0.9478399827651389,0.55359765051395,0.8203520966384292,1.0,3/27,3.90%,GJA5;RNF207;HCN4
prerank,mRNA methylation (GO:0080009),0.41514695123652445,0.9477516334627848,0.5394957983193277,0.8200648105435099,1.0,5/15,14.38%,VIRMA;CBLL1;CMTR1;METTL3;TRMT10C
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),0.3637996928092967,0.9476003968585371,0.5568513119533528,0.8199065973119457,1.0,10/30,18.80%,RAC2;FBXW7;UBE2D3;ARIH2;CSNK2A2;RNF31;SREBF2;UBE2J2;ATG13;PINK1
prerank,regulation of integrin activation (GO:0033623),-0.3609534859854592,-0.9475619169661431,0.5274725274725275,0.8229570567018932,1.0,6/15,16.72%,FBLIM1;FARP2;JAM3;SKAP1;SRC;PLEK
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),-0.2980484138284703,-0.9471343073467926,0.5236686390532544,0.8229471374075094,1.0,8/28,15.92%,PRKN;TREM2;CLU;PSMC2;ECSCR;CCDC22;DAB2IP;RNF139
prerank,secondary alcohol metabolic process (GO:1902652),-0.2794144351365616,-0.9465022535990243,0.5401459854014599,0.8233896776679275,1.0,5/42,10.36%,ABCA1;APOE;OSBPL1A;STARD3;CH25H
prerank,cellular protein metabolic process (GO:0044267),0.2778246558810413,0.9463349766553419,0.6294416243654822,0.8221217474896477,1.0,66/396,14.11%,NAPSA;ST3GAL1;ST8SIA4;ZAR1;RPL5;DENND3;TNC;MSRB1;NOTUM;STK38;RPS10;MMP1;LAMB1;GPC3;ABCA3;RPL37A;PARP4;MRPL55;RPL6;MRPL18;UBE2D3;RPS18;PARL;SHISA5;LGALS1;RPS14;FBXW2;ADAM17;NEDD8;WFS1;CSF2RB;RPL35A;SFTPA1;SFTPA2;PPP4R2;MRPL13;RPL13;IL6;CSNK1G3;WWP2;FBN1;RPS3;IGF2BP3;RPS21;FN1;FARSB;MBTPS1;RIPK1;PRSS23;UBE2S;DUSP12;RPL34;RPLP0;APP;UBE2G1;RPL19;RPL11;RPL30;PCSK5;SLC35A1;KTN1;YME1L1;DNAJC3;RPS2;RPL4;RPL7
prerank,negative regulation of proteolysis (GO:0045861),0.3624152193061442,0.9460388114479454,0.5470085470085471,0.8222465645040863,1.0,3/34,6.34%,LRRK2;DNAJC1;PRNP
prerank,"transcription, DNA-templated (GO:0006351)",0.28561683604905025,0.9458219584477806,0.5806111696522656,0.8222228664901073,1.0,36/207,12.30%,BCL3;NFKB1;GTF2F2;TAF1A;TAF13;TAF9;GTF2E2;POLR3A;POLR2C;SCX;MBD1;DEAF1;SMARCA5;KLF13;DEK;ELOA;SETX;CBFB;ELOB;THRA;CCNH;GTF2A1;NFKBIB;CREBL2;SNAPC3;PKNOX1;GMEB2;CCNT2;NELFA;FOXO3;TAF7;GTF3C6;BAZ2A;CCNT1;NFYA;TFAM
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),0.4350625006145865,0.9448442980844538,0.5553719008264463,0.8238729076923135,1.0,3/12,17.98%,TAPT1;KDELR1;HSPA5
prerank,negative regulation of lipid biosynthetic process (GO:0051055),0.38922799822008564,0.9448226885728175,0.5515625,0.8234352062936405,1.0,3/20,7.71%,SIK1;FBXW7;ERLIN1
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),0.40264116806982364,0.9447414535093082,0.5389312977099237,0.8231478748660918,1.0,4/19,4.87%,FOXJ1;ERBIN;CLIC4;SYNJ2BP
prerank,contractile actin filament bundle assembly (GO:0030038),0.42042611520261675,0.9446721288809617,0.5592654424040067,0.8223290234972441,1.0,7/15,17.45%,PDLIM1;CUL3;RHOA;FHDC1;KCTD13;PHACTR1;FAM171A1
prerank,stress fiber assembly (GO:0043149),0.42042611520261675,0.9446721288809617,0.5592654424040067,0.8223290234972441,1.0,7/15,17.45%,PDLIM1;CUL3;RHOA;FHDC1;KCTD13;PHACTR1;FAM171A1
prerank,focal adhesion assembly (GO:0048041),0.3884100104332936,0.944166680171078,0.5314465408805031,0.8229200337030171,1.0,3/21,4.86%,RCC2;BCR;DLC1
prerank,sphingolipid metabolic process (GO:0006665),0.30441359518085614,0.9440558709929945,0.5490196078431373,0.8226645077041987,1.0,25/108,16.42%,CERS6;CERKL;ACER3;GM2A;ESYT3;CERS1;ELOVL5;ESYT1;SAMD8;SGMS1;SGMS2;PSAP;ST6GALNAC3;ELOVL6;SUMF2;SUMF1;SPTSSB;ESYT2;SGPP2;TEX2;SGPP1;FA2H;VAPA;PPT1;HACD4
prerank,positive regulation of telomerase activity (GO:0051973),0.3595707827459699,0.9438687227856557,0.5135908440629471,0.8225831179648727,1.0,9/33,15.81%,KLF4;PKIB;PARM1;WRAP53;TNKS;MAP3K4;AURKB;MAPK1;TCP1
prerank,positive regulation of osteoclast differentiation (GO:0045672),0.413268139154677,0.9437888744239218,0.531502423263328,0.8222850890588589,1.0,1/14,1.95%,CCR1
prerank,positive regulation of TORC1 signaling (GO:1904263),-0.35834367467640627,-0.9437791169238754,0.5267379679144385,0.8288975514315575,1.0,6/16,14.97%,FLCN;GPR137B;KLHL22;LARS1;LAMTOR5;PIH1D1
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),0.4077469718248289,0.9437653795813501,0.5448818897637795,0.8218480358515009,1.0,2/17,5.23%,RAPGEF2;ADRA2A
prerank,DNA synthesis involved in DNA repair (GO:0000731),0.3440210797644471,0.9436172776176354,0.5429740791268759,0.8216883333850232,1.0,11/42,18.71%,DTL;POLI;POLD4;WRN;TRIM25;RPA3;PCLAF;VCP;POLD1;SIRT1;PRIMPOL
prerank,osteoclast differentiation (GO:0030316),0.38847927507045316,0.9435759562826898,0.5525925925925926,0.821287520296101,1.0,5/22,9.99%,FOXP1;ANXA2;MAPK14;EFNA2;SBNO2
prerank,negative regulation of interferon-beta production (GO:0032688),0.4571369223778704,0.9434656051380524,0.5385996409335727,0.8210442737383381,1.0,3/10,11.03%,LILRB1;REL;CACTIN
prerank,import into nucleus (GO:0051170),0.3111309708987997,0.9432590614792193,0.5407407407407407,0.8209756993530615,1.0,17/73,18.20%,BACH2;SYK;STAT3;SNRPD2;PTTG1IP;SNRPB;HIKESHI;NUP153;EIF4ENIF1;AKT1;FAM53C;GEMIN7;TNPO1;KPNB1;HTATIP2;APPL1;NUP93
prerank,axonemal dynein complex assembly (GO:0070286),0.36948528279185455,0.943061320214932,0.525,0.8209118370195724,1.0,4/27,12.32%,DNAH8;DNAAF5;ODAD1;CCDC39
prerank,regulation of macrophage chemotaxis (GO:0010758),-0.33490362959766085,-0.9428754198243993,0.5440729483282675,0.8301988635380002,1.0,6/21,13.69%,CSF1R;CMKLR1;CSF1;MTUS1;AKIRIN1;MDK
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),0.3194732712154165,0.9428256352056801,0.5461346633416458,0.8209122836691832,1.0,17/62,17.20%,CDK13;GTF2F2;POLR2C;ELOA;ELOB;CCNH;ELOF1;SETD2;CCNT2;NELFA;CCNT1;CDK12;ERCC3;EAF1;NCBP1;ELL;SUPT4H1
prerank,protein localization to vacuole (GO:0072665),0.42386046947617406,0.94274039362853,0.5522388059701493,0.8206062019806654,1.0,3/13,12.46%,RTN4;LMBRD1;SH3BP4
prerank,positive regulation of brown fat cell differentiation (GO:0090336),0.4264567942174877,0.942629318830107,0.5347334410339257,0.8203675261191573,1.0,2/13,2.01%,METRNL;PIM1
prerank,peptide metabolic process (GO:0006518),0.31651328899530656,0.942610116340757,0.554320987654321,0.8199292492681323,1.0,18/75,18.35%,ACE;LNPEP;GPX1;GSR;ETHE1;DPEP1;PARL;GSTA3;CPQ;MGAT3;BACE2;PCSK5;GSTP1;MIPEP;PSEN1;SPCS2;ANPEP;CTNS
prerank,positive regulation of cell growth (GO:0030307),0.3044997990553593,0.9425095011072453,0.5722679200940071,0.8196762323136375,1.0,24/96,16.72%,NGF;SHTN1;NEDD4L;RPS6KA3;CDC42;H3-3A;CXCL16;ADAM17;CIB1;MTPN;DDX49;CSNK2A1;NTN1;RPS6KA1;PSMD10;PABIR1;AKT1;ITSN2;MAP3K13;ZFYVE27;NCBP1;INO80;USP47;SEMA4D
prerank,organophosphate biosynthetic process (GO:0090407),0.3530198299016288,0.9422360583649044,0.573170731707317,0.8198043371227445,1.0,9/37,18.15%,ITPKC;AGPAT4;IP6K3;TPK1;PIP5K1A;GNPAT;IPMK;GK;MOCS1
prerank,B cell activation involved in immune response (GO:0002312),0.42374419853833306,0.9421373990584727,0.5427574171029669,0.8195136251870326,1.0,3/13,11.69%,GAPT;MSH6;FCGR2B
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.37610445369090834,0.941790873866747,0.5548686244204019,0.819774234856089,1.0,5/24,16.84%,IL1B;PTPN1;CNMD;ITGA5;NIBAN2
prerank,defense response to protozoan (GO:0042832),0.4281856651091045,0.9416184759127287,0.5400340715502555,0.8196682002649963,1.0,4/12,14.98%,CD40;IRF4;GBP2;MYD88
prerank,mitochondrion organization (GO:0007005),0.28834214484660925,0.9415935042179007,0.6039387308533917,0.8192473931848839,1.0,51/165,21.93%,LRRK2;PID1;AKT3;LONP1;IFIT2;CAV2;CLUH;ATP2A1;ATP7A;DNAJC19;GABPB1;TOMM40;FIS1;IMMP2L;AIFM1;TFAM;DNM1L;SIRT4;YME1L1;PNPT1;MYH14;TIMM50;RAB29;FBXO7;TFB1M;POLG2;AIP;COX7A2;CHCHD2;HSPD1;VPS13D;AIFM2;HAX1;PINK1;FANCG;NRF1;NIPSNAP2;MTFR1;PARK7;SUPV3L1;HIGD2A;TRAK1;MUL1;SIRT3;DNAJA3;TRAK2;BNIP3L;TOMM22;PARP1;BID;RHOT1
prerank,positive regulation of lipid storage (GO:0010884),-0.32697166676039985,-0.9415802286686874,0.5419161676646707,0.832333480329618,1.0,6/21,13.74%,OSBPL11;MSR1;IKBKE;VSTM2A;APOC4;C3
prerank,modulation of excitatory postsynaptic potential (GO:0098815),0.37177355108575394,0.94116005964848,0.5565891472868217,0.8196872119313343,1.0,7/26,16.70%,LRRK2;PTEN;PTK2B;APP;RELN;WNT7A;MTMR2
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),0.4470949825819648,0.9405629292309923,0.563922942206655,0.8204778541126515,1.0,3/10,12.78%,INPP5F;PARP14;NF2
prerank,negative regulation of interleukin-6 production (GO:0032715),0.36938807781451505,0.9404046669000566,0.5323529411764706,0.820337177319135,1.0,3/27,3.76%,PTPN22;FOXJ1;PTPN6
prerank,membrane assembly (GO:0071709),0.3533655157478063,0.9399788259419642,0.5650929899856938,0.8207710102707966,1.0,7/34,9.32%,ANXA2;PICALM;CHMP4B;CEL;PTEN;S100A10;SPAST
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),0.42305668201238733,0.9394285434718985,0.5373376623376623,0.821419598505779,1.0,2/13,6.95%,RUNX3;CBFB
prerank,tetrahydrofolate metabolic process (GO:0046653),-0.4142802528561771,-0.9390078981046582,0.5471698113207547,0.8378281887710939,1.0,5/10,27.17%,MTHFD2L;MTHFS;DHFR;SHMT2;MTHFD1
prerank,monocyte chemotaxis (GO:0002548),0.35577862891851314,0.9389292741520677,0.5357643758765779,0.821965896439489,1.0,5/32,12.84%,PTPRO;IL6R;IL6;ANXA1;LGALS3
prerank,amyloid-beta metabolic process (GO:0050435),0.41231665708727866,0.9387031900198168,0.5347334410339257,0.8219754784643809,1.0,5/16,16.94%,ACE;DYRK1A;MGAT3;BACE2;PSEN1
prerank,cellular response to hormone stimulus (GO:0032870),0.31533895694351,0.9385687211531042,0.5685279187817259,0.8217701654800862,1.0,10/69,10.42%,RARA;STAT3;NCOA3;STAT5B;ADRA2A;SERPINB9;BCAS3;NCOA2;NCOA1;NR3C1
prerank,positive regulation of phospholipid transport (GO:2001140),-0.411793081050176,-0.9384971600049119,0.5550239234449761,0.8380292926386018,1.0,2/10,3.76%,APOE;ABCB4
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),0.3394770110541667,0.9382092742484317,0.5472703062583223,0.8220243895050418,1.0,9/42,12.79%,MAD2L2;SMCHD1;KLHL15;ACTR2;PPP4R2;WRAP53;ARID2;SETD2;SPIDR
prerank,regulation of chemotaxis (GO:0050920),-0.297944490067625,-0.9381520498446391,0.5344262295081967,0.8378221966764468,1.0,9/30,14.51%,TREM2;P2RY12;AIF1;P2RX4;ZSWIM8;PPM1F;ZSWIM6;GPR183;ZSWIM5
prerank,purine nucleotide metabolic process (GO:0006163),0.3752928185959951,0.937866226857491,0.5406626506024096,0.8223160970401264,1.0,2/24,2.68%,GDA;GPX1
prerank,regulation of neuron projection development (GO:0010975),0.2888332108158398,0.9377950117421023,0.5952121871599565,0.8219713657443091,1.0,20/163,8.64%,LRRK2;LYN;PDLIM5;RAP1A;CAMK1D;RET;NTNG2;NDNF;PTPRO;PAK1;RAPGEF2;NPTN;CCDC88A;PTEN;SETX;PTK2B;CIB1;PAK2;PAQR3;CBFA2T2
prerank,regulation of mitotic cell cycle (GO:0007346),0.28636968768449006,0.937746856566471,0.6034858387799564,0.8215910131740738,1.0,42/171,18.60%,IQGAP1;SIK1;CDK13;PSME3;BTG2;EIF4EBP1;UBE2E1;PSMB7;PSME2;BTG1;RNF20;CAV2;PKN2;AFAP1L2;GBF1;PSME4;PSMB8;PSMA5;PSMD9;CYLD;PSMB3;UBE2S;PSMD6;PSMC4;APP;PSMD10;PSMB1;ERCC3;TGFB1;ANAPC7;TRIM35;RPS6KB1;PSMD12;RB1;DAPK3;MAEA;SIRT1;FOXC1;ANAPC11;FZR1;PIN1;ANAPC4
prerank,embryonic appendage morphogenesis (GO:0035113),0.4298061015823139,0.9375730243474764,0.5387149917627677,0.8214836449625947,1.0,1/12,0.58%,MBNL1
prerank,protein modification by small protein conjugation (GO:0032446),0.2763434935829511,0.93734396572891,0.6429298067141404,0.8214660549094726,1.0,75/361,17.31%,BCL11A;NUP210;ITCH;DTX3L;ASB5;NEDD4L;TRIM26;CUL3;CUL5;BIRC6;UBE2E1;RNF38;TRIM7;CBL;FBXW7;SUMO1;CBLL1;TRIM62;PEX12;ARIH1;WAC;RNF213;RNF20;UBE2D3;IFIH1;FBXW11;DCUN1D1;UBE2N;HLTF;NEDD8;NFE2L2;ELOB;MYCBP2;NUP98;FBXO4;UBR2;PCNP;ARIH2;PEX14;WWP2;UBE2W;FBXO32;UBE2Z;SUMO2;TRIM14;UBE2S;FBXL17;DCUN1D3;KLHL8;RCHY1;TRIM17;UBE2G1;NUP153;AREL1;ATG10;RNF138;VCP;UBE2J2;USP7;UHRF2;FBXO7;ANAPC7;KCTD13;VCPIP1;USP9X;TRIM35;RNF41;HACE1;SEH1L;UBR3;UBA6;MSL2;SIRT1;RNF144A;UBE2Q2
prerank,nuclear export (GO:0051168),-0.23965883718269237,-0.9372969078960365,0.5862068965517241,0.8389530961541063,1.0,23/80,18.34%,ATXN1;SRSF5;SRSF3;DDX39B;STRADA;RNPS1;SRSF7;NUP155;NUP188;THOC5;DHX38;NXF1;NUTF2;CHP1;ZC3H11A;SRSF2;DDX39A;NUP42;TPR;RAN;RANBP3L;CASC3;SRSF1
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),-0.36040356932890033,-0.9372968857080369,0.5283505154639175,0.8378857258027651,1.0,3/14,7.12%,GAS6;RFFL;PYDC1
prerank,nitrogen compound transport (GO:0071705),-0.21881582572751815,-0.9370829609181401,0.6991150442477876,0.8373403009397604,1.0,28/141,16.77%,LRP1B;SEC14L1;SLC11A1;SCAMP1;SLC7A6;ABCG2;SLC7A1;FLVCR1;SCAMP2;SCAMP5;SLC7A7;SLC6A15;SLC36A1;HSP90B1;SLC22A5;SLC7A2;SLC7A8;SLC5A7;TOM1;SLC3A2;SLC15A2;SLC6A8;SLC22A4;SLC25A47;TXNIP;CHMP1B;VPS33B;ARRDC2
prerank,maturation of SSU-rRNA (GO:0030490),0.34945566681534185,0.937034282408705,0.5496402877697841,0.8216436721757292,1.0,16/34,27.36%,DHX37;RPS14;UTP6;RIOK1;NOL11;RRP36;TSR3;DDX52;HEATR1;DCAF13;RPS16;WDR46;NOB1;RIOK2;WDR3;TSR1
prerank,cell cycle G2/M phase transition (GO:0044839),0.29223988232926035,0.9366741134760204,0.5757918552036199,0.821923186523668,1.0,25/129,14.85%,SDCCAG8;CNTRL;PPP1R12A;HAUS8;PHLDA1;FBXW11;FBXL8;CDK14;CEP63;PAFAH1B1;PLCB1;HAUS1;PPP2R2A;CCNH;DCTN3;LATS1;CEP250;FBXL17;DYNC1H1;PPP1CB;HAUS3;FBXL12;CLASP1;WEE1;BRSK1
prerank,positive regulation of regulated secretory pathway (GO:1903307),0.3977216806196888,0.9363602138902805,0.5464743589743589,0.8221128797574918,1.0,3/17,7.51%,RAB3D;UNC13D;SLC4A8
prerank,positive regulation of embryonic development (GO:0040019),0.3885903997097003,0.9359728511379082,0.5334370139968896,0.8224852428831122,1.0,3/19,7.50%,SCX;B4GALT5;PLCB1
prerank,nucleotide-excision repair (GO:0006289),-0.22816245710754124,-0.9358913399517889,0.6423841059602649,0.8392055760202622,1.0,36/101,24.76%,GTF2H2;ERCC6;COPS4;POLD3;MMS19;TCEA1;GTF2H1;UBC;XRCC1;POLR2A;COPS7A;ERCC2;COPS2;PCNA;SLC30A9;LIG3;POLA1;PPIE;ISY1;POLR2K;RFC3;LIG1;GTF2H3;OGG1;COPS7B;XAB2;CDK7;POLR2H;GTF2H5;SLX4;POLR2J;RAD23A;UBA52;XPC;COPS6;ERCC1
prerank,regulation of myoblast differentiation (GO:0045661),0.3520210638336424,0.9358336053705079,0.5558739255014327,0.8223014298308786,1.0,4/32,7.50%,RIPOR2;BTG1;MAPK14;PLCB1
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.4359704499377046,0.9356445058436249,0.541095890410959,0.8222293687540548,1.0,2/11,6.95%,RUNX3;CBFB
prerank,regulation of actin nucleation (GO:0051125),0.43150001501374,0.9353403924574819,0.5366269165247018,0.8224212969178156,1.0,2/12,7.47%,CORO1A;ARF1
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),0.3633192551455389,0.9352653605321418,0.5519662921348315,0.8221053890574578,1.0,10/27,16.94%,NTNG2;CCDC88A;PTEN;FCGR2B;AKT1;BRSK1;FBXO7;EFHC2;DISC1;PSEN1
prerank,negative regulation of chondrocyte differentiation (GO:0032331),-0.3627796522340757,-0.9350899024977929,0.5470737913486005,0.8401290011578147,1.0,9/14,43.93%,TGFBR1;EFEMP1;CHADL;GREM1;PTHLH;RFLNB;RFLNA;WNT9A;SNAI2
prerank,cytosolic transport (GO:0016482),0.2975185173096816,0.9350533369663606,0.5799522673031027,0.8220835575307249,1.0,23/108,14.50%,LMTK2;EPS15;LAPTM5;TBC1D10C;RAB7A;SNX1;VPS53;RAB6A;TMEM87A;STX6;GCC2;RHOBTB3;GBF1;STX5;SNF8;PIKFYVE;TBC1D5;VPS13A;AP1G1;ANKFY1;STX16;EVI5;RAB29
prerank,positive regulation of leukocyte proliferation (GO:0070665),-0.3777410288944366,-0.9349859456887788,0.5617128463476071,0.83933826117761,1.0,2/12,3.39%,CSF1R;CSF1
prerank,response to insulin (GO:0032868),-0.2418639877672677,-0.9348674621502608,0.5989010989010989,0.8385840462740307,1.0,13/80,11.87%,PDE3B;CPEB2;ENPP1;SORT1;CPEB1;GOT1;RAB31;RHOQ;SLC27A1;PCK2;IRS1;PIK3R1;MYO5A
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),-0.2893349281413283,-0.9345661871397039,0.5514950166112956,0.838301714763833,1.0,11/32,16.85%,FHIT;CDIP1;DDX5;USP28;PYCARD;MSH2;MYBBP1A;SNW1;PPP1R13B;JMY;AEN
prerank,protein localization to cell-cell junction (GO:0150105),0.40634494700778556,0.9344232001069477,0.5422297297297297,0.8229140049538614,1.0,3/15,7.54%,ARHGEF18;PAK2;F11R
prerank,regulation of glucose import (GO:0046324),0.3558006690268746,0.9340699915035066,0.5555555555555556,0.8231550417139429,1.0,8/30,18.12%,PID1;PRKAG2;RTN2;CREBL2;AKT1;OCLN;INSR;APPL1
prerank,protein alkylation (GO:0008213),0.3768503713925249,0.9332653418310022,0.5602409638554217,0.8243383959638375,1.0,7/22,18.23%,PRMT8;SNRPB;CAMKMT;ETF1;PRMT3;EEF1AKMT1;GSPT1
prerank,regulation of dendritic spine morphogenesis (GO:0061001),0.35942035031323677,0.9328662860968341,0.5507042253521127,0.8246803740629396,1.0,3/31,5.92%,LRRK2;PDLIM5;PTEN
prerank,cytoplasmic sequestering of protein (GO:0051220),0.4326515978818095,0.9327629766535535,0.5503472222222222,0.8244209088691667,1.0,4/13,9.15%,NFKBIA;NFKBIE;FLNA;LATS1
prerank,"DNA-templated transcription, elongation (GO:0006354)",0.31485457704238556,0.9320408985302894,0.573019801980198,0.825444691640207,1.0,17/64,17.20%,CDK13;GTF2F2;POLR2C;ELOA;ELOB;CCNH;ELOF1;SETD2;CCNT2;NELFA;CCNT1;CDK12;ERCC3;EAF1;NCBP1;ELL;SUPT4H1
prerank,cellular response to calcium ion (GO:0071277),0.3164167642894012,0.9320327079983068,0.5886699507389163,0.824985340764104,1.0,12/67,12.43%,IQGAP1;PLCG2;ALOX5AP;HPCA;RASGRP2;DPEP1;CLIC4;KCNH1;CPNE1;BRAF;PRKAA1;CPNE2
prerank,genitalia development (GO:0048806),-0.3909356806333806,-0.9319954483212589,0.5491606714628298,0.843673137218573,1.0,1/12,0.65%,CHD7
prerank,supramolecular fiber organization (GO:0097435),0.27369240948546075,0.9319716732148993,0.6656378600823045,0.8246667639323259,1.0,61/333,15.52%,MYO1G;RND3;SLK;TPM4;VIM;CCDC88C;CD36;MAD2L2;MYO1E;MYO1C;COL5A2;SORL1;CORO1A;SHROOM3;CCDC88A;RAC2;SCX;CDC42;CD2AP;H3-3A;CARMIL1;PPP1R9B;BCAR1;ELMO2;HSPG2;BIN3;KATNA1;MYO5B;KATNB1;TPPP3;CIB1;ATP7A;TGFBI;RHOBTB3;RAC1;PXDN;TSPAN14;KIF24;RHOA;SPAST;HIP1;TLL1;TSPAN33;RIPK1;B2M;DYNC1H1;APP;CLIP3;TMOD3;TCHH;ARHGAP17;TRIOBP;MYO1F;STMN3;RHOG;ELMO1;COL16A1;USP9X;TSPAN15;SHROOM1;STMN2
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),-0.3980659705806065,-0.9319558554637194,0.5688073394495413,0.8427099407466919,1.0,4/10,20.87%,CTBP1;SET;BRCA1;THAP7
prerank,regulation of osteoclast differentiation (GO:0045670),0.3565615482262622,0.9316675343070551,0.5808720112517581,0.8248329340531847,1.0,4/33,9.63%,LILRB3;CCR1;TLR3;FBN1
prerank,positive regulation of epithelial cell proliferation (GO:0050679),0.29613948247869215,0.9314618764217416,0.5833333333333334,0.8248096776373387,1.0,8/113,5.00%,JAML;NOTCH2;AKT3;STAT5A;CLDN1;BMPR2;LAMB1;VEGFC
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.40606774934422585,0.9314409225368198,0.546644844517185,0.8243923788743525,1.0,3/17,7.47%,WASF2;GMFG;ARF1
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.31206099875132776,0.9312146442437426,0.5690072639225182,0.8243942256502893,1.0,13/72,13.35%,DNA2;MRE11;FEN1;XRN2;POLD4;IHO1;RNASE1;RNASE6;DCP1A;RPA3;EXD2;ERCC3;ERCC4
prerank,diacylglycerol metabolic process (GO:0046339),-0.3111485754482204,-0.9308923316100172,0.5700934579439252,0.8442823107881606,1.0,5/23,9.67%,DGKZ;PLA2G15;DAGLA;DGKQ;GPAM
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),0.32934366325343906,0.930809335930395,0.5482093663911846,0.8247676990835185,1.0,13/46,18.43%,IL1B;XPO4;UBR5;FLNA;RBM22;ZPR1;HCLS1;HDAC3;TGFB1;PSEN1;PIK3R2;BAG3;PRKCD
prerank,protein O-linked glycosylation via serine (GO:0018242),-0.4095045525425147,-0.930624889878112,0.5513784461152882,0.8438760644299147,1.0,6/10,27.24%,GALNT3;GALNT13;GALNT16;POGLUT2;MGAT5B;POGLUT3
prerank,nucleic acid-templated transcription (GO:0097659),0.3406879777372438,0.9302152039677163,0.5822102425876011,0.8255313302130656,1.0,7/42,12.12%,BCL3;POLR3A;POLR2C;SCX;NFKBIB;CREBL2;BAZ2A
prerank,protein localization to organelle (GO:0033365),0.2893350516591029,0.9300926475922723,0.5937149270482603,0.8253111560858227,1.0,30/133,17.61%,LRRK2;SORL1;RAB6A;PRNP;TRAM2;TRAM1;GCC2;IFT140;LMNA;PAQR3;GBF1;STX5;PPP1R15A;PIKFYVE;LAMP5;CEP250;DCP1A;LMBRD1;TOR1AIP1;APP;PACSIN2;RPL11;GBP5;UBE2J2;GBP2;EHD1;VAPA;RAB35;TMEM30A;TSPAN17
prerank,chloride transport (GO:0006821),-0.23866726254950887,-0.929975501975832,0.644808743169399,0.8443972836568724,1.0,17/74,18.60%,SLC1A3;TTYH3;CLCN6;GABRG3;ANO10;GABRG2;CLCN4;GLRA3;GABRB1;GLRA2;GABRA4;CLCN3;GABRB3;LRRC8A;GABRA2;ANO8;GABRA5
prerank,positive regulation of heart contraction (GO:0045823),0.3895326256511648,0.9298891285410923,0.5358208955223881,0.8252488630085353,1.0,2/19,3.31%,RGS2;KCNQ1
prerank,protein import into nucleus (GO:0006606),-0.2504366412360236,-0.9298440416731887,0.5685279187817259,0.8436648927835488,1.0,21/66,17.54%,E2F3;APPL2;KPNA6;NUP54;NUP133;NUP155;IPO5;NUP188;TNPO2;PPP1R10;IPO13;RANBP2;NUTF2;SEC13;TSC2;NUP85;FAM53A;TPR;RAN;IPO7;NUP35
prerank,regulation of protein modification process (GO:0031399),0.32749457811117605,0.9295594857076712,0.5765765765765766,0.8254764064083754,1.0,17/50,20.89%,LYN;CCDC88C;RABL3;CCDC88A;SPRED3;FN1;PARG;NDUFS4;ATG10;STAT2;KAT2B;SPRED1;PPIB;PIN1;PUM3;PTK2;PHIP
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),-0.3835206867209696,-0.9294785583581481,0.5544041450777202,0.8435343848511866,1.0,9/12,40.20%,RMDN1;MAD1L1;CENPE;BOD1;NDC80;MIS12;CDT1;KIF2C;NUF2
prerank,regulation of necroptotic process (GO:0060544),0.3707453520413794,0.9292533767761062,0.5520361990950227,0.8256080957064291,1.0,6/23,10.65%,BIRC3;PELI1;PDCD6IP;SPATA2;CYLD;RIPK1
prerank,spliceosomal complex assembly (GO:0000245),0.3291021468746275,0.9290976241029867,0.5468956406869221,0.8254766123963897,1.0,16/46,20.52%,CRNKL1;SNRPD2;PRPF6;SETX;SRSF10;CELF2;YTHDC1;DDX23;SF3A1;NCBP1;TXNL4A;CELF1;SF3B1;SF3A2;LUC7L3;LUC7L
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.31783200060627875,0.9281874605730439,0.5542929292929293,0.8268736614659732,1.0,10/57,11.90%,DAPK1;FYN;MAP3K5;SYK;MALT1;NLRC4;FIS1;GRAMD4;NLRP3;REST
prerank,visual perception (GO:0007601),0.3032222399735553,0.9281570909492605,0.6051344743276283,0.8264637280915743,1.0,11/84,11.35%,CRYBG3;RP2;ATF6;WFS1;ATXN7;DNAJC19;OPA3;KIFC3;CEP250;UNC119;IMPG2
prerank,protein deneddylation (GO:0000338),-0.3988175915126482,-0.927615636368699,0.5539906103286385,0.8470202303719702,1.0,5/10,24.02%,COPS4;COPS7A;COPS2;COPS7B;COPS6
prerank,L-glutamate transmembrane transport (GO:0015813),0.44816700347690097,0.9273648645061715,0.5573192239858906,0.8276229968936112,1.0,3/10,11.49%,SLC25A13;SLC25A12;SLC25A18
prerank,regulation of feeding behavior (GO:0060259),0.43186264428417026,0.9273446347402388,0.5714285714285714,0.8271940377962524,1.0,1/11,2.37%,STAT3
prerank,muscle cell differentiation (GO:0042692),-0.2883531421461516,-0.927280861229857,0.5577557755775577,0.846831560397739,1.0,4/32,9.45%,MEF2C;NEBL;SPEG;NRAP
prerank,regulation of postsynapse organization (GO:0099175),0.36520318931163154,0.9270295643158856,0.5674074074074074,0.8274005332285214,1.0,2/28,1.08%,LRRK2;PDLIM5
prerank,development of primary male sexual characteristics (GO:0046546),-0.28814158826149594,-0.9268386401792017,0.5783582089552238,0.8468388457114171,1.0,14/34,33.12%,LHFPL2;KITLG;MSH2;TGFB2;AR;NCOA4;FGF9;WNT4;INHBA;MEA1;BIK;WNT5A;WNT2B;MAMLD1
prerank,cellular component disassembly (GO:0022411),0.32316171711014907,0.9268288779258499,0.573076923076923,0.8273564233856963,1.0,4/53,6.14%,CD44;LCP1;MMP1;CAPN2
prerank,positive regulation of developmental growth (GO:0048639),0.3306187303409573,0.9267147871784274,0.5810276679841897,0.8271304272874074,1.0,11/49,16.72%,NGF;SHTN1;NEDD4L;PLCB1;NTN1;ITSN2;MAP3K13;ZFYVE27;INSR;PPIB;SEMA4D
prerank,establishment of protein localization to membrane (GO:0090150),0.31879434933623774,0.9266903721833717,0.5617834394904458,0.8267166974612083,1.0,10/66,9.62%,SYNE3;VPS37C;MYO1C;ZDHHC7;AFDN;ZDHHC6;ZDHHC23;SEC63;PIKFYVE;BRAF
prerank,negative regulation of ion transport (GO:0043271),0.36851769124452,0.9265456085630662,0.5757575757575758,0.8265662442715644,1.0,3/24,6.44%,LILRB1;ADRA2A;PTK2B
prerank,regulation of cell growth (GO:0001558),0.27772222602159097,0.9264656390326823,0.6278825995807128,0.8262639504052702,1.0,44/204,17.56%,SGK3;ITCH;BCL6;HSPA1A;RASGRP2;RPS6KA3;BMPR2;MAD2L2;CRLF3;CDC42;H3-3A;BTG1;PPP1R9B;BCAR1;CDKN2C;OSGIN2;CXCL16;ADAM17;CIB1;MTPN;TMC8;DDX49;CSNK2A1;SMAD4;RTN4;IL17RB;NET1;DCUN1D3;RPS6KA1;PSMD10;SH3BP4;PABIR1;AKT1;TGFB1;PTPRJ;SERTAD3;NCBP1;INO80;USP47;PPT1;RB1;ST7L;SIRT1;NUBP1
prerank,ncRNA 3'-end processing (GO:0043628),-0.36646455141338635,-0.9262876061670581,0.5660847880299252,0.8471358258451042,1.0,5/14,12.45%,INTS6L;TRNT1;INTS8;PTCD1;SSB
prerank,actin cytoskeleton reorganization (GO:0031532),0.31629941736015904,0.9261050091731249,0.5655526992287918,0.8265495858641289,1.0,14/63,13.20%,NEDD9;PAK1;MYH9;BCAR1;GRB2;FLNA;EZR;MINK1;RHOA;ANXA1;PTPN1;CASS4;PIP5K1A;KIT
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.3855559846406662,0.925985736360821,0.5355450236966824,0.8263592870321512,1.0,7/18,21.95%,HSPA1A;ACAA2;SLC25A5;FZD9;MUL1;BID;GSK3B
prerank,positive regulation of collagen metabolic process (GO:0010714),0.4039985253246684,0.9257695484944355,0.5620094191522763,0.8263761895975162,1.0,2/17,4.20%,VIM;SCX
prerank,establishment of epithelial cell polarity (GO:0090162),0.39813263187465464,0.9253701749737205,0.5687919463087249,0.8266941805812681,1.0,6/19,8.94%,MSN;SIPA1L3;CDC42;EZR;CYTH3;RHOA
prerank,keratan sulfate metabolic process (GO:0042339),0.3613624175649529,0.9248641864853875,0.5708274894810659,0.8272698423258806,1.0,3/31,4.27%,ST3GAL1;ST3GAL4;B4GALT5
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),-0.36558328692953135,-0.9246376955027467,0.5667506297229219,0.850073982500729,1.0,4/13,14.85%,IGF1;GOLGA2;CHP1;ALG10B
prerank,organophosphate ester transport (GO:0015748),0.3694798807453452,0.924217000206437,0.5472263868065967,0.828174035686295,1.0,6/24,13.14%,LDLR;ABCA3;SCARB1;PITPNB;PITPNM1;PRELID1
prerank,glutamate metabolic process (GO:0006536),-0.3302222824739258,-0.924205045796918,0.5767195767195767,0.8500545959529445,1.0,12/19,25.91%,GLUL;GOT1;GCLC;MTHFS;ALDH18A1;GCLM;GAD1;ALDH5A1;OAT;GLS;PRODH;FPGS
prerank,regulation of exosomal secretion (GO:1903541),-0.32687847835452444,-0.9241010771546601,0.5794117647058824,0.8492747680095876,1.0,3/19,7.23%,PRKN;VPS4B;HGS
prerank,transition metal ion transport (GO:0000041),-0.28917081019882873,-0.9240966831188465,0.5819935691318328,0.8482324099440013,1.0,12/35,17.82%,SLC11A1;TRPC4;SLC11A2;TFRC;FTH1;TRPC1;TRPC7;SLC30A9;TRPC3;ATP2C1;SLC31A2;CP
prerank,positive regulation of cellular protein catabolic process (GO:1903364),0.3902327958985517,0.9240537663090196,0.5532915360501567,0.8280429239743617,1.0,4/18,7.99%,MSN;PTTG1IP;FAF1;EZR
prerank,positive regulation of histone methylation (GO:0031062),0.3728517225092191,0.9239233688917209,0.5612244897959183,0.8278540976051677,1.0,9/24,19.62%,JARID2;FAM47E;PHF19;SMAD4;MYB;KMT2A;SIRT1;DNMT1;WDR5
prerank,negative regulation of biomineral tissue development (GO:0070168),0.38803040614199785,0.9235801664388703,0.5789473684210527,0.8280936391437631,1.0,5/21,14.21%,CCR1;SRGN;PTK2B;ROCK1;TGFB1
prerank,positive regulation of translational initiation (GO:0045948),-0.33593637801625975,-0.9235736159812178,0.5894428152492669,0.8484482143533283,1.0,10/18,32.38%,LARP1;CDC123;EIF2B5;DDX3X;HABP4;UHMK1;YTHDF2;MTOR;CCL5;RPS6KB2
prerank,positive regulation of histone deacetylation (GO:0031065),-0.37895485863928646,-0.9234507731527258,0.5758293838862559,0.8477282761694004,1.0,5/12,12.15%,CTBP1;AKAP8;AKAP8L;VEGFA;PRKD1
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),0.35834054027817497,0.9232594563617228,0.5724743777452416,0.8282567770465985,1.0,7/29,17.32%,RET;PAK2;CYLD;RIPK1;DEDD2;THBS1;TRAF2
prerank,regulation of endocytosis (GO:0030100),0.3148338381367535,0.9230187825460634,0.5797665369649806,0.8282686566654461,1.0,18/61,17.10%,LILRB1;NEDD4L;CD177;PICALM;GPC3;CBLL1;HIP1;PTPN1;CLIP3;PACSIN2;LGALS3;ROCK1;STON1;AP2S1;SNX33;SNX12;MTMR2;ABL2
prerank,negative regulation of reproductive process (GO:2000242),0.40479338482381355,0.9218953109734344,0.5662460567823344,0.8300463499561588,1.0,3/17,11.47%,PAEP;ARHGDIB;DUSP1
prerank,negative regulation of centrosome duplication (GO:0010826),-0.37860156386897437,-0.9212883090568333,0.571072319201995,0.8520113031679614,1.0,6/11,24.42%,TRIM37;CENATAC;NPM1;RBM14;BRCA1;CCNF
prerank,lipid phosphorylation (GO:0046834),0.4502363025166771,0.921199207871591,0.5983050847457627,0.8309698762769465,1.0,1/10,1.04%,DGKG
prerank,cellular glucose homeostasis (GO:0001678),0.3326222882528131,0.9210156144665843,0.5981308411214953,0.8308848500449593,1.0,11/41,17.17%,NGFR;ERN1;ZBTB20;LRRC8D;PRKAA1;PDK3;PRKAA2;GCK;FOXK1;PIK3R2;SIRT1
prerank,positive regulation of angiogenesis (GO:0045766),0.2949588373384531,0.9206684383216475,0.6179906542056075,0.8311534912277093,1.0,11/108,6.64%,IL1B;KLF4;ITGAX;CD40;PTGIS;VEGFC;BTG1;HIPK2;HIPK1;PIK3R6;PDPK1
prerank,regulation of cellular component organization (GO:0051128),0.2843419760025617,0.9205380464596271,0.6370875995449374,0.8309637740142501,1.0,34/135,18.80%,SGK3;RAP1A;ITCH;CD36;RASGRP2;MAD2L2;RAPGEF2;CD177;PICALM;BCAR1;TMC8;STK38L;LATS1;SETD5;HIP1;METTL4;PTPN1;IL17RB;NET1;PACSIN2;SLITRK4;ROCK1;STON1;AP2S1;SNX12;IRAK3;SEMA4D;ABL2;TRAF2;BBS10;NUBP1;NCLN;ARHGEF11;PINK1
prerank,positive regulation of actin filament polymerization (GO:0030838),0.3329066556298618,0.9203408014063896,0.5775623268698061,0.830894946723379,1.0,7/44,10.61%,HCK;PRKCE;CARMIL1;PTK2B;ARPC4;SNX9;VASP
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",-0.2780272767761438,-0.920125672741702,0.5882352941176471,0.8537769034270215,1.0,15/39,28.18%,GTF2H2;POLD3;GTF2H1;UBC;ERCC2;PCNA;RFC3;GTF2H3;OGG1;GTF2H5;UBA52;ERCC1;RFC2;GTF2H4;DDB1
prerank,negative regulation of ERBB signaling pathway (GO:1901185),0.342977625547535,0.9197754880630656,0.5961538461538461,0.8315338212551637,1.0,10/39,14.36%,EPS15;CBL;CDC42;PTPN12;TSG101;GRB2;EPS15L1;STAM;MVP;PTPRJ
prerank,protein destabilization (GO:0031648),-0.28723501527755557,-0.9196341435804007,0.5620689655172414,0.8538727071426444,1.0,6/32,8.07%,PRKN;CAPN3;SENP2;FBXL3;BTRC;GGA3
prerank,androgen metabolic process (GO:0008209),0.37611403893594875,0.9195593369036373,0.5714285714285714,0.8315316614016872,1.0,4/18,15.78%,HSD17B7;DHRS9;HSD17B11;MED1
prerank,positive regulation of protein import into nucleus (GO:0042307),0.35900319926140833,0.9195222687917577,0.562874251497006,0.8311321487877597,1.0,11/28,18.43%,UBR5;FLNA;RBM22;ZPR1;HCLS1;HDAC3;TGFB1;PSEN1;PIK3R2;BAG3;PRKCD
prerank,blood vessel diameter maintenance (GO:0097746),0.34675194802389653,0.9195031159189246,0.5742024965325936,0.8307076720578269,1.0,2/34,2.21%,ACE;ACE2
prerank,translation (GO:0006412),0.28022833903811317,0.9188741426955898,0.6598712446351931,0.8315113953152398,1.0,59/208,21.91%,ZAR1;RPL5;NOA1;MRPL57;RPS10;FARS2;RPL37A;MRPL55;VARS1;RPL6;MRPL18;RPS18;DARS2;RPS14;RPL35A;RPL22L1;MRPL13;RPL13;ETF1;RWDD1;EEF1G;RPS3;IGF2BP3;RPS21;FARSB;RPL34;RPLP0;PTCD3;RPL19;RPL11;RPL30;TMA7;RPS2;RPL4;RPL7;DRG2;RPS15A;MRPS6;RPS4X;MRPS33;HARS2;GSPT1;RPL32;TUFM;RPSA;ABCE1;RPS13;MRPS15;RPS6;RPL18A;RPS27;RPLP2;EEFSEC;RPL22;RPS7;AARS1;MRPS12;RPS12;TARS1
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),-0.3962811593731741,-0.9187970455812354,0.569047619047619,0.8547545641301131,1.0,3/10,7.75%,SYNGR1;DLG4;NETO1
prerank,transition metal ion homeostasis (GO:0055076),0.34892678344975053,0.918529956128789,0.5919881305637982,0.8317233240036812,1.0,9/28,15.19%,ABCB7;PICALM;HEPH;TMC8;B2M;HMOX2;IREB2;CUTC;XIAP
prerank,positive regulation of vasculature development (GO:1904018),0.29757220642540844,0.9173715885714522,0.6140142517814727,0.8335788137214081,1.0,10/94,6.64%,IL1B;ITGAX;CD40;PTGIS;VEGFC;BTG1;HIPK2;HIPK1;PIK3R6;PDPK1
prerank,negative regulation of tumor necrosis factor production (GO:0032720),0.33187568271820533,0.917178953093428,0.5863509749303621,0.833503331518276,1.0,4/41,3.76%,RARA;PTPN22;LILRB1;PTPN6
prerank,regulation of proteolysis (GO:0030162),0.3305300723526653,0.9170835492101577,0.5826446280991735,0.8332197253306107,1.0,8/48,7.45%,ITCH;DNAJC1;SPOP;FBXW11;PARL;NEDD8;GSAP;TRAF3
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.380645157446443,0.9169621424683603,0.5748407643312102,0.8330162568261271,1.0,5/20,15.91%,HEXIM1;PTEN;LATS1;LATS2;APC
prerank,sulfur compound biosynthetic process (GO:0044272),0.29917421018456364,0.9164481499305006,0.6282051282051282,0.8336086089357184,1.0,23/104,18.66%,ST3GAL1;ST3GAL4;B4GALT5;GSTA3;GSS;GGTA1;CHST12;TPK1;PAPSS1;PAPSS2;ACAN;NCAN;SLC10A7;CHST15;UST;GSTP1;CSGALNACT1;CHSY3;GLCE;MGST3;GGCT;VCAN;DSEL
prerank,phosphatidic acid biosynthetic process (GO:0006654),-0.262384824366914,-0.916318258188487,0.6186770428015564,0.859680158933569,1.0,9/46,11.76%,PLD1;DGKZ;LPCAT1;SLC27A1;PLA2G4A;DGKQ;GPAM;DDHD2;ABHD4
prerank,cell junction maintenance (GO:0034331),0.4072746168413664,0.9158129274095834,0.5869565217391305,0.834440612553454,1.0,2/14,3.32%,CLDN1;CD177
prerank,negative regulation of interleukin-1 beta production (GO:0032691),0.38395436212353573,0.9156728312899374,0.5609375,0.834270332148042,1.0,5/19,14.82%,FFAR4;CARD16;GIT1;NLRP3;GSTP1
prerank,engulfment of apoptotic cell (GO:0043652),0.4061144495340893,0.915618854313787,0.5853658536585366,0.8339134801922653,1.0,6/15,15.64%,RAC2;XKR4;RAC1;MEGF10;RHOG;THBS1
prerank,early endosome to late endosome transport (GO:0045022),0.3802861032879721,0.9151054569785569,0.6025437201907791,0.8344941477084487,1.0,3/20,8.94%,LMTK2;RAB7A;SNF8
prerank,snRNA 3'-end processing (GO:0034472),-0.33146257586464717,-0.9148061194212747,0.5805555555555556,0.8622579632142762,1.0,7/19,20.85%,INTS6L;INTS8;EXOSC9;EXOSC5;INTS1;EXOSC3;INTS7
prerank,organelle fission (GO:0048285),-0.29801517269386946,-0.9147068616482229,0.5767045454545454,0.8614479457972285,1.0,4/24,9.44%,PRKN;GDAP1;MFF;DNM1
prerank,protein homotrimerization (GO:0070207),0.4121813588309805,0.9147039208254757,0.5825242718446602,0.8343577294922944,1.0,3/14,13.83%,ALOX5AP;SLC1A5;PNPT1
prerank,protein trimerization (GO:0070206),0.4121813588309805,0.9147039208254757,0.5825242718446602,0.8343577294922944,1.0,3/14,13.83%,ALOX5AP;SLC1A5;PNPT1
prerank,plasma membrane repair (GO:0001778),0.42142637076498385,0.9141752549329657,0.5752066115702479,0.8349826832997896,1.0,5/13,19.86%,DYSF;MYH9;ARL8B;MYOF;ANXA6
prerank,modulation by host of symbiont process (GO:0051851),-0.28943898644833105,-0.9140308889551122,0.589171974522293,0.8620252745614723,1.0,17/31,34.32%,CX3CR1;TARDBP;HPN;SMARCB1;SNW1;CCL3;SP1;HMGA2;NAPEPLD;RRP1B;CHD1;TAF11;CTDP1;CCL5;LEF1;TFAP4;SMARCA4
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),-0.38346007462351206,-0.9135249690451436,0.6025,0.86210534588349,1.0,3/11,14.85%,TREM2;AKAP6;ALG10B
prerank,positive regulation of cation transmembrane transport (GO:1904064),-0.2688266354936247,-0.9134954336882206,0.6014760147601476,0.8611206399513193,1.0,10/41,15.01%,KCNMA1;KCNJ2;ANK2;KCNN2;KCNMB2;AKAP6;KCNJ6;KCNN3;KCNJ9;GABBR1
prerank,positive regulation of protein kinase B signaling (GO:0051897),0.2834208790048025,0.9133899253316585,0.6342541436464089,0.8361251492565656,1.0,38/150,20.30%,FLT3;FYN;RET;FGF5;FGF22;NRG2;KL;RAC2;GRB2;PDPK1;ENG;RAC1;HGF;CPNE1;HIP1;RTN4;PIK3CA;CASS4;KIT;HCLS1;TGFB1;FGFR3;PTPRJ;IL18;MAZ;RHOG;FRS2;THBS1;INSR;PIK3R2;HAX1;PINK1;PIK3R5;FGFR1;PARK7;PTK2;TSPYL5;STRN
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.32886467667652863,0.9132107768359351,0.5886426592797784,0.8360131780230391,1.0,4/43,3.76%,RARA;PTPN22;LILRB1;PTPN6
prerank,regulation of phosphorylation (GO:0042325),0.28957978247764016,0.9130621726924233,0.6314606741573033,0.8358679521148362,1.0,30/120,18.67%,LYN;STAP1;NUP210;PRKAG2;CCDC88C;CCDC88A;IKBKB;PRKRIP1;GLMN;CDKN2C;NUP98;ANKLE2;SLAMF8;FN1;PRKAG1;APP;NDUFS4;BTBD10;NUP153;STAT2;ROCK1;THBS1;SEH1L;PSEN1;GCK;SIRT1;RAD17;NUP93;PIN1;FZD7
prerank,positive regulation of autophagy (GO:0010508),0.302702528993931,0.9130618024827155,0.6179640718562874,0.8354095252797265,1.0,18/81,15.47%,LRRK2;DAPK1;PIK3C2A;PLEKHF1;ATF6;WAC;SVIP;CAMKK2;TRIM14;FOXO3;PRKAA1;HTT;MAP3K7;SH3BP4;PRKAA2;ROCK1;FBXO7;TBK1
prerank,neuron migration (GO:0001764),0.3286632856275654,0.9129753405160393,0.5854304635761589,0.8351112025957091,1.0,9/48,8.19%,SDCCAG8;NDNF;CELSR1;NAV1;RAPGEF2;CEP85L;PAFAH1B1;DDIT4;RAC1
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),-0.3297017927052831,-0.9128599748091965,0.5945945945945946,0.8616740525559526,1.0,9/17,30.45%,ALG8;MPDU1;ALG2;ALG9;ALG1;ALG6;ALG3;DOLPP1;DOLK
prerank,DNA catabolic process (GO:0006308),0.4335614356646722,0.9127948235858107,0.5934256055363322,0.8350284405038072,1.0,4/11,19.58%,XRN2;DFFB;SETMAR;DNASE1L1
prerank,protein localization to condensed chromosome (GO:1903083),-0.38109346433737085,-0.9127621780346716,0.5886889460154242,0.8608906235579574,1.0,7/12,34.39%,IK;BUB3;ZW10;KNL1;SPDL1;MIS12;CDK1
prerank,nuclear membrane disassembly (GO:0051081),0.4070352678819367,0.9126535132921492,0.6017094017094017,0.8348562290826372,1.0,1/14,1.25%,VRK1
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",0.36460293165549496,0.912047792514709,0.5913461538461539,0.8356064010515912,1.0,10/25,17.20%,KAT7;HTATSF1;SCAF8;SETD5;CCNT2;CCNT1;EAF1;HMGN1;ELL;SUPT4H1
prerank,protein localization to cell periphery (GO:1990778),0.2859655389986595,0.9109857932882516,0.6419612314709237,0.8372828931130161,1.0,32/133,17.90%,RAP1A;TTC7A;PLEKHF1;C2CD5;RAB3D;RAPGEF2;IKBKB;EHD2;KCNIP3;RAB34;FLNA;S100A10;F11R;EZR;ZDHHC23;TSPAN14;TSPAN33;PACS2;PACS1;RAB40B;PIP5K1A;ROCK1;EFR3A;RAB29;EHD1;ZFYVE27;TSPAN15;TSPAN5;MYADM;TSPAN17;EHD3;ZDHHC3
prerank,regulation of cellular biosynthetic process (GO:0031326),0.3614655592041211,0.910896987396474,0.5967976710334789,0.8370143406040482,1.0,10/28,18.35%,CD47;PRKAG2;JAK2;PRKAB2;RAC1;TNFRSF1B;PRKAA2;MED1;SIRT1;CTNS
prerank,cellular response to hydroxyurea (GO:0072711),-0.3974946310753001,-0.9106792014378922,0.568075117370892,0.8648723903961275,1.0,5/10,23.67%,BLM;RTF2;NSMCE3;DDX11;TIMELESS
prerank,aortic valve morphogenesis (GO:0003180),-0.291590186237635,-0.9104941784028361,0.5830508474576271,0.8642713307060721,1.0,4/30,12.71%,ROBO2;ROBO1;SLIT2;SLIT3
prerank,glial cell differentiation (GO:0010001),0.3515227335855675,0.9103714077924939,0.5709876543209876,0.8376128283028516,1.0,3/28,4.08%,ADGRG6;STAT3;MYRF
prerank,regulation of postsynaptic membrane potential (GO:0060078),0.3475541043834606,0.9098698261859858,0.5948644793152639,0.8381921484377527,1.0,2/34,3.56%,LRRK2;CHRNA4
prerank,inositol phosphate-mediated signaling (GO:0048016),0.37549344718860445,0.9097933261301232,0.5711974110032363,0.8378936091007342,1.0,6/19,24.95%,PPP3CA;HRH1;NFATC3;NFAT5;NFATC2;PPP3CC
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.37123619497537713,0.9094711220117632,0.5811209439528023,0.8380653146780553,1.0,10/22,22.73%,IKBKB;CRY2;PPP1R15A;FKBP1B;LGALS3;ROCK1;PTPA;TIPRL;GSK3B;TNF
prerank,negative regulation of protein secretion (GO:0050709),0.3326124746046828,0.9093119581191459,0.5881542699724518,0.8379166581453132,1.0,7/38,13.78%,IL1B;RAB11FIP1;ADRA2A;OPRM1;PSMD9;REST;SIRT4
prerank,negative regulation of kinase activity (GO:0033673),0.31473407140233656,0.9091847741022007,0.5959849435382685,0.8377214407900206,1.0,15/62,18.56%,PTPRC;PPP2R5A;PRKAG2;PRKRIP1;PDPK1;PAK2;GSKIP;DBNDD2;TAF7;AKT1;GSTP1;SPRED1;RB1;TAB1;DEPTOR
prerank,regulation of hormone secretion (GO:0046883),-0.35432190667339525,-0.9089255886124105,0.5868421052631579,0.8669393870248324,1.0,4/15,18.71%,SNX6;SCG5;SOX11;VAMP3
prerank,Golgi to lysosome transport (GO:0090160),0.4221881307593932,0.908419097183586,0.5787610619469027,0.8388008492589801,1.0,4/11,17.86%,LAPTM5;AP1G1;ANKFY1;EHD3
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),0.36955077460996943,0.9083297003616116,0.5646153846153846,0.8385212439970933,1.0,3/21,8.20%,EXT1;SULF2;XYLT1
prerank,negative regulation of RNA splicing (GO:0033119),0.3879358321518529,0.908252083388425,0.5646687697160884,0.8382186202624397,1.0,4/19,9.17%,PTBP3;SRSF10;SAP18;SRSF4
prerank,regulation of smooth muscle contraction (GO:0006940),-0.3163364761843995,-0.9081365763282336,0.5810473815461347,0.8677508935246302,1.0,3/20,6.11%,CHRM3;CHRM2;SETD3
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),-0.36447172756360885,-0.9081269169214088,0.6040609137055838,0.8667236140488968,1.0,7/13,27.11%,ALG8;MPDU1;ALG2;ALG9;ALG1;ALG6;ALG3
prerank,positive regulation of mitotic nuclear division (GO:0045840),0.3398315250870871,0.9077671840629047,0.5787234042553191,0.8386817838939202,1.0,2/34,2.62%,IL1B;CUL3
prerank,polyamine metabolic process (GO:0006595),-0.371605524159389,-0.9075173193703512,0.5666666666666667,0.8671004533275556,1.0,6/13,31.48%,SMOX;HDAC6;PAOX;ODC1;SAT2;DHPS
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),0.3916219391215441,0.9074913318489809,0.5965189873417721,0.8387478355321503,1.0,4/17,11.65%,PPARG;PTEN;PDCD4;TAFA5
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),-0.30554728621009675,-0.9072507929462645,0.584375,0.8666347071766187,1.0,12/24,24.73%,CTC1;XRN1;SRC;TEN1;TERF1;TNKS2;EXOSC10;SLX4;HNRNPU;TINF2;PINX1;NAT10
prerank,regulation of DNA-dependent DNA replication (GO:0090329),0.4200258202424476,0.907020965944612,0.6010452961672473,0.8392713984090305,1.0,2/12,9.78%,KAT7;METTL4
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.41279357544256773,0.9070091686895436,0.6219512195121951,0.838841296291685,1.0,3/13,10.69%,MBD4;SMUG1;TDG
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",-0.24845775810697343,-0.9069586405112596,0.6297872340425532,0.866261593356733,1.0,22/54,26.21%,CNOT4;CRADD;PLK3;CNOT10;SOX4;PCNA;BAX;TFDP2;TFDP1;CNOT11;ARID3A;PCBP4;CNOT7;GADD45A;MDM4;CARM1;E2F1;CDKN1A;MDM2;RGCC;PLK2;RPL26
prerank,regulation of neurotransmitter secretion (GO:0046928),0.3469719391137346,0.9065834655308589,0.5797317436661699,0.839239284211087,1.0,4/32,10.75%,LRRK2;MCTP2;SLC30A1;SNAPIN
prerank,positive regulation of protein dephosphorylation (GO:0035307),0.3488155858337961,0.9065416415895103,0.5986206896551725,0.8388604867968873,1.0,12/32,18.57%,PPP2R5A;CD300A;DLC1;PPP1R15A;ANKLE2;PPP1R15B;TGFB1;DUSP26;PPP1R7;PTPA;PRKCD;PIN1
prerank,acetyl-CoA metabolic process (GO:0006084),-0.35072696186521146,-0.9064932794715878,0.5941644562334217,0.8663475894819948,1.0,6/15,25.12%,ACACA;PMVK;MLYCD;DIP2A;PPCS;ACSS1
prerank,protein import (GO:0017038),-0.2347748960645257,-0.9063043286196756,0.6797752808988764,0.8657761017260834,1.0,23/84,17.51%,APOE;ABCD2;E2F3;APPL2;LAMP2;NUP133;NUP155;IPO5;NUP188;GDAP1;TNPO2;PPP1R10;IPO13;NUTF2;CLU;SEC13;TSC2;NUP85;FAM53A;TPR;RAN;ABCD3;IPO7
prerank,protein kinase B signaling (GO:0043491),0.36691034872543177,0.9054731437129765,0.5785498489425982,0.840479204732745,1.0,3/23,6.44%,IL1B;PTEN;SETX
prerank,sphingolipid catabolic process (GO:0030149),0.40302666453933234,0.9054700600118267,0.6016260162601627,0.8400293991027602,1.0,2/15,5.04%,ACER3;SMPDL3A
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),-0.2979951332012979,-0.9054314713533197,0.5861027190332326,0.8669006965518679,1.0,10/26,23.38%,EPHA5;KLF7;EFNA5;C2CD2L;GPLD1;ADCY8;STXBP4;PIM3;BRSK2;CDK16
prerank,regulation of fat cell differentiation (GO:0045598),0.3018255789039039,0.9054044793424972,0.6,0.8396907314889975,1.0,13/74,15.15%,CREB1;PPARG;LMO3;WDFY2;ZFP36L2;IL6;ID2;CREBL2;CCDC71L;AKT1;TGFB1;GPS2;ASXL2
prerank,positive regulation of CREB transcription factor activity (GO:0032793),0.38240356505717565,0.9048666807867412,0.5500794912559619,0.8402447027741934,1.0,6/18,16.32%,CAMK1D;RPS6KA5;LPAR5;CRTC3;LRP8;RELN
prerank,regulation of oxidative stress-induced cell death (GO:1903201),-0.38041302854207604,-0.9042245929038825,0.585812356979405,0.8687268603677608,1.0,1/11,0.12%,PRKN
prerank,regulation of mRNA polyadenylation (GO:1900363),0.3864052807168341,0.9041674565857093,0.5875796178343949,0.8412040689156497,1.0,6/17,15.48%,VIRMA;RNF20;ZC3H3;NUDT21;CCNT1;NCBP1
prerank,protein neddylation (GO:0045116),0.3995168058264509,0.90408348340565,0.5646481178396072,0.8408992646892691,1.0,3/13,11.52%,DCUN1D1;NEDD8;DCUN1D3
prerank,positive regulation of vasoconstriction (GO:0045907),-0.3610251204454921,-0.9040379517233835,0.5764705882352941,0.868132745060229,1.0,8/13,54.15%,ADRA1B;ADRA1A;CAV1;SMTNL2;AVPR2;TBXA2R;OXTR;AVPR1A
prerank,positive regulation of telomere maintenance (GO:0032206),0.3491877676692381,0.9034860800541773,0.6129496402877698,0.8416186437198429,1.0,7/31,15.12%,PKIB;MRE11;TNKS;MAP3K4;ATRX;AURKB;MAPK1
prerank,negative regulation of cellular catabolic process (GO:0031330),0.3113557714572985,0.9033861836041728,0.6248366013071895,0.8413548554661644,1.0,12/63,13.81%,PTPN22;MCL1;STAT3;EIF4G3;IL10RA;SORL1;HP;HGF;TLK2;TAB3;AKT1;ROCK1
prerank,cellular response to hypoxia (GO:0071456),0.28406798300242314,0.903357749448084,0.6357308584686775,0.8409498574728514,1.0,21/126,12.96%,LIMD1;NDNF;PSME3;PTGIS;PSMB7;PSME2;HIPK2;ELOB;LMNA;CARD16;PSME4;BACH1;ACAA2;PSMB8;PSMA5;PSMD9;PSMB3;PSMD6;PSMC4;PSMD10;PSMB1
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),-0.2816646247122404,-0.9030570537391568,0.6223776223776224,0.8694176432139717,1.0,4/33,4.22%,PRKG1;MEF2C;AIF1;APOD
prerank,extracellular matrix disassembly (GO:0022617),0.3170449713995288,0.9030227690373935,0.6162790697674418,0.8411545264351501,1.0,4/53,6.14%,CD44;LCP1;MMP1;CAPN2
prerank,pseudouridine synthesis (GO:0001522),0.414866259451533,0.903009413300829,0.5855704697986577,0.840731801894655,1.0,5/13,21.47%,NHP2;PUS3;PUS1;PUS7L;TRUB2
prerank,cellular response to interferon-beta (GO:0035458),0.40707663177410053,0.9017538567088531,0.597682119205298,0.8426949396165134,1.0,7/14,25.02%,STAT1;ACOD1;PNPT1;AIM2;CDC34;UBE2K;IRF1
prerank,synaptic vesicle transport (GO:0048489),0.4276893515480885,0.9016633481964457,0.5979557069846678,0.8424334296809525,1.0,4/11,14.63%,KIF5B;SYNJ1;SNAPIN;KIF5A
prerank,response to interferon-beta (GO:0035456),0.3706777105400191,0.9011065770022331,0.6059701492537314,0.843072538020971,1.0,10/22,22.85%,PLSCR1;STAT1;ACOD1;PNPT1;IFITM3;IFNAR2;AIM2;CDC34;UBE2K;BST2
prerank,cellular amide metabolic process (GO:0043603),-0.22461729466023017,-0.9001817600084451,0.7358490566037735,0.8752075536684579,1.0,44/102,29.41%,CERK;PCCA;MCCC1;PLA2G15;ST6GAL1;PLPP3;MTHFD2L;ATF4;PANK2;PLPP1;ACSF2;MTHFS;AASDHPPT;ABHD4;ACOT9;SGPL1;NLN;GPAT4;ACOT7;AEBP1;ORMDL3;MLYCD;NAPEPLD;ABCB9;PPP2R1A;OXSM;ACOT6;PDZD11;PLAAT3;CPE;DHFR;SMPD3;ORMDL1;ACOT8;SHMT2;FPGS;ALDH1L1;MTHFD1;SMPD1;SLC46A1;SMPD2;ACSL6;ABCA2;CPD
prerank,phosphatidylserine metabolic process (GO:0006658),0.34018727562856577,0.9001194962023956,0.5870503597122302,0.8446156344861099,1.0,2/32,2.32%,PLA1A;PLSCR1
prerank,carboxylic acid transmembrane transport (GO:1905039),0.3284154318522069,0.9000618644914462,0.6027972027972028,0.8442763319984629,1.0,5/40,6.93%,SLC23A2;SLC23A1;SLC38A10;SLC25A30;ABCC1
prerank,chaperone-mediated protein complex assembly (GO:0051131),0.3716509145565753,0.8995762995022841,0.616822429906542,0.8447425315038921,1.0,2/20,2.48%,LONP1;HSPA1A
prerank,regulation of sprouting angiogenesis (GO:1903670),-0.27532543671745124,-0.899470695006985,0.6118881118881119,0.8758005693024521,1.0,7/33,11.95%,TJP1;GLUL;FGF2;EPN1;EPN2;JAK1;VEGFA
prerank,protein autoubiquitination (GO:0051865),0.30796576937489784,0.8992570120586507,0.6167979002624672,0.8449539151194316,1.0,17/61,17.79%,ITCH;DTX3L;CUL3;RNF146;RNF213;UBE2D3;RNF141;WWP2;RNF13;TRIM71;TRIM17;SH3RF1;UHRF2;RNF122;RNF41;TRAF2;RNF19B
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),0.33715504836261534,0.8992200654034431,0.6028985507246377,0.8445609321072007,1.0,3/30,3.31%,KCNE3;NEDD4L;KCNQ1
prerank,post-translational protein modification (GO:0043687),0.2641797746422494,0.8972831322134456,0.7245934959349594,0.8479666798116422,1.0,55/332,14.05%,FEM1C;DTL;TNC;PSME3;ASB5;CUL3;CUL5;NOTUM;KLHL11;LAMB1;PSMB7;GPC3;FBXW7;PSME2;DCAF5;FBXW11;FBXL8;DCUN1D1;SHISA5;LGALS1;FBXW2;NEDD8;WFS1;ATG5;ELOB;UBXN7;FBXO4;COP1;PSME4;IL6;COPS3;SUMF2;FBN1;FBXO32;PSMB8;PSMA5;PSMD9;FN1;MBTPS1;KLHL5;SUMF1;PTP4A2;PRSS23;PSMB3;DCUN1D3;PSMD6;PSMC4;APP;PSMD10;PSMB1;FBXL12;DCAF10;KTN1;DNAJC3;FBXO30
prerank,response to zinc ion (GO:0010043),0.3574139282628335,0.8972698138969772,0.5985185185185186,0.8475447044222103,1.0,3/25,6.72%,SLC30A4;HAAO;CRIP1
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),-0.3701152448642827,-0.8971875593416904,0.5985221674876847,0.8791379250471049,1.0,5/11,34.73%,PKD2;CALM1;GSTO1;FKBP1A;CALM2
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),-0.3701152448642827,-0.8971875593416904,0.5985221674876847,0.8791379250471049,1.0,5/11,34.73%,PKD2;CALM1;GSTO1;FKBP1A;CALM2
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),0.4130338035551189,0.896989302606363,0.6092943201376936,0.8476253752757089,1.0,4/13,15.48%,FIP1L1;TUT1;NUDT21;NCBP1
prerank,limb development (GO:0060173),-0.2933016245464435,-0.896820887676205,0.6276923076923077,0.8789679449296922,1.0,6/28,14.26%,CHD7;SALL1;IQCE;ZNRF3;GLI3;BMPR1B
prerank,glycolipid biosynthetic process (GO:0009247),0.3293365891195197,0.896744366091423,0.61212976022567,0.8476488256885802,1.0,3/38,3.54%,ST3GAL4;ST8SIA1;ST8SIA6
prerank,peptidyl-methionine modification (GO:0018206),-0.37229346340651054,-0.8963744159854552,0.6070528967254408,0.8789005990949506,1.0,2/12,3.63%,METAP1D;METAP2
prerank,response to hexose (GO:0009746),-0.2919040719961192,-0.896263260872642,0.6114457831325302,0.8781342693896472,1.0,6/25,18.06%,PFKL;EIF2B5;EIF2B4;SLC2A5;GPLD1;TCF7L2
prerank,cortical actin cytoskeleton organization (GO:0030866),0.3736338850776422,0.8953820813842975,0.6043276661514683,0.8498058821424225,1.0,5/20,17.98%,LCP1;IKBKB;ROCK1;FHOD1;FMNL1
prerank,fatty acid transport (GO:0015908),0.385422107754419,0.8950693841021844,0.5878594249201278,0.8499662858525049,1.0,2/17,2.75%,PPARG;CD36
prerank,positive regulation of phosphatase activity (GO:0010922),-0.31359442317575026,-0.8949502260483816,0.5852272727272727,0.8801006233653759,1.0,7/21,18.44%,MEF2C;MAGI2;MTMR9;CALM1;GPLD1;PLEK;HSP90AB1
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),0.405861555264579,0.8949487144797517,0.6203389830508474,0.8497549451004285,1.0,4/14,10.64%,MYO1C;VEGFC;PGF;PIK3CA
prerank,acylglycerol homeostasis (GO:0055090),-0.31995738352792713,-0.8948644399918765,0.6158357771260997,0.8792543928710704,1.0,3/20,13.39%,APOE;PNPLA8;APOC4
prerank,glucose metabolic process (GO:0006006),-0.24082698722522372,-0.8947974743624398,0.6763285024154589,0.8783598907357126,1.0,14/58,16.20%,APOD;GOT1;PPARGC1A;AKR1A1;PGK1;ATF4;GAA;PCK2;CRTC2;ENO2;SLC25A11;BRAT1;PER2;PGAM1
prerank,sterol metabolic process (GO:0016125),-0.25014429710659575,-0.8946667934737588,0.676056338028169,0.8776683637717293,1.0,6/60,7.51%,ABCA1;APOE;OSBPL1A;LIPA;ARV1;STARD3
prerank,positive regulation of calcium ion transport (GO:0051928),-0.2752377243846276,-0.8945740450103464,0.6132404181184669,0.8768291963555961,1.0,10/36,17.99%,CACNA1D;CACNB2;P2RX7;ANK2;P2RX4;CRACR2A;TRPC3;CAMK2A;CCL3;SPHK2
prerank,spindle assembly (GO:0051225),-0.23640206591434723,-0.8939901388053475,0.7093596059113301,0.8771084487476855,1.0,20/67,20.30%,STARD9;NUMA1;TUBGCP5;NEK6;PIBF1;GOLGA8B;CLASP2;NEK7;GOLGA2;LSM14A;MAPRE1;BCCIP;TUBGCP6;HAUS4;SMC1A;RAB11A;SPICE1;HAUS5;MAP9;TUBGCP2
prerank,positive regulation of endocytosis (GO:0045807),0.3172726142085887,0.893747265383343,0.6163101604278075,0.8516612458984851,1.0,10/45,13.71%,STAP1;NEDD4L;CBL;GPC3;CDC42;CBLL1;HIP1;B2M;CLIP3;ANKFY1
prerank,negative regulation of DNA recombination (GO:0045910),0.31852621468321884,0.8930793933781449,0.5967523680649527,0.8524716852371884,1.0,8/43,12.73%,MAD2L2;POLR2C;SMCHD1;KLHL15;MSH3;MSH6;DAXX;ATRX
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.2895797892060905,0.8930540276906361,0.6463700234192038,0.8520725245383892,1.0,15/104,10.52%,PPARG;HSPA1A;BMPR2;SORL1;LEMD3;HIPK2;UBE2D3;ADAM17;PDPK1;MTMR4;ACVR2A;SPRED3;SMAD4;PMEPA1;LEMD2
prerank,regulation of lymphocyte activation (GO:0051249),-0.36662726107926435,-0.8928968812108936,0.60381861575179,0.8786630043623989,1.0,1/12,0.27%,PAG1
prerank,regulation of pH (GO:0006885),0.43458549442024863,0.8926561432731928,0.5872193436960277,0.8523855563240446,1.0,1/11,2.03%,SLC9A7
prerank,cellular response to increased oxygen levels (GO:0036295),-0.3715822433687005,-0.8917828124627402,0.5855421686746988,0.8802424615253652,1.0,5/11,28.43%,ATP6AP1;ATP6V0D1;ATG7;FAS;CAV1
prerank,negative regulation of epithelial cell migration (GO:0010633),0.3371486672492633,0.8917451456831499,0.6134094151212554,0.8537111000721106,1.0,4/33,5.92%,SP100;MARVELD3;SYNJ2BP;PTEN
prerank,protein prenylation (GO:0018342),-0.38148866410234916,-0.8916531456635478,0.6130536130536131,0.879519505339578,1.0,5/10,30.56%,PGGT1B;FNTB;CHML;RCE1;FNTA
prerank,negative regulation of protein transport (GO:0051224),-0.3033777212335073,-0.8903238930126794,0.6030769230769231,0.8815228210348234,1.0,6/25,17.90%,APOE;ERP29;PPM1F;CYP51A1;PKDCC;RHBDF2
prerank,cellular response to hydrogen peroxide (GO:0070301),0.33558767758010194,0.8902903713258151,0.6104815864022662,0.8561570003265382,1.0,8/33,11.32%,MAP3K5;SETX;NFE2L2;IL6;RPS3;ANXA1;RIPK1;NET1
prerank,glycolipid metabolic process (GO:0006664),0.3206704968613196,0.8902388019548199,0.6271409749670619,0.8558050555137434,1.0,11/47,12.56%,ST3GAL4;GM2A;ST8SIA6;ESYT3;ESYT1;PSAP;ST6GALNAC3;SUMF2;FUCA1;SUMF1;ESYT2
prerank,protein import into mitochondrial matrix (GO:0030150),0.376242457150017,0.8902363950834485,0.6089030206677265,0.855352629206746,1.0,5/18,14.19%,GRPEL2;DNAJC19;TIMM21;TOMM40;TIMM50
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.3128972468786381,0.8901805374366475,0.6431424766977364,0.8550237716370436,1.0,14/52,18.89%,RAC2;FBXW7;BBC3;UBE2D3;ARIH2;CSNK2A2;YWHAZ;RNF31;MAPK8;SREBF2;UBE2J2;ATG13;PINK1;BAD
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),0.3927596272857615,0.8901297465072894,0.5959252971137521,0.8546782963116576,1.0,5/13,12.01%,WFS1;PPP1R15A;PTPN1;PPP1R15B;ATF6B
prerank,positive regulation of microtubule polymerization (GO:0031116),0.3492120723386277,0.8883715454429311,0.6145833333333334,0.8576641035731983,1.0,9/28,16.55%,PAK1;HSPA1A;MECP2;RAC1;GIT1;RPS3;CLASP1;OCLN;FES
prerank,positive regulation of ion transport (GO:0043270),0.31361632657188876,0.8881918426094662,0.6305220883534136,0.8575485377960771,1.0,7/48,6.83%,CCR1;KIF5B;ATP2B1;GDNF;ADRA2A;STIM2;WFS1
prerank,protein targeting (GO:0006605),0.2814680990593762,0.887950874681715,0.6735870818915801,0.8575088012758149,1.0,16/118,10.59%,AP1S3;VPS37C;MYO1C;SORL1;PEX16;PEX12;ZDHHC7;KATNB1;ZFAND6;ZDHHC6;DNAJC19;ZDHHC23;SEC63;PIKFYVE;TOMM40;FIS1
prerank,positive regulation of calcium-mediated signaling (GO:0050850),0.42272821132188,0.8873928016221483,0.6053571428571428,0.85814639691785,1.0,1/11,1.21%,PLCG2
prerank,protein localization to cilium (GO:0061512),-0.27354521521685216,-0.8873659048077152,0.6556291390728477,0.8873681319834982,1.0,12/32,26.67%,ATP6V1D;ZNF423;IFT20;ARL6;TTC21B;RABEP1;ARL3;TULP2;TULP3;TCTN2;TUB;NPHP4
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),-0.2468947722618331,-0.887215458202281,0.640495867768595,0.8856153796103294,1.0,33/56,33.66%,NDUFAF6;NDUFAF2;OXA1L;NDUFA7;NDUFB4;NDUFB2;NDUFV1;NDUFV3;NDUFS7;NDUFB3;FOXRED1;NDUFA5;NDUFB5;NDUFAF7;NDUFB9;NDUFB7;ACAD9;NDUFA13;TIMMDC1;NDUFAF1;BCS1L;NDUFB8;NDUFAB1;NDUFB6;NDUFS8;NDUFB10;TMEM126A;NDUFAF4;NDUFS3;NDUFS6;NDUFA11;NDUFAF8;NDUFB11
prerank,NADH dehydrogenase complex assembly (GO:0010257),-0.2468947722618331,-0.887215458202281,0.640495867768595,0.8856153796103294,1.0,33/56,33.66%,NDUFAF6;NDUFAF2;OXA1L;NDUFA7;NDUFB4;NDUFB2;NDUFV1;NDUFV3;NDUFS7;NDUFB3;FOXRED1;NDUFA5;NDUFB5;NDUFAF7;NDUFB9;NDUFB7;ACAD9;NDUFA13;TIMMDC1;NDUFAF1;BCS1L;NDUFB8;NDUFAB1;NDUFB6;NDUFS8;NDUFB10;TMEM126A;NDUFAF4;NDUFS3;NDUFS6;NDUFA11;NDUFAF8;NDUFB11
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",-0.269211033307702,-0.8871434054980564,0.6288659793814433,0.8847462105441106,1.0,14/37,28.18%,GTF2H2;POLD3;GTF2H1;UBC;ERCC2;PCNA;RFC3;GTF2H3;GTF2H5;UBA52;ERCC1;RFC2;GTF2H4;DDB1
prerank,positive regulation of protein polymerization (GO:0032273),0.3000308245067817,0.8864222711034138,0.6446173800259404,0.8595305816867473,1.0,10/65,10.61%,HCK;PRKCE;PAK1;CARMIL1;PTK2B;TPPP3;RAC1;RPS3;SNX9;VASP
prerank,iron ion homeostasis (GO:0055072),-0.24418611547748773,-0.8862938854856267,0.7095238095238096,0.8856494481767506,1.0,13/58,10.86%,FRRS1;SLC11A1;ABCG2;ATP6AP1;FLVCR1;SLC22A17;SLC11A2;TFRC;FTH1;ATP6V0D1;CAND1;FTL;HMOX1
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.3113320909782371,0.8862779113563423,0.6474358974358975,0.8593349842179342,1.0,8/56,10.08%,BMPR2;RBPMS;GDF1;BMP3;ENG;ACVR2A;SMAD4;PMEPA1
prerank,sno(s)RNA 3'-end processing (GO:0031126),-0.3755742531875815,-0.8862733671184739,0.6111111111111112,0.8846820609264695,1.0,4/11,19.78%,DKC1;EXOSC5;EXOSC10;EXOSC3
prerank,generation of neurons (GO:0048699),0.27122876562050874,0.8861261587137863,0.6967391304347826,0.8591649524061261,1.0,15/190,8.19%,IL1B;RUNX2;RUNX3;SDCCAG8;IER2;NDNF;CELSR1;RACGAP1;NAV1;RAPGEF2;CEP85L;MTPN;PAFAH1B1;DDIT4;RAC1
prerank,regulation of DNA recombination (GO:0000018),0.33337002782756897,0.8856115599522071,0.6408759124087591,0.8597364261552575,1.0,7/32,16.30%,MRE11;MSH3;PPP4R2;MSH6;SETD2;SPIDR;KPNA2
prerank,protein localization to microtubule organizing center (GO:1905508),-0.3437919210771969,-0.8855085723104738,0.6122994652406417,0.8853383493603112,1.0,8/15,38.40%,PIBF1;CEP83;CCDC14;NEDD1;CEP192;STIL;CEP131;SPAG5
prerank,regulation of neuron projection arborization (GO:0150011),-0.3365437807121082,-0.8852798030026449,0.609254498714653,0.8848240333113043,1.0,3/15,3.73%,MYO9A;GRIP1;DLG4
prerank,organonitrogen compound biosynthetic process (GO:1901566),0.2751077663242968,0.885210299181752,0.6994475138121546,0.860063482679945,1.0,29/151,16.42%,CERS6;ST3GAL4;ACER3;SLC44A2;B4GALT5;CERS1;ELOVL5;GSTA3;SAMD8;SGMS1;SGMS2;CEPT1;ELOVL6;PCYT1A;CSNK2A2;CSNK2A1;ARG2;SLC44A1;SPTSSB;SLC44A5;SGPP2;PCSK5;ASL;GSTP1;SGPP1;ASS1;FA2H;VAPA;HACD4
prerank,positive regulation of nervous system process (GO:0031646),0.37182647290281123,0.8851273406909421,0.5958466453674122,0.8597561982278703,1.0,2/18,4.08%,ITGAX;MYRF
prerank,regulation of neuroblast proliferation (GO:1902692),0.3984396032158776,0.8847929542921372,0.608,0.8599331813926006,1.0,1/15,0.22%,LRRK2
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.2624148870487475,0.8845235203597893,0.7593360995850622,0.8599777275249578,1.0,77/314,18.60%,FEM1C;ITCH;PSME3;NEDD4L;CUL3;CUL5;UBE2E1;TBL1XR1;PSMB7;FBXW7;PSME2;KCTD2;PELI1;UBE2D3;SPOP;DCAF12;FBXW11;FBXL8;FAF1;KLHL15;FBXO38;WFS1;NFE2L2;TRIM25;FBXO4;ERLIN1;CLOCK;UBR2;COP1;PCNP;PSME4;ATXN3;WWP2;TRIM71;UBE2W;PSMB8;KCTD5;PSMA5;PSMD9;DNAJB12;PSMB3;UBE2S;FBXL17;PSMD6;PSMC4;FOXRED2;PSMD10;UBE2G1;AREL1;PSMB1;FBXL12;VCP;UBE2J2;STT3B;PPP2R5C;AURKB;ANAPC7;KCTD13;UBXN11;RMND5B;RNF122;TAF1;HACE1;FBXL16;PSMD12;RB1;UBR3;MAEA;MAN1B1;SIRT1;ECRG4;HSPA5;SMURF2;ANAPC11;FZR1;FBXL14;ANAPC4
prerank,proteoglycan biosynthetic process (GO:0030166),0.3429665983458816,0.8844178526811086,0.6061493411420205,0.8597125788066001,1.0,5/31,8.20%,EXT1;BMPR2;CHST12;PXYLP1;XYLT1
prerank,DNA damage checkpoint signaling (GO:0000077),0.3446204348816013,0.8841871344490141,0.6240822320117474,0.8596724548949289,1.0,10/28,18.67%,CDC5L;CEP63;CLOCK;DOT1L;BRIP1;MAP3K20;DONSON;HUS1;RAD17;CHEK2
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),-0.3126743029096344,-0.8840823841451287,0.6264367816091954,0.8865277011173583,1.0,1/20,0.42%,IGF1
prerank,protein deacylation (GO:0035601),0.3565317355867748,0.8840253187355577,0.5981873111782477,0.8595098026641063,1.0,13/23,25.46%,NOTUM;ABHD17B;HDAC3;PPT1;SIRT1;ABHD17A;HDAC7;HDAC1;SIRT3;HDAC5;SIRT2;LYPLA1;SIN3A
prerank,regulation of protein-containing complex assembly (GO:0043254),0.27865135669321545,0.8839456073702342,0.6842105263157895,0.8592074657666848,1.0,27/110,17.99%,HCK;SYK;ATF7IP;CD36;SORL1;MMP1;EIF2AK2;SUMO1;CDC42;FAF1;TIRAP;SVIP;TMC8;RALB;LATS1;RPS3;SPIDR;LGALS3;VCP;TGFB1;RB1;AJUBA;TFIP11;TRAF2;BBS10;HSPA5;NCLN
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",0.3524624739709091,0.8837818148275369,0.6091603053435114,0.8590809649470054,1.0,5/24,12.18%,ITCH;UBE2N;CYLD;TAB3;MAP3K7
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),0.4090886823600347,0.8837640304456914,0.5959933222036727,0.8586615241097202,1.0,2/12,6.13%,WAC;CCND1
prerank,autophagy of peroxisome (GO:0030242),-0.3640267645065832,-0.8837595707270631,0.6020408163265306,0.8862267585450871,1.0,4/12,14.34%,NBR1;MAP1LC3B;USP30;SQSTM1
prerank,tRNA aminoacylation (GO:0043039),-0.2645041418225444,-0.8835975637090475,0.6825396825396826,0.8855901360589622,1.0,16/37,26.71%,YARS1;LARS1;NARS1;WARS2;LARS2;WARS1;GATB;GATC;IARS1;DARS1;KARS1;PPA2;FARSA;RARS1;CARS1;QRSL1
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),0.37611469769946543,0.8831301177838552,0.6107491856677525,0.8594163014991959,1.0,4/17,12.38%,MMGT1;EMC9;CAMLG;EMC10
prerank,organic cation transport (GO:0015695),-0.3063979031912757,-0.8827574667184391,0.649025069637883,0.8865108342078417,1.0,5/20,14.59%,SEC14L1;SLC25A26;SLC22A5;SLC5A7;SLC22A4
prerank,cellular response to nitrogen compound (GO:1901699),-0.3165202401074828,-0.8825919809550632,0.5950413223140496,0.8858765246066238,1.0,7/20,24.68%,EPG5;BLM;RTF2;NSMCE3;DDX11;TIMELESS;PDE12
prerank,positive regulation of macroautophagy (GO:0016239),0.31265600490463086,0.8825802267596392,0.6503957783641161,0.8599604157215813,1.0,15/48,18.80%,UVRAG;PIP4K2A;WAC;RALB;PIP4K2B;SLC25A5;HTT;MAP3K7;PRKAA2;FYCO1;TBK1;SIRT1;VPS13D;BAG3;PINK1
prerank,negative regulation of cartilage development (GO:0061037),-0.3495253628873756,-0.8825396939954792,0.6159600997506235,0.8849773790474137,1.0,1/13,1.22%,TGFBR1
prerank,negative regulation of leukocyte migration (GO:0002686),0.4129481653781113,0.8821663032006116,0.614100185528757,0.86028843162913,1.0,2/10,9.77%,CD300A;SLAMF8
prerank,negative regulation of G0 to G1 transition (GO:0070317),0.32901604749488766,0.8821139271921504,0.6111888111888112,0.8599347529031725,1.0,8/36,15.71%,UXT;RBBP8;RYBP;RBBP4;APAF1;L3MBTL2;EZH2;PHC3
prerank,posttranscriptional regulation of gene expression (GO:0010608),0.31999860053020557,0.8820281387268069,0.6360052562417872,0.8596411642684781,1.0,10/45,12.09%,MEX3D;RC3H1;MTPN;PUM2;TRIM71;PARP9;YTHDC1;NUDT21;FOXO3;APP
prerank,positive regulation of nuclear division (GO:0051785),0.3525290651866643,0.8818927773029178,0.6068249258160238,0.8594452673753263,1.0,1/25,0.33%,IL1B
prerank,protein localization to phagophore assembly site (GO:0034497),0.41474525938495926,0.8815421981504231,0.625,0.8597090230002126,1.0,5/11,21.63%,STX17;PACS2;WIPI2;ATG13;TRAPPC8
prerank,glucose 6-phosphate metabolic process (GO:0051156),0.36804111395917993,0.8815036691853084,0.6178623718887262,0.8593239659424878,1.0,8/21,16.97%,TALDO1;RPE;DERA;GPI;RBKS;PGM2L1;H6PD;GCK
prerank,cellular response to dsRNA (GO:0071359),0.38734224941963946,0.8814992419035431,0.5944625407166124,0.8588807669653247,1.0,4/15,13.79%,IFIH1;RALB;PQBP1;IFIT1
prerank,phosphatidylethanolamine metabolic process (GO:0046337),-0.28392741000294897,-0.8814846616722614,0.6698412698412698,0.8863645870796983,1.0,6/27,12.28%,PLA2G15;PNPLA8;SLC27A1;ABHD4;CHKA;PCYT2
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),0.4152808341506021,0.881398660410575,0.6356073211314476,0.8586188057264104,1.0,2/12,4.16%,CBLB;CBL
prerank,RNA processing (GO:0006396),0.27008982306514356,0.8811690453406146,0.7158234660925726,0.8586056813465022,1.0,51/176,20.93%,MBNL1;RSRC1;RBPMS;RNPC3;SNRPD2;PRPF6;PPP1R9B;NUFIP1;RBMS1;XRN2;SNRPB;SETX;RBMS2;TUT1;LSM5;MAGOHB;PRPF3;TENT2;RP9;SRSF4;DHX8;SLU7;CELF2;NUDT21;MTPAP;TUT7;DEDD2;DDX23;SNRPA1;CDK12;SF3A1;METTL3;SYNCRIP;TENT4B;NCBP1;CELF1;RBM39;AURKAIP1;TFIP11;SF3B3;SUPT4H1;CSTF3;SF3B2;SF3B1;DDX20;PDCD7;SF3A2;HNRNPC;LUC7L3;PRPF18;NONO
prerank,sulfate transport (GO:0008272),0.3939709267431495,0.880265881007911,0.6209150326797386,0.8598655208282859,1.0,2/14,5.59%,RACGAP1;SLC25A30
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.31414247327877626,0.8799251512592952,0.6243315508021391,0.8600750188345258,1.0,8/48,10.48%,BCL3;MCL1;HIPK2;HIPK1;CRIP1;DDIT4;MSH6;CASP2
prerank,branched-chain amino acid metabolic process (GO:0009081),0.3617504317692387,0.8798173955871127,0.6355421686746988,0.8593855093476247,1.0,8/20,17.96%,HIBADH;DLD;BCKDHA;BCKDHB;ACAT1;HIBCH;BCAT1;AUH
prerank,branched-chain amino acid catabolic process (GO:0009083),0.3617504317692387,0.8798173955871127,0.6355421686746988,0.8593855093476247,1.0,8/20,17.96%,HIBADH;DLD;BCKDHA;BCKDHB;ACAT1;HIBCH;BCAT1;AUH
prerank,apoptotic cell clearance (GO:0043277),0.33093526304084225,0.8798133074668276,0.6084425036390102,0.8589433816164878,1.0,9/30,15.64%,RARA;RAC2;SCARB1;XKR4;RAC1;ANXA1;MEGF10;RHOG;THBS1
prerank,pancreas development (GO:0031016),0.40053712996648894,0.8797469270103232,0.612565445026178,0.8586089497396808,1.0,3/12,16.73%,SELENOT;CCDC39;PROX1
prerank,neuron fate commitment (GO:0048663),-0.33661384786959275,-0.8796532651681126,0.6276346604215457,0.889582773246464,1.0,1/14,1.22%,TGFBR1
prerank,positive regulation of mitochondrial translation (GO:0070131),-0.33539445553889535,-0.8792770032930773,0.6381418092909535,0.8894413648888456,1.0,6/14,29.68%,RMND1;RCC1L;C1QBP;FASTKD3;MPV17L2;COA3
prerank,cellular response to oxygen levels (GO:0071453),-0.3839466443981179,-0.8791088478151794,0.6141552511415526,0.8887933809240679,1.0,3/10,9.87%,ATP6AP1;ATP6V0D1;CPEB4
prerank,positive regulation of macrophage activation (GO:0043032),0.3703772731129478,0.8790136689024385,0.6039933444259568,0.8595547489797174,1.0,5/17,18.02%,STAP1;IL33;THBS1;HSPD1;MMP8
prerank,regulation of axon regeneration (GO:0048679),0.4075735886368328,0.8789630417073281,0.6231404958677685,0.8592182671386085,1.0,2/12,4.11%,STK24;INPP5F
prerank,rRNA transcription (GO:0009303),-0.3161439477459723,-0.8789349132695207,0.6529562982005142,0.8881735943405059,1.0,6/17,20.56%,GTF3C3;GTF3C4;GTF3C2;GTF3C5;ANG;TCOF1
prerank,copper ion transport (GO:0006825),0.4120975897375666,0.8787297892885693,0.6048526863084922,0.8592085294069148,1.0,5/11,16.64%,ATP7A;ATOX1;COX17;CUTC;SLC31A1
prerank,nucleic acid metabolic process (GO:0090304),0.29850026018546644,0.8784446807055034,0.6733668341708543,0.8593141223854179,1.0,7/69,7.01%,DNA2;GTF2F2;FEN1;POLR2C;DNTT;XRN2;WRN
prerank,pyrimidine nucleoside catabolic process (GO:0046135),0.4277055061744249,0.8782472061208227,0.6227758007117438,0.8592368499887758,1.0,2/10,13.21%,UPB1;NT5C3A
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.3740205226883513,0.8781238045297982,0.6177924217462932,0.8590247390257681,1.0,2/18,3.22%,PTPN22;LAPTM5
prerank,ncRNA catabolic process (GO:0034661),-0.282659830780532,-0.8780462929449964,0.6565349544072948,0.8891466802691593,1.0,9/28,19.78%,XRN1;POP1;TRIR;EXOSC9;EXOSC5;DIS3L2;LIN28B;EXOSC10;EXOSC3
prerank,negative regulation of epithelial cell proliferation (GO:0050680),0.2960170360395018,0.8778848618083802,0.6801517067003793,0.8590358684786636,1.0,7/66,5.44%,RUNX3;MARVELD3;CASK;FBXW7;SYNJ2BP;STAT1;CAV2
prerank,signal transduction by p53 class mediator (GO:0072331),-0.27780177380882937,-0.8776751163784413,0.6624203821656051,0.8889229986522903,1.0,11/30,24.29%,FHIT;DDX5;MYO6;PYCARD;MYBBP1A;PPP1R13B;JMY;SESN2;ACER2;MDM4;HINT1
prerank,negative regulation of mitotic cell cycle (GO:0045930),0.31422382654340153,0.8775761452436457,0.6384105960264901,0.8591682870456594,1.0,11/45,19.50%,BCL6;BTG2;BTG1;NABP1;ZFP36L2;TGFB1;WEE1;TRIM35;AURKAIP1;FOXC1;FZD3
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),-0.3814274434354331,-0.8773744401448097,0.6133004926108374,0.8886280765810182,1.0,7/10,28.22%,ABCD2;NR1H2;LPGAT1;MID1IP1;MLXIPL;SLC45A3;NR1H3
prerank,regulation of nervous system development (GO:0051960),-0.26324103716024855,-0.8773140640286949,0.6631205673758865,0.8877512183634663,1.0,10/37,16.92%,CX3CR1;TENM4;CTNNB1;PTN;PTPRZ1;HMGB2;BHLHE41;CX3CL1;PER2;NSUN5
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),0.3518553122271416,0.8771955518157334,0.6226993865030674,0.8594642901609811,1.0,5/22,13.81%,RGS2;MTPN;IL6ST;SMAD4;ROCK1
prerank,regulation of actin polymerization or depolymerization (GO:0008064),-0.28186679579676943,-0.8766854147321171,0.6622073578595318,0.8881360886618169,1.0,8/28,18.77%,COTL1;RASA1;PFN1;FCHSD2;ARHGAP35;PFN2;CTTN;GBA2
prerank,post-Golgi vesicle-mediated transport (GO:0006892),0.2888383325352074,0.8764884282625572,0.6766826923076923,0.8603410009290295,1.0,12/88,12.09%,AP1S3;STXBP6;EXOC6;EPS15;SORL1;AP1S2;RP2;ARF1;GBF1;VPS13A;AP1G1;APP
prerank,cardiac muscle contraction (GO:0060048),0.3265444990117773,0.8764328999313096,0.637155297532656,0.8599974045053086,1.0,3/34,3.70%,TNNC1;KCNQ1;MYL4
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.3855738763782084,0.8764008388179111,0.6236044657097288,0.859611746766867,1.0,6/15,18.66%,CHST12;NCAN;UST;CSGALNACT1;VCAN;DSEL
prerank,regulation of fatty acid biosynthetic process (GO:0042304),0.3519144442269526,0.8763567086798931,0.6461769115442278,0.8592440690072868,1.0,4/26,7.71%,PRKAG2;ELOVL5;PRKAB2;ERLIN1
prerank,amyloid precursor protein metabolic process (GO:0042982),-0.3203103223624749,-0.8763504814091105,0.6277777777777778,0.8878373060381257,1.0,8/18,27.34%,APOE;PSEN2;BACE1;PSENEN;TMCC2;CLN3;APH1A;NSG1
prerank,embryonic digestive tract development (GO:0048566),-0.32291117647283885,-0.8763454996425134,0.6451612903225806,0.8868387740693888,1.0,6/18,16.72%,SALL1;FGFR2;GLI3;TGFB2;PKDCC;SOX11
prerank,chemical homeostasis (GO:0048878),0.30358801863507534,0.8760312914626252,0.6517285531370038,0.8594204083364773,1.0,7/61,7.51%,PPARG;NEDD4L;ZBTB20;SLC4A7;FBXW7;ACOX3;SLC4A8
prerank,positive regulation of viral transcription (GO:0050434),0.3537806458688185,0.875896861980068,0.6185243328100472,0.8592417324307895,1.0,7/25,18.81%,GTF2F2;POLR2C;NELFA;CCNT1;RSF1;SUPT4H1;MDFIC
prerank,membrane protein ectodomain proteolysis (GO:0006509),0.3666769891311103,0.8757488358186195,0.6422018348623854,0.8590637581967865,1.0,7/21,16.94%,MYH9;ADAM17;SPPL2A;ADAM19;BACE2;ADAM9;PSEN1
prerank,cellular response to glucagon stimulus (GO:0071377),0.37719208433036333,0.874616917915518,0.6179775280898876,0.8606763473447497,1.0,4/17,12.62%,CYSLTR2;PRKAR2A;ADCY7;ADCY5
prerank,positive regulation of DNA recombination (GO:0045911),-0.28467857089380394,-0.8739483523602741,0.6862745098039216,0.8911081736803795,1.0,10/27,17.36%,ERCC6;MMS19;TFRC;FUS;ZCWPW1;RIF1;SHLD2;ERCC2;HMCES;MRNIP
prerank,negative regulation of activated T cell proliferation (GO:0046007),0.4163987651115636,0.873921243938638,0.6376554174067496,0.8615673587657655,1.0,2/10,6.34%,RC3H1;PRNP
prerank,atrioventricular valve morphogenesis (GO:0003181),-0.3081235911945728,-0.8737397771102239,0.6260623229461756,0.8905323245413943,1.0,5/19,13.75%,TGFBR2;ACVR1;SLIT3;SOX4;TGFB2
prerank,regulation of response to DNA damage stimulus (GO:2001020),0.32074909412497926,0.8735499007603467,0.6593103448275862,0.8618394527342473,1.0,7/40,12.25%,MCL1;ARMT1;CRY1;UBE2N;ING2;PARG;SMG1
prerank,primary miRNA processing (GO:0031053),0.4137757150855392,0.8735462845032975,0.6167763157894737,0.8613982866247271,1.0,3/10,13.39%,DGCR8;SRRT;METTL3
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),0.37700263011199464,0.8732859407276562,0.6290571870170015,0.8614045026476976,1.0,7/17,15.56%,RBPJ;STAT1;PLXND1;PBX1;KAT2B;CREBBP;MAML1
prerank,neural crest cell migration (GO:0001755),-0.26427431372053817,-0.8732498844013354,0.6586206896551724,0.890574312386378,1.0,6/36,8.32%,ERBB4;NRP1;SEMA3D;SEMA3E;HTR2B;SEMA6D
prerank,negative regulation of Notch signaling pathway (GO:0045746),0.3429346655064828,0.8731860400187751,0.6296296296296297,0.8611544291437533,1.0,7/28,16.84%,LFNG;FBXW7;WWP2;AKT1;METTL3;TSPAN15;NIBAN2
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.3337840402787208,0.8728547293069112,0.6183844011142061,0.8613531349432534,1.0,4/32,13.25%,CXCL10;FAM3A;RNASE6;RPL30
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),0.32515246016207056,0.8728135547602135,0.6470588235294118,0.8609737950798243,1.0,9/35,13.11%,PPP1R12A;CD300A;CRY2;PPP1R15A;PPP1R2;FKBP1B;PPP1R15B;HTT;PPP6R2
prerank,pyrimidine nucleoside metabolic process (GO:0006213),0.39705585886992445,0.8724309465979097,0.643581081081081,0.8612412417568156,1.0,4/14,17.58%,UPB1;CAD;NT5C3A;ERH
prerank,eye photoreceptor cell differentiation (GO:0001754),0.4106037956802233,0.8721059885285758,0.6336805555555556,0.8614190525067473,1.0,1/12,2.37%,STAT3
prerank,hippo signaling (GO:0035329),-0.29252756359858306,-0.8711923253898004,0.6376404494382022,0.8941437567122729,1.0,7/26,11.74%,TJP1;AMOTL1;TJP2;SAV1;WWC1;FAT4;CASP3
prerank,embryonic digit morphogenesis (GO:0042733),-0.3207771708747075,-0.8707891409466656,0.6361256544502618,0.8940085890597762,1.0,3/18,11.77%,SALL1;WDPCP;GLI3
prerank,regulation of histone modification (GO:0031056),-0.34786080026270977,-0.8707307849423341,0.6418269230769231,0.8931299947641005,1.0,4/13,11.55%,FLCN;HPF1;AKAP8;AKAP8L
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),-0.2930924908150031,-0.8706741410194291,0.64576802507837,0.8922408139724973,1.0,13/24,32.66%,ABCG2;FLVCR1;FECH;ALAS1;CPOX;COX10;FXN;SLC25A38;PGRMC1;ABCB10;HMBS;UROD;ATP5IF1
prerank,regulation of cellular localization (GO:0060341),0.3117315118200332,0.8705538986315557,0.6525759577278731,0.8638490268554765,1.0,7/46,12.62%,LRRK2;LYN;UNC13D;TRIM46;DVL3;DYNC1H1;ADCY5
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),0.40643044441144566,0.8705217081358217,0.6219512195121951,0.8634681562692477,1.0,1/11,1.24%,BCL3
prerank,regulation of protein localization to cell periphery (GO:1904375),-0.3218679540112026,-0.8701631900619258,0.6476964769647696,0.892343425698722,1.0,7/18,17.79%,ZDHHC2;MMP14;VTI1B;CDK5;VAMP8;AR;STX8
prerank,gene expression (GO:0010467),0.2574987334131143,0.8701354191729637,0.8004094165813715,0.8637399189701583,1.0,87/348,20.32%,ZAR1;BCL3;RPL5;NUP210;RBPMS;SORL1;RPS10;POLR3A;POLR2C;SCX;RPL37A;MRPL55;RPL6;MRPL18;NUFIP1;RBMS1;RPS18;XRN2;SETX;RPS14;RPL35A;THOC3;NUP98;RBMS2;FIP1L1;GALNT2;MAGOHB;TSPAN14;MRPL13;RPL13;NFKBIB;SRSF4;CREBL2;DHX8;SLU7;RPS3;TSPAN33;IGF2BP3;RPS21;CELF2;FARSB;UPF2;YTHDC1;DEDD2;RPL34;RPLP0;BAZ2A;SMG1;AGFG1;NUP153;RPL19;RPL11;RPL30;RPS2;RPL4;RPL7;SYNCRIP;RPS15A;CPSF3;TSPAN15;NCBP1;MRPS6;RBM39;RPS4X;MRPS33;TSPAN5;SEH1L;SMG6;TFIP11;HARS2;HSPD1;TSPAN17;NUP93;GSPT1;RPL32;RPSA;ANGPT2;DDX20;RPS13;MRPS15;UPF3B;WDR33;CDC40;RPS6;RPL18A;RPS27;RPLP2
prerank,cardiac ventricle morphogenesis (GO:0003208),-0.2597156909196898,-0.8701074705748967,0.7157894736842105,0.8914753819407284,1.0,8/41,16.72%,TGFBR2;MEF2C;SMAD7;FGFR2;SOX4;TGFB2;PKP2;SOX11
prerank,sodium ion import across plasma membrane (GO:0098719),0.36958063136581915,0.8696169864146933,0.6166134185303515,0.8642702159754245,1.0,2/17,3.90%,SLC9A7;HCN4
prerank,positive regulation of ruffle assembly (GO:1900029),-0.3481041749937658,-0.8694384641571179,0.6209476309226932,0.8919704576298875,1.0,3/13,5.76%,P2RY12;NLGN1;PFN1
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),-0.36403128583618705,-0.8691976537511842,0.6231884057971014,0.8914756987713963,1.0,1/11,0.72%,MEF2C
prerank,positive regulation of cytoplasmic transport (GO:1903651),0.4074193365132777,0.8688257414878966,0.6317567567567568,0.865298376087732,1.0,3/11,7.99%,MSN;SORL1;EZR
prerank,clathrin-dependent endocytosis (GO:0072583),0.34220513108357636,0.8687890086079645,0.6454948301329394,0.8649303430574677,1.0,9/26,17.85%,INPP5F;PICALM;AP2A2;LMBRD1;AP2B1;ITSN2;CANX;AP2S1;GPR107
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),-0.3567742082416776,-0.8687247968729527,0.6527093596059114,0.8914821073479634,1.0,4/12,15.23%,SNX5;IRS1;PRKCZ;GKAP1
prerank,regulation of nucleocytoplasmic transport (GO:0046822),-0.36209768674146475,-0.8686759809854671,0.6370192307692307,0.8906007637866248,1.0,9/12,41.43%,IFI27;TPR;UHMK1;PTPN14;NEDD4;RBM4;BMP4;AAAS;SIRT7
prerank,Golgi to endosome transport (GO:0006895),-0.33488714911175643,-0.8685653704523874,0.6418732782369146,0.8898325226337747,1.0,5/16,11.28%,AP2A1;SORT1;DOP1B;MON2;AP1AR
prerank,regulation of intracellular protein transport (GO:0033157),0.32948596614545655,0.8683049185282908,0.6396011396011396,0.8653901281280701,1.0,6/32,14.50%,LCP1;GCC2;BCAS3;PTPN1;TGFB1;RAB29
prerank,heart morphogenesis (GO:0003007),-0.24547405805313283,-0.8682784585706327,0.7035573122529645,0.8894907540822715,1.0,7/50,13.75%,CHD7;TGFBR1;FLRT2;ACVR1;HTR2B;VEGFA;TGFB2
prerank,cardiac muscle cell development (GO:0055013),0.35694426087020226,0.867899877263445,0.628125,0.8657139062607382,1.0,1/20,1.08%,PDLIM5
prerank,monocarboxylic acid metabolic process (GO:0032787),0.2738567240957583,0.8678688867072231,0.7104072398190046,0.8653242460358903,1.0,10/117,9.85%,HLCS;KYNU;PPARG;ME2;CD36;ACOT11;ACOT2;NAAA;MSMO1;DLD
prerank,regulation of viral life cycle (GO:1903900),-0.30361822518313636,-0.8678531725062261,0.6506024096385542,0.8894574922934927,1.0,4/21,4.37%,HS3ST5;PPIA;KPNA6;TRIM5
prerank,regulation of interleukin-17 production (GO:0032660),-0.2782260660806378,-0.8678043446947418,0.6734006734006734,0.8885653977235194,1.0,5/31,12.54%,VSIR;LY9;SLAMF6;NCKAP1L;TLR4
prerank,cellular response to unfolded protein (GO:0034620),0.34062963634428856,0.8676738995848287,0.623688155922039,0.8652384750859967,1.0,10/26,20.02%,HSPA1A;ERN1;TM7SF3;DAXX;PTPN1;HSPA9;HSPD1;BAG3;HSPA5;RHBDD1
prerank,protein peptidyl-prolyl isomerization (GO:0000413),-0.3047958163471328,-0.867186337962097,0.6699029126213593,0.8888199783658516,1.0,13/20,42.70%,FKBP5;PPIA;CWC27;PPIE;PPID;FKBP1A;PPIF;PPIH;PPIL6;NKTR;PPIG;PPIL3;PPIC
prerank,histone methylation (GO:0016571),0.34206108235000454,0.8670073387182543,0.6268436578171092,0.8660224495380946,1.0,7/26,19.45%,NSD3;PRMT8;NSD1;EZH2;CREBBP;NTMT1;EHMT1
prerank,regulation of blood coagulation (GO:0030193),0.3390364231014836,0.866557033041448,0.6452095808383234,0.86637994593334,1.0,3/27,8.43%,ST3GAL4;FAP;EPHB2
prerank,protein stabilization (GO:0050821),0.26130204242595617,0.8658230498528137,0.7250554323725056,0.8672563963715199,1.0,42/168,18.80%,CREB1;RPL5;ATF7IP;HSPA1A;RABL3;TAF9;NAA16;FBXW7;SUMO1;PTEN;STK4;WFS1;FLNA;CCNH;STX12;CREBL2;NAA15;HIP1;CAMLG;RTN4;NLK;TSPAN1;DVL3;HYPK;MORC3;RPL11;USP7;USP9X;TAF1;TCP1;PPIB;RASSF2;HSPD1;EFNA1;BAG3;NCLN;ATP1B2;PRKCD;PIN1;CHEK2;STK3;PINK1
prerank,response to laminar fluid shear stress (GO:0034616),0.41720660862565767,0.8657249022438029,0.6392857142857142,0.867008180005952,1.0,5/10,15.00%,KLF4;NFE2L2;MAP2K5;SREBF2;ASS1
prerank,folic acid-containing compound metabolic process (GO:0006760),-0.30531561638937166,-0.8657198220489334,0.6298200514138818,0.8910484559440122,1.0,8/19,27.88%,MTHFD2L;MTHFS;DHFR;SHMT2;FPGS;ALDH1L1;MTHFD1;SLC46A1
prerank,amyloid fibril formation (GO:1990000),0.3040352093257332,0.8656265359639507,0.6732542819499341,0.866740342954551,1.0,13/51,16.13%,CD36;SORL1;H3-3A;HSPG2;TGFBI;TSPAN14;TSPAN33;RIPK1;B2M;APP;USP9X;TSPAN15;TSPAN5
prerank,regulation of isotype switching (GO:0045191),0.3929052061962411,0.8650457877399474,0.6474464579901154,0.8673417391258114,1.0,3/14,11.01%,MAD2L2;SLC15A4;KMT5B
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),0.3848931433474447,0.864820921337353,0.6274834437086093,0.8673168433120958,1.0,1/16,1.38%,NGFR
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.25781854261143694,0.8647975132010037,0.7706806282722513,0.8669118743303018,1.0,67/241,20.26%,RSRC1;GTF2F2;CRNKL1;RNPC3;POLR2C;SNRPD2;PRPF6;DDX42;SNRPB;DBR1;CDC5L;USP49;BUD31;SRSF10;BUD13;DDX41;DNAJC8;FIP1L1;RBM10;LSM5;MAGOHB;DDX46;PRPF3;SF3B6;RBM22;SRSF4;DHX8;SLU7;YTHDC1;NUDT21;SPEN;RBM15;CACTIN;SRRT;FRG1;PQBP1;DDX23;SNRPA1;SF3A1;METTL3;SYNCRIP;AQR;U2SURP;GEMIN7;CPSF3;WBP11;PAPOLA;NCBP1;PHF5A;TXNL4A;PABPC1;PPWD1;SYF2;TFIP11;SF3B3;CWF19L1;RBM41;CSTF3;SF3B2;SF3B1;UPF3B;WDR33;PDCD7;CDC40;SMNDC1;SF3A2;HNRNPC
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),0.3534443725570097,0.8644365843871695,0.655786350148368,0.8671420190014935,1.0,8/23,22.84%,PRKAG2;AXIN1;APP;TGFB1;MAPK1;TNKS1BP1;RIPK2;UBE2K
prerank,glycerophospholipid metabolic process (GO:0006650),0.2890232617958133,0.8641746066879419,0.6736711990111248,0.867184360788633,1.0,11/75,9.48%,PLA1A;IP6K3;PRDX6;ABCA3;GPCPD1;PAFAH1B1;PLCB1;SYNJ1;CPNE1;FAR1;PIGF
prerank,protein maturation (GO:0051604),-0.21559133487263646,-0.8636708151781226,0.825,0.8944231157660604,1.0,31/95,25.09%,NAA50;MMP16;NAA40;MMS19;METAP2;PSEN2;STUB1;FURIN;LONP2;MMP14;AFG3L2;PCSK1;BACE1;PCSK7;DNAJB11;CIAO1;PSENEN;LMF2;AEBP1;LMF1;ECE1;PTCH1;CLN3;CPE;PCSK2;EEF1AKMT4-ECE2;NAA10;APH1A;BOLA2;TYSND1;NDUFAB1
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),-0.26128611784021427,-0.8634865146665621,0.7153024911032029,0.8938444984737973,1.0,2/36,0.83%,OPHN1;FHIT
prerank,carbohydrate derivative transport (GO:1901264),0.36518769861344563,0.8633648398605989,0.6506410256410257,0.8682102516651212,1.0,4/18,14.76%,SCARB1;SLC15A4;SLC10A7;ABCG1
prerank,ATP-dependent chromatin remodeling (GO:0043044),0.31493050116104754,0.8633137243630659,0.6556473829201102,0.8678594797416378,1.0,14/42,20.26%,GATAD2B;RBBP4;SMARCA5;ACTR6;SMARCE1;MBD2;CHD4;SMARCC2;SRCAP;INO80;HDAC1;ACTB;PBRM1;HNRNPC
prerank,positive regulation of DNA biosynthetic process (GO:2000573),0.2979132954367273,0.8631644052244563,0.6713735558408216,0.8677141100793647,1.0,13/60,16.09%,KLF4;PKIB;FBXO4;HGF;PARM1;WRAP53;TNKS;MAP3K4;CHTF18;AURKB;MAPK1;TCP1;POLG2
prerank,regulation of muscle cell differentiation (GO:0051147),0.3280801644108969,0.8629899916647015,0.6623188405797101,0.8675972961706497,1.0,7/31,11.97%,CTNNA1;CDC42;MAPK14;MAPK12;HDAC9;ID2;MEGF10
prerank,negative regulation of interleukin-1 production (GO:0032692),0.34380456230585255,0.8629704646606466,0.62555720653789,0.8671860238183857,1.0,5/23,14.82%,FFAR4;CARD16;GIT1;NLRP3;GSTP1
prerank,positive regulation of protein maturation (GO:1903319),-0.36387734345737766,-0.8623495016159535,0.6405867970660146,0.8953069772037114,1.0,3/11,14.70%,ADAM8;SOX4;CCBE1
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),-0.33485234390526053,-0.8622713759610402,0.6632911392405063,0.8944682166370667,1.0,3/15,7.36%,KCNJ2;ATP1B1;KCNN2
prerank,positive regulation of cell development (GO:0010720),-0.2698827719441856,-0.8621842206571778,0.6989966555183946,0.8936582287404637,1.0,8/31,19.65%,CX3CR1;NUMB;ATP6AP1;TGM2;SNW1;SOX11;TRIM32;TYROBP
prerank,cellular response to inorganic substance (GO:0071241),0.35277846883988195,0.861901182355556,0.6422893481717011,0.8686957902051372,1.0,4/21,12.79%,DPEP1;ADCY10;ATRX;SPIDR
prerank,negative regulation of cytoskeleton organization (GO:0051494),0.32923537292168914,0.8618149478119317,0.6366322008862629,0.868409483292466,1.0,10/29,18.43%,CYRIB;CORO1A;KANK3;ARFGEF1;SMAD4;PIK3CA;CLASP1;MYADM;KANK1;PRKCD
prerank,error-free translesion synthesis (GO:0070987),-0.2954573511757066,-0.8614033762640207,0.6458923512747875,0.8942513157286003,1.0,11/22,32.67%,UBC;NPLOC4;POLH;PCNA;RFC3;SPRTN;UBA52;RFC2;POLDIP2;RFC4;REV1
prerank,inositol lipid-mediated signaling (GO:0048017),0.3063406174894093,0.8613929169732887,0.6529801324503312,0.8687375417984844,1.0,9/50,10.64%,NGF;PIK3C2A;INPP5F;KCNH1;PLCB1;PLCD4;EZR;RHOA;PIK3CA
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),-0.29851131289486366,-0.8613832722129456,0.6637426900584795,0.89328671524104,1.0,7/23,16.72%,BCL9;SMAD7;NREP;SMAD3;TRIM33;DKK3;SOX11
prerank,renal water homeostasis (GO:0003091),-0.2942640945376598,-0.8613556941506615,0.6839080459770115,0.8923432465714616,1.0,8/23,17.70%,RAB11FIP2;ADCY9;PRKACA;PRKAR1A;ADCY3;AQP4;ADCY8;RAB11A
prerank,positive regulation of cytoskeleton organization (GO:0051495),0.28703240715493217,0.8612853815988575,0.6919191919191919,0.8684975496818521,1.0,11/76,11.89%,HCK;PRKCE;STAP1;CDC42;CARMIL1;PTK2B;KATNBL1;BCAS3;SNX9;VASP;DYNC1H1
prerank,negative regulation of protein kinase activity (GO:0006469),0.2826817919808977,0.8610960631658932,0.6845168800931315,0.8683913141177615,1.0,17/88,15.32%,PTPRC;PTPRO;PRKAG2;SORL1;PRKRIP1;PDPK1;PAK2;GSKIP;PTPN1;DBNDD2;TAF7;SH3BP5;AKT1;MVP;GSTP1;DUSP26;SPRED1
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),0.353973315256974,0.8604902255234853,0.6389776357827476,0.869060581054978,1.0,7/22,15.66%,IL1B;ADRA2A;SNX9;TNFRSF1B;ROCK1;ADAM9;SNX33
prerank,folic acid metabolic process (GO:0046655),-0.3097427091507947,-0.8603441666238113,0.6288659793814433,0.8935252906463382,1.0,8/18,27.88%,MTHFD2L;MTHFS;DHFR;SHMT2;FPGS;ALDH1L1;MTHFD1;SLC46A1
prerank,regulation of smoothened signaling pathway (GO:0008589),0.3035700865361613,0.8603101552389729,0.661437908496732,0.8689385057674126,1.0,9/50,15.26%,GLI1;HERC4;GPC3;RAB34;FBXL17;TUBD1;VCP;TXNDC15;CREBBP
prerank,establishment of endothelial intestinal barrier (GO:0090557),0.40392373090631584,0.8602895898732213,0.6561954624781849,0.8685302425762256,1.0,3/11,7.54%,RAPGEF2;AFDN;F11R
prerank,cilium organization (GO:0044782),0.26157699429089143,0.86007440541274,0.7655913978494624,0.8684857797830225,1.0,34/209,15.25%,CDC14A;ATAT1;ACTR3;TSGA10IP;FOXJ1;EXOC6;OCRL;EHD2;RP2;RFX3;ARF4;ACTR2;FLNA;IFT140;GBF1;KIF24;EXOC7;UNC119B;CEP250;KIF3B;RILPL2;FHDC1;CFAP61;PTPDC1;TTC17;ABCC4;IQCB1;CFAP54;CFAP70;TXNDC15;NUDCD3;EHD1;DYNLT2B;DISC1
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),0.38833234541006223,0.8599353564549981,0.6295081967213115,0.8682905324247047,1.0,1/13,0.53%,SP100
prerank,regulation of vacuole organization (GO:0044088),0.35118196307200633,0.8597096937084585,0.6550632911392406,0.8682709415739578,1.0,4/20,11.08%,ANXA2;MTMR3;PIKFYVE;SCARB2
prerank,sister chromatid segregation (GO:0000819),-0.26998319180532393,-0.8593668514573021,0.7256317689530686,0.8946132827573386,1.0,20/31,40.87%,KLHL22;ZW10;SMC1A;RAN;KIF18A;CENPK;NCAPG2;NDC80;NSL1;CDCA8;DSN1;KIFC1;MIS12;TOP2B;SPAG5;SGO1;ZWINT;PLK1;TUBG1;KIF18B
prerank,regulation of neutrophil migration (GO:1902622),0.412432455141026,0.859220216892013,0.6307420494699647,0.8686988656775959,1.0,4/10,15.03%,RAC2;RAC1;SLAMF8;RHOG
prerank,regulation of neurogenesis (GO:0050767),0.30298359538462927,0.8591336172751852,0.6928104575163399,0.8684217070400858,1.0,9/55,12.70%,IL1B;SORL1;IL6;OPRM1;B2M;SPEN;NAP1L1;REST;RGS14
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",0.28281978018366083,0.8590323337313457,0.6946847960444994,0.8681448289275123,1.0,22/80,16.79%,TBC1D10C;RAB7A;RAB7B;SNX1;VPS53;RAB6A;TMEM87A;STX6;GCC2;RHOBTB3;GBF1;STX5;PIKFYVE;TBC1D5;SNX3;ANKFY1;STX16;EVI5;RAB29;SNX12;DENND5A;RAB9B
prerank,positive regulation of protein import (GO:1904591),0.3328120502422239,0.858849300818162,0.6482861400894188,0.8680302520507985,1.0,11/30,18.43%,UBR5;FLNA;RBM22;ZPR1;HCLS1;HDAC3;TGFB1;PSEN1;PIK3R2;BAG3;PRKCD
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),0.3467266456479386,0.8588272005513236,0.645412130637636,0.8676401925926996,1.0,2/23,4.77%,ITGAX;GDNF
prerank,regulation of receptor-mediated endocytosis (GO:0048259),0.3209971431470668,0.8585326399634972,0.6657142857142857,0.8677386128353336,1.0,6/35,10.76%,CBL;PICALM;ARF1;RAC1;HIP1;B2M
prerank,regulation of Notch signaling pathway (GO:0008593),0.2866521892165992,0.8584310421567483,0.6925925925925925,0.8674973052802776,1.0,18/76,16.84%,STAT3;LFNG;FBXW7;SYNJ2BP;RBPJ;TSPAN14;IL6ST;WWP2;AKT1;METTL3;SREBF2;KAT2B;CREBBP;TSPAN15;POGLUT1;MAML1;TSPAN5;NIBAN2
prerank,nucleotide-sugar biosynthetic process (GO:0009226),-0.3099034920908118,-0.8577261169304333,0.6469002695417789,0.8971759900346872,1.0,9/19,24.58%,RENBP;AMDHD2;NAGK;UAP1L1;GFPT1;GNPDA2;NANS;GNPNAT1;MPI
prerank,response to X-ray (GO:0010165),0.38501837863516736,0.8576840552962003,0.6558966074313409,0.8684307824471944,1.0,3/14,12.20%,NIPBL;ANXA1;XRCC4
prerank,regulation of trans-synaptic signaling (GO:0099177),0.3253511700229226,0.8576802062339738,0.6620879120879121,0.8679991483510181,1.0,9/33,16.77%,NGF;CACNA1A;BCR;CEL;SLC4A8;GRID1;LRP8;RELN;LRRC4
prerank,sphingosine metabolic process (GO:0006670),0.3700220123221499,0.8575398449757905,0.6480891719745223,0.8678142591388547,1.0,4/17,15.00%,ACER3;NAAA;SGPP2;SGPP1
prerank,phosphatidic acid metabolic process (GO:0046473),-0.24640757104543531,-0.8568722123737764,0.7306122448979592,0.8980550543786738,1.0,9/48,11.76%,PLD1;DGKZ;LPCAT1;SLC27A1;PLA2G4A;DGKQ;GPAM;DDHD2;ABHD4
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),-0.2407042400999816,-0.8564827302826777,0.7479338842975206,0.8979051494066097,1.0,19/53,26.35%,EYA4;DDX5;ERCC6;FXR1;CEBPG;TMEM161A;FXR2;TIGAR;PCNA;DHX9;NPAS2;BRCA1;FBH1;HMGA2;FGF10;RNF8;CCAR2;BABAM2;MYC
prerank,mitochondrial protein processing (GO:0034982),0.39749294461542783,0.8560839391945123,0.643598615916955,0.8700187079132548,1.0,5/11,19.63%,IMMP2L;PMPCA;YME1L1;MIPEP;IMMP1L
prerank,embryo development ending in birth or egg hatching (GO:0009792),-0.33249313876077735,-0.8554611715639872,0.664,0.8990845932202428,1.0,5/15,17.62%,STOX2;RAI2;USP22;TGFB2;BRCA1
prerank,positive regulation of protein processing (GO:0010954),-0.30996855492579295,-0.8552561430048808,0.68,0.898531293987244,1.0,3/19,8.19%,PLGRKT;ADAM8;HPN
prerank,negative regulation of cell projection organization (GO:0031345),0.3046346425311459,0.8552033570276222,0.6581081081081082,0.8711930905952368,1.0,8/48,8.64%,FYN;PTPRO;RAPGEF2;PTEN;PRNP;CIB1;PAQR3;CBFA2T2
prerank,morphogenesis of a polarized epithelium (GO:0001738),0.3965345405236304,0.8551829130032002,0.6473429951690821,0.8707929919863923,1.0,2/12,5.50%,CELSR1;ZDHHC7
prerank,digestive tract development (GO:0048565),0.3310594585072813,0.8550909800405627,0.6580459770114943,0.8705284686009921,1.0,5/32,13.35%,GLI1;NIPBL;CCDC39;KIT;PCSK5
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),-0.35242788424407795,-0.8548339703123374,0.6486486486486487,0.8984201350612252,1.0,2/12,8.94%,IGF1;IRS1
prerank,positive regulation of stem cell differentiation (GO:2000738),-0.3167008568621382,-0.8546055464245808,0.6614173228346457,0.8979041862581509,1.0,3/16,15.29%,PTN;TGFB2;SOX5
prerank,regulation of translational initiation (GO:0006446),-0.23071960119601725,-0.8543175332098504,0.7616822429906542,0.8975319667655097,1.0,19/63,19.24%,LARP1;ATF3;EIF2AK4;CDC123;KLHL25;IMPACT;ATF4;EIF5;PAIP2B;EIF2B5;NPM1;EIF4G1;EIF4H;GLE1;TPR;DDX3X;HABP4;EIF3B;UHMK1
prerank,regulation of chromatin organization (GO:1902275),0.37638666189249464,0.8538514228477688,0.6161449752883031,0.8722732654821373,1.0,5/14,13.90%,SETD5;TLK2;METTL4;PARG;TLK1
prerank,positive regulation of natural killer cell activation (GO:0032816),-0.3380843608168507,-0.8534143033476757,0.6776649746192893,0.8984635532537777,1.0,4/13,19.65%,GAS6;LAMP1;TICAM1;TYROBP
prerank,"mRNA splicing, via spliceosome (GO:0000398)",0.2527168828981291,0.8527619752271325,0.8024948024948025,0.8737897465319026,1.0,71/264,20.41%,CDK13;RSRC1;GTF2F2;CRNKL1;RNPC3;POLR2C;SNRPD2;PRPF6;DDX42;SNRPB;DBR1;CDC5L;USP49;BUD31;SRSF10;BUD13;DDX41;DNAJC8;FIP1L1;RBM10;LSM5;MAGOHB;DDX46;COIL;PRPF3;SF3B6;RBM22;SRSF4;DHX8;SLU7;YTHDC1;NUDT21;SPEN;RBM15;CACTIN;SRRT;FRG1;PQBP1;DDX23;SNRPA1;SF3A1;METTL3;SYNCRIP;AQR;U2SURP;GEMIN7;CPSF3;WBP11;PAPOLA;NCBP1;PHF5A;TXNL4A;PABPC1;PPWD1;SYF2;TFIP11;SF3B3;CWF19L1;RBM41;CSTF3;SF3B2;SF3B1;DDX20;UPF3B;WDR33;PDCD7;CDC40;SMNDC1;SF3A2;HNRNPC;SNUPN
prerank,histone H3-K9 demethylation (GO:0033169),0.40502190865736865,0.8522192139092623,0.643859649122807,0.8743264301331025,1.0,2/11,7.20%,KDM7A;KDM3B
prerank,positive regulation of supramolecular fiber organization (GO:1902905),0.2775737574082132,0.851564276874304,0.6946182728410513,0.8750729201646634,1.0,19/86,16.94%,HCK;PRKCE;PAK1;GPX1;CARMIL1;PTK2B;KATNB1;RAC1;RPS3;SNX9;VASP;APP;CLASP1;OCLN;STMN2;RB1;FES;PROX1;PSEN1
prerank,oligodendrocyte differentiation (GO:0048709),-0.30611593800795495,-0.85129332205381,0.6563307493540051,0.9019113195061343,1.0,7/19,21.30%,PTPRZ1;CDK5;EIF2B5;EIF2B4;TPPP;NSUN5;SOX13
prerank,regulation of apoptotic signaling pathway (GO:2001233),0.3231240019743967,0.8511964062780674,0.6977401129943502,0.8753072932415424,1.0,7/36,10.50%,TRAF1;BCL2L14;SGMS1;CSNK2A2;CSNK2A1;RPS3;CYLD
prerank,mitotic spindle assembly (GO:0090307),0.31028033237298347,0.8510253023147003,0.6352459016393442,0.8751725727784447,1.0,10/42,16.03%,RACGAP1;KIF23;FLNA;RHOA;STAG1;KIF3B;STAG2;CLASP1;AURKB;KPNB1
prerank,regulation of G0 to G1 transition (GO:0070316),0.3150328353982964,0.8503900157655412,0.6587412587412588,0.8758446786759038,1.0,8/38,15.71%,UXT;RBBP8;RYBP;RBBP4;APAF1;L3MBTL2;EZH2;PHC3
prerank,peptidyl-glutamic acid modification (GO:0018200),-0.27987581577001486,-0.8503806729031874,0.6871165644171779,0.9027721999578463,1.0,10/24,29.76%,CFAP20;TTLL11;TTLL5;GGCX;AGBL4;CEP41;TTLL1;NAA10;TTLL3;NAA80
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.29354908840859967,0.8503116026023038,0.6962962962962963,0.8755447769309495,1.0,5/62,7.10%,LRRK2;MCL1;HSPA1A;PTTG1IP;NFE2L2
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),0.41274971498844854,0.850266610864565,0.6565143824027073,0.8751878618133038,1.0,1/10,3.69%,GPR35
prerank,regulation of receptor recycling (GO:0001919),0.3690007514598793,0.8494872542248592,0.6501597444089456,0.8761219640565341,1.0,2/16,4.11%,ANXA2;INPP5F
prerank,leukotriene biosynthetic process (GO:0019370),0.3861138348233347,0.8492980091443025,0.6700167504187605,0.876030986661357,1.0,2/14,6.70%,ALOX5AP;GGTA1
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.3143692925955903,0.8489652735862927,0.6735537190082644,0.8762028508189679,1.0,8/38,17.32%,SP100;GPX1;TMC8;ICAM1;RIPK1;LGALS3;THBS1;TRAF2
prerank,positive regulation of cholesterol efflux (GO:0010875),0.3442016882496734,0.8483550069114909,0.6571428571428571,0.8768570063320758,1.0,3/21,4.47%,PPARG;NFKBIA;ABCA3
prerank,establishment of protein localization to plasma membrane (GO:0061951),0.31641251613599614,0.8481538597640399,0.6803977272727273,0.8767702722230735,1.0,6/36,10.77%,GOLPH3L;RAB7A;AFDN;RAB34;GCC2;RILPL2
prerank,atrioventricular valve development (GO:0003171),0.386627698524929,0.8478475381052246,0.6634304207119741,0.8768923176688882,1.0,2/14,2.93%,GJA5;BMPR2
prerank,unsaturated fatty acid metabolic process (GO:0033559),-0.25187193148180625,-0.8474126205392746,0.7045454545454546,0.9079192493560313,1.0,5/41,7.25%,PTGS1;MGLL;DAGLA;PNPLA8;PLA2G4A
prerank,defense response to fungus (GO:0050832),0.36810509865225455,0.847027428697162,0.6645569620253164,0.8779002466602935,1.0,2/17,9.84%,PLCG2;FAM3A
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),0.35355465610994846,0.8469950576222622,0.6696696696696697,0.8775346459137858,1.0,3/21,8.43%,CYRIB;CD2AP;EPHB2
prerank,beta-catenin destruction complex disassembly (GO:1904886),-0.29264838062199805,-0.8469504322595756,0.6789772727272727,0.9078833880599292,1.0,2/21,3.17%,LRP6;CTNNB1
prerank,establishment of vesicle localization (GO:0051650),0.3647465557084306,0.8463241550636387,0.6342229199372057,0.87825398151804,1.0,5/18,14.63%,KIF5B;SYNJ1;SNAPIN;LIMK2;KIF5A
prerank,regulation of cell cycle phase transition (GO:1901987),0.27423771887261394,0.8461194622833791,0.7258261933904528,0.8781717261680654,1.0,22/91,18.60%,PSME3;UBE2E1;PSMB7;FBXW7;PSME2;PSME4;PSMB8;PSMA5;PSMD9;PSMB3;UBE2S;PSMD6;PSMC4;PSMD10;PSMB1;ERCC3;ANAPC7;TAF1;PSMD12;ANAPC11;FZR1;ANAPC4
prerank,icosanoid biosynthetic process (GO:0046456),-0.37793998923983013,-0.8452760024612648,0.6746411483253588,0.9103559775948508,1.0,3/10,7.25%,LTA4H;LTC4S;PLA2G4A
prerank,cilium assembly (GO:0060271),0.25021906890005,0.8451350346573824,0.8006230529595015,0.8794491207024672,1.0,53/296,17.90%,CDC14A;ATAT1;ACTR3;SDCCAG8;CNTRL;FOXJ1;EXOC6;HAUS8;TBC1D32;OCRL;EHD2;RP2;SPATA6;RFX3;ARF4;ACTR2;CEP63;FLNA;PAFAH1B1;HAUS1;IFT140;GBF1;DCTN3;KIF24;EXOC7;UNC119B;CEP250;KIF3B;RILPL2;FHDC1;PTPDC1;ABCC4;DYNC1H1;CCDC39;IQCB1;CFAP54;HAUS3;CFAP70;CLASP1;TXNDC15;NUDCD3;EHD1;DYNLT2B;DISC1;EXOC2;TNPO1;DYNC1I2;CEP135;BBS10;ASAP1;EHD3;CC2D2A;LZTFL1
prerank,RNA metabolic process (GO:0016070),0.26821384344371857,0.8448405429894372,0.7425287356321839,0.8795372661780214,1.0,27/127,15.83%,FASTKD1;RBPMS;GTF2F2;SND1;POLR2C;NUFIP1;RBMS1;XRN2;RNASEH2C;SETX;RBMS2;RNASE1;TENT2;DHX8;CELF2;PAPOLG;RNASE6;DEDD2;METTL3;RNASEH2A;RNASEH1;PNPT1;SYNCRIP;PAPOLA;NCBP1;SIDT2;RBM39
prerank,negative regulation of sprouting angiogenesis (GO:1903671),0.3926020617771134,0.8445923806882281,0.6678700361010831,0.8795485746364846,1.0,5/11,19.55%,SYNJ2BP;E2F2;THBS1;SEMA6A;KLF2
prerank,positive regulation of synaptic transmission (GO:0050806),0.28609076875703393,0.8441823135423023,0.7142857142857143,0.8798632518023836,1.0,3/72,3.56%,CCR2;CRHR2;NPTN
prerank,triglyceride catabolic process (GO:0019433),0.3519437626935259,0.8441713194580359,0.6661367249602543,0.8794435344732437,1.0,1/19,3.29%,FABP7
prerank,gliogenesis (GO:0042063),-0.31738956622242775,-0.8436325945192392,0.6520618556701031,0.9127453133503054,1.0,4/15,13.75%,CD9;NFIB;METTL14;TGFB2
prerank,protein homooligomerization (GO:0051260),0.2714622296135023,0.8435595194497075,0.7505800464037123,0.880087233602126,1.0,17/114,14.89%,CARD11;SAMHD1;ALOX5AP;UPB1;RNF213;PRMT8;PDCD6IP;SPAST;SLC1A5;ATL3;NLRC4;B2M;LETM1;GBP5;PNPT1;EHD1;ATL1
prerank,regulation of cholesterol transport (GO:0032374),-0.29277907562489686,-0.8430899454173283,0.6988636363636364,0.9129169362255156,1.0,7/20,19.91%,LRP1;ABCB4;TTC39B;ARV1;NR1H2;APOC1;OSBPL6
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),0.3832676893232526,0.8425486647210193,0.6486486486486487,0.8814152164684536,1.0,6/13,22.73%,ITGB2;IL6;RHOA;RELA;NFAT5;TNF
prerank,histone H2A ubiquitination (GO:0033522),0.36077868605191016,0.8423632014426111,0.6671899529042387,0.8813248032408714,1.0,3/17,7.92%,DTX3L;RYBP;UBR2
prerank,autophagosome assembly (GO:0000045),0.2944159109764387,0.8422387576340666,0.6911764705882353,0.8811115528990039,1.0,17/52,21.86%,RAB19;RAB7A;STX17;ATG5;STX12;PACS2;WIPI2;VMP1;RB1CC1;AMBRA1;BECN1;ATG13;RAB43;ULK1;GABARAPL1;TRAPPC8;SMURF1
prerank,myelination in peripheral nervous system (GO:0022011),0.38419632850292973,0.8421792013987529,0.6893039049235993,0.8807845301069352,1.0,2/13,3.41%,ADGRG6;PRX
prerank,regulation of osteoblast proliferation (GO:0033688),-0.31373066109948355,-0.842159309884166,0.6759776536312849,0.913839132026042,1.0,3/17,6.22%,NELL1;TMEM119;FGFR2
prerank,regulation of transcription by RNA polymerase I (GO:0006356),-0.29630496413991664,-0.8415576405224365,0.6948717948717948,0.9140409124617866,1.0,7/18,23.76%,ATF4;UTP15;PHF8;MAF1;POLR2K;WDR43;LYAR
prerank,negative regulation of transport (GO:0051051),0.2926376585005592,0.8414979584394224,0.7107652399481194,0.8815566647503754,1.0,13/51,16.70%,LILRB1;PLSCR1;DYSF;RAB7A;PTEN;WWP2;FCGR2B;TLR2;SNX3;LGALS3;SNX33;SNX12;MTMR2
prerank,negative regulation of cellular metabolic process (GO:0031324),0.3119963396963129,0.8410342727930916,0.6888888888888889,0.8819169153238511,1.0,3/37,2.15%,RIN3;NFKB1;PTX3
prerank,negative regulation of nuclear division (GO:0051784),-0.3501770769870363,-0.8407744771484628,0.6615776081424937,0.914666072141142,1.0,6/11,42.78%,TOM1L1;FBXO5;TOM1L2;BMP4;CHEK1;BMP7
prerank,aminoglycan biosynthetic process (GO:0006023),0.295086234415284,0.8402648241638221,0.6830238726790451,0.8828246959670253,1.0,8/49,12.68%,EXT1;GPC3;HSPG2;PXYLP1;XYLT1;GALNT5;SDC3;B3GALT2
prerank,regulation of activated T cell proliferation (GO:0046006),0.31761360282980966,0.8401396368348182,0.6934523809523809,0.8825866079433411,1.0,6/30,14.64%,IL27RA;RC3H1;PRNP;RPS3;ICOSLG;IL18
prerank,positive regulation of dendrite development (GO:1900006),-0.3645206508013683,-0.8397127729926118,0.6480582524271845,0.9157612505594884,1.0,2/10,14.55%,PTN;DAB2IP
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.3254721725238955,0.8396568902291507,0.6795827123695977,0.8829984812997301,1.0,9/28,21.33%,ITCH;UBE2N;CYLD;TAB3;MAP3K7;RELA;TAB1;TNFAIP3;RIPK2
prerank,cellular polysaccharide biosynthetic process (GO:0033692),0.33486196063591406,0.8396355239282074,0.6832844574780058,0.8826006515822129,1.0,9/25,23.60%,EXT1;B3GALT2;CSGALNACT1;HS2ST1;NDST2;EXT2;B3GALT5;B3GNT2;NDST4
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),0.3766035222297181,0.8392884092824838,0.6567656765676567,0.8827849316064569,1.0,4/12,13.81%,PICALM;PRNP;TMED10;ROCK1
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),0.3149865511181063,0.8392644025215447,0.6912378303198887,0.882379245232419,1.0,8/33,16.89%,KLF4;PPARG;MECP2;RHOA;MAP2K5;TGFB1;THBS1;STARD13
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.3151057532799126,0.8388920731399044,0.6932773109243697,0.8826160157186297,1.0,9/36,14.04%,PPP3CA;PLCB1;GNB1;NLK;MAP3K7;PDE6B;GNG2;TNRC6B;TNRC6A
prerank,dermatan sulfate biosynthetic process (GO:0030208),0.39086163224910975,0.8386968556561194,0.6840336134453782,0.88251670728277,1.0,5/12,18.66%,CHST12;NCAN;UST;VCAN;DSEL
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),-0.33914291759900883,-0.8384056027945844,0.6773399014778325,0.9173739761326306,1.0,4/13,15.23%,SNX5;IRS1;PRKCZ;GKAP1
prerank,substantia nigra development (GO:0021762),-0.2519997661291734,-0.8380648473815364,0.7727272727272727,0.9170669778639148,1.0,11/37,19.33%,BASP1;PLP1;DYNLL1;CKB;ATP5PF;CALM1;CCDC14;INA;NDRG2;FGF9;YWHAH
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),0.32312384885674555,0.8379265678107203,0.7035971223021583,0.8834392581306054,1.0,7/29,17.64%,SDHAF2;MAD2L2;PTEN;SPRED3;USF3;SPRED1;EFNA1
prerank,postreplication repair (GO:0006301),0.29975923368496404,0.837557425489924,0.7067567567567568,0.8836609306678104,1.0,11/45,19.38%,DTL;POLI;UBE2N;POLD4;TRIM25;RPA3;PCLAF;VCP;POLD1;PRIMPOL;WDR33
prerank,ncRNA transcription (GO:0098781),0.37587681499048786,0.8371721173431284,0.6706081081081081,0.8838818944250254,1.0,2/13,9.38%,POLR1G;SNAPC3
prerank,negative regulation of receptor internalization (GO:0002091),0.3885808217619984,0.8368198066424786,0.6625874125874126,0.8840482466823409,1.0,1/12,1.22%,RIN3
prerank,triglyceride biosynthetic process (GO:0019432),-0.30910116382490904,-0.8363754217789389,0.7060518731988472,0.9194633475441151,1.0,5/18,18.27%,AGMO;PCK2;GPAM;GPAT4;LPGAT1
prerank,regulation of actin filament-based movement (GO:1903115),-0.3651650315407128,-0.8356209241927139,0.6743119266055045,0.9199956695264898,1.0,6/10,45.33%,ANK2;PDPN;PDE4D;MYBPC3;PLN;STC1
prerank,regulation of macrophage differentiation (GO:0045649),-0.3183546059548507,-0.8342205334277243,0.672972972972973,0.9217792563329503,1.0,2/15,3.39%,C1QC;CSF1
prerank,cellular response to heat (GO:0034605),0.31177720885073573,0.8340581675103066,0.7142857142857143,0.8883683693175644,1.0,10/35,18.62%,HSPA1A;SUMO1;ATXN3;SLU7;DAXX;HIKESHI;VCP;THBS1;BAG3;CLPB
prerank,proton transmembrane transport (GO:1902600),-0.25363045671601053,-0.8338461652164867,0.7508417508417509,0.9214753572814753,1.0,7/36,12.44%,ATP6V0C;SLC36A1;ATP5PO;ATP1A2;ATP6V0D1;SLC25A14;SLC25A27
prerank,protein import into peroxisome membrane (GO:0045046),0.33562622030816497,0.8332985590574667,0.6635367762128326,0.8892637405173182,1.0,5/22,13.06%,PEX16;PEX12;PEX14;FIS1;ABCD1
prerank,positive regulation of proteolysis (GO:0045862),0.2880774119169988,0.833184908282911,0.7082785808147175,0.8890293901053079,1.0,17/55,20.61%,IL1B;ADRA2A;FBXW11;MAPK12;TANK;NLRC4;SNX9;TNFRSF1B;CYFIP2;ADAM9;SNX33;AURKAIP1;CTSC;PINK1;BAD;RHBDD1;SH3D19
prerank,negative regulation of wound healing (GO:0061045),0.32764931105891837,0.8330563317928622,0.7037593984962406,0.8888216799367477,1.0,4/28,7.31%,CASK;CRK;PTEN;PHLDB2
prerank,dermatan sulfate metabolic process (GO:0030205),0.3804017457392772,0.8327773073699865,0.6938110749185668,0.8888615220040688,1.0,5/13,18.66%,CHST12;NCAN;UST;VCAN;DSEL
prerank,positive regulation of reproductive process (GO:2000243),-0.2554978174783375,-0.8322888031865083,0.7648902821316614,0.9236347393108695,1.0,1/31,0.19%,LHFPL2
prerank,ribosomal subunit export from nucleus (GO:0000054),0.3921743788419421,0.8322395377572385,0.6975206611570248,0.8893781889104492,1.0,1/13,1.09%,XPO1
prerank,cardiac left ventricle morphogenesis (GO:0003214),-0.3312044067409494,-0.8322293831523792,0.6690647482014388,0.9227702190329028,1.0,1/13,0.40%,TGFBR2
prerank,myofibril assembly (GO:0030239),-0.2475668800331943,-0.8321532330922923,0.7490774907749077,0.9219453683118675,1.0,6/42,21.92%,CAPN3;CFLAR;TMOD1;ACTN2;TMOD2;FHOD3
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.32142508319914326,0.8318335739144063,0.6915492957746479,0.8896731258567583,1.0,6/33,9.32%,PKN1;AXIN1;H3-3A;CBFB;LATS1;NCOA2
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),0.37642174574275006,0.8318277893023869,0.6638655462184874,0.8892487863632694,1.0,4/12,14.76%,PPARG;NFKBIA;ABCA5;ABCG1
prerank,phosphatidylinositol-mediated signaling (GO:0048015),0.2828429148573439,0.831114046888636,0.710828025477707,0.8900801558776129,1.0,10/69,10.64%,NGF;PIK3C2A;INPP5F;KCNH1;PTEN;PLCB1;PLCD4;EZR;RHOA;PIK3CA
prerank,ncRNA export from nucleus (GO:0097064),-0.25852575910960024,-0.8309836096964921,0.7649122807017544,0.9231765355062155,1.0,14/36,19.43%,NUP54;NUP133;NUP155;NUP188;RANBP2;SSB;NPM1;SEC13;NUP85;NUP42;TPR;RAN;NUP35;NUP37
prerank,regulation of coagulation (GO:0050818),-0.34453941628397033,-0.8308071565370544,0.6950904392764858,0.9225320135947866,1.0,1/11,1.65%,HS3ST5
prerank,proteoglycan metabolic process (GO:0006029),0.3298436408540525,0.8302102784983101,0.6943231441048034,0.8911906111607586,1.0,7/26,14.99%,SULF2;BMPR2;CHST12;XYLT1;ADAMTS12;CNMD;CSGALNACT1
prerank,endocardial cushion development (GO:0003197),0.3460060166017133,0.8301829369575779,0.6888217522658611,0.8908041685590538,1.0,2/21,8.15%,BMPR2;ENG
prerank,response to ionizing radiation (GO:0010212),0.2773830078393909,0.8300935573465305,0.7227214377406932,0.890519919745763,1.0,23/70,21.07%,MAPK14;GRB2;NABP1;CLOCK;COP1;UIMC1;TANK;ANXA1;NET1;DCUN1D3;PRKAA1;XRCC4;SPIDR;BRSK1;INO80;INIP;HUS1;EYA3;SIRT1;TNKS1BP1;RNF168;STK11;CLK2
prerank,mitochondrial gene expression (GO:0140053),-0.2395433562985352,-0.8300017066440409,0.7528089887640449,0.9230479148625806,1.0,19/42,26.71%,GFM2;LARS2;MRPS21;NDUFA7;MRPS17;GATB;GATC;POLRMT;MRPS7;MRPL2;MRPS24;MRPS18B;SLC25A33;MRPL47;MRPS14;MRPL51;MRPL16;TEFM;QRSL1
prerank,protein polyglutamylation (GO:0018095),-0.3385390841725203,-0.829723318384713,0.6658536585365854,0.9225813714092773,1.0,5/11,22.20%,CFAP20;TTLL11;TTLL5;CEP41;TTLL1
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),0.2776225722004927,0.8296764740986261,0.7300832342449465,0.8907769129490996,1.0,23/77,16.37%,MCL1;PSME3;HSPA1A;GPX1;BIRC6;HGF;ACAA2;CSNK2A2;CSNK2A1;RIPK1;SLC25A5;HTT;PSMD10;SH3RF1;LGALS3;PRELID1;AKT1;CAAP1;GSTP1;MAZ;RELA;THBS1;RB1
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),0.3903537570772013,0.8295495615142922,0.6723842195540308,0.8905747174789823,1.0,4/11,18.98%,IL6;RIPK1;TGFB1;MAP2K1
prerank,protein insertion into membrane (GO:0051205),0.309923569821946,0.8291026135682017,0.6912378303198887,0.8909014798889051,1.0,8/32,15.93%,MAIP1;PRNP;TRAM2;TRAM1;STX5;APP;UBE2J2;VAPA
prerank,renal system development (GO:0072001),0.2944268399733643,0.8288615817066234,0.7096336499321574,0.8908798021694224,1.0,7/52,13.35%,ACE;SULF2;STAT1;WFS1;ITGA8;LRP4;PCSK5
prerank,regulation of protein kinase B signaling (GO:0051896),0.2529860639455571,0.8288008163978768,0.8064516129032258,0.8905446984664392,1.0,48/193,20.84%,FLT3;FYN;RET;FGF5;FGF22;NRG2;KL;RAC2;PTEN;GRB2;PDPK1;CIB1;PHLPP1;ENG;RAC1;HGF;CPNE1;HIP1;RTN4;PIK3CA;CASS4;AKT1;KIT;HCLS1;TGFB1;FGFR3;PTPRJ;PPP2R5C;IL18;MAZ;RHOG;FRS2;THBS1;RNF41;INSR;PIK3R2;SIRT1;HAX1;PINK1;PIK3R5;FGFR1;PARK7;PTK2;TSPYL5;STRN;MUL1;XDH;RICTOR
prerank,axonal fasciculation (GO:0007413),-0.34877906239202683,-0.8286397928560233,0.7007481296758105,0.9236787167843238,1.0,3/12,9.06%,CNTN4;CDK5R1;ARHGAP35
prerank,regulation of cellular protein catabolic process (GO:1903362),0.3515938352799695,0.8282753824493198,0.6713836477987422,0.8910006860692204,1.0,4/18,7.99%,MSN;PTTG1IP;FAF1;EZR
prerank,organelle assembly (GO:0070925),0.24422447674222275,0.8281605486344961,0.8744897959183674,0.890764404980729,1.0,64/384,15.25%,CDC14A;LIMD1;ATAT1;ACTR3;RAB19;VPS37C;FOXJ1;EXOC6;HAUS8;CORO1A;OCRL;EHD2;ABCA3;RP2;CHMP4A;CHMP4B;RFX3;RAB7A;RC3H1;ARF4;TSG101;DHX37;ACTR2;CEP63;FLNA;ATG5;HAUS1;IFT140;YTHDF3;PDCD6IP;GBF1;STX12;KIF24;SNF8;TNKS;EXOC7;UNC119B;RPS3;STX7;CEP250;KIF3B;RILPL2;FHDC1;STAM;PTPDC1;ABCC4;DYNC1H1;PACS2;IQCB1;WIPI2;CFAP54;EIF4ENIF1;HAUS3;CFAP70;TMOD3;VMP1;HDAC3;TXNDC15;NUDCD3;RB1CC1;EHD1;CENPC;DYNLT2B;DISC1
prerank,ERK1 and ERK2 cascade (GO:0070371),-0.29627344689458135,-0.8280740785992029,0.6640826873385013,0.9237590349422712,1.0,10/21,28.53%,IGF1;LGALS9;HTR2B;KARS1;MT3;FGF10;CTSH;KDR;MYC;EGF
prerank,DNA conformation change (GO:0071103),-0.30639687712535957,-0.8279886679957645,0.6855670103092784,0.92297036444081,1.0,9/17,33.92%,HMGB1;TOP1;HMGB2;TOP1MT;NAA10;ABL1;HHEX;TOP2B;HMGB3
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),0.388288168665846,0.8279756619884253,0.6897746967071057,0.8906239493354638,1.0,1/12,1.34%,STX11
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),-0.2662205142566486,-0.8278312498417426,0.7467105263157895,0.9213113329151978,1.0,13/32,19.43%,NUP54;NUP133;NUP155;NUP188;RANBP2;SSB;SEC13;NUP85;NUP42;TPR;RAN;NUP35;NUP37
prerank,tRNA export from nucleus (GO:0006409),-0.2662205142566486,-0.8278312498417426,0.7467105263157895,0.9213113329151978,1.0,13/32,19.43%,NUP54;NUP133;NUP155;NUP188;RANBP2;SSB;SEC13;NUP85;NUP42;TPR;RAN;NUP35;NUP37
prerank,regulation of neuron differentiation (GO:0045664),0.2808378307180507,0.8278306751616566,0.7575392038600723,0.8904380390709566,1.0,3/76,1.01%,LRRK2;TIAM1;NGF
prerank,diol biosynthetic process (GO:0034312),0.36403509234456843,0.8278225533177977,0.6807131280388979,0.8900186458188518,1.0,1/15,1.59%,ACER3
prerank,gastrulation (GO:0007369),0.36582343241346094,0.8274765691529531,0.6736334405144695,0.8901656089192926,1.0,2/15,11.20%,GPC3;LMBRD1
prerank,histone lysine methylation (GO:0034968),0.3162976039014099,0.8274744301528175,0.7152777777777778,0.8897341646491761,1.0,10/33,21.35%,KDM6A;SETDB2;DOT1L;EZH2;KMT2A;ASH2L;SETMAR;WDR5;PRDM9;RBBP5
prerank,rRNA processing (GO:0006364),0.2505122372712018,0.8271984000172766,0.8071895424836601,0.8897804360190846,1.0,36/172,15.90%,RPL5;NOL6;RPL37A;RPL6;XRN2;DHX37;RPS14;RPL35A;NHP2;UTP6;RIOK1;RPL13;ERI1;NSA2;DDX49;NOC4L;MPHOSPH6;NOL11;MAK16;RPL34;RPLP0;UTP20;RPL19;RPL11;RPL30;NOP58;RRP36;RPS2;RPL4;RPL7;UTP18;MRTO4;DDX10;TBL3;TSR3;TFB1M
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),0.28330496194041305,0.826703206768808,0.7209595959595959,0.8901938949020191,1.0,7/58,8.42%,UVRAG;POLL;MRE11;SUMO1;DNTT;UBE2N;UIMC1
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),-0.3207218556963899,-0.8262039182595998,0.693717277486911,0.9234402889526342,1.0,6/15,35.07%,DAGLA;GRM5;GRM7;HOMER3;HOMER2;GRM4
prerank,negative regulation of cellular component organization (GO:0051129),0.2777990811861654,0.8259788327551494,0.7651612903225806,0.8909730385747958,1.0,8/74,8.08%,LILRB1;HSPA1A;SORL1;CDC42;CARMIL1;FAP;SVIP;TMC8
prerank,positive regulation of glucose transmembrane transport (GO:0010828),-0.27361204991735544,-0.8257894205653543,0.7477203647416414,0.9232192349531555,1.0,6/26,13.74%,IGF1;OSBPL8;RHOQ;IRS1;PIK3R1;C3
prerank,cellular response to hexose stimulus (GO:0071331),0.3339994167701471,0.8255746489901531,0.7038167938931298,0.8912182711331468,1.0,5/23,13.77%,ERN1;ZBTB20;PRKAA1;PDK3;PRKAA2
prerank,negative regulation of cell-substrate adhesion (GO:0010812),0.3011716054491805,0.8253288547777702,0.6979020979020979,0.8912086547333511,1.0,10/39,20.03%,CASK;PTPRO;RCC2;RHOA;NF2;TBCD;THBS1;KANK1;FZD7;NEXMIF
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),-0.3038612254021798,-0.8251928017243759,0.7150395778364116,0.9233582121409752,1.0,9/16,43.36%,PRMT5;C3;CHGA;ACP3;GRP;PDE6G;NECAB2;GSK3A;SLC39A14
prerank,fatty acid metabolic process (GO:0006631),0.26015183091641775,0.8250908915206508,0.754325259515571,0.8911753856763086,1.0,11/115,9.55%,PPARG;ALOX5AP;GPX1;CD36;ACOT11;ACSL5;NUDT19;ACOT2;CEL;NAAA;MSMO1
prerank,positive regulation of cell cycle (GO:0045787),0.28506889113673994,0.8250531566209632,0.7104247104247104,0.8908120070525374,1.0,15/62,16.73%,RARA;ANKRD17;EIF4EBP1;CCND3;CCND1;ADAM17;PKN2;APP;PSMD10;CCND2;AKT1;CITED2;RPS15A;RPS6KB1;PROX1
prerank,regulated exocytosis (GO:0045055),0.25224955100018204,0.8249367024354912,0.7967741935483871,0.8905826138388968,1.0,26/173,14.58%,CYRIB;PHACTR2;LYN;PECAM1;RAB11FIP1;CD36;TOR4A;MYH9;VEGFC;F13A1;SRGN;NHLRC2;FLNA;TMED10;PSAP;HGF;FN1;SNAPIN;CYB5R1;ABCC4;APP;TLN1;SYNGR2;ARHGAP17;TGFB1;TAGLN2
prerank,negative regulation of mRNA processing (GO:0050686),-0.31402758784361035,-0.8249352592157663,0.6825,0.9228179604009831,1.0,8/15,26.23%,SFSWAP;RNPS1;SRSF7;PTBP1;PCBP4;C1QBP;SRSF12;BARD1
prerank,regulation of protein localization to membrane (GO:1905475),-0.2724490995222046,-0.8248142411539355,0.7452830188679245,0.9220712272474301,1.0,12/28,23.79%,PRKN;ZDHHC2;MMP14;VTI1B;GPC6;CDK5;VAMP8;AR;STX8;GSN;CLN3;GPC4
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.30469925516477037,0.8240031457118867,0.7047353760445683,0.8917802597968919,1.0,9/38,14.82%,TNIP3;NLRX1;STAT1;TANK;RIPK1;CACTIN;CARD19;TLE1;GSTP1
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),0.3628253176717494,0.8237115418074581,0.6945812807881774,0.8918585934535019,1.0,1/15,1.35%,LILRB1
prerank,cellular protein catabolic process (GO:0044257),0.2827824485384801,0.8235222181078901,0.7464968152866241,0.8917374156085678,1.0,13/59,13.80%,DENND3;LONP1;RSPRY1;MALT1;RAB7A;FAP;AP2A2;CAPN2;RIPK1;AP2B1;UBE2G1;ADAMTS12;YME1L1
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),-0.28890079901948995,-0.8232472867438665,0.71900826446281,0.924008443914344,1.0,8/20,19.40%,ATP2A2;CCDC47;TGM2;SELENOK;BCAP31;BAX;HERPUD1;RAP1GDS1
prerank,positive regulation of pseudopodium assembly (GO:0031274),0.3891785322673336,0.8228839222252912,0.6624775583482945,0.8919237352667279,1.0,2/10,15.91%,CDC42;APC
prerank,regulation of pseudopodium assembly (GO:0031272),0.3891785322673336,0.8228839222252912,0.6624775583482945,0.8919237352667279,1.0,2/10,15.91%,CDC42;APC
prerank,negative regulation of protein autophosphorylation (GO:0031953),-0.3559362201899855,-0.8228586191640096,0.6925133689839572,0.9237720169873525,1.0,3/10,12.14%,ENPP1;IMPACT;CHP1
prerank,regulation of DNA repair (GO:0006282),0.2968443731955425,0.8228140315965395,0.7228260869565217,0.8916151001089058,1.0,9/44,11.81%,KAT7;SMCHD1;UBE2N;UBR5;DEK;UIMC1;WRAP53;RPS3;PARG
prerank,phosphate ion transport (GO:0006817),-0.31287741937855296,-0.82270293614955,0.6657963446475196,0.92311578765146,1.0,4/16,12.26%,SLC37A2;SLC25A3;SLC25A11;SLC25A14
prerank,peptidyl-lysine modification (GO:0018205),0.26423873616889726,0.8223681345921844,0.7529002320185615,0.8919342037140227,1.0,14/99,14.65%,BCL11A;NUP210;SUMO1;IFIH1;NUP98;ATP7A;HDAC9;SUMO2;SENP6;NUP153;SIRT4;GCSH;KAT2B;EEF1AKMT1
prerank,negative regulation of T cell differentiation (GO:0045581),0.4011018510504214,0.8222432425870216,0.6695352839931153,0.8917061160501879,1.0,1/10,2.49%,FOXJ1
prerank,regulation of lipoprotein lipase activity (GO:0051004),-0.31078615006867755,-0.8219225237975047,0.7032085561497327,0.9236166038564818,1.0,5/17,20.31%,SORT1;FURIN;NR1H2;APOC1;LMF1
prerank,regulation of centrosome duplication (GO:0010824),-0.2642648603075018,-0.8217216746679947,0.7628865979381443,0.9230063953263284,1.0,18/29,37.39%,VPS4B;CHMP5;CENATAC;NPM1;CHMP1B;CEP76;SPICE1;CHMP2A;CCNF;NAT10;GEN1;PLK2;CEP295NL;STIL;CEP131;CHMP1A;FBXW5;CHMP4C
prerank,maturation of LSU-rRNA (GO:0000470),-0.27441790757977236,-0.8214081015742969,0.744408945686901,0.9226281137988241,1.0,9/26,17.40%,MRPL1;RPF1;NOP2;WDR12;LAS1L;PES1;FTSJ3;SNU13;RRP15
prerank,regulation of alcohol biosynthetic process (GO:1902930),0.3786673728347532,0.8212993986556847,0.6801346801346801,0.892902435830648,1.0,5/12,16.03%,SEC14L2;MBTPS1;SREBF2;H6PD;KPNB1
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.24417984411709956,0.8207549927734321,0.879837067209776,0.8933745685723515,1.0,68/366,16.38%,SP3;RUNX3;LIMD1;SAP30;PITX3;STAT3;NSD3;RABL3;NAB1;ANKRD17;SPI1;CCDC88A;KAT7;RYBP;ATF2;IRF2;RFX3;RPL6;BTG1;ORC5;RNF20;RPS6KA5;AHR;PHF19;CREM;SRSF10;MTPN;CLOCK;ENG;PHF12;NFYC;ZBTB11;BACH1;RBAK;ASCC1;CREBL2;NCOA2;SBNO2;BNC2;DAXX;NR3C1;ING2;SRRT;NLK;FOXO3;REST;APP;BAZ2A;NFYA;PQBP1;MSL3;ATRX;MYB;NSD1;HCLS1;EZH2;NFIL3;ZNF431;USP37;SERTAD3;CREBBP;RELA;DVL2;BHLHE40;FOXN2;INSR;RB1;DAPK3
prerank,cGMP biosynthetic process (GO:0006182),0.3918388256318855,0.8203665550394732,0.6877192982456141,0.8935967136543759,1.0,3/10,23.38%,GUCY1A1;NPR2;NPPC
prerank,response to growth factor (GO:0070848),0.3017600149114651,0.820194477783458,0.708502024291498,0.893459395542362,1.0,7/41,13.17%,KLF4;BMPR2;STAT5B;CIB1;ACVR2A;MAP2K5;AKT1
prerank,Golgi to plasma membrane transport (GO:0006893),0.29251184702002714,0.8196781678604479,0.7427055702917772,0.8938648985091884,1.0,5/47,7.44%,STXBP6;EXOC6;GOLPH3L;RAB34;GCC2
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.31446977406722376,0.819575568404997,0.7142857142857143,0.8935962892610966,1.0,6/31,16.73%,TNNC1;RBPJ;ENG;SMAD4;TGFB1;PROX1
prerank,zinc ion transport (GO:0006829),0.3339781072398778,0.819259086045352,0.6945736434108527,0.8936957687052259,1.0,3/21,8.93%,SLC30A4;SLC30A1;SLC39A11
prerank,response to calcium ion (GO:0051592),0.2651461409239975,0.8188450407733846,0.7660818713450293,0.8939464263067334,1.0,10/102,5.68%,IQGAP1;PLCG2;ALOX5AP;HPCA;RASGRP2;DPEP1;CLIC4;PPP3CA;SLC25A13;KCNH1
prerank,regulation of tissue remodeling (GO:0034103),-0.299375821223907,-0.8182413688521635,0.7270341207349081,0.9277846761657038,1.0,4/18,19.28%,CST3;SYT7;MDK;LEPR
prerank,error-prone translesion synthesis (GO:0042276),0.34078828630103497,0.8181348127477541,0.7060653188180405,0.8947069073803485,1.0,2/21,2.97%,POLI;MAD2L2
prerank,cellular response to radiation (GO:0071478),0.298047672590873,0.8179098267867413,0.7004279600570613,0.894684232730335,1.0,10/40,17.17%,MAPK14;GRB2;CLOCK;TANK;GPR88;NET1;SPIDR;INO80;HUS1;SIRT1
prerank,positive regulation of DNA metabolic process (GO:0051054),0.28172050439531,0.8177732109148279,0.7292191435768262,0.894491403057918,1.0,15/61,17.17%,MRE11;SMCHD1;UBE2N;WRN;MECP2;UIMC1;HGF;WRAP53;RPS3;ATRX;OTUD4;USP7;USP9X;EYA3;SIRT1
prerank,monocarboxylic acid catabolic process (GO:0072329),0.33663172584977163,0.8177348608426087,0.7046875,0.8941329636996934,1.0,4/21,15.22%,NUDT19;CEL;LDHD;FAAH
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",-0.2741698690167407,-0.8175050917098271,0.7044776119402985,0.9281718898206329,1.0,10/24,27.71%,POLD3;UBC;XRCC1;PCNA;LIG3;RFC3;LIG1;UBA52;RFC2;POLE
prerank,regulation of cellular response to heat (GO:1900034),-0.2161072773239697,-0.8174694284767533,0.907608695652174,0.9272820851743176,1.0,30/77,27.54%,RPTOR;NUP54;CD34;NUP133;BAG4;NUP155;BAG1;NUP188;DNAJC2;RANBP2;PTGES3;SEC13;NUP85;HSBP1;NUP42;TPR;CAMK2A;NUP35;AKT1S1;HSP90AB1;CRYAB;NUP37;HSPH1;BAG5;POM121;CCAR2;DNAJB6;MLST8;HSP90AA1;DNAJB1
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.3143884423474534,0.816964975022011,0.6965811965811965,0.8950184497960901,1.0,7/29,16.02%,DGCR8;PUM2;TRIM71;SRRT;TUT7;METTL3;PUM1
prerank,cellular zinc ion homeostasis (GO:0006882),-0.2684379396990535,-0.816931408417338,0.7662721893491125,0.927325535228839,1.0,17/26,43.36%,SLC39A10;SLC39A7;SLC30A9;SLC39A6;MT2A;MT3;LCK;ATP13A2;MT1B;MT1X;MT1G;MT1F;MT1E;MT1M;MT1H;MT1A;SLC39A14
prerank,nucleotide metabolic process (GO:0009117),-0.2827516360871657,-0.8167337107074674,0.7485029940119761,0.9267636932148433,1.0,9/23,30.73%,FHIT;DCTD;AK1;NMNAT2;CMPK2;RNASEH2B;GUK1;ENPP3;AK4
prerank,potassium ion transmembrane transport (GO:0071805),0.2541066621132268,0.8157114211995864,0.8040313549832027,0.8966420031922,1.0,9/135,5.68%,KCNE3;KCNG4;KCNA6;SLC9A7;KCNK7;KCNQ1;HCN4;SLC12A7;KCNH1
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),0.35983340251542767,0.8156610264770456,0.7169179229480737,0.8962849565419084,1.0,5/15,14.84%,RIPOR2;EHD2;MAPK14;ADAM9;EHD1
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.33446793408401415,0.8155839251861743,0.6952380952380952,0.8955547303122404,1.0,4/22,12.69%,ZDHHC7;ZDHHC6;ZDHHC23;CLIP3
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.33446793408401415,0.8155839251861743,0.6952380952380952,0.8955547303122404,1.0,4/22,12.69%,ZDHHC7;ZDHHC6;ZDHHC23;CLIP3
prerank,response to ketone (GO:1901654),-0.27772712785844067,-0.8150996779713418,0.7484848484848485,0.9288589326993147,1.0,5/24,13.75%,ABCB4;SLIT2;SLIT3;CATSPER2;TGFB2
prerank,mRNA processing (GO:0006397),0.24115196938926364,0.8147256284970894,0.8615702479338843,0.8965388929947212,1.0,75/287,19.71%,RSRC1;ERN1;GTF2F2;CRNKL1;RNPC3;POLR2C;SNRPD2;PRPF6;DDX42;SNRPB;DBR1;CDC5L;USP49;CMTR1;BUD31;SRSF10;BUD13;THOC3;DDX41;DNAJC8;FIP1L1;CCNH;RBM10;LSM5;MAGOHB;DDX46;PRPF3;SF3B6;RBM22;RPRD2;SRSF4;DHX8;SLU7;RPRD1B;YTHDC1;NUDT21;SPEN;RBM15;CACTIN;SRRT;FRG1;PQBP1;DDX23;SNRPA1;SF3A1;ERCC3;METTL3;SYNCRIP;AQR;U2SURP;GEMIN7;CPSF3;WBP11;PAPOLA;NCBP1;PHF5A;TXNL4A;CELF1;PABPC1;PPWD1;AURKAIP1;SYF2;TFIP11;SF3B3;SUPT4H1;CWF19L1;RBM41;CSTF3;SF3B2;SF3B1;UPF3B;WDR33;PDCD7;CDC40;SMNDC1
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),0.36027063685280036,0.8145239811863368,0.7027914614121511,0.89645020047075,1.0,2/14,6.97%,CD177;FLNA
prerank,histone H4 acetylation (GO:0043967),0.287724781433284,0.8139309776935373,0.7240437158469946,0.8970174743537562,1.0,16/47,20.73%,KAT7;ATF2;TRIM16;TADA3;KANSL1;ING3;MORF4L1;JADE3;MSL3;KMT2A;PHF20;MSL2;HAT1;WDR5;EP400;KANSL3
prerank,positive regulation of rRNA processing (GO:2000234),-0.3474915998236152,-0.81386705530009,0.7149532710280374,0.930195677537849,1.0,6/10,29.21%,DIMT1;UTP15;WDR43;TRMT112;BUD23;WDR75
prerank,positive regulation of glycogen metabolic process (GO:0070875),-0.32519448000998136,-0.813527774328836,0.6821515892420538,0.9298340624965609,1.0,2/13,8.94%,IGF1;IRS1
prerank,positive regulation of mitotic cell cycle (GO:0045931),-0.2673237590336167,-0.8134740345998395,0.7666666666666667,0.9289648384444062,1.0,6/26,13.56%,LGMN;TAL1;USP2;CCDC57;PPP1R10;USP22
prerank,negative regulation of double-strand break repair (GO:2000780),0.3149707362409603,0.813213047397603,0.7120115774240231,0.8977906762262939,1.0,4/30,6.03%,MAD2L2;SMCHD1;KLHL15;UBR5
prerank,mRNA splice site selection (GO:0006376),-0.25983114816827296,-0.8132128749203337,0.7847682119205298,0.9284827382699488,1.0,4/30,3.29%,SRSF5;LUC7L2;PSIP1;SFSWAP
prerank,glycosaminoglycan metabolic process (GO:0030203),0.2819361561780804,0.8125883384710145,0.7564432989690721,0.8983724588907558,1.0,8/54,11.56%,EXT1;GPC3;HSPG2;PXYLP1;XYLT1;FUCA1;GALNT5;SDC3
prerank,apoptotic nuclear changes (GO:0030262),0.32668844251617857,0.812412546385788,0.7291361639824304,0.8982388584061392,1.0,6/24,16.72%,DFFA;DEDD2;DFFB;EXOG;KPNB1;ACIN1
prerank,positive regulation of viral process (GO:0048524),-0.21510974762174262,-0.8123179419528018,0.8932038834951457,0.9291490905470481,1.0,25/60,26.97%,LARP1;PPIA;KPNA6;SRPK1;TBC1D20;POLR2A;ADAR;SRPK2;DHX9;PPIE;POLR2K;VAPB;DDX3X;CDK9;PPID;POLR2H;ADARB1;NELFCD;POLR2J;RAD23A;CNOT7;TYRO3;PDE12;CD28;NELFE
prerank,regulation of inclusion body assembly (GO:0090083),-0.33943739688355146,-0.8122725974328716,0.7259615384615384,0.9282707290263849,1.0,3/11,9.88%,SNCAIP;SACS;DNAJB2
prerank,cholesterol homeostasis (GO:0042632),-0.22155642369846745,-0.812194379103723,0.8416289592760181,0.9274630735407723,1.0,8/64,13.46%,ABCA1;APOE;TTC39B;LIMA1;CNBP;MTTP;NPC1;NR1H2
prerank,aminoglycan catabolic process (GO:0006026),0.31734477730258526,0.8121214586258727,0.7098150782361309,0.8982759310163012,1.0,9/28,22.75%,GPC3;HSPG2;FUCA1;SDC3;CTBS;GPC1;NAGLU;IDS;HPSE
prerank,smooth muscle tissue development (GO:0048745),-0.34696865842739577,-0.8119191214375464,0.7146282973621103,0.9269886806551212,1.0,2/10,4.00%,SMO;NF1
prerank,positive regulation of glucose metabolic process (GO:0010907),-0.3250528238162974,-0.8112240667157044,0.7239709443099274,0.9273163206569415,1.0,8/14,37.68%,PPARGC1A;IRS1;GPLD1;SLC45A3;DDB1;IRS2;ARPP19;PMAIP1
prerank,carnitine shuttle (GO:0006853),0.3783267995060186,0.8106670715605764,0.6986301369863014,0.9002089657115944,1.0,3/11,13.77%,PRKAG2;PRKAB2;PRKAA2
prerank,androgen receptor signaling pathway (GO:0030521),-0.3378836809421446,-0.8106610553548175,0.7091346153846154,0.9273893768552733,1.0,4/11,22.73%,DDX5;PLPP1;AR;ARID1A
prerank,neuron projection fasciculation (GO:0106030),-0.3587742773248138,-0.8106154305731619,0.7153465346534653,0.9265121398367882,1.0,3/10,9.06%,CNTN4;CDK5R1;ARHGAP35
prerank,regulation of oxidative phosphorylation (GO:0002082),0.35539836299465116,0.8099232935032844,0.7277310924369748,0.9010352783058696,1.0,6/16,22.78%,ATP7A;ABCD1;VCP;COX7A2;PINK1;COX7A2L
prerank,release of cytochrome c from mitochondria (GO:0001836),0.3386080297091297,0.8097962023215702,0.6862123613312203,0.900823813691288,1.0,9/17,22.11%,BBC3;FIS1;DNM1L;TIMM50;GGCT;BAD;FZD9;BID;BCL2
prerank,retina homeostasis (GO:0001895),-0.2721231481745683,-0.809416434043536,0.7647058823529411,0.9277365036595729,1.0,2/23,5.32%,WHRN;CCDC66
prerank,tRNA transport (GO:0051031),-0.2518394082482195,-0.8093816833332089,0.8148148148148148,0.9268461863142569,1.0,13/35,19.43%,NUP54;NUP133;NUP155;NUP188;RANBP2;SSB;SEC13;NUP85;NUP42;TPR;RAN;NUP35;NUP37
prerank,regulation of protein-containing complex disassembly (GO:0043244),0.35186735199293284,0.8091661126544033,0.735632183908046,0.9013967969907583,1.0,7/16,18.69%,CLEC16A;ETF1;MTRF1;IRAK3;INSR;GSPT1;TBC1D25
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),0.28268588641370984,0.809159493150278,0.7253886010362695,0.9009773083595222,1.0,9/50,14.75%,CCNJL;CCND3;CDKN2C;CCND1;CCNH;CCNT2;CCNT1;CCND2;CDK5R2
prerank,zinc ion transmembrane transport (GO:0071577),0.332505577938807,0.8085304646546313,0.7142857142857143,0.9016122012380595,1.0,5/22,17.41%,SLC30A4;SLC30A1;SLC39A11;SLC39A13;SLC39A12
prerank,protein depolymerization (GO:0051261),-0.2617890178039779,-0.8084711938106578,0.7647058823529411,0.9274977072595015,1.0,8/27,23.22%,MICAL3;VPS4B;CKAP5;CFL1;KIF18A;GSN;NCKAP5L;NCKAP5
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),-0.2859737516973537,-0.8078969922105608,0.7378917378917379,0.9275588157556008,1.0,10/21,24.94%,IK;KLHL22;BUB3;ZW10;MAD1L1;TPR;FBXO5;BUB1B;BUB1;CENPF
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),-0.3003097421249168,-0.8078951161543507,0.7222222222222222,0.9266145285253199,1.0,5/17,14.53%,SMAD7;DGKQ;PARD3;CALM1;EIF4G1
prerank,cellular response to estradiol stimulus (GO:0071392),0.3470689413209103,0.807850917919269,0.7151799687010955,0.9022829472663697,1.0,5/18,22.91%,NCOA3;NRIP1;LCOR;CCDC62;FAM210B
prerank,metallo-sulfur cluster assembly (GO:0031163),0.33153719636533097,0.8078442379794449,0.7337278106508875,0.9018641090086555,1.0,7/22,18.11%,ABCB7;GLRX5;LYRM4;HSPA9;NUBP2;NUBP1;NFU1
prerank,mRNA metabolic process (GO:0016071),0.2593171452956801,0.8075629986691701,0.780952380952381,0.9018761209384456,1.0,25/90,21.01%,ZC3H12D;HSPA1A;ERN1;SNRPB;DCP2;LSM5;ZFP36L2;PRPF3;SRSF4;NUDT21;SF3A1;METTL3;RNH1;PNPT1;CPSF3;NCBP1;CELF1;AURKAIP1;SUPT4H1;CSTF3;SF3B2;SF3A2;PRPF18;NONO;SLBP
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.2729413211475352,0.8073351917502306,0.7706766917293233,0.9018512431121454,1.0,8/72,10.48%,SP100;BCL3;BTG2;HIPK2;CNOT6;PIDD1;CNOT2;CASP2
prerank,positive regulation of heart rate (GO:0010460),-0.29578100318704725,-0.8066729242776558,0.7311827956989247,0.92789865768503,1.0,6/17,22.39%,ATP2A2;ADRA1B;ADRB1;SCN3B;RYR2;ADRA1A
prerank,autophagy of nucleus (GO:0044804),-0.3105651394017631,-0.8065169276730445,0.7169811320754716,0.9272150125388966,1.0,6/16,20.63%,ULK2;ATG12;ATG9A;ATG7;WDR45;ATG2A
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),0.3504032748338089,0.8064172679447006,0.7347611202635914,0.9029203991130039,1.0,2/15,7.19%,PTK2B;DYRK1A
prerank,dicarboxylic acid metabolic process (GO:0043648),0.27993509785387344,0.8062046541556833,0.7567204301075269,0.9028430905315854,1.0,7/52,12.50%,TAT;ME2;HAAO;IDH1;MDH2;MTRR;OGDH
prerank,regulation of receptor internalization (GO:0002090),-0.2504821240554604,-0.806142798140974,0.7927631578947368,0.9269328149266542,1.0,10/35,18.27%,MAGI2;DLG4;CD63;FLOT1;VEGFA;ANKRD13D;SCYL2;ATXN2;ANKRD13B;ANGPT1
prerank,Wnt signaling pathway (GO:0016055),0.2621115443783445,0.8060163912073941,0.7961859356376639,0.9027266688730825,1.0,8/92,8.89%,LRRK2;PLCG2;CCDC88C;CSNK1G1;AXIN1;PTEN;RARG;CSNK1G3
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),0.32005955938437647,0.8059727901938263,0.7383040935672515,0.9023640248005542,1.0,7/25,19.97%,MAD2L2;DOT1L;NSD1;TGFB1;RB1;NIBAN2;PARK7
prerank,negative regulation of developmental process (GO:0051093),0.27079570000394526,0.8058646623785429,0.761723700887199,0.9021083239242369,1.0,4/69,5.44%,BCL11A;FOXJ1;SPI1;RC3H1
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),0.35840341255994806,0.8058355356456341,0.6998368678629691,0.9017298157283516,1.0,1/14,1.61%,SULF2
prerank,fatty acid derivative biosynthetic process (GO:1901570),0.3023818064407526,0.8054983264703752,0.7465564738292011,0.9018572974504119,1.0,9/35,18.81%,ALOX5AP;GGTA1;FAR1;BDH1;ACAT1;PPT1;HMGCLL1;SLC25A1;HPGD
prerank,fatty acid transmembrane transport (GO:1902001),0.33737522622804117,0.8053669137451112,0.7188498402555911,0.9016365833190324,1.0,6/19,15.17%,PRKAG2;CD36;PRKAB2;ABCD1;PRKAA2;SLC2A1
prerank,regulation of brown fat cell differentiation (GO:0090335),0.35068819442688887,0.8051717813167572,0.7027027027027027,0.9015121183175039,1.0,2/16,2.01%,METRNL;PIM1
prerank,apoptotic mitochondrial changes (GO:0008637),0.29999617425558023,0.8050801809586208,0.7224669603524229,0.9012258975039517,1.0,13/32,22.11%,IFIT2;BBC3;ATP2A1;FIS1;DNM1L;TIMM50;HSPD1;AIFM2;GGCT;BAD;FZD9;BID;BCL2
prerank,T cell homeostasis (GO:0043029),-0.34931748578220256,-0.805049182704249,0.6959619952494062,0.9278676414599184,1.0,5/10,27.19%,NCKAP1L;JAK3;PPP2R3C;ZC3H8;FAS
prerank,negative regulation of mRNA catabolic process (GO:1902373),0.3140811212258987,0.8046034604184101,0.7341954022988506,0.9015800803619057,1.0,6/29,16.00%,TENT5A;GDNF;DHX34;EIF4ENIF1;PAIP1;PABPC1
prerank,determination of left/right symmetry (GO:0007368),0.30156163566303573,0.8045566077527398,0.7581329561527581,0.9012306320406502,1.0,5/36,13.94%,FOXJ1;RFX3;KIF3B;CCDC39;CITED2
prerank,carboxylic acid transport (GO:0046942),0.2777794182975892,0.8045278291018364,0.7643908969210174,0.9008669470832895,1.0,14/55,19.15%,SLC23A2;SLC23A1;PSAP;SLC15A4;SLC1A5;SLC1A4;SLC38A1;SLC66A1;SLC6A9;SLC16A3;SLC16A4;SLC16A7;SLC6A11;SLC38A2
prerank,regulation of cholesterol biosynthetic process (GO:0045540),0.3467548727658846,0.8043314320251322,0.7101910828025477,0.900774607445039,1.0,8/17,17.22%,SEC14L2;ERLIN1;MBTPS1;PRKAA1;SREBF2;ABCG1;KPNB1;SCAP
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),0.3208823447576936,0.8041967011949341,0.7308868501529052,0.9005659307785021,1.0,9/25,19.82%,RPL5;HIPK2;CSNK2A2;CSNK2A1;RPL11;TAF1;EFNA1;PRKCG;PSMF1
prerank,tRNA aminoacylation for protein translation (GO:0006418),-0.237715993680365,-0.804145471610318,0.8464730290456431,0.9285134837665442,1.0,17/42,24.62%,YARS1;LARS1;NARS1;WARS2;LARS2;NARS2;WARS1;TARS3;IARS1;DARS1;TARS2;KARS1;PPA2;FARSA;EARS2;RARS1;CARS1
prerank,catecholamine biosynthetic process (GO:0042423),-0.3378766478594824,-0.8040148615147525,0.747072599531616,0.9277980713867132,1.0,3/11,32.84%,TGFB2;DDC;MOXD1
prerank,regulation of amyloid-beta formation (GO:1902003),0.29955774036425326,0.8035623942707463,0.7384196185286104,0.901182828144001,1.0,12/34,15.81%,IFNGR1;SORL1;PICALM;PRNP;RTN2;GSAP;TMED10;RTN4;ROCK1;ABCG1;RELA;RTN1
prerank,maintenance of gastrointestinal epithelium (GO:0030277),-0.3332668581952279,-0.8034246573721956,0.7638190954773869,0.927925125788083,1.0,4/12,42.55%,TLR4;TLR9;INAVA;NOD2
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),0.29852270185817414,0.8024626305023747,0.7575342465753425,0.9025748858111128,1.0,8/37,15.32%,PRKAG2;AXIN1;DDIT4;SPRED3;APP;TGFB1;MAPK1;SPRED1
prerank,positive regulation of double-strand break repair (GO:2000781),0.29330166573241284,0.8023840750033021,0.7549668874172185,0.9022808050294003,1.0,9/39,12.79%,DTX3L;MAD2L2;SMCHD1;ACTR2;WRAP53;PARP9;ARID2;KMT5B;SPIDR
prerank,positive regulation of cell-substrate junction organization (GO:0150117),-0.2676670420011159,-0.8015599537994368,0.7735294117647059,0.9302031044761637,1.0,5/24,11.95%,NRP1;IQSEC1;PIK3R1;PPM1F;VEGFA
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),-0.254902058572288,-0.8012584916264466,0.8098159509202454,0.9298150654535328,1.0,8/30,16.72%,BCL9;SMAD7;NREP;SMAD3;TRIM33;FSTL1;DKK3;SOX11
prerank,regulation of dendrite extension (GO:1903859),-0.29690997185791995,-0.8012137225647245,0.7701492537313432,0.9289486916604309,1.0,3/18,6.89%,SYT1;RNF157;PLAA
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",-0.31446339170863064,-0.8011465160581511,0.7463768115942029,0.9281260016581576,1.0,7/14,24.31%,SFSWAP;RNPS1;SRSF7;PTBP1;PCBP4;C1QBP;SRSF12
prerank,activation of protein kinase activity (GO:0032147),0.25652636606985646,0.800980800275226,0.8150765606595995,0.9041002422503209,1.0,27/106,18.80%,PAK1;JAK2;MALT1;CCDC88A;AXIN1;TAOK3;ADRA2A;TIRAP;STK4;PTK2B;PDPK1;PAK2;TLR3;MINK1;PRKAR2A;ADCY7;MAP3K7;ADCY5;AKT1;MAPKAP1;IL18;PRR5;INSR;TRAF2;PRKCD;STK3;PINK1
prerank,endochondral bone morphogenesis (GO:0060350),-0.3431809490994293,-0.8008478716688514,0.7331730769230769,0.9277351064366123,1.0,5/11,14.26%,MEF2C;INPPL1;TMEM119;TRPV4;BMPR1B
prerank,regulation of transforming growth factor beta production (GO:0071634),0.33622941306990395,0.8007667888559025,0.7169517884914464,0.9040220966502011,1.0,3/18,10.32%,LILRB1;SMAD4;FN1
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),-0.276736180194736,-0.8004618194456405,0.7281795511221946,0.9274838101503136,1.0,2/20,1.56%,DCC;BCL2L1
prerank,cholesterol metabolic process (GO:0008203),0.276291351010856,0.8004614968539135,0.787765293383271,0.9040868032836548,1.0,17/68,17.22%,CEL;HSD17B7;CYP27A1;SULT2B1;ACAA2;MSMO1;IDI1;FDPS;NSDHL;ABCA5;DHCR24;SOAT1;ABCG1;ANGPTL3;MVD;MVK;SCAP
prerank,positive regulation of potassium ion transport (GO:0043268),0.29505927240111696,0.8000855484081211,0.7572413793103449,0.904249241533981,1.0,6/38,8.38%,KCNQ1;KIF5B;ADRA2A;FLNA;KCNN4;GNB1
prerank,negative regulation of heart contraction (GO:0045822),-0.33107431881878246,-0.7993322036028282,0.7275,0.9284657570495197,1.0,2/11,7.88%,ATP1A2;PIK3CG
prerank,response to interleukin-4 (GO:0070670),-0.33836931473524595,-0.7991908799758736,0.7304964539007093,0.9277619698648663,1.0,4/10,35.69%,JAK3;SHPK;LEF1;TCF7
prerank,positive regulation of muscle hypertrophy (GO:0014742),-0.30610493336008293,-0.7989879110842519,0.7222222222222222,0.9271583041686267,1.0,1/15,0.42%,IGF1
prerank,mitotic sister chromatid cohesion (GO:0007064),0.35222434500097655,0.7983616088686374,0.717607973421927,0.9066222818851368,1.0,6/16,20.31%,NIPBL;MAU2;HASPIN;RB1;RAD21;PDS5B
prerank,adrenergic receptor signaling pathway (GO:0071875),0.3340158188628039,0.798263536753506,0.7243491577335375,0.9063537739189998,1.0,2/20,5.23%,RAPGEF2;ADRA2A
prerank,snRNA metabolic process (GO:0016073),0.3437962000294761,0.7977816135752371,0.7149606299212599,0.90668546373873,1.0,5/17,16.66%,TUT1;INTS2;INTS11;INTS4;INTS6
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.3282473246739745,0.7971290257898207,0.713841368584759,0.9073176081098686,1.0,9/21,22.00%,PNLDC1;CNOT6;CNOT2;TUT7;CNOT8;TNKS1BP1;CNOT6L;PARN;CNOT3
prerank,glutamine family amino acid catabolic process (GO:0009065),-0.31566775467003616,-0.7969063351522475,0.7336814621409922,0.9296766877853868,1.0,6/13,32.31%,GLUL;GAD1;GLS;PRODH;GLS2;NOS1
prerank,positive regulation of tissue remodeling (GO:0034105),0.381179848363983,0.796849059336464,0.7183600713012478,0.907324102230984,1.0,2/10,14.64%,ROCK1;IL18
prerank,protein K11-linked ubiquitination (GO:0070979),-0.25959993537923426,-0.796768766818562,0.7747747747747747,0.9289738046477397,1.0,2/27,3.12%,PRKN;UBE2B
prerank,regulation of cholesterol efflux (GO:0010874),0.30079754805035824,0.7966474274971203,0.7394957983193278,0.9072209416491767,1.0,7/30,14.69%,PPARG;NFKBIA;ABCA3;NAXE;ABCA5;SREBF2;GPS2
prerank,"DNA-templated transcription, termination (GO:0006353)",0.2686646245971372,0.7962397105787282,0.7967781908302355,0.90747511804691,1.0,19/68,19.38%,TAF1A;SNRPB;POLR1G;SETX;SSU72;FIP1L1;CCNH;SCAF8;NUDT21;ERCC3;POLR1B;MAZ;CPSF3;PAPOLA;NCBP1;TAF1C;CSTF3;POLR3K;WDR33
prerank,regulation of cellular metabolic process (GO:0031323),0.2818054256524383,0.7960627789969306,0.7573726541554959,0.90731371431361,1.0,8/45,15.85%,PID1;PARL;ARF4;ARF1;PDK3;AGPAT1;ABCG1;RNF41
prerank,regulation of chromatin binding (GO:0035561),0.3804354751002357,0.795979440784206,0.704225352112676,0.9070192045959068,1.0,2/10,9.67%,DTX3L;PARP9
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),0.3681067553809369,0.7958041346906631,0.6941580756013745,0.9068730683465579,1.0,4/12,14.36%,UCK2;CAD;UCK1;DCK
prerank,protein targeting to peroxisome (GO:0006625),0.3052041728106398,0.7957816458937212,0.7359635811836115,0.9064808203488427,1.0,6/29,13.06%,PEX16;PEX12;ZFAND6;PEX14;FIS1;ABCD1
prerank,retinoid metabolic process (GO:0001523),-0.2095162287662021,-0.7957430582402334,0.8985507246376812,0.9298488951112611,1.0,20/71,33.74%,APOE;LRP1;BCO2;DHRS3;GPC6;AGRN;AKR1B1;RDH13;NAPEPLD;GPC4;SCPEP1;AWAT2;SDC2;ALDH1A2;GPC2;DHRS13;RDH11;RETSAT;CYP26B1;RBP1
prerank,ribonucleoprotein complex biogenesis (GO:0022613),0.27666736516026935,0.7953894362357992,0.7742346938775511,0.9066951996603654,1.0,10/57,14.59%,XPO1;RPL5;DHX37;RPL35A;RIOK1;RPF2;RPL11;RRP36;RPL7;MRTO4
prerank,positive regulation of actin filament depolymerization (GO:0030836),0.38334620216148946,0.7952267155884667,0.6887298747763864,0.9065126798772175,1.0,1/10,5.06%,CARMIL1
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),0.3324502561310616,0.7942979591104572,0.7507987220447284,0.9075431127718505,1.0,5/20,11.52%,ITCH;HSPA1A;DCUN1D1;DAXX;DCUN1D3
prerank,RNA 3'-end processing (GO:0031123),0.2668564264415702,0.7941983607565051,0.8044831880448319,0.9072655832471529,1.0,22/69,20.04%,THOC3;FIP1L1;TUT1;MAGOHB;TENT2;RPRD2;SRSF4;SLU7;RPRD1B;NUDT21;MTPAP;TUT7;PNPT1;TENT4B;CPSF3;PAPOLA;NCBP1;CSTF3;UPF3B;WDR33;CDC40;SUPV3L1
prerank,negative regulation of translational initiation (GO:0045947),0.3595076077815864,0.7939851702328279,0.718381112984823,0.9071801148209147,1.0,4/13,14.62%,EIF4EBP1;EIF2AK1;PAIP2;EIF3E
prerank,positive regulation of dendrite extension (GO:1903861),-0.2969142859132621,-0.7936797721394344,0.7542372881355932,0.9323063372966061,1.0,3/17,6.89%,SYT1;RNF157;PLAA
prerank,early endosome to Golgi transport (GO:0034498),0.3734626529411488,0.7935118845946376,0.7167832167832168,0.907538960614152,1.0,3/11,8.37%,SNX1;RAB6A;STX5
prerank,sprouting angiogenesis (GO:0002040),0.2799648500004656,0.7933838292707776,0.7601078167115903,0.907324922412281,1.0,8/51,9.47%,RSPO3;ADGRA2;VEGFC;RNF213;PTK2B;ENG;NAXE;PGF
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),-0.340245033406388,-0.7932875448622736,0.7405660377358491,0.9320170404844801,1.0,3/10,10.71%,BIN1;ATP1A2;VDAC1
prerank,high-density lipoprotein particle remodeling (GO:0034375),-0.31241816139002215,-0.793206335809368,0.7462311557788944,0.9312246071506521,1.0,1/15,0.41%,APOE
prerank,sensory perception of chemical stimulus (GO:0007606),0.3496255952341815,0.7931518019997976,0.7050473186119873,0.9072724729615173,1.0,3/15,16.43%,CD36;SLC24A4;UBR3
prerank,regulation of cellular amide metabolic process (GO:0034248),0.3024064504649726,0.7930744106646828,0.7556179775280899,0.9069655856867288,1.0,11/32,21.67%,PICALM;SAMD8;MTPN;TMED10;FOXO3;APP;ROCK1;PRKCD;PUM3;PCIF1;EIF4E
prerank,meiosis I (GO:0007127),-0.26756040448501134,-0.7929245637148004,0.7507692307692307,0.930772263099499,1.0,13/23,51.66%,FOXJ2;ZCWPW1;ZSCAN21;DDX4;SYCP3;SGO1;HSF2BP;FOXJ3;SLC25A31;TDRD9;BCL2L11;MEIOB;MOV10L1
prerank,response to nitric oxide (GO:0071731),0.35071131152848256,0.7928533467082113,0.6976351351351351,0.9069068658411239,1.0,1/13,4.37%,DPEP1
prerank,regulation of keratinocyte migration (GO:0051547),-0.32144227317554835,-0.7926120764867834,0.7402912621359223,0.9303601907622926,1.0,2/12,4.10%,EPB41L4B;IQSEC1
prerank,negative regulation of interleukin-10 production (GO:0032693),0.3378362966050622,0.7922675042169933,0.7284552845528456,0.9074025484914174,1.0,1/16,1.35%,LILRB1
prerank,negative regulation of myeloid cell differentiation (GO:0045638),-0.27805591054078815,-0.7921816810420643,0.7834757834757835,0.9301506302612909,1.0,3/20,5.82%,MAFB;CTR9;LDB1
prerank,sensory perception of light stimulus (GO:0050953),0.25760035550162863,0.7919560752034654,0.811965811965812,0.9074533869772813,1.0,15/87,17.46%,CRYBG3;RP2;ATF6;WFS1;ATXN7;DNAJC19;OPA3;KIFC3;UNC119;IMPG2;USH2A;GRM8;EYA3;PRPH2;PITPNA
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),-0.18973475659988256,-0.7916552751463115,0.9133858267716536,0.9301832743354367,1.0,73/125,40.40%,NEK6;CLIP1;RMDN1;CENPO;CLASP2;PPP1CC;CKAP5;BUB3;NUP133;DYNLL2;DYNLL1;WDR62;ZW10;CEP126;MAPRE1;RANBP2;MAD1L1;BCCIP;SEC13;NUP85;RAN;CENPE;KNL1;CENPA;NUP37;DCTN6;KIF18A;NDEL1;CENPP;SUN2;TACC3;PMF1;BUB1B;CENPK;CENPU;BUB1;CENPF;PLK2;DLGAP5;CENPT;SPDL1;EFHC1;NDC80;NSL1;CDCA8;B9D2;RCC1;KIF4A;DSN1;RANGAP1;CENPN;MIS12;CENPH;STIL;BIRC5;SKA2;KIF2A;MAD2L1;CENPI;TBCE;INCENP;SPC25;KNTC1;KIF2C;TTK;SGO1;ZWINT;PLK1;DYNC1I1;NDE1;NUF2;TUBG1;AURKA
prerank,negative regulation of potassium ion transport (GO:0043267),0.34932874847583395,0.7914048892329603,0.7215815485996705,0.9078928323115544,1.0,3/13,13.74%,NEDD4L;PTK2B;STK39
prerank,response to metal ion (GO:0010038),0.27034812483448234,0.7912432858341772,0.7874213836477988,0.9077232606371574,1.0,7/67,6.72%,PLSCR1;NEDD4L;SLC30A4;PPP3CA;HAAO;SLC25A13;CRIP1
prerank,termination of RNA polymerase I transcription (GO:0006363),-0.24657960688816427,-0.7904304298923646,0.8214285714285714,0.9311991491518067,1.0,16/30,32.26%,GTF2H2;TTF1;GTF2H1;TAF1D;ERCC2;POLR2K;GTF2H3;CDK7;POLR2H;GTF2H5;TBP;GTF2H4;CAVIN1;POLR1F;MNAT1;POLR2L
prerank,protein localization to nucleus (GO:0034504),0.2529326792092068,0.7903591814212968,0.8014018691588785,0.908663254949515,1.0,19/102,16.03%,BCL3;SYK;STAT3;PTTG1IP;WRN;LMNA;RPF2;PIKFYVE;HIKESHI;TOR1AIP1;NUP153;MORC3;RPL11;EIF4ENIF1;AKT1;FAM53C;GBP2;TNPO1;KPNB1
prerank,platelet aggregation (GO:0070527),-0.2509638377116253,-0.7900461834638811,0.7773972602739726,0.9309210094717993,1.0,11/33,24.48%,P2RY12;PPIA;ILK;PIK3CG;ITGB3;GNAS;PLEK;RAP2B;FIBP;TYRO3;ACTG1
prerank,DNA strand elongation (GO:0022616),-0.28803560351402097,-0.7899700729516772,0.7941176470588235,0.9301422041392582,1.0,12/18,38.36%,POLD3;GINS1;POLA1;RFC3;GINS3;RFC4;MCM4;GINS4;GINS2;DCLRE1B;POLD2;NBN
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),0.3219078348115442,0.7895180720865199,0.7488921713441654,0.9095612546142392,1.0,5/22,16.08%,IL10RA;CRLF3;IL6;KIT;OCIAD1
prerank,regulation of exit from mitosis (GO:0007096),0.28808604928549225,0.7873650099249837,0.7689075630252101,0.9125047639197329,1.0,4/38,6.85%,CDC14A;UBE2E1;PPP1R9B;MAD2L1BP
prerank,positive regulation of protein localization to Cajal body (GO:1904871),-0.3334339131668018,-0.7872660735318964,0.7429245283018868,0.9327353745714542,1.0,3/11,13.17%,CCT2;DKC1;CCT8
prerank,regulation of protein localization to Cajal body (GO:1904869),-0.3334339131668018,-0.7872660735318964,0.7429245283018868,0.9327353745714542,1.0,3/11,13.17%,CCT2;DKC1;CCT8
prerank,oligodendrocyte development (GO:0014003),0.3479873420033065,0.7871270694789129,0.7297734627831716,0.9124381523554417,1.0,2/15,4.27%,MYRF;B4GALT5
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",-0.2801449377077291,-0.7869686993256353,0.7560975609756098,0.93136842585086,1.0,9/21,31.22%,GTF2H2;GTF2H1;ERCC2;GTF2H3;GTF2H5;ERCC1;GTF2H4;DDB1;CHD1L
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",-0.2801449377077291,-0.7869686993256353,0.7560975609756098,0.93136842585086,1.0,9/21,31.22%,GTF2H2;GTF2H1;ERCC2;GTF2H3;GTF2H5;ERCC1;GTF2H4;DDB1;CHD1L
prerank,peptidyl-lysine dimethylation (GO:0018027),0.33138331638822954,0.7868356537865036,0.7515723270440252,0.9124786464279517,1.0,7/18,20.53%,SETD7;ASH1L;SETD2;KMT2A;SETMAR;EHMT1;PRDM9
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),0.2598520926286979,0.786152646777902,0.7954271961492179,0.9131380091673542,1.0,22/87,18.81%,ARHGEF18;FOS;CBL;ZFYVE9;F11R;ENG;PXN;RHOA;USP15;NRROS;SMAD4;NLK;MAP3K7;TGFB1;ADAM9;USP9X;ZMIZ2;DUSP22;SMAD5;SIRT1;APPL1;HPGD
prerank,cGMP-mediated signaling (GO:0019934),0.35801843683550455,0.7854030199826535,0.7098360655737705,0.9139014006170023,1.0,3/13,11.50%,CD36;PDE2A;IRAG1
prerank,regulation of DNA biosynthetic process (GO:2000278),0.3092720600069807,0.7853625861629493,0.7474150664697193,0.9135352357353398,1.0,4/27,9.12%,BMPR2;PARP4;HGF;TNKS
prerank,axoneme assembly (GO:0035082),-0.252571003084415,-0.7851975480543602,0.8187919463087249,0.9333396037493408,1.0,23/30,47.10%,CFAP74;DCX;DNAI4;LRGUK;SPAG16;SPEF1;TTLL3;CFAP46;CCDC40;RSPH9;JHY;DNAJB13;CFAP206;DRC1;SPAG17;GAS8;TTC12;DNAAF2;RSPH1;RP1;RSPH4A;DNAAF1;CCDC65
prerank,glycerolipid metabolic process (GO:0046486),0.36913680259839965,0.7850828564357248,0.7238421955403087,0.9135429090085792,1.0,1/11,1.04%,DGKG
prerank,vasoconstriction (GO:0042310),-0.33237502852498646,-0.7846334770993814,0.7505938242280285,0.9333218804508219,1.0,2/11,7.38%,SLC8A1;HTR2B
prerank,modulation by symbiont of entry into host (GO:0052372),0.34445952165437466,0.7846054978259578,0.7341772151898734,0.9138838528924609,1.0,5/16,15.93%,TRIM62;TRIM25;EXOC7;TRIM14;EXOC2
prerank,glucan biosynthetic process (GO:0009250),0.36544752238555744,0.7843276920457262,0.7237936772046589,0.9134693066925869,1.0,3/12,12.77%,PGM1;UGP2;PGM2L1
prerank,glycogen biosynthetic process (GO:0005978),0.36544752238555744,0.7843276920457262,0.7237936772046589,0.9134693066925869,1.0,3/12,12.77%,PGM1;UGP2;PGM2L1
prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.23377098023631263,0.7836583668817976,0.9209445585215605,0.9140957392156795,1.0,60/327,16.38%,SP3;RUNX3;LIMD1;SAP30;PITX3;STAT3;NSD3;NAB1;SPI1;KAT7;RYBP;ATF2;IRF2;RFX3;RPL6;BTG1;RNF20;RPS6KA5;AHR;PHF19;CREM;SRSF10;CLOCK;ENG;PHF12;NFYC;ZBTB11;BACH1;RBAK;ASCC1;CREBL2;NCOA2;SBNO2;BNC2;DAXX;NR3C1;ING2;SRRT;NLK;REST;BAZ2A;NFYA;PQBP1;MSL3;ATRX;MYB;NSD1;HCLS1;EZH2;NFIL3;ZNF431;SERTAD3;CREBBP;RELA;DVL2;BHLHE40;FOXN2;INSR;RB1;DAPK3
prerank,regulation of autophagy of mitochondrion (GO:1903146),0.32819807297725717,0.7832899954555358,0.7504,0.9142294922808567,1.0,10/19,19.97%,FBXW7;CSNK2A2;CAMKK2;HTT;DNM1L;SREBF2;FBXO7;HAX1;PINK1;PARK7
prerank,DNA replication-independent nucleosome assembly (GO:0006336),0.28711349600091307,0.7829778558753717,0.758273381294964,0.914288261533146,1.0,8/38,14.92%,H3-3A;RBBP4;SMARCA5;CENPL;CENPQ;ATRX;RSF1;CENPC
prerank,embryonic skeletal system development (GO:0048706),0.29438488864294354,0.7829385688201075,0.7585227272727273,0.9139237289669713,1.0,3/35,8.20%,SULF2;DEAF1;XYLT1
prerank,C21-steroid hormone metabolic process (GO:0008207),-0.28104398509046813,-0.7818385495577739,0.7683923705722071,0.9369121893294134,1.0,7/20,38.14%,STARD3;AKR1B1;FDX1;TSPOAP1;HSD17B10;STAR;CYP46A1
prerank,negative regulation of chemokine production (GO:0032682),0.3469613129308225,0.7811983138452914,0.7313432835820896,0.9161322599580622,1.0,4/14,14.82%,KLF4;IL6;MAP2K5;GSTP1
prerank,regulation of protein localization (GO:0032880),0.2713196829133826,0.7811479591221525,0.8025806451612904,0.915788768993725,1.0,13/58,13.15%,PICALM;FBXW7;SUMO1;ZDHHC7;AFDN;RABGAP1L;STX6;TRIM25;TRIM46;TRIM14;DVL3;TRIM17;MAPK8
prerank,sterol homeostasis (GO:0055092),-0.21274652128518767,-0.7807017615694067,0.8617511520737328,0.9378845197922782,1.0,8/65,13.46%,ABCA1;APOE;TTC39B;LIMA1;CNBP;MTTP;NPC1;NR1H2
prerank,amyloid precursor protein catabolic process (GO:0042987),0.3484330627624364,0.7804335073959724,0.7293354943273906,0.9164394472977111,1.0,5/14,16.94%,ADAM17;DYRK1A;ADAM19;ABCG1;PSEN1
prerank,activation of protein kinase A activity (GO:0034199),-0.2959921209801551,-0.7804197162832165,0.763681592039801,0.9374014370481473,1.0,5/16,17.65%,ADCY9;PRKACA;PRKAR1A;ADCY3;ADCY8
prerank,vasculogenesis (GO:0001570),-0.2407535910893167,-0.7798895759421947,0.8576388888888888,0.9373181262761902,1.0,4/32,11.95%,TGFBR2;RASA1;ITGB8;VEGFA
prerank,telomere maintenance in response to DNA damage (GO:0043247),-0.34015718358678276,-0.7798279826668028,0.7619047619047619,0.9364818368314113,1.0,3/10,14.31%,RIF1;TERF2IP;DCLRE1A
prerank,ncRNA processing (GO:0034470),0.23411475685159047,0.7797986774662785,0.8765822784810127,0.9169988009943412,1.0,37/200,14.68%,RPL5;NOL6;FARS2;RPL37A;DGCR8;RPL6;XRN2;DHX37;RPS14;RPL35A;TUT1;UTP6;RPL13;DDX49;NOC4L;MPHOSPH6;INTS2;SRRT;TUT7;NOL11;INTS11;RPL34;RPLP0;UTP20;RPL19;RPL11;RPL30;NOP58;METTL3;RRP36;INTS4;RPS2;RPL4;RPL7;UTP18;MRTO4;DDX10
prerank,kidney development (GO:0001822),0.2649555668273084,0.7790051898088685,0.7866323907455013,0.9178159499509811,1.0,5/65,6.83%,ACE;SULF2;NIPBL;GDNF;WFS1
prerank,regulation of multicellular organism growth (GO:0040014),0.3427770387885893,0.7780638779636784,0.7602523659305994,0.9188607821543271,1.0,2/15,3.80%,STAT5A;STAT5B
prerank,purine-containing compound salvage (GO:0043101),-0.31782001286535577,-0.7779405708593089,0.7600950118764845,0.9384066624354315,1.0,4/12,27.68%,GMPR;AMPD2;HPRT1;ADK
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.29930103953640036,0.7777925671240098,0.7568345323741007,0.9188417048493362,1.0,11/28,23.70%,NGF;SPI1;DAXX;DEDD2;BAG3;ZDHHC3;DIABLO;BID;BCL2;TNF;CASP8AP2
prerank,regulation of calcium ion import (GO:0090279),0.31974600599749214,0.7776897330973274,0.7600596125186289,0.9185619468663339,1.0,4/21,12.84%,FYN;PRNP;SLC30A1;LGALS3
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),0.24833930724090023,0.7776087700995516,0.8304297328687572,0.9182691885155646,1.0,24/112,17.17%,ARHGEF18;FOS;CBL;ZFYVE9;PDE2A;F11R;ENG;PXN;ZFP36L2;RHOA;USP15;NRROS;SMAD4;NR3C1;NLK;MAP3K7;TGFB1;ADAM9;USP9X;ZMIZ2;DUSP22;WNT7A;SMAD5;SIRT1
prerank,positive regulation of protein autophosphorylation (GO:0031954),0.31906836886324585,0.77731737083575,0.7518796992481203,0.9182970176493014,1.0,2/22,4.01%,ACE;MRE11
prerank,regulation of mitotic spindle assembly (GO:1901673),0.3304714283431147,0.7772845097834062,0.7383627608346709,0.9179265480299981,1.0,3/19,8.00%,HSPA1A;CHMP4B;PDCD6IP
prerank,inner ear receptor cell stereocilium organization (GO:0060122),-0.3383331067078313,-0.7770413413179186,0.7388059701492538,0.9388908227736648,1.0,3/10,21.90%,WHRN;ADGRV1;SOD1
prerank,negative regulation of phosphatase activity (GO:0010923),0.31253638171228765,0.7767477029611238,0.7638483965014577,0.9183297730021096,1.0,9/25,21.95%,CRY2;PPP1R15A;GPATCH2;FKBP1B;ZCCHC9;SEMA4D;PTPA;TIPRL;GSK3B
prerank,negative regulation of cellular protein catabolic process (GO:1903363),-0.3345533294989302,-0.7760561908307293,0.7690355329949239,0.9394780552700945,1.0,6/10,24.40%,NELL1;FURIN;RIC1;DAB2IP;RGP1;EPHA4
prerank,mRNA 3'-end processing (GO:0031124),0.2568481974774668,0.7758017674720288,0.833939393939394,0.9193554997869571,1.0,24/78,19.56%,SSU72;THOC3;FIP1L1;TUT1;MAGOHB;SCAF8;TENT2;RPRD2;SRSF4;SLU7;RPRD1B;PAPOLG;NUDT21;MTPAP;APP;TENT4B;CPSF3;PAPOLA;NCBP1;PABPC1;CSTF3;UPF3B;WDR33;CDC40
prerank,aminoglycan metabolic process (GO:0006022),-0.3339911678803864,-0.7743029467782142,0.75177304964539,0.9412517817951338,1.0,3/10,13.76%,CHST9;B3GAT1;B3GAT2
prerank,oxoacid metabolic process (GO:0043436),-0.24768761239472223,-0.774099519825631,0.8272425249169435,0.940616447821664,1.0,2/27,3.14%,TPST2;ENPP1
prerank,membrane lipid catabolic process (GO:0046466),0.37002547272955816,0.7733610711566843,0.7626527050610821,0.9226298060509579,1.0,3/10,16.31%,SMPDL3B;FUCA1;PPT1
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),0.32119978226490353,0.7732708872782784,0.7761194029850746,0.9223437387051593,1.0,3/23,3.95%,CCDC88C;KIF5B;CCDC88A
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.3134847237357865,0.773119655843811,0.7788018433179723,0.9221281095827008,1.0,5/22,15.91%,HEXIM1;PTEN;LATS1;LATS2;APC
prerank,cellular modified amino acid biosynthetic process (GO:0042398),0.32390069289466916,0.7730354245445861,0.7543581616481775,0.9218234037346618,1.0,2/20,6.34%,PLSCR1;GSS
prerank,magnesium ion transport (GO:0015693),0.35188526493779426,0.7729742772297582,0.7504244482173175,0.9214912051958528,1.0,3/12,10.58%,MMGT1;MAGT1;NIPA2
prerank,negative regulation of DNA replication (GO:0008156),-0.30855821954528434,-0.7729320468171968,0.7396593673965937,0.9414798135443851,1.0,1/13,1.57%,WAPL
prerank,regulation of axon extension involved in axon guidance (GO:0048841),-0.25904678500849027,-0.7728841447060378,0.8368580060422961,0.9406224786242267,1.0,7/24,19.55%,NRP1;SEMA3D;SEMA3E;SEMA6D;VEGFA;SEMA7A;SEMA5B
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),-0.25122846278672584,-0.7728240688482462,0.85625,0.939797376092013,1.0,3/27,6.52%,GNA15;C3AR1;GPR157
prerank,regulation of rRNA processing (GO:2000232),-0.28915793758112074,-0.7725263592810243,0.7634961439588689,0.9393560154736449,1.0,9/16,29.21%,DIMT1;UTP15;WDR43;TRMT112;YTHDF2;BUD23;NUDT16;USP36;WDR75
prerank,cellular response to osmotic stress (GO:0071470),-0.2662238126783388,-0.7724256048131724,0.7964601769911505,0.9385927857394142,1.0,6/21,21.63%,CAPN3;PKD2;RCSD1;TRPV4;DDX3X;WNK3
prerank,embryonic heart tube development (GO:0035050),-0.30157381723081733,-0.7723449748159269,0.7797927461139896,0.937804499254764,1.0,3/14,25.52%,ACVR1;RYR2;NDRG4
prerank,positive regulation of axon extension (GO:0045773),-0.2667416445215098,-0.7718554682281275,0.8089887640449438,0.9376187370106063,1.0,6/22,18.10%,NRP1;LIMK1;GOLGA4;VEGFA;MACF1;SEMA7A
prerank,histone H3 deacetylation (GO:0070932),0.34348781263808575,0.7714083995247759,0.7779578606158833,0.923392308787215,1.0,5/15,18.05%,HDAC9;HDAC3;ELK4;SIRT1;HDAC1
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),0.35674258416073795,0.7710041883834046,0.744954128440367,0.9235554894319186,1.0,1/11,3.37%,RSPO3
prerank,hyaluronan catabolic process (GO:0030214),0.3271613000828271,0.7704695730030786,0.7523961661341853,0.9239558471016646,1.0,1/18,0.26%,CD44
prerank,protein localization to cell surface (GO:0034394),0.29955595819359065,0.7704119522775612,0.7736686390532544,0.923608739346769,1.0,7/26,18.45%,PTPRU;CD177;FLNA;USP4;PIGK;UNC50;VCL
prerank,regulation of cellular senescence (GO:2000772),-0.24890875090231357,-0.7701789140856213,0.8110749185667753,0.9391678548164094,1.0,3/28,3.42%,NUAK1;NEK6;ZKSCAN3
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.3238995342118857,0.7700950580916961,0.7319277108433735,0.923658039464642,1.0,4/19,11.42%,PAPSS1;SULT2B1;PAPSS2;TPST1
prerank,DNA biosynthetic process (GO:0071897),0.33770708554151685,0.7697056608776474,0.7416267942583732,0.9238126284595476,1.0,3/16,7.01%,POLL;POLD4;WRN
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),0.37740553470145727,0.7694861582095284,0.7508771929824561,0.9237025003873454,1.0,4/10,18.66%,PXYLP1;XYLT1;CSGALNACT1;DSEL
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),0.3098403010480271,0.7693415141082415,0.7675840978593272,0.9234808843776051,1.0,8/25,22.64%,HSPA1A;DNAJB12;HSPA9;HSPA5;DNAJB14;DNAJB4;SDF2;HSPA8
prerank,microtubule anchoring (GO:0034453),0.3607601597101925,0.7692022281960279,0.764505119453925,0.923260377196976,1.0,3/12,13.91%,GCC2;PEX14;CLASP1
prerank,iron-sulfur cluster assembly (GO:0016226),0.31114008251885933,0.769043859553937,0.791907514450867,0.9230595584463873,1.0,7/24,18.11%,ABCB7;GLRX5;LYRM4;HSPA9;NUBP2;NUBP1;NFU1
prerank,heart development (GO:0007507),0.23876122311359874,0.7688965634040807,0.8721973094170403,0.9228462388263994,1.0,15/150,10.32%,KDM6A;PDLIM5;HEG1;PDLIM1;NIPBL;BMPR2;GPC3;DLC1;PTEN;CRIP1;SGCD;HDAC9;ID2;FBN1;FN1
prerank,striated muscle cell development (GO:0055002),-0.29215841614440885,-0.7686271274862098,0.7877237851662404,0.940577734813682,1.0,3/14,18.62%,CAPN3;TMOD1;TMOD2
prerank,cytosolic calcium ion transport (GO:0060401),0.29764971259777595,0.7679033006409662,0.7406340057636888,0.9239452854890097,1.0,4/28,5.27%,MCUB;ATP2B1;ATP2A3;MAIP1
prerank,histone H3-K36 demethylation (GO:0070544),-0.3341215670627352,-0.767854674098938,0.7561576354679803,0.9408705968033613,1.0,4/10,11.67%,KDM2A;KDM2B;KDM4A;PHF8
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),-0.2556687931861242,-0.7678537133314339,0.828080229226361,0.9399616421412063,1.0,2/26,2.16%,ANAPC15;NEK6
prerank,regulation of transcription by RNA polymerase III (GO:0006359),-0.2773539313895831,-0.7675718005362461,0.7939560439560439,0.9394502389226046,1.0,6/19,15.91%,RPTOR;ICE2;NAB2;TENM1;AR;MAF1
prerank,mitotic recombination (GO:0006312),0.3321285335444831,0.7674610076651056,0.7619808306709265,0.9241807157694123,1.0,4/15,18.87%,TEP1;MSH3;SMC6;SMC5
prerank,triglyceride homeostasis (GO:0070328),-0.25325014803420515,-0.7672563161275758,0.8259493670886076,0.9389671601617466,1.0,2/26,5.87%,APOE;PNPLA8
prerank,regulation of synapse organization (GO:0050807),0.30068936314105826,0.7668887890984172,0.7776119402985074,0.9246326188747097,1.0,8/26,17.55%,PDLIM5;SETD5;ABHD17B;YWHAZ;SLITRK4;GRIPAP1;MDGA1;ABHD17A
prerank,mitochondrial transport (GO:0006839),-0.21506424986333703,-0.7666171400786416,0.904,0.9390214758385722,1.0,25/53,28.62%,BCL2L1;FLVCR1;TIMM44;TIMM17A;STARD3;TIMM9;GDAP1;MFF;OXA1L;SPG7;BCAP31;TMEM14C;COX18;TIMM10B;TOMM34;TIMM13;BCS1L;TOMM7;MFN2;TIMM8B;HSP90AA1;TMEM14A;ABCB10;SLC25A4;TIMM17B
prerank,regulation of cell division (GO:0051302),0.2568771295684218,0.7662242383948946,0.8260869565217391,0.9251745447521896,1.0,12/72,15.06%,UVRAG;KIF20A;BIRC6;NCOA3;CIB1;GIT1;SETD2;INSC;CSPP1;PIK3R4;AURKB;ORC6
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),0.2584299685540342,0.7660458914534092,0.8387909319899244,0.9250312549630532,1.0,16/71,15.85%,LONP1;RSPRY1;MALT1;CHMP4B;FAP;CAPN2;NEDD8;PDCD6IP;ATXN3;UBE2W;FBXL17;ADAMTS12;YME1L1;VCP;USP9X;RNF41
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),0.3543413339356548,0.7659884000293782,0.7532894736842105,0.9247024230779938,1.0,2/12,7.29%,ATF7IP;SETDB2
prerank,regulation of cellular pH (GO:0030641),0.2994660854203749,0.7659417863356097,0.7769886363636364,0.9243508605610652,1.0,3/29,7.51%,SLC9A7;SLC4A7;SLC4A8
prerank,long-chain fatty acid transport (GO:0015909),0.2917025653371977,0.7654810767058048,0.788546255506608,0.9245899793798055,1.0,4/30,6.35%,PPARG;PRKAG2;CD36;PRKAB2
prerank,ribosomal large subunit biogenesis (GO:0042273),0.26903609907734416,0.7653758937288365,0.8151476251604621,0.9243272106931009,1.0,13/54,17.54%,RPL5;RPL6;RPL35A;NHP2;RPF2;NSA2;MAK16;RPLP0;RPL11;RPL7;MRTO4;MRPL20;LTO1
prerank,ventricular cardiac muscle tissue development (GO:0003229),0.309806809159895,0.7652938811093469,0.7546583850931677,0.9240290561246618,1.0,4/23,16.73%,TNNC1;ID2;TGFB1;PROX1
prerank,chromosome organization (GO:0051276),0.2446785554282983,0.7650524196171095,0.8485915492957746,0.9239678069979056,1.0,28/99,22.41%,PADI1;H3-3A;SETD7;PHF19;MSH3;DOT1L;MSH6;COPS3;LATS1;EZH1;EZH2;HDAC3;HMGN1;SIRT1;SUPT4H1;LRWD1;PADI2;HDAC1;GATAD1;EHMT1;SATB1;XPA;BRWD1;HDAC5;PARP1;CUL4A;GPS1;HMG20A
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),-0.3102294995926589,-0.7646207075730517,0.7853535353535354,0.9411113069441691,1.0,5/11,27.19%,LGALS9;PIH1D1;HTRA2;GSN;FAS
prerank,mitotic spindle organization (GO:0007052),-0.17836381708612692,-0.7645601396240338,0.9807692307692307,0.9402911900942679,1.0,65/153,31.42%,NEK6;CLIP1;RMDN1;PIBF1;CENPO;CLASP2;PPP1CC;CKAP5;BUB3;NUP133;GOLGA2;DYNLL2;LSM14A;DYNLL1;WDR62;ZW10;CEP126;MAPRE1;RANBP2;MAD1L1;BCCIP;SEC13;NUP85;SMC1A;RAN;CENPE;RAB11A;SPICE1;KNL1;CENPA;NUP37;DCTN6;KIF18A;NDEL1;MAP9;CENPP;SUN2;PMF1;BUB1B;CENPK;CENPU;TPX2;BUB1;PRC1;CENPF;PLK2;DLGAP5;CCDC61;CENPT;KIFC2;SPDL1;EFHC1;NDC80;NSL1;CDCA8;B9D2;RCC1;KIF4A;DSN1;CEP192;KIFC1;RANGAP1;TOGARAM2;CENPN;MIS12
prerank,autophagosome maturation (GO:0097352),0.29138732238961346,0.7640026004341016,0.8103932584269663,0.9250856495130604,1.0,6/32,14.18%,UVRAG;STX17;TSG101;WIPI2;VMP1;VCP
prerank,steroid metabolic process (GO:0008202),0.25564762634299043,0.763525873720963,0.8333333333333334,0.9253392055345195,1.0,9/72,13.24%,HSD17B14;HSD17B7;CYP27A1;SULT2B1;MSMO1;DHRS4;DHRS9;RDH5;DHCR24
prerank,RNA biosynthetic process (GO:0032774),0.2947395236513972,0.7635161365623616,0.78328611898017,0.9249344537923214,1.0,6/31,14.54%,TAF13;SMARCA5;SETX;TAF7;POLA2;RSF1
prerank,protein localization to chromatin (GO:0071168),0.32316876272261824,0.7634363885035312,0.7702060221870047,0.9246407480956457,1.0,7/18,18.32%,NIPBL;FAM47E;LEMD2;MCM9;PPHLN1;LRWD1;RAD21
prerank,mitochondrial transcription (GO:0006390),0.3612067268224336,0.7623391563322658,0.7539823008849558,0.9258088816249386,1.0,3/10,15.90%,FOXO3;TFAM;TFB1M
prerank,response to hydroxyurea (GO:0072710),0.3598371347820836,0.7621974310604079,0.7615780445969125,0.9255946098141626,1.0,3/11,12.79%,KAT7;ATRX;SPIDR
prerank,L-serine metabolic process (GO:0006563),-0.3403161979112579,-0.7621815472345317,0.7629107981220657,0.9428776291895693,1.0,4/10,25.86%,PSAT1;SERINC3;PHGDH;SHMT2
prerank,histone exchange (GO:0043486),0.28060631102319394,0.7619215041302185,0.7908961593172119,0.925576879478578,1.0,8/37,14.92%,RBBP4;SMARCA5;CENPL;ACTR6;CENPQ;SRCAP;RSF1;CENPC
prerank,establishment of protein localization to organelle (GO:0072594),0.25247000643829487,0.7618644451749186,0.8177278401997503,0.9252371562360869,1.0,17/72,18.80%,NEURL1B;SYK;STAT3;IL10RA;PTTG1IP;LAMP5;HIKESHI;NUP153;EIF4ENIF1;AKT1;FAM53C;TNPO1;KPNB1;TSPAN17;APPL1;NUP93;PINK1
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),0.2729699647772184,0.7617912099061949,0.8251655629139073,0.9249224292798608,1.0,10/48,18.20%,NUP210;PRKAG2;NOA1;NUP98;PRKAG1;NUP153;PNPT1;SEH1L;GCK;NUP93
prerank,regulation of lipid kinase activity (GO:0043550),0.3620412072054668,0.7617002928250534,0.7609841827768014,0.9246344595883577,1.0,4/11,17.09%,PPP2R5A;RBL2;RB1;PIK3R2
prerank,negative regulation of secretion by cell (GO:1903531),0.2844403440098733,0.7610181380160511,0.7823613086770982,0.9251724351786496,1.0,5/38,13.54%,LILRB1;STXBP6;SLC30A1;ANXA1;TNFRSF1B
prerank,regulation of transport (GO:0051049),0.27954934637777157,0.7606231023788832,0.8091286307053942,0.9253087006850702,1.0,1/36,0.22%,LRRK2
prerank,miRNA mediated inhibition of translation (GO:0035278),-0.3214207724919029,-0.7603384646570224,0.7688564476885644,0.9437761542939929,1.0,2/11,4.93%,AGO3;AGO1
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",-0.3214207724919029,-0.7603384646570224,0.7688564476885644,0.9437761542939929,1.0,2/11,4.93%,AGO3;AGO1
prerank,histone H4-K16 acetylation (GO:0043984),0.3199250097750563,0.7602339258036976,0.7707006369426752,0.9254322967871148,1.0,9/19,20.73%,KAT7;KANSL1;JADE3;MSL3;KMT2A;PHF20;MSL2;WDR5;KANSL3
prerank,positive regulation of actin nucleation (GO:0051127),0.36094689351970544,0.7600647195700273,0.7538461538461538,0.9252507667123151,1.0,1/11,2.44%,WASF2
prerank,phosphate ion transmembrane transport (GO:0035435),-0.31290814844335263,-0.7597177964281303,0.749379652605459,0.9437838464214355,1.0,4/12,12.26%,SLC37A2;SLC25A3;SLC25A11;SLC25A14
prerank,negative regulation of cellular senescence (GO:2000773),0.35024839383008005,0.759660351083611,0.7609427609427609,0.9253980052655735,1.0,1/13,1.61%,AKT3
prerank,endoplasmic reticulum membrane organization (GO:0090158),0.3568442123513347,0.759391610292776,0.7401433691756273,0.9253665629742048,1.0,3/11,15.27%,RTN4;ATL1;VCPIP1
prerank,positive regulation of ERAD pathway (GO:1904294),0.3382942250045505,0.759341496574353,0.75,0.9250135485587639,1.0,2/13,8.57%,NFE2L2;ATXN3
prerank,regulation of mitotic nuclear division (GO:0007088),0.2672939060691795,0.7592957504225434,0.8221941992433796,0.9246639810716405,1.0,3/55,5.44%,IL1B;CDK13;CAV2
prerank,cellular response to amino acid stimulus (GO:0071230),0.2917651237470651,0.7588571217693374,0.7907949790794979,0.9248818267301941,1.0,6/33,12.67%,SPAAR;FYN;CAPN2;UBR2;SH3BP4;CASTOR2
prerank,ceramide transport (GO:0035627),-0.3152818553474594,-0.7587775988793173,0.785,0.9441645298590259,1.0,2/12,5.07%,ABCB4;PLEKHA8
prerank,endosome organization (GO:0007032),0.27536186098457893,0.7584612432563992,0.7991746905089409,0.9250271136306081,1.0,13/41,23.35%,PLEKHF1;TMCC1;PI4K2B;SNX3;SNX33;PI4K2A;SNX10;HOOK3;USP8;AKTIP;CHMP2B;CORO1C;USP50
prerank,negative regulation of cation transmembrane transport (GO:1904063),-0.2740007258710611,-0.7579945285988159,0.8251928020565553,0.9443915533959125,1.0,2/18,7.62%,BIN1;ATP1A2
prerank,negative regulation of cellular protein metabolic process (GO:0032269),0.25047187517352454,0.757416766324321,0.8400954653937948,0.9261228375799695,1.0,20/88,18.37%,DAPK1;NFKB1;DNAJC1;BTG2;EIF2AK2;GIGYF2;MRPL13;TRIM71;RPS3;IGF2BP3;PAIP2;EIF4ENIF1;EIF2AK3;AKT1;SYNCRIP;DAPK3;CNOT8;CAPRIN1;DDX6;SHMT1
prerank,regulation of gastrulation (GO:0010470),0.33908733466372043,0.7572462314713054,0.7727272727272727,0.9259519137855117,1.0,4/14,15.51%,SCX;PHLDB2;CLASP1;POGLUT1
prerank,iron ion transmembrane transport (GO:0034755),0.36345930269504817,0.7558451948090898,0.7623931623931623,0.9275302425270875,1.0,1/10,3.48%,ABCB7
prerank,regulation of lipase activity (GO:0060191),0.3434451906992801,0.7558067229889746,0.7618243243243243,0.9271720152864804,1.0,3/13,15.05%,RHOA;PCSK5;ANGPTL3
prerank,sensory perception of mechanical stimulus (GO:0050954),0.2443690741255694,0.7555605089266014,0.8672248803827751,0.92712029481926,1.0,7/85,8.63%,CDC14A;NIPBL;KCNQ1;RIPOR2;MYO3B;WFS1;PDZD7
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",-0.2547796329990216,-0.7554855155229511,0.8307692307692308,0.9470636716735535,1.0,6/23,17.65%,HMGB1;REXO4;CECR2;CASP3;HMGB2;FBH1
prerank,positive regulation of heterochromatin assembly (GO:0031453),0.3538945344030112,0.755424630903313,0.7595356550580431,0.9268917628605413,1.0,2/11,7.29%,ATF7IP;SETDB2
prerank,water transport (GO:0006833),-0.3098256154651219,-0.7549482256810149,0.8018648018648019,0.9468769124536633,1.0,5/12,52.78%,AQP4;PDPN;AQP11;AQP1;SLC5A1
prerank,negative regulation of stem cell differentiation (GO:2000737),0.3481936281455867,0.7546566877534595,0.7661016949152543,0.9275722647713698,1.0,2/12,11.90%,ZFP36L2;REST
prerank,positive regulation of translation (GO:0045727),0.24498350249916168,0.7542333938399491,0.8615916955017301,0.9277857065184012,1.0,4/94,2.39%,NIBAN1;BCL3;RPL5;VIM
prerank,mitotic spindle checkpoint signaling (GO:0071174),-0.2687880265510827,-0.7539198655015731,0.8356545961002786,0.9455962862313676,1.0,9/20,24.94%,IK;KLHL22;BUB3;ZW10;MAD1L1;TPR;BUB1B;BUB1;CENPF
prerank,spindle assembly checkpoint signaling (GO:0071173),-0.2687880265510827,-0.7539198655015731,0.8356545961002786,0.9455962862313676,1.0,9/20,24.94%,IK;KLHL22;BUB3;ZW10;MAD1L1;TPR;BUB1B;BUB1;CENPF
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),-0.2687880265510827,-0.7539198655015731,0.8356545961002786,0.9455962862313676,1.0,9/20,24.94%,IK;KLHL22;BUB3;ZW10;MAD1L1;TPR;BUB1B;BUB1;CENPF
prerank,peroxisome organization (GO:0007031),0.29619957033567784,0.7536185727939758,0.7757296466973886,0.9282445355169263,1.0,6/25,13.06%,PEX16;PEX12;PEX14;FIS1;DNM1L;ABCD1
prerank,sulfur compound transport (GO:0072348),0.2925287991611254,0.753392003598682,0.8023774145616642,0.9281453141612163,1.0,3/27,5.59%,RACGAP1;LRRC8D;SLC25A30
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.3372081346804844,0.753337403495048,0.7801652892561983,0.9277999337911307,1.0,3/15,13.63%,ZC3H12D;KHNYN;RNASEH1
prerank,embryonic eye morphogenesis (GO:0048048),-0.3170674372055926,-0.7532863357764371,0.8117913832199547,0.9456272102432612,1.0,3/11,16.23%,LRP6;KDM2B;EFEMP1
prerank,PERK-mediated unfolded protein response (GO:0036499),0.3677216736360525,0.7532697239194892,0.7482517482517482,0.9274806308632932,1.0,5/10,24.63%,NFE2L2;EIF2AK3;HSPA5;QRICH1;EIF2S1
prerank,macrophage chemotaxis (GO:0048246),0.365833305441188,0.752503440855917,0.7343485617597293,0.9281155259469235,1.0,2/10,12.84%,CKLF;LGALS3
prerank,positive regulation of activated T cell proliferation (GO:0042104),0.3157802565039483,0.752446764162291,0.7841845140032949,0.9277799430285786,1.0,4/18,14.64%,IL27RA;RPS3;ICOSLG;IL18
prerank,gluconeogenesis (GO:0006094),0.2783116080875324,0.7504593284618976,0.7886178861788617,0.9301636370127373,1.0,7/39,11.16%,CRY1;SLC25A13;SLC37A4;PGM1;MDH2;SLC25A12;GPI
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),0.292993938597765,0.7502378266203038,0.7916041979010495,0.9300620514789346,1.0,7/27,14.60%,SLC25A13;SLC25A12;SLC1A4;SLC6A5;SLC25A18;SLC38A1;SLC6A9
prerank,ribosome assembly (GO:0042255),0.2720535718897088,0.750062521422041,0.8194993412384717,0.9298931745918602,1.0,7/47,12.90%,RPL5;RPL6;DHX37;RPS14;RPF2;RPLP0;RPL11
prerank,neuromuscular process (GO:0050905),0.3235689948410309,0.7497702324677528,0.7856,0.9299078934006209,1.0,3/16,13.67%,MYCBP2;PAFAH1B1;TIFAB
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.2638107660697523,0.7495854760584496,0.8401084010840109,0.9297432216950148,1.0,15/49,22.43%,MCL1;BBC3;SGMS1;CYLD;FIS1;DNM1L;EIF2AK3;PLAUR;BECN1;PINK1;BAD;BCLAF1;BID;BCL2;SIAH1
prerank,positive regulation of protein-containing complex assembly (GO:0031334),0.2365429767837047,0.7494562216749736,0.8868144690781797,0.929510076498989,1.0,20/113,14.98%,LCP1;SYK;CD36;MMP1;SUMO1;FAF1;TIRAP;TPPP3;PIEZO1;RPS3;PSMC4;RPA3;SPIDR;LGALS3;ERCC3;GBP5;ERCC4;VCP;TGFB1;MYD88
prerank,histone H2A acetylation (GO:0043968),-0.2871682330977317,-0.7493879911506328,0.8286445012787724,0.9500847257745512,1.0,8/16,28.60%,NAA40;MEAF6;SPHK2;RUVBL1;MORF4L2;DMAP1;RUVBL2;TRRAP
prerank,positive regulation of response to stimulus (GO:0048584),0.2714806477654833,0.7492646798975026,0.8149659863945579,0.9293625437623622,1.0,9/40,20.59%,TAF9;IFIH1;ARG2;B2M;FCGR2B;NSMCE4A;SIRT1;PRKCD;BCLAF1
prerank,RNA stabilization (GO:0043489),0.2860443383872524,0.7489849548397638,0.8169209431345353,0.9293447409218297,1.0,7/33,16.00%,TENT5A;GDNF;TRDMT1;TENT2;EIF4ENIF1;PAIP1;PABPC1
prerank,regulation of epithelial cell proliferation (GO:0050678),0.24784668679804203,0.7488261084301042,0.8571428571428571,0.9291708856205572,1.0,5/85,5.24%,RUNX3;MARVELD3;GPX1;LAMB1;DEAF1
prerank,embryonic organ morphogenesis (GO:0048562),0.2720806545547448,0.7486782278059273,0.8337874659400545,0.9289609470716377,1.0,4/42,9.63%,NIPBL;RARG;ID2;FBN1
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),-0.2800488291541191,-0.748661385846266,0.8102981029810298,0.9501478300386483,1.0,5/17,15.50%,SASH1;TRIM5;NFKBIL1;CX3CL1;BMP6
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),0.23977920175431303,0.748524398664378,0.875,0.9287684223275919,1.0,18/104,13.59%,UVRAG;CCNJL;CCND3;CDKN2C;CCND1;TSG101;CIB1;CCNH;RALB;SNF8;RHOA;CCNT2;HTT;CCNT1;CDK12;CCND2;AKT1;EZH2
prerank,plasma membrane organization (GO:0007009),0.2588054899489357,0.7481432544643056,0.850632911392405,0.9288573237872534,1.0,12/61,15.66%,PLSCR1;DYSF;MYH9;EHD2;CHMP4A;BIN3;SNX9;PACSIN2;ABCD1;ARL8B;FA2H;SNX33
prerank,chromosome condensation (GO:0030261),0.2791189730620638,0.7479117504332266,0.8024357239512855,0.9287753496439343,1.0,9/36,17.71%,SMC4;CSNK2A2;CSNK2A1;AIFM1;DFFB;RB1;ACIN1;MCPH1;PHF13
prerank,negative regulation of histone acetylation (GO:0035067),0.3531086982618369,0.7478510083625266,0.7590361445783133,0.9284481746546517,1.0,3/11,17.17%,SPI1;TAF7;SIRT1
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),0.3594034454876988,0.7474096778358778,0.7344827586206897,0.9286592413189833,1.0,1/10,2.97%,MAD2L2
prerank,skeletal muscle tissue development (GO:0007519),0.2867387755399416,0.7470520375653894,0.8238636363636364,0.9287546448247438,1.0,4/32,14.07%,SVIL;CAV2;LEMD2;MYH14
prerank,protein K63-linked deubiquitination (GO:0070536),0.2824230431601278,0.7465754364536913,0.7979651162790697,0.9290037169563836,1.0,7/31,14.86%,OTUD1;SPATA2;UIMC1;ATXN3;CYLD;OTUD4;USP7
prerank,cellular response to peptide hormone stimulus (GO:0071375),0.240808872974565,0.7462726376330061,0.9036427732079906,0.9290108118354681,1.0,20/102,19.19%,CYSLTR2;PPARG;NFKB1;C2CD5;PDPK1;HDAC9;PRKAR2A;ADCY7;ADCY5;AKT1;KAT2B;RELA;RPS6KB1;INSR;GCK;PIK3R2;NR4A1;SYAP1;PRKCD;RAB10
prerank,serine family amino acid biosynthetic process (GO:0009070),-0.3048236229901582,-0.7461956740304837,0.8051044083526682,0.9524957525848768,1.0,5/12,28.63%,PSAT1;SERINC3;PHGDH;MTHFD1;SEPHS2
prerank,odontogenesis of dentin-containing tooth (GO:0042475),0.3304208835652771,0.7456367726161461,0.7949526813880127,0.9294659868856829,1.0,1/15,1.71%,ANKRD11
prerank,regulation of fatty acid oxidation (GO:0046320),-0.27774983628729893,-0.7450006145234029,0.8155844155844156,0.9532783869859047,1.0,3/16,5.68%,APPL2;PPARGC1A;LONP2
prerank,toll-like receptor 3 signaling pathway (GO:0034138),0.35701501528636037,0.7448352012333379,0.768595041322314,0.9301565825972565,1.0,2/11,10.65%,TLR3;RIPK1
prerank,negative regulation of protein dephosphorylation (GO:0035308),-0.2627959732582451,-0.7446616899342005,0.8147058823529412,0.9528574533770185,1.0,5/21,11.19%,ENSA;PPP1R8;PPP1R11;PPP4R4;MFHAS1
prerank,autophagosome organization (GO:1905037),0.26147583462766133,0.7446528617901236,0.8369565217391305,0.9300000021252908,1.0,14/50,21.55%,RAB19;RAB7A;ATG5;STX12;PACS2;WIPI2;VMP1;RB1CC1;AMBRA1;BECN1;ATG13;RAB43;ULK1;GABARAPL1
prerank,regulation of ATP metabolic process (GO:1903578),0.2611010608418125,0.7442428110195619,0.8573281452658884,0.9301297266121225,1.0,13/54,18.80%,NUP210;PRKAG2;NUP98;ATP7A;FIS1;PRKAG1;NUP153;ABCD1;SEH1L;COX7A2;GCK;NUP93;PINK1
prerank,NLS-bearing protein import into nucleus (GO:0006607),-0.29934199487523117,-0.744202714372817,0.8148148148148148,0.9525961667933546,1.0,6/13,20.44%,KPNA6;NUP54;IPO5;RANBP2;NUP35;RGPD1
prerank,rRNA metabolic process (GO:0016072),0.22711097940113634,0.7441791848260536,0.9165751920965971,0.9298050115504175,1.0,29/160,14.68%,RPL5;NOL6;RPL37A;RPL6;XRN2;DHX37;RPS14;RPL35A;UTP6;RPL13;DDX49;NOC4L;MPHOSPH6;NOL11;DEDD2;RPL34;RPLP0;UTP20;RPL19;RPL11;RPL30;NOP58;RRP36;RPS2;RPL4;RPL7;UTP18;MRTO4;DDX10
prerank,purine nucleotide biosynthetic process (GO:0006164),-0.3060528888423672,-0.7441102236534273,0.7980997624703088,0.9518105155357267,1.0,5/12,27.58%,PRPSAP1;AMPD2;HPRT1;MTHFD1;PRPSAP2
prerank,monocyte differentiation (GO:0030224),0.35321293701522755,0.7440270684773312,0.7750865051903114,0.929601800161578,1.0,3/10,10.41%,PPARG;MYH9;IL31RA
prerank,alcohol catabolic process (GO:0046164),-0.32440133222520384,-0.7440256977804329,0.8181818181818182,0.9510225275434195,1.0,1/10,0.41%,APOE
prerank,nucleoside triphosphate metabolic process (GO:0009141),-0.2977171161231557,-0.7439624701839311,0.8102564102564103,0.9502007200784542,1.0,8/14,34.24%,ENPP1;AK3;ITPA;AK1;CMPK2;ENPP3;AK4;NME2
prerank,aortic valve development (GO:0003176),-0.229697089151469,-0.7439202384579785,0.8737201365187713,0.9493623485874393,1.0,5/34,12.71%,ROBO2;ROBO1;TNFRSF1A;SLIT2;SLIT3
prerank,myelination (GO:0042552),0.26341533642501813,0.7436865614721277,0.82907133243607,0.929649875000061,1.0,4/46,4.27%,ACER3;ADGRG6;MYRF;B4GALT5
prerank,regulation of gene silencing by RNA (GO:0060966),0.26580585461166434,0.7436805369490146,0.8447121820615796,0.9288362184847836,1.0,10/50,16.20%,NUP210;POLR2C;H3-3A;NUP98;PUM2;TRIM71;NUP153;TNRC6A;PUM1;SEH1L
prerank,regulation of posttranscriptional gene silencing (GO:0060147),0.26580585461166434,0.7436805369490146,0.8447121820615796,0.9288362184847836,1.0,10/50,16.20%,NUP210;POLR2C;H3-3A;NUP98;PUM2;TRIM71;NUP153;TNRC6A;PUM1;SEH1L
prerank,epithelium development (GO:0060429),0.23567414447039503,0.7435734310916766,0.8943661971830986,0.9285728522588518,1.0,13/107,15.18%,PPARG;JAK2;EHF;FOXJ1;STAT1;ANXA4;TRIM71;PPP2R3A;DHRS9;LGALS3;TGFB1;TAGLN2;CASP6
prerank,piRNA metabolic process (GO:0034587),0.31136496275403314,0.742925150352526,0.7918622848200313,0.9290371706778776,1.0,1/19,5.46%,EXD1
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.2598845297235334,0.7427484522050162,0.8612945838837517,0.9288659345182256,1.0,11/54,15.37%,RPL5;HSPA1A;CRY1;RPS3;CAMLG;DCUN1D3;USP4;RPL11;AKT1;PRMT3;SVBP
prerank,positive regulation of sprouting angiogenesis (GO:1903672),0.32539197904475725,0.7421985559658637,0.7730829420970265,0.9292425853075926,1.0,2/15,6.64%,KLF4;PDPK1
prerank,stress granule assembly (GO:0034063),-0.26165241305160464,-0.7419969778029014,0.844632768361582,0.9509275736651048,1.0,6/20,18.25%,LSM14A;ATXN2L;RPS23;OGFOD1;ATXN2;DDX3X
prerank,ribonucleoprotein complex assembly (GO:0022618),0.2323002926208351,0.7416640670074919,0.9093922651933701,0.9295353142839965,1.0,33/132,20.61%,RPL5;CRNKL1;SNRPD2;PRPF6;RPL6;SNRPB;SETX;RPS14;SRSF10;RPF2;COIL;CELF2;YTHDC1;NUDT21;MCTS1;RPLP0;DDX23;RPL11;GEMIN7;NCBP1;TXNL4A;CELF1;MRPL20;RPSA;SHQ1;SF3B1;DDX20;RPS27;SF3A2;LUC7L3;SNUPN;LUC7L;PRPF18
prerank,negative regulation of interleukin-12 production (GO:0032695),0.32358982231896116,0.7405500057579618,0.7753378378378378,0.9306191393962329,1.0,4/14,17.75%,LILRB1;THBS1;IRAK3;LILRA5
prerank,histone H3-K4 trimethylation (GO:0080182),0.3454321418692061,0.7400280963219639,0.7810945273631841,0.9309096941657723,1.0,1/11,2.29%,TET2
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),-0.2928526243191133,-0.7394585751253375,0.8225,0.9533091209462002,1.0,5/13,15.71%,USP19;CLU;NR1H2;MANF;MBTPS2
prerank,regulation of protein localization to centrosome (GO:1904779),0.3550642609485348,0.7376005811316125,0.8,0.9337590338473044,1.0,4/10,21.95%,CEP250;APC;MARK4;GSK3B
prerank,regulation of DNA metabolic process (GO:0051052),-0.2102094171850375,-0.7375069935919607,0.9233870967741935,0.9549275845332673,1.0,8/44,11.59%,MPHOSPH8;YLPM1;PDGFA;UPF1;POLH;TERF2IP;TOM1L1;XRCC5
prerank,renal absorption (GO:0070293),0.3600601714669584,0.736843955157779,0.7832764505119454,0.9343389147036688,1.0,1/10,3.31%,KCNQ1
prerank,negative regulation of cell division (GO:0051782),-0.30813170271169715,-0.7365860519356074,0.8132118451025057,0.9552105195336208,1.0,3/11,15.71%,BLM;ZFYVE19;TXNIP
prerank,negative regulation of DNA biosynthetic process (GO:2000279),0.2807318769343563,0.736398269264364,0.8183139534883721,0.9345401168197278,1.0,9/30,20.26%,BMPR2;CERS1;DCP2;ERCC4;TENT4B;STN1;NIBAN2;TERF2;HNRNPC
prerank,linoleic acid metabolic process (GO:0043651),0.3228539047299943,0.7362871074966644,0.8080133555926544,0.9342570706657011,1.0,4/17,20.16%,ELOVL5;ABCD1;GSTP1;ACSL1
prerank,regulation of establishment of protein localization to telomere (GO:0070203),-0.30806670257038077,-0.7361454704527204,0.7931034482758621,0.9548989424039259,1.0,5/11,24.78%,CCT2;DKC1;CCT8;TERF1;CCT3
prerank,sensory perception of sound (GO:0007605),0.23731554741329985,0.7359834878414776,0.8755924170616114,0.9342356179493148,1.0,7/88,8.63%,CDC14A;NIPBL;KCNQ1;RIPOR2;MYO3B;WFS1;PDZD7
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.29722715230610874,0.7359262802208296,0.8044117647058824,0.9339093423514793,1.0,3/26,7.17%,PLCG2;PRNP;CIB1
prerank,potassium ion import across plasma membrane (GO:1990573),-0.21592763539031978,-0.7357438200260213,0.9446494464944649,0.9545064245119373,1.0,7/41,13.32%,ATP1B3;KCNJ2;ATP1B1;ATP1A2;KCNJ6;HCN2;KCNJ9
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.27031676830840407,0.7351202458756619,0.853625170998632,0.9345994823163581,1.0,10/40,18.77%,FAM111A;WRN;MSH3;EXD2;ATRX;DONSON;MCM9;POLD1;PRIMPOL;SETMAR
prerank,autonomic nervous system development (GO:0048483),-0.2834791220618146,-0.7348976989318202,0.8272251308900523,0.9546809925418867,1.0,4/17,16.72%,NRP1;NF1;SOX4;SOX11
prerank,regulation of myelination (GO:0031641),0.29279199885732826,0.7344173299842247,0.8115501519756839,0.935116904698088,1.0,5/25,13.54%,ITGAX;MYRF;EIF2AK3;ZPR1;TNFRSF1B
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),-0.2780110456172716,-0.7343260474754048,0.8165829145728644,0.9544701350123564,1.0,3/14,12.28%,SLC27A1;CHKA;PCYT2
prerank,regulation of endopeptidase activity (GO:0052548),0.2550358773764959,0.7335168407176479,0.8482490272373541,0.9358647093055267,1.0,8/59,13.17%,PSME3;PICALM;PSME2;BIRC3;SERPINB9;PSMB8;PRELID1;AKT1
prerank,response to ethanol (GO:0045471),-0.29896751313377334,-0.7331506217860837,0.8337531486146096,0.9550839773939921,1.0,4/14,22.56%,SDF4;GLRA2;SOD1;GRIN2B
prerank,hexose biosynthetic process (GO:0019319),0.26876380511157666,0.7331233990636151,0.8209959623149394,0.9359788638041453,1.0,8/42,12.55%,CRY1;SLC25A13;SLC37A4;PGM1;MDH2;SLC25A12;GPI;CHST15
prerank,epithelial structure maintenance (GO:0010669),-0.30785071136175857,-0.7329513092641669,0.8210023866348448,0.9544434252694052,1.0,6/11,57.39%,CXADR;TLR9;NOD2;PIWIL4;MUC6;STRAP
prerank,axonogenesis (GO:0007409),0.21992512016997404,0.7329189061703574,0.9426485922836287,0.9358466194137953,1.0,22/237,9.01%,NOTCH2;EMB;FYN;RET;LMTK2;NTNG2;PTPRO;SEMA4A;SHTN1;NPTN;KIF5B;B4GALT5;GDNF;RPS6KA5;PTEN;GRB2;EFNA2;IGSF9;EZR;EPHB2;SOS1;ZDHHC17
prerank,cardiac muscle tissue morphogenesis (GO:0055008),0.2829173810347074,0.7326057227342759,0.8251121076233184,0.935850200375697,1.0,4/29,16.73%,TNNC1;ENG;TGFB1;PROX1
prerank,positive regulation of cellular component biogenesis (GO:0044089),0.23755946890689472,0.7322224566863301,0.8731884057971014,0.9359581246610653,1.0,15/88,14.21%,SYK;MMP1;SUMO1;RAB7A;FAF1;TIRAP;TSG101;PDCD6IP;SNF8;RPS3;STAM;SPIDR;LGALS3;VCP;TGFB1
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.23989955701432936,0.7321209589759532,0.8907563025210085,0.9356891677639085,1.0,20/95,15.64%,HSPA1A;ZEB2;LEMD3;HIPK2;ADAM17;PDPK1;MTMR4;ENG;LATS1;SPRED3;SMAD4;PMEPA1;ING2;LATS2;ITGA3;CITED2;TGFB1;CREBBP;SPRED1;THBS1
prerank,mammary gland development (GO:0030879),-0.25164632232075396,-0.7318530610587746,0.8850574712643678,0.9549476401038696,1.0,14/21,44.39%,ERBB4;ARHGAP35;VEGFA;GPAT4;WNT4;CAV1;NOTCH4;GLI2;WNT7B;ZBTB7B;PRLR;WNT3;TGFB3;APLN
prerank,negative regulation of cell aging (GO:0090344),0.3211069731852484,0.7316352805180237,0.8028616852146264,0.9359330344271742,1.0,1/16,1.61%,AKT3
prerank,7-methylguanosine mRNA capping (GO:0006370),0.27897979844876325,0.7314606666916645,0.8277777777777777,0.9353350840658203,1.0,4/31,7.88%,GTF2F2;POLR2C;CMTR1;CCNH
prerank,7-methylguanosine RNA capping (GO:0009452),0.27897979844876325,0.7314606666916645,0.8277777777777777,0.9353350840658203,1.0,4/31,7.88%,GTF2F2;POLR2C;CMTR1;CCNH
prerank,cellular response to copper ion (GO:0071280),0.3136108460700858,0.7312070714880076,0.8117088607594937,0.9352616572100664,1.0,2/16,10.37%,PRNP;DAXX
prerank,toll-like receptor 9 signaling pathway (GO:0034162),-0.29319464841962295,-0.7308225918551423,0.8212435233160622,0.9553641902280761,1.0,4/13,17.39%,IRAK2;EPG5;IRAK1;TLR7
prerank,epithelial cell differentiation (GO:0030855),0.23586861589384914,0.7302985176553521,0.8864734299516909,0.9360642466116516,1.0,16/88,19.19%,GLI1;PPARG;EHF;ZDHHC7;ANXA4;LATS1;ANXA1;DHRS9;LGALS3;AKT1;TAGLN2;CASP6;PROX1;HDAC1;FZD7;RAB10
prerank,transcription by RNA polymerase I (GO:0006360),-0.22564504683349035,-0.7302635206319855,0.900355871886121,0.9551612124928133,1.0,12/34,22.97%,GTF2H2;TTF1;GTF2H1;TAF1D;ERCC2;POLR2K;GTF2H3;CDK7;TCOF1;POLR2H;GTF2H5;TBP
prerank,regulation of hemopoiesis (GO:1903706),0.3567235245284836,0.7300312203004666,0.7741379310344828,0.9359992350420272,1.0,4/10,15.26%,CBFB;PURB;LGALS3;CREBBP
prerank,organic acid transport (GO:0015849),0.23775490157935564,0.7296824885720153,0.9069212410501193,0.9360282979541439,1.0,14/94,13.59%,SLC23A2;SLC23A1;LRRC8D;SLC25A30;SLCO1B1;NCOA2;SLC1A5;SLC43A2;NCOA1;SLC1A4;ABCC4;SLC38A1;SLCO1C1;SLC26A7
prerank,muscle tissue development (GO:0060537),-0.2892077341490544,-0.7289528445541524,0.835,0.9558854068027928,1.0,2/13,4.00%,SMO;NF1
prerank,diol metabolic process (GO:0034311),0.30596355937889835,0.7286751969819493,0.8206686930091185,0.9369724195866047,1.0,5/19,15.00%,NAAA;PRKG2;AKT1;SGPP2;SGPP1
prerank,response to organophosphorus (GO:0046683),0.3129955395025397,0.7285703872447655,0.8115015974440895,0.9367036417789276,1.0,3/16,12.16%,STAT1;TRIM16;NDUFS4
prerank,neuron apoptotic process (GO:0051402),0.3007302259345116,0.7281952232919459,0.784251968503937,0.9368076495809475,1.0,7/19,22.43%,NGFR;APP;TRPC5;DIABLO;BID;BCL2;SIAH1
prerank,regulation of protein dephosphorylation (GO:0035304),0.279438057553152,0.7281457128083535,0.8314447592067988,0.936464785672101,1.0,12/37,18.57%,PPP2R5A;DLC1;PPP1R15A;PPP1R2;ANKLE2;HTT;PPP6R2;TGFB1;PPP1R7;PTPA;PRKCD;PIN1
prerank,regulation of protein autophosphorylation (GO:0031952),0.274465502427299,0.7281194625734226,0.825136612021858,0.9360971451858379,1.0,9/36,17.12%,PPP2R5A;MRE11;MOB1B;ENG;PDGFD;MVP;PPP2R5C;PPP2R5E;RASSF2
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.31472886233191344,0.7277571075417028,0.8137254901960784,0.9361610925653365,1.0,4/15,14.98%,CD36;EIF2AK2;GBP5;MYD88
prerank,cholesterol transport (GO:0030301),0.2608916603395145,0.7275555630375777,0.8497913769123783,0.9360012368581047,1.0,9/45,15.34%,LDLR;CD36;SCARB1;CEL;STX12;ABCA5;SOAT1;ABCG1;RELCH
prerank,regulation of glycogen metabolic process (GO:0070873),-0.29782065708500083,-0.7275527362254424,0.8362282878411911,0.9566289357655179,1.0,5/12,35.92%,PPP1R3B;KHK;PPP1R3D;PPP1R3C;PPP1R3E
prerank,endoplasmic reticulum tubular network organization (GO:0071786),-0.2816304416374707,-0.7272694811015352,0.8575197889182058,0.9560712854998005,1.0,7/15,31.17%,RTN3;TMEM33;REEP1;TMEM170A;ARL6IP1;REEP4;REEP2
prerank,alpha-linolenic acid metabolic process (GO:0036109),0.3316456842403739,0.7272339526714752,0.7822445561139029,0.9360142229570528,1.0,3/12,20.16%,ELOVL5;ABCD1;ACSL1
prerank,synaptic vesicle localization (GO:0097479),0.32922002828667707,0.727177958722121,0.7911908646003263,0.9356866888271631,1.0,4/13,14.63%,KIF5B;SYNJ1;SNAPIN;KIF5A
prerank,microtubule bundle formation (GO:0001578),0.2654375805573413,0.7271375086250585,0.8385826771653543,0.9353322616305695,1.0,7/42,13.94%,FOXJ1;NAV1;KIF20A;TPPP3;SPAST;CLASP1;CAPN6
prerank,purine ribonucleotide metabolic process (GO:0009150),0.24862417707643755,0.7268657979237909,0.8633540372670807,0.9352799790035191,1.0,13/68,20.67%,LRRK2;ACOT11;ACOT2;SULT2B1;TPST1;ACAT1;NT5C2;EFL1;BAD;GLYAT;ABHD14B;GMPR2;ACOT1
prerank,positive regulation of macrophage differentiation (GO:0045651),0.3405540743125643,0.7264979034404297,0.7855917667238422,0.9353531653959865,1.0,3/11,14.21%,ID2;RIPK1;TGFB1
prerank,negative regulation of growth (GO:0045926),0.22957299381641355,0.7262726237062364,0.9306818181818182,0.9352216476320271,1.0,22/121,17.17%,NOTCH2;BCL6;HSPA1A;BMPR2;CRLF3;BTG1;PPP1R9B;CDKN2C;OSGIN2;SMAD4;RTN4;DCUN1D3;SH3BP4;PNPT1;TGFB1;FGFR3;PTPRJ;SERTAD3;PPT1;RB1;ST7L;SIRT1
prerank,striated muscle contraction (GO:0006941),0.25344953870631487,0.725652696864836,0.8778833107191316,0.9356039926727978,1.0,3/53,3.70%,TNNC1;KCNQ1;MYL4
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),-0.19634696707796584,-0.7256067714254834,0.9605911330049262,0.9571594914173158,1.0,33/69,32.10%,UQCRC2;COX7C;NDUFA7;NDUFB4;NDUFB2;NDUFV1;NDUFV3;NDUFS7;NDUFB3;COX10;NDUFA5;UQCRC1;UQCR10;COX5B;NDUFB5;NDUFB9;NDUFB7;NDUFA13;NDUFAF1;NDUFB8;NDUFAB1;COX6A1;NDUFB6;NDUFS8;NDUFB10;SDHA;UQCC3;COX6C;NDUFS3;CYC1;COA6;NDUFS6;NDUFA11
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",-0.29078547115327347,-0.7242673476331557,0.8455497382198953,0.9578557135683109,1.0,1/13,1.57%,DDX5
prerank,fatty acid elongation (GO:0030497),0.33020063676227046,0.7241486083412151,0.8006535947712419,0.9371628566194258,1.0,4/13,16.42%,ELOVL5;ELOVL6;ABCD1;HACD4
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.28597662596308177,0.7240826579458446,0.8361408882082695,0.9368349568174759,1.0,7/24,19.98%,ATF6;RBPJ;NFE2L2;ATF6B;HSPA5;KLF2;GCN1
prerank,regulation of TORC1 signaling (GO:1903432),0.27255916424786775,0.7223104585394985,0.8287769784172662,0.938671921182944,1.0,6/33,12.67%,SPAAR;SIK3;CLEC16A;DEPDC5;GPR137C;CASTOR2
prerank,sulfur amino acid metabolic process (GO:0000096),0.2859093830658291,0.7220219095853816,0.8163265306122449,0.9386015876947698,1.0,3/24,10.44%,DPEP1;ADO;MTRR
prerank,positive regulation of intracellular transport (GO:0032388),0.2668518466614714,0.7215340245238946,0.8658367911479945,0.9387942950775735,1.0,7/38,14.84%,SORL1;EHD2;ATP2A1;BCAS3;DYNC1H1;RAB29;EHD1
prerank,DNA dealkylation (GO:0035510),-0.3177575948893586,-0.7214969138683233,0.8486238532110092,0.9593940032437744,1.0,3/10,10.69%,MGMT;ALKBH5;ASCC2
prerank,DNA dealkylation involved in DNA repair (GO:0006307),-0.3177575948893586,-0.7214969138683233,0.8486238532110092,0.9593940032437744,1.0,3/10,10.69%,MGMT;ALKBH5;ASCC2
prerank,regulation of trophoblast cell migration (GO:1901163),0.3254501425662867,0.721424418259369,0.8213689482470785,0.9385285376512209,1.0,2/14,7.80%,ARHGDIB;YTHDF3
prerank,negative regulation of dephosphorylation (GO:0035305),-0.26685187705810454,-0.7211555192269427,0.8556430446194225,0.9589242475626768,1.0,4/18,12.14%,ENSA;PPP1R8;MFHAS1;CHP1
prerank,canonical Wnt signaling pathway (GO:0060070),0.2440313759283334,0.7204271466230379,0.8759493670886076,0.9393440755114274,1.0,12/68,19.50%,LRRK2;AXIN1;PTEN;RARG;DVL3;DVL2;APC;WNT7A;WNT5B;FZD7;FZD9;FZD3
prerank,determination of bilateral symmetry (GO:0009855),0.28973392050977587,0.7193946132069798,0.8269230769230769,0.940230148602626,1.0,3/24,13.94%,FOXJ1;KIF3B;CITED2
prerank,regulation of stem cell population maintenance (GO:2000036),0.30874496517671207,0.7189623666588626,0.8126064735945485,0.9403669138165437,1.0,3/18,11.90%,NCOA3;CNOT2;REST
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),0.2742819487503194,0.7186746141350931,0.8304597701149425,0.9403037496644672,1.0,7/32,15.81%,PKIB;FBXO4;TNKS;MAP3K4;AURKB;MAPK1;TCP1
prerank,negative regulation of TOR signaling (GO:0032007),0.27188867383449244,0.7183904221821418,0.8468965517241379,0.9402654984640312,1.0,8/36,13.77%,SPAAR;DDIT4;UBR2;DEPDC5;PRKAA1;SH3BP4;CASTOR2;PRKAA2
prerank,proteasome assembly (GO:0043248),0.3345512724514489,0.7181853645366089,0.8034188034188035,0.940115465031192,1.0,3/11,13.20%,PSMD9;PSMD10;POMP
prerank,nuclear pore organization (GO:0006999),0.32856686064402474,0.7179386132244558,0.7990033222591362,0.9400152350128053,1.0,5/14,18.20%,NUP98;RTN4;NUP153;SEH1L;NUP93
prerank,positive regulation of neuron differentiation (GO:0045666),-0.21340851879066275,-0.7178227092674249,0.9302325581395349,0.9619025970767402,1.0,15/40,26.95%,MEF2C;BEND6;IMPACT;GPRC5B;ZEB1;SOX11;TCF4;TRIM32;TCF3;MMD;HOXD3;ZC4H2;ECT2;BRINP2;NBL1
prerank,aspartate family amino acid metabolic process (GO:0009066),-0.26584298911851545,-0.7168121178598792,0.8575,0.9621041561659409,1.0,3/18,4.99%,FOLH1;GOT1;NAALAD2
prerank,response to gamma radiation (GO:0010332),0.2852693105791728,0.7167585256801757,0.8315301391035549,0.9410545389598876,1.0,5/24,12.87%,WRN;TLK2;DCUN1D3;PRKAA1;MAP3K20
prerank,CENP-A containing chromatin organization (GO:0061641),0.27217296072671715,0.7161269746993404,0.849478390461997,0.941025882599319,1.0,6/29,14.92%,RBBP4;SMARCA5;CENPL;CENPQ;RSF1;CENPC
prerank,CENP-A containing nucleosome assembly (GO:0034080),0.27217296072671715,0.7161269746993404,0.849478390461997,0.941025882599319,1.0,6/29,14.92%,RBBP4;SMARCA5;CENPL;CENPQ;RSF1;CENPC
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.317864216577525,0.7159275622246415,0.8024691358024691,0.9404580146772447,1.0,3/15,16.00%,ZFP36L2;TNRC6B;PABPC1
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.317864216577525,0.7159275622246415,0.8024691358024691,0.9404580146772447,1.0,3/15,16.00%,ZFP36L2;TNRC6B;PABPC1
prerank,establishment of mitotic spindle localization (GO:0040001),0.2808748820687716,0.7158012456527483,0.8268156424581006,0.9402271961469623,1.0,7/28,16.27%,FBXW11;PAFAH1B1;INSC;HTT;CLASP1;KPNB1;GPSM2
prerank,integrated stress response signaling (GO:0140467),0.3199058601966465,0.715727404482516,0.7876823338735819,0.939911614741819,1.0,4/14,17.98%,EIF2AK1;NFE2L2;EIF2AK3;HSPA5
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),-0.31133045744369475,-0.715602680855382,0.8231292517006803,0.962567302053124,1.0,2/10,4.30%,TREM2;CD68
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.29293970020096993,0.7152976754646543,0.8440779610194903,0.9400281817374359,1.0,5/22,13.84%,VPS37C;TSG101;SNF8;STAM;UBAP1
prerank,chloride transmembrane transport (GO:1902476),0.24855310418184587,0.7145669836745507,0.8776595744680851,0.9404991313837108,1.0,6/48,11.21%,GABRB2;SLC12A7;GABRR2;SLC4A8;SLC12A6;SLC12A9
prerank,snRNA processing (GO:0016180),0.31169084546747994,0.7143884645474164,0.8188976377952756,0.9403062133573378,1.0,6/16,16.66%,TUT1;INTS2;INTS11;INTS14;INTS4;INTS6
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),0.25123705244915573,0.7142717671010284,0.87248322147651,0.9400554963509494,1.0,6/46,11.72%,LNPEP;ACOT11;RBPJ;ADAM17;RHEB;PGAM5
prerank,ER-associated misfolded protein catabolic process (GO:0071712),-0.3003008347932902,-0.7131996361399133,0.8350253807106599,0.9643176903005256,1.0,2/11,12.72%,AUP1;DERL1
prerank,ethanol metabolic process (GO:0006067),-0.2954300343668521,-0.7128499612152845,0.8353808353808354,0.9638269553817508,1.0,3/12,25.62%,ADH5;ACSS1;SULT1A1
prerank,regulation of cellular protein metabolic process (GO:0032268),0.2557619776458769,0.7120305598918927,0.8794871794871795,0.9423087459110701,1.0,8/47,14.21%,KLF4;NFKB1;NFKBIA;MTPN;FOXO3;APP;AKT1;TGFB1
prerank,odontogenesis (GO:0042476),0.2714423853673685,0.7119159491466642,0.8527027027027027,0.9420446110175701,1.0,2/35,3.88%,ANKRD11;LAMB1
prerank,histone H4-K8 acetylation (GO:0043982),-0.27911661386024106,-0.7115719235470872,0.8625,0.9634834966424421,1.0,4/15,10.44%,JADE2;HCFC1;MEAF6;ING4
prerank,histone H4-K5 acetylation (GO:0043981),-0.27911661386024106,-0.7115719235470872,0.8625,0.9634834966424421,1.0,4/15,10.44%,JADE2;HCFC1;MEAF6;ING4
prerank,sulfation (GO:0051923),-0.29392495531747925,-0.7109972312131202,0.8451776649746193,0.9632407870211356,1.0,1/11,1.65%,HS3ST5
prerank,negative regulation of transposition (GO:0010529),0.3109488834441785,0.7108123709945271,0.841091492776886,0.9429653164569897,1.0,2/16,11.53%,UBR2;TUT7
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),-0.2710183119877214,-0.7106027174073126,0.8511749347258486,0.9627750890136341,1.0,3/16,14.65%,IGF1;AKAP6;TRPC3
prerank,peptidyl-lysine trimethylation (GO:0018023),0.28096095455376346,0.710434551443967,0.8488549618320611,0.943027468956545,1.0,9/26,23.06%,TET2;SETD5;SETD2;KMT5B;KMT2A;PRDM9;SMYD5;ATPSCKMT;ANTKMT
prerank,glial cell development (GO:0021782),-0.23555641632037708,-0.7102175304396435,0.9029411764705882,0.962309317672689,1.0,8/25,16.92%,NF1;EIF2B5;SOX4;MDK;EIF2B4;TPPP;SOX11;NSUN5
prerank,protein acetylation (GO:0006473),0.2726942186202686,0.7097756593336192,0.8589928057553957,0.943386850867395,1.0,8/30,19.13%,NAA16;CLOCK;KAT6A;NAA15;KAT2B;CREBBP;SIRT1;HAT1
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.24830203745067805,0.7096386206204668,0.8738255033557047,0.9431605420090866,1.0,15/52,22.00%,RC3H1;PNLDC1;DCP2;CNOT6;LSM5;CNOT2;DCP1A;TUT7;CNOT8;DDX6;TNKS1BP1;CNOT6L;EDC3;PARN;CNOT3
prerank,cyclic purine nucleotide metabolic process (GO:0052652),0.2882305451954297,0.7089502273199526,0.8280757097791798,0.9435875494163638,1.0,4/21,12.62%,ADCY10;GUCY1A1;ADCY7;ADCY5
prerank,membrane fusion (GO:0061025),0.26620962608859106,0.7079883294789245,0.8680555555555556,0.94430599689576,1.0,7/33,17.58%,STX11;DYSF;DNM1L;SNAP23;VAPA;HACE1;MYOF
prerank,endoderm development (GO:0007492),0.3169690501600856,0.707892678554298,0.8216666666666667,0.944010805031684,1.0,13/13,68.33%,DUSP1;TBX20;GATA4;APELA;SOX17;EOMES;DUSP4;DUSP2;SOX7;DUSP5;KIF16B;LHX1;LAMC1
prerank,regulation of phosphatase activity (GO:0010921),0.28698364386805425,0.7078264596218092,0.833810888252149,0.9436865821464897,1.0,8/24,22.56%,PPP1R2;GPATCH2;HTT;PPP6R2;ZCCHC9;PTPA;TIPRL;PPP6R1
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),-0.2720291872801633,-0.7070561170432673,0.8780487804878049,0.9648381088569327,1.0,7/14,27.12%,ERCC6;MMS19;FUS;MRNIP;TIMELESS;WDR48;RAD51AP1
prerank,ribosome biogenesis (GO:0042254),0.21434151567768195,0.7069564970490371,0.9647058823529412,0.9442857140298686,1.0,31/187,14.68%,XPO1;RPL5;NOL6;RPL37A;RPL6;XRN2;DHX37;RPS14;RPL35A;UTP6;RIOK1;RPL13;RPF2;DDX49;NOC4L;MPHOSPH6;NOL11;RPL34;RPLP0;UTP20;RPL19;RPL11;RPL30;NOP58;RRP36;RPS2;RPL4;RPL7;UTP18;MRTO4;DDX10
prerank,motor neuron axon guidance (GO:0008045),0.31556365226914657,0.7066546057182431,0.840983606557377,0.9442262437961707,1.0,6/15,18.50%,RAC2;RAC1;NTN1;RHOG;TMEFF1;SEMA3A
prerank,protein-containing complex disassembly (GO:0032984),0.24770704124566129,0.7061464830329017,0.8875661375661376,0.9444181656667885,1.0,9/54,15.91%,UVRAG;AXIN1;STX17;TSG101;DVL3;WIPI2;VCP;DVL2;APC
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.27828067674235685,0.7060317972823269,0.8620689655172413,0.9441477036380947,1.0,3/26,11.63%,GPR35;ADRA2A;FKBP1B
prerank,negative regulation of receptor binding (GO:1900121),0.33752852592354,0.7050896660954573,0.8306595365418895,0.9448497966343473,1.0,2/10,10.76%,ATP2A3;B2M
prerank,regulation of spindle assembly (GO:0090169),0.28571655463409584,0.7048446146215969,0.8374613003095975,0.9447330412570099,1.0,5/25,11.89%,HSPA1A;CHMP4B;PDCD6IP;SENP6;DYNC1H1
prerank,epithelial to mesenchymal transition (GO:0001837),0.2530551717144214,0.7046531790158223,0.8667563930013459,0.9445376837440251,1.0,8/47,14.21%,AKNA;RBPJ;S100A4;ENG;HGF;OLFM1;ROCK1;TGFB1
prerank,regulation of carbohydrate catabolic process (GO:0043470),0.2578170785204714,0.703891014806455,0.873485868102288,0.9450153997979617,1.0,9/41,18.20%,NUP210;PRKAG2;NUP98;PRKAG1;SCARB2;NUP153;SEH1L;GCK;NUP93
prerank,organelle disassembly (GO:1903008),0.26363519145555964,0.7038076023684112,0.862914862914863,0.9447093235178368,1.0,7/33,14.77%,VRK1;KIF5B;GBF1;STX5;MCTS1;VCP;RB1CC1
prerank,response to steroid hormone (GO:0048545),-0.22575999933003896,-0.7035955269187469,0.9230769230769231,0.9676035889707164,1.0,13/31,30.94%,PAQR8;ATP1A2;CATSPER2;TGFB2;AR;PAQR7;TFPI;NR1H3;CAV1;ABCA2;ATP1A1;ATP1A3;WBP2
prerank,mitotic sister chromatid segregation (GO:0000070),0.22917269310600824,0.7032790195987885,0.914519906323185,0.9449317408905948,1.0,21/98,18.32%,NIPBL;CUL3;KIF23;CHMP4A;CHMP4B;TEX14;PDCD6IP;SMC4;CSNK2A2;CSNK2A1;EML4;HASPIN;INO80;KPNB1;SEH1L;RB1;KNSTRN;MCPH1;PHF13;BECN1;RAD21
prerank,"base-excision repair, AP site formation (GO:0006285)",0.2934701414619184,0.7032015183774746,0.856198347107438,0.9446225808122818,1.0,3/17,10.69%,MBD4;SMUG1;TDG
prerank,acyl-CoA metabolic process (GO:0006637),-0.21378479669260217,-0.7030507585496807,0.9355932203389831,0.9673646910286104,1.0,9/35,21.91%,ACACA;SUCLG2;ACSF2;ACOT9;GPAT4;ACOT7;MLYCD;OXSM;ACOT6
prerank,response to copper ion (GO:0046688),-0.2482625742587987,-0.7030016967634233,0.8810198300283286,0.9665355860330016,1.0,14/20,42.23%,IL1A;ATP5F1D;MT2A;MT3;ATP7B;MT1B;MT1X;MT1G;MT1F;MT1E;MT1M;MT1H;MT1A;HSF1
prerank,DNA modification (GO:0006304),-0.24697546581436478,-0.702265151039615,0.8932584269662921,0.9664723624649826,1.0,10/22,25.57%,TERF2IP;EXOSC5;NEIL2;TERF1;OGG1;EXOSC3;PARP3;TINF2;NEIL3;PARP2
prerank,ether lipid biosynthetic process (GO:0008611),0.3428102306727741,0.7014514329303551,0.8140350877192982,0.9462555104478543,1.0,4/10,19.44%,AGPS;FAR1;GNPAT;PEDS1
prerank,regulation of fibrinolysis (GO:0051917),0.3240595140326872,0.7012601391728174,0.8283828382838284,0.9460785744601092,1.0,2/13,15.64%,FAP;THBS1
prerank,inorganic anion transmembrane transport (GO:0098661),0.23386520085825868,0.7009594037102881,0.9111389236545682,0.9460262402034364,1.0,8/63,11.21%,GABRB2;SLC12A7;GABRR2;SLC25A30;SLC37A4;SLC4A8;SLC12A6;SLC12A9
prerank,chromatin remodeling at centromere (GO:0031055),0.2656564212077477,0.70008282867234,0.8650674662668666,0.9466478128435681,1.0,6/31,14.92%,RBBP4;SMARCA5;CENPL;CENPQ;RSF1;CENPC
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",-0.28192309804647875,-0.7000506319377213,0.8740554156171285,0.9678988323011012,1.0,4/13,21.43%,DERL2;BCAP31;UBE2G2;BRSK2
prerank,respiratory chain complex IV assembly (GO:0008535),-0.24230336152012902,-0.7000350410774668,0.8861788617886179,0.9670346901155984,1.0,10/21,31.70%,OXA1L;COX10;SMIM20;COX18;BCS1L;SCO1;SURF1;FASTKD3;COA3;COA6
prerank,aspartate family amino acid catabolic process (GO:0009068),-0.24651236502958596,-0.6997689452997143,0.868632707774799,0.9664167124176704,1.0,3/19,11.72%,GOT1;PHYKPL;ALDH7A1
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.28609401830333026,0.6994001548253023,0.8646153846153846,0.9470302826462145,1.0,3/21,7.95%,PTEN;DDIT4;PAQR3
prerank,negative regulation of microtubule polymerization (GO:0031115),0.31949354358249205,0.6993912101548742,0.8305084745762712,0.9466384379392705,1.0,4/12,15.52%,DYRK1A;CLIP3;TBCD;STMN2
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),0.2708647849073717,0.6992903455036076,0.8646723646723646,0.9463517927671081,1.0,4/29,8.29%,ACSL5;ELOVL5;HSD17B12;ELOVL6
prerank,aerobic electron transport chain (GO:0019646),-0.19142820662062446,-0.6989569137404912,0.965,0.9663823058597135,1.0,32/68,32.10%,UQCRC2;COX7C;NDUFA7;NDUFB4;NDUFB2;NDUFV1;NDUFV3;NDUFS7;NDUFB3;COX10;NDUFA5;UQCRC1;UQCR10;COX5B;NDUFB5;NDUFB9;NDUFB7;NDUFA13;NDUFAF1;NDUFB8;NDUFAB1;COX6A1;NDUFB6;NDUFS8;NDUFB10;SDHA;UQCC3;COX6C;NDUFS3;CYC1;NDUFS6;NDUFA11
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.24906208905702462,0.6988722000860192,0.8933161953727506,0.9464354293143166,1.0,4/48,6.64%,CXCL10;DIAPH1;PTK2B;PDPK1
prerank,regulation of regulatory T cell differentiation (GO:0045589),0.2866289402250664,0.698163453325448,0.8323262839879154,0.9468232329907657,1.0,2/22,6.95%,BCL6;CBFB
prerank,establishment of spindle orientation (GO:0051294),0.2768329025189518,0.6980260487384179,0.8594202898550725,0.9465869272325343,1.0,6/28,16.27%,FBXW11;PAFAH1B1;INSC;HTT;CLASP1;GPSM2
prerank,microtubule depolymerization (GO:0007019),0.2990691817496011,0.697277638238722,0.8161888701517707,0.9470243718507465,1.0,4/17,15.52%,KATNB1;KIF24;STMN3;STMN2
prerank,regulation of microtubule-based process (GO:0032886),0.2615947617889421,0.6972214857169794,0.8718309859154929,0.9466818534954794,1.0,9/36,16.40%,DIAPH1;PHLDB2;CYLD;PRKAA1;PRKAA2;ROCK1;CLASP1;APC;TRIM36
prerank,protein targeting to mitochondrion (GO:0006626),0.2425750334399636,0.6965847961030048,0.889920424403183,0.9469701772406461,1.0,13/52,17.38%,GRPEL2;DNAJC19;TIMM21;TOMM40;FIS1;IMMP2L;AIFM1;PMPCA;TIMM50;FBXO7;MIPEP;AIP;HSPD1
prerank,nucleoside salvage (GO:0043174),0.333271508135991,0.696395239942755,0.8194444444444444,0.946771580543839,1.0,3/10,14.36%,UCK2;UCK1;DCK
prerank,apoptotic DNA fragmentation (GO:0006309),0.3007162880609913,0.6960015448063211,0.8560250391236307,0.9467733645461237,1.0,4/16,16.03%,DFFA;DFFB;EXOG;KPNB1
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.3191399166055595,0.695834315011173,0.8284734133790738,0.9461621168560247,1.0,1/12,3.39%,RCC2
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.3191399166055595,0.695834315011173,0.8284734133790738,0.9461621168560247,1.0,1/12,3.39%,RCC2
prerank,chondroitin sulfate biosynthetic process (GO:0030206),-0.23955856516786822,-0.6956727870818176,0.8934426229508197,0.9687573309424078,1.0,7/21,22.19%,CHST11;CHST9;CHPF2;CSPG4;CHST3;BGN;CHSY1
prerank,long-chain fatty acid biosynthetic process (GO:0042759),-0.23654155022656168,-0.6954377941842371,0.8823529411764706,0.9681027913649325,1.0,2/23,5.81%,LTA4H;LTC4S
prerank,establishment of spindle localization (GO:0051293),0.30859412985032764,0.6953665234429025,0.8333333333333334,0.9462609914069695,1.0,4/14,21.09%,DYNC1H1;CLASP1;KPNB1;LLGL2
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.26294150705411123,0.6937382132836671,0.8705722070844687,0.947710724929985,1.0,2/35,3.22%,PCDHB11;SELL
prerank,rRNA 3'-end processing (GO:0031125),0.33195093327825725,0.6925939887474215,0.8146853146853147,0.9486046797926942,1.0,2/10,10.23%,ERI1;RPS21
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),0.22580025818455357,0.6925201608964017,0.9325842696629213,0.9482858208150088,1.0,11/82,13.91%,SDCCAG8;CNTRL;HAUS8;CEP63;PAFAH1B1;HAUS1;DCTN3;CEP250;DYNC1H1;HAUS3;CLASP1
prerank,negative regulation of viral release from host cell (GO:1902187),0.31319163170735853,0.6921848067236828,0.8246205733558178,0.948253482692644,1.0,1/13,2.61%,TRIM26
prerank,regulation of mitochondrial membrane permeability (GO:0046902),-0.2547843935851077,-0.6917357239960664,0.8782383419689119,0.970864085695989,1.0,8/18,37.68%,BCL2L1;SPG7;CAMK2A;SLC25A4;PPIF;NAIF1;ALKBH7;PMAIP1
prerank,negative regulation of protein ubiquitination (GO:0031397),0.2441679579566371,0.6904908883256754,0.9158031088082902,0.9497095611583418,1.0,10/50,15.44%,DTX3L;HSPA1A;CRY1;RPS3;CAMLG;USP4;AKT1;PRMT3;SVBP;TAF1
prerank,centromere complex assembly (GO:0034508),-0.21050470338507737,-0.6901994754164488,0.9545454545454546,0.9714820941985632,1.0,19/36,31.95%,CENPO;NPM1;POGZ;CENPE;KNL1;CENPA;RUVBL1;CENPP;MIS18BP1;CENPK;CENPU;CENPF;DLGAP5;CENPT;CENPX;RBBP7;CENPN;MIS12;CENPH
prerank,telomere capping (GO:0016233),-0.2537122909269181,-0.6901733128044704,0.8846153846153846,0.9706229250345855,1.0,5/16,17.49%,CTC1;TERF2IP;DCLRE1A;TEN1;TERF1
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),0.31820680121860184,0.6901715943951375,0.8421052631578947,0.9496532355801124,1.0,1/12,4.77%,GDNF
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),0.22656382962585617,0.6889889963114705,0.9334155363748459,0.9505691564583741,1.0,18/87,16.21%,SDHAF2;NDUFA2;NDUFS5;TIMM21;NDUFA3;NDUFA10;IMMP2L;AIFM1;NDUFS2;NDUFS4;UQCC1;COA5;NDUFA12;NDUFA9;COX17;NDUFAF5;COX16;NDUFC2
prerank,endothelial tube morphogenesis (GO:0061154),0.3325099954643319,0.6888596913973056,0.8422939068100358,0.9503065443114764,1.0,4/10,20.34%,RBPJ;RHOA;STARD13;CCM2
prerank,cellular transition metal ion homeostasis (GO:0046916),0.22256779572832616,0.6882906299362027,0.9338747099767981,0.9505148097796243,1.0,18/91,17.56%,CYB561A3;ABCB7;HEPH;PRNP;NEDD8;ARF1;ATP7A;SLC30A1;SMAD4;ATOX1;APP;HMOX2;IREB2;CCDC115;SLC31A1;SLC39A13;SLC39A12;NUBP1
prerank,serine family amino acid metabolic process (GO:0009069),0.3040521598570544,0.6880052840944917,0.8406504065040651,0.9504177487459858,1.0,4/16,19.33%,SEPSECS;SRR;SHMT1;GLYAT
prerank,synaptic vesicle membrane organization (GO:0048499),0.2954154984604944,0.6875662362199442,0.8496,0.9504960221597438,1.0,4/17,15.37%,STX11;SYP;SYNGR2;SNAP23
prerank,regulation of leukocyte migration (GO:0002685),0.29835237149955246,0.6871473039104242,0.8513931888544891,0.9505504555694113,1.0,4/16,15.03%,RAC2;RAC1;ANXA1;RHOG
prerank,tetrahydrobiopterin metabolic process (GO:0046146),-0.29208229110113604,-0.687117338197392,0.8719211822660099,0.9727229849473444,1.0,5/11,30.14%,QDPR;CALM1;DHFR;HSP90AA1;SPR
prerank,cellular response to UV (GO:0034644),0.23064070964110994,0.6870771452610802,0.9314214463840399,0.9502216944860569,1.0,22/76,22.08%,MMP1;CERS1;CRIP1;CARD16;ERCC4;METTL3;AURKB;CREBBP;TAF1;INO80;USP47;POLD1;SIRT1;PRKCD;N4BP1;RHBDD1;XPA;STK11;POLK;PARP1;CASP9;SDE2
prerank,peroxisomal membrane transport (GO:0015919),0.26649055765634727,0.6869794180291554,0.8659638554216867,0.9499344665845822,1.0,5/27,13.06%,PEX16;PEX12;PEX14;FIS1;ABCD1
prerank,response to unfolded protein (GO:0006986),0.2440359223964007,0.6865701925696197,0.9124487004103967,0.9499807353647879,1.0,11/48,17.98%,HSPA1A;ERN1;ERP44;TM7SF3;DAXX;PTPN1;HSPA9;STT3B;HSPD1;BAG3;HSPA5
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.28358520088784356,0.6858348455238642,0.845679012345679,0.9503825674086359,1.0,8/19,23.60%,EXT1;XYLT1;CSGALNACT1;GLCE;HS2ST1;NDST2;EXT2;NDST4
prerank,cellular response to pH (GO:0071467),0.2968270442984467,0.6856759454521834,0.8469055374592834,0.9501434982126693,1.0,1/17,1.67%,GPR68
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),0.31488358909725817,0.6852222340695698,0.8578767123287672,0.9502137522686945,1.0,3/11,17.98%,ATF6;ATF6B;HSPA5
prerank,negative regulation of T-helper cell differentiation (GO:0045623),0.3192397540065949,0.6838260055873072,0.8299319727891157,0.9512612504199465,1.0,2/11,10.39%,RC3H1;ANXA1
prerank,response to interferon-alpha (GO:0035455),0.3045288676109887,0.6833172655955958,0.8615136876006442,0.9513634032484897,1.0,7/16,24.74%,EIF2AK2;IFNAR1;IFITM3;IFNAR2;AXL;BST2;GATA3
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),0.2524018920989104,0.6830116076964386,0.9004149377593361,0.9512622784649142,1.0,5/40,10.76%,ANXA2;CBL;HIP1;TBC1D5;B2M
prerank,dendrite morphogenesis (GO:0048813),0.2557094923610665,0.6830107509207514,0.9034090909090909,0.9508655070624341,1.0,8/35,16.49%,DOCK10;CDC42;PTEN;EPHB2;MINK1;LRP4;PHACTR1;WNT7A
prerank,intermediate filament organization (GO:0045109),0.28033385008989314,0.681824063964527,0.867862969004894,0.9516805599575059,1.0,1/17,2.39%,VIM
prerank,N-terminal protein amino acid acetylation (GO:0006474),0.3006667699243626,0.6817059727421457,0.8553459119496856,0.9514134270002204,1.0,4/16,15.26%,NAA16;NAA15;KAT2B;CREBBP
prerank,positive regulation of calcium ion import (GO:0090280),0.3168985832022092,0.6810823283133887,0.8541329011345219,0.9516679619157109,1.0,2/12,12.84%,ATP2A1;LGALS3
prerank,regulation of protein localization to cell surface (GO:2000008),0.2556476670372193,0.6807950076346402,0.8896952104499274,0.9515627743434735,1.0,10/33,23.07%,NEDD4L;PICALM;GBF1;TAX1BP3;SNX33;GOPC;KCNAB2;TNF;RAB11B;COMMD1
prerank,glutamine family amino acid metabolic process (GO:0009064),0.25459255400134034,0.6807262293967892,0.8933717579250721,0.9512429700050538,1.0,7/33,17.44%,TAT;KYAT1;GLUD1;CAD;SIRT4;PYCR2;DDAH1
prerank,negative regulation of cell differentiation (GO:0045596),0.20734702603425992,0.6807035730922751,0.9839055793991416,0.9508695711520232,1.0,30/181,17.70%,LIMD1;PPARG;SDHAF2;MAD2L2;COL5A2;NFKBIA;PTEN;PTK2B;PDCD4;ZFP36L2;IL6;ID2;SPRED3;ABCA5;REST;USF3;IQCB1;USH2A;MYB;ADAMTS12;TGFB1;GPS2;ABCG1;SPRED1;MED1;RB1;SEMA4D;SIRT1;EFNA1;HDAC7
prerank,tRNA metabolic process (GO:0006399),0.28761056726629297,0.6806729372081538,0.849445324881141,0.950503523622736,1.0,2/17,6.02%,FARS2;DARS2
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),0.30839733890500354,0.6805655136309484,0.8595317725752508,0.9502222305995544,1.0,3/13,11.90%,NFKB1;ERLIN1;REST
prerank,peptidyl-lysine methylation (GO:0018022),-0.2235464677591371,-0.6800245859035445,0.9302325581395349,0.9785210011853581,1.0,10/26,26.96%,SETD3;SETD4;KMT5A;EHMT2;SUV39H1;N6AMT1;ETFBKMT;TRMT112;METTL21A;SMYD1
prerank,DNA duplex unwinding (GO:0032508),0.2429571187013138,0.6798512557021317,0.9173228346456693,0.9505167641135635,1.0,8/50,12.97%,MRE11;MCM6;WRN;ASCC3;ANXA1;RECQL5;MCM2;ERCC3
prerank,chordate embryonic development (GO:0043009),0.23832504540018712,0.6797063039670512,0.9148099606815203,0.95025265815736,1.0,9/55,16.73%,MBNL1;SULF2;DEAF1;XYLT1;TRIM71;PCSK5;TGFB1;FUT8;PROX1
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",-0.27650043281372233,-0.6792208141717867,0.8948655256723717,0.9783473275657545,1.0,3/12,13.17%,CCT2;DKC1;CCT8
prerank,mitotic nuclear division (GO:0140014),0.23194037593445307,0.6790234248689728,0.9347553324968633,0.9505667799683837,1.0,14/71,17.36%,EPS8;CHMP4B;FLNA;RHOA;SMC4;SPAST;STAG1;KIF3B;STAG2;UBE2S;CLASP1;INO80;KPNB1;KNSTRN
prerank,negative regulation of complement activation (GO:0045916),-0.2944667398560384,-0.6785686722839371,0.864406779661017,0.9780937777725853,1.0,7/10,42.65%,SUSD4;CD46;A2M;SERPING1;VSIG4;CR2;CD55
prerank,dicarboxylic acid transport (GO:0006835),-0.2218181387270181,-0.6782196922831354,0.9573170731707317,0.9775593647695255,1.0,12/28,31.13%,SLC1A3;GJA1;GIPC1;SLC13A3;SLC1A1;SLC26A8;SLC26A6;PDPN;SLC25A10;SLC46A1;PRAF2;SLC1A6
prerank,positive regulation of dephosphorylation (GO:0035306),0.27110771980807813,0.6781973209335814,0.8924581005586593,0.9510310753828558,1.0,8/27,18.57%,PPP2R5A;DLC1;ANKLE2;TGFB1;PPP1R7;PTPA;PRKCD;PIN1
prerank,negative regulation of establishment of protein localization (GO:1904950),0.3246759467152919,0.6780853744865376,0.8244406196213425,0.9507468424747717,1.0,4/10,19.92%,WWP2;SNX3;SNX12;NDFIP2
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",-0.23358436457311305,-0.678044631538009,0.9266862170087976,0.9768430831718907,1.0,9/22,27.98%,WDR12;PES1;EXOSC9;FTSJ3;EXOSC10;EXOSC3;RPP40;ERI2;RRS1
prerank,negative regulation of smoothened signaling pathway (GO:0045879),0.27095760915742456,0.6778335138944868,0.8785607196401799,0.9506222399122626,1.0,2/23,4.33%,HERC4;GPC3
prerank,regulation of muscle contraction (GO:0006937),0.2625044056596514,0.6775214515635262,0.8751902587519026,0.9505258089401389,1.0,1/26,1.85%,TNNC1
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),0.2982798633523496,0.6773611064581814,0.8694158075601375,0.9502978397612337,1.0,1/15,4.77%,GDNF
prerank,regulation of response to stress (GO:0080134),-0.2949659840883389,-0.6765132695772417,0.8678414096916299,0.977327683031264,1.0,7/10,39.58%,CORO2B;EIF4G1;ADCY8;MLC1;STOX1;DYRK3;CRHBP
prerank,positive regulation of positive chemotaxis (GO:0050927),-0.25843101315282235,-0.6756622592557578,0.8819095477386935,0.9771703876023383,1.0,3/15,11.95%,NTRK3;SCG2;VEGFA
prerank,positive regulation of cilium assembly (GO:0045724),0.2864985634334648,0.674721353642644,0.875195007800312,0.9526316323810492,1.0,5/18,20.71%,CCDC88A;TAPT1;HTT;CEP135;MARK4
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.2525567891660646,0.6736115286783667,0.8737864077669902,0.9533107633302428,1.0,7/35,15.81%,PKIB;FBXO4;TNKS;MAP3K4;AURKB;MAPK1;TCP1
prerank,replicative senescence (GO:0090399),-0.275340594167119,-0.6728189321884493,0.8848039215686274,0.978740594552126,1.0,9/12,50.98%,SERPINE1;ROMO1;CDKN2A;CHEK1;ATM;TERT;MME;PLA2R1;ATR
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.25571372385565416,0.6715818854813601,0.9060693641618497,0.9548575915153128,1.0,7/32,18.94%,CDC45;CDK14;BACH1;ID2;ZPR1;RB1;BRD4
prerank,regulation of histone deacetylation (GO:0031063),0.3060678107317598,0.671537203578451,0.8595890410958904,0.9545033966337355,1.0,2/13,11.12%,NIPBL;ING2
prerank,regulation of protein import into nucleus (GO:0042306),0.2500096244642612,0.6714455573640439,0.9073033707865169,0.9542001392692715,1.0,12/36,18.81%,UBR5;FLNA;RBM22;ZPR1;HCLS1;HDAC3;TGFB1;PSEN1;PIK3R2;BAG3;PRKCD;MDFIC
prerank,negative regulation by host of viral transcription (GO:0043922),-0.2761579392821952,-0.6713730243588539,0.8785714285714286,0.9790345789357434,1.0,3/12,19.46%,TARDBP;CCL3;HMGA2
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),0.25166722061346597,0.6710286379956878,0.8972222222222223,0.9542161011421478,1.0,9/37,16.40%,PHLDB2;CYLD;PRKAA1;PRKAA2;ROCK1;CLASP1;STMN3;STMN2;TRIM36
prerank,regulation of telomere maintenance (GO:0032204),0.2662056788212825,0.6699440624553764,0.8833819241982507,0.9548697225849577,1.0,6/26,16.35%,MRE11;SMG1;ATRX;ERCC4;USP7;SMG6
prerank,negative regulation of ATPase activity (GO:0032780),-0.2552545875668826,-0.6696761654955498,0.8983957219251337,0.9796024122899933,1.0,11/16,44.13%,OXA1L;PAM16;TSC1;PXK;PPIF;ATP5IF1;TLR9;PLN;LTF;VCPKMT;THADA
prerank,very long-chain fatty acid metabolic process (GO:0000038),-0.22058004213467985,-0.6694537695330712,0.9256756756756757,0.978918907821752,1.0,12/30,29.07%,ABCD2;ABCD4;HACD2;ELOVL7;ELOVL4;ABCD3;ELOVL1;TECR;ACSBG1;ACOX1;SLC27A2;ACSL6
prerank,modification-dependent macromolecule catabolic process (GO:0043632),0.3211928428974927,0.6693078570796139,0.8631578947368421,0.9550926552447582,1.0,2/10,11.53%,NEDD8;TUT7
prerank,metal ion homeostasis (GO:0055065),0.23792994319397887,0.6692867111585408,0.8975817923186344,0.9547189530094414,1.0,5/40,11.21%,SLC12A7;WFS1;SLC12A6;LETM1;SLC12A9
prerank,cAMP biosynthetic process (GO:0006171),0.3265557581972947,0.6691228687551642,0.8555758683729433,0.9544815647424294,1.0,3/10,12.62%,ADCY10;ADCY7;ADCY5
prerank,neural tube closure (GO:0001843),0.25098385046971605,0.6689694678482766,0.9079497907949791,0.9542312293869502,1.0,7/34,15.53%,CELSR1;DLC1;DEAF1;VASP;DVL3;TGFB1;DVL2
prerank,glycosaminoglycan catabolic process (GO:0006027),0.23546949811197113,0.6687643989961195,0.9248704663212435,0.9540295458988535,1.0,7/55,11.56%,CD44;GPC3;HSPG2;ACAN;FUCA1;NCAN;SDC3
prerank,Golgi to plasma membrane protein transport (GO:0043001),0.2570228939556588,0.6679629840794176,0.8971014492753623,0.9543914853170626,1.0,3/30,7.44%,GOLPH3L;RAB34;GCC2
prerank,regulation of dephosphorylation (GO:0035303),0.2949692409791857,0.6676870008277321,0.8642172523961661,0.9542780981419287,1.0,4/15,16.70%,MTMR3;MTMR4;SMG6;MTMR2
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),-0.28947552285163536,-0.6665068689315317,0.8779342723004695,0.9796426331488768,1.0,5/10,28.79%,TNFRSF1A;SPHK2;RACK1;SMPD3;SMPD2
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),-0.28947552285163536,-0.6665068689315317,0.8779342723004695,0.9796426331488768,1.0,5/10,28.79%,TNFRSF1A;SPHK2;RACK1;SMPD3;SMPD2
prerank,positive regulation of lymphocyte differentiation (GO:0045621),0.2828637713693375,0.6647672586339773,0.8584905660377359,0.9566131840123395,1.0,2/19,4.42%,SYK;ZAP70
prerank,cellular response to light stimulus (GO:0071482),0.22448888429949557,0.6646814791373541,0.9345911949685535,0.9562985454065914,1.0,19/66,22.08%,GNB1;GPR88;PDE6B;ERCC4;METTL3;AURKB;CREBBP;TAF1;INO80;USP47;POLD1;PRKCD;N4BP1;RHBDD1;POLK;SAG;PARP1;CASP9;SDE2
prerank,mitochondrial membrane organization (GO:0007006),-0.2095402239038128,-0.6646351607174645,0.9486301369863014,0.9803242943655796,1.0,7/32,15.53%,BCL2L1;APOO;TMEM11;RCC1L;CHCHD6;SPG7;MFN1
prerank,muscle tissue morphogenesis (GO:0060415),0.29002888358658785,0.6643224218259575,0.8986928104575164,0.9562533437263693,1.0,16/16,71.03%,PROX1;TGFBR3;TBX20;ANKRD1;MYLK2;ACTC1;TCAP;NOTCH1;TBX1;TTN;MYLK;HEY2;BMP4;BMP2;EFEMP2;ZFPM1
prerank,nuclear envelope organization (GO:0006998),0.2787685330220533,0.6640039793267324,0.8834355828220859,0.956155758309693,1.0,4/20,12.04%,LEMD3;LEMD2;DMPK;TOR1AIP1
prerank,glycerol metabolic process (GO:0006071),-0.2884996156188938,-0.6635566841853116,0.9060240963855422,0.9803178021620949,1.0,3/10,10.61%,GOT1;COQ3;GK5
prerank,mitotic metaphase plate congression (GO:0007080),-0.18389882324107065,-0.6635519446552864,0.9879032258064516,0.9794502608038126,1.0,24/51,32.37%,VPS4B;RMDN1;PIBF1;CHMP5;ZW10;MAD1L1;EML3;CHMP1B;CENPE;RAB11A;CHMP7;KIF18A;CHMP2A;BOD1;PINX1;SPDL1;NDC80;RRS1;CDCA8;CEP55;KIFC1;CHMP6;MIS12;KIF22
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),-0.22022886755380502,-0.663234001891747,0.9492537313432836,0.9788362322574259,1.0,7/25,20.25%,VPS4B;SORT1;CHMP5;LYST;CHMP1B;CHMP7;CHMP2A
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),-0.28915396467035676,-0.6627065155135874,0.8758620689655172,0.9784318841736681,1.0,3/10,13.17%,CCT2;DKC1;CCT8
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.25454210415685685,0.6613263960386947,0.9125925925925926,0.958215634032073,1.0,7/29,20.36%,DCP2;CNOT6;LSM5;DCP1A;CNOT8;DDX6;EDC3
prerank,endothelial cell differentiation (GO:0045446),0.3090728662594353,0.661018223341365,0.8552412645590682,0.9580927695981295,1.0,1/12,2.93%,BMPR2
prerank,cellular response to arsenic-containing substance (GO:0071243),-0.25495081866556746,-0.6608966896224463,0.8973684210526316,0.9789885278169875,1.0,2/15,4.49%,CPEB2;ATF3
prerank,cellular modified amino acid catabolic process (GO:0042219),-0.2557582792203311,-0.6602894301746807,0.8926553672316384,0.9785847621650026,1.0,1/15,0.58%,ABHD12
prerank,synaptonemal complex assembly (GO:0007130),0.29390343441953903,0.6593041848736401,0.8689320388349514,0.9588678717705869,1.0,15/15,70.64%,STAG3;RAD21;SYCE1;SYCE3;SYCE2;SYCP2;BAG6;SYCP1;RAD21L1;TEX12;HORMAD1;REC8;TEX11;TRIP13;P3H4
prerank,synaptonemal complex organization (GO:0070193),0.29390343441953903,0.6593041848736401,0.8689320388349514,0.9588678717705869,1.0,15/15,70.64%,STAG3;RAD21;SYCE1;SYCE3;SYCE2;SYCP2;BAG6;SYCP1;RAD21L1;TEX12;HORMAD1;REC8;TEX11;TRIP13;P3H4
prerank,protein localization to centrosome (GO:0071539),-0.24395930746099648,-0.6587623453831198,0.8961748633879781,0.9788811373966653,1.0,7/17,34.25%,PIBF1;CEP83;CCDC14;NEDD1;CEP192;STIL;CEP131
prerank,cell proliferation in forebrain (GO:0021846),0.3142121136215176,0.6575261088116473,0.8747826086956522,0.9600698878443725,1.0,3/10,19.31%,AKNA;WNT7A;HOOK3
prerank,protein lipidation (GO:0006497),0.22484290502322238,0.6568787001274012,0.9397116644823067,0.9602822750545869,1.0,10/59,13.09%,HHAT;ZDHHC7;ATG5;ZDHHC13;ZDHHC6;ZDHHC23;ZDHHC17;PIGF;WIPI2;ATG10
prerank,muscle cell migration (GO:0014812),-0.28585952478382887,-0.6566736388467763,0.8839907192575406,0.9795837282305551,1.0,2/10,8.49%,ITGB3;AAMP
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),-0.2635449482887984,-0.6553794417967077,0.8729411764705882,0.9796978823154585,1.0,3/12,17.65%,C2CD2L;GPLD1;ADCY8
prerank,transcription preinitiation complex assembly (GO:0070897),-0.2744373515526146,-0.6529761006933584,0.9065656565656566,0.9806238772691379,1.0,1/12,2.04%,BDP1
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",-0.24613082573608253,-0.6517961870592387,0.9327485380116959,0.9805930524538872,1.0,6/17,22.59%,IK;BUB3;ZW10;KNL1;CENPA;BOD1
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),-0.2515306478618995,-0.6504833565041579,0.9155672823218998,0.9806595908763829,1.0,7/15,28.56%,CCT2;DKC1;CCT8;RUVBL1;CCT3;NAF1;RUVBL2
prerank,regulation of sister chromatid cohesion (GO:0007063),0.3027415392566969,0.6502923957171385,0.8967851099830795,0.9656770084339859,1.0,4/12,18.32%,FEN1;CTCF;RB1;RAD21
prerank,DNA recombination (GO:0006310),-0.1970139106579309,-0.6501258165063213,0.966789667896679,0.9800534784322292,1.0,14/37,28.46%,RAD51B;HMGB1;TSN;BLM;MSH2;RHNO1;IGHMBP2;FBH1;RAD51C;DMC1;ERCC1;GEN1;RAD51D;RAD54B
prerank,regulation of receptor binding (GO:1900120),0.3092058566677863,0.6501153682122291,0.8689655172413793,0.9654326002496972,1.0,2/10,10.76%,ATP2A3;B2M
prerank,sphingoid metabolic process (GO:0046519),-0.267090601017295,-0.650108383732537,0.9191176470588235,0.9792042538857365,1.0,4/12,18.08%,PLPP3;PLPP1;SPHK2;KDSR
prerank,I-kappaB phosphorylation (GO:0007252),0.31121015363411453,0.6493604183881309,0.8702702702702703,0.9656800649505882,1.0,3/10,12.51%,TLR3;MAP3K7;TLR2
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",0.24240537695713232,0.6488582185578531,0.9132867132867133,0.96570341181685,1.0,9/38,16.21%,NDUFA2;NDUFS5;NDUFA3;NDUFA10;NDUFS2;NDUFS4;NDUFA12;NDUFA9;NDUFC2
prerank,response to glucose (GO:0009749),0.23138606710164072,0.6484473351168633,0.9428191489361702,0.9656737395306567,1.0,9/46,18.96%,ERN1;ZBTB20;SELENOT;PRKAA1;PDK3;PRKAA2;THBS1;GCK;EIF2B3
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.25759134333033384,0.6484252557907453,0.9086826347305389,0.965295657330758,1.0,8/27,18.63%,CHST12;PXYLP1;XYLT1;NCAN;CHST15;CSGALNACT1;CHSY3;VCAN
prerank,lysosome localization (GO:0032418),0.2414119832774,0.6482108757797906,0.917900403768506,0.9650730883796095,1.0,10/37,19.82%,KIF5B;MYH9;RAB34;SNAPIN;KIT;ARL8B;MILR1;BORCS5;PLEKHM1;DEF8
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),-0.260344688551118,-0.6478503710918663,0.9023136246786633,0.9799369559141211,1.0,1/13,2.75%,B3GALNT1
prerank,regulation of actin filament depolymerization (GO:0030834),0.300318976025554,0.647627870925887,0.8732394366197183,0.9651463228722174,1.0,2/12,10.64%,MTPN;PIK3CA
prerank,cellular response to gamma radiation (GO:0071480),0.27824069761937986,0.6474127357786018,0.9119086460032626,0.9649272533599237,1.0,3/17,12.87%,WRN;TLK2;MAP3K20
prerank,ciliary basal body-plasma membrane docking (GO:0097711),0.21025345892849234,0.6460372893551409,0.9700956937799043,0.9657210343535205,1.0,13/94,13.91%,SDCCAG8;CNTRL;HAUS8;CEP63;PAFAH1B1;HAUS1;DCTN3;KIF24;CEP250;DYNC1H1;IQCB1;HAUS3;CLASP1
prerank,positive regulation of ATPase activity (GO:0032781),0.23669556284731202,0.645548071001937,0.9338028169014084,0.9657320968848606,1.0,7/41,13.93%,PLSCR1;MYL4;ATP2A1;MSH3;MSH6;TOR1AIP1;VMP1
prerank,cardiac muscle cell membrane repolarization (GO:0099622),0.30606658097638606,0.644720816870116,0.8779174147217235,0.9660179620618398,1.0,1/11,3.31%,KCNQ1
prerank,oogenesis (GO:0048477),-0.24629042919272764,-0.6444173218282084,0.9394812680115274,0.9814574450382483,1.0,3/15,13.69%,PTN;FMN2;MDK
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),-0.2596435899489772,-0.6440876857224914,0.8910891089108911,0.9808100986232031,1.0,3/13,14.55%,EPN2;HGS;DAB2IP
prerank,electron transport chain (GO:0022900),-0.2533270465982514,-0.6437526334929423,0.9263657957244655,0.9801541204744817,1.0,4/15,22.11%,PPARGC1A;SDHB;NDUFA5;PDIA5
prerank,negative regulation of cell cycle process (GO:0010948),0.2212087198126945,0.6433415190975659,0.9512195121951219,0.9667546533999561,1.0,10/61,16.38%,UXT;RBBP8;RYBP;RBBP4;APAF1;L3MBTL2;EZH2;AURKB;PHC3;AURKAIP1
prerank,amide transport (GO:0042886),0.24829330433810876,0.6432851505402001,0.9218523878437048,0.9664110790050022,1.0,2/26,6.29%,SLC14A1;TAP1
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),-0.2786223830230053,-0.6423907503675125,0.9032258064516129,0.9802437041097292,1.0,5/10,35.09%,DAB2IP;CADM4;PIK3CB;SPRY2;DCN
prerank,sulfur amino acid catabolic process (GO:0000098),0.30469248526944037,0.6414243524791674,0.8838028169014085,0.9675514127706052,1.0,2/10,10.44%,ADO;MTRR
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),-0.2760507122718626,-0.6413703659079387,0.8902147971360382,0.9800485699477218,1.0,3/11,13.29%,NECAB1;ITM2C;ABCA7
prerank,primary neural tube formation (GO:0014020),0.24707244170277554,0.6412813113261481,0.9250720461095101,0.9672658320237553,1.0,6/30,15.53%,CELSR1;DLC1;DEAF1;VASP;TGFB1;DVL2
prerank,smooth muscle contraction (GO:0006939),0.28366414360435244,0.6409036826910475,0.8713355048859935,0.9671764359596534,1.0,3/14,14.62%,PIK3C2A;ROCK1;EDNRA
prerank,regulation of peptidase activity (GO:0052547),0.26865969912545673,0.6400878092265739,0.9045383411580594,0.9674395199238462,1.0,6/19,19.48%,MAPK12;PSMB8;SVBP;HDAC1;PINK1;ECM1
prerank,tube closure (GO:0060606),0.244022437172756,0.639033655905033,0.9222065063649222,0.9678872366245914,1.0,6/31,15.53%,CELSR1;DLC1;DEAF1;VASP;TGFB1;DVL2
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),-0.21269694307770398,-0.6386503302547287,0.945054945054945,0.9809254816630418,1.0,4/23,10.79%,PLK3;ZFYVE19;NABP2;ZW10
prerank,stabilization of membrane potential (GO:0030322),0.27970912646853563,0.6376009715626094,0.8982785602503912,0.9685724418295361,1.0,2/16,8.09%,KCNK7;KCNN4
prerank,positive regulation of focal adhesion assembly (GO:0051894),0.27162205979491416,0.6370538551613425,0.912,0.9686090307272704,1.0,5/19,15.29%,S100A10;RAC1;ROCK1;PTPRJ;COL16A1
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),0.3000273507759268,0.6363855950685353,0.8775510204081632,0.9683668525449488,1.0,3/12,21.95%,PRNP;DYRK2;GSK3B
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.3000273507759268,0.6363855950685353,0.8775510204081632,0.9683668525449488,1.0,3/12,21.95%,PRNP;DYRK2;GSK3B
prerank,negative regulation of myotube differentiation (GO:0010832),-0.2510732489278968,-0.6357622269880179,0.9338235294117647,0.9819406780729637,1.0,2/12,14.21%,TMEM119;BHLHE41
prerank,low-density lipoprotein particle remodeling (GO:0034374),0.2970937166530665,0.6351695333764379,0.8898601398601399,0.968883267583112,1.0,11/11,70.31%,ABCG1;MPO;APOB;AGT;PLA2G7;AGTR1;APOA2;PLA2G10;PLA2G5;LIPC;PLA2G3
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),0.2930217273202887,0.635167152833485,0.878682842287695,0.9684922432412796,1.0,3/12,15.00%,FUT4;AKT1;ASS1
prerank,purine-containing compound biosynthetic process (GO:0072522),-0.21040387551307133,-0.6349339129869297,0.9591836734693877,0.9816216743705115,1.0,8/25,27.68%,PRPSAP1;GMPR;AMPD2;HPRT1;SHMT2;MTHFD1;PRPSAP2;ADK
prerank,nuclear body organization (GO:0030575),0.29034002012029947,0.634685600735344,0.8865619546247818,0.9684819016185722,1.0,3/12,13.02%,HIPK2;WRAP53;ZPR1
prerank,regulation of epidermal cell differentiation (GO:0045604),0.25964829145543744,0.6345689034449943,0.9174311926605505,0.9681729759195954,1.0,4/21,15.00%,CBFB;SULT2B1;ROCK1;SGPP1
prerank,telomere maintenance via telomerase (GO:0007004),0.24632923812404972,0.6340931596872373,0.9237410071942446,0.9681526751870384,1.0,10/28,25.20%,MRE11;NHP2;WRAP53;SHQ1;TNKS1BP1;TERF2;TELO2;RFC1;ANKRD28;RPA1
prerank,mesenchyme morphogenesis (GO:0072132),-0.2327856476098907,-0.6340764398942197,0.9497206703910615,0.9813173620441014,1.0,10/17,46.87%,ACVR1;TGFB2;MDM4;BMP2;ACVRL1;HEY1;TBX2;HEYL;ISL1;NOG
prerank,pharyngeal system development (GO:0060037),0.28583473707217016,0.6336727218198976,0.9054726368159204,0.9680597210806803,1.0,1/15,2.93%,BMPR2
prerank,regulation of purine nucleotide metabolic process (GO:1900542),0.23290241249836507,0.633404682575259,0.9416553595658074,0.9678772526025774,1.0,8/41,18.20%,NUP210;PRKAG2;NUP98;PRKAG1;NUP153;SEH1L;GCK;NUP93
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),-0.26034640678469345,-0.6332475066994261,0.9047619047619048,0.9809985763584891,1.0,1/12,2.75%,B3GALNT1
prerank,establishment of mitotic spindle orientation (GO:0000132),0.26154103620922753,0.6324731559977483,0.9321266968325792,0.968210872996944,1.0,5/23,16.27%,FBXW11;PAFAH1B1;INSC;HTT;GPSM2
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.23287711014053386,0.6317479083991578,0.946685878962536,0.9683716402913854,1.0,12/37,22.43%,BBC3;RPS3;FIS1;DNM1L;BECN1;BAD;BCLAF1;NCK1;RPS7;BID;BCL2;SIAH1
prerank,regulation of extracellular matrix organization (GO:1903053),-0.24298412985836654,-0.6314278705582782,0.9265822784810127,0.9813214477972505,1.0,3/15,18.52%,LRP1;RIC1;AEBP1
prerank,regulation of centrosome cycle (GO:0046605),-0.21674790105808012,-0.6308115717342684,0.93993993993994,0.9808842685640485,1.0,8/21,25.13%,VPS4B;CHMP5;NPM1;CHMP1B;ATF5;CHMP2A;NAT10;GEN1
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),0.29439592874305065,0.6305751207867129,0.8917525773195877,0.9688587616298753,1.0,1/10,2.96%,DHX58
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),0.23859434598324158,0.6303766277268195,0.9304964539007092,0.9686146208536875,1.0,7/32,17.04%,TAF1A;POLR1G;CCNH;ERCC3;POLR1B;TAF1;TAF1C
prerank,regulation of phosphate metabolic process (GO:0019220),0.27630718826630696,0.6301892052226269,0.9034267912772586,0.9683598037634821,1.0,4/16,18.19%,IKBKB;SMG6;PSEN1;RAD17
prerank,positive regulation of protein depolymerization (GO:1901881),0.2954679456453968,0.6300803674301219,0.8884892086330936,0.9680419882187017,1.0,2/11,15.52%,KATNB1;STMN2
prerank,rRNA pseudouridine synthesis (GO:0031118),0.3005327147333124,0.6296591271117454,0.8890756302521008,0.9679666835498019,1.0,2/10,15.76%,NHP2;TSR3
prerank,positive regulation of interleukin-17 production (GO:0032740),0.25839230802911634,0.6274526292586626,0.909375,0.969196345702025,1.0,4/22,14.98%,IL6;TGFB1;IL18;MYD88
prerank,hexose metabolic process (GO:0019318),-0.187193136802344,-0.6268545378881534,0.9823321554770318,0.9824373507964712,1.0,6/39,13.60%,HK1;APOD;AKR1A1;GAA;CHST1;BRAT1
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),0.2874957656392978,0.6267376544017049,0.8760330578512396,0.9692907191903423,1.0,3/12,19.55%,TRIM16;EZH2;KLF2
prerank,aorta morphogenesis (GO:0035909),0.2719666200548848,0.6264923161000101,0.9129720853858785,0.9690646805338312,1.0,2/17,8.15%,RBPJ;ENG
prerank,cell cycle checkpoint signaling (GO:0000075),-0.2566041074887753,-0.6262954730857037,0.9119047619047619,0.9819076093556799,1.0,5/12,25.24%,NABP2;ZW10;BUB1B;BUB1;PLK2
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.2718357611364897,0.6258685786119845,0.9166666666666666,0.9691112209626612,1.0,2/16,7.26%,PRDX6;NUP98
prerank,methylguanosine-cap decapping (GO:0110156),0.294394014827988,0.6255702115688616,0.8964346349745331,0.9689525049085829,1.0,2/10,10.96%,DCP2;DCP1A
prerank,negative regulation of neuron differentiation (GO:0045665),-0.2120467753260108,-0.6239970978406647,0.9556213017751479,0.9824315672136222,1.0,2/22,5.15%,CNTN4;EIF2AK4
prerank,regulation of tau-protein kinase activity (GO:1902947),0.29915122305848185,0.6238844386545834,0.8900709219858156,0.9698051455396287,1.0,1/10,3.50%,SORL1
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.25212179725541095,0.6235649088094299,0.9241274658573596,0.9692645168956803,1.0,9/23,24.95%,BBC3;YWHAZ;MAPK8;BAD;BID;BCL2;YWHAQ;TP53;PPP3CC
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.25212179725541095,0.6235649088094299,0.9241274658573596,0.9692645168956803,1.0,9/23,24.95%,BBC3;YWHAZ;MAPK8;BAD;BID;BCL2;YWHAQ;TP53;PPP3CC
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),-0.22643087449210295,-0.6218666850395796,0.9408450704225352,0.9828518873775252,1.0,4/19,14.70%,ROBO1;CD63;DAB2IP;CCBE1
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),0.24132459957337,0.6215946455916851,0.9289940828402367,0.9698602075825435,1.0,3/29,11.96%,ACOT11;ACOT2;ACAT1
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),0.24132459957337,0.6215946455916851,0.9289940828402367,0.9698602075825435,1.0,3/29,11.96%,ACOT11;ACOT2;ACAT1
prerank,epidermis development (GO:0008544),0.2151694652968117,0.6207176503420715,0.962532299741602,0.9700585366176856,1.0,1/56,0.98%,GLI1
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",0.279115742795085,0.6201091769648097,0.8771929824561403,0.970118543533578,1.0,4/13,19.88%,RPS21;UTP20;TBL3;NOP9
prerank,glycine transport (GO:0015816),-0.2668466793573304,-0.6199046568477597,0.9395973154362416,0.9831039225612462,1.0,2/10,11.93%,SLC36A1;SLC7A8
prerank,membrane depolarization (GO:0051899),0.2337201607698452,0.6190995446023753,0.9452449567723343,0.9704210898129935,1.0,2/32,3.56%,CACNA1A;CHRNA4
prerank,embryonic axis specification (GO:0000578),-0.24198064511099868,-0.6187506480985275,0.9389920424403183,0.9828944841596304,1.0,6/15,41.97%,TASOR;PTCH1;STIL;FZD5;RIPPLY2;HOXD8
prerank,organic cyclic compound biosynthetic process (GO:1901362),-0.19205370010112785,-0.6185594346800584,0.9741935483870968,0.9821468302200573,1.0,19/31,55.33%,NFS1;CYP51A1;LSS;DHRS11;PYCR3;NOXRED1;STAR;HSD17B1;MOCS3;GPHN;PRLR;SRD5A1;SRD5A2;PYCR1;HSD3B2;ALOX5;HDC;HSD17B3;CYP19A1
prerank,neural tube development (GO:0021915),-0.23535057013085087,-0.6178684468661955,0.9265822784810127,0.9817032126564842,1.0,7/15,33.30%,PKD2;SOX4;SOX11;PTCH1;ALDH1A2;DACT1;STIL
prerank,nucleoside phosphate biosynthetic process (GO:1901293),-0.2454035051290247,-0.6177194526102135,0.9373368146214099,0.9809491385077759,1.0,6/14,34.24%,AK3;AK1;NMNAT2;CMPK2;AK4;NME2
prerank,negative regulation of transferase activity (GO:0051348),0.2425456792515611,0.6173313346698672,0.9405646359583952,0.9712275799817971,1.0,4/28,13.35%,DTX3L;CERS1;EIF4A2;ERCC4
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),0.27971045265563976,0.6165429344319584,0.893719806763285,0.9713694419270624,1.0,2/13,8.29%,ELOVL5;ELOVL6
prerank,male meiosis I (GO:0007141),-0.23006556519964314,-0.6158239601192069,0.9487870619946092,0.9811248633918891,1.0,9/16,51.66%,FOXJ2;ZSCAN21;DDX4;SYCP3;HSF2BP;FOXJ3;SLC25A31;TDRD9;MOV10L1
prerank,microtubule polymerization or depolymerization (GO:0031109),0.2476654482817029,0.6147991296856954,0.9292452830188679,0.9721277230378238,1.0,6/24,18.57%,KATNB1;TPPP3;KIF24;STMN3;STMN2;PIN1
prerank,regulation of telomere maintenance via telomerase (GO:0032210),0.2145235139559711,0.6139632008355551,0.9528178243774574,0.9722826979991219,1.0,15/51,21.43%,PKIB;DCP2;FBXO4;TNKS;MAP3K4;AURKB;TENT4B;MAPK1;STN1;TCP1;SMG6;TERF2;HNRNPC;PARN;CCT7
prerank,nucleobase-containing small molecule interconversion (GO:0015949),-0.2011982591233991,-0.6137448027308327,0.9623824451410659,0.9814259559323438,1.0,12/27,34.34%,AK2;AK6;RRM1;DTYMK;GLRX;DCTD;AK1;DUT;GUK1;AK4;NME2;RRM2B
prerank,negative regulation of vascular permeability (GO:0043116),-0.24980075401033394,-0.6115437578287296,0.9418886198547215,0.9817919265116419,1.0,4/12,18.27%,SH3GL2;SLIT2;VEGFA;ANGPT1
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.23063086822824888,0.6106820093472916,0.9481268011527377,0.9740215891118039,1.0,7/31,20.36%,DCP2;CNOT6;LSM5;DCP1A;CNOT8;DDX6;EDC3
prerank,glycogen metabolic process (GO:0005977),0.23978591370749222,0.6094018103674619,0.934402332361516,0.9744588152883858,1.0,8/27,21.95%,PRKAG2;PGM1;UGP2;PGM2L1;PHKA2;PYGL;PHKG1;GSK3B
prerank,peptidyl-lysine monomethylation (GO:0018026),0.2872382477790142,0.6079230684329759,0.9070175438596492,0.9749763259720743,1.0,2/10,10.79%,SETD7;SETD2
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),-0.23237668302423473,-0.6074873817637747,0.9552631578947368,0.9830702959268779,1.0,7/16,25.00%,TERF1;TNKS2;HNRNPA2B1;SLX4;TINF2;PINX1;NAF1
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),-0.22791469721584473,-0.6067835602679122,0.9451697127937336,0.9825472213573682,1.0,5/16,28.68%,ADSS2;AMPD2;ATIC;NUDT2;ADSS1
prerank,regulation of steroid biosynthetic process (GO:0050810),-0.2573282331657937,-0.6063010544262667,0.9172749391727494,0.9819424235860491,1.0,7/11,46.07%,DGKQ;WNT4;BMP5;STAR;BMP2;NR1H4;FGFR4
prerank,ubiquinone biosynthetic process (GO:0006744),0.2722518979432187,0.60614912601646,0.9024390243902439,0.9756737808210094,1.0,5/15,20.83%,COQ2;COQ8A;NDUFA9;PDSS1;COQ10A
prerank,sequestering of extracellular ligand from receptor (GO:0035581),0.27627248784041986,0.6043142838926305,0.9110738255033557,0.9763758616098517,1.0,2/13,9.63%,NRROS;FBN1
prerank,regulation of mitotic spindle organization (GO:0060236),0.22676992365019435,0.6030077359035922,0.953125,0.9767707752939443,1.0,5/35,12.17%,HSPA1A;CHMP4B;PDCD6IP;DYNC1H1;GNAI1
prerank,vitamin transport (GO:0051180),0.23305960382525814,0.6029577327814238,0.9497716894977168,0.9764121215783037,1.0,1/29,2.23%,SLC23A1
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),0.2767131363730993,0.6025995590873497,0.9143835616438356,0.9762398013330816,1.0,6/12,23.79%,HUS1;RAD17;CHEK2;SETMAR;STK33;ORC1
prerank,response to progesterone (GO:0032570),0.25767163084152356,0.6016111463507775,0.9198767334360555,0.9764319962023198,1.0,5/18,20.05%,CATSPER3;ACOD1;TGFB1;THBS1;ABHD2
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),-0.2081356706860827,-0.5988401898020818,0.9758713136729222,0.9846468176035809,1.0,7/20,30.73%,ADSS2;AK3;AMPD2;ATIC;HPRT1;ADSS1;AK4
prerank,regulation of transferase activity (GO:0051338),0.25896289445042636,0.5988060353063124,0.9249201277955271,0.9777051873261912,1.0,5/17,20.12%,PARP4;SLAMF8;SPTSSB;SMG6;FEM1B
prerank,intraciliary retrograde transport (GO:0035721),0.2774734931010309,0.598323846098844,0.9261862917398945,0.9775854783776974,1.0,2/12,15.02%,IFT140;DYNLT2B
prerank,cAMP metabolic process (GO:0046058),0.2749780693333189,0.598298048088519,0.9379194630872483,0.9772049420039565,1.0,3/13,12.62%,ADCY10;ADCY7;ADCY5
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),0.25136272297046713,0.5976839563939699,0.9379727685325264,0.9771706128882295,1.0,6/18,24.95%,IL6;RIPK1;TGFB1;MAP2K1;TNF;TP53
prerank,establishment of protein localization to mitochondrion (GO:0072655),0.21450185713294828,0.5975722206520907,0.9709944751381215,0.9768402251876286,1.0,12/46,18.80%,GRPEL2;DNAJC19;TIMM21;TOMM40;FIS1;AIFM1;AKT1;TIMM50;FBXO7;AIP;HSPD1;PINK1
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),0.24644912170058403,0.5964486169530853,0.9428571428571428,0.97708455693936,1.0,6/20,19.78%,SEMA4A;SEMA4D;SEMA3A;SEMA3C;SEMA6A;SEMA4F
prerank,long-chain fatty acid metabolic process (GO:0001676),0.2022245973380431,0.5964045904138153,0.9776674937965261,0.9767175358118207,1.0,5/64,8.29%,GPX1;ACSL5;ELOVL5;ACOT2;ELOVL6
prerank,secretion (GO:0046903),-0.23139980082375342,-0.5958891358139925,0.9420654911838791,0.9851291353659041,1.0,11/14,55.68%,SLC22A4;RIMS1;GUCA1B;PRKCI;NPR1;FBLN5;DRD3;VIP;ABCB11;SLC22A2;SLC22A6
prerank,regulation of synapse maturation (GO:0090128),-0.26113278860289074,-0.5957242457971549,0.9223529411764706,0.9843493168193977,1.0,3/10,19.15%,ADGRL1;DAB2IP;NRXN1
prerank,regulation of spindle organization (GO:0090224),-0.22138042693590598,-0.5948929382144658,0.9576719576719577,0.9838828582092773,1.0,10/18,38.76%,NUMA1;MAP9;TACC3;PARP3;TPX2;RNF4;FSD1;RAE1;BORA;NUP62
prerank,regulation of mRNA 3'-end processing (GO:0031440),0.27886067401428216,0.5944042341189806,0.918825561312608,0.9774579154215726,1.0,3/11,15.48%,ZC3H3;PAPOLA;NCBP1
prerank,pteridine-containing compound metabolic process (GO:0042558),-0.23888365257340935,-0.5923646699301602,0.9464285714285714,0.9841810013700991,1.0,5/13,30.14%,QDPR;CALM1;FPGS;HSP90AA1;SPR
prerank,regulation of stress-activated MAPK cascade (GO:0032872),-0.17117408651315946,-0.5892544780797001,0.9846153846153847,0.9846309182806834,1.0,7/47,14.55%,RAP2A;PPIA;LGALS9;NBR1;PER1;TGFB2;DAB2IP
prerank,lung development (GO:0030324),0.2235154138396179,0.588561795428542,0.9711399711399712,0.9802904105941304,1.0,5/33,16.73%,FOXJ1;ABCA3;CCDC39;ITGA3;PROX1
prerank,nuclear membrane organization (GO:0071763),0.2492314554607829,0.5881967048012346,0.9418238993710691,0.9800962779281959,1.0,3/19,12.04%,CHMP4B;SPAST;TOR1AIP1
prerank,regulation of biosynthetic process (GO:0009889),0.28081715274846475,0.587701164919778,0.9362416107382551,0.9799574107980586,1.0,2/11,14.82%,PIKFYVE;GSTP1
prerank,negative regulation of DNA recombination at telomere (GO:0048239),0.23867376533109164,0.5871243727763782,0.9480916030534351,0.9794918301333146,1.0,3/19,12.73%,POLR2C;DAXX;ATRX
prerank,regulation of DNA recombination at telomere (GO:0072695),0.23867376533109164,0.5871243727763782,0.9480916030534351,0.9794918301333146,1.0,3/19,12.73%,POLR2C;DAXX;ATRX
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",-0.218173105758881,-0.5867561671584479,0.9566326530612245,0.9849158092942526,1.0,5/17,30.15%,COX7C;COX10;COX5B;COX6A1;COX6C
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),-0.19320892707327458,-0.5841715999582175,0.9911242603550295,0.9851380222004253,1.0,6/25,19.92%,FAM162A;PYCARD;MFF;BAX;PDCD5;TNFSF10
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),-0.20081474194957363,-0.5841495691216588,0.9658385093167702,0.9843052280562413,1.0,2/22,6.15%,DDX5;RPS20
prerank,ubiquinone metabolic process (GO:0006743),0.2583748693347151,0.5830689082707023,0.9299674267100977,0.9811706454871312,1.0,5/15,20.83%,COQ2;COQ8A;AIFM2;PDSS1;COQ10A
prerank,male gonad development (GO:0008584),0.2160496025645597,0.5807275343367995,0.9741496598639455,0.9819341084875558,1.0,3/34,13.20%,ADAM21;ING2;KIT
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.19864410534421414,0.5799629299897003,0.9810366624525917,0.9819360485274816,1.0,7/63,10.48%,BTG2;WAC;CCND1;CNOT6;PIDD1;CNOT2;CASP2
prerank,ribosomal small subunit assembly (GO:0000028),-0.2199620138637563,-0.5782074054658722,0.9645776566757494,0.9858443124149847,1.0,7/16,31.97%,XRCC5;RRP7A;MRPS7;MRPS11;RPS28;RPS27L;PRKDC
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),0.24017980966967592,0.5730242541966811,0.9325657894736842,0.9848870930202018,1.0,4/18,16.16%,TIMM21;COA5;COX17;COX16
prerank,nonribosomal peptide biosynthetic process (GO:0019184),0.268057523353952,0.572238376123613,0.9481605351170569,0.9848645305694317,1.0,1/12,6.34%,GSS
prerank,isotype switching (GO:0045190),0.26502847699968646,0.572012507431239,0.9502664298401421,0.9845712601330573,1.0,4/10,23.01%,MSH6;HSPD1;RNF168;BATF
prerank,activation of adenylate cyclase activity (GO:0007190),-0.1795800422350986,-0.5719725356662182,0.99,0.987299787808289,1.0,15/35,35.15%,ADCY9;ADORA3;ADCY3;ADRB1;LGR4;ADCY8;RXFP1;ADCY1;GIPR;RAF1;TMIGD3;ADCY6;CRHR1;ADCY2;TSHR
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",-0.21878928865252623,-0.5717812159608765,0.9627659574468085,0.9865240949762304,1.0,3/14,14.11%,WDR12;PES1;FTSJ3
prerank,ribosomal small subunit biogenesis (GO:0042274),0.2065986594294058,0.5702126177908413,0.9752066115702479,0.9849838057858936,1.0,12/39,23.69%,RPS14;RIOK1;NOL11;RRP36;TSR3;RPSA;RPS6;DDX52;RPS27;RPS7;RPS25;RPS16
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),0.23133029299241817,0.5701865913141563,0.9528301886792453,0.9846022617854233,1.0,3/23,12.88%,CAMKMT;NMT2;PDE6B
prerank,positive regulation of insulin secretion (GO:0032024),-0.1737164733733397,-0.5679298936575948,0.9934426229508196,0.9870484704688364,1.0,8/36,18.06%,SOX4;NLGN2;C2CD2L;GPLD1;LRRC8A;ADCY8;CAPN10;TCF7L2
prerank,nucleotide biosynthetic process (GO:0009165),-0.2050148228462585,-0.5671735012489904,0.9717223650385605,0.9864650889409549,1.0,6/18,27.58%,PRPSAP1;RRM1;HPRT1;NMNAT2;MTHFD1;PRPSAP2
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),0.2422667812429866,0.5660333756273003,0.9543307086614173,0.9860633179680733,1.0,7/18,22.99%,DCP2;NHP2;TCP1;SHQ1;PARN;CCT7;CCT4
prerank,megakaryocyte differentiation (GO:0030219),-0.23592312282364203,-0.5660002355431457,0.9610091743119266,0.9860389700783203,1.0,1/11,4.87%,TAL1
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),0.2669093619625045,0.5622800743884886,0.9402985074626866,0.987227664715326,1.0,1/10,6.84%,SVIP
prerank,glutathione biosynthetic process (GO:0006750),0.26806150316598115,0.5608481605401917,0.9502487562189055,0.9874444398711266,1.0,1/11,6.34%,GSS
prerank,sensory perception of smell (GO:0007608),0.26172278261083687,0.5581184702521289,0.9320066334991708,0.9881570479687489,1.0,2/11,16.43%,SLC24A4;UBR3
prerank,mitotic chromosome condensation (GO:0007076),0.22662429209264678,0.5580524841765125,0.9643916913946587,0.9877939205352448,1.0,6/26,17.71%,SMC4;CSNK2A2;CSNK2A1;RB1;MCPH1;PHF13
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),0.1907016632951637,0.5576779625321273,0.9897172236503856,0.9875425737078632,1.0,16/55,22.73%,BBC3;PAK2;RPS3;CYLD;FIS1;RIPK1;DEDD2;DNM1L;TRAF2;BECN1;BAD;BCLAF1;BID;BCL2;SIAH1;TNF
prerank,protein localization to kinetochore (GO:0034501),0.2446940485477097,0.5563266306359712,0.9543973941368078,0.9876785432450067,1.0,3/14,14.73%,RCC2;MTBP;AURKB
prerank,chromatin-mediated maintenance of transcription (GO:0048096),0.26081837252848444,0.5555014374115033,0.9513888888888888,0.9876030117239657,1.0,3/11,17.80%,ELOF1;ZMIZ2;PADI2
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),-0.21579689141759045,-0.5545283449009968,0.9799498746867168,0.9889311128378373,1.0,5/14,28.68%,ADSS2;ATIC;RFK;ADK;ADSS1
prerank,modified amino acid transport (GO:0072337),-0.21188796251925066,-0.5541061538577782,0.9597989949748744,0.9881984691529143,1.0,6/15,33.94%,SLC6A8;MGST1;PDPN;SLC46A1;SLC5A6;SLC16A12
prerank,spermatid development (GO:0007286),-0.17310909766101557,-0.5540333553793008,0.9896193771626297,0.987388272108916,1.0,10/32,33.73%,CEP57;JAM2;NECTIN2;RNF8;IQCG;TDRD5;ZMYND15;NME5;MKKS;SYCP3
prerank,quinone biosynthetic process (GO:1901663),0.2517130088783427,0.5504717159626947,0.9527027027027027,0.9891365639256374,1.0,2/14,8.25%,COQ2;COQ8A
prerank,lipid modification (GO:0030258),0.20632081550676343,0.5504226492518134,0.988950276243094,0.9887615734102566,1.0,1/37,1.04%,DGKG
prerank,lipid biosynthetic process (GO:0008610),0.18325009248286503,0.5497508612472043,0.9964071856287425,0.9886172883979258,1.0,12/77,20.67%,AGPAT4;AGPS;ACSL5;PRKAA1;PIP5K1A;PRKAA2;GNPAT;MVD;MVK;ACSS2;ACSL1;PDSS1
prerank,positive regulation of mRNA processing (GO:0050685),0.22793641789636213,0.5496413149053999,0.9638364779874213,0.9882671674863033,1.0,2/21,7.26%,PRDX6;NUP98
prerank,interstrand cross-link repair (GO:0036297),0.1908867551505134,0.5477883265728342,0.9859514687100894,0.9885431793137194,1.0,12/53,20.37%,MSH6;FANCC;FANCL;RPA3;FANCI;ERCC4;FANCA;VCP;MCM9;FANCG;RNF168;XPA
prerank,regulation of ceramide biosynthetic process (GO:2000303),-0.21492533492051868,-0.5468112160114186,0.9758064516129032,0.9886255030119012,1.0,7/15,28.79%,TNFRSF1A;SPHK2;ORMDL3;RACK1;SMPD3;ORMDL1;SMPD2
prerank,cellular response to superoxide (GO:0071451),0.26165614843238183,0.5454990938900772,0.9369369369369369,0.9889426812227541,1.0,1/10,7.73%,ATP7A
prerank,response to UV-B (GO:0010224),0.2529617675300384,0.5446431462063211,0.9521452145214522,0.9888550824155716,1.0,3/12,20.64%,CRIP1;RELA;STK11
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),0.23038858373305088,0.5439903530157937,0.9674922600619195,0.9886937788852739,1.0,5/19,23.18%,POLL;DCK;POLD1;GMPR2;TYMS
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),0.2509249349232416,0.5404323339106515,0.9604810996563574,0.9895128584977952,1.0,2/12,11.32%,PTEN;UBE2S
prerank,negative regulation of protein kinase B signaling (GO:0051898),0.20041274797289976,0.5401680279645716,0.9803370786516854,0.9892059520259052,1.0,10/38,22.22%,PTEN;CIB1;PHLPP1;AKT1;PTPRJ;PPP2R5C;SIRT1;MUL1;XDH;PPP2R5B
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),0.2478522552121261,0.5400339413964006,0.9698046181172292,0.9888585245856691,1.0,3/12,14.82%,TAF7;TGFB1;GSTP1
prerank,regulation of DNA damage checkpoint (GO:2000001),0.2602601758284969,0.5387204132968112,0.9457092819614711,0.9889168794665513,1.0,1/10,4.15%,CRY1
prerank,neural crest cell development (GO:0014032),0.19092560083131047,0.5313993175566809,0.9876373626373627,0.9908131621708001,1.0,10/44,19.86%,SEMA4A;GDNF;TAPT1;KLHL12;SEMA4D;SEMA3A;SEMA3C;SEMA6A;SEMA4F;ANXA6
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.20284506455182058,0.5299765330621391,0.9750367107195301,0.9908554338722942,1.0,11/31,25.90%,BBC3;YWHAZ;MAPK8;BAD;BID;GSK3B;BCL2;YWHAQ;TP53;PPP3CC;BAK1
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),0.20465621752750257,0.5294179633542571,0.9814020028612304,0.9906256955960857,1.0,3/29,9.10%,MRE11;NHP2;WRAP53
prerank,regulation of transposition (GO:0010528),0.23775179123803583,0.5276058965786806,0.9737274220032841,0.9907751909598052,1.0,1/13,7.92%,UBR2
prerank,positive regulation of transporter activity (GO:0032411),-0.21025548252224324,-0.52712983271768,0.9802955665024631,0.9926932884153838,1.0,7/13,42.40%,SGK1;WNK3;NR1H3;SGK2;KCTD7;TRPC6;PDZK1
prerank,homologous chromosome segregation (GO:0045143),-0.18663152283778162,-0.5248181241761747,0.988795518207283,0.992396483163101,1.0,5/20,26.53%,FMN2;ZCWPW1;FANCD2;MEI4;TERB1
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.23194064321689145,0.5233007734584928,0.966832504145937,0.9915795369382063,1.0,3/14,19.33%,ACOX3;ABCD1;CRAT
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),-0.22246097866148995,-0.5231065216377325,0.973621103117506,0.9918927622227612,1.0,7/10,42.25%,CPEB1;CPEB3;LEO1;CDC73;NCBP2;HSF1;PAF1
prerank,glycoprotein catabolic process (GO:0006516),0.219466248037677,0.5225620584202234,0.9678456591639871,0.9913892630367696,1.0,17/17,78.08%,ADAMTS12;STT3B;NGLY1;EDEM2;MANBA;EDEM1;NEU2;OGA;FBXO27;MMP12;NEU4;CTSL;ADAMTS9;FBXO2;FBXO6;FBXO17;FBXO44
prerank,lysine metabolic process (GO:0006553),0.23646012359577115,0.5209044347184781,0.9663865546218487,0.9910798557629279,1.0,2/12,12.50%,DLD;OGDH
prerank,lysine catabolic process (GO:0006554),0.23646012359577115,0.5209044347184781,0.9663865546218487,0.9910798557629279,1.0,2/12,12.50%,DLD;OGDH
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),0.24106131966915276,0.5196211906429286,0.9597423510466989,0.9910364064591274,1.0,1/13,3.64%,GLRX5
prerank,telomere maintenance via telomere lengthening (GO:0010833),0.19484073164702706,0.5159602042500645,0.9888579387186629,0.9915733059910954,1.0,8/33,21.06%,MRE11;NHP2;WRAP53;STN1;SHQ1;TNKS1BP1;TERF2;TELO2
prerank,cellular biogenic amine metabolic process (GO:0006576),-0.20729656905646543,-0.5146501971539528,0.9739336492890995,0.9927126558925099,1.0,4/12,23.33%,HNMT;ODC1;DDC;MAOA
prerank,respiratory tube development (GO:0030323),0.20152817476786428,0.5108671294720285,0.9820089955022488,0.9924300612018915,1.0,5/28,16.73%,ABCA3;CCDC39;PCSK5;ITGA3;PROX1
prerank,regulation of ERAD pathway (GO:1904292),-0.20970494850496796,-0.5065358183553227,0.9906103286384976,0.9934101659072151,1.0,2/11,15.14%,USP19;HERPUD1
prerank,negative regulation of telomere maintenance (GO:0032205),0.22151570310725177,0.5063356822814145,0.9701492537313433,0.9930864888912242,1.0,5/15,21.66%,TNKS;ERCC4;SMG6;TERF2;PARP1
prerank,organic hydroxy compound biosynthetic process (GO:1901617),0.1851131398475501,0.5026650593925731,0.9919137466307277,0.9935174875557374,1.0,3/44,9.55%,PRKAG2;CYP27A1;MSMO1
prerank,steroid biosynthetic process (GO:0006694),0.17391087775374192,0.5016032645931876,0.9962640099626401,0.9933422470471996,1.0,3/56,9.55%,PRKAG2;CYP27A1;MSMO1
prerank,non-motile cilium assembly (GO:1905515),0.1896105648367224,0.4940714819451342,0.9955686853766618,0.9944649401872608,1.0,4/30,17.43%,TBC1D32;CEP250;DISC1;BBS10
prerank,gas transport (GO:0015669),-0.21146382191160648,-0.49306551030478785,0.9839449541284404,0.9947203689130352,1.0,2/10,26.35%,CA2;MYC
prerank,'de novo' posttranslational protein folding (GO:0051084),0.1927163822673927,0.49295133078388076,0.9955882352941177,0.9942863512921027,1.0,8/30,22.64%,HSPA1A;DNAJB12;HSPA9;HSPA5;DNAJB14;DNAJB4;SDF2;HSPA8
prerank,positive regulation of extracellular matrix organization (GO:1903055),0.20498106706026387,0.4825243539640439,0.9826224328593997,0.9957642945864797,1.0,5/18,20.23%,IL6;CLASP1;TGFB1;RB1;RUNX1
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),0.2046725771019129,0.48079378825821756,0.9817351598173516,0.9956662570736461,1.0,7/18,26.72%,HDAC3;FRS2;HDAC1;FZD7;HDAC5;BDNF;XBP1
prerank,regulation of cilium movement (GO:0003352),0.22495606326889278,0.47693497668897994,0.9836363636363636,0.9958992379114197,1.0,10/10,77.52%,CCDC39;CFAP43;CCDC65;DNAAF1;DRC1;CFAP206;CCDC40;ODAD2;CFAP298;DNAH11
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),0.21831286347857765,0.47622331085108704,0.9743150684931506,0.9956142433802766,1.0,3/12,16.65%,ADSL;GMPS;LHPP
prerank,mitochondrial outer membrane permeabilization (GO:0097345),0.2119498695849935,0.47168520663233576,0.9758620689655172,0.9959061269601701,1.0,4/13,21.93%,VDAC2;BAD;BNIP3L;RHOT1
prerank,purine ribonucleotide catabolic process (GO:0009154),0.1966726331203133,0.47045114621002565,0.9908396946564886,0.9956862201333218,1.0,3/21,14.73%,PDE2A;ACAT1;NT5C2
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),-0.19197061641076277,-0.45453037876665664,0.995260663507109,0.9981576571672796,1.0,1/10,9.25%,DGKQ
prerank,negative regulation of myoblast differentiation (GO:0045662),0.20679264235042993,0.45002172290021863,0.9895287958115183,0.9978485735913704,1.0,13/13,79.34%,TGFB1;TBX3;SOSTDC1;MSTN;SOX9;NOTCH1;ANKRD2;DLL1;SOX8;PRICKLE1;BMP4;EID2B;SRA1
prerank,retinol metabolic process (GO:0042572),-0.17437780906201356,-0.44368580525064183,0.9925187032418953,0.9981424997873087,1.0,6/14,46.07%,DHRS3;RDH11;RETSAT;CYP1A1;CYP1B1;RDH12
prerank,mesonephros development (GO:0001823),0.21059569393007374,0.4431433885241227,0.9800332778702163,0.9981559332183285,1.0,11/11,78.95%,ZBTB16;FGF1;GATA3;PAX8;OSR2;FGF8;PAX2;BMP7;BMP4;OSR1;FGF10
prerank,negative regulation of epithelial cell differentiation (GO:0030857),0.19600379333261048,0.44199792672397425,0.9851485148514851,0.9978682864485734,1.0,3/14,20.69%,SPRED3;SPRED1;XDH
prerank,axonal transport of mitochondrion (GO:0019896),0.2119030942341661,0.4403360129558127,0.9862778730703259,0.9976258515924427,1.0,3/11,21.44%,SPAST;TRAK1;TRAK2
prerank,heterocycle biosynthetic process (GO:0018130),-0.16913611250627827,-0.4392528873250218,0.9975,0.9976093154319325,1.0,14/14,83.11%,NFS1;PYCR3;NOXRED1;MOCS3;GPHN;PYCR1;ALOX5;HDC;MOCOS;LIAS;GCH1;MOCS2;MOCS1;PYCR2
prerank,cellular response to steroid hormone stimulus (GO:0071383),0.17977011130693682,0.4272210462795283,0.9953846153846154,0.9983256516605564,1.0,4/17,20.05%,NR3C1;ACOD1;MED1;ABHD2
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),0.19238291407087227,0.40669416541523035,0.9964973730297724,0.9992140173414843,1.0,2/10,15.62%,ATRX;INO80
prerank,mesenchymal cell development (GO:0014031),0.16729464958553117,0.3967998456088479,0.9983552631578947,0.9993033188781313,1.0,18/18,83.29%,TAPT1;KLHL12;FOXC1;TBX20;NOTCH1;NRG1;PEF1;SNAI2;HEYL;CYP26C1;SOX8;PDCD6;HEY2;NOLC1;CDH2;KBTBD8;TCOF1;SOX11
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),0.18642260964976146,0.3955452827467669,0.9934959349593496,0.9989635105522475,1.0,3/12,20.69%,ADAMTS12;SEMA6A;XDH
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.142680349288116,0.3609336935994953,0.9985163204747775,0.9995409351530261,1.0,4/29,20.53%,IHO1;STAG3;RAD21;PRDM9
